<!DOCTYPE html>
<html>
<head><meta charset="utf-8" />

<title>n-grams</title>

<script src="https://cdnjs.cloudflare.com/ajax/libs/require.js/2.1.10/require.min.js"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/2.0.3/jquery.min.js"></script>



<style type="text/css">
    /*!
*
* Twitter Bootstrap
*
*/
/*!
 * Bootstrap v3.3.7 (http://getbootstrap.com)
 * Copyright 2011-2016 Twitter, Inc.
 * Licensed under MIT (https://github.com/twbs/bootstrap/blob/master/LICENSE)
 */
/*! normalize.css v3.0.3 | MIT License | github.com/necolas/normalize.css */
html {
  font-family: sans-serif;
  -ms-text-size-adjust: 100%;
  -webkit-text-size-adjust: 100%;
}
body {
  margin: 0;
}
article,
aside,
details,
figcaption,
figure,
footer,
header,
hgroup,
main,
menu,
nav,
section,
summary {
  display: block;
}
audio,
canvas,
progress,
video {
  display: inline-block;
  vertical-align: baseline;
}
audio:not([controls]) {
  display: none;
  height: 0;
}
[hidden],
template {
  display: none;
}
a {
  background-color: transparent;
}
a:active,
a:hover {
  outline: 0;
}
abbr[title] {
  border-bottom: 1px dotted;
}
b,
strong {
  font-weight: bold;
}
dfn {
  font-style: italic;
}
h1 {
  font-size: 2em;
  margin: 0.67em 0;
}
mark {
  background: #ff0;
  color: #000;
}
small {
  font-size: 80%;
}
sub,
sup {
  font-size: 75%;
  line-height: 0;
  position: relative;
  vertical-align: baseline;
}
sup {
  top: -0.5em;
}
sub {
  bottom: -0.25em;
}
img {
  border: 0;
}
svg:not(:root) {
  overflow: hidden;
}
figure {
  margin: 1em 40px;
}
hr {
  box-sizing: content-box;
  height: 0;
}
pre {
  overflow: auto;
}
code,
kbd,
pre,
samp {
  font-family: monospace, monospace;
  font-size: 1em;
}
button,
input,
optgroup,
select,
textarea {
  color: inherit;
  font: inherit;
  margin: 0;
}
button {
  overflow: visible;
}
button,
select {
  text-transform: none;
}
button,
html input[type="button"],
input[type="reset"],
input[type="submit"] {
  -webkit-appearance: button;
  cursor: pointer;
}
button[disabled],
html input[disabled] {
  cursor: default;
}
button::-moz-focus-inner,
input::-moz-focus-inner {
  border: 0;
  padding: 0;
}
input {
  line-height: normal;
}
input[type="checkbox"],
input[type="radio"] {
  box-sizing: border-box;
  padding: 0;
}
input[type="number"]::-webkit-inner-spin-button,
input[type="number"]::-webkit-outer-spin-button {
  height: auto;
}
input[type="search"] {
  -webkit-appearance: textfield;
  box-sizing: content-box;
}
input[type="search"]::-webkit-search-cancel-button,
input[type="search"]::-webkit-search-decoration {
  -webkit-appearance: none;
}
fieldset {
  border: 1px solid #c0c0c0;
  margin: 0 2px;
  padding: 0.35em 0.625em 0.75em;
}
legend {
  border: 0;
  padding: 0;
}
textarea {
  overflow: auto;
}
optgroup {
  font-weight: bold;
}
table {
  border-collapse: collapse;
  border-spacing: 0;
}
td,
th {
  padding: 0;
}
/*! Source: https://github.com/h5bp/html5-boilerplate/blob/master/src/css/main.css */
@media print {
  *,
  *:before,
  *:after {
    background: transparent !important;
    box-shadow: none !important;
    text-shadow: none !important;
  }
  a,
  a:visited {
    text-decoration: underline;
  }
  a[href]:after {
    content: " (" attr(href) ")";
  }
  abbr[title]:after {
    content: " (" attr(title) ")";
  }
  a[href^="#"]:after,
  a[href^="javascript:"]:after {
    content: "";
  }
  pre,
  blockquote {
    border: 1px solid #999;
    page-break-inside: avoid;
  }
  thead {
    display: table-header-group;
  }
  tr,
  img {
    page-break-inside: avoid;
  }
  img {
    max-width: 100% !important;
  }
  p,
  h2,
  h3 {
    orphans: 3;
    widows: 3;
  }
  h2,
  h3 {
    page-break-after: avoid;
  }
  .navbar {
    display: none;
  }
  .btn > .caret,
  .dropup > .btn > .caret {
    border-top-color: #000 !important;
  }
  .label {
    border: 1px solid #000;
  }
  .table {
    border-collapse: collapse !important;
  }
  .table td,
  .table th {
    background-color: #fff !important;
  }
  .table-bordered th,
  .table-bordered td {
    border: 1px solid #ddd !important;
  }
}
@font-face {
  font-family: 'Glyphicons Halflings';
  src: url('../components/bootstrap/fonts/glyphicons-halflings-regular.eot');
  src: url('../components/bootstrap/fonts/glyphicons-halflings-regular.eot?#iefix') format('embedded-opentype'), url('../components/bootstrap/fonts/glyphicons-halflings-regular.woff2') format('woff2'), url('../components/bootstrap/fonts/glyphicons-halflings-regular.woff') format('woff'), url('../components/bootstrap/fonts/glyphicons-halflings-regular.ttf') format('truetype'), url('../components/bootstrap/fonts/glyphicons-halflings-regular.svg#glyphicons_halflingsregular') format('svg');
}
.glyphicon {
  position: relative;
  top: 1px;
  display: inline-block;
  font-family: 'Glyphicons Halflings';
  font-style: normal;
  font-weight: normal;
  line-height: 1;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
}
.glyphicon-asterisk:before {
  content: "\002a";
}
.glyphicon-plus:before {
  content: "\002b";
}
.glyphicon-euro:before,
.glyphicon-eur:before {
  content: "\20ac";
}
.glyphicon-minus:before {
  content: "\2212";
}
.glyphicon-cloud:before {
  content: "\2601";
}
.glyphicon-envelope:before {
  content: "\2709";
}
.glyphicon-pencil:before {
  content: "\270f";
}
.glyphicon-glass:before {
  content: "\e001";
}
.glyphicon-music:before {
  content: "\e002";
}
.glyphicon-search:before {
  content: "\e003";
}
.glyphicon-heart:before {
  content: "\e005";
}
.glyphicon-star:before {
  content: "\e006";
}
.glyphicon-star-empty:before {
  content: "\e007";
}
.glyphicon-user:before {
  content: "\e008";
}
.glyphicon-film:before {
  content: "\e009";
}
.glyphicon-th-large:before {
  content: "\e010";
}
.glyphicon-th:before {
  content: "\e011";
}
.glyphicon-th-list:before {
  content: "\e012";
}
.glyphicon-ok:before {
  content: "\e013";
}
.glyphicon-remove:before {
  content: "\e014";
}
.glyphicon-zoom-in:before {
  content: "\e015";
}
.glyphicon-zoom-out:before {
  content: "\e016";
}
.glyphicon-off:before {
  content: "\e017";
}
.glyphicon-signal:before {
  content: "\e018";
}
.glyphicon-cog:before {
  content: "\e019";
}
.glyphicon-trash:before {
  content: "\e020";
}
.glyphicon-home:before {
  content: "\e021";
}
.glyphicon-file:before {
  content: "\e022";
}
.glyphicon-time:before {
  content: "\e023";
}
.glyphicon-road:before {
  content: "\e024";
}
.glyphicon-download-alt:before {
  content: "\e025";
}
.glyphicon-download:before {
  content: "\e026";
}
.glyphicon-upload:before {
  content: "\e027";
}
.glyphicon-inbox:before {
  content: "\e028";
}
.glyphicon-play-circle:before {
  content: "\e029";
}
.glyphicon-repeat:before {
  content: "\e030";
}
.glyphicon-refresh:before {
  content: "\e031";
}
.glyphicon-list-alt:before {
  content: "\e032";
}
.glyphicon-lock:before {
  content: "\e033";
}
.glyphicon-flag:before {
  content: "\e034";
}
.glyphicon-headphones:before {
  content: "\e035";
}
.glyphicon-volume-off:before {
  content: "\e036";
}
.glyphicon-volume-down:before {
  content: "\e037";
}
.glyphicon-volume-up:before {
  content: "\e038";
}
.glyphicon-qrcode:before {
  content: "\e039";
}
.glyphicon-barcode:before {
  content: "\e040";
}
.glyphicon-tag:before {
  content: "\e041";
}
.glyphicon-tags:before {
  content: "\e042";
}
.glyphicon-book:before {
  content: "\e043";
}
.glyphicon-bookmark:before {
  content: "\e044";
}
.glyphicon-print:before {
  content: "\e045";
}
.glyphicon-camera:before {
  content: "\e046";
}
.glyphicon-font:before {
  content: "\e047";
}
.glyphicon-bold:before {
  content: "\e048";
}
.glyphicon-italic:before {
  content: "\e049";
}
.glyphicon-text-height:before {
  content: "\e050";
}
.glyphicon-text-width:before {
  content: "\e051";
}
.glyphicon-align-left:before {
  content: "\e052";
}
.glyphicon-align-center:before {
  content: "\e053";
}
.glyphicon-align-right:before {
  content: "\e054";
}
.glyphicon-align-justify:before {
  content: "\e055";
}
.glyphicon-list:before {
  content: "\e056";
}
.glyphicon-indent-left:before {
  content: "\e057";
}
.glyphicon-indent-right:before {
  content: "\e058";
}
.glyphicon-facetime-video:before {
  content: "\e059";
}
.glyphicon-picture:before {
  content: "\e060";
}
.glyphicon-map-marker:before {
  content: "\e062";
}
.glyphicon-adjust:before {
  content: "\e063";
}
.glyphicon-tint:before {
  content: "\e064";
}
.glyphicon-edit:before {
  content: "\e065";
}
.glyphicon-share:before {
  content: "\e066";
}
.glyphicon-check:before {
  content: "\e067";
}
.glyphicon-move:before {
  content: "\e068";
}
.glyphicon-step-backward:before {
  content: "\e069";
}
.glyphicon-fast-backward:before {
  content: "\e070";
}
.glyphicon-backward:before {
  content: "\e071";
}
.glyphicon-play:before {
  content: "\e072";
}
.glyphicon-pause:before {
  content: "\e073";
}
.glyphicon-stop:before {
  content: "\e074";
}
.glyphicon-forward:before {
  content: "\e075";
}
.glyphicon-fast-forward:before {
  content: "\e076";
}
.glyphicon-step-forward:before {
  content: "\e077";
}
.glyphicon-eject:before {
  content: "\e078";
}
.glyphicon-chevron-left:before {
  content: "\e079";
}
.glyphicon-chevron-right:before {
  content: "\e080";
}
.glyphicon-plus-sign:before {
  content: "\e081";
}
.glyphicon-minus-sign:before {
  content: "\e082";
}
.glyphicon-remove-sign:before {
  content: "\e083";
}
.glyphicon-ok-sign:before {
  content: "\e084";
}
.glyphicon-question-sign:before {
  content: "\e085";
}
.glyphicon-info-sign:before {
  content: "\e086";
}
.glyphicon-screenshot:before {
  content: "\e087";
}
.glyphicon-remove-circle:before {
  content: "\e088";
}
.glyphicon-ok-circle:before {
  content: "\e089";
}
.glyphicon-ban-circle:before {
  content: "\e090";
}
.glyphicon-arrow-left:before {
  content: "\e091";
}
.glyphicon-arrow-right:before {
  content: "\e092";
}
.glyphicon-arrow-up:before {
  content: "\e093";
}
.glyphicon-arrow-down:before {
  content: "\e094";
}
.glyphicon-share-alt:before {
  content: "\e095";
}
.glyphicon-resize-full:before {
  content: "\e096";
}
.glyphicon-resize-small:before {
  content: "\e097";
}
.glyphicon-exclamation-sign:before {
  content: "\e101";
}
.glyphicon-gift:before {
  content: "\e102";
}
.glyphicon-leaf:before {
  content: "\e103";
}
.glyphicon-fire:before {
  content: "\e104";
}
.glyphicon-eye-open:before {
  content: "\e105";
}
.glyphicon-eye-close:before {
  content: "\e106";
}
.glyphicon-warning-sign:before {
  content: "\e107";
}
.glyphicon-plane:before {
  content: "\e108";
}
.glyphicon-calendar:before {
  content: "\e109";
}
.glyphicon-random:before {
  content: "\e110";
}
.glyphicon-comment:before {
  content: "\e111";
}
.glyphicon-magnet:before {
  content: "\e112";
}
.glyphicon-chevron-up:before {
  content: "\e113";
}
.glyphicon-chevron-down:before {
  content: "\e114";
}
.glyphicon-retweet:before {
  content: "\e115";
}
.glyphicon-shopping-cart:before {
  content: "\e116";
}
.glyphicon-folder-close:before {
  content: "\e117";
}
.glyphicon-folder-open:before {
  content: "\e118";
}
.glyphicon-resize-vertical:before {
  content: "\e119";
}
.glyphicon-resize-horizontal:before {
  content: "\e120";
}
.glyphicon-hdd:before {
  content: "\e121";
}
.glyphicon-bullhorn:before {
  content: "\e122";
}
.glyphicon-bell:before {
  content: "\e123";
}
.glyphicon-certificate:before {
  content: "\e124";
}
.glyphicon-thumbs-up:before {
  content: "\e125";
}
.glyphicon-thumbs-down:before {
  content: "\e126";
}
.glyphicon-hand-right:before {
  content: "\e127";
}
.glyphicon-hand-left:before {
  content: "\e128";
}
.glyphicon-hand-up:before {
  content: "\e129";
}
.glyphicon-hand-down:before {
  content: "\e130";
}
.glyphicon-circle-arrow-right:before {
  content: "\e131";
}
.glyphicon-circle-arrow-left:before {
  content: "\e132";
}
.glyphicon-circle-arrow-up:before {
  content: "\e133";
}
.glyphicon-circle-arrow-down:before {
  content: "\e134";
}
.glyphicon-globe:before {
  content: "\e135";
}
.glyphicon-wrench:before {
  content: "\e136";
}
.glyphicon-tasks:before {
  content: "\e137";
}
.glyphicon-filter:before {
  content: "\e138";
}
.glyphicon-briefcase:before {
  content: "\e139";
}
.glyphicon-fullscreen:before {
  content: "\e140";
}
.glyphicon-dashboard:before {
  content: "\e141";
}
.glyphicon-paperclip:before {
  content: "\e142";
}
.glyphicon-heart-empty:before {
  content: "\e143";
}
.glyphicon-link:before {
  content: "\e144";
}
.glyphicon-phone:before {
  content: "\e145";
}
.glyphicon-pushpin:before {
  content: "\e146";
}
.glyphicon-usd:before {
  content: "\e148";
}
.glyphicon-gbp:before {
  content: "\e149";
}
.glyphicon-sort:before {
  content: "\e150";
}
.glyphicon-sort-by-alphabet:before {
  content: "\e151";
}
.glyphicon-sort-by-alphabet-alt:before {
  content: "\e152";
}
.glyphicon-sort-by-order:before {
  content: "\e153";
}
.glyphicon-sort-by-order-alt:before {
  content: "\e154";
}
.glyphicon-sort-by-attributes:before {
  content: "\e155";
}
.glyphicon-sort-by-attributes-alt:before {
  content: "\e156";
}
.glyphicon-unchecked:before {
  content: "\e157";
}
.glyphicon-expand:before {
  content: "\e158";
}
.glyphicon-collapse-down:before {
  content: "\e159";
}
.glyphicon-collapse-up:before {
  content: "\e160";
}
.glyphicon-log-in:before {
  content: "\e161";
}
.glyphicon-flash:before {
  content: "\e162";
}
.glyphicon-log-out:before {
  content: "\e163";
}
.glyphicon-new-window:before {
  content: "\e164";
}
.glyphicon-record:before {
  content: "\e165";
}
.glyphicon-save:before {
  content: "\e166";
}
.glyphicon-open:before {
  content: "\e167";
}
.glyphicon-saved:before {
  content: "\e168";
}
.glyphicon-import:before {
  content: "\e169";
}
.glyphicon-export:before {
  content: "\e170";
}
.glyphicon-send:before {
  content: "\e171";
}
.glyphicon-floppy-disk:before {
  content: "\e172";
}
.glyphicon-floppy-saved:before {
  content: "\e173";
}
.glyphicon-floppy-remove:before {
  content: "\e174";
}
.glyphicon-floppy-save:before {
  content: "\e175";
}
.glyphicon-floppy-open:before {
  content: "\e176";
}
.glyphicon-credit-card:before {
  content: "\e177";
}
.glyphicon-transfer:before {
  content: "\e178";
}
.glyphicon-cutlery:before {
  content: "\e179";
}
.glyphicon-header:before {
  content: "\e180";
}
.glyphicon-compressed:before {
  content: "\e181";
}
.glyphicon-earphone:before {
  content: "\e182";
}
.glyphicon-phone-alt:before {
  content: "\e183";
}
.glyphicon-tower:before {
  content: "\e184";
}
.glyphicon-stats:before {
  content: "\e185";
}
.glyphicon-sd-video:before {
  content: "\e186";
}
.glyphicon-hd-video:before {
  content: "\e187";
}
.glyphicon-subtitles:before {
  content: "\e188";
}
.glyphicon-sound-stereo:before {
  content: "\e189";
}
.glyphicon-sound-dolby:before {
  content: "\e190";
}
.glyphicon-sound-5-1:before {
  content: "\e191";
}
.glyphicon-sound-6-1:before {
  content: "\e192";
}
.glyphicon-sound-7-1:before {
  content: "\e193";
}
.glyphicon-copyright-mark:before {
  content: "\e194";
}
.glyphicon-registration-mark:before {
  content: "\e195";
}
.glyphicon-cloud-download:before {
  content: "\e197";
}
.glyphicon-cloud-upload:before {
  content: "\e198";
}
.glyphicon-tree-conifer:before {
  content: "\e199";
}
.glyphicon-tree-deciduous:before {
  content: "\e200";
}
.glyphicon-cd:before {
  content: "\e201";
}
.glyphicon-save-file:before {
  content: "\e202";
}
.glyphicon-open-file:before {
  content: "\e203";
}
.glyphicon-level-up:before {
  content: "\e204";
}
.glyphicon-copy:before {
  content: "\e205";
}
.glyphicon-paste:before {
  content: "\e206";
}
.glyphicon-alert:before {
  content: "\e209";
}
.glyphicon-equalizer:before {
  content: "\e210";
}
.glyphicon-king:before {
  content: "\e211";
}
.glyphicon-queen:before {
  content: "\e212";
}
.glyphicon-pawn:before {
  content: "\e213";
}
.glyphicon-bishop:before {
  content: "\e214";
}
.glyphicon-knight:before {
  content: "\e215";
}
.glyphicon-baby-formula:before {
  content: "\e216";
}
.glyphicon-tent:before {
  content: "\26fa";
}
.glyphicon-blackboard:before {
  content: "\e218";
}
.glyphicon-bed:before {
  content: "\e219";
}
.glyphicon-apple:before {
  content: "\f8ff";
}
.glyphicon-erase:before {
  content: "\e221";
}
.glyphicon-hourglass:before {
  content: "\231b";
}
.glyphicon-lamp:before {
  content: "\e223";
}
.glyphicon-duplicate:before {
  content: "\e224";
}
.glyphicon-piggy-bank:before {
  content: "\e225";
}
.glyphicon-scissors:before {
  content: "\e226";
}
.glyphicon-bitcoin:before {
  content: "\e227";
}
.glyphicon-btc:before {
  content: "\e227";
}
.glyphicon-xbt:before {
  content: "\e227";
}
.glyphicon-yen:before {
  content: "\00a5";
}
.glyphicon-jpy:before {
  content: "\00a5";
}
.glyphicon-ruble:before {
  content: "\20bd";
}
.glyphicon-rub:before {
  content: "\20bd";
}
.glyphicon-scale:before {
  content: "\e230";
}
.glyphicon-ice-lolly:before {
  content: "\e231";
}
.glyphicon-ice-lolly-tasted:before {
  content: "\e232";
}
.glyphicon-education:before {
  content: "\e233";
}
.glyphicon-option-horizontal:before {
  content: "\e234";
}
.glyphicon-option-vertical:before {
  content: "\e235";
}
.glyphicon-menu-hamburger:before {
  content: "\e236";
}
.glyphicon-modal-window:before {
  content: "\e237";
}
.glyphicon-oil:before {
  content: "\e238";
}
.glyphicon-grain:before {
  content: "\e239";
}
.glyphicon-sunglasses:before {
  content: "\e240";
}
.glyphicon-text-size:before {
  content: "\e241";
}
.glyphicon-text-color:before {
  content: "\e242";
}
.glyphicon-text-background:before {
  content: "\e243";
}
.glyphicon-object-align-top:before {
  content: "\e244";
}
.glyphicon-object-align-bottom:before {
  content: "\e245";
}
.glyphicon-object-align-horizontal:before {
  content: "\e246";
}
.glyphicon-object-align-left:before {
  content: "\e247";
}
.glyphicon-object-align-vertical:before {
  content: "\e248";
}
.glyphicon-object-align-right:before {
  content: "\e249";
}
.glyphicon-triangle-right:before {
  content: "\e250";
}
.glyphicon-triangle-left:before {
  content: "\e251";
}
.glyphicon-triangle-bottom:before {
  content: "\e252";
}
.glyphicon-triangle-top:before {
  content: "\e253";
}
.glyphicon-console:before {
  content: "\e254";
}
.glyphicon-superscript:before {
  content: "\e255";
}
.glyphicon-subscript:before {
  content: "\e256";
}
.glyphicon-menu-left:before {
  content: "\e257";
}
.glyphicon-menu-right:before {
  content: "\e258";
}
.glyphicon-menu-down:before {
  content: "\e259";
}
.glyphicon-menu-up:before {
  content: "\e260";
}
* {
  -webkit-box-sizing: border-box;
  -moz-box-sizing: border-box;
  box-sizing: border-box;
}
*:before,
*:after {
  -webkit-box-sizing: border-box;
  -moz-box-sizing: border-box;
  box-sizing: border-box;
}
html {
  font-size: 10px;
  -webkit-tap-highlight-color: rgba(0, 0, 0, 0);
}
body {
  font-family: "Helvetica Neue", Helvetica, Arial, sans-serif;
  font-size: 13px;
  line-height: 1.42857143;
  color: #000;
  background-color: #fff;
}
input,
button,
select,
textarea {
  font-family: inherit;
  font-size: inherit;
  line-height: inherit;
}
a {
  color: #337ab7;
  text-decoration: none;
}
a:hover,
a:focus {
  color: #23527c;
  text-decoration: underline;
}
a:focus {
  outline: 5px auto -webkit-focus-ring-color;
  outline-offset: -2px;
}
figure {
  margin: 0;
}
img {
  vertical-align: middle;
}
.img-responsive,
.thumbnail > img,
.thumbnail a > img,
.carousel-inner > .item > img,
.carousel-inner > .item > a > img {
  display: block;
  max-width: 100%;
  height: auto;
}
.img-rounded {
  border-radius: 3px;
}
.img-thumbnail {
  padding: 4px;
  line-height: 1.42857143;
  background-color: #fff;
  border: 1px solid #ddd;
  border-radius: 2px;
  -webkit-transition: all 0.2s ease-in-out;
  -o-transition: all 0.2s ease-in-out;
  transition: all 0.2s ease-in-out;
  display: inline-block;
  max-width: 100%;
  height: auto;
}
.img-circle {
  border-radius: 50%;
}
hr {
  margin-top: 18px;
  margin-bottom: 18px;
  border: 0;
  border-top: 1px solid #eeeeee;
}
.sr-only {
  position: absolute;
  width: 1px;
  height: 1px;
  margin: -1px;
  padding: 0;
  overflow: hidden;
  clip: rect(0, 0, 0, 0);
  border: 0;
}
.sr-only-focusable:active,
.sr-only-focusable:focus {
  position: static;
  width: auto;
  height: auto;
  margin: 0;
  overflow: visible;
  clip: auto;
}
[role="button"] {
  cursor: pointer;
}
h1,
h2,
h3,
h4,
h5,
h6,
.h1,
.h2,
.h3,
.h4,
.h5,
.h6 {
  font-family: inherit;
  font-weight: 500;
  line-height: 1.1;
  color: inherit;
}
h1 small,
h2 small,
h3 small,
h4 small,
h5 small,
h6 small,
.h1 small,
.h2 small,
.h3 small,
.h4 small,
.h5 small,
.h6 small,
h1 .small,
h2 .small,
h3 .small,
h4 .small,
h5 .small,
h6 .small,
.h1 .small,
.h2 .small,
.h3 .small,
.h4 .small,
.h5 .small,
.h6 .small {
  font-weight: normal;
  line-height: 1;
  color: #777777;
}
h1,
.h1,
h2,
.h2,
h3,
.h3 {
  margin-top: 18px;
  margin-bottom: 9px;
}
h1 small,
.h1 small,
h2 small,
.h2 small,
h3 small,
.h3 small,
h1 .small,
.h1 .small,
h2 .small,
.h2 .small,
h3 .small,
.h3 .small {
  font-size: 65%;
}
h4,
.h4,
h5,
.h5,
h6,
.h6 {
  margin-top: 9px;
  margin-bottom: 9px;
}
h4 small,
.h4 small,
h5 small,
.h5 small,
h6 small,
.h6 small,
h4 .small,
.h4 .small,
h5 .small,
.h5 .small,
h6 .small,
.h6 .small {
  font-size: 75%;
}
h1,
.h1 {
  font-size: 33px;
}
h2,
.h2 {
  font-size: 27px;
}
h3,
.h3 {
  font-size: 23px;
}
h4,
.h4 {
  font-size: 17px;
}
h5,
.h5 {
  font-size: 13px;
}
h6,
.h6 {
  font-size: 12px;
}
p {
  margin: 0 0 9px;
}
.lead {
  margin-bottom: 18px;
  font-size: 14px;
  font-weight: 300;
  line-height: 1.4;
}
@media (min-width: 768px) {
  .lead {
    font-size: 19.5px;
  }
}
small,
.small {
  font-size: 92%;
}
mark,
.mark {
  background-color: #fcf8e3;
  padding: .2em;
}
.text-left {
  text-align: left;
}
.text-right {
  text-align: right;
}
.text-center {
  text-align: center;
}
.text-justify {
  text-align: justify;
}
.text-nowrap {
  white-space: nowrap;
}
.text-lowercase {
  text-transform: lowercase;
}
.text-uppercase {
  text-transform: uppercase;
}
.text-capitalize {
  text-transform: capitalize;
}
.text-muted {
  color: #777777;
}
.text-primary {
  color: #337ab7;
}
a.text-primary:hover,
a.text-primary:focus {
  color: #286090;
}
.text-success {
  color: #3c763d;
}
a.text-success:hover,
a.text-success:focus {
  color: #2b542c;
}
.text-info {
  color: #31708f;
}
a.text-info:hover,
a.text-info:focus {
  color: #245269;
}
.text-warning {
  color: #8a6d3b;
}
a.text-warning:hover,
a.text-warning:focus {
  color: #66512c;
}
.text-danger {
  color: #a94442;
}
a.text-danger:hover,
a.text-danger:focus {
  color: #843534;
}
.bg-primary {
  color: #fff;
  background-color: #337ab7;
}
a.bg-primary:hover,
a.bg-primary:focus {
  background-color: #286090;
}
.bg-success {
  background-color: #dff0d8;
}
a.bg-success:hover,
a.bg-success:focus {
  background-color: #c1e2b3;
}
.bg-info {
  background-color: #d9edf7;
}
a.bg-info:hover,
a.bg-info:focus {
  background-color: #afd9ee;
}
.bg-warning {
  background-color: #fcf8e3;
}
a.bg-warning:hover,
a.bg-warning:focus {
  background-color: #f7ecb5;
}
.bg-danger {
  background-color: #f2dede;
}
a.bg-danger:hover,
a.bg-danger:focus {
  background-color: #e4b9b9;
}
.page-header {
  padding-bottom: 8px;
  margin: 36px 0 18px;
  border-bottom: 1px solid #eeeeee;
}
ul,
ol {
  margin-top: 0;
  margin-bottom: 9px;
}
ul ul,
ol ul,
ul ol,
ol ol {
  margin-bottom: 0;
}
.list-unstyled {
  padding-left: 0;
  list-style: none;
}
.list-inline {
  padding-left: 0;
  list-style: none;
  margin-left: -5px;
}
.list-inline > li {
  display: inline-block;
  padding-left: 5px;
  padding-right: 5px;
}
dl {
  margin-top: 0;
  margin-bottom: 18px;
}
dt,
dd {
  line-height: 1.42857143;
}
dt {
  font-weight: bold;
}
dd {
  margin-left: 0;
}
@media (min-width: 541px) {
  .dl-horizontal dt {
    float: left;
    width: 160px;
    clear: left;
    text-align: right;
    overflow: hidden;
    text-overflow: ellipsis;
    white-space: nowrap;
  }
  .dl-horizontal dd {
    margin-left: 180px;
  }
}
abbr[title],
abbr[data-original-title] {
  cursor: help;
  border-bottom: 1px dotted #777777;
}
.initialism {
  font-size: 90%;
  text-transform: uppercase;
}
blockquote {
  padding: 9px 18px;
  margin: 0 0 18px;
  font-size: inherit;
  border-left: 5px solid #eeeeee;
}
blockquote p:last-child,
blockquote ul:last-child,
blockquote ol:last-child {
  margin-bottom: 0;
}
blockquote footer,
blockquote small,
blockquote .small {
  display: block;
  font-size: 80%;
  line-height: 1.42857143;
  color: #777777;
}
blockquote footer:before,
blockquote small:before,
blockquote .small:before {
  content: '\2014 \00A0';
}
.blockquote-reverse,
blockquote.pull-right {
  padding-right: 15px;
  padding-left: 0;
  border-right: 5px solid #eeeeee;
  border-left: 0;
  text-align: right;
}
.blockquote-reverse footer:before,
blockquote.pull-right footer:before,
.blockquote-reverse small:before,
blockquote.pull-right small:before,
.blockquote-reverse .small:before,
blockquote.pull-right .small:before {
  content: '';
}
.blockquote-reverse footer:after,
blockquote.pull-right footer:after,
.blockquote-reverse small:after,
blockquote.pull-right small:after,
.blockquote-reverse .small:after,
blockquote.pull-right .small:after {
  content: '\00A0 \2014';
}
address {
  margin-bottom: 18px;
  font-style: normal;
  line-height: 1.42857143;
}
code,
kbd,
pre,
samp {
  font-family: monospace;
}
code {
  padding: 2px 4px;
  font-size: 90%;
  color: #c7254e;
  background-color: #f9f2f4;
  border-radius: 2px;
}
kbd {
  padding: 2px 4px;
  font-size: 90%;
  color: #888;
  background-color: transparent;
  border-radius: 1px;
  box-shadow: inset 0 -1px 0 rgba(0, 0, 0, 0.25);
}
kbd kbd {
  padding: 0;
  font-size: 100%;
  font-weight: bold;
  box-shadow: none;
}
pre {
  display: block;
  padding: 8.5px;
  margin: 0 0 9px;
  font-size: 12px;
  line-height: 1.42857143;
  word-break: break-all;
  word-wrap: break-word;
  color: #333333;
  background-color: #f5f5f5;
  border: 1px solid #ccc;
  border-radius: 2px;
}
pre code {
  padding: 0;
  font-size: inherit;
  color: inherit;
  white-space: pre-wrap;
  background-color: transparent;
  border-radius: 0;
}
.pre-scrollable {
  max-height: 340px;
  overflow-y: scroll;
}
.container {
  margin-right: auto;
  margin-left: auto;
  padding-left: 0px;
  padding-right: 0px;
}
@media (min-width: 768px) {
  .container {
    width: 768px;
  }
}
@media (min-width: 992px) {
  .container {
    width: 940px;
  }
}
@media (min-width: 1200px) {
  .container {
    width: 1140px;
  }
}
.container-fluid {
  margin-right: auto;
  margin-left: auto;
  padding-left: 0px;
  padding-right: 0px;
}
.row {
  margin-left: 0px;
  margin-right: 0px;
}
.col-xs-1, .col-sm-1, .col-md-1, .col-lg-1, .col-xs-2, .col-sm-2, .col-md-2, .col-lg-2, .col-xs-3, .col-sm-3, .col-md-3, .col-lg-3, .col-xs-4, .col-sm-4, .col-md-4, .col-lg-4, .col-xs-5, .col-sm-5, .col-md-5, .col-lg-5, .col-xs-6, .col-sm-6, .col-md-6, .col-lg-6, .col-xs-7, .col-sm-7, .col-md-7, .col-lg-7, .col-xs-8, .col-sm-8, .col-md-8, .col-lg-8, .col-xs-9, .col-sm-9, .col-md-9, .col-lg-9, .col-xs-10, .col-sm-10, .col-md-10, .col-lg-10, .col-xs-11, .col-sm-11, .col-md-11, .col-lg-11, .col-xs-12, .col-sm-12, .col-md-12, .col-lg-12 {
  position: relative;
  min-height: 1px;
  padding-left: 0px;
  padding-right: 0px;
}
.col-xs-1, .col-xs-2, .col-xs-3, .col-xs-4, .col-xs-5, .col-xs-6, .col-xs-7, .col-xs-8, .col-xs-9, .col-xs-10, .col-xs-11, .col-xs-12 {
  float: left;
}
.col-xs-12 {
  width: 100%;
}
.col-xs-11 {
  width: 91.66666667%;
}
.col-xs-10 {
  width: 83.33333333%;
}
.col-xs-9 {
  width: 75%;
}
.col-xs-8 {
  width: 66.66666667%;
}
.col-xs-7 {
  width: 58.33333333%;
}
.col-xs-6 {
  width: 50%;
}
.col-xs-5 {
  width: 41.66666667%;
}
.col-xs-4 {
  width: 33.33333333%;
}
.col-xs-3 {
  width: 25%;
}
.col-xs-2 {
  width: 16.66666667%;
}
.col-xs-1 {
  width: 8.33333333%;
}
.col-xs-pull-12 {
  right: 100%;
}
.col-xs-pull-11 {
  right: 91.66666667%;
}
.col-xs-pull-10 {
  right: 83.33333333%;
}
.col-xs-pull-9 {
  right: 75%;
}
.col-xs-pull-8 {
  right: 66.66666667%;
}
.col-xs-pull-7 {
  right: 58.33333333%;
}
.col-xs-pull-6 {
  right: 50%;
}
.col-xs-pull-5 {
  right: 41.66666667%;
}
.col-xs-pull-4 {
  right: 33.33333333%;
}
.col-xs-pull-3 {
  right: 25%;
}
.col-xs-pull-2 {
  right: 16.66666667%;
}
.col-xs-pull-1 {
  right: 8.33333333%;
}
.col-xs-pull-0 {
  right: auto;
}
.col-xs-push-12 {
  left: 100%;
}
.col-xs-push-11 {
  left: 91.66666667%;
}
.col-xs-push-10 {
  left: 83.33333333%;
}
.col-xs-push-9 {
  left: 75%;
}
.col-xs-push-8 {
  left: 66.66666667%;
}
.col-xs-push-7 {
  left: 58.33333333%;
}
.col-xs-push-6 {
  left: 50%;
}
.col-xs-push-5 {
  left: 41.66666667%;
}
.col-xs-push-4 {
  left: 33.33333333%;
}
.col-xs-push-3 {
  left: 25%;
}
.col-xs-push-2 {
  left: 16.66666667%;
}
.col-xs-push-1 {
  left: 8.33333333%;
}
.col-xs-push-0 {
  left: auto;
}
.col-xs-offset-12 {
  margin-left: 100%;
}
.col-xs-offset-11 {
  margin-left: 91.66666667%;
}
.col-xs-offset-10 {
  margin-left: 83.33333333%;
}
.col-xs-offset-9 {
  margin-left: 75%;
}
.col-xs-offset-8 {
  margin-left: 66.66666667%;
}
.col-xs-offset-7 {
  margin-left: 58.33333333%;
}
.col-xs-offset-6 {
  margin-left: 50%;
}
.col-xs-offset-5 {
  margin-left: 41.66666667%;
}
.col-xs-offset-4 {
  margin-left: 33.33333333%;
}
.col-xs-offset-3 {
  margin-left: 25%;
}
.col-xs-offset-2 {
  margin-left: 16.66666667%;
}
.col-xs-offset-1 {
  margin-left: 8.33333333%;
}
.col-xs-offset-0 {
  margin-left: 0%;
}
@media (min-width: 768px) {
  .col-sm-1, .col-sm-2, .col-sm-3, .col-sm-4, .col-sm-5, .col-sm-6, .col-sm-7, .col-sm-8, .col-sm-9, .col-sm-10, .col-sm-11, .col-sm-12 {
    float: left;
  }
  .col-sm-12 {
    width: 100%;
  }
  .col-sm-11 {
    width: 91.66666667%;
  }
  .col-sm-10 {
    width: 83.33333333%;
  }
  .col-sm-9 {
    width: 75%;
  }
  .col-sm-8 {
    width: 66.66666667%;
  }
  .col-sm-7 {
    width: 58.33333333%;
  }
  .col-sm-6 {
    width: 50%;
  }
  .col-sm-5 {
    width: 41.66666667%;
  }
  .col-sm-4 {
    width: 33.33333333%;
  }
  .col-sm-3 {
    width: 25%;
  }
  .col-sm-2 {
    width: 16.66666667%;
  }
  .col-sm-1 {
    width: 8.33333333%;
  }
  .col-sm-pull-12 {
    right: 100%;
  }
  .col-sm-pull-11 {
    right: 91.66666667%;
  }
  .col-sm-pull-10 {
    right: 83.33333333%;
  }
  .col-sm-pull-9 {
    right: 75%;
  }
  .col-sm-pull-8 {
    right: 66.66666667%;
  }
  .col-sm-pull-7 {
    right: 58.33333333%;
  }
  .col-sm-pull-6 {
    right: 50%;
  }
  .col-sm-pull-5 {
    right: 41.66666667%;
  }
  .col-sm-pull-4 {
    right: 33.33333333%;
  }
  .col-sm-pull-3 {
    right: 25%;
  }
  .col-sm-pull-2 {
    right: 16.66666667%;
  }
  .col-sm-pull-1 {
    right: 8.33333333%;
  }
  .col-sm-pull-0 {
    right: auto;
  }
  .col-sm-push-12 {
    left: 100%;
  }
  .col-sm-push-11 {
    left: 91.66666667%;
  }
  .col-sm-push-10 {
    left: 83.33333333%;
  }
  .col-sm-push-9 {
    left: 75%;
  }
  .col-sm-push-8 {
    left: 66.66666667%;
  }
  .col-sm-push-7 {
    left: 58.33333333%;
  }
  .col-sm-push-6 {
    left: 50%;
  }
  .col-sm-push-5 {
    left: 41.66666667%;
  }
  .col-sm-push-4 {
    left: 33.33333333%;
  }
  .col-sm-push-3 {
    left: 25%;
  }
  .col-sm-push-2 {
    left: 16.66666667%;
  }
  .col-sm-push-1 {
    left: 8.33333333%;
  }
  .col-sm-push-0 {
    left: auto;
  }
  .col-sm-offset-12 {
    margin-left: 100%;
  }
  .col-sm-offset-11 {
    margin-left: 91.66666667%;
  }
  .col-sm-offset-10 {
    margin-left: 83.33333333%;
  }
  .col-sm-offset-9 {
    margin-left: 75%;
  }
  .col-sm-offset-8 {
    margin-left: 66.66666667%;
  }
  .col-sm-offset-7 {
    margin-left: 58.33333333%;
  }
  .col-sm-offset-6 {
    margin-left: 50%;
  }
  .col-sm-offset-5 {
    margin-left: 41.66666667%;
  }
  .col-sm-offset-4 {
    margin-left: 33.33333333%;
  }
  .col-sm-offset-3 {
    margin-left: 25%;
  }
  .col-sm-offset-2 {
    margin-left: 16.66666667%;
  }
  .col-sm-offset-1 {
    margin-left: 8.33333333%;
  }
  .col-sm-offset-0 {
    margin-left: 0%;
  }
}
@media (min-width: 992px) {
  .col-md-1, .col-md-2, .col-md-3, .col-md-4, .col-md-5, .col-md-6, .col-md-7, .col-md-8, .col-md-9, .col-md-10, .col-md-11, .col-md-12 {
    float: left;
  }
  .col-md-12 {
    width: 100%;
  }
  .col-md-11 {
    width: 91.66666667%;
  }
  .col-md-10 {
    width: 83.33333333%;
  }
  .col-md-9 {
    width: 75%;
  }
  .col-md-8 {
    width: 66.66666667%;
  }
  .col-md-7 {
    width: 58.33333333%;
  }
  .col-md-6 {
    width: 50%;
  }
  .col-md-5 {
    width: 41.66666667%;
  }
  .col-md-4 {
    width: 33.33333333%;
  }
  .col-md-3 {
    width: 25%;
  }
  .col-md-2 {
    width: 16.66666667%;
  }
  .col-md-1 {
    width: 8.33333333%;
  }
  .col-md-pull-12 {
    right: 100%;
  }
  .col-md-pull-11 {
    right: 91.66666667%;
  }
  .col-md-pull-10 {
    right: 83.33333333%;
  }
  .col-md-pull-9 {
    right: 75%;
  }
  .col-md-pull-8 {
    right: 66.66666667%;
  }
  .col-md-pull-7 {
    right: 58.33333333%;
  }
  .col-md-pull-6 {
    right: 50%;
  }
  .col-md-pull-5 {
    right: 41.66666667%;
  }
  .col-md-pull-4 {
    right: 33.33333333%;
  }
  .col-md-pull-3 {
    right: 25%;
  }
  .col-md-pull-2 {
    right: 16.66666667%;
  }
  .col-md-pull-1 {
    right: 8.33333333%;
  }
  .col-md-pull-0 {
    right: auto;
  }
  .col-md-push-12 {
    left: 100%;
  }
  .col-md-push-11 {
    left: 91.66666667%;
  }
  .col-md-push-10 {
    left: 83.33333333%;
  }
  .col-md-push-9 {
    left: 75%;
  }
  .col-md-push-8 {
    left: 66.66666667%;
  }
  .col-md-push-7 {
    left: 58.33333333%;
  }
  .col-md-push-6 {
    left: 50%;
  }
  .col-md-push-5 {
    left: 41.66666667%;
  }
  .col-md-push-4 {
    left: 33.33333333%;
  }
  .col-md-push-3 {
    left: 25%;
  }
  .col-md-push-2 {
    left: 16.66666667%;
  }
  .col-md-push-1 {
    left: 8.33333333%;
  }
  .col-md-push-0 {
    left: auto;
  }
  .col-md-offset-12 {
    margin-left: 100%;
  }
  .col-md-offset-11 {
    margin-left: 91.66666667%;
  }
  .col-md-offset-10 {
    margin-left: 83.33333333%;
  }
  .col-md-offset-9 {
    margin-left: 75%;
  }
  .col-md-offset-8 {
    margin-left: 66.66666667%;
  }
  .col-md-offset-7 {
    margin-left: 58.33333333%;
  }
  .col-md-offset-6 {
    margin-left: 50%;
  }
  .col-md-offset-5 {
    margin-left: 41.66666667%;
  }
  .col-md-offset-4 {
    margin-left: 33.33333333%;
  }
  .col-md-offset-3 {
    margin-left: 25%;
  }
  .col-md-offset-2 {
    margin-left: 16.66666667%;
  }
  .col-md-offset-1 {
    margin-left: 8.33333333%;
  }
  .col-md-offset-0 {
    margin-left: 0%;
  }
}
@media (min-width: 1200px) {
  .col-lg-1, .col-lg-2, .col-lg-3, .col-lg-4, .col-lg-5, .col-lg-6, .col-lg-7, .col-lg-8, .col-lg-9, .col-lg-10, .col-lg-11, .col-lg-12 {
    float: left;
  }
  .col-lg-12 {
    width: 100%;
  }
  .col-lg-11 {
    width: 91.66666667%;
  }
  .col-lg-10 {
    width: 83.33333333%;
  }
  .col-lg-9 {
    width: 75%;
  }
  .col-lg-8 {
    width: 66.66666667%;
  }
  .col-lg-7 {
    width: 58.33333333%;
  }
  .col-lg-6 {
    width: 50%;
  }
  .col-lg-5 {
    width: 41.66666667%;
  }
  .col-lg-4 {
    width: 33.33333333%;
  }
  .col-lg-3 {
    width: 25%;
  }
  .col-lg-2 {
    width: 16.66666667%;
  }
  .col-lg-1 {
    width: 8.33333333%;
  }
  .col-lg-pull-12 {
    right: 100%;
  }
  .col-lg-pull-11 {
    right: 91.66666667%;
  }
  .col-lg-pull-10 {
    right: 83.33333333%;
  }
  .col-lg-pull-9 {
    right: 75%;
  }
  .col-lg-pull-8 {
    right: 66.66666667%;
  }
  .col-lg-pull-7 {
    right: 58.33333333%;
  }
  .col-lg-pull-6 {
    right: 50%;
  }
  .col-lg-pull-5 {
    right: 41.66666667%;
  }
  .col-lg-pull-4 {
    right: 33.33333333%;
  }
  .col-lg-pull-3 {
    right: 25%;
  }
  .col-lg-pull-2 {
    right: 16.66666667%;
  }
  .col-lg-pull-1 {
    right: 8.33333333%;
  }
  .col-lg-pull-0 {
    right: auto;
  }
  .col-lg-push-12 {
    left: 100%;
  }
  .col-lg-push-11 {
    left: 91.66666667%;
  }
  .col-lg-push-10 {
    left: 83.33333333%;
  }
  .col-lg-push-9 {
    left: 75%;
  }
  .col-lg-push-8 {
    left: 66.66666667%;
  }
  .col-lg-push-7 {
    left: 58.33333333%;
  }
  .col-lg-push-6 {
    left: 50%;
  }
  .col-lg-push-5 {
    left: 41.66666667%;
  }
  .col-lg-push-4 {
    left: 33.33333333%;
  }
  .col-lg-push-3 {
    left: 25%;
  }
  .col-lg-push-2 {
    left: 16.66666667%;
  }
  .col-lg-push-1 {
    left: 8.33333333%;
  }
  .col-lg-push-0 {
    left: auto;
  }
  .col-lg-offset-12 {
    margin-left: 100%;
  }
  .col-lg-offset-11 {
    margin-left: 91.66666667%;
  }
  .col-lg-offset-10 {
    margin-left: 83.33333333%;
  }
  .col-lg-offset-9 {
    margin-left: 75%;
  }
  .col-lg-offset-8 {
    margin-left: 66.66666667%;
  }
  .col-lg-offset-7 {
    margin-left: 58.33333333%;
  }
  .col-lg-offset-6 {
    margin-left: 50%;
  }
  .col-lg-offset-5 {
    margin-left: 41.66666667%;
  }
  .col-lg-offset-4 {
    margin-left: 33.33333333%;
  }
  .col-lg-offset-3 {
    margin-left: 25%;
  }
  .col-lg-offset-2 {
    margin-left: 16.66666667%;
  }
  .col-lg-offset-1 {
    margin-left: 8.33333333%;
  }
  .col-lg-offset-0 {
    margin-left: 0%;
  }
}
table {
  background-color: transparent;
}
caption {
  padding-top: 8px;
  padding-bottom: 8px;
  color: #777777;
  text-align: left;
}
th {
  text-align: left;
}
.table {
  width: 100%;
  max-width: 100%;
  margin-bottom: 18px;
}
.table > thead > tr > th,
.table > tbody > tr > th,
.table > tfoot > tr > th,
.table > thead > tr > td,
.table > tbody > tr > td,
.table > tfoot > tr > td {
  padding: 8px;
  line-height: 1.42857143;
  vertical-align: top;
  border-top: 1px solid #ddd;
}
.table > thead > tr > th {
  vertical-align: bottom;
  border-bottom: 2px solid #ddd;
}
.table > caption + thead > tr:first-child > th,
.table > colgroup + thead > tr:first-child > th,
.table > thead:first-child > tr:first-child > th,
.table > caption + thead > tr:first-child > td,
.table > colgroup + thead > tr:first-child > td,
.table > thead:first-child > tr:first-child > td {
  border-top: 0;
}
.table > tbody + tbody {
  border-top: 2px solid #ddd;
}
.table .table {
  background-color: #fff;
}
.table-condensed > thead > tr > th,
.table-condensed > tbody > tr > th,
.table-condensed > tfoot > tr > th,
.table-condensed > thead > tr > td,
.table-condensed > tbody > tr > td,
.table-condensed > tfoot > tr > td {
  padding: 5px;
}
.table-bordered {
  border: 1px solid #ddd;
}
.table-bordered > thead > tr > th,
.table-bordered > tbody > tr > th,
.table-bordered > tfoot > tr > th,
.table-bordered > thead > tr > td,
.table-bordered > tbody > tr > td,
.table-bordered > tfoot > tr > td {
  border: 1px solid #ddd;
}
.table-bordered > thead > tr > th,
.table-bordered > thead > tr > td {
  border-bottom-width: 2px;
}
.table-striped > tbody > tr:nth-of-type(odd) {
  background-color: #f9f9f9;
}
.table-hover > tbody > tr:hover {
  background-color: #f5f5f5;
}
table col[class*="col-"] {
  position: static;
  float: none;
  display: table-column;
}
table td[class*="col-"],
table th[class*="col-"] {
  position: static;
  float: none;
  display: table-cell;
}
.table > thead > tr > td.active,
.table > tbody > tr > td.active,
.table > tfoot > tr > td.active,
.table > thead > tr > th.active,
.table > tbody > tr > th.active,
.table > tfoot > tr > th.active,
.table > thead > tr.active > td,
.table > tbody > tr.active > td,
.table > tfoot > tr.active > td,
.table > thead > tr.active > th,
.table > tbody > tr.active > th,
.table > tfoot > tr.active > th {
  background-color: #f5f5f5;
}
.table-hover > tbody > tr > td.active:hover,
.table-hover > tbody > tr > th.active:hover,
.table-hover > tbody > tr.active:hover > td,
.table-hover > tbody > tr:hover > .active,
.table-hover > tbody > tr.active:hover > th {
  background-color: #e8e8e8;
}
.table > thead > tr > td.success,
.table > tbody > tr > td.success,
.table > tfoot > tr > td.success,
.table > thead > tr > th.success,
.table > tbody > tr > th.success,
.table > tfoot > tr > th.success,
.table > thead > tr.success > td,
.table > tbody > tr.success > td,
.table > tfoot > tr.success > td,
.table > thead > tr.success > th,
.table > tbody > tr.success > th,
.table > tfoot > tr.success > th {
  background-color: #dff0d8;
}
.table-hover > tbody > tr > td.success:hover,
.table-hover > tbody > tr > th.success:hover,
.table-hover > tbody > tr.success:hover > td,
.table-hover > tbody > tr:hover > .success,
.table-hover > tbody > tr.success:hover > th {
  background-color: #d0e9c6;
}
.table > thead > tr > td.info,
.table > tbody > tr > td.info,
.table > tfoot > tr > td.info,
.table > thead > tr > th.info,
.table > tbody > tr > th.info,
.table > tfoot > tr > th.info,
.table > thead > tr.info > td,
.table > tbody > tr.info > td,
.table > tfoot > tr.info > td,
.table > thead > tr.info > th,
.table > tbody > tr.info > th,
.table > tfoot > tr.info > th {
  background-color: #d9edf7;
}
.table-hover > tbody > tr > td.info:hover,
.table-hover > tbody > tr > th.info:hover,
.table-hover > tbody > tr.info:hover > td,
.table-hover > tbody > tr:hover > .info,
.table-hover > tbody > tr.info:hover > th {
  background-color: #c4e3f3;
}
.table > thead > tr > td.warning,
.table > tbody > tr > td.warning,
.table > tfoot > tr > td.warning,
.table > thead > tr > th.warning,
.table > tbody > tr > th.warning,
.table > tfoot > tr > th.warning,
.table > thead > tr.warning > td,
.table > tbody > tr.warning > td,
.table > tfoot > tr.warning > td,
.table > thead > tr.warning > th,
.table > tbody > tr.warning > th,
.table > tfoot > tr.warning > th {
  background-color: #fcf8e3;
}
.table-hover > tbody > tr > td.warning:hover,
.table-hover > tbody > tr > th.warning:hover,
.table-hover > tbody > tr.warning:hover > td,
.table-hover > tbody > tr:hover > .warning,
.table-hover > tbody > tr.warning:hover > th {
  background-color: #faf2cc;
}
.table > thead > tr > td.danger,
.table > tbody > tr > td.danger,
.table > tfoot > tr > td.danger,
.table > thead > tr > th.danger,
.table > tbody > tr > th.danger,
.table > tfoot > tr > th.danger,
.table > thead > tr.danger > td,
.table > tbody > tr.danger > td,
.table > tfoot > tr.danger > td,
.table > thead > tr.danger > th,
.table > tbody > tr.danger > th,
.table > tfoot > tr.danger > th {
  background-color: #f2dede;
}
.table-hover > tbody > tr > td.danger:hover,
.table-hover > tbody > tr > th.danger:hover,
.table-hover > tbody > tr.danger:hover > td,
.table-hover > tbody > tr:hover > .danger,
.table-hover > tbody > tr.danger:hover > th {
  background-color: #ebcccc;
}
.table-responsive {
  overflow-x: auto;
  min-height: 0.01%;
}
@media screen and (max-width: 767px) {
  .table-responsive {
    width: 100%;
    margin-bottom: 13.5px;
    overflow-y: hidden;
    -ms-overflow-style: -ms-autohiding-scrollbar;
    border: 1px solid #ddd;
  }
  .table-responsive > .table {
    margin-bottom: 0;
  }
  .table-responsive > .table > thead > tr > th,
  .table-responsive > .table > tbody > tr > th,
  .table-responsive > .table > tfoot > tr > th,
  .table-responsive > .table > thead > tr > td,
  .table-responsive > .table > tbody > tr > td,
  .table-responsive > .table > tfoot > tr > td {
    white-space: nowrap;
  }
  .table-responsive > .table-bordered {
    border: 0;
  }
  .table-responsive > .table-bordered > thead > tr > th:first-child,
  .table-responsive > .table-bordered > tbody > tr > th:first-child,
  .table-responsive > .table-bordered > tfoot > tr > th:first-child,
  .table-responsive > .table-bordered > thead > tr > td:first-child,
  .table-responsive > .table-bordered > tbody > tr > td:first-child,
  .table-responsive > .table-bordered > tfoot > tr > td:first-child {
    border-left: 0;
  }
  .table-responsive > .table-bordered > thead > tr > th:last-child,
  .table-responsive > .table-bordered > tbody > tr > th:last-child,
  .table-responsive > .table-bordered > tfoot > tr > th:last-child,
  .table-responsive > .table-bordered > thead > tr > td:last-child,
  .table-responsive > .table-bordered > tbody > tr > td:last-child,
  .table-responsive > .table-bordered > tfoot > tr > td:last-child {
    border-right: 0;
  }
  .table-responsive > .table-bordered > tbody > tr:last-child > th,
  .table-responsive > .table-bordered > tfoot > tr:last-child > th,
  .table-responsive > .table-bordered > tbody > tr:last-child > td,
  .table-responsive > .table-bordered > tfoot > tr:last-child > td {
    border-bottom: 0;
  }
}
fieldset {
  padding: 0;
  margin: 0;
  border: 0;
  min-width: 0;
}
legend {
  display: block;
  width: 100%;
  padding: 0;
  margin-bottom: 18px;
  font-size: 19.5px;
  line-height: inherit;
  color: #333333;
  border: 0;
  border-bottom: 1px solid #e5e5e5;
}
label {
  display: inline-block;
  max-width: 100%;
  margin-bottom: 5px;
  font-weight: bold;
}
input[type="search"] {
  -webkit-box-sizing: border-box;
  -moz-box-sizing: border-box;
  box-sizing: border-box;
}
input[type="radio"],
input[type="checkbox"] {
  margin: 4px 0 0;
  margin-top: 1px \9;
  line-height: normal;
}
input[type="file"] {
  display: block;
}
input[type="range"] {
  display: block;
  width: 100%;
}
select[multiple],
select[size] {
  height: auto;
}
input[type="file"]:focus,
input[type="radio"]:focus,
input[type="checkbox"]:focus {
  outline: 5px auto -webkit-focus-ring-color;
  outline-offset: -2px;
}
output {
  display: block;
  padding-top: 7px;
  font-size: 13px;
  line-height: 1.42857143;
  color: #555555;
}
.form-control {
  display: block;
  width: 100%;
  height: 32px;
  padding: 6px 12px;
  font-size: 13px;
  line-height: 1.42857143;
  color: #555555;
  background-color: #fff;
  background-image: none;
  border: 1px solid #ccc;
  border-radius: 2px;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
  -webkit-transition: border-color ease-in-out .15s, box-shadow ease-in-out .15s;
  -o-transition: border-color ease-in-out .15s, box-shadow ease-in-out .15s;
  transition: border-color ease-in-out .15s, box-shadow ease-in-out .15s;
}
.form-control:focus {
  border-color: #66afe9;
  outline: 0;
  -webkit-box-shadow: inset 0 1px 1px rgba(0,0,0,.075), 0 0 8px rgba(102, 175, 233, 0.6);
  box-shadow: inset 0 1px 1px rgba(0,0,0,.075), 0 0 8px rgba(102, 175, 233, 0.6);
}
.form-control::-moz-placeholder {
  color: #999;
  opacity: 1;
}
.form-control:-ms-input-placeholder {
  color: #999;
}
.form-control::-webkit-input-placeholder {
  color: #999;
}
.form-control::-ms-expand {
  border: 0;
  background-color: transparent;
}
.form-control[disabled],
.form-control[readonly],
fieldset[disabled] .form-control {
  background-color: #eeeeee;
  opacity: 1;
}
.form-control[disabled],
fieldset[disabled] .form-control {
  cursor: not-allowed;
}
textarea.form-control {
  height: auto;
}
input[type="search"] {
  -webkit-appearance: none;
}
@media screen and (-webkit-min-device-pixel-ratio: 0) {
  input[type="date"].form-control,
  input[type="time"].form-control,
  input[type="datetime-local"].form-control,
  input[type="month"].form-control {
    line-height: 32px;
  }
  input[type="date"].input-sm,
  input[type="time"].input-sm,
  input[type="datetime-local"].input-sm,
  input[type="month"].input-sm,
  .input-group-sm input[type="date"],
  .input-group-sm input[type="time"],
  .input-group-sm input[type="datetime-local"],
  .input-group-sm input[type="month"] {
    line-height: 30px;
  }
  input[type="date"].input-lg,
  input[type="time"].input-lg,
  input[type="datetime-local"].input-lg,
  input[type="month"].input-lg,
  .input-group-lg input[type="date"],
  .input-group-lg input[type="time"],
  .input-group-lg input[type="datetime-local"],
  .input-group-lg input[type="month"] {
    line-height: 45px;
  }
}
.form-group {
  margin-bottom: 15px;
}
.radio,
.checkbox {
  position: relative;
  display: block;
  margin-top: 10px;
  margin-bottom: 10px;
}
.radio label,
.checkbox label {
  min-height: 18px;
  padding-left: 20px;
  margin-bottom: 0;
  font-weight: normal;
  cursor: pointer;
}
.radio input[type="radio"],
.radio-inline input[type="radio"],
.checkbox input[type="checkbox"],
.checkbox-inline input[type="checkbox"] {
  position: absolute;
  margin-left: -20px;
  margin-top: 4px \9;
}
.radio + .radio,
.checkbox + .checkbox {
  margin-top: -5px;
}
.radio-inline,
.checkbox-inline {
  position: relative;
  display: inline-block;
  padding-left: 20px;
  margin-bottom: 0;
  vertical-align: middle;
  font-weight: normal;
  cursor: pointer;
}
.radio-inline + .radio-inline,
.checkbox-inline + .checkbox-inline {
  margin-top: 0;
  margin-left: 10px;
}
input[type="radio"][disabled],
input[type="checkbox"][disabled],
input[type="radio"].disabled,
input[type="checkbox"].disabled,
fieldset[disabled] input[type="radio"],
fieldset[disabled] input[type="checkbox"] {
  cursor: not-allowed;
}
.radio-inline.disabled,
.checkbox-inline.disabled,
fieldset[disabled] .radio-inline,
fieldset[disabled] .checkbox-inline {
  cursor: not-allowed;
}
.radio.disabled label,
.checkbox.disabled label,
fieldset[disabled] .radio label,
fieldset[disabled] .checkbox label {
  cursor: not-allowed;
}
.form-control-static {
  padding-top: 7px;
  padding-bottom: 7px;
  margin-bottom: 0;
  min-height: 31px;
}
.form-control-static.input-lg,
.form-control-static.input-sm {
  padding-left: 0;
  padding-right: 0;
}
.input-sm {
  height: 30px;
  padding: 5px 10px;
  font-size: 12px;
  line-height: 1.5;
  border-radius: 1px;
}
select.input-sm {
  height: 30px;
  line-height: 30px;
}
textarea.input-sm,
select[multiple].input-sm {
  height: auto;
}
.form-group-sm .form-control {
  height: 30px;
  padding: 5px 10px;
  font-size: 12px;
  line-height: 1.5;
  border-radius: 1px;
}
.form-group-sm select.form-control {
  height: 30px;
  line-height: 30px;
}
.form-group-sm textarea.form-control,
.form-group-sm select[multiple].form-control {
  height: auto;
}
.form-group-sm .form-control-static {
  height: 30px;
  min-height: 30px;
  padding: 6px 10px;
  font-size: 12px;
  line-height: 1.5;
}
.input-lg {
  height: 45px;
  padding: 10px 16px;
  font-size: 17px;
  line-height: 1.3333333;
  border-radius: 3px;
}
select.input-lg {
  height: 45px;
  line-height: 45px;
}
textarea.input-lg,
select[multiple].input-lg {
  height: auto;
}
.form-group-lg .form-control {
  height: 45px;
  padding: 10px 16px;
  font-size: 17px;
  line-height: 1.3333333;
  border-radius: 3px;
}
.form-group-lg select.form-control {
  height: 45px;
  line-height: 45px;
}
.form-group-lg textarea.form-control,
.form-group-lg select[multiple].form-control {
  height: auto;
}
.form-group-lg .form-control-static {
  height: 45px;
  min-height: 35px;
  padding: 11px 16px;
  font-size: 17px;
  line-height: 1.3333333;
}
.has-feedback {
  position: relative;
}
.has-feedback .form-control {
  padding-right: 40px;
}
.form-control-feedback {
  position: absolute;
  top: 0;
  right: 0;
  z-index: 2;
  display: block;
  width: 32px;
  height: 32px;
  line-height: 32px;
  text-align: center;
  pointer-events: none;
}
.input-lg + .form-control-feedback,
.input-group-lg + .form-control-feedback,
.form-group-lg .form-control + .form-control-feedback {
  width: 45px;
  height: 45px;
  line-height: 45px;
}
.input-sm + .form-control-feedback,
.input-group-sm + .form-control-feedback,
.form-group-sm .form-control + .form-control-feedback {
  width: 30px;
  height: 30px;
  line-height: 30px;
}
.has-success .help-block,
.has-success .control-label,
.has-success .radio,
.has-success .checkbox,
.has-success .radio-inline,
.has-success .checkbox-inline,
.has-success.radio label,
.has-success.checkbox label,
.has-success.radio-inline label,
.has-success.checkbox-inline label {
  color: #3c763d;
}
.has-success .form-control {
  border-color: #3c763d;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
}
.has-success .form-control:focus {
  border-color: #2b542c;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075), 0 0 6px #67b168;
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075), 0 0 6px #67b168;
}
.has-success .input-group-addon {
  color: #3c763d;
  border-color: #3c763d;
  background-color: #dff0d8;
}
.has-success .form-control-feedback {
  color: #3c763d;
}
.has-warning .help-block,
.has-warning .control-label,
.has-warning .radio,
.has-warning .checkbox,
.has-warning .radio-inline,
.has-warning .checkbox-inline,
.has-warning.radio label,
.has-warning.checkbox label,
.has-warning.radio-inline label,
.has-warning.checkbox-inline label {
  color: #8a6d3b;
}
.has-warning .form-control {
  border-color: #8a6d3b;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
}
.has-warning .form-control:focus {
  border-color: #66512c;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075), 0 0 6px #c0a16b;
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075), 0 0 6px #c0a16b;
}
.has-warning .input-group-addon {
  color: #8a6d3b;
  border-color: #8a6d3b;
  background-color: #fcf8e3;
}
.has-warning .form-control-feedback {
  color: #8a6d3b;
}
.has-error .help-block,
.has-error .control-label,
.has-error .radio,
.has-error .checkbox,
.has-error .radio-inline,
.has-error .checkbox-inline,
.has-error.radio label,
.has-error.checkbox label,
.has-error.radio-inline label,
.has-error.checkbox-inline label {
  color: #a94442;
}
.has-error .form-control {
  border-color: #a94442;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
}
.has-error .form-control:focus {
  border-color: #843534;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075), 0 0 6px #ce8483;
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075), 0 0 6px #ce8483;
}
.has-error .input-group-addon {
  color: #a94442;
  border-color: #a94442;
  background-color: #f2dede;
}
.has-error .form-control-feedback {
  color: #a94442;
}
.has-feedback label ~ .form-control-feedback {
  top: 23px;
}
.has-feedback label.sr-only ~ .form-control-feedback {
  top: 0;
}
.help-block {
  display: block;
  margin-top: 5px;
  margin-bottom: 10px;
  color: #404040;
}
@media (min-width: 768px) {
  .form-inline .form-group {
    display: inline-block;
    margin-bottom: 0;
    vertical-align: middle;
  }
  .form-inline .form-control {
    display: inline-block;
    width: auto;
    vertical-align: middle;
  }
  .form-inline .form-control-static {
    display: inline-block;
  }
  .form-inline .input-group {
    display: inline-table;
    vertical-align: middle;
  }
  .form-inline .input-group .input-group-addon,
  .form-inline .input-group .input-group-btn,
  .form-inline .input-group .form-control {
    width: auto;
  }
  .form-inline .input-group > .form-control {
    width: 100%;
  }
  .form-inline .control-label {
    margin-bottom: 0;
    vertical-align: middle;
  }
  .form-inline .radio,
  .form-inline .checkbox {
    display: inline-block;
    margin-top: 0;
    margin-bottom: 0;
    vertical-align: middle;
  }
  .form-inline .radio label,
  .form-inline .checkbox label {
    padding-left: 0;
  }
  .form-inline .radio input[type="radio"],
  .form-inline .checkbox input[type="checkbox"] {
    position: relative;
    margin-left: 0;
  }
  .form-inline .has-feedback .form-control-feedback {
    top: 0;
  }
}
.form-horizontal .radio,
.form-horizontal .checkbox,
.form-horizontal .radio-inline,
.form-horizontal .checkbox-inline {
  margin-top: 0;
  margin-bottom: 0;
  padding-top: 7px;
}
.form-horizontal .radio,
.form-horizontal .checkbox {
  min-height: 25px;
}
.form-horizontal .form-group {
  margin-left: 0px;
  margin-right: 0px;
}
@media (min-width: 768px) {
  .form-horizontal .control-label {
    text-align: right;
    margin-bottom: 0;
    padding-top: 7px;
  }
}
.form-horizontal .has-feedback .form-control-feedback {
  right: 0px;
}
@media (min-width: 768px) {
  .form-horizontal .form-group-lg .control-label {
    padding-top: 11px;
    font-size: 17px;
  }
}
@media (min-width: 768px) {
  .form-horizontal .form-group-sm .control-label {
    padding-top: 6px;
    font-size: 12px;
  }
}
.btn {
  display: inline-block;
  margin-bottom: 0;
  font-weight: normal;
  text-align: center;
  vertical-align: middle;
  touch-action: manipulation;
  cursor: pointer;
  background-image: none;
  border: 1px solid transparent;
  white-space: nowrap;
  padding: 6px 12px;
  font-size: 13px;
  line-height: 1.42857143;
  border-radius: 2px;
  -webkit-user-select: none;
  -moz-user-select: none;
  -ms-user-select: none;
  user-select: none;
}
.btn:focus,
.btn:active:focus,
.btn.active:focus,
.btn.focus,
.btn:active.focus,
.btn.active.focus {
  outline: 5px auto -webkit-focus-ring-color;
  outline-offset: -2px;
}
.btn:hover,
.btn:focus,
.btn.focus {
  color: #333;
  text-decoration: none;
}
.btn:active,
.btn.active {
  outline: 0;
  background-image: none;
  -webkit-box-shadow: inset 0 3px 5px rgba(0, 0, 0, 0.125);
  box-shadow: inset 0 3px 5px rgba(0, 0, 0, 0.125);
}
.btn.disabled,
.btn[disabled],
fieldset[disabled] .btn {
  cursor: not-allowed;
  opacity: 0.65;
  filter: alpha(opacity=65);
  -webkit-box-shadow: none;
  box-shadow: none;
}
a.btn.disabled,
fieldset[disabled] a.btn {
  pointer-events: none;
}
.btn-default {
  color: #333;
  background-color: #fff;
  border-color: #ccc;
}
.btn-default:focus,
.btn-default.focus {
  color: #333;
  background-color: #e6e6e6;
  border-color: #8c8c8c;
}
.btn-default:hover {
  color: #333;
  background-color: #e6e6e6;
  border-color: #adadad;
}
.btn-default:active,
.btn-default.active,
.open > .dropdown-toggle.btn-default {
  color: #333;
  background-color: #e6e6e6;
  border-color: #adadad;
}
.btn-default:active:hover,
.btn-default.active:hover,
.open > .dropdown-toggle.btn-default:hover,
.btn-default:active:focus,
.btn-default.active:focus,
.open > .dropdown-toggle.btn-default:focus,
.btn-default:active.focus,
.btn-default.active.focus,
.open > .dropdown-toggle.btn-default.focus {
  color: #333;
  background-color: #d4d4d4;
  border-color: #8c8c8c;
}
.btn-default:active,
.btn-default.active,
.open > .dropdown-toggle.btn-default {
  background-image: none;
}
.btn-default.disabled:hover,
.btn-default[disabled]:hover,
fieldset[disabled] .btn-default:hover,
.btn-default.disabled:focus,
.btn-default[disabled]:focus,
fieldset[disabled] .btn-default:focus,
.btn-default.disabled.focus,
.btn-default[disabled].focus,
fieldset[disabled] .btn-default.focus {
  background-color: #fff;
  border-color: #ccc;
}
.btn-default .badge {
  color: #fff;
  background-color: #333;
}
.btn-primary {
  color: #fff;
  background-color: #337ab7;
  border-color: #2e6da4;
}
.btn-primary:focus,
.btn-primary.focus {
  color: #fff;
  background-color: #286090;
  border-color: #122b40;
}
.btn-primary:hover {
  color: #fff;
  background-color: #286090;
  border-color: #204d74;
}
.btn-primary:active,
.btn-primary.active,
.open > .dropdown-toggle.btn-primary {
  color: #fff;
  background-color: #286090;
  border-color: #204d74;
}
.btn-primary:active:hover,
.btn-primary.active:hover,
.open > .dropdown-toggle.btn-primary:hover,
.btn-primary:active:focus,
.btn-primary.active:focus,
.open > .dropdown-toggle.btn-primary:focus,
.btn-primary:active.focus,
.btn-primary.active.focus,
.open > .dropdown-toggle.btn-primary.focus {
  color: #fff;
  background-color: #204d74;
  border-color: #122b40;
}
.btn-primary:active,
.btn-primary.active,
.open > .dropdown-toggle.btn-primary {
  background-image: none;
}
.btn-primary.disabled:hover,
.btn-primary[disabled]:hover,
fieldset[disabled] .btn-primary:hover,
.btn-primary.disabled:focus,
.btn-primary[disabled]:focus,
fieldset[disabled] .btn-primary:focus,
.btn-primary.disabled.focus,
.btn-primary[disabled].focus,
fieldset[disabled] .btn-primary.focus {
  background-color: #337ab7;
  border-color: #2e6da4;
}
.btn-primary .badge {
  color: #337ab7;
  background-color: #fff;
}
.btn-success {
  color: #fff;
  background-color: #5cb85c;
  border-color: #4cae4c;
}
.btn-success:focus,
.btn-success.focus {
  color: #fff;
  background-color: #449d44;
  border-color: #255625;
}
.btn-success:hover {
  color: #fff;
  background-color: #449d44;
  border-color: #398439;
}
.btn-success:active,
.btn-success.active,
.open > .dropdown-toggle.btn-success {
  color: #fff;
  background-color: #449d44;
  border-color: #398439;
}
.btn-success:active:hover,
.btn-success.active:hover,
.open > .dropdown-toggle.btn-success:hover,
.btn-success:active:focus,
.btn-success.active:focus,
.open > .dropdown-toggle.btn-success:focus,
.btn-success:active.focus,
.btn-success.active.focus,
.open > .dropdown-toggle.btn-success.focus {
  color: #fff;
  background-color: #398439;
  border-color: #255625;
}
.btn-success:active,
.btn-success.active,
.open > .dropdown-toggle.btn-success {
  background-image: none;
}
.btn-success.disabled:hover,
.btn-success[disabled]:hover,
fieldset[disabled] .btn-success:hover,
.btn-success.disabled:focus,
.btn-success[disabled]:focus,
fieldset[disabled] .btn-success:focus,
.btn-success.disabled.focus,
.btn-success[disabled].focus,
fieldset[disabled] .btn-success.focus {
  background-color: #5cb85c;
  border-color: #4cae4c;
}
.btn-success .badge {
  color: #5cb85c;
  background-color: #fff;
}
.btn-info {
  color: #fff;
  background-color: #5bc0de;
  border-color: #46b8da;
}
.btn-info:focus,
.btn-info.focus {
  color: #fff;
  background-color: #31b0d5;
  border-color: #1b6d85;
}
.btn-info:hover {
  color: #fff;
  background-color: #31b0d5;
  border-color: #269abc;
}
.btn-info:active,
.btn-info.active,
.open > .dropdown-toggle.btn-info {
  color: #fff;
  background-color: #31b0d5;
  border-color: #269abc;
}
.btn-info:active:hover,
.btn-info.active:hover,
.open > .dropdown-toggle.btn-info:hover,
.btn-info:active:focus,
.btn-info.active:focus,
.open > .dropdown-toggle.btn-info:focus,
.btn-info:active.focus,
.btn-info.active.focus,
.open > .dropdown-toggle.btn-info.focus {
  color: #fff;
  background-color: #269abc;
  border-color: #1b6d85;
}
.btn-info:active,
.btn-info.active,
.open > .dropdown-toggle.btn-info {
  background-image: none;
}
.btn-info.disabled:hover,
.btn-info[disabled]:hover,
fieldset[disabled] .btn-info:hover,
.btn-info.disabled:focus,
.btn-info[disabled]:focus,
fieldset[disabled] .btn-info:focus,
.btn-info.disabled.focus,
.btn-info[disabled].focus,
fieldset[disabled] .btn-info.focus {
  background-color: #5bc0de;
  border-color: #46b8da;
}
.btn-info .badge {
  color: #5bc0de;
  background-color: #fff;
}
.btn-warning {
  color: #fff;
  background-color: #f0ad4e;
  border-color: #eea236;
}
.btn-warning:focus,
.btn-warning.focus {
  color: #fff;
  background-color: #ec971f;
  border-color: #985f0d;
}
.btn-warning:hover {
  color: #fff;
  background-color: #ec971f;
  border-color: #d58512;
}
.btn-warning:active,
.btn-warning.active,
.open > .dropdown-toggle.btn-warning {
  color: #fff;
  background-color: #ec971f;
  border-color: #d58512;
}
.btn-warning:active:hover,
.btn-warning.active:hover,
.open > .dropdown-toggle.btn-warning:hover,
.btn-warning:active:focus,
.btn-warning.active:focus,
.open > .dropdown-toggle.btn-warning:focus,
.btn-warning:active.focus,
.btn-warning.active.focus,
.open > .dropdown-toggle.btn-warning.focus {
  color: #fff;
  background-color: #d58512;
  border-color: #985f0d;
}
.btn-warning:active,
.btn-warning.active,
.open > .dropdown-toggle.btn-warning {
  background-image: none;
}
.btn-warning.disabled:hover,
.btn-warning[disabled]:hover,
fieldset[disabled] .btn-warning:hover,
.btn-warning.disabled:focus,
.btn-warning[disabled]:focus,
fieldset[disabled] .btn-warning:focus,
.btn-warning.disabled.focus,
.btn-warning[disabled].focus,
fieldset[disabled] .btn-warning.focus {
  background-color: #f0ad4e;
  border-color: #eea236;
}
.btn-warning .badge {
  color: #f0ad4e;
  background-color: #fff;
}
.btn-danger {
  color: #fff;
  background-color: #d9534f;
  border-color: #d43f3a;
}
.btn-danger:focus,
.btn-danger.focus {
  color: #fff;
  background-color: #c9302c;
  border-color: #761c19;
}
.btn-danger:hover {
  color: #fff;
  background-color: #c9302c;
  border-color: #ac2925;
}
.btn-danger:active,
.btn-danger.active,
.open > .dropdown-toggle.btn-danger {
  color: #fff;
  background-color: #c9302c;
  border-color: #ac2925;
}
.btn-danger:active:hover,
.btn-danger.active:hover,
.open > .dropdown-toggle.btn-danger:hover,
.btn-danger:active:focus,
.btn-danger.active:focus,
.open > .dropdown-toggle.btn-danger:focus,
.btn-danger:active.focus,
.btn-danger.active.focus,
.open > .dropdown-toggle.btn-danger.focus {
  color: #fff;
  background-color: #ac2925;
  border-color: #761c19;
}
.btn-danger:active,
.btn-danger.active,
.open > .dropdown-toggle.btn-danger {
  background-image: none;
}
.btn-danger.disabled:hover,
.btn-danger[disabled]:hover,
fieldset[disabled] .btn-danger:hover,
.btn-danger.disabled:focus,
.btn-danger[disabled]:focus,
fieldset[disabled] .btn-danger:focus,
.btn-danger.disabled.focus,
.btn-danger[disabled].focus,
fieldset[disabled] .btn-danger.focus {
  background-color: #d9534f;
  border-color: #d43f3a;
}
.btn-danger .badge {
  color: #d9534f;
  background-color: #fff;
}
.btn-link {
  color: #337ab7;
  font-weight: normal;
  border-radius: 0;
}
.btn-link,
.btn-link:active,
.btn-link.active,
.btn-link[disabled],
fieldset[disabled] .btn-link {
  background-color: transparent;
  -webkit-box-shadow: none;
  box-shadow: none;
}
.btn-link,
.btn-link:hover,
.btn-link:focus,
.btn-link:active {
  border-color: transparent;
}
.btn-link:hover,
.btn-link:focus {
  color: #23527c;
  text-decoration: underline;
  background-color: transparent;
}
.btn-link[disabled]:hover,
fieldset[disabled] .btn-link:hover,
.btn-link[disabled]:focus,
fieldset[disabled] .btn-link:focus {
  color: #777777;
  text-decoration: none;
}
.btn-lg,
.btn-group-lg > .btn {
  padding: 10px 16px;
  font-size: 17px;
  line-height: 1.3333333;
  border-radius: 3px;
}
.btn-sm,
.btn-group-sm > .btn {
  padding: 5px 10px;
  font-size: 12px;
  line-height: 1.5;
  border-radius: 1px;
}
.btn-xs,
.btn-group-xs > .btn {
  padding: 1px 5px;
  font-size: 12px;
  line-height: 1.5;
  border-radius: 1px;
}
.btn-block {
  display: block;
  width: 100%;
}
.btn-block + .btn-block {
  margin-top: 5px;
}
input[type="submit"].btn-block,
input[type="reset"].btn-block,
input[type="button"].btn-block {
  width: 100%;
}
.fade {
  opacity: 0;
  -webkit-transition: opacity 0.15s linear;
  -o-transition: opacity 0.15s linear;
  transition: opacity 0.15s linear;
}
.fade.in {
  opacity: 1;
}
.collapse {
  display: none;
}
.collapse.in {
  display: block;
}
tr.collapse.in {
  display: table-row;
}
tbody.collapse.in {
  display: table-row-group;
}
.collapsing {
  position: relative;
  height: 0;
  overflow: hidden;
  -webkit-transition-property: height, visibility;
  transition-property: height, visibility;
  -webkit-transition-duration: 0.35s;
  transition-duration: 0.35s;
  -webkit-transition-timing-function: ease;
  transition-timing-function: ease;
}
.caret {
  display: inline-block;
  width: 0;
  height: 0;
  margin-left: 2px;
  vertical-align: middle;
  border-top: 4px dashed;
  border-top: 4px solid \9;
  border-right: 4px solid transparent;
  border-left: 4px solid transparent;
}
.dropup,
.dropdown {
  position: relative;
}
.dropdown-toggle:focus {
  outline: 0;
}
.dropdown-menu {
  position: absolute;
  top: 100%;
  left: 0;
  z-index: 1000;
  display: none;
  float: left;
  min-width: 160px;
  padding: 5px 0;
  margin: 2px 0 0;
  list-style: none;
  font-size: 13px;
  text-align: left;
  background-color: #fff;
  border: 1px solid #ccc;
  border: 1px solid rgba(0, 0, 0, 0.15);
  border-radius: 2px;
  -webkit-box-shadow: 0 6px 12px rgba(0, 0, 0, 0.175);
  box-shadow: 0 6px 12px rgba(0, 0, 0, 0.175);
  background-clip: padding-box;
}
.dropdown-menu.pull-right {
  right: 0;
  left: auto;
}
.dropdown-menu .divider {
  height: 1px;
  margin: 8px 0;
  overflow: hidden;
  background-color: #e5e5e5;
}
.dropdown-menu > li > a {
  display: block;
  padding: 3px 20px;
  clear: both;
  font-weight: normal;
  line-height: 1.42857143;
  color: #333333;
  white-space: nowrap;
}
.dropdown-menu > li > a:hover,
.dropdown-menu > li > a:focus {
  text-decoration: none;
  color: #262626;
  background-color: #f5f5f5;
}
.dropdown-menu > .active > a,
.dropdown-menu > .active > a:hover,
.dropdown-menu > .active > a:focus {
  color: #fff;
  text-decoration: none;
  outline: 0;
  background-color: #337ab7;
}
.dropdown-menu > .disabled > a,
.dropdown-menu > .disabled > a:hover,
.dropdown-menu > .disabled > a:focus {
  color: #777777;
}
.dropdown-menu > .disabled > a:hover,
.dropdown-menu > .disabled > a:focus {
  text-decoration: none;
  background-color: transparent;
  background-image: none;
  filter: progid:DXImageTransform.Microsoft.gradient(enabled = false);
  cursor: not-allowed;
}
.open > .dropdown-menu {
  display: block;
}
.open > a {
  outline: 0;
}
.dropdown-menu-right {
  left: auto;
  right: 0;
}
.dropdown-menu-left {
  left: 0;
  right: auto;
}
.dropdown-header {
  display: block;
  padding: 3px 20px;
  font-size: 12px;
  line-height: 1.42857143;
  color: #777777;
  white-space: nowrap;
}
.dropdown-backdrop {
  position: fixed;
  left: 0;
  right: 0;
  bottom: 0;
  top: 0;
  z-index: 990;
}
.pull-right > .dropdown-menu {
  right: 0;
  left: auto;
}
.dropup .caret,
.navbar-fixed-bottom .dropdown .caret {
  border-top: 0;
  border-bottom: 4px dashed;
  border-bottom: 4px solid \9;
  content: "";
}
.dropup .dropdown-menu,
.navbar-fixed-bottom .dropdown .dropdown-menu {
  top: auto;
  bottom: 100%;
  margin-bottom: 2px;
}
@media (min-width: 541px) {
  .navbar-right .dropdown-menu {
    left: auto;
    right: 0;
  }
  .navbar-right .dropdown-menu-left {
    left: 0;
    right: auto;
  }
}
.btn-group,
.btn-group-vertical {
  position: relative;
  display: inline-block;
  vertical-align: middle;
}
.btn-group > .btn,
.btn-group-vertical > .btn {
  position: relative;
  float: left;
}
.btn-group > .btn:hover,
.btn-group-vertical > .btn:hover,
.btn-group > .btn:focus,
.btn-group-vertical > .btn:focus,
.btn-group > .btn:active,
.btn-group-vertical > .btn:active,
.btn-group > .btn.active,
.btn-group-vertical > .btn.active {
  z-index: 2;
}
.btn-group .btn + .btn,
.btn-group .btn + .btn-group,
.btn-group .btn-group + .btn,
.btn-group .btn-group + .btn-group {
  margin-left: -1px;
}
.btn-toolbar {
  margin-left: -5px;
}
.btn-toolbar .btn,
.btn-toolbar .btn-group,
.btn-toolbar .input-group {
  float: left;
}
.btn-toolbar > .btn,
.btn-toolbar > .btn-group,
.btn-toolbar > .input-group {
  margin-left: 5px;
}
.btn-group > .btn:not(:first-child):not(:last-child):not(.dropdown-toggle) {
  border-radius: 0;
}
.btn-group > .btn:first-child {
  margin-left: 0;
}
.btn-group > .btn:first-child:not(:last-child):not(.dropdown-toggle) {
  border-bottom-right-radius: 0;
  border-top-right-radius: 0;
}
.btn-group > .btn:last-child:not(:first-child),
.btn-group > .dropdown-toggle:not(:first-child) {
  border-bottom-left-radius: 0;
  border-top-left-radius: 0;
}
.btn-group > .btn-group {
  float: left;
}
.btn-group > .btn-group:not(:first-child):not(:last-child) > .btn {
  border-radius: 0;
}
.btn-group > .btn-group:first-child:not(:last-child) > .btn:last-child,
.btn-group > .btn-group:first-child:not(:last-child) > .dropdown-toggle {
  border-bottom-right-radius: 0;
  border-top-right-radius: 0;
}
.btn-group > .btn-group:last-child:not(:first-child) > .btn:first-child {
  border-bottom-left-radius: 0;
  border-top-left-radius: 0;
}
.btn-group .dropdown-toggle:active,
.btn-group.open .dropdown-toggle {
  outline: 0;
}
.btn-group > .btn + .dropdown-toggle {
  padding-left: 8px;
  padding-right: 8px;
}
.btn-group > .btn-lg + .dropdown-toggle {
  padding-left: 12px;
  padding-right: 12px;
}
.btn-group.open .dropdown-toggle {
  -webkit-box-shadow: inset 0 3px 5px rgba(0, 0, 0, 0.125);
  box-shadow: inset 0 3px 5px rgba(0, 0, 0, 0.125);
}
.btn-group.open .dropdown-toggle.btn-link {
  -webkit-box-shadow: none;
  box-shadow: none;
}
.btn .caret {
  margin-left: 0;
}
.btn-lg .caret {
  border-width: 5px 5px 0;
  border-bottom-width: 0;
}
.dropup .btn-lg .caret {
  border-width: 0 5px 5px;
}
.btn-group-vertical > .btn,
.btn-group-vertical > .btn-group,
.btn-group-vertical > .btn-group > .btn {
  display: block;
  float: none;
  width: 100%;
  max-width: 100%;
}
.btn-group-vertical > .btn-group > .btn {
  float: none;
}
.btn-group-vertical > .btn + .btn,
.btn-group-vertical > .btn + .btn-group,
.btn-group-vertical > .btn-group + .btn,
.btn-group-vertical > .btn-group + .btn-group {
  margin-top: -1px;
  margin-left: 0;
}
.btn-group-vertical > .btn:not(:first-child):not(:last-child) {
  border-radius: 0;
}
.btn-group-vertical > .btn:first-child:not(:last-child) {
  border-top-right-radius: 2px;
  border-top-left-radius: 2px;
  border-bottom-right-radius: 0;
  border-bottom-left-radius: 0;
}
.btn-group-vertical > .btn:last-child:not(:first-child) {
  border-top-right-radius: 0;
  border-top-left-radius: 0;
  border-bottom-right-radius: 2px;
  border-bottom-left-radius: 2px;
}
.btn-group-vertical > .btn-group:not(:first-child):not(:last-child) > .btn {
  border-radius: 0;
}
.btn-group-vertical > .btn-group:first-child:not(:last-child) > .btn:last-child,
.btn-group-vertical > .btn-group:first-child:not(:last-child) > .dropdown-toggle {
  border-bottom-right-radius: 0;
  border-bottom-left-radius: 0;
}
.btn-group-vertical > .btn-group:last-child:not(:first-child) > .btn:first-child {
  border-top-right-radius: 0;
  border-top-left-radius: 0;
}
.btn-group-justified {
  display: table;
  width: 100%;
  table-layout: fixed;
  border-collapse: separate;
}
.btn-group-justified > .btn,
.btn-group-justified > .btn-group {
  float: none;
  display: table-cell;
  width: 1%;
}
.btn-group-justified > .btn-group .btn {
  width: 100%;
}
.btn-group-justified > .btn-group .dropdown-menu {
  left: auto;
}
[data-toggle="buttons"] > .btn input[type="radio"],
[data-toggle="buttons"] > .btn-group > .btn input[type="radio"],
[data-toggle="buttons"] > .btn input[type="checkbox"],
[data-toggle="buttons"] > .btn-group > .btn input[type="checkbox"] {
  position: absolute;
  clip: rect(0, 0, 0, 0);
  pointer-events: none;
}
.input-group {
  position: relative;
  display: table;
  border-collapse: separate;
}
.input-group[class*="col-"] {
  float: none;
  padding-left: 0;
  padding-right: 0;
}
.input-group .form-control {
  position: relative;
  z-index: 2;
  float: left;
  width: 100%;
  margin-bottom: 0;
}
.input-group .form-control:focus {
  z-index: 3;
}
.input-group-lg > .form-control,
.input-group-lg > .input-group-addon,
.input-group-lg > .input-group-btn > .btn {
  height: 45px;
  padding: 10px 16px;
  font-size: 17px;
  line-height: 1.3333333;
  border-radius: 3px;
}
select.input-group-lg > .form-control,
select.input-group-lg > .input-group-addon,
select.input-group-lg > .input-group-btn > .btn {
  height: 45px;
  line-height: 45px;
}
textarea.input-group-lg > .form-control,
textarea.input-group-lg > .input-group-addon,
textarea.input-group-lg > .input-group-btn > .btn,
select[multiple].input-group-lg > .form-control,
select[multiple].input-group-lg > .input-group-addon,
select[multiple].input-group-lg > .input-group-btn > .btn {
  height: auto;
}
.input-group-sm > .form-control,
.input-group-sm > .input-group-addon,
.input-group-sm > .input-group-btn > .btn {
  height: 30px;
  padding: 5px 10px;
  font-size: 12px;
  line-height: 1.5;
  border-radius: 1px;
}
select.input-group-sm > .form-control,
select.input-group-sm > .input-group-addon,
select.input-group-sm > .input-group-btn > .btn {
  height: 30px;
  line-height: 30px;
}
textarea.input-group-sm > .form-control,
textarea.input-group-sm > .input-group-addon,
textarea.input-group-sm > .input-group-btn > .btn,
select[multiple].input-group-sm > .form-control,
select[multiple].input-group-sm > .input-group-addon,
select[multiple].input-group-sm > .input-group-btn > .btn {
  height: auto;
}
.input-group-addon,
.input-group-btn,
.input-group .form-control {
  display: table-cell;
}
.input-group-addon:not(:first-child):not(:last-child),
.input-group-btn:not(:first-child):not(:last-child),
.input-group .form-control:not(:first-child):not(:last-child) {
  border-radius: 0;
}
.input-group-addon,
.input-group-btn {
  width: 1%;
  white-space: nowrap;
  vertical-align: middle;
}
.input-group-addon {
  padding: 6px 12px;
  font-size: 13px;
  font-weight: normal;
  line-height: 1;
  color: #555555;
  text-align: center;
  background-color: #eeeeee;
  border: 1px solid #ccc;
  border-radius: 2px;
}
.input-group-addon.input-sm {
  padding: 5px 10px;
  font-size: 12px;
  border-radius: 1px;
}
.input-group-addon.input-lg {
  padding: 10px 16px;
  font-size: 17px;
  border-radius: 3px;
}
.input-group-addon input[type="radio"],
.input-group-addon input[type="checkbox"] {
  margin-top: 0;
}
.input-group .form-control:first-child,
.input-group-addon:first-child,
.input-group-btn:first-child > .btn,
.input-group-btn:first-child > .btn-group > .btn,
.input-group-btn:first-child > .dropdown-toggle,
.input-group-btn:last-child > .btn:not(:last-child):not(.dropdown-toggle),
.input-group-btn:last-child > .btn-group:not(:last-child) > .btn {
  border-bottom-right-radius: 0;
  border-top-right-radius: 0;
}
.input-group-addon:first-child {
  border-right: 0;
}
.input-group .form-control:last-child,
.input-group-addon:last-child,
.input-group-btn:last-child > .btn,
.input-group-btn:last-child > .btn-group > .btn,
.input-group-btn:last-child > .dropdown-toggle,
.input-group-btn:first-child > .btn:not(:first-child),
.input-group-btn:first-child > .btn-group:not(:first-child) > .btn {
  border-bottom-left-radius: 0;
  border-top-left-radius: 0;
}
.input-group-addon:last-child {
  border-left: 0;
}
.input-group-btn {
  position: relative;
  font-size: 0;
  white-space: nowrap;
}
.input-group-btn > .btn {
  position: relative;
}
.input-group-btn > .btn + .btn {
  margin-left: -1px;
}
.input-group-btn > .btn:hover,
.input-group-btn > .btn:focus,
.input-group-btn > .btn:active {
  z-index: 2;
}
.input-group-btn:first-child > .btn,
.input-group-btn:first-child > .btn-group {
  margin-right: -1px;
}
.input-group-btn:last-child > .btn,
.input-group-btn:last-child > .btn-group {
  z-index: 2;
  margin-left: -1px;
}
.nav {
  margin-bottom: 0;
  padding-left: 0;
  list-style: none;
}
.nav > li {
  position: relative;
  display: block;
}
.nav > li > a {
  position: relative;
  display: block;
  padding: 10px 15px;
}
.nav > li > a:hover,
.nav > li > a:focus {
  text-decoration: none;
  background-color: #eeeeee;
}
.nav > li.disabled > a {
  color: #777777;
}
.nav > li.disabled > a:hover,
.nav > li.disabled > a:focus {
  color: #777777;
  text-decoration: none;
  background-color: transparent;
  cursor: not-allowed;
}
.nav .open > a,
.nav .open > a:hover,
.nav .open > a:focus {
  background-color: #eeeeee;
  border-color: #337ab7;
}
.nav .nav-divider {
  height: 1px;
  margin: 8px 0;
  overflow: hidden;
  background-color: #e5e5e5;
}
.nav > li > a > img {
  max-width: none;
}
.nav-tabs {
  border-bottom: 1px solid #ddd;
}
.nav-tabs > li {
  float: left;
  margin-bottom: -1px;
}
.nav-tabs > li > a {
  margin-right: 2px;
  line-height: 1.42857143;
  border: 1px solid transparent;
  border-radius: 2px 2px 0 0;
}
.nav-tabs > li > a:hover {
  border-color: #eeeeee #eeeeee #ddd;
}
.nav-tabs > li.active > a,
.nav-tabs > li.active > a:hover,
.nav-tabs > li.active > a:focus {
  color: #555555;
  background-color: #fff;
  border: 1px solid #ddd;
  border-bottom-color: transparent;
  cursor: default;
}
.nav-tabs.nav-justified {
  width: 100%;
  border-bottom: 0;
}
.nav-tabs.nav-justified > li {
  float: none;
}
.nav-tabs.nav-justified > li > a {
  text-align: center;
  margin-bottom: 5px;
}
.nav-tabs.nav-justified > .dropdown .dropdown-menu {
  top: auto;
  left: auto;
}
@media (min-width: 768px) {
  .nav-tabs.nav-justified > li {
    display: table-cell;
    width: 1%;
  }
  .nav-tabs.nav-justified > li > a {
    margin-bottom: 0;
  }
}
.nav-tabs.nav-justified > li > a {
  margin-right: 0;
  border-radius: 2px;
}
.nav-tabs.nav-justified > .active > a,
.nav-tabs.nav-justified > .active > a:hover,
.nav-tabs.nav-justified > .active > a:focus {
  border: 1px solid #ddd;
}
@media (min-width: 768px) {
  .nav-tabs.nav-justified > li > a {
    border-bottom: 1px solid #ddd;
    border-radius: 2px 2px 0 0;
  }
  .nav-tabs.nav-justified > .active > a,
  .nav-tabs.nav-justified > .active > a:hover,
  .nav-tabs.nav-justified > .active > a:focus {
    border-bottom-color: #fff;
  }
}
.nav-pills > li {
  float: left;
}
.nav-pills > li > a {
  border-radius: 2px;
}
.nav-pills > li + li {
  margin-left: 2px;
}
.nav-pills > li.active > a,
.nav-pills > li.active > a:hover,
.nav-pills > li.active > a:focus {
  color: #fff;
  background-color: #337ab7;
}
.nav-stacked > li {
  float: none;
}
.nav-stacked > li + li {
  margin-top: 2px;
  margin-left: 0;
}
.nav-justified {
  width: 100%;
}
.nav-justified > li {
  float: none;
}
.nav-justified > li > a {
  text-align: center;
  margin-bottom: 5px;
}
.nav-justified > .dropdown .dropdown-menu {
  top: auto;
  left: auto;
}
@media (min-width: 768px) {
  .nav-justified > li {
    display: table-cell;
    width: 1%;
  }
  .nav-justified > li > a {
    margin-bottom: 0;
  }
}
.nav-tabs-justified {
  border-bottom: 0;
}
.nav-tabs-justified > li > a {
  margin-right: 0;
  border-radius: 2px;
}
.nav-tabs-justified > .active > a,
.nav-tabs-justified > .active > a:hover,
.nav-tabs-justified > .active > a:focus {
  border: 1px solid #ddd;
}
@media (min-width: 768px) {
  .nav-tabs-justified > li > a {
    border-bottom: 1px solid #ddd;
    border-radius: 2px 2px 0 0;
  }
  .nav-tabs-justified > .active > a,
  .nav-tabs-justified > .active > a:hover,
  .nav-tabs-justified > .active > a:focus {
    border-bottom-color: #fff;
  }
}
.tab-content > .tab-pane {
  display: none;
}
.tab-content > .active {
  display: block;
}
.nav-tabs .dropdown-menu {
  margin-top: -1px;
  border-top-right-radius: 0;
  border-top-left-radius: 0;
}
.navbar {
  position: relative;
  min-height: 30px;
  margin-bottom: 18px;
  border: 1px solid transparent;
}
@media (min-width: 541px) {
  .navbar {
    border-radius: 2px;
  }
}
@media (min-width: 541px) {
  .navbar-header {
    float: left;
  }
}
.navbar-collapse {
  overflow-x: visible;
  padding-right: 0px;
  padding-left: 0px;
  border-top: 1px solid transparent;
  box-shadow: inset 0 1px 0 rgba(255, 255, 255, 0.1);
  -webkit-overflow-scrolling: touch;
}
.navbar-collapse.in {
  overflow-y: auto;
}
@media (min-width: 541px) {
  .navbar-collapse {
    width: auto;
    border-top: 0;
    box-shadow: none;
  }
  .navbar-collapse.collapse {
    display: block !important;
    height: auto !important;
    padding-bottom: 0;
    overflow: visible !important;
  }
  .navbar-collapse.in {
    overflow-y: visible;
  }
  .navbar-fixed-top .navbar-collapse,
  .navbar-static-top .navbar-collapse,
  .navbar-fixed-bottom .navbar-collapse {
    padding-left: 0;
    padding-right: 0;
  }
}
.navbar-fixed-top .navbar-collapse,
.navbar-fixed-bottom .navbar-collapse {
  max-height: 340px;
}
@media (max-device-width: 540px) and (orientation: landscape) {
  .navbar-fixed-top .navbar-collapse,
  .navbar-fixed-bottom .navbar-collapse {
    max-height: 200px;
  }
}
.container > .navbar-header,
.container-fluid > .navbar-header,
.container > .navbar-collapse,
.container-fluid > .navbar-collapse {
  margin-right: 0px;
  margin-left: 0px;
}
@media (min-width: 541px) {
  .container > .navbar-header,
  .container-fluid > .navbar-header,
  .container > .navbar-collapse,
  .container-fluid > .navbar-collapse {
    margin-right: 0;
    margin-left: 0;
  }
}
.navbar-static-top {
  z-index: 1000;
  border-width: 0 0 1px;
}
@media (min-width: 541px) {
  .navbar-static-top {
    border-radius: 0;
  }
}
.navbar-fixed-top,
.navbar-fixed-bottom {
  position: fixed;
  right: 0;
  left: 0;
  z-index: 1030;
}
@media (min-width: 541px) {
  .navbar-fixed-top,
  .navbar-fixed-bottom {
    border-radius: 0;
  }
}
.navbar-fixed-top {
  top: 0;
  border-width: 0 0 1px;
}
.navbar-fixed-bottom {
  bottom: 0;
  margin-bottom: 0;
  border-width: 1px 0 0;
}
.navbar-brand {
  float: left;
  padding: 6px 0px;
  font-size: 17px;
  line-height: 18px;
  height: 30px;
}
.navbar-brand:hover,
.navbar-brand:focus {
  text-decoration: none;
}
.navbar-brand > img {
  display: block;
}
@media (min-width: 541px) {
  .navbar > .container .navbar-brand,
  .navbar > .container-fluid .navbar-brand {
    margin-left: 0px;
  }
}
.navbar-toggle {
  position: relative;
  float: right;
  margin-right: 0px;
  padding: 9px 10px;
  margin-top: -2px;
  margin-bottom: -2px;
  background-color: transparent;
  background-image: none;
  border: 1px solid transparent;
  border-radius: 2px;
}
.navbar-toggle:focus {
  outline: 0;
}
.navbar-toggle .icon-bar {
  display: block;
  width: 22px;
  height: 2px;
  border-radius: 1px;
}
.navbar-toggle .icon-bar + .icon-bar {
  margin-top: 4px;
}
@media (min-width: 541px) {
  .navbar-toggle {
    display: none;
  }
}
.navbar-nav {
  margin: 3px 0px;
}
.navbar-nav > li > a {
  padding-top: 10px;
  padding-bottom: 10px;
  line-height: 18px;
}
@media (max-width: 540px) {
  .navbar-nav .open .dropdown-menu {
    position: static;
    float: none;
    width: auto;
    margin-top: 0;
    background-color: transparent;
    border: 0;
    box-shadow: none;
  }
  .navbar-nav .open .dropdown-menu > li > a,
  .navbar-nav .open .dropdown-menu .dropdown-header {
    padding: 5px 15px 5px 25px;
  }
  .navbar-nav .open .dropdown-menu > li > a {
    line-height: 18px;
  }
  .navbar-nav .open .dropdown-menu > li > a:hover,
  .navbar-nav .open .dropdown-menu > li > a:focus {
    background-image: none;
  }
}
@media (min-width: 541px) {
  .navbar-nav {
    float: left;
    margin: 0;
  }
  .navbar-nav > li {
    float: left;
  }
  .navbar-nav > li > a {
    padding-top: 6px;
    padding-bottom: 6px;
  }
}
.navbar-form {
  margin-left: 0px;
  margin-right: 0px;
  padding: 10px 0px;
  border-top: 1px solid transparent;
  border-bottom: 1px solid transparent;
  -webkit-box-shadow: inset 0 1px 0 rgba(255, 255, 255, 0.1), 0 1px 0 rgba(255, 255, 255, 0.1);
  box-shadow: inset 0 1px 0 rgba(255, 255, 255, 0.1), 0 1px 0 rgba(255, 255, 255, 0.1);
  margin-top: -1px;
  margin-bottom: -1px;
}
@media (min-width: 768px) {
  .navbar-form .form-group {
    display: inline-block;
    margin-bottom: 0;
    vertical-align: middle;
  }
  .navbar-form .form-control {
    display: inline-block;
    width: auto;
    vertical-align: middle;
  }
  .navbar-form .form-control-static {
    display: inline-block;
  }
  .navbar-form .input-group {
    display: inline-table;
    vertical-align: middle;
  }
  .navbar-form .input-group .input-group-addon,
  .navbar-form .input-group .input-group-btn,
  .navbar-form .input-group .form-control {
    width: auto;
  }
  .navbar-form .input-group > .form-control {
    width: 100%;
  }
  .navbar-form .control-label {
    margin-bottom: 0;
    vertical-align: middle;
  }
  .navbar-form .radio,
  .navbar-form .checkbox {
    display: inline-block;
    margin-top: 0;
    margin-bottom: 0;
    vertical-align: middle;
  }
  .navbar-form .radio label,
  .navbar-form .checkbox label {
    padding-left: 0;
  }
  .navbar-form .radio input[type="radio"],
  .navbar-form .checkbox input[type="checkbox"] {
    position: relative;
    margin-left: 0;
  }
  .navbar-form .has-feedback .form-control-feedback {
    top: 0;
  }
}
@media (max-width: 540px) {
  .navbar-form .form-group {
    margin-bottom: 5px;
  }
  .navbar-form .form-group:last-child {
    margin-bottom: 0;
  }
}
@media (min-width: 541px) {
  .navbar-form {
    width: auto;
    border: 0;
    margin-left: 0;
    margin-right: 0;
    padding-top: 0;
    padding-bottom: 0;
    -webkit-box-shadow: none;
    box-shadow: none;
  }
}
.navbar-nav > li > .dropdown-menu {
  margin-top: 0;
  border-top-right-radius: 0;
  border-top-left-radius: 0;
}
.navbar-fixed-bottom .navbar-nav > li > .dropdown-menu {
  margin-bottom: 0;
  border-top-right-radius: 2px;
  border-top-left-radius: 2px;
  border-bottom-right-radius: 0;
  border-bottom-left-radius: 0;
}
.navbar-btn {
  margin-top: -1px;
  margin-bottom: -1px;
}
.navbar-btn.btn-sm {
  margin-top: 0px;
  margin-bottom: 0px;
}
.navbar-btn.btn-xs {
  margin-top: 4px;
  margin-bottom: 4px;
}
.navbar-text {
  margin-top: 6px;
  margin-bottom: 6px;
}
@media (min-width: 541px) {
  .navbar-text {
    float: left;
    margin-left: 0px;
    margin-right: 0px;
  }
}
@media (min-width: 541px) {
  .navbar-left {
    float: left !important;
    float: left;
  }
  .navbar-right {
    float: right !important;
    float: right;
    margin-right: 0px;
  }
  .navbar-right ~ .navbar-right {
    margin-right: 0;
  }
}
.navbar-default {
  background-color: #f8f8f8;
  border-color: #e7e7e7;
}
.navbar-default .navbar-brand {
  color: #777;
}
.navbar-default .navbar-brand:hover,
.navbar-default .navbar-brand:focus {
  color: #5e5e5e;
  background-color: transparent;
}
.navbar-default .navbar-text {
  color: #777;
}
.navbar-default .navbar-nav > li > a {
  color: #777;
}
.navbar-default .navbar-nav > li > a:hover,
.navbar-default .navbar-nav > li > a:focus {
  color: #333;
  background-color: transparent;
}
.navbar-default .navbar-nav > .active > a,
.navbar-default .navbar-nav > .active > a:hover,
.navbar-default .navbar-nav > .active > a:focus {
  color: #555;
  background-color: #e7e7e7;
}
.navbar-default .navbar-nav > .disabled > a,
.navbar-default .navbar-nav > .disabled > a:hover,
.navbar-default .navbar-nav > .disabled > a:focus {
  color: #ccc;
  background-color: transparent;
}
.navbar-default .navbar-toggle {
  border-color: #ddd;
}
.navbar-default .navbar-toggle:hover,
.navbar-default .navbar-toggle:focus {
  background-color: #ddd;
}
.navbar-default .navbar-toggle .icon-bar {
  background-color: #888;
}
.navbar-default .navbar-collapse,
.navbar-default .navbar-form {
  border-color: #e7e7e7;
}
.navbar-default .navbar-nav > .open > a,
.navbar-default .navbar-nav > .open > a:hover,
.navbar-default .navbar-nav > .open > a:focus {
  background-color: #e7e7e7;
  color: #555;
}
@media (max-width: 540px) {
  .navbar-default .navbar-nav .open .dropdown-menu > li > a {
    color: #777;
  }
  .navbar-default .navbar-nav .open .dropdown-menu > li > a:hover,
  .navbar-default .navbar-nav .open .dropdown-menu > li > a:focus {
    color: #333;
    background-color: transparent;
  }
  .navbar-default .navbar-nav .open .dropdown-menu > .active > a,
  .navbar-default .navbar-nav .open .dropdown-menu > .active > a:hover,
  .navbar-default .navbar-nav .open .dropdown-menu > .active > a:focus {
    color: #555;
    background-color: #e7e7e7;
  }
  .navbar-default .navbar-nav .open .dropdown-menu > .disabled > a,
  .navbar-default .navbar-nav .open .dropdown-menu > .disabled > a:hover,
  .navbar-default .navbar-nav .open .dropdown-menu > .disabled > a:focus {
    color: #ccc;
    background-color: transparent;
  }
}
.navbar-default .navbar-link {
  color: #777;
}
.navbar-default .navbar-link:hover {
  color: #333;
}
.navbar-default .btn-link {
  color: #777;
}
.navbar-default .btn-link:hover,
.navbar-default .btn-link:focus {
  color: #333;
}
.navbar-default .btn-link[disabled]:hover,
fieldset[disabled] .navbar-default .btn-link:hover,
.navbar-default .btn-link[disabled]:focus,
fieldset[disabled] .navbar-default .btn-link:focus {
  color: #ccc;
}
.navbar-inverse {
  background-color: #222;
  border-color: #080808;
}
.navbar-inverse .navbar-brand {
  color: #9d9d9d;
}
.navbar-inverse .navbar-brand:hover,
.navbar-inverse .navbar-brand:focus {
  color: #fff;
  background-color: transparent;
}
.navbar-inverse .navbar-text {
  color: #9d9d9d;
}
.navbar-inverse .navbar-nav > li > a {
  color: #9d9d9d;
}
.navbar-inverse .navbar-nav > li > a:hover,
.navbar-inverse .navbar-nav > li > a:focus {
  color: #fff;
  background-color: transparent;
}
.navbar-inverse .navbar-nav > .active > a,
.navbar-inverse .navbar-nav > .active > a:hover,
.navbar-inverse .navbar-nav > .active > a:focus {
  color: #fff;
  background-color: #080808;
}
.navbar-inverse .navbar-nav > .disabled > a,
.navbar-inverse .navbar-nav > .disabled > a:hover,
.navbar-inverse .navbar-nav > .disabled > a:focus {
  color: #444;
  background-color: transparent;
}
.navbar-inverse .navbar-toggle {
  border-color: #333;
}
.navbar-inverse .navbar-toggle:hover,
.navbar-inverse .navbar-toggle:focus {
  background-color: #333;
}
.navbar-inverse .navbar-toggle .icon-bar {
  background-color: #fff;
}
.navbar-inverse .navbar-collapse,
.navbar-inverse .navbar-form {
  border-color: #101010;
}
.navbar-inverse .navbar-nav > .open > a,
.navbar-inverse .navbar-nav > .open > a:hover,
.navbar-inverse .navbar-nav > .open > a:focus {
  background-color: #080808;
  color: #fff;
}
@media (max-width: 540px) {
  .navbar-inverse .navbar-nav .open .dropdown-menu > .dropdown-header {
    border-color: #080808;
  }
  .navbar-inverse .navbar-nav .open .dropdown-menu .divider {
    background-color: #080808;
  }
  .navbar-inverse .navbar-nav .open .dropdown-menu > li > a {
    color: #9d9d9d;
  }
  .navbar-inverse .navbar-nav .open .dropdown-menu > li > a:hover,
  .navbar-inverse .navbar-nav .open .dropdown-menu > li > a:focus {
    color: #fff;
    background-color: transparent;
  }
  .navbar-inverse .navbar-nav .open .dropdown-menu > .active > a,
  .navbar-inverse .navbar-nav .open .dropdown-menu > .active > a:hover,
  .navbar-inverse .navbar-nav .open .dropdown-menu > .active > a:focus {
    color: #fff;
    background-color: #080808;
  }
  .navbar-inverse .navbar-nav .open .dropdown-menu > .disabled > a,
  .navbar-inverse .navbar-nav .open .dropdown-menu > .disabled > a:hover,
  .navbar-inverse .navbar-nav .open .dropdown-menu > .disabled > a:focus {
    color: #444;
    background-color: transparent;
  }
}
.navbar-inverse .navbar-link {
  color: #9d9d9d;
}
.navbar-inverse .navbar-link:hover {
  color: #fff;
}
.navbar-inverse .btn-link {
  color: #9d9d9d;
}
.navbar-inverse .btn-link:hover,
.navbar-inverse .btn-link:focus {
  color: #fff;
}
.navbar-inverse .btn-link[disabled]:hover,
fieldset[disabled] .navbar-inverse .btn-link:hover,
.navbar-inverse .btn-link[disabled]:focus,
fieldset[disabled] .navbar-inverse .btn-link:focus {
  color: #444;
}
.breadcrumb {
  padding: 8px 15px;
  margin-bottom: 18px;
  list-style: none;
  background-color: #f5f5f5;
  border-radius: 2px;
}
.breadcrumb > li {
  display: inline-block;
}
.breadcrumb > li + li:before {
  content: "/\00a0";
  padding: 0 5px;
  color: #5e5e5e;
}
.breadcrumb > .active {
  color: #777777;
}
.pagination {
  display: inline-block;
  padding-left: 0;
  margin: 18px 0;
  border-radius: 2px;
}
.pagination > li {
  display: inline;
}
.pagination > li > a,
.pagination > li > span {
  position: relative;
  float: left;
  padding: 6px 12px;
  line-height: 1.42857143;
  text-decoration: none;
  color: #337ab7;
  background-color: #fff;
  border: 1px solid #ddd;
  margin-left: -1px;
}
.pagination > li:first-child > a,
.pagination > li:first-child > span {
  margin-left: 0;
  border-bottom-left-radius: 2px;
  border-top-left-radius: 2px;
}
.pagination > li:last-child > a,
.pagination > li:last-child > span {
  border-bottom-right-radius: 2px;
  border-top-right-radius: 2px;
}
.pagination > li > a:hover,
.pagination > li > span:hover,
.pagination > li > a:focus,
.pagination > li > span:focus {
  z-index: 2;
  color: #23527c;
  background-color: #eeeeee;
  border-color: #ddd;
}
.pagination > .active > a,
.pagination > .active > span,
.pagination > .active > a:hover,
.pagination > .active > span:hover,
.pagination > .active > a:focus,
.pagination > .active > span:focus {
  z-index: 3;
  color: #fff;
  background-color: #337ab7;
  border-color: #337ab7;
  cursor: default;
}
.pagination > .disabled > span,
.pagination > .disabled > span:hover,
.pagination > .disabled > span:focus,
.pagination > .disabled > a,
.pagination > .disabled > a:hover,
.pagination > .disabled > a:focus {
  color: #777777;
  background-color: #fff;
  border-color: #ddd;
  cursor: not-allowed;
}
.pagination-lg > li > a,
.pagination-lg > li > span {
  padding: 10px 16px;
  font-size: 17px;
  line-height: 1.3333333;
}
.pagination-lg > li:first-child > a,
.pagination-lg > li:first-child > span {
  border-bottom-left-radius: 3px;
  border-top-left-radius: 3px;
}
.pagination-lg > li:last-child > a,
.pagination-lg > li:last-child > span {
  border-bottom-right-radius: 3px;
  border-top-right-radius: 3px;
}
.pagination-sm > li > a,
.pagination-sm > li > span {
  padding: 5px 10px;
  font-size: 12px;
  line-height: 1.5;
}
.pagination-sm > li:first-child > a,
.pagination-sm > li:first-child > span {
  border-bottom-left-radius: 1px;
  border-top-left-radius: 1px;
}
.pagination-sm > li:last-child > a,
.pagination-sm > li:last-child > span {
  border-bottom-right-radius: 1px;
  border-top-right-radius: 1px;
}
.pager {
  padding-left: 0;
  margin: 18px 0;
  list-style: none;
  text-align: center;
}
.pager li {
  display: inline;
}
.pager li > a,
.pager li > span {
  display: inline-block;
  padding: 5px 14px;
  background-color: #fff;
  border: 1px solid #ddd;
  border-radius: 15px;
}
.pager li > a:hover,
.pager li > a:focus {
  text-decoration: none;
  background-color: #eeeeee;
}
.pager .next > a,
.pager .next > span {
  float: right;
}
.pager .previous > a,
.pager .previous > span {
  float: left;
}
.pager .disabled > a,
.pager .disabled > a:hover,
.pager .disabled > a:focus,
.pager .disabled > span {
  color: #777777;
  background-color: #fff;
  cursor: not-allowed;
}
.label {
  display: inline;
  padding: .2em .6em .3em;
  font-size: 75%;
  font-weight: bold;
  line-height: 1;
  color: #fff;
  text-align: center;
  white-space: nowrap;
  vertical-align: baseline;
  border-radius: .25em;
}
a.label:hover,
a.label:focus {
  color: #fff;
  text-decoration: none;
  cursor: pointer;
}
.label:empty {
  display: none;
}
.btn .label {
  position: relative;
  top: -1px;
}
.label-default {
  background-color: #777777;
}
.label-default[href]:hover,
.label-default[href]:focus {
  background-color: #5e5e5e;
}
.label-primary {
  background-color: #337ab7;
}
.label-primary[href]:hover,
.label-primary[href]:focus {
  background-color: #286090;
}
.label-success {
  background-color: #5cb85c;
}
.label-success[href]:hover,
.label-success[href]:focus {
  background-color: #449d44;
}
.label-info {
  background-color: #5bc0de;
}
.label-info[href]:hover,
.label-info[href]:focus {
  background-color: #31b0d5;
}
.label-warning {
  background-color: #f0ad4e;
}
.label-warning[href]:hover,
.label-warning[href]:focus {
  background-color: #ec971f;
}
.label-danger {
  background-color: #d9534f;
}
.label-danger[href]:hover,
.label-danger[href]:focus {
  background-color: #c9302c;
}
.badge {
  display: inline-block;
  min-width: 10px;
  padding: 3px 7px;
  font-size: 12px;
  font-weight: bold;
  color: #fff;
  line-height: 1;
  vertical-align: middle;
  white-space: nowrap;
  text-align: center;
  background-color: #777777;
  border-radius: 10px;
}
.badge:empty {
  display: none;
}
.btn .badge {
  position: relative;
  top: -1px;
}
.btn-xs .badge,
.btn-group-xs > .btn .badge {
  top: 0;
  padding: 1px 5px;
}
a.badge:hover,
a.badge:focus {
  color: #fff;
  text-decoration: none;
  cursor: pointer;
}
.list-group-item.active > .badge,
.nav-pills > .active > a > .badge {
  color: #337ab7;
  background-color: #fff;
}
.list-group-item > .badge {
  float: right;
}
.list-group-item > .badge + .badge {
  margin-right: 5px;
}
.nav-pills > li > a > .badge {
  margin-left: 3px;
}
.jumbotron {
  padding-top: 30px;
  padding-bottom: 30px;
  margin-bottom: 30px;
  color: inherit;
  background-color: #eeeeee;
}
.jumbotron h1,
.jumbotron .h1 {
  color: inherit;
}
.jumbotron p {
  margin-bottom: 15px;
  font-size: 20px;
  font-weight: 200;
}
.jumbotron > hr {
  border-top-color: #d5d5d5;
}
.container .jumbotron,
.container-fluid .jumbotron {
  border-radius: 3px;
  padding-left: 0px;
  padding-right: 0px;
}
.jumbotron .container {
  max-width: 100%;
}
@media screen and (min-width: 768px) {
  .jumbotron {
    padding-top: 48px;
    padding-bottom: 48px;
  }
  .container .jumbotron,
  .container-fluid .jumbotron {
    padding-left: 60px;
    padding-right: 60px;
  }
  .jumbotron h1,
  .jumbotron .h1 {
    font-size: 59px;
  }
}
.thumbnail {
  display: block;
  padding: 4px;
  margin-bottom: 18px;
  line-height: 1.42857143;
  background-color: #fff;
  border: 1px solid #ddd;
  border-radius: 2px;
  -webkit-transition: border 0.2s ease-in-out;
  -o-transition: border 0.2s ease-in-out;
  transition: border 0.2s ease-in-out;
}
.thumbnail > img,
.thumbnail a > img {
  margin-left: auto;
  margin-right: auto;
}
a.thumbnail:hover,
a.thumbnail:focus,
a.thumbnail.active {
  border-color: #337ab7;
}
.thumbnail .caption {
  padding: 9px;
  color: #000;
}
.alert {
  padding: 15px;
  margin-bottom: 18px;
  border: 1px solid transparent;
  border-radius: 2px;
}
.alert h4 {
  margin-top: 0;
  color: inherit;
}
.alert .alert-link {
  font-weight: bold;
}
.alert > p,
.alert > ul {
  margin-bottom: 0;
}
.alert > p + p {
  margin-top: 5px;
}
.alert-dismissable,
.alert-dismissible {
  padding-right: 35px;
}
.alert-dismissable .close,
.alert-dismissible .close {
  position: relative;
  top: -2px;
  right: -21px;
  color: inherit;
}
.alert-success {
  background-color: #dff0d8;
  border-color: #d6e9c6;
  color: #3c763d;
}
.alert-success hr {
  border-top-color: #c9e2b3;
}
.alert-success .alert-link {
  color: #2b542c;
}
.alert-info {
  background-color: #d9edf7;
  border-color: #bce8f1;
  color: #31708f;
}
.alert-info hr {
  border-top-color: #a6e1ec;
}
.alert-info .alert-link {
  color: #245269;
}
.alert-warning {
  background-color: #fcf8e3;
  border-color: #faebcc;
  color: #8a6d3b;
}
.alert-warning hr {
  border-top-color: #f7e1b5;
}
.alert-warning .alert-link {
  color: #66512c;
}
.alert-danger {
  background-color: #f2dede;
  border-color: #ebccd1;
  color: #a94442;
}
.alert-danger hr {
  border-top-color: #e4b9c0;
}
.alert-danger .alert-link {
  color: #843534;
}
@-webkit-keyframes progress-bar-stripes {
  from {
    background-position: 40px 0;
  }
  to {
    background-position: 0 0;
  }
}
@keyframes progress-bar-stripes {
  from {
    background-position: 40px 0;
  }
  to {
    background-position: 0 0;
  }
}
.progress {
  overflow: hidden;
  height: 18px;
  margin-bottom: 18px;
  background-color: #f5f5f5;
  border-radius: 2px;
  -webkit-box-shadow: inset 0 1px 2px rgba(0, 0, 0, 0.1);
  box-shadow: inset 0 1px 2px rgba(0, 0, 0, 0.1);
}
.progress-bar {
  float: left;
  width: 0%;
  height: 100%;
  font-size: 12px;
  line-height: 18px;
  color: #fff;
  text-align: center;
  background-color: #337ab7;
  -webkit-box-shadow: inset 0 -1px 0 rgba(0, 0, 0, 0.15);
  box-shadow: inset 0 -1px 0 rgba(0, 0, 0, 0.15);
  -webkit-transition: width 0.6s ease;
  -o-transition: width 0.6s ease;
  transition: width 0.6s ease;
}
.progress-striped .progress-bar,
.progress-bar-striped {
  background-image: -webkit-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: -o-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-size: 40px 40px;
}
.progress.active .progress-bar,
.progress-bar.active {
  -webkit-animation: progress-bar-stripes 2s linear infinite;
  -o-animation: progress-bar-stripes 2s linear infinite;
  animation: progress-bar-stripes 2s linear infinite;
}
.progress-bar-success {
  background-color: #5cb85c;
}
.progress-striped .progress-bar-success {
  background-image: -webkit-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: -o-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
}
.progress-bar-info {
  background-color: #5bc0de;
}
.progress-striped .progress-bar-info {
  background-image: -webkit-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: -o-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
}
.progress-bar-warning {
  background-color: #f0ad4e;
}
.progress-striped .progress-bar-warning {
  background-image: -webkit-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: -o-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
}
.progress-bar-danger {
  background-color: #d9534f;
}
.progress-striped .progress-bar-danger {
  background-image: -webkit-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: -o-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
}
.media {
  margin-top: 15px;
}
.media:first-child {
  margin-top: 0;
}
.media,
.media-body {
  zoom: 1;
  overflow: hidden;
}
.media-body {
  width: 10000px;
}
.media-object {
  display: block;
}
.media-object.img-thumbnail {
  max-width: none;
}
.media-right,
.media > .pull-right {
  padding-left: 10px;
}
.media-left,
.media > .pull-left {
  padding-right: 10px;
}
.media-left,
.media-right,
.media-body {
  display: table-cell;
  vertical-align: top;
}
.media-middle {
  vertical-align: middle;
}
.media-bottom {
  vertical-align: bottom;
}
.media-heading {
  margin-top: 0;
  margin-bottom: 5px;
}
.media-list {
  padding-left: 0;
  list-style: none;
}
.list-group {
  margin-bottom: 20px;
  padding-left: 0;
}
.list-group-item {
  position: relative;
  display: block;
  padding: 10px 15px;
  margin-bottom: -1px;
  background-color: #fff;
  border: 1px solid #ddd;
}
.list-group-item:first-child {
  border-top-right-radius: 2px;
  border-top-left-radius: 2px;
}
.list-group-item:last-child {
  margin-bottom: 0;
  border-bottom-right-radius: 2px;
  border-bottom-left-radius: 2px;
}
a.list-group-item,
button.list-group-item {
  color: #555;
}
a.list-group-item .list-group-item-heading,
button.list-group-item .list-group-item-heading {
  color: #333;
}
a.list-group-item:hover,
button.list-group-item:hover,
a.list-group-item:focus,
button.list-group-item:focus {
  text-decoration: none;
  color: #555;
  background-color: #f5f5f5;
}
button.list-group-item {
  width: 100%;
  text-align: left;
}
.list-group-item.disabled,
.list-group-item.disabled:hover,
.list-group-item.disabled:focus {
  background-color: #eeeeee;
  color: #777777;
  cursor: not-allowed;
}
.list-group-item.disabled .list-group-item-heading,
.list-group-item.disabled:hover .list-group-item-heading,
.list-group-item.disabled:focus .list-group-item-heading {
  color: inherit;
}
.list-group-item.disabled .list-group-item-text,
.list-group-item.disabled:hover .list-group-item-text,
.list-group-item.disabled:focus .list-group-item-text {
  color: #777777;
}
.list-group-item.active,
.list-group-item.active:hover,
.list-group-item.active:focus {
  z-index: 2;
  color: #fff;
  background-color: #337ab7;
  border-color: #337ab7;
}
.list-group-item.active .list-group-item-heading,
.list-group-item.active:hover .list-group-item-heading,
.list-group-item.active:focus .list-group-item-heading,
.list-group-item.active .list-group-item-heading > small,
.list-group-item.active:hover .list-group-item-heading > small,
.list-group-item.active:focus .list-group-item-heading > small,
.list-group-item.active .list-group-item-heading > .small,
.list-group-item.active:hover .list-group-item-heading > .small,
.list-group-item.active:focus .list-group-item-heading > .small {
  color: inherit;
}
.list-group-item.active .list-group-item-text,
.list-group-item.active:hover .list-group-item-text,
.list-group-item.active:focus .list-group-item-text {
  color: #c7ddef;
}
.list-group-item-success {
  color: #3c763d;
  background-color: #dff0d8;
}
a.list-group-item-success,
button.list-group-item-success {
  color: #3c763d;
}
a.list-group-item-success .list-group-item-heading,
button.list-group-item-success .list-group-item-heading {
  color: inherit;
}
a.list-group-item-success:hover,
button.list-group-item-success:hover,
a.list-group-item-success:focus,
button.list-group-item-success:focus {
  color: #3c763d;
  background-color: #d0e9c6;
}
a.list-group-item-success.active,
button.list-group-item-success.active,
a.list-group-item-success.active:hover,
button.list-group-item-success.active:hover,
a.list-group-item-success.active:focus,
button.list-group-item-success.active:focus {
  color: #fff;
  background-color: #3c763d;
  border-color: #3c763d;
}
.list-group-item-info {
  color: #31708f;
  background-color: #d9edf7;
}
a.list-group-item-info,
button.list-group-item-info {
  color: #31708f;
}
a.list-group-item-info .list-group-item-heading,
button.list-group-item-info .list-group-item-heading {
  color: inherit;
}
a.list-group-item-info:hover,
button.list-group-item-info:hover,
a.list-group-item-info:focus,
button.list-group-item-info:focus {
  color: #31708f;
  background-color: #c4e3f3;
}
a.list-group-item-info.active,
button.list-group-item-info.active,
a.list-group-item-info.active:hover,
button.list-group-item-info.active:hover,
a.list-group-item-info.active:focus,
button.list-group-item-info.active:focus {
  color: #fff;
  background-color: #31708f;
  border-color: #31708f;
}
.list-group-item-warning {
  color: #8a6d3b;
  background-color: #fcf8e3;
}
a.list-group-item-warning,
button.list-group-item-warning {
  color: #8a6d3b;
}
a.list-group-item-warning .list-group-item-heading,
button.list-group-item-warning .list-group-item-heading {
  color: inherit;
}
a.list-group-item-warning:hover,
button.list-group-item-warning:hover,
a.list-group-item-warning:focus,
button.list-group-item-warning:focus {
  color: #8a6d3b;
  background-color: #faf2cc;
}
a.list-group-item-warning.active,
button.list-group-item-warning.active,
a.list-group-item-warning.active:hover,
button.list-group-item-warning.active:hover,
a.list-group-item-warning.active:focus,
button.list-group-item-warning.active:focus {
  color: #fff;
  background-color: #8a6d3b;
  border-color: #8a6d3b;
}
.list-group-item-danger {
  color: #a94442;
  background-color: #f2dede;
}
a.list-group-item-danger,
button.list-group-item-danger {
  color: #a94442;
}
a.list-group-item-danger .list-group-item-heading,
button.list-group-item-danger .list-group-item-heading {
  color: inherit;
}
a.list-group-item-danger:hover,
button.list-group-item-danger:hover,
a.list-group-item-danger:focus,
button.list-group-item-danger:focus {
  color: #a94442;
  background-color: #ebcccc;
}
a.list-group-item-danger.active,
button.list-group-item-danger.active,
a.list-group-item-danger.active:hover,
button.list-group-item-danger.active:hover,
a.list-group-item-danger.active:focus,
button.list-group-item-danger.active:focus {
  color: #fff;
  background-color: #a94442;
  border-color: #a94442;
}
.list-group-item-heading {
  margin-top: 0;
  margin-bottom: 5px;
}
.list-group-item-text {
  margin-bottom: 0;
  line-height: 1.3;
}
.panel {
  margin-bottom: 18px;
  background-color: #fff;
  border: 1px solid transparent;
  border-radius: 2px;
  -webkit-box-shadow: 0 1px 1px rgba(0, 0, 0, 0.05);
  box-shadow: 0 1px 1px rgba(0, 0, 0, 0.05);
}
.panel-body {
  padding: 15px;
}
.panel-heading {
  padding: 10px 15px;
  border-bottom: 1px solid transparent;
  border-top-right-radius: 1px;
  border-top-left-radius: 1px;
}
.panel-heading > .dropdown .dropdown-toggle {
  color: inherit;
}
.panel-title {
  margin-top: 0;
  margin-bottom: 0;
  font-size: 15px;
  color: inherit;
}
.panel-title > a,
.panel-title > small,
.panel-title > .small,
.panel-title > small > a,
.panel-title > .small > a {
  color: inherit;
}
.panel-footer {
  padding: 10px 15px;
  background-color: #f5f5f5;
  border-top: 1px solid #ddd;
  border-bottom-right-radius: 1px;
  border-bottom-left-radius: 1px;
}
.panel > .list-group,
.panel > .panel-collapse > .list-group {
  margin-bottom: 0;
}
.panel > .list-group .list-group-item,
.panel > .panel-collapse > .list-group .list-group-item {
  border-width: 1px 0;
  border-radius: 0;
}
.panel > .list-group:first-child .list-group-item:first-child,
.panel > .panel-collapse > .list-group:first-child .list-group-item:first-child {
  border-top: 0;
  border-top-right-radius: 1px;
  border-top-left-radius: 1px;
}
.panel > .list-group:last-child .list-group-item:last-child,
.panel > .panel-collapse > .list-group:last-child .list-group-item:last-child {
  border-bottom: 0;
  border-bottom-right-radius: 1px;
  border-bottom-left-radius: 1px;
}
.panel > .panel-heading + .panel-collapse > .list-group .list-group-item:first-child {
  border-top-right-radius: 0;
  border-top-left-radius: 0;
}
.panel-heading + .list-group .list-group-item:first-child {
  border-top-width: 0;
}
.list-group + .panel-footer {
  border-top-width: 0;
}
.panel > .table,
.panel > .table-responsive > .table,
.panel > .panel-collapse > .table {
  margin-bottom: 0;
}
.panel > .table caption,
.panel > .table-responsive > .table caption,
.panel > .panel-collapse > .table caption {
  padding-left: 15px;
  padding-right: 15px;
}
.panel > .table:first-child,
.panel > .table-responsive:first-child > .table:first-child {
  border-top-right-radius: 1px;
  border-top-left-radius: 1px;
}
.panel > .table:first-child > thead:first-child > tr:first-child,
.panel > .table-responsive:first-child > .table:first-child > thead:first-child > tr:first-child,
.panel > .table:first-child > tbody:first-child > tr:first-child,
.panel > .table-responsive:first-child > .table:first-child > tbody:first-child > tr:first-child {
  border-top-left-radius: 1px;
  border-top-right-radius: 1px;
}
.panel > .table:first-child > thead:first-child > tr:first-child td:first-child,
.panel > .table-responsive:first-child > .table:first-child > thead:first-child > tr:first-child td:first-child,
.panel > .table:first-child > tbody:first-child > tr:first-child td:first-child,
.panel > .table-responsive:first-child > .table:first-child > tbody:first-child > tr:first-child td:first-child,
.panel > .table:first-child > thead:first-child > tr:first-child th:first-child,
.panel > .table-responsive:first-child > .table:first-child > thead:first-child > tr:first-child th:first-child,
.panel > .table:first-child > tbody:first-child > tr:first-child th:first-child,
.panel > .table-responsive:first-child > .table:first-child > tbody:first-child > tr:first-child th:first-child {
  border-top-left-radius: 1px;
}
.panel > .table:first-child > thead:first-child > tr:first-child td:last-child,
.panel > .table-responsive:first-child > .table:first-child > thead:first-child > tr:first-child td:last-child,
.panel > .table:first-child > tbody:first-child > tr:first-child td:last-child,
.panel > .table-responsive:first-child > .table:first-child > tbody:first-child > tr:first-child td:last-child,
.panel > .table:first-child > thead:first-child > tr:first-child th:last-child,
.panel > .table-responsive:first-child > .table:first-child > thead:first-child > tr:first-child th:last-child,
.panel > .table:first-child > tbody:first-child > tr:first-child th:last-child,
.panel > .table-responsive:first-child > .table:first-child > tbody:first-child > tr:first-child th:last-child {
  border-top-right-radius: 1px;
}
.panel > .table:last-child,
.panel > .table-responsive:last-child > .table:last-child {
  border-bottom-right-radius: 1px;
  border-bottom-left-radius: 1px;
}
.panel > .table:last-child > tbody:last-child > tr:last-child,
.panel > .table-responsive:last-child > .table:last-child > tbody:last-child > tr:last-child,
.panel > .table:last-child > tfoot:last-child > tr:last-child,
.panel > .table-responsive:last-child > .table:last-child > tfoot:last-child > tr:last-child {
  border-bottom-left-radius: 1px;
  border-bottom-right-radius: 1px;
}
.panel > .table:last-child > tbody:last-child > tr:last-child td:first-child,
.panel > .table-responsive:last-child > .table:last-child > tbody:last-child > tr:last-child td:first-child,
.panel > .table:last-child > tfoot:last-child > tr:last-child td:first-child,
.panel > .table-responsive:last-child > .table:last-child > tfoot:last-child > tr:last-child td:first-child,
.panel > .table:last-child > tbody:last-child > tr:last-child th:first-child,
.panel > .table-responsive:last-child > .table:last-child > tbody:last-child > tr:last-child th:first-child,
.panel > .table:last-child > tfoot:last-child > tr:last-child th:first-child,
.panel > .table-responsive:last-child > .table:last-child > tfoot:last-child > tr:last-child th:first-child {
  border-bottom-left-radius: 1px;
}
.panel > .table:last-child > tbody:last-child > tr:last-child td:last-child,
.panel > .table-responsive:last-child > .table:last-child > tbody:last-child > tr:last-child td:last-child,
.panel > .table:last-child > tfoot:last-child > tr:last-child td:last-child,
.panel > .table-responsive:last-child > .table:last-child > tfoot:last-child > tr:last-child td:last-child,
.panel > .table:last-child > tbody:last-child > tr:last-child th:last-child,
.panel > .table-responsive:last-child > .table:last-child > tbody:last-child > tr:last-child th:last-child,
.panel > .table:last-child > tfoot:last-child > tr:last-child th:last-child,
.panel > .table-responsive:last-child > .table:last-child > tfoot:last-child > tr:last-child th:last-child {
  border-bottom-right-radius: 1px;
}
.panel > .panel-body + .table,
.panel > .panel-body + .table-responsive,
.panel > .table + .panel-body,
.panel > .table-responsive + .panel-body {
  border-top: 1px solid #ddd;
}
.panel > .table > tbody:first-child > tr:first-child th,
.panel > .table > tbody:first-child > tr:first-child td {
  border-top: 0;
}
.panel > .table-bordered,
.panel > .table-responsive > .table-bordered {
  border: 0;
}
.panel > .table-bordered > thead > tr > th:first-child,
.panel > .table-responsive > .table-bordered > thead > tr > th:first-child,
.panel > .table-bordered > tbody > tr > th:first-child,
.panel > .table-responsive > .table-bordered > tbody > tr > th:first-child,
.panel > .table-bordered > tfoot > tr > th:first-child,
.panel > .table-responsive > .table-bordered > tfoot > tr > th:first-child,
.panel > .table-bordered > thead > tr > td:first-child,
.panel > .table-responsive > .table-bordered > thead > tr > td:first-child,
.panel > .table-bordered > tbody > tr > td:first-child,
.panel > .table-responsive > .table-bordered > tbody > tr > td:first-child,
.panel > .table-bordered > tfoot > tr > td:first-child,
.panel > .table-responsive > .table-bordered > tfoot > tr > td:first-child {
  border-left: 0;
}
.panel > .table-bordered > thead > tr > th:last-child,
.panel > .table-responsive > .table-bordered > thead > tr > th:last-child,
.panel > .table-bordered > tbody > tr > th:last-child,
.panel > .table-responsive > .table-bordered > tbody > tr > th:last-child,
.panel > .table-bordered > tfoot > tr > th:last-child,
.panel > .table-responsive > .table-bordered > tfoot > tr > th:last-child,
.panel > .table-bordered > thead > tr > td:last-child,
.panel > .table-responsive > .table-bordered > thead > tr > td:last-child,
.panel > .table-bordered > tbody > tr > td:last-child,
.panel > .table-responsive > .table-bordered > tbody > tr > td:last-child,
.panel > .table-bordered > tfoot > tr > td:last-child,
.panel > .table-responsive > .table-bordered > tfoot > tr > td:last-child {
  border-right: 0;
}
.panel > .table-bordered > thead > tr:first-child > td,
.panel > .table-responsive > .table-bordered > thead > tr:first-child > td,
.panel > .table-bordered > tbody > tr:first-child > td,
.panel > .table-responsive > .table-bordered > tbody > tr:first-child > td,
.panel > .table-bordered > thead > tr:first-child > th,
.panel > .table-responsive > .table-bordered > thead > tr:first-child > th,
.panel > .table-bordered > tbody > tr:first-child > th,
.panel > .table-responsive > .table-bordered > tbody > tr:first-child > th {
  border-bottom: 0;
}
.panel > .table-bordered > tbody > tr:last-child > td,
.panel > .table-responsive > .table-bordered > tbody > tr:last-child > td,
.panel > .table-bordered > tfoot > tr:last-child > td,
.panel > .table-responsive > .table-bordered > tfoot > tr:last-child > td,
.panel > .table-bordered > tbody > tr:last-child > th,
.panel > .table-responsive > .table-bordered > tbody > tr:last-child > th,
.panel > .table-bordered > tfoot > tr:last-child > th,
.panel > .table-responsive > .table-bordered > tfoot > tr:last-child > th {
  border-bottom: 0;
}
.panel > .table-responsive {
  border: 0;
  margin-bottom: 0;
}
.panel-group {
  margin-bottom: 18px;
}
.panel-group .panel {
  margin-bottom: 0;
  border-radius: 2px;
}
.panel-group .panel + .panel {
  margin-top: 5px;
}
.panel-group .panel-heading {
  border-bottom: 0;
}
.panel-group .panel-heading + .panel-collapse > .panel-body,
.panel-group .panel-heading + .panel-collapse > .list-group {
  border-top: 1px solid #ddd;
}
.panel-group .panel-footer {
  border-top: 0;
}
.panel-group .panel-footer + .panel-collapse .panel-body {
  border-bottom: 1px solid #ddd;
}
.panel-default {
  border-color: #ddd;
}
.panel-default > .panel-heading {
  color: #333333;
  background-color: #f5f5f5;
  border-color: #ddd;
}
.panel-default > .panel-heading + .panel-collapse > .panel-body {
  border-top-color: #ddd;
}
.panel-default > .panel-heading .badge {
  color: #f5f5f5;
  background-color: #333333;
}
.panel-default > .panel-footer + .panel-collapse > .panel-body {
  border-bottom-color: #ddd;
}
.panel-primary {
  border-color: #337ab7;
}
.panel-primary > .panel-heading {
  color: #fff;
  background-color: #337ab7;
  border-color: #337ab7;
}
.panel-primary > .panel-heading + .panel-collapse > .panel-body {
  border-top-color: #337ab7;
}
.panel-primary > .panel-heading .badge {
  color: #337ab7;
  background-color: #fff;
}
.panel-primary > .panel-footer + .panel-collapse > .panel-body {
  border-bottom-color: #337ab7;
}
.panel-success {
  border-color: #d6e9c6;
}
.panel-success > .panel-heading {
  color: #3c763d;
  background-color: #dff0d8;
  border-color: #d6e9c6;
}
.panel-success > .panel-heading + .panel-collapse > .panel-body {
  border-top-color: #d6e9c6;
}
.panel-success > .panel-heading .badge {
  color: #dff0d8;
  background-color: #3c763d;
}
.panel-success > .panel-footer + .panel-collapse > .panel-body {
  border-bottom-color: #d6e9c6;
}
.panel-info {
  border-color: #bce8f1;
}
.panel-info > .panel-heading {
  color: #31708f;
  background-color: #d9edf7;
  border-color: #bce8f1;
}
.panel-info > .panel-heading + .panel-collapse > .panel-body {
  border-top-color: #bce8f1;
}
.panel-info > .panel-heading .badge {
  color: #d9edf7;
  background-color: #31708f;
}
.panel-info > .panel-footer + .panel-collapse > .panel-body {
  border-bottom-color: #bce8f1;
}
.panel-warning {
  border-color: #faebcc;
}
.panel-warning > .panel-heading {
  color: #8a6d3b;
  background-color: #fcf8e3;
  border-color: #faebcc;
}
.panel-warning > .panel-heading + .panel-collapse > .panel-body {
  border-top-color: #faebcc;
}
.panel-warning > .panel-heading .badge {
  color: #fcf8e3;
  background-color: #8a6d3b;
}
.panel-warning > .panel-footer + .panel-collapse > .panel-body {
  border-bottom-color: #faebcc;
}
.panel-danger {
  border-color: #ebccd1;
}
.panel-danger > .panel-heading {
  color: #a94442;
  background-color: #f2dede;
  border-color: #ebccd1;
}
.panel-danger > .panel-heading + .panel-collapse > .panel-body {
  border-top-color: #ebccd1;
}
.panel-danger > .panel-heading .badge {
  color: #f2dede;
  background-color: #a94442;
}
.panel-danger > .panel-footer + .panel-collapse > .panel-body {
  border-bottom-color: #ebccd1;
}
.embed-responsive {
  position: relative;
  display: block;
  height: 0;
  padding: 0;
  overflow: hidden;
}
.embed-responsive .embed-responsive-item,
.embed-responsive iframe,
.embed-responsive embed,
.embed-responsive object,
.embed-responsive video {
  position: absolute;
  top: 0;
  left: 0;
  bottom: 0;
  height: 100%;
  width: 100%;
  border: 0;
}
.embed-responsive-16by9 {
  padding-bottom: 56.25%;
}
.embed-responsive-4by3 {
  padding-bottom: 75%;
}
.well {
  min-height: 20px;
  padding: 19px;
  margin-bottom: 20px;
  background-color: #f5f5f5;
  border: 1px solid #e3e3e3;
  border-radius: 2px;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.05);
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.05);
}
.well blockquote {
  border-color: #ddd;
  border-color: rgba(0, 0, 0, 0.15);
}
.well-lg {
  padding: 24px;
  border-radius: 3px;
}
.well-sm {
  padding: 9px;
  border-radius: 1px;
}
.close {
  float: right;
  font-size: 19.5px;
  font-weight: bold;
  line-height: 1;
  color: #000;
  text-shadow: 0 1px 0 #fff;
  opacity: 0.2;
  filter: alpha(opacity=20);
}
.close:hover,
.close:focus {
  color: #000;
  text-decoration: none;
  cursor: pointer;
  opacity: 0.5;
  filter: alpha(opacity=50);
}
button.close {
  padding: 0;
  cursor: pointer;
  background: transparent;
  border: 0;
  -webkit-appearance: none;
}
.modal-open {
  overflow: hidden;
}
.modal {
  display: none;
  overflow: hidden;
  position: fixed;
  top: 0;
  right: 0;
  bottom: 0;
  left: 0;
  z-index: 1050;
  -webkit-overflow-scrolling: touch;
  outline: 0;
}
.modal.fade .modal-dialog {
  -webkit-transform: translate(0, -25%);
  -ms-transform: translate(0, -25%);
  -o-transform: translate(0, -25%);
  transform: translate(0, -25%);
  -webkit-transition: -webkit-transform 0.3s ease-out;
  -moz-transition: -moz-transform 0.3s ease-out;
  -o-transition: -o-transform 0.3s ease-out;
  transition: transform 0.3s ease-out;
}
.modal.in .modal-dialog {
  -webkit-transform: translate(0, 0);
  -ms-transform: translate(0, 0);
  -o-transform: translate(0, 0);
  transform: translate(0, 0);
}
.modal-open .modal {
  overflow-x: hidden;
  overflow-y: auto;
}
.modal-dialog {
  position: relative;
  width: auto;
  margin: 10px;
}
.modal-content {
  position: relative;
  background-color: #fff;
  border: 1px solid #999;
  border: 1px solid rgba(0, 0, 0, 0.2);
  border-radius: 3px;
  -webkit-box-shadow: 0 3px 9px rgba(0, 0, 0, 0.5);
  box-shadow: 0 3px 9px rgba(0, 0, 0, 0.5);
  background-clip: padding-box;
  outline: 0;
}
.modal-backdrop {
  position: fixed;
  top: 0;
  right: 0;
  bottom: 0;
  left: 0;
  z-index: 1040;
  background-color: #000;
}
.modal-backdrop.fade {
  opacity: 0;
  filter: alpha(opacity=0);
}
.modal-backdrop.in {
  opacity: 0.5;
  filter: alpha(opacity=50);
}
.modal-header {
  padding: 15px;
  border-bottom: 1px solid #e5e5e5;
}
.modal-header .close {
  margin-top: -2px;
}
.modal-title {
  margin: 0;
  line-height: 1.42857143;
}
.modal-body {
  position: relative;
  padding: 15px;
}
.modal-footer {
  padding: 15px;
  text-align: right;
  border-top: 1px solid #e5e5e5;
}
.modal-footer .btn + .btn {
  margin-left: 5px;
  margin-bottom: 0;
}
.modal-footer .btn-group .btn + .btn {
  margin-left: -1px;
}
.modal-footer .btn-block + .btn-block {
  margin-left: 0;
}
.modal-scrollbar-measure {
  position: absolute;
  top: -9999px;
  width: 50px;
  height: 50px;
  overflow: scroll;
}
@media (min-width: 768px) {
  .modal-dialog {
    width: 600px;
    margin: 30px auto;
  }
  .modal-content {
    -webkit-box-shadow: 0 5px 15px rgba(0, 0, 0, 0.5);
    box-shadow: 0 5px 15px rgba(0, 0, 0, 0.5);
  }
  .modal-sm {
    width: 300px;
  }
}
@media (min-width: 992px) {
  .modal-lg {
    width: 900px;
  }
}
.tooltip {
  position: absolute;
  z-index: 1070;
  display: block;
  font-family: "Helvetica Neue", Helvetica, Arial, sans-serif;
  font-style: normal;
  font-weight: normal;
  letter-spacing: normal;
  line-break: auto;
  line-height: 1.42857143;
  text-align: left;
  text-align: start;
  text-decoration: none;
  text-shadow: none;
  text-transform: none;
  white-space: normal;
  word-break: normal;
  word-spacing: normal;
  word-wrap: normal;
  font-size: 12px;
  opacity: 0;
  filter: alpha(opacity=0);
}
.tooltip.in {
  opacity: 0.9;
  filter: alpha(opacity=90);
}
.tooltip.top {
  margin-top: -3px;
  padding: 5px 0;
}
.tooltip.right {
  margin-left: 3px;
  padding: 0 5px;
}
.tooltip.bottom {
  margin-top: 3px;
  padding: 5px 0;
}
.tooltip.left {
  margin-left: -3px;
  padding: 0 5px;
}
.tooltip-inner {
  max-width: 200px;
  padding: 3px 8px;
  color: #fff;
  text-align: center;
  background-color: #000;
  border-radius: 2px;
}
.tooltip-arrow {
  position: absolute;
  width: 0;
  height: 0;
  border-color: transparent;
  border-style: solid;
}
.tooltip.top .tooltip-arrow {
  bottom: 0;
  left: 50%;
  margin-left: -5px;
  border-width: 5px 5px 0;
  border-top-color: #000;
}
.tooltip.top-left .tooltip-arrow {
  bottom: 0;
  right: 5px;
  margin-bottom: -5px;
  border-width: 5px 5px 0;
  border-top-color: #000;
}
.tooltip.top-right .tooltip-arrow {
  bottom: 0;
  left: 5px;
  margin-bottom: -5px;
  border-width: 5px 5px 0;
  border-top-color: #000;
}
.tooltip.right .tooltip-arrow {
  top: 50%;
  left: 0;
  margin-top: -5px;
  border-width: 5px 5px 5px 0;
  border-right-color: #000;
}
.tooltip.left .tooltip-arrow {
  top: 50%;
  right: 0;
  margin-top: -5px;
  border-width: 5px 0 5px 5px;
  border-left-color: #000;
}
.tooltip.bottom .tooltip-arrow {
  top: 0;
  left: 50%;
  margin-left: -5px;
  border-width: 0 5px 5px;
  border-bottom-color: #000;
}
.tooltip.bottom-left .tooltip-arrow {
  top: 0;
  right: 5px;
  margin-top: -5px;
  border-width: 0 5px 5px;
  border-bottom-color: #000;
}
.tooltip.bottom-right .tooltip-arrow {
  top: 0;
  left: 5px;
  margin-top: -5px;
  border-width: 0 5px 5px;
  border-bottom-color: #000;
}
.popover {
  position: absolute;
  top: 0;
  left: 0;
  z-index: 1060;
  display: none;
  max-width: 276px;
  padding: 1px;
  font-family: "Helvetica Neue", Helvetica, Arial, sans-serif;
  font-style: normal;
  font-weight: normal;
  letter-spacing: normal;
  line-break: auto;
  line-height: 1.42857143;
  text-align: left;
  text-align: start;
  text-decoration: none;
  text-shadow: none;
  text-transform: none;
  white-space: normal;
  word-break: normal;
  word-spacing: normal;
  word-wrap: normal;
  font-size: 13px;
  background-color: #fff;
  background-clip: padding-box;
  border: 1px solid #ccc;
  border: 1px solid rgba(0, 0, 0, 0.2);
  border-radius: 3px;
  -webkit-box-shadow: 0 5px 10px rgba(0, 0, 0, 0.2);
  box-shadow: 0 5px 10px rgba(0, 0, 0, 0.2);
}
.popover.top {
  margin-top: -10px;
}
.popover.right {
  margin-left: 10px;
}
.popover.bottom {
  margin-top: 10px;
}
.popover.left {
  margin-left: -10px;
}
.popover-title {
  margin: 0;
  padding: 8px 14px;
  font-size: 13px;
  background-color: #f7f7f7;
  border-bottom: 1px solid #ebebeb;
  border-radius: 2px 2px 0 0;
}
.popover-content {
  padding: 9px 14px;
}
.popover > .arrow,
.popover > .arrow:after {
  position: absolute;
  display: block;
  width: 0;
  height: 0;
  border-color: transparent;
  border-style: solid;
}
.popover > .arrow {
  border-width: 11px;
}
.popover > .arrow:after {
  border-width: 10px;
  content: "";
}
.popover.top > .arrow {
  left: 50%;
  margin-left: -11px;
  border-bottom-width: 0;
  border-top-color: #999999;
  border-top-color: rgba(0, 0, 0, 0.25);
  bottom: -11px;
}
.popover.top > .arrow:after {
  content: " ";
  bottom: 1px;
  margin-left: -10px;
  border-bottom-width: 0;
  border-top-color: #fff;
}
.popover.right > .arrow {
  top: 50%;
  left: -11px;
  margin-top: -11px;
  border-left-width: 0;
  border-right-color: #999999;
  border-right-color: rgba(0, 0, 0, 0.25);
}
.popover.right > .arrow:after {
  content: " ";
  left: 1px;
  bottom: -10px;
  border-left-width: 0;
  border-right-color: #fff;
}
.popover.bottom > .arrow {
  left: 50%;
  margin-left: -11px;
  border-top-width: 0;
  border-bottom-color: #999999;
  border-bottom-color: rgba(0, 0, 0, 0.25);
  top: -11px;
}
.popover.bottom > .arrow:after {
  content: " ";
  top: 1px;
  margin-left: -10px;
  border-top-width: 0;
  border-bottom-color: #fff;
}
.popover.left > .arrow {
  top: 50%;
  right: -11px;
  margin-top: -11px;
  border-right-width: 0;
  border-left-color: #999999;
  border-left-color: rgba(0, 0, 0, 0.25);
}
.popover.left > .arrow:after {
  content: " ";
  right: 1px;
  border-right-width: 0;
  border-left-color: #fff;
  bottom: -10px;
}
.carousel {
  position: relative;
}
.carousel-inner {
  position: relative;
  overflow: hidden;
  width: 100%;
}
.carousel-inner > .item {
  display: none;
  position: relative;
  -webkit-transition: 0.6s ease-in-out left;
  -o-transition: 0.6s ease-in-out left;
  transition: 0.6s ease-in-out left;
}
.carousel-inner > .item > img,
.carousel-inner > .item > a > img {
  line-height: 1;
}
@media all and (transform-3d), (-webkit-transform-3d) {
  .carousel-inner > .item {
    -webkit-transition: -webkit-transform 0.6s ease-in-out;
    -moz-transition: -moz-transform 0.6s ease-in-out;
    -o-transition: -o-transform 0.6s ease-in-out;
    transition: transform 0.6s ease-in-out;
    -webkit-backface-visibility: hidden;
    -moz-backface-visibility: hidden;
    backface-visibility: hidden;
    -webkit-perspective: 1000px;
    -moz-perspective: 1000px;
    perspective: 1000px;
  }
  .carousel-inner > .item.next,
  .carousel-inner > .item.active.right {
    -webkit-transform: translate3d(100%, 0, 0);
    transform: translate3d(100%, 0, 0);
    left: 0;
  }
  .carousel-inner > .item.prev,
  .carousel-inner > .item.active.left {
    -webkit-transform: translate3d(-100%, 0, 0);
    transform: translate3d(-100%, 0, 0);
    left: 0;
  }
  .carousel-inner > .item.next.left,
  .carousel-inner > .item.prev.right,
  .carousel-inner > .item.active {
    -webkit-transform: translate3d(0, 0, 0);
    transform: translate3d(0, 0, 0);
    left: 0;
  }
}
.carousel-inner > .active,
.carousel-inner > .next,
.carousel-inner > .prev {
  display: block;
}
.carousel-inner > .active {
  left: 0;
}
.carousel-inner > .next,
.carousel-inner > .prev {
  position: absolute;
  top: 0;
  width: 100%;
}
.carousel-inner > .next {
  left: 100%;
}
.carousel-inner > .prev {
  left: -100%;
}
.carousel-inner > .next.left,
.carousel-inner > .prev.right {
  left: 0;
}
.carousel-inner > .active.left {
  left: -100%;
}
.carousel-inner > .active.right {
  left: 100%;
}
.carousel-control {
  position: absolute;
  top: 0;
  left: 0;
  bottom: 0;
  width: 15%;
  opacity: 0.5;
  filter: alpha(opacity=50);
  font-size: 20px;
  color: #fff;
  text-align: center;
  text-shadow: 0 1px 2px rgba(0, 0, 0, 0.6);
  background-color: rgba(0, 0, 0, 0);
}
.carousel-control.left {
  background-image: -webkit-linear-gradient(left, rgba(0, 0, 0, 0.5) 0%, rgba(0, 0, 0, 0.0001) 100%);
  background-image: -o-linear-gradient(left, rgba(0, 0, 0, 0.5) 0%, rgba(0, 0, 0, 0.0001) 100%);
  background-image: linear-gradient(to right, rgba(0, 0, 0, 0.5) 0%, rgba(0, 0, 0, 0.0001) 100%);
  background-repeat: repeat-x;
  filter: progid:DXImageTransform.Microsoft.gradient(startColorstr='#80000000', endColorstr='#00000000', GradientType=1);
}
.carousel-control.right {
  left: auto;
  right: 0;
  background-image: -webkit-linear-gradient(left, rgba(0, 0, 0, 0.0001) 0%, rgba(0, 0, 0, 0.5) 100%);
  background-image: -o-linear-gradient(left, rgba(0, 0, 0, 0.0001) 0%, rgba(0, 0, 0, 0.5) 100%);
  background-image: linear-gradient(to right, rgba(0, 0, 0, 0.0001) 0%, rgba(0, 0, 0, 0.5) 100%);
  background-repeat: repeat-x;
  filter: progid:DXImageTransform.Microsoft.gradient(startColorstr='#00000000', endColorstr='#80000000', GradientType=1);
}
.carousel-control:hover,
.carousel-control:focus {
  outline: 0;
  color: #fff;
  text-decoration: none;
  opacity: 0.9;
  filter: alpha(opacity=90);
}
.carousel-control .icon-prev,
.carousel-control .icon-next,
.carousel-control .glyphicon-chevron-left,
.carousel-control .glyphicon-chevron-right {
  position: absolute;
  top: 50%;
  margin-top: -10px;
  z-index: 5;
  display: inline-block;
}
.carousel-control .icon-prev,
.carousel-control .glyphicon-chevron-left {
  left: 50%;
  margin-left: -10px;
}
.carousel-control .icon-next,
.carousel-control .glyphicon-chevron-right {
  right: 50%;
  margin-right: -10px;
}
.carousel-control .icon-prev,
.carousel-control .icon-next {
  width: 20px;
  height: 20px;
  line-height: 1;
  font-family: serif;
}
.carousel-control .icon-prev:before {
  content: '\2039';
}
.carousel-control .icon-next:before {
  content: '\203a';
}
.carousel-indicators {
  position: absolute;
  bottom: 10px;
  left: 50%;
  z-index: 15;
  width: 60%;
  margin-left: -30%;
  padding-left: 0;
  list-style: none;
  text-align: center;
}
.carousel-indicators li {
  display: inline-block;
  width: 10px;
  height: 10px;
  margin: 1px;
  text-indent: -999px;
  border: 1px solid #fff;
  border-radius: 10px;
  cursor: pointer;
  background-color: #000 \9;
  background-color: rgba(0, 0, 0, 0);
}
.carousel-indicators .active {
  margin: 0;
  width: 12px;
  height: 12px;
  background-color: #fff;
}
.carousel-caption {
  position: absolute;
  left: 15%;
  right: 15%;
  bottom: 20px;
  z-index: 10;
  padding-top: 20px;
  padding-bottom: 20px;
  color: #fff;
  text-align: center;
  text-shadow: 0 1px 2px rgba(0, 0, 0, 0.6);
}
.carousel-caption .btn {
  text-shadow: none;
}
@media screen and (min-width: 768px) {
  .carousel-control .glyphicon-chevron-left,
  .carousel-control .glyphicon-chevron-right,
  .carousel-control .icon-prev,
  .carousel-control .icon-next {
    width: 30px;
    height: 30px;
    margin-top: -10px;
    font-size: 30px;
  }
  .carousel-control .glyphicon-chevron-left,
  .carousel-control .icon-prev {
    margin-left: -10px;
  }
  .carousel-control .glyphicon-chevron-right,
  .carousel-control .icon-next {
    margin-right: -10px;
  }
  .carousel-caption {
    left: 20%;
    right: 20%;
    padding-bottom: 30px;
  }
  .carousel-indicators {
    bottom: 20px;
  }
}
.clearfix:before,
.clearfix:after,
.dl-horizontal dd:before,
.dl-horizontal dd:after,
.container:before,
.container:after,
.container-fluid:before,
.container-fluid:after,
.row:before,
.row:after,
.form-horizontal .form-group:before,
.form-horizontal .form-group:after,
.btn-toolbar:before,
.btn-toolbar:after,
.btn-group-vertical > .btn-group:before,
.btn-group-vertical > .btn-group:after,
.nav:before,
.nav:after,
.navbar:before,
.navbar:after,
.navbar-header:before,
.navbar-header:after,
.navbar-collapse:before,
.navbar-collapse:after,
.pager:before,
.pager:after,
.panel-body:before,
.panel-body:after,
.modal-header:before,
.modal-header:after,
.modal-footer:before,
.modal-footer:after,
.item_buttons:before,
.item_buttons:after {
  content: " ";
  display: table;
}
.clearfix:after,
.dl-horizontal dd:after,
.container:after,
.container-fluid:after,
.row:after,
.form-horizontal .form-group:after,
.btn-toolbar:after,
.btn-group-vertical > .btn-group:after,
.nav:after,
.navbar:after,
.navbar-header:after,
.navbar-collapse:after,
.pager:after,
.panel-body:after,
.modal-header:after,
.modal-footer:after,
.item_buttons:after {
  clear: both;
}
.center-block {
  display: block;
  margin-left: auto;
  margin-right: auto;
}
.pull-right {
  float: right !important;
}
.pull-left {
  float: left !important;
}
.hide {
  display: none !important;
}
.show {
  display: block !important;
}
.invisible {
  visibility: hidden;
}
.text-hide {
  font: 0/0 a;
  color: transparent;
  text-shadow: none;
  background-color: transparent;
  border: 0;
}
.hidden {
  display: none !important;
}
.affix {
  position: fixed;
}
@-ms-viewport {
  width: device-width;
}
.visible-xs,
.visible-sm,
.visible-md,
.visible-lg {
  display: none !important;
}
.visible-xs-block,
.visible-xs-inline,
.visible-xs-inline-block,
.visible-sm-block,
.visible-sm-inline,
.visible-sm-inline-block,
.visible-md-block,
.visible-md-inline,
.visible-md-inline-block,
.visible-lg-block,
.visible-lg-inline,
.visible-lg-inline-block {
  display: none !important;
}
@media (max-width: 767px) {
  .visible-xs {
    display: block !important;
  }
  table.visible-xs {
    display: table !important;
  }
  tr.visible-xs {
    display: table-row !important;
  }
  th.visible-xs,
  td.visible-xs {
    display: table-cell !important;
  }
}
@media (max-width: 767px) {
  .visible-xs-block {
    display: block !important;
  }
}
@media (max-width: 767px) {
  .visible-xs-inline {
    display: inline !important;
  }
}
@media (max-width: 767px) {
  .visible-xs-inline-block {
    display: inline-block !important;
  }
}
@media (min-width: 768px) and (max-width: 991px) {
  .visible-sm {
    display: block !important;
  }
  table.visible-sm {
    display: table !important;
  }
  tr.visible-sm {
    display: table-row !important;
  }
  th.visible-sm,
  td.visible-sm {
    display: table-cell !important;
  }
}
@media (min-width: 768px) and (max-width: 991px) {
  .visible-sm-block {
    display: block !important;
  }
}
@media (min-width: 768px) and (max-width: 991px) {
  .visible-sm-inline {
    display: inline !important;
  }
}
@media (min-width: 768px) and (max-width: 991px) {
  .visible-sm-inline-block {
    display: inline-block !important;
  }
}
@media (min-width: 992px) and (max-width: 1199px) {
  .visible-md {
    display: block !important;
  }
  table.visible-md {
    display: table !important;
  }
  tr.visible-md {
    display: table-row !important;
  }
  th.visible-md,
  td.visible-md {
    display: table-cell !important;
  }
}
@media (min-width: 992px) and (max-width: 1199px) {
  .visible-md-block {
    display: block !important;
  }
}
@media (min-width: 992px) and (max-width: 1199px) {
  .visible-md-inline {
    display: inline !important;
  }
}
@media (min-width: 992px) and (max-width: 1199px) {
  .visible-md-inline-block {
    display: inline-block !important;
  }
}
@media (min-width: 1200px) {
  .visible-lg {
    display: block !important;
  }
  table.visible-lg {
    display: table !important;
  }
  tr.visible-lg {
    display: table-row !important;
  }
  th.visible-lg,
  td.visible-lg {
    display: table-cell !important;
  }
}
@media (min-width: 1200px) {
  .visible-lg-block {
    display: block !important;
  }
}
@media (min-width: 1200px) {
  .visible-lg-inline {
    display: inline !important;
  }
}
@media (min-width: 1200px) {
  .visible-lg-inline-block {
    display: inline-block !important;
  }
}
@media (max-width: 767px) {
  .hidden-xs {
    display: none !important;
  }
}
@media (min-width: 768px) and (max-width: 991px) {
  .hidden-sm {
    display: none !important;
  }
}
@media (min-width: 992px) and (max-width: 1199px) {
  .hidden-md {
    display: none !important;
  }
}
@media (min-width: 1200px) {
  .hidden-lg {
    display: none !important;
  }
}
.visible-print {
  display: none !important;
}
@media print {
  .visible-print {
    display: block !important;
  }
  table.visible-print {
    display: table !important;
  }
  tr.visible-print {
    display: table-row !important;
  }
  th.visible-print,
  td.visible-print {
    display: table-cell !important;
  }
}
.visible-print-block {
  display: none !important;
}
@media print {
  .visible-print-block {
    display: block !important;
  }
}
.visible-print-inline {
  display: none !important;
}
@media print {
  .visible-print-inline {
    display: inline !important;
  }
}
.visible-print-inline-block {
  display: none !important;
}
@media print {
  .visible-print-inline-block {
    display: inline-block !important;
  }
}
@media print {
  .hidden-print {
    display: none !important;
  }
}
/*!
*
* Font Awesome
*
*/
/*!
 *  Font Awesome 4.7.0 by @davegandy - http://fontawesome.io - @fontawesome
 *  License - http://fontawesome.io/license (Font: SIL OFL 1.1, CSS: MIT License)
 */
/* FONT PATH
 * -------------------------- */
@font-face {
  font-family: 'FontAwesome';
  src: url('../components/font-awesome/fonts/fontawesome-webfont.eot?v=4.7.0');
  src: url('../components/font-awesome/fonts/fontawesome-webfont.eot?#iefix&v=4.7.0') format('embedded-opentype'), url('../components/font-awesome/fonts/fontawesome-webfont.woff2?v=4.7.0') format('woff2'), url('../components/font-awesome/fonts/fontawesome-webfont.woff?v=4.7.0') format('woff'), url('../components/font-awesome/fonts/fontawesome-webfont.ttf?v=4.7.0') format('truetype'), url('../components/font-awesome/fonts/fontawesome-webfont.svg?v=4.7.0#fontawesomeregular') format('svg');
  font-weight: normal;
  font-style: normal;
}
.fa {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
}
/* makes the font 33% larger relative to the icon container */
.fa-lg {
  font-size: 1.33333333em;
  line-height: 0.75em;
  vertical-align: -15%;
}
.fa-2x {
  font-size: 2em;
}
.fa-3x {
  font-size: 3em;
}
.fa-4x {
  font-size: 4em;
}
.fa-5x {
  font-size: 5em;
}
.fa-fw {
  width: 1.28571429em;
  text-align: center;
}
.fa-ul {
  padding-left: 0;
  margin-left: 2.14285714em;
  list-style-type: none;
}
.fa-ul > li {
  position: relative;
}
.fa-li {
  position: absolute;
  left: -2.14285714em;
  width: 2.14285714em;
  top: 0.14285714em;
  text-align: center;
}
.fa-li.fa-lg {
  left: -1.85714286em;
}
.fa-border {
  padding: .2em .25em .15em;
  border: solid 0.08em #eee;
  border-radius: .1em;
}
.fa-pull-left {
  float: left;
}
.fa-pull-right {
  float: right;
}
.fa.fa-pull-left {
  margin-right: .3em;
}
.fa.fa-pull-right {
  margin-left: .3em;
}
/* Deprecated as of 4.4.0 */
.pull-right {
  float: right;
}
.pull-left {
  float: left;
}
.fa.pull-left {
  margin-right: .3em;
}
.fa.pull-right {
  margin-left: .3em;
}
.fa-spin {
  -webkit-animation: fa-spin 2s infinite linear;
  animation: fa-spin 2s infinite linear;
}
.fa-pulse {
  -webkit-animation: fa-spin 1s infinite steps(8);
  animation: fa-spin 1s infinite steps(8);
}
@-webkit-keyframes fa-spin {
  0% {
    -webkit-transform: rotate(0deg);
    transform: rotate(0deg);
  }
  100% {
    -webkit-transform: rotate(359deg);
    transform: rotate(359deg);
  }
}
@keyframes fa-spin {
  0% {
    -webkit-transform: rotate(0deg);
    transform: rotate(0deg);
  }
  100% {
    -webkit-transform: rotate(359deg);
    transform: rotate(359deg);
  }
}
.fa-rotate-90 {
  -ms-filter: "progid:DXImageTransform.Microsoft.BasicImage(rotation=1)";
  -webkit-transform: rotate(90deg);
  -ms-transform: rotate(90deg);
  transform: rotate(90deg);
}
.fa-rotate-180 {
  -ms-filter: "progid:DXImageTransform.Microsoft.BasicImage(rotation=2)";
  -webkit-transform: rotate(180deg);
  -ms-transform: rotate(180deg);
  transform: rotate(180deg);
}
.fa-rotate-270 {
  -ms-filter: "progid:DXImageTransform.Microsoft.BasicImage(rotation=3)";
  -webkit-transform: rotate(270deg);
  -ms-transform: rotate(270deg);
  transform: rotate(270deg);
}
.fa-flip-horizontal {
  -ms-filter: "progid:DXImageTransform.Microsoft.BasicImage(rotation=0, mirror=1)";
  -webkit-transform: scale(-1, 1);
  -ms-transform: scale(-1, 1);
  transform: scale(-1, 1);
}
.fa-flip-vertical {
  -ms-filter: "progid:DXImageTransform.Microsoft.BasicImage(rotation=2, mirror=1)";
  -webkit-transform: scale(1, -1);
  -ms-transform: scale(1, -1);
  transform: scale(1, -1);
}
:root .fa-rotate-90,
:root .fa-rotate-180,
:root .fa-rotate-270,
:root .fa-flip-horizontal,
:root .fa-flip-vertical {
  filter: none;
}
.fa-stack {
  position: relative;
  display: inline-block;
  width: 2em;
  height: 2em;
  line-height: 2em;
  vertical-align: middle;
}
.fa-stack-1x,
.fa-stack-2x {
  position: absolute;
  left: 0;
  width: 100%;
  text-align: center;
}
.fa-stack-1x {
  line-height: inherit;
}
.fa-stack-2x {
  font-size: 2em;
}
.fa-inverse {
  color: #fff;
}
/* Font Awesome uses the Unicode Private Use Area (PUA) to ensure screen
   readers do not read off random characters that represent icons */
.fa-glass:before {
  content: "\f000";
}
.fa-music:before {
  content: "\f001";
}
.fa-search:before {
  content: "\f002";
}
.fa-envelope-o:before {
  content: "\f003";
}
.fa-heart:before {
  content: "\f004";
}
.fa-star:before {
  content: "\f005";
}
.fa-star-o:before {
  content: "\f006";
}
.fa-user:before {
  content: "\f007";
}
.fa-film:before {
  content: "\f008";
}
.fa-th-large:before {
  content: "\f009";
}
.fa-th:before {
  content: "\f00a";
}
.fa-th-list:before {
  content: "\f00b";
}
.fa-check:before {
  content: "\f00c";
}
.fa-remove:before,
.fa-close:before,
.fa-times:before {
  content: "\f00d";
}
.fa-search-plus:before {
  content: "\f00e";
}
.fa-search-minus:before {
  content: "\f010";
}
.fa-power-off:before {
  content: "\f011";
}
.fa-signal:before {
  content: "\f012";
}
.fa-gear:before,
.fa-cog:before {
  content: "\f013";
}
.fa-trash-o:before {
  content: "\f014";
}
.fa-home:before {
  content: "\f015";
}
.fa-file-o:before {
  content: "\f016";
}
.fa-clock-o:before {
  content: "\f017";
}
.fa-road:before {
  content: "\f018";
}
.fa-download:before {
  content: "\f019";
}
.fa-arrow-circle-o-down:before {
  content: "\f01a";
}
.fa-arrow-circle-o-up:before {
  content: "\f01b";
}
.fa-inbox:before {
  content: "\f01c";
}
.fa-play-circle-o:before {
  content: "\f01d";
}
.fa-rotate-right:before,
.fa-repeat:before {
  content: "\f01e";
}
.fa-refresh:before {
  content: "\f021";
}
.fa-list-alt:before {
  content: "\f022";
}
.fa-lock:before {
  content: "\f023";
}
.fa-flag:before {
  content: "\f024";
}
.fa-headphones:before {
  content: "\f025";
}
.fa-volume-off:before {
  content: "\f026";
}
.fa-volume-down:before {
  content: "\f027";
}
.fa-volume-up:before {
  content: "\f028";
}
.fa-qrcode:before {
  content: "\f029";
}
.fa-barcode:before {
  content: "\f02a";
}
.fa-tag:before {
  content: "\f02b";
}
.fa-tags:before {
  content: "\f02c";
}
.fa-book:before {
  content: "\f02d";
}
.fa-bookmark:before {
  content: "\f02e";
}
.fa-print:before {
  content: "\f02f";
}
.fa-camera:before {
  content: "\f030";
}
.fa-font:before {
  content: "\f031";
}
.fa-bold:before {
  content: "\f032";
}
.fa-italic:before {
  content: "\f033";
}
.fa-text-height:before {
  content: "\f034";
}
.fa-text-width:before {
  content: "\f035";
}
.fa-align-left:before {
  content: "\f036";
}
.fa-align-center:before {
  content: "\f037";
}
.fa-align-right:before {
  content: "\f038";
}
.fa-align-justify:before {
  content: "\f039";
}
.fa-list:before {
  content: "\f03a";
}
.fa-dedent:before,
.fa-outdent:before {
  content: "\f03b";
}
.fa-indent:before {
  content: "\f03c";
}
.fa-video-camera:before {
  content: "\f03d";
}
.fa-photo:before,
.fa-image:before,
.fa-picture-o:before {
  content: "\f03e";
}
.fa-pencil:before {
  content: "\f040";
}
.fa-map-marker:before {
  content: "\f041";
}
.fa-adjust:before {
  content: "\f042";
}
.fa-tint:before {
  content: "\f043";
}
.fa-edit:before,
.fa-pencil-square-o:before {
  content: "\f044";
}
.fa-share-square-o:before {
  content: "\f045";
}
.fa-check-square-o:before {
  content: "\f046";
}
.fa-arrows:before {
  content: "\f047";
}
.fa-step-backward:before {
  content: "\f048";
}
.fa-fast-backward:before {
  content: "\f049";
}
.fa-backward:before {
  content: "\f04a";
}
.fa-play:before {
  content: "\f04b";
}
.fa-pause:before {
  content: "\f04c";
}
.fa-stop:before {
  content: "\f04d";
}
.fa-forward:before {
  content: "\f04e";
}
.fa-fast-forward:before {
  content: "\f050";
}
.fa-step-forward:before {
  content: "\f051";
}
.fa-eject:before {
  content: "\f052";
}
.fa-chevron-left:before {
  content: "\f053";
}
.fa-chevron-right:before {
  content: "\f054";
}
.fa-plus-circle:before {
  content: "\f055";
}
.fa-minus-circle:before {
  content: "\f056";
}
.fa-times-circle:before {
  content: "\f057";
}
.fa-check-circle:before {
  content: "\f058";
}
.fa-question-circle:before {
  content: "\f059";
}
.fa-info-circle:before {
  content: "\f05a";
}
.fa-crosshairs:before {
  content: "\f05b";
}
.fa-times-circle-o:before {
  content: "\f05c";
}
.fa-check-circle-o:before {
  content: "\f05d";
}
.fa-ban:before {
  content: "\f05e";
}
.fa-arrow-left:before {
  content: "\f060";
}
.fa-arrow-right:before {
  content: "\f061";
}
.fa-arrow-up:before {
  content: "\f062";
}
.fa-arrow-down:before {
  content: "\f063";
}
.fa-mail-forward:before,
.fa-share:before {
  content: "\f064";
}
.fa-expand:before {
  content: "\f065";
}
.fa-compress:before {
  content: "\f066";
}
.fa-plus:before {
  content: "\f067";
}
.fa-minus:before {
  content: "\f068";
}
.fa-asterisk:before {
  content: "\f069";
}
.fa-exclamation-circle:before {
  content: "\f06a";
}
.fa-gift:before {
  content: "\f06b";
}
.fa-leaf:before {
  content: "\f06c";
}
.fa-fire:before {
  content: "\f06d";
}
.fa-eye:before {
  content: "\f06e";
}
.fa-eye-slash:before {
  content: "\f070";
}
.fa-warning:before,
.fa-exclamation-triangle:before {
  content: "\f071";
}
.fa-plane:before {
  content: "\f072";
}
.fa-calendar:before {
  content: "\f073";
}
.fa-random:before {
  content: "\f074";
}
.fa-comment:before {
  content: "\f075";
}
.fa-magnet:before {
  content: "\f076";
}
.fa-chevron-up:before {
  content: "\f077";
}
.fa-chevron-down:before {
  content: "\f078";
}
.fa-retweet:before {
  content: "\f079";
}
.fa-shopping-cart:before {
  content: "\f07a";
}
.fa-folder:before {
  content: "\f07b";
}
.fa-folder-open:before {
  content: "\f07c";
}
.fa-arrows-v:before {
  content: "\f07d";
}
.fa-arrows-h:before {
  content: "\f07e";
}
.fa-bar-chart-o:before,
.fa-bar-chart:before {
  content: "\f080";
}
.fa-twitter-square:before {
  content: "\f081";
}
.fa-facebook-square:before {
  content: "\f082";
}
.fa-camera-retro:before {
  content: "\f083";
}
.fa-key:before {
  content: "\f084";
}
.fa-gears:before,
.fa-cogs:before {
  content: "\f085";
}
.fa-comments:before {
  content: "\f086";
}
.fa-thumbs-o-up:before {
  content: "\f087";
}
.fa-thumbs-o-down:before {
  content: "\f088";
}
.fa-star-half:before {
  content: "\f089";
}
.fa-heart-o:before {
  content: "\f08a";
}
.fa-sign-out:before {
  content: "\f08b";
}
.fa-linkedin-square:before {
  content: "\f08c";
}
.fa-thumb-tack:before {
  content: "\f08d";
}
.fa-external-link:before {
  content: "\f08e";
}
.fa-sign-in:before {
  content: "\f090";
}
.fa-trophy:before {
  content: "\f091";
}
.fa-github-square:before {
  content: "\f092";
}
.fa-upload:before {
  content: "\f093";
}
.fa-lemon-o:before {
  content: "\f094";
}
.fa-phone:before {
  content: "\f095";
}
.fa-square-o:before {
  content: "\f096";
}
.fa-bookmark-o:before {
  content: "\f097";
}
.fa-phone-square:before {
  content: "\f098";
}
.fa-twitter:before {
  content: "\f099";
}
.fa-facebook-f:before,
.fa-facebook:before {
  content: "\f09a";
}
.fa-github:before {
  content: "\f09b";
}
.fa-unlock:before {
  content: "\f09c";
}
.fa-credit-card:before {
  content: "\f09d";
}
.fa-feed:before,
.fa-rss:before {
  content: "\f09e";
}
.fa-hdd-o:before {
  content: "\f0a0";
}
.fa-bullhorn:before {
  content: "\f0a1";
}
.fa-bell:before {
  content: "\f0f3";
}
.fa-certificate:before {
  content: "\f0a3";
}
.fa-hand-o-right:before {
  content: "\f0a4";
}
.fa-hand-o-left:before {
  content: "\f0a5";
}
.fa-hand-o-up:before {
  content: "\f0a6";
}
.fa-hand-o-down:before {
  content: "\f0a7";
}
.fa-arrow-circle-left:before {
  content: "\f0a8";
}
.fa-arrow-circle-right:before {
  content: "\f0a9";
}
.fa-arrow-circle-up:before {
  content: "\f0aa";
}
.fa-arrow-circle-down:before {
  content: "\f0ab";
}
.fa-globe:before {
  content: "\f0ac";
}
.fa-wrench:before {
  content: "\f0ad";
}
.fa-tasks:before {
  content: "\f0ae";
}
.fa-filter:before {
  content: "\f0b0";
}
.fa-briefcase:before {
  content: "\f0b1";
}
.fa-arrows-alt:before {
  content: "\f0b2";
}
.fa-group:before,
.fa-users:before {
  content: "\f0c0";
}
.fa-chain:before,
.fa-link:before {
  content: "\f0c1";
}
.fa-cloud:before {
  content: "\f0c2";
}
.fa-flask:before {
  content: "\f0c3";
}
.fa-cut:before,
.fa-scissors:before {
  content: "\f0c4";
}
.fa-copy:before,
.fa-files-o:before {
  content: "\f0c5";
}
.fa-paperclip:before {
  content: "\f0c6";
}
.fa-save:before,
.fa-floppy-o:before {
  content: "\f0c7";
}
.fa-square:before {
  content: "\f0c8";
}
.fa-navicon:before,
.fa-reorder:before,
.fa-bars:before {
  content: "\f0c9";
}
.fa-list-ul:before {
  content: "\f0ca";
}
.fa-list-ol:before {
  content: "\f0cb";
}
.fa-strikethrough:before {
  content: "\f0cc";
}
.fa-underline:before {
  content: "\f0cd";
}
.fa-table:before {
  content: "\f0ce";
}
.fa-magic:before {
  content: "\f0d0";
}
.fa-truck:before {
  content: "\f0d1";
}
.fa-pinterest:before {
  content: "\f0d2";
}
.fa-pinterest-square:before {
  content: "\f0d3";
}
.fa-google-plus-square:before {
  content: "\f0d4";
}
.fa-google-plus:before {
  content: "\f0d5";
}
.fa-money:before {
  content: "\f0d6";
}
.fa-caret-down:before {
  content: "\f0d7";
}
.fa-caret-up:before {
  content: "\f0d8";
}
.fa-caret-left:before {
  content: "\f0d9";
}
.fa-caret-right:before {
  content: "\f0da";
}
.fa-columns:before {
  content: "\f0db";
}
.fa-unsorted:before,
.fa-sort:before {
  content: "\f0dc";
}
.fa-sort-down:before,
.fa-sort-desc:before {
  content: "\f0dd";
}
.fa-sort-up:before,
.fa-sort-asc:before {
  content: "\f0de";
}
.fa-envelope:before {
  content: "\f0e0";
}
.fa-linkedin:before {
  content: "\f0e1";
}
.fa-rotate-left:before,
.fa-undo:before {
  content: "\f0e2";
}
.fa-legal:before,
.fa-gavel:before {
  content: "\f0e3";
}
.fa-dashboard:before,
.fa-tachometer:before {
  content: "\f0e4";
}
.fa-comment-o:before {
  content: "\f0e5";
}
.fa-comments-o:before {
  content: "\f0e6";
}
.fa-flash:before,
.fa-bolt:before {
  content: "\f0e7";
}
.fa-sitemap:before {
  content: "\f0e8";
}
.fa-umbrella:before {
  content: "\f0e9";
}
.fa-paste:before,
.fa-clipboard:before {
  content: "\f0ea";
}
.fa-lightbulb-o:before {
  content: "\f0eb";
}
.fa-exchange:before {
  content: "\f0ec";
}
.fa-cloud-download:before {
  content: "\f0ed";
}
.fa-cloud-upload:before {
  content: "\f0ee";
}
.fa-user-md:before {
  content: "\f0f0";
}
.fa-stethoscope:before {
  content: "\f0f1";
}
.fa-suitcase:before {
  content: "\f0f2";
}
.fa-bell-o:before {
  content: "\f0a2";
}
.fa-coffee:before {
  content: "\f0f4";
}
.fa-cutlery:before {
  content: "\f0f5";
}
.fa-file-text-o:before {
  content: "\f0f6";
}
.fa-building-o:before {
  content: "\f0f7";
}
.fa-hospital-o:before {
  content: "\f0f8";
}
.fa-ambulance:before {
  content: "\f0f9";
}
.fa-medkit:before {
  content: "\f0fa";
}
.fa-fighter-jet:before {
  content: "\f0fb";
}
.fa-beer:before {
  content: "\f0fc";
}
.fa-h-square:before {
  content: "\f0fd";
}
.fa-plus-square:before {
  content: "\f0fe";
}
.fa-angle-double-left:before {
  content: "\f100";
}
.fa-angle-double-right:before {
  content: "\f101";
}
.fa-angle-double-up:before {
  content: "\f102";
}
.fa-angle-double-down:before {
  content: "\f103";
}
.fa-angle-left:before {
  content: "\f104";
}
.fa-angle-right:before {
  content: "\f105";
}
.fa-angle-up:before {
  content: "\f106";
}
.fa-angle-down:before {
  content: "\f107";
}
.fa-desktop:before {
  content: "\f108";
}
.fa-laptop:before {
  content: "\f109";
}
.fa-tablet:before {
  content: "\f10a";
}
.fa-mobile-phone:before,
.fa-mobile:before {
  content: "\f10b";
}
.fa-circle-o:before {
  content: "\f10c";
}
.fa-quote-left:before {
  content: "\f10d";
}
.fa-quote-right:before {
  content: "\f10e";
}
.fa-spinner:before {
  content: "\f110";
}
.fa-circle:before {
  content: "\f111";
}
.fa-mail-reply:before,
.fa-reply:before {
  content: "\f112";
}
.fa-github-alt:before {
  content: "\f113";
}
.fa-folder-o:before {
  content: "\f114";
}
.fa-folder-open-o:before {
  content: "\f115";
}
.fa-smile-o:before {
  content: "\f118";
}
.fa-frown-o:before {
  content: "\f119";
}
.fa-meh-o:before {
  content: "\f11a";
}
.fa-gamepad:before {
  content: "\f11b";
}
.fa-keyboard-o:before {
  content: "\f11c";
}
.fa-flag-o:before {
  content: "\f11d";
}
.fa-flag-checkered:before {
  content: "\f11e";
}
.fa-terminal:before {
  content: "\f120";
}
.fa-code:before {
  content: "\f121";
}
.fa-mail-reply-all:before,
.fa-reply-all:before {
  content: "\f122";
}
.fa-star-half-empty:before,
.fa-star-half-full:before,
.fa-star-half-o:before {
  content: "\f123";
}
.fa-location-arrow:before {
  content: "\f124";
}
.fa-crop:before {
  content: "\f125";
}
.fa-code-fork:before {
  content: "\f126";
}
.fa-unlink:before,
.fa-chain-broken:before {
  content: "\f127";
}
.fa-question:before {
  content: "\f128";
}
.fa-info:before {
  content: "\f129";
}
.fa-exclamation:before {
  content: "\f12a";
}
.fa-superscript:before {
  content: "\f12b";
}
.fa-subscript:before {
  content: "\f12c";
}
.fa-eraser:before {
  content: "\f12d";
}
.fa-puzzle-piece:before {
  content: "\f12e";
}
.fa-microphone:before {
  content: "\f130";
}
.fa-microphone-slash:before {
  content: "\f131";
}
.fa-shield:before {
  content: "\f132";
}
.fa-calendar-o:before {
  content: "\f133";
}
.fa-fire-extinguisher:before {
  content: "\f134";
}
.fa-rocket:before {
  content: "\f135";
}
.fa-maxcdn:before {
  content: "\f136";
}
.fa-chevron-circle-left:before {
  content: "\f137";
}
.fa-chevron-circle-right:before {
  content: "\f138";
}
.fa-chevron-circle-up:before {
  content: "\f139";
}
.fa-chevron-circle-down:before {
  content: "\f13a";
}
.fa-html5:before {
  content: "\f13b";
}
.fa-css3:before {
  content: "\f13c";
}
.fa-anchor:before {
  content: "\f13d";
}
.fa-unlock-alt:before {
  content: "\f13e";
}
.fa-bullseye:before {
  content: "\f140";
}
.fa-ellipsis-h:before {
  content: "\f141";
}
.fa-ellipsis-v:before {
  content: "\f142";
}
.fa-rss-square:before {
  content: "\f143";
}
.fa-play-circle:before {
  content: "\f144";
}
.fa-ticket:before {
  content: "\f145";
}
.fa-minus-square:before {
  content: "\f146";
}
.fa-minus-square-o:before {
  content: "\f147";
}
.fa-level-up:before {
  content: "\f148";
}
.fa-level-down:before {
  content: "\f149";
}
.fa-check-square:before {
  content: "\f14a";
}
.fa-pencil-square:before {
  content: "\f14b";
}
.fa-external-link-square:before {
  content: "\f14c";
}
.fa-share-square:before {
  content: "\f14d";
}
.fa-compass:before {
  content: "\f14e";
}
.fa-toggle-down:before,
.fa-caret-square-o-down:before {
  content: "\f150";
}
.fa-toggle-up:before,
.fa-caret-square-o-up:before {
  content: "\f151";
}
.fa-toggle-right:before,
.fa-caret-square-o-right:before {
  content: "\f152";
}
.fa-euro:before,
.fa-eur:before {
  content: "\f153";
}
.fa-gbp:before {
  content: "\f154";
}
.fa-dollar:before,
.fa-usd:before {
  content: "\f155";
}
.fa-rupee:before,
.fa-inr:before {
  content: "\f156";
}
.fa-cny:before,
.fa-rmb:before,
.fa-yen:before,
.fa-jpy:before {
  content: "\f157";
}
.fa-ruble:before,
.fa-rouble:before,
.fa-rub:before {
  content: "\f158";
}
.fa-won:before,
.fa-krw:before {
  content: "\f159";
}
.fa-bitcoin:before,
.fa-btc:before {
  content: "\f15a";
}
.fa-file:before {
  content: "\f15b";
}
.fa-file-text:before {
  content: "\f15c";
}
.fa-sort-alpha-asc:before {
  content: "\f15d";
}
.fa-sort-alpha-desc:before {
  content: "\f15e";
}
.fa-sort-amount-asc:before {
  content: "\f160";
}
.fa-sort-amount-desc:before {
  content: "\f161";
}
.fa-sort-numeric-asc:before {
  content: "\f162";
}
.fa-sort-numeric-desc:before {
  content: "\f163";
}
.fa-thumbs-up:before {
  content: "\f164";
}
.fa-thumbs-down:before {
  content: "\f165";
}
.fa-youtube-square:before {
  content: "\f166";
}
.fa-youtube:before {
  content: "\f167";
}
.fa-xing:before {
  content: "\f168";
}
.fa-xing-square:before {
  content: "\f169";
}
.fa-youtube-play:before {
  content: "\f16a";
}
.fa-dropbox:before {
  content: "\f16b";
}
.fa-stack-overflow:before {
  content: "\f16c";
}
.fa-instagram:before {
  content: "\f16d";
}
.fa-flickr:before {
  content: "\f16e";
}
.fa-adn:before {
  content: "\f170";
}
.fa-bitbucket:before {
  content: "\f171";
}
.fa-bitbucket-square:before {
  content: "\f172";
}
.fa-tumblr:before {
  content: "\f173";
}
.fa-tumblr-square:before {
  content: "\f174";
}
.fa-long-arrow-down:before {
  content: "\f175";
}
.fa-long-arrow-up:before {
  content: "\f176";
}
.fa-long-arrow-left:before {
  content: "\f177";
}
.fa-long-arrow-right:before {
  content: "\f178";
}
.fa-apple:before {
  content: "\f179";
}
.fa-windows:before {
  content: "\f17a";
}
.fa-android:before {
  content: "\f17b";
}
.fa-linux:before {
  content: "\f17c";
}
.fa-dribbble:before {
  content: "\f17d";
}
.fa-skype:before {
  content: "\f17e";
}
.fa-foursquare:before {
  content: "\f180";
}
.fa-trello:before {
  content: "\f181";
}
.fa-female:before {
  content: "\f182";
}
.fa-male:before {
  content: "\f183";
}
.fa-gittip:before,
.fa-gratipay:before {
  content: "\f184";
}
.fa-sun-o:before {
  content: "\f185";
}
.fa-moon-o:before {
  content: "\f186";
}
.fa-archive:before {
  content: "\f187";
}
.fa-bug:before {
  content: "\f188";
}
.fa-vk:before {
  content: "\f189";
}
.fa-weibo:before {
  content: "\f18a";
}
.fa-renren:before {
  content: "\f18b";
}
.fa-pagelines:before {
  content: "\f18c";
}
.fa-stack-exchange:before {
  content: "\f18d";
}
.fa-arrow-circle-o-right:before {
  content: "\f18e";
}
.fa-arrow-circle-o-left:before {
  content: "\f190";
}
.fa-toggle-left:before,
.fa-caret-square-o-left:before {
  content: "\f191";
}
.fa-dot-circle-o:before {
  content: "\f192";
}
.fa-wheelchair:before {
  content: "\f193";
}
.fa-vimeo-square:before {
  content: "\f194";
}
.fa-turkish-lira:before,
.fa-try:before {
  content: "\f195";
}
.fa-plus-square-o:before {
  content: "\f196";
}
.fa-space-shuttle:before {
  content: "\f197";
}
.fa-slack:before {
  content: "\f198";
}
.fa-envelope-square:before {
  content: "\f199";
}
.fa-wordpress:before {
  content: "\f19a";
}
.fa-openid:before {
  content: "\f19b";
}
.fa-institution:before,
.fa-bank:before,
.fa-university:before {
  content: "\f19c";
}
.fa-mortar-board:before,
.fa-graduation-cap:before {
  content: "\f19d";
}
.fa-yahoo:before {
  content: "\f19e";
}
.fa-google:before {
  content: "\f1a0";
}
.fa-reddit:before {
  content: "\f1a1";
}
.fa-reddit-square:before {
  content: "\f1a2";
}
.fa-stumbleupon-circle:before {
  content: "\f1a3";
}
.fa-stumbleupon:before {
  content: "\f1a4";
}
.fa-delicious:before {
  content: "\f1a5";
}
.fa-digg:before {
  content: "\f1a6";
}
.fa-pied-piper-pp:before {
  content: "\f1a7";
}
.fa-pied-piper-alt:before {
  content: "\f1a8";
}
.fa-drupal:before {
  content: "\f1a9";
}
.fa-joomla:before {
  content: "\f1aa";
}
.fa-language:before {
  content: "\f1ab";
}
.fa-fax:before {
  content: "\f1ac";
}
.fa-building:before {
  content: "\f1ad";
}
.fa-child:before {
  content: "\f1ae";
}
.fa-paw:before {
  content: "\f1b0";
}
.fa-spoon:before {
  content: "\f1b1";
}
.fa-cube:before {
  content: "\f1b2";
}
.fa-cubes:before {
  content: "\f1b3";
}
.fa-behance:before {
  content: "\f1b4";
}
.fa-behance-square:before {
  content: "\f1b5";
}
.fa-steam:before {
  content: "\f1b6";
}
.fa-steam-square:before {
  content: "\f1b7";
}
.fa-recycle:before {
  content: "\f1b8";
}
.fa-automobile:before,
.fa-car:before {
  content: "\f1b9";
}
.fa-cab:before,
.fa-taxi:before {
  content: "\f1ba";
}
.fa-tree:before {
  content: "\f1bb";
}
.fa-spotify:before {
  content: "\f1bc";
}
.fa-deviantart:before {
  content: "\f1bd";
}
.fa-soundcloud:before {
  content: "\f1be";
}
.fa-database:before {
  content: "\f1c0";
}
.fa-file-pdf-o:before {
  content: "\f1c1";
}
.fa-file-word-o:before {
  content: "\f1c2";
}
.fa-file-excel-o:before {
  content: "\f1c3";
}
.fa-file-powerpoint-o:before {
  content: "\f1c4";
}
.fa-file-photo-o:before,
.fa-file-picture-o:before,
.fa-file-image-o:before {
  content: "\f1c5";
}
.fa-file-zip-o:before,
.fa-file-archive-o:before {
  content: "\f1c6";
}
.fa-file-sound-o:before,
.fa-file-audio-o:before {
  content: "\f1c7";
}
.fa-file-movie-o:before,
.fa-file-video-o:before {
  content: "\f1c8";
}
.fa-file-code-o:before {
  content: "\f1c9";
}
.fa-vine:before {
  content: "\f1ca";
}
.fa-codepen:before {
  content: "\f1cb";
}
.fa-jsfiddle:before {
  content: "\f1cc";
}
.fa-life-bouy:before,
.fa-life-buoy:before,
.fa-life-saver:before,
.fa-support:before,
.fa-life-ring:before {
  content: "\f1cd";
}
.fa-circle-o-notch:before {
  content: "\f1ce";
}
.fa-ra:before,
.fa-resistance:before,
.fa-rebel:before {
  content: "\f1d0";
}
.fa-ge:before,
.fa-empire:before {
  content: "\f1d1";
}
.fa-git-square:before {
  content: "\f1d2";
}
.fa-git:before {
  content: "\f1d3";
}
.fa-y-combinator-square:before,
.fa-yc-square:before,
.fa-hacker-news:before {
  content: "\f1d4";
}
.fa-tencent-weibo:before {
  content: "\f1d5";
}
.fa-qq:before {
  content: "\f1d6";
}
.fa-wechat:before,
.fa-weixin:before {
  content: "\f1d7";
}
.fa-send:before,
.fa-paper-plane:before {
  content: "\f1d8";
}
.fa-send-o:before,
.fa-paper-plane-o:before {
  content: "\f1d9";
}
.fa-history:before {
  content: "\f1da";
}
.fa-circle-thin:before {
  content: "\f1db";
}
.fa-header:before {
  content: "\f1dc";
}
.fa-paragraph:before {
  content: "\f1dd";
}
.fa-sliders:before {
  content: "\f1de";
}
.fa-share-alt:before {
  content: "\f1e0";
}
.fa-share-alt-square:before {
  content: "\f1e1";
}
.fa-bomb:before {
  content: "\f1e2";
}
.fa-soccer-ball-o:before,
.fa-futbol-o:before {
  content: "\f1e3";
}
.fa-tty:before {
  content: "\f1e4";
}
.fa-binoculars:before {
  content: "\f1e5";
}
.fa-plug:before {
  content: "\f1e6";
}
.fa-slideshare:before {
  content: "\f1e7";
}
.fa-twitch:before {
  content: "\f1e8";
}
.fa-yelp:before {
  content: "\f1e9";
}
.fa-newspaper-o:before {
  content: "\f1ea";
}
.fa-wifi:before {
  content: "\f1eb";
}
.fa-calculator:before {
  content: "\f1ec";
}
.fa-paypal:before {
  content: "\f1ed";
}
.fa-google-wallet:before {
  content: "\f1ee";
}
.fa-cc-visa:before {
  content: "\f1f0";
}
.fa-cc-mastercard:before {
  content: "\f1f1";
}
.fa-cc-discover:before {
  content: "\f1f2";
}
.fa-cc-amex:before {
  content: "\f1f3";
}
.fa-cc-paypal:before {
  content: "\f1f4";
}
.fa-cc-stripe:before {
  content: "\f1f5";
}
.fa-bell-slash:before {
  content: "\f1f6";
}
.fa-bell-slash-o:before {
  content: "\f1f7";
}
.fa-trash:before {
  content: "\f1f8";
}
.fa-copyright:before {
  content: "\f1f9";
}
.fa-at:before {
  content: "\f1fa";
}
.fa-eyedropper:before {
  content: "\f1fb";
}
.fa-paint-brush:before {
  content: "\f1fc";
}
.fa-birthday-cake:before {
  content: "\f1fd";
}
.fa-area-chart:before {
  content: "\f1fe";
}
.fa-pie-chart:before {
  content: "\f200";
}
.fa-line-chart:before {
  content: "\f201";
}
.fa-lastfm:before {
  content: "\f202";
}
.fa-lastfm-square:before {
  content: "\f203";
}
.fa-toggle-off:before {
  content: "\f204";
}
.fa-toggle-on:before {
  content: "\f205";
}
.fa-bicycle:before {
  content: "\f206";
}
.fa-bus:before {
  content: "\f207";
}
.fa-ioxhost:before {
  content: "\f208";
}
.fa-angellist:before {
  content: "\f209";
}
.fa-cc:before {
  content: "\f20a";
}
.fa-shekel:before,
.fa-sheqel:before,
.fa-ils:before {
  content: "\f20b";
}
.fa-meanpath:before {
  content: "\f20c";
}
.fa-buysellads:before {
  content: "\f20d";
}
.fa-connectdevelop:before {
  content: "\f20e";
}
.fa-dashcube:before {
  content: "\f210";
}
.fa-forumbee:before {
  content: "\f211";
}
.fa-leanpub:before {
  content: "\f212";
}
.fa-sellsy:before {
  content: "\f213";
}
.fa-shirtsinbulk:before {
  content: "\f214";
}
.fa-simplybuilt:before {
  content: "\f215";
}
.fa-skyatlas:before {
  content: "\f216";
}
.fa-cart-plus:before {
  content: "\f217";
}
.fa-cart-arrow-down:before {
  content: "\f218";
}
.fa-diamond:before {
  content: "\f219";
}
.fa-ship:before {
  content: "\f21a";
}
.fa-user-secret:before {
  content: "\f21b";
}
.fa-motorcycle:before {
  content: "\f21c";
}
.fa-street-view:before {
  content: "\f21d";
}
.fa-heartbeat:before {
  content: "\f21e";
}
.fa-venus:before {
  content: "\f221";
}
.fa-mars:before {
  content: "\f222";
}
.fa-mercury:before {
  content: "\f223";
}
.fa-intersex:before,
.fa-transgender:before {
  content: "\f224";
}
.fa-transgender-alt:before {
  content: "\f225";
}
.fa-venus-double:before {
  content: "\f226";
}
.fa-mars-double:before {
  content: "\f227";
}
.fa-venus-mars:before {
  content: "\f228";
}
.fa-mars-stroke:before {
  content: "\f229";
}
.fa-mars-stroke-v:before {
  content: "\f22a";
}
.fa-mars-stroke-h:before {
  content: "\f22b";
}
.fa-neuter:before {
  content: "\f22c";
}
.fa-genderless:before {
  content: "\f22d";
}
.fa-facebook-official:before {
  content: "\f230";
}
.fa-pinterest-p:before {
  content: "\f231";
}
.fa-whatsapp:before {
  content: "\f232";
}
.fa-server:before {
  content: "\f233";
}
.fa-user-plus:before {
  content: "\f234";
}
.fa-user-times:before {
  content: "\f235";
}
.fa-hotel:before,
.fa-bed:before {
  content: "\f236";
}
.fa-viacoin:before {
  content: "\f237";
}
.fa-train:before {
  content: "\f238";
}
.fa-subway:before {
  content: "\f239";
}
.fa-medium:before {
  content: "\f23a";
}
.fa-yc:before,
.fa-y-combinator:before {
  content: "\f23b";
}
.fa-optin-monster:before {
  content: "\f23c";
}
.fa-opencart:before {
  content: "\f23d";
}
.fa-expeditedssl:before {
  content: "\f23e";
}
.fa-battery-4:before,
.fa-battery:before,
.fa-battery-full:before {
  content: "\f240";
}
.fa-battery-3:before,
.fa-battery-three-quarters:before {
  content: "\f241";
}
.fa-battery-2:before,
.fa-battery-half:before {
  content: "\f242";
}
.fa-battery-1:before,
.fa-battery-quarter:before {
  content: "\f243";
}
.fa-battery-0:before,
.fa-battery-empty:before {
  content: "\f244";
}
.fa-mouse-pointer:before {
  content: "\f245";
}
.fa-i-cursor:before {
  content: "\f246";
}
.fa-object-group:before {
  content: "\f247";
}
.fa-object-ungroup:before {
  content: "\f248";
}
.fa-sticky-note:before {
  content: "\f249";
}
.fa-sticky-note-o:before {
  content: "\f24a";
}
.fa-cc-jcb:before {
  content: "\f24b";
}
.fa-cc-diners-club:before {
  content: "\f24c";
}
.fa-clone:before {
  content: "\f24d";
}
.fa-balance-scale:before {
  content: "\f24e";
}
.fa-hourglass-o:before {
  content: "\f250";
}
.fa-hourglass-1:before,
.fa-hourglass-start:before {
  content: "\f251";
}
.fa-hourglass-2:before,
.fa-hourglass-half:before {
  content: "\f252";
}
.fa-hourglass-3:before,
.fa-hourglass-end:before {
  content: "\f253";
}
.fa-hourglass:before {
  content: "\f254";
}
.fa-hand-grab-o:before,
.fa-hand-rock-o:before {
  content: "\f255";
}
.fa-hand-stop-o:before,
.fa-hand-paper-o:before {
  content: "\f256";
}
.fa-hand-scissors-o:before {
  content: "\f257";
}
.fa-hand-lizard-o:before {
  content: "\f258";
}
.fa-hand-spock-o:before {
  content: "\f259";
}
.fa-hand-pointer-o:before {
  content: "\f25a";
}
.fa-hand-peace-o:before {
  content: "\f25b";
}
.fa-trademark:before {
  content: "\f25c";
}
.fa-registered:before {
  content: "\f25d";
}
.fa-creative-commons:before {
  content: "\f25e";
}
.fa-gg:before {
  content: "\f260";
}
.fa-gg-circle:before {
  content: "\f261";
}
.fa-tripadvisor:before {
  content: "\f262";
}
.fa-odnoklassniki:before {
  content: "\f263";
}
.fa-odnoklassniki-square:before {
  content: "\f264";
}
.fa-get-pocket:before {
  content: "\f265";
}
.fa-wikipedia-w:before {
  content: "\f266";
}
.fa-safari:before {
  content: "\f267";
}
.fa-chrome:before {
  content: "\f268";
}
.fa-firefox:before {
  content: "\f269";
}
.fa-opera:before {
  content: "\f26a";
}
.fa-internet-explorer:before {
  content: "\f26b";
}
.fa-tv:before,
.fa-television:before {
  content: "\f26c";
}
.fa-contao:before {
  content: "\f26d";
}
.fa-500px:before {
  content: "\f26e";
}
.fa-amazon:before {
  content: "\f270";
}
.fa-calendar-plus-o:before {
  content: "\f271";
}
.fa-calendar-minus-o:before {
  content: "\f272";
}
.fa-calendar-times-o:before {
  content: "\f273";
}
.fa-calendar-check-o:before {
  content: "\f274";
}
.fa-industry:before {
  content: "\f275";
}
.fa-map-pin:before {
  content: "\f276";
}
.fa-map-signs:before {
  content: "\f277";
}
.fa-map-o:before {
  content: "\f278";
}
.fa-map:before {
  content: "\f279";
}
.fa-commenting:before {
  content: "\f27a";
}
.fa-commenting-o:before {
  content: "\f27b";
}
.fa-houzz:before {
  content: "\f27c";
}
.fa-vimeo:before {
  content: "\f27d";
}
.fa-black-tie:before {
  content: "\f27e";
}
.fa-fonticons:before {
  content: "\f280";
}
.fa-reddit-alien:before {
  content: "\f281";
}
.fa-edge:before {
  content: "\f282";
}
.fa-credit-card-alt:before {
  content: "\f283";
}
.fa-codiepie:before {
  content: "\f284";
}
.fa-modx:before {
  content: "\f285";
}
.fa-fort-awesome:before {
  content: "\f286";
}
.fa-usb:before {
  content: "\f287";
}
.fa-product-hunt:before {
  content: "\f288";
}
.fa-mixcloud:before {
  content: "\f289";
}
.fa-scribd:before {
  content: "\f28a";
}
.fa-pause-circle:before {
  content: "\f28b";
}
.fa-pause-circle-o:before {
  content: "\f28c";
}
.fa-stop-circle:before {
  content: "\f28d";
}
.fa-stop-circle-o:before {
  content: "\f28e";
}
.fa-shopping-bag:before {
  content: "\f290";
}
.fa-shopping-basket:before {
  content: "\f291";
}
.fa-hashtag:before {
  content: "\f292";
}
.fa-bluetooth:before {
  content: "\f293";
}
.fa-bluetooth-b:before {
  content: "\f294";
}
.fa-percent:before {
  content: "\f295";
}
.fa-gitlab:before {
  content: "\f296";
}
.fa-wpbeginner:before {
  content: "\f297";
}
.fa-wpforms:before {
  content: "\f298";
}
.fa-envira:before {
  content: "\f299";
}
.fa-universal-access:before {
  content: "\f29a";
}
.fa-wheelchair-alt:before {
  content: "\f29b";
}
.fa-question-circle-o:before {
  content: "\f29c";
}
.fa-blind:before {
  content: "\f29d";
}
.fa-audio-description:before {
  content: "\f29e";
}
.fa-volume-control-phone:before {
  content: "\f2a0";
}
.fa-braille:before {
  content: "\f2a1";
}
.fa-assistive-listening-systems:before {
  content: "\f2a2";
}
.fa-asl-interpreting:before,
.fa-american-sign-language-interpreting:before {
  content: "\f2a3";
}
.fa-deafness:before,
.fa-hard-of-hearing:before,
.fa-deaf:before {
  content: "\f2a4";
}
.fa-glide:before {
  content: "\f2a5";
}
.fa-glide-g:before {
  content: "\f2a6";
}
.fa-signing:before,
.fa-sign-language:before {
  content: "\f2a7";
}
.fa-low-vision:before {
  content: "\f2a8";
}
.fa-viadeo:before {
  content: "\f2a9";
}
.fa-viadeo-square:before {
  content: "\f2aa";
}
.fa-snapchat:before {
  content: "\f2ab";
}
.fa-snapchat-ghost:before {
  content: "\f2ac";
}
.fa-snapchat-square:before {
  content: "\f2ad";
}
.fa-pied-piper:before {
  content: "\f2ae";
}
.fa-first-order:before {
  content: "\f2b0";
}
.fa-yoast:before {
  content: "\f2b1";
}
.fa-themeisle:before {
  content: "\f2b2";
}
.fa-google-plus-circle:before,
.fa-google-plus-official:before {
  content: "\f2b3";
}
.fa-fa:before,
.fa-font-awesome:before {
  content: "\f2b4";
}
.fa-handshake-o:before {
  content: "\f2b5";
}
.fa-envelope-open:before {
  content: "\f2b6";
}
.fa-envelope-open-o:before {
  content: "\f2b7";
}
.fa-linode:before {
  content: "\f2b8";
}
.fa-address-book:before {
  content: "\f2b9";
}
.fa-address-book-o:before {
  content: "\f2ba";
}
.fa-vcard:before,
.fa-address-card:before {
  content: "\f2bb";
}
.fa-vcard-o:before,
.fa-address-card-o:before {
  content: "\f2bc";
}
.fa-user-circle:before {
  content: "\f2bd";
}
.fa-user-circle-o:before {
  content: "\f2be";
}
.fa-user-o:before {
  content: "\f2c0";
}
.fa-id-badge:before {
  content: "\f2c1";
}
.fa-drivers-license:before,
.fa-id-card:before {
  content: "\f2c2";
}
.fa-drivers-license-o:before,
.fa-id-card-o:before {
  content: "\f2c3";
}
.fa-quora:before {
  content: "\f2c4";
}
.fa-free-code-camp:before {
  content: "\f2c5";
}
.fa-telegram:before {
  content: "\f2c6";
}
.fa-thermometer-4:before,
.fa-thermometer:before,
.fa-thermometer-full:before {
  content: "\f2c7";
}
.fa-thermometer-3:before,
.fa-thermometer-three-quarters:before {
  content: "\f2c8";
}
.fa-thermometer-2:before,
.fa-thermometer-half:before {
  content: "\f2c9";
}
.fa-thermometer-1:before,
.fa-thermometer-quarter:before {
  content: "\f2ca";
}
.fa-thermometer-0:before,
.fa-thermometer-empty:before {
  content: "\f2cb";
}
.fa-shower:before {
  content: "\f2cc";
}
.fa-bathtub:before,
.fa-s15:before,
.fa-bath:before {
  content: "\f2cd";
}
.fa-podcast:before {
  content: "\f2ce";
}
.fa-window-maximize:before {
  content: "\f2d0";
}
.fa-window-minimize:before {
  content: "\f2d1";
}
.fa-window-restore:before {
  content: "\f2d2";
}
.fa-times-rectangle:before,
.fa-window-close:before {
  content: "\f2d3";
}
.fa-times-rectangle-o:before,
.fa-window-close-o:before {
  content: "\f2d4";
}
.fa-bandcamp:before {
  content: "\f2d5";
}
.fa-grav:before {
  content: "\f2d6";
}
.fa-etsy:before {
  content: "\f2d7";
}
.fa-imdb:before {
  content: "\f2d8";
}
.fa-ravelry:before {
  content: "\f2d9";
}
.fa-eercast:before {
  content: "\f2da";
}
.fa-microchip:before {
  content: "\f2db";
}
.fa-snowflake-o:before {
  content: "\f2dc";
}
.fa-superpowers:before {
  content: "\f2dd";
}
.fa-wpexplorer:before {
  content: "\f2de";
}
.fa-meetup:before {
  content: "\f2e0";
}
.sr-only {
  position: absolute;
  width: 1px;
  height: 1px;
  padding: 0;
  margin: -1px;
  overflow: hidden;
  clip: rect(0, 0, 0, 0);
  border: 0;
}
.sr-only-focusable:active,
.sr-only-focusable:focus {
  position: static;
  width: auto;
  height: auto;
  margin: 0;
  overflow: visible;
  clip: auto;
}
.sr-only-focusable:active,
.sr-only-focusable:focus {
  position: static;
  width: auto;
  height: auto;
  margin: 0;
  overflow: visible;
  clip: auto;
}
/*!
*
* IPython base
*
*/
.modal.fade .modal-dialog {
  -webkit-transform: translate(0, 0);
  -ms-transform: translate(0, 0);
  -o-transform: translate(0, 0);
  transform: translate(0, 0);
}
code {
  color: #000;
}
pre {
  font-size: inherit;
  line-height: inherit;
}
label {
  font-weight: normal;
}
/* Make the page background atleast 100% the height of the view port */
/* Make the page itself atleast 70% the height of the view port */
.border-box-sizing {
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
}
.corner-all {
  border-radius: 2px;
}
.no-padding {
  padding: 0px;
}
/* Flexible box model classes */
/* Taken from Alex Russell http://infrequently.org/2009/08/css-3-progress/ */
/* This file is a compatability layer.  It allows the usage of flexible box 
model layouts accross multiple browsers, including older browsers.  The newest,
universal implementation of the flexible box model is used when available (see
`Modern browsers` comments below).  Browsers that are known to implement this 
new spec completely include:

    Firefox 28.0+
    Chrome 29.0+
    Internet Explorer 11+ 
    Opera 17.0+

Browsers not listed, including Safari, are supported via the styling under the
`Old browsers` comments below.
*/
.hbox {
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: horizontal;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: horizontal;
  -moz-box-align: stretch;
  display: box;
  box-orient: horizontal;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: row;
  align-items: stretch;
}
.hbox > * {
  /* Old browsers */
  -webkit-box-flex: 0;
  -moz-box-flex: 0;
  box-flex: 0;
  /* Modern browsers */
  flex: none;
}
.vbox {
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: vertical;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: vertical;
  -moz-box-align: stretch;
  display: box;
  box-orient: vertical;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: column;
  align-items: stretch;
}
.vbox > * {
  /* Old browsers */
  -webkit-box-flex: 0;
  -moz-box-flex: 0;
  box-flex: 0;
  /* Modern browsers */
  flex: none;
}
.hbox.reverse,
.vbox.reverse,
.reverse {
  /* Old browsers */
  -webkit-box-direction: reverse;
  -moz-box-direction: reverse;
  box-direction: reverse;
  /* Modern browsers */
  flex-direction: row-reverse;
}
.hbox.box-flex0,
.vbox.box-flex0,
.box-flex0 {
  /* Old browsers */
  -webkit-box-flex: 0;
  -moz-box-flex: 0;
  box-flex: 0;
  /* Modern browsers */
  flex: none;
  width: auto;
}
.hbox.box-flex1,
.vbox.box-flex1,
.box-flex1 {
  /* Old browsers */
  -webkit-box-flex: 1;
  -moz-box-flex: 1;
  box-flex: 1;
  /* Modern browsers */
  flex: 1;
}
.hbox.box-flex,
.vbox.box-flex,
.box-flex {
  /* Old browsers */
  /* Old browsers */
  -webkit-box-flex: 1;
  -moz-box-flex: 1;
  box-flex: 1;
  /* Modern browsers */
  flex: 1;
}
.hbox.box-flex2,
.vbox.box-flex2,
.box-flex2 {
  /* Old browsers */
  -webkit-box-flex: 2;
  -moz-box-flex: 2;
  box-flex: 2;
  /* Modern browsers */
  flex: 2;
}
.box-group1 {
  /*  Deprecated */
  -webkit-box-flex-group: 1;
  -moz-box-flex-group: 1;
  box-flex-group: 1;
}
.box-group2 {
  /* Deprecated */
  -webkit-box-flex-group: 2;
  -moz-box-flex-group: 2;
  box-flex-group: 2;
}
.hbox.start,
.vbox.start,
.start {
  /* Old browsers */
  -webkit-box-pack: start;
  -moz-box-pack: start;
  box-pack: start;
  /* Modern browsers */
  justify-content: flex-start;
}
.hbox.end,
.vbox.end,
.end {
  /* Old browsers */
  -webkit-box-pack: end;
  -moz-box-pack: end;
  box-pack: end;
  /* Modern browsers */
  justify-content: flex-end;
}
.hbox.center,
.vbox.center,
.center {
  /* Old browsers */
  -webkit-box-pack: center;
  -moz-box-pack: center;
  box-pack: center;
  /* Modern browsers */
  justify-content: center;
}
.hbox.baseline,
.vbox.baseline,
.baseline {
  /* Old browsers */
  -webkit-box-pack: baseline;
  -moz-box-pack: baseline;
  box-pack: baseline;
  /* Modern browsers */
  justify-content: baseline;
}
.hbox.stretch,
.vbox.stretch,
.stretch {
  /* Old browsers */
  -webkit-box-pack: stretch;
  -moz-box-pack: stretch;
  box-pack: stretch;
  /* Modern browsers */
  justify-content: stretch;
}
.hbox.align-start,
.vbox.align-start,
.align-start {
  /* Old browsers */
  -webkit-box-align: start;
  -moz-box-align: start;
  box-align: start;
  /* Modern browsers */
  align-items: flex-start;
}
.hbox.align-end,
.vbox.align-end,
.align-end {
  /* Old browsers */
  -webkit-box-align: end;
  -moz-box-align: end;
  box-align: end;
  /* Modern browsers */
  align-items: flex-end;
}
.hbox.align-center,
.vbox.align-center,
.align-center {
  /* Old browsers */
  -webkit-box-align: center;
  -moz-box-align: center;
  box-align: center;
  /* Modern browsers */
  align-items: center;
}
.hbox.align-baseline,
.vbox.align-baseline,
.align-baseline {
  /* Old browsers */
  -webkit-box-align: baseline;
  -moz-box-align: baseline;
  box-align: baseline;
  /* Modern browsers */
  align-items: baseline;
}
.hbox.align-stretch,
.vbox.align-stretch,
.align-stretch {
  /* Old browsers */
  -webkit-box-align: stretch;
  -moz-box-align: stretch;
  box-align: stretch;
  /* Modern browsers */
  align-items: stretch;
}
div.error {
  margin: 2em;
  text-align: center;
}
div.error > h1 {
  font-size: 500%;
  line-height: normal;
}
div.error > p {
  font-size: 200%;
  line-height: normal;
}
div.traceback-wrapper {
  text-align: left;
  max-width: 800px;
  margin: auto;
}
div.traceback-wrapper pre.traceback {
  max-height: 600px;
  overflow: auto;
}
/**
 * Primary styles
 *
 * Author: Jupyter Development Team
 */
body {
  background-color: #fff;
  /* This makes sure that the body covers the entire window and needs to
       be in a different element than the display: box in wrapper below */
  position: absolute;
  left: 0px;
  right: 0px;
  top: 0px;
  bottom: 0px;
  overflow: visible;
}
body > #header {
  /* Initially hidden to prevent FLOUC */
  display: none;
  background-color: #fff;
  /* Display over codemirror */
  position: relative;
  z-index: 100;
}
body > #header #header-container {
  display: flex;
  flex-direction: row;
  justify-content: space-between;
  padding: 5px;
  padding-bottom: 5px;
  padding-top: 5px;
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
}
body > #header .header-bar {
  width: 100%;
  height: 1px;
  background: #e7e7e7;
  margin-bottom: -1px;
}
@media print {
  body > #header {
    display: none !important;
  }
}
#header-spacer {
  width: 100%;
  visibility: hidden;
}
@media print {
  #header-spacer {
    display: none;
  }
}
#ipython_notebook {
  padding-left: 0px;
  padding-top: 1px;
  padding-bottom: 1px;
}
[dir="rtl"] #ipython_notebook {
  margin-right: 10px;
  margin-left: 0;
}
[dir="rtl"] #ipython_notebook.pull-left {
  float: right !important;
  float: right;
}
.flex-spacer {
  flex: 1;
}
#noscript {
  width: auto;
  padding-top: 16px;
  padding-bottom: 16px;
  text-align: center;
  font-size: 22px;
  color: red;
  font-weight: bold;
}
#ipython_notebook img {
  height: 28px;
}
#site {
  width: 100%;
  display: none;
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
  overflow: auto;
}
@media print {
  #site {
    height: auto !important;
  }
}
/* Smaller buttons */
.ui-button .ui-button-text {
  padding: 0.2em 0.8em;
  font-size: 77%;
}
input.ui-button {
  padding: 0.3em 0.9em;
}
span#kernel_logo_widget {
  margin: 0 10px;
}
span#login_widget {
  float: right;
}
[dir="rtl"] span#login_widget {
  float: left;
}
span#login_widget > .button,
#logout {
  color: #333;
  background-color: #fff;
  border-color: #ccc;
}
span#login_widget > .button:focus,
#logout:focus,
span#login_widget > .button.focus,
#logout.focus {
  color: #333;
  background-color: #e6e6e6;
  border-color: #8c8c8c;
}
span#login_widget > .button:hover,
#logout:hover {
  color: #333;
  background-color: #e6e6e6;
  border-color: #adadad;
}
span#login_widget > .button:active,
#logout:active,
span#login_widget > .button.active,
#logout.active,
.open > .dropdown-togglespan#login_widget > .button,
.open > .dropdown-toggle#logout {
  color: #333;
  background-color: #e6e6e6;
  border-color: #adadad;
}
span#login_widget > .button:active:hover,
#logout:active:hover,
span#login_widget > .button.active:hover,
#logout.active:hover,
.open > .dropdown-togglespan#login_widget > .button:hover,
.open > .dropdown-toggle#logout:hover,
span#login_widget > .button:active:focus,
#logout:active:focus,
span#login_widget > .button.active:focus,
#logout.active:focus,
.open > .dropdown-togglespan#login_widget > .button:focus,
.open > .dropdown-toggle#logout:focus,
span#login_widget > .button:active.focus,
#logout:active.focus,
span#login_widget > .button.active.focus,
#logout.active.focus,
.open > .dropdown-togglespan#login_widget > .button.focus,
.open > .dropdown-toggle#logout.focus {
  color: #333;
  background-color: #d4d4d4;
  border-color: #8c8c8c;
}
span#login_widget > .button:active,
#logout:active,
span#login_widget > .button.active,
#logout.active,
.open > .dropdown-togglespan#login_widget > .button,
.open > .dropdown-toggle#logout {
  background-image: none;
}
span#login_widget > .button.disabled:hover,
#logout.disabled:hover,
span#login_widget > .button[disabled]:hover,
#logout[disabled]:hover,
fieldset[disabled] span#login_widget > .button:hover,
fieldset[disabled] #logout:hover,
span#login_widget > .button.disabled:focus,
#logout.disabled:focus,
span#login_widget > .button[disabled]:focus,
#logout[disabled]:focus,
fieldset[disabled] span#login_widget > .button:focus,
fieldset[disabled] #logout:focus,
span#login_widget > .button.disabled.focus,
#logout.disabled.focus,
span#login_widget > .button[disabled].focus,
#logout[disabled].focus,
fieldset[disabled] span#login_widget > .button.focus,
fieldset[disabled] #logout.focus {
  background-color: #fff;
  border-color: #ccc;
}
span#login_widget > .button .badge,
#logout .badge {
  color: #fff;
  background-color: #333;
}
.nav-header {
  text-transform: none;
}
#header > span {
  margin-top: 10px;
}
.modal_stretch .modal-dialog {
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: vertical;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: vertical;
  -moz-box-align: stretch;
  display: box;
  box-orient: vertical;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: column;
  align-items: stretch;
  min-height: 80vh;
}
.modal_stretch .modal-dialog .modal-body {
  max-height: calc(100vh - 200px);
  overflow: auto;
  flex: 1;
}
.modal-header {
  cursor: move;
}
@media (min-width: 768px) {
  .modal .modal-dialog {
    width: 700px;
  }
}
@media (min-width: 768px) {
  select.form-control {
    margin-left: 12px;
    margin-right: 12px;
  }
}
/*!
*
* IPython auth
*
*/
.center-nav {
  display: inline-block;
  margin-bottom: -4px;
}
[dir="rtl"] .center-nav form.pull-left {
  float: right !important;
  float: right;
}
[dir="rtl"] .center-nav .navbar-text {
  float: right;
}
[dir="rtl"] .navbar-inner {
  text-align: right;
}
[dir="rtl"] div.text-left {
  text-align: right;
}
/*!
*
* IPython tree view
*
*/
/* We need an invisible input field on top of the sentense*/
/* "Drag file onto the list ..." */
.alternate_upload {
  background-color: none;
  display: inline;
}
.alternate_upload.form {
  padding: 0;
  margin: 0;
}
.alternate_upload input.fileinput {
  position: absolute;
  display: block;
  width: 100%;
  height: 100%;
  overflow: hidden;
  cursor: pointer;
  opacity: 0;
  z-index: 2;
}
.alternate_upload .btn-xs > input.fileinput {
  margin: -1px -5px;
}
.alternate_upload .btn-upload {
  position: relative;
  height: 22px;
}
::-webkit-file-upload-button {
  cursor: pointer;
}
/**
 * Primary styles
 *
 * Author: Jupyter Development Team
 */
ul#tabs {
  margin-bottom: 4px;
}
ul#tabs a {
  padding-top: 6px;
  padding-bottom: 4px;
}
[dir="rtl"] ul#tabs.nav-tabs > li {
  float: right;
}
[dir="rtl"] ul#tabs.nav.nav-tabs {
  padding-right: 0;
}
ul.breadcrumb a:focus,
ul.breadcrumb a:hover {
  text-decoration: none;
}
ul.breadcrumb i.icon-home {
  font-size: 16px;
  margin-right: 4px;
}
ul.breadcrumb span {
  color: #5e5e5e;
}
.list_toolbar {
  padding: 4px 0 4px 0;
  vertical-align: middle;
}
.list_toolbar .tree-buttons {
  padding-top: 1px;
}
[dir="rtl"] .list_toolbar .tree-buttons .pull-right {
  float: left !important;
  float: left;
}
[dir="rtl"] .list_toolbar .col-sm-4,
[dir="rtl"] .list_toolbar .col-sm-8 {
  float: right;
}
.dynamic-buttons {
  padding-top: 3px;
  display: inline-block;
}
.list_toolbar [class*="span"] {
  min-height: 24px;
}
.list_header {
  font-weight: bold;
  background-color: #EEE;
}
.list_placeholder {
  font-weight: bold;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 7px;
  padding-right: 7px;
}
.list_container {
  margin-top: 4px;
  margin-bottom: 20px;
  border: 1px solid #ddd;
  border-radius: 2px;
}
.list_container > div {
  border-bottom: 1px solid #ddd;
}
.list_container > div:hover .list-item {
  background-color: red;
}
.list_container > div:last-child {
  border: none;
}
.list_item:hover .list_item {
  background-color: #ddd;
}
.list_item a {
  text-decoration: none;
}
.list_item:hover {
  background-color: #fafafa;
}
.list_header > div,
.list_item > div {
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 7px;
  padding-right: 7px;
  line-height: 22px;
}
.list_header > div input,
.list_item > div input {
  margin-right: 7px;
  margin-left: 14px;
  vertical-align: text-bottom;
  line-height: 22px;
  position: relative;
  top: -1px;
}
.list_header > div .item_link,
.list_item > div .item_link {
  margin-left: -1px;
  vertical-align: baseline;
  line-height: 22px;
}
[dir="rtl"] .list_item > div input {
  margin-right: 0;
}
.new-file input[type=checkbox] {
  visibility: hidden;
}
.item_name {
  line-height: 22px;
  height: 24px;
}
.item_icon {
  font-size: 14px;
  color: #5e5e5e;
  margin-right: 7px;
  margin-left: 7px;
  line-height: 22px;
  vertical-align: baseline;
}
.item_modified {
  margin-right: 7px;
  margin-left: 7px;
}
[dir="rtl"] .item_modified.pull-right {
  float: left !important;
  float: left;
}
.item_buttons {
  line-height: 1em;
  margin-left: -5px;
}
.item_buttons .btn,
.item_buttons .btn-group,
.item_buttons .input-group {
  float: left;
}
.item_buttons > .btn,
.item_buttons > .btn-group,
.item_buttons > .input-group {
  margin-left: 5px;
}
.item_buttons .btn {
  min-width: 13ex;
}
.item_buttons .running-indicator {
  padding-top: 4px;
  color: #5cb85c;
}
.item_buttons .kernel-name {
  padding-top: 4px;
  color: #5bc0de;
  margin-right: 7px;
  float: left;
}
[dir="rtl"] .item_buttons.pull-right {
  float: left !important;
  float: left;
}
[dir="rtl"] .item_buttons .kernel-name {
  margin-left: 7px;
  float: right;
}
.toolbar_info {
  height: 24px;
  line-height: 24px;
}
.list_item input:not([type=checkbox]) {
  padding-top: 3px;
  padding-bottom: 3px;
  height: 22px;
  line-height: 14px;
  margin: 0px;
}
.highlight_text {
  color: blue;
}
#project_name {
  display: inline-block;
  padding-left: 7px;
  margin-left: -2px;
}
#project_name > .breadcrumb {
  padding: 0px;
  margin-bottom: 0px;
  background-color: transparent;
  font-weight: bold;
}
.sort_button {
  display: inline-block;
  padding-left: 7px;
}
[dir="rtl"] .sort_button.pull-right {
  float: left !important;
  float: left;
}
#tree-selector {
  padding-right: 0px;
}
#button-select-all {
  min-width: 50px;
}
[dir="rtl"] #button-select-all.btn {
  float: right ;
}
#select-all {
  margin-left: 7px;
  margin-right: 2px;
  margin-top: 2px;
  height: 16px;
}
[dir="rtl"] #select-all.pull-left {
  float: right !important;
  float: right;
}
.menu_icon {
  margin-right: 2px;
}
.tab-content .row {
  margin-left: 0px;
  margin-right: 0px;
}
.folder_icon:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f114";
}
.folder_icon:before.fa-pull-left {
  margin-right: .3em;
}
.folder_icon:before.fa-pull-right {
  margin-left: .3em;
}
.folder_icon:before.pull-left {
  margin-right: .3em;
}
.folder_icon:before.pull-right {
  margin-left: .3em;
}
.notebook_icon:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f02d";
  position: relative;
  top: -1px;
}
.notebook_icon:before.fa-pull-left {
  margin-right: .3em;
}
.notebook_icon:before.fa-pull-right {
  margin-left: .3em;
}
.notebook_icon:before.pull-left {
  margin-right: .3em;
}
.notebook_icon:before.pull-right {
  margin-left: .3em;
}
.running_notebook_icon:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f02d";
  position: relative;
  top: -1px;
  color: #5cb85c;
}
.running_notebook_icon:before.fa-pull-left {
  margin-right: .3em;
}
.running_notebook_icon:before.fa-pull-right {
  margin-left: .3em;
}
.running_notebook_icon:before.pull-left {
  margin-right: .3em;
}
.running_notebook_icon:before.pull-right {
  margin-left: .3em;
}
.file_icon:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f016";
  position: relative;
  top: -2px;
}
.file_icon:before.fa-pull-left {
  margin-right: .3em;
}
.file_icon:before.fa-pull-right {
  margin-left: .3em;
}
.file_icon:before.pull-left {
  margin-right: .3em;
}
.file_icon:before.pull-right {
  margin-left: .3em;
}
#notebook_toolbar .pull-right {
  padding-top: 0px;
  margin-right: -1px;
}
ul#new-menu {
  left: auto;
  right: 0;
}
#new-menu .dropdown-header {
  font-size: 10px;
  border-bottom: 1px solid #e5e5e5;
  padding: 0 0 3px;
  margin: -3px 20px 0;
}
.kernel-menu-icon {
  padding-right: 12px;
  width: 24px;
  content: "\f096";
}
.kernel-menu-icon:before {
  content: "\f096";
}
.kernel-menu-icon-current:before {
  content: "\f00c";
}
#tab_content {
  padding-top: 20px;
}
#running .panel-group .panel {
  margin-top: 3px;
  margin-bottom: 1em;
}
#running .panel-group .panel .panel-heading {
  background-color: #EEE;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 7px;
  padding-right: 7px;
  line-height: 22px;
}
#running .panel-group .panel .panel-heading a:focus,
#running .panel-group .panel .panel-heading a:hover {
  text-decoration: none;
}
#running .panel-group .panel .panel-body {
  padding: 0px;
}
#running .panel-group .panel .panel-body .list_container {
  margin-top: 0px;
  margin-bottom: 0px;
  border: 0px;
  border-radius: 0px;
}
#running .panel-group .panel .panel-body .list_container .list_item {
  border-bottom: 1px solid #ddd;
}
#running .panel-group .panel .panel-body .list_container .list_item:last-child {
  border-bottom: 0px;
}
.delete-button {
  display: none;
}
.duplicate-button {
  display: none;
}
.rename-button {
  display: none;
}
.move-button {
  display: none;
}
.download-button {
  display: none;
}
.shutdown-button {
  display: none;
}
.dynamic-instructions {
  display: inline-block;
  padding-top: 4px;
}
/*!
*
* IPython text editor webapp
*
*/
.selected-keymap i.fa {
  padding: 0px 5px;
}
.selected-keymap i.fa:before {
  content: "\f00c";
}
#mode-menu {
  overflow: auto;
  max-height: 20em;
}
.edit_app #header {
  -webkit-box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
  box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
}
.edit_app #menubar .navbar {
  /* Use a negative 1 bottom margin, so the border overlaps the border of the
    header */
  margin-bottom: -1px;
}
.dirty-indicator {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  width: 20px;
}
.dirty-indicator.fa-pull-left {
  margin-right: .3em;
}
.dirty-indicator.fa-pull-right {
  margin-left: .3em;
}
.dirty-indicator.pull-left {
  margin-right: .3em;
}
.dirty-indicator.pull-right {
  margin-left: .3em;
}
.dirty-indicator-dirty {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  width: 20px;
}
.dirty-indicator-dirty.fa-pull-left {
  margin-right: .3em;
}
.dirty-indicator-dirty.fa-pull-right {
  margin-left: .3em;
}
.dirty-indicator-dirty.pull-left {
  margin-right: .3em;
}
.dirty-indicator-dirty.pull-right {
  margin-left: .3em;
}
.dirty-indicator-clean {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  width: 20px;
}
.dirty-indicator-clean.fa-pull-left {
  margin-right: .3em;
}
.dirty-indicator-clean.fa-pull-right {
  margin-left: .3em;
}
.dirty-indicator-clean.pull-left {
  margin-right: .3em;
}
.dirty-indicator-clean.pull-right {
  margin-left: .3em;
}
.dirty-indicator-clean:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f00c";
}
.dirty-indicator-clean:before.fa-pull-left {
  margin-right: .3em;
}
.dirty-indicator-clean:before.fa-pull-right {
  margin-left: .3em;
}
.dirty-indicator-clean:before.pull-left {
  margin-right: .3em;
}
.dirty-indicator-clean:before.pull-right {
  margin-left: .3em;
}
#filename {
  font-size: 16pt;
  display: table;
  padding: 0px 5px;
}
#current-mode {
  padding-left: 5px;
  padding-right: 5px;
}
#texteditor-backdrop {
  padding-top: 20px;
  padding-bottom: 20px;
}
@media not print {
  #texteditor-backdrop {
    background-color: #EEE;
  }
}
@media print {
  #texteditor-backdrop #texteditor-container .CodeMirror-gutter,
  #texteditor-backdrop #texteditor-container .CodeMirror-gutters {
    background-color: #fff;
  }
}
@media not print {
  #texteditor-backdrop #texteditor-container .CodeMirror-gutter,
  #texteditor-backdrop #texteditor-container .CodeMirror-gutters {
    background-color: #fff;
  }
}
@media not print {
  #texteditor-backdrop #texteditor-container {
    padding: 0px;
    background-color: #fff;
    -webkit-box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
    box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
  }
}
.CodeMirror-dialog {
  background-color: #fff;
}
/*!
*
* IPython notebook
*
*/
/* CSS font colors for translated ANSI escape sequences */
/* The color values are a mix of
   http://www.xcolors.net/dl/baskerville-ivorylight and
   http://www.xcolors.net/dl/euphrasia */
.ansi-black-fg {
  color: #3E424D;
}
.ansi-black-bg {
  background-color: #3E424D;
}
.ansi-black-intense-fg {
  color: #282C36;
}
.ansi-black-intense-bg {
  background-color: #282C36;
}
.ansi-red-fg {
  color: #E75C58;
}
.ansi-red-bg {
  background-color: #E75C58;
}
.ansi-red-intense-fg {
  color: #B22B31;
}
.ansi-red-intense-bg {
  background-color: #B22B31;
}
.ansi-green-fg {
  color: #00A250;
}
.ansi-green-bg {
  background-color: #00A250;
}
.ansi-green-intense-fg {
  color: #007427;
}
.ansi-green-intense-bg {
  background-color: #007427;
}
.ansi-yellow-fg {
  color: #DDB62B;
}
.ansi-yellow-bg {
  background-color: #DDB62B;
}
.ansi-yellow-intense-fg {
  color: #B27D12;
}
.ansi-yellow-intense-bg {
  background-color: #B27D12;
}
.ansi-blue-fg {
  color: #208FFB;
}
.ansi-blue-bg {
  background-color: #208FFB;
}
.ansi-blue-intense-fg {
  color: #0065CA;
}
.ansi-blue-intense-bg {
  background-color: #0065CA;
}
.ansi-magenta-fg {
  color: #D160C4;
}
.ansi-magenta-bg {
  background-color: #D160C4;
}
.ansi-magenta-intense-fg {
  color: #A03196;
}
.ansi-magenta-intense-bg {
  background-color: #A03196;
}
.ansi-cyan-fg {
  color: #60C6C8;
}
.ansi-cyan-bg {
  background-color: #60C6C8;
}
.ansi-cyan-intense-fg {
  color: #258F8F;
}
.ansi-cyan-intense-bg {
  background-color: #258F8F;
}
.ansi-white-fg {
  color: #C5C1B4;
}
.ansi-white-bg {
  background-color: #C5C1B4;
}
.ansi-white-intense-fg {
  color: #A1A6B2;
}
.ansi-white-intense-bg {
  background-color: #A1A6B2;
}
.ansi-default-inverse-fg {
  color: #FFFFFF;
}
.ansi-default-inverse-bg {
  background-color: #000000;
}
.ansi-bold {
  font-weight: bold;
}
.ansi-underline {
  text-decoration: underline;
}
/* The following styles are deprecated an will be removed in a future version */
.ansibold {
  font-weight: bold;
}
.ansi-inverse {
  outline: 0.5px dotted;
}
/* use dark versions for foreground, to improve visibility */
.ansiblack {
  color: black;
}
.ansired {
  color: darkred;
}
.ansigreen {
  color: darkgreen;
}
.ansiyellow {
  color: #c4a000;
}
.ansiblue {
  color: darkblue;
}
.ansipurple {
  color: darkviolet;
}
.ansicyan {
  color: steelblue;
}
.ansigray {
  color: gray;
}
/* and light for background, for the same reason */
.ansibgblack {
  background-color: black;
}
.ansibgred {
  background-color: red;
}
.ansibggreen {
  background-color: green;
}
.ansibgyellow {
  background-color: yellow;
}
.ansibgblue {
  background-color: blue;
}
.ansibgpurple {
  background-color: magenta;
}
.ansibgcyan {
  background-color: cyan;
}
.ansibggray {
  background-color: gray;
}
div.cell {
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: vertical;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: vertical;
  -moz-box-align: stretch;
  display: box;
  box-orient: vertical;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: column;
  align-items: stretch;
  border-radius: 2px;
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
  border-width: 1px;
  border-style: solid;
  border-color: transparent;
  width: 100%;
  padding: 5px;
  /* This acts as a spacer between cells, that is outside the border */
  margin: 0px;
  outline: none;
  position: relative;
  overflow: visible;
}
div.cell:before {
  position: absolute;
  display: block;
  top: -1px;
  left: -1px;
  width: 5px;
  height: calc(100% +  2px);
  content: '';
  background: transparent;
}
div.cell.jupyter-soft-selected {
  border-left-color: #E3F2FD;
  border-left-width: 1px;
  padding-left: 5px;
  border-right-color: #E3F2FD;
  border-right-width: 1px;
  background: #E3F2FD;
}
@media print {
  div.cell.jupyter-soft-selected {
    border-color: transparent;
  }
}
div.cell.selected,
div.cell.selected.jupyter-soft-selected {
  border-color: #ababab;
}
div.cell.selected:before,
div.cell.selected.jupyter-soft-selected:before {
  position: absolute;
  display: block;
  top: -1px;
  left: -1px;
  width: 5px;
  height: calc(100% +  2px);
  content: '';
  background: #42A5F5;
}
@media print {
  div.cell.selected,
  div.cell.selected.jupyter-soft-selected {
    border-color: transparent;
  }
}
.edit_mode div.cell.selected {
  border-color: #66BB6A;
}
.edit_mode div.cell.selected:before {
  position: absolute;
  display: block;
  top: -1px;
  left: -1px;
  width: 5px;
  height: calc(100% +  2px);
  content: '';
  background: #66BB6A;
}
@media print {
  .edit_mode div.cell.selected {
    border-color: transparent;
  }
}
.prompt {
  /* This needs to be wide enough for 3 digit prompt numbers: In[100]: */
  min-width: 14ex;
  /* This padding is tuned to match the padding on the CodeMirror editor. */
  padding: 0.4em;
  margin: 0px;
  font-family: monospace;
  text-align: right;
  /* This has to match that of the the CodeMirror class line-height below */
  line-height: 1.21429em;
  /* Don't highlight prompt number selection */
  -webkit-touch-callout: none;
  -webkit-user-select: none;
  -khtml-user-select: none;
  -moz-user-select: none;
  -ms-user-select: none;
  user-select: none;
  /* Use default cursor */
  cursor: default;
}
@media (max-width: 540px) {
  .prompt {
    text-align: left;
  }
}
div.inner_cell {
  min-width: 0;
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: vertical;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: vertical;
  -moz-box-align: stretch;
  display: box;
  box-orient: vertical;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: column;
  align-items: stretch;
  /* Old browsers */
  -webkit-box-flex: 1;
  -moz-box-flex: 1;
  box-flex: 1;
  /* Modern browsers */
  flex: 1;
}
/* input_area and input_prompt must match in top border and margin for alignment */
div.input_area {
  border: 1px solid #cfcfcf;
  border-radius: 2px;
  background: #f7f7f7;
  line-height: 1.21429em;
}
/* This is needed so that empty prompt areas can collapse to zero height when there
   is no content in the output_subarea and the prompt. The main purpose of this is
   to make sure that empty JavaScript output_subareas have no height. */
div.prompt:empty {
  padding-top: 0;
  padding-bottom: 0;
}
div.unrecognized_cell {
  padding: 5px 5px 5px 0px;
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: horizontal;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: horizontal;
  -moz-box-align: stretch;
  display: box;
  box-orient: horizontal;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: row;
  align-items: stretch;
}
div.unrecognized_cell .inner_cell {
  border-radius: 2px;
  padding: 5px;
  font-weight: bold;
  color: red;
  border: 1px solid #cfcfcf;
  background: #eaeaea;
}
div.unrecognized_cell .inner_cell a {
  color: inherit;
  text-decoration: none;
}
div.unrecognized_cell .inner_cell a:hover {
  color: inherit;
  text-decoration: none;
}
@media (max-width: 540px) {
  div.unrecognized_cell > div.prompt {
    display: none;
  }
}
div.code_cell {
  /* avoid page breaking on code cells when printing */
}
@media print {
  div.code_cell {
    page-break-inside: avoid;
  }
}
/* any special styling for code cells that are currently running goes here */
div.input {
  page-break-inside: avoid;
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: horizontal;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: horizontal;
  -moz-box-align: stretch;
  display: box;
  box-orient: horizontal;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: row;
  align-items: stretch;
}
@media (max-width: 540px) {
  div.input {
    /* Old browsers */
    display: -webkit-box;
    -webkit-box-orient: vertical;
    -webkit-box-align: stretch;
    display: -moz-box;
    -moz-box-orient: vertical;
    -moz-box-align: stretch;
    display: box;
    box-orient: vertical;
    box-align: stretch;
    /* Modern browsers */
    display: flex;
    flex-direction: column;
    align-items: stretch;
  }
}
/* input_area and input_prompt must match in top border and margin for alignment */
div.input_prompt {
  color: #303F9F;
  border-top: 1px solid transparent;
}
div.input_area > div.highlight {
  margin: 0.4em;
  border: none;
  padding: 0px;
  background-color: transparent;
}
div.input_area > div.highlight > pre {
  margin: 0px;
  border: none;
  padding: 0px;
  background-color: transparent;
}
/* The following gets added to the <head> if it is detected that the user has a
 * monospace font with inconsistent normal/bold/italic height.  See
 * notebookmain.js.  Such fonts will have keywords vertically offset with
 * respect to the rest of the text.  The user should select a better font.
 * See: https://github.com/ipython/ipython/issues/1503
 *
 * .CodeMirror span {
 *      vertical-align: bottom;
 * }
 */
.CodeMirror {
  line-height: 1.21429em;
  /* Changed from 1em to our global default */
  font-size: 14px;
  height: auto;
  /* Changed to auto to autogrow */
  background: none;
  /* Changed from white to allow our bg to show through */
}
.CodeMirror-scroll {
  /*  The CodeMirror docs are a bit fuzzy on if overflow-y should be hidden or visible.*/
  /*  We have found that if it is visible, vertical scrollbars appear with font size changes.*/
  overflow-y: hidden;
  overflow-x: auto;
}
.CodeMirror-lines {
  /* In CM2, this used to be 0.4em, but in CM3 it went to 4px. We need the em value because */
  /* we have set a different line-height and want this to scale with that. */
  /* Note that this should set vertical padding only, since CodeMirror assumes
       that horizontal padding will be set on CodeMirror pre */
  padding: 0.4em 0;
}
.CodeMirror-linenumber {
  padding: 0 8px 0 4px;
}
.CodeMirror-gutters {
  border-bottom-left-radius: 2px;
  border-top-left-radius: 2px;
}
.CodeMirror pre {
  /* In CM3 this went to 4px from 0 in CM2. This sets horizontal padding only,
    use .CodeMirror-lines for vertical */
  padding: 0 0.4em;
  border: 0;
  border-radius: 0;
}
.CodeMirror-cursor {
  border-left: 1.4px solid black;
}
@media screen and (min-width: 2138px) and (max-width: 4319px) {
  .CodeMirror-cursor {
    border-left: 2px solid black;
  }
}
@media screen and (min-width: 4320px) {
  .CodeMirror-cursor {
    border-left: 4px solid black;
  }
}
/*

Original style from softwaremaniacs.org (c) Ivan Sagalaev <Maniac@SoftwareManiacs.Org>
Adapted from GitHub theme

*/
.highlight-base {
  color: #000;
}
.highlight-variable {
  color: #000;
}
.highlight-variable-2 {
  color: #1a1a1a;
}
.highlight-variable-3 {
  color: #333333;
}
.highlight-string {
  color: #BA2121;
}
.highlight-comment {
  color: #408080;
  font-style: italic;
}
.highlight-number {
  color: #080;
}
.highlight-atom {
  color: #88F;
}
.highlight-keyword {
  color: #008000;
  font-weight: bold;
}
.highlight-builtin {
  color: #008000;
}
.highlight-error {
  color: #f00;
}
.highlight-operator {
  color: #AA22FF;
  font-weight: bold;
}
.highlight-meta {
  color: #AA22FF;
}
/* previously not defined, copying from default codemirror */
.highlight-def {
  color: #00f;
}
.highlight-string-2 {
  color: #f50;
}
.highlight-qualifier {
  color: #555;
}
.highlight-bracket {
  color: #997;
}
.highlight-tag {
  color: #170;
}
.highlight-attribute {
  color: #00c;
}
.highlight-header {
  color: blue;
}
.highlight-quote {
  color: #090;
}
.highlight-link {
  color: #00c;
}
/* apply the same style to codemirror */
.cm-s-ipython span.cm-keyword {
  color: #008000;
  font-weight: bold;
}
.cm-s-ipython span.cm-atom {
  color: #88F;
}
.cm-s-ipython span.cm-number {
  color: #080;
}
.cm-s-ipython span.cm-def {
  color: #00f;
}
.cm-s-ipython span.cm-variable {
  color: #000;
}
.cm-s-ipython span.cm-operator {
  color: #AA22FF;
  font-weight: bold;
}
.cm-s-ipython span.cm-variable-2 {
  color: #1a1a1a;
}
.cm-s-ipython span.cm-variable-3 {
  color: #333333;
}
.cm-s-ipython span.cm-comment {
  color: #408080;
  font-style: italic;
}
.cm-s-ipython span.cm-string {
  color: #BA2121;
}
.cm-s-ipython span.cm-string-2 {
  color: #f50;
}
.cm-s-ipython span.cm-meta {
  color: #AA22FF;
}
.cm-s-ipython span.cm-qualifier {
  color: #555;
}
.cm-s-ipython span.cm-builtin {
  color: #008000;
}
.cm-s-ipython span.cm-bracket {
  color: #997;
}
.cm-s-ipython span.cm-tag {
  color: #170;
}
.cm-s-ipython span.cm-attribute {
  color: #00c;
}
.cm-s-ipython span.cm-header {
  color: blue;
}
.cm-s-ipython span.cm-quote {
  color: #090;
}
.cm-s-ipython span.cm-link {
  color: #00c;
}
.cm-s-ipython span.cm-error {
  color: #f00;
}
.cm-s-ipython span.cm-tab {
  background: url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAADAAAAAMCAYAAAAkuj5RAAAAAXNSR0IArs4c6QAAAGFJREFUSMft1LsRQFAQheHPowAKoACx3IgEKtaEHujDjORSgWTH/ZOdnZOcM/sgk/kFFWY0qV8foQwS4MKBCS3qR6ixBJvElOobYAtivseIE120FaowJPN75GMu8j/LfMwNjh4HUpwg4LUAAAAASUVORK5CYII=);
  background-position: right;
  background-repeat: no-repeat;
}
div.output_wrapper {
  /* this position must be relative to enable descendents to be absolute within it */
  position: relative;
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: vertical;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: vertical;
  -moz-box-align: stretch;
  display: box;
  box-orient: vertical;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: column;
  align-items: stretch;
  z-index: 1;
}
/* class for the output area when it should be height-limited */
div.output_scroll {
  /* ideally, this would be max-height, but FF barfs all over that */
  height: 24em;
  /* FF needs this *and the wrapper* to specify full width, or it will shrinkwrap */
  width: 100%;
  overflow: auto;
  border-radius: 2px;
  -webkit-box-shadow: inset 0 2px 8px rgba(0, 0, 0, 0.8);
  box-shadow: inset 0 2px 8px rgba(0, 0, 0, 0.8);
  display: block;
}
/* output div while it is collapsed */
div.output_collapsed {
  margin: 0px;
  padding: 0px;
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: vertical;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: vertical;
  -moz-box-align: stretch;
  display: box;
  box-orient: vertical;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: column;
  align-items: stretch;
}
div.out_prompt_overlay {
  height: 100%;
  padding: 0px 0.4em;
  position: absolute;
  border-radius: 2px;
}
div.out_prompt_overlay:hover {
  /* use inner shadow to get border that is computed the same on WebKit/FF */
  -webkit-box-shadow: inset 0 0 1px #000;
  box-shadow: inset 0 0 1px #000;
  background: rgba(240, 240, 240, 0.5);
}
div.output_prompt {
  color: #D84315;
}
/* This class is the outer container of all output sections. */
div.output_area {
  padding: 0px;
  page-break-inside: avoid;
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: horizontal;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: horizontal;
  -moz-box-align: stretch;
  display: box;
  box-orient: horizontal;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: row;
  align-items: stretch;
}
div.output_area .MathJax_Display {
  text-align: left !important;
}
div.output_area .rendered_html table {
  margin-left: 0;
  margin-right: 0;
}
div.output_area .rendered_html img {
  margin-left: 0;
  margin-right: 0;
}
div.output_area img,
div.output_area svg {
  max-width: 100%;
  height: auto;
}
div.output_area img.unconfined,
div.output_area svg.unconfined {
  max-width: none;
}
div.output_area .mglyph > img {
  max-width: none;
}
/* This is needed to protect the pre formating from global settings such
   as that of bootstrap */
.output {
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: vertical;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: vertical;
  -moz-box-align: stretch;
  display: box;
  box-orient: vertical;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: column;
  align-items: stretch;
}
@media (max-width: 540px) {
  div.output_area {
    /* Old browsers */
    display: -webkit-box;
    -webkit-box-orient: vertical;
    -webkit-box-align: stretch;
    display: -moz-box;
    -moz-box-orient: vertical;
    -moz-box-align: stretch;
    display: box;
    box-orient: vertical;
    box-align: stretch;
    /* Modern browsers */
    display: flex;
    flex-direction: column;
    align-items: stretch;
  }
}
div.output_area pre {
  margin: 0;
  padding: 1px 0 1px 0;
  border: 0;
  vertical-align: baseline;
  color: black;
  background-color: transparent;
  border-radius: 0;
}
/* This class is for the output subarea inside the output_area and after
   the prompt div. */
div.output_subarea {
  overflow-x: auto;
  padding: 0.4em;
  /* Old browsers */
  -webkit-box-flex: 1;
  -moz-box-flex: 1;
  box-flex: 1;
  /* Modern browsers */
  flex: 1;
  max-width: calc(100% - 14ex);
}
div.output_scroll div.output_subarea {
  overflow-x: visible;
}
/* The rest of the output_* classes are for special styling of the different
   output types */
/* all text output has this class: */
div.output_text {
  text-align: left;
  color: #000;
  /* This has to match that of the the CodeMirror class line-height below */
  line-height: 1.21429em;
}
/* stdout/stderr are 'text' as well as 'stream', but execute_result/error are *not* streams */
div.output_stderr {
  background: #fdd;
  /* very light red background for stderr */
}
div.output_latex {
  text-align: left;
}
/* Empty output_javascript divs should have no height */
div.output_javascript:empty {
  padding: 0;
}
.js-error {
  color: darkred;
}
/* raw_input styles */
div.raw_input_container {
  line-height: 1.21429em;
  padding-top: 5px;
}
pre.raw_input_prompt {
  /* nothing needed here. */
}
input.raw_input {
  font-family: monospace;
  font-size: inherit;
  color: inherit;
  width: auto;
  /* make sure input baseline aligns with prompt */
  vertical-align: baseline;
  /* padding + margin = 0.5em between prompt and cursor */
  padding: 0em 0.25em;
  margin: 0em 0.25em;
}
input.raw_input:focus {
  box-shadow: none;
}
p.p-space {
  margin-bottom: 10px;
}
div.output_unrecognized {
  padding: 5px;
  font-weight: bold;
  color: red;
}
div.output_unrecognized a {
  color: inherit;
  text-decoration: none;
}
div.output_unrecognized a:hover {
  color: inherit;
  text-decoration: none;
}
.rendered_html {
  color: #000;
  /* any extras will just be numbers: */
}
.rendered_html em {
  font-style: italic;
}
.rendered_html strong {
  font-weight: bold;
}
.rendered_html u {
  text-decoration: underline;
}
.rendered_html :link {
  text-decoration: underline;
}
.rendered_html :visited {
  text-decoration: underline;
}
.rendered_html h1 {
  font-size: 185.7%;
  margin: 1.08em 0 0 0;
  font-weight: bold;
  line-height: 1.0;
}
.rendered_html h2 {
  font-size: 157.1%;
  margin: 1.27em 0 0 0;
  font-weight: bold;
  line-height: 1.0;
}
.rendered_html h3 {
  font-size: 128.6%;
  margin: 1.55em 0 0 0;
  font-weight: bold;
  line-height: 1.0;
}
.rendered_html h4 {
  font-size: 100%;
  margin: 2em 0 0 0;
  font-weight: bold;
  line-height: 1.0;
}
.rendered_html h5 {
  font-size: 100%;
  margin: 2em 0 0 0;
  font-weight: bold;
  line-height: 1.0;
  font-style: italic;
}
.rendered_html h6 {
  font-size: 100%;
  margin: 2em 0 0 0;
  font-weight: bold;
  line-height: 1.0;
  font-style: italic;
}
.rendered_html h1:first-child {
  margin-top: 0.538em;
}
.rendered_html h2:first-child {
  margin-top: 0.636em;
}
.rendered_html h3:first-child {
  margin-top: 0.777em;
}
.rendered_html h4:first-child {
  margin-top: 1em;
}
.rendered_html h5:first-child {
  margin-top: 1em;
}
.rendered_html h6:first-child {
  margin-top: 1em;
}
.rendered_html ul:not(.list-inline),
.rendered_html ol:not(.list-inline) {
  padding-left: 2em;
}
.rendered_html ul {
  list-style: disc;
}
.rendered_html ul ul {
  list-style: square;
  margin-top: 0;
}
.rendered_html ul ul ul {
  list-style: circle;
}
.rendered_html ol {
  list-style: decimal;
}
.rendered_html ol ol {
  list-style: upper-alpha;
  margin-top: 0;
}
.rendered_html ol ol ol {
  list-style: lower-alpha;
}
.rendered_html ol ol ol ol {
  list-style: lower-roman;
}
.rendered_html ol ol ol ol ol {
  list-style: decimal;
}
.rendered_html * + ul {
  margin-top: 1em;
}
.rendered_html * + ol {
  margin-top: 1em;
}
.rendered_html hr {
  color: black;
  background-color: black;
}
.rendered_html pre {
  margin: 1em 2em;
  padding: 0px;
  background-color: #fff;
}
.rendered_html code {
  background-color: #eff0f1;
}
.rendered_html p code {
  padding: 1px 5px;
}
.rendered_html pre code {
  background-color: #fff;
}
.rendered_html pre,
.rendered_html code {
  border: 0;
  color: #000;
  font-size: 100%;
}
.rendered_html blockquote {
  margin: 1em 2em;
}
.rendered_html table {
  margin-left: auto;
  margin-right: auto;
  border: none;
  border-collapse: collapse;
  border-spacing: 0;
  color: black;
  font-size: 12px;
  table-layout: fixed;
}
.rendered_html thead {
  border-bottom: 1px solid black;
  vertical-align: bottom;
}
.rendered_html tr,
.rendered_html th,
.rendered_html td {
  text-align: right;
  vertical-align: middle;
  padding: 0.5em 0.5em;
  line-height: normal;
  white-space: normal;
  max-width: none;
  border: none;
}
.rendered_html th {
  font-weight: bold;
}
.rendered_html tbody tr:nth-child(odd) {
  background: #f5f5f5;
}
.rendered_html tbody tr:hover {
  background: rgba(66, 165, 245, 0.2);
}
.rendered_html * + table {
  margin-top: 1em;
}
.rendered_html p {
  text-align: left;
}
.rendered_html * + p {
  margin-top: 1em;
}
.rendered_html img {
  display: block;
  margin-left: auto;
  margin-right: auto;
}
.rendered_html * + img {
  margin-top: 1em;
}
.rendered_html img,
.rendered_html svg {
  max-width: 100%;
  height: auto;
}
.rendered_html img.unconfined,
.rendered_html svg.unconfined {
  max-width: none;
}
.rendered_html .alert {
  margin-bottom: initial;
}
.rendered_html * + .alert {
  margin-top: 1em;
}
[dir="rtl"] .rendered_html p {
  text-align: right;
}
div.text_cell {
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: horizontal;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: horizontal;
  -moz-box-align: stretch;
  display: box;
  box-orient: horizontal;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: row;
  align-items: stretch;
}
@media (max-width: 540px) {
  div.text_cell > div.prompt {
    display: none;
  }
}
div.text_cell_render {
  /*font-family: "Helvetica Neue", Arial, Helvetica, Geneva, sans-serif;*/
  outline: none;
  resize: none;
  width: inherit;
  border-style: none;
  padding: 0.5em 0.5em 0.5em 0.4em;
  color: #000;
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
}
a.anchor-link:link {
  text-decoration: none;
  padding: 0px 20px;
  visibility: hidden;
}
h1:hover .anchor-link,
h2:hover .anchor-link,
h3:hover .anchor-link,
h4:hover .anchor-link,
h5:hover .anchor-link,
h6:hover .anchor-link {
  visibility: visible;
}
.text_cell.rendered .input_area {
  display: none;
}
.text_cell.rendered .rendered_html {
  overflow-x: auto;
  overflow-y: hidden;
}
.text_cell.rendered .rendered_html tr,
.text_cell.rendered .rendered_html th,
.text_cell.rendered .rendered_html td {
  max-width: none;
}
.text_cell.unrendered .text_cell_render {
  display: none;
}
.text_cell .dropzone .input_area {
  border: 2px dashed #bababa;
  margin: -1px;
}
.cm-header-1,
.cm-header-2,
.cm-header-3,
.cm-header-4,
.cm-header-5,
.cm-header-6 {
  font-weight: bold;
  font-family: "Helvetica Neue", Helvetica, Arial, sans-serif;
}
.cm-header-1 {
  font-size: 185.7%;
}
.cm-header-2 {
  font-size: 157.1%;
}
.cm-header-3 {
  font-size: 128.6%;
}
.cm-header-4 {
  font-size: 110%;
}
.cm-header-5 {
  font-size: 100%;
  font-style: italic;
}
.cm-header-6 {
  font-size: 100%;
  font-style: italic;
}
/*!
*
* IPython notebook webapp
*
*/
@media (max-width: 767px) {
  .notebook_app {
    padding-left: 0px;
    padding-right: 0px;
  }
}
#ipython-main-app {
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
  height: 100%;
}
div#notebook_panel {
  margin: 0px;
  padding: 0px;
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
  height: 100%;
}
div#notebook {
  font-size: 14px;
  line-height: 20px;
  overflow-y: hidden;
  overflow-x: auto;
  width: 100%;
  /* This spaces the page away from the edge of the notebook area */
  padding-top: 20px;
  margin: 0px;
  outline: none;
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
  min-height: 100%;
}
@media not print {
  #notebook-container {
    padding: 15px;
    background-color: #fff;
    min-height: 0;
    -webkit-box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
    box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
  }
}
@media print {
  #notebook-container {
    width: 100%;
  }
}
div.ui-widget-content {
  border: 1px solid #ababab;
  outline: none;
}
pre.dialog {
  background-color: #f7f7f7;
  border: 1px solid #ddd;
  border-radius: 2px;
  padding: 0.4em;
  padding-left: 2em;
}
p.dialog {
  padding: 0.2em;
}
/* Word-wrap output correctly.  This is the CSS3 spelling, though Firefox seems
   to not honor it correctly.  Webkit browsers (Chrome, rekonq, Safari) do.
 */
pre,
code,
kbd,
samp {
  white-space: pre-wrap;
}
#fonttest {
  font-family: monospace;
}
p {
  margin-bottom: 0;
}
.end_space {
  min-height: 100px;
  transition: height .2s ease;
}
.notebook_app > #header {
  -webkit-box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
  box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
}
@media not print {
  .notebook_app {
    background-color: #EEE;
  }
}
kbd {
  border-style: solid;
  border-width: 1px;
  box-shadow: none;
  margin: 2px;
  padding-left: 2px;
  padding-right: 2px;
  padding-top: 1px;
  padding-bottom: 1px;
}
.jupyter-keybindings {
  padding: 1px;
  line-height: 24px;
  border-bottom: 1px solid gray;
}
.jupyter-keybindings input {
  margin: 0;
  padding: 0;
  border: none;
}
.jupyter-keybindings i {
  padding: 6px;
}
.well code {
  background-color: #ffffff;
  border-color: #ababab;
  border-width: 1px;
  border-style: solid;
  padding: 2px;
  padding-top: 1px;
  padding-bottom: 1px;
}
/* CSS for the cell toolbar */
.celltoolbar {
  border: thin solid #CFCFCF;
  border-bottom: none;
  background: #EEE;
  border-radius: 2px 2px 0px 0px;
  width: 100%;
  height: 29px;
  padding-right: 4px;
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: horizontal;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: horizontal;
  -moz-box-align: stretch;
  display: box;
  box-orient: horizontal;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: row;
  align-items: stretch;
  /* Old browsers */
  -webkit-box-pack: end;
  -moz-box-pack: end;
  box-pack: end;
  /* Modern browsers */
  justify-content: flex-end;
  display: -webkit-flex;
}
@media print {
  .celltoolbar {
    display: none;
  }
}
.ctb_hideshow {
  display: none;
  vertical-align: bottom;
}
/* ctb_show is added to the ctb_hideshow div to show the cell toolbar.
   Cell toolbars are only shown when the ctb_global_show class is also set.
*/
.ctb_global_show .ctb_show.ctb_hideshow {
  display: block;
}
.ctb_global_show .ctb_show + .input_area,
.ctb_global_show .ctb_show + div.text_cell_input,
.ctb_global_show .ctb_show ~ div.text_cell_render {
  border-top-right-radius: 0px;
  border-top-left-radius: 0px;
}
.ctb_global_show .ctb_show ~ div.text_cell_render {
  border: 1px solid #cfcfcf;
}
.celltoolbar {
  font-size: 87%;
  padding-top: 3px;
}
.celltoolbar select {
  display: block;
  width: 100%;
  height: 32px;
  padding: 6px 12px;
  font-size: 13px;
  line-height: 1.42857143;
  color: #555555;
  background-color: #fff;
  background-image: none;
  border: 1px solid #ccc;
  border-radius: 2px;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
  -webkit-transition: border-color ease-in-out .15s, box-shadow ease-in-out .15s;
  -o-transition: border-color ease-in-out .15s, box-shadow ease-in-out .15s;
  transition: border-color ease-in-out .15s, box-shadow ease-in-out .15s;
  height: 30px;
  padding: 5px 10px;
  font-size: 12px;
  line-height: 1.5;
  border-radius: 1px;
  width: inherit;
  font-size: inherit;
  height: 22px;
  padding: 0px;
  display: inline-block;
}
.celltoolbar select:focus {
  border-color: #66afe9;
  outline: 0;
  -webkit-box-shadow: inset 0 1px 1px rgba(0,0,0,.075), 0 0 8px rgba(102, 175, 233, 0.6);
  box-shadow: inset 0 1px 1px rgba(0,0,0,.075), 0 0 8px rgba(102, 175, 233, 0.6);
}
.celltoolbar select::-moz-placeholder {
  color: #999;
  opacity: 1;
}
.celltoolbar select:-ms-input-placeholder {
  color: #999;
}
.celltoolbar select::-webkit-input-placeholder {
  color: #999;
}
.celltoolbar select::-ms-expand {
  border: 0;
  background-color: transparent;
}
.celltoolbar select[disabled],
.celltoolbar select[readonly],
fieldset[disabled] .celltoolbar select {
  background-color: #eeeeee;
  opacity: 1;
}
.celltoolbar select[disabled],
fieldset[disabled] .celltoolbar select {
  cursor: not-allowed;
}
textarea.celltoolbar select {
  height: auto;
}
select.celltoolbar select {
  height: 30px;
  line-height: 30px;
}
textarea.celltoolbar select,
select[multiple].celltoolbar select {
  height: auto;
}
.celltoolbar label {
  margin-left: 5px;
  margin-right: 5px;
}
.tags_button_container {
  width: 100%;
  display: flex;
}
.tag-container {
  display: flex;
  flex-direction: row;
  flex-grow: 1;
  overflow: hidden;
  position: relative;
}
.tag-container > * {
  margin: 0 4px;
}
.remove-tag-btn {
  margin-left: 4px;
}
.tags-input {
  display: flex;
}
.cell-tag:last-child:after {
  content: "";
  position: absolute;
  right: 0;
  width: 40px;
  height: 100%;
  /* Fade to background color of cell toolbar */
  background: linear-gradient(to right, rgba(0, 0, 0, 0), #EEE);
}
.tags-input > * {
  margin-left: 4px;
}
.cell-tag,
.tags-input input,
.tags-input button {
  display: block;
  width: 100%;
  height: 32px;
  padding: 6px 12px;
  font-size: 13px;
  line-height: 1.42857143;
  color: #555555;
  background-color: #fff;
  background-image: none;
  border: 1px solid #ccc;
  border-radius: 2px;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
  -webkit-transition: border-color ease-in-out .15s, box-shadow ease-in-out .15s;
  -o-transition: border-color ease-in-out .15s, box-shadow ease-in-out .15s;
  transition: border-color ease-in-out .15s, box-shadow ease-in-out .15s;
  height: 30px;
  padding: 5px 10px;
  font-size: 12px;
  line-height: 1.5;
  border-radius: 1px;
  box-shadow: none;
  width: inherit;
  font-size: inherit;
  height: 22px;
  line-height: 22px;
  padding: 0px 4px;
  display: inline-block;
}
.cell-tag:focus,
.tags-input input:focus,
.tags-input button:focus {
  border-color: #66afe9;
  outline: 0;
  -webkit-box-shadow: inset 0 1px 1px rgba(0,0,0,.075), 0 0 8px rgba(102, 175, 233, 0.6);
  box-shadow: inset 0 1px 1px rgba(0,0,0,.075), 0 0 8px rgba(102, 175, 233, 0.6);
}
.cell-tag::-moz-placeholder,
.tags-input input::-moz-placeholder,
.tags-input button::-moz-placeholder {
  color: #999;
  opacity: 1;
}
.cell-tag:-ms-input-placeholder,
.tags-input input:-ms-input-placeholder,
.tags-input button:-ms-input-placeholder {
  color: #999;
}
.cell-tag::-webkit-input-placeholder,
.tags-input input::-webkit-input-placeholder,
.tags-input button::-webkit-input-placeholder {
  color: #999;
}
.cell-tag::-ms-expand,
.tags-input input::-ms-expand,
.tags-input button::-ms-expand {
  border: 0;
  background-color: transparent;
}
.cell-tag[disabled],
.tags-input input[disabled],
.tags-input button[disabled],
.cell-tag[readonly],
.tags-input input[readonly],
.tags-input button[readonly],
fieldset[disabled] .cell-tag,
fieldset[disabled] .tags-input input,
fieldset[disabled] .tags-input button {
  background-color: #eeeeee;
  opacity: 1;
}
.cell-tag[disabled],
.tags-input input[disabled],
.tags-input button[disabled],
fieldset[disabled] .cell-tag,
fieldset[disabled] .tags-input input,
fieldset[disabled] .tags-input button {
  cursor: not-allowed;
}
textarea.cell-tag,
textarea.tags-input input,
textarea.tags-input button {
  height: auto;
}
select.cell-tag,
select.tags-input input,
select.tags-input button {
  height: 30px;
  line-height: 30px;
}
textarea.cell-tag,
textarea.tags-input input,
textarea.tags-input button,
select[multiple].cell-tag,
select[multiple].tags-input input,
select[multiple].tags-input button {
  height: auto;
}
.cell-tag,
.tags-input button {
  padding: 0px 4px;
}
.cell-tag {
  background-color: #fff;
  white-space: nowrap;
}
.tags-input input[type=text]:focus {
  outline: none;
  box-shadow: none;
  border-color: #ccc;
}
.completions {
  position: absolute;
  z-index: 110;
  overflow: hidden;
  border: 1px solid #ababab;
  border-radius: 2px;
  -webkit-box-shadow: 0px 6px 10px -1px #adadad;
  box-shadow: 0px 6px 10px -1px #adadad;
  line-height: 1;
}
.completions select {
  background: white;
  outline: none;
  border: none;
  padding: 0px;
  margin: 0px;
  overflow: auto;
  font-family: monospace;
  font-size: 110%;
  color: #000;
  width: auto;
}
.completions select option.context {
  color: #286090;
}
#kernel_logo_widget .current_kernel_logo {
  display: none;
  margin-top: -1px;
  margin-bottom: -1px;
  width: 32px;
  height: 32px;
}
[dir="rtl"] #kernel_logo_widget {
  float: left !important;
  float: left;
}
.modal .modal-body .move-path {
  display: flex;
  flex-direction: row;
  justify-content: space;
  align-items: center;
}
.modal .modal-body .move-path .server-root {
  padding-right: 20px;
}
.modal .modal-body .move-path .path-input {
  flex: 1;
}
#menubar {
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
  margin-top: 1px;
}
#menubar .navbar {
  border-top: 1px;
  border-radius: 0px 0px 2px 2px;
  margin-bottom: 0px;
}
#menubar .navbar-toggle {
  float: left;
  padding-top: 7px;
  padding-bottom: 7px;
  border: none;
}
#menubar .navbar-collapse {
  clear: left;
}
[dir="rtl"] #menubar .navbar-toggle {
  float: right;
}
[dir="rtl"] #menubar .navbar-collapse {
  clear: right;
}
[dir="rtl"] #menubar .navbar-nav {
  float: right;
}
[dir="rtl"] #menubar .nav {
  padding-right: 0px;
}
[dir="rtl"] #menubar .navbar-nav > li {
  float: right;
}
[dir="rtl"] #menubar .navbar-right {
  float: left !important;
}
[dir="rtl"] ul.dropdown-menu {
  text-align: right;
  left: auto;
}
[dir="rtl"] ul#new-menu.dropdown-menu {
  right: auto;
  left: 0;
}
.nav-wrapper {
  border-bottom: 1px solid #e7e7e7;
}
i.menu-icon {
  padding-top: 4px;
}
[dir="rtl"] i.menu-icon.pull-right {
  float: left !important;
  float: left;
}
ul#help_menu li a {
  overflow: hidden;
  padding-right: 2.2em;
}
ul#help_menu li a i {
  margin-right: -1.2em;
}
[dir="rtl"] ul#help_menu li a {
  padding-left: 2.2em;
}
[dir="rtl"] ul#help_menu li a i {
  margin-right: 0;
  margin-left: -1.2em;
}
[dir="rtl"] ul#help_menu li a i.pull-right {
  float: left !important;
  float: left;
}
.dropdown-submenu {
  position: relative;
}
.dropdown-submenu > .dropdown-menu {
  top: 0;
  left: 100%;
  margin-top: -6px;
  margin-left: -1px;
}
[dir="rtl"] .dropdown-submenu > .dropdown-menu {
  right: 100%;
  margin-right: -1px;
}
.dropdown-submenu:hover > .dropdown-menu {
  display: block;
}
.dropdown-submenu > a:after {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  display: block;
  content: "\f0da";
  float: right;
  color: #333333;
  margin-top: 2px;
  margin-right: -10px;
}
.dropdown-submenu > a:after.fa-pull-left {
  margin-right: .3em;
}
.dropdown-submenu > a:after.fa-pull-right {
  margin-left: .3em;
}
.dropdown-submenu > a:after.pull-left {
  margin-right: .3em;
}
.dropdown-submenu > a:after.pull-right {
  margin-left: .3em;
}
[dir="rtl"] .dropdown-submenu > a:after {
  float: left;
  content: "\f0d9";
  margin-right: 0;
  margin-left: -10px;
}
.dropdown-submenu:hover > a:after {
  color: #262626;
}
.dropdown-submenu.pull-left {
  float: none;
}
.dropdown-submenu.pull-left > .dropdown-menu {
  left: -100%;
  margin-left: 10px;
}
#notification_area {
  float: right !important;
  float: right;
  z-index: 10;
}
[dir="rtl"] #notification_area {
  float: left !important;
  float: left;
}
.indicator_area {
  float: right !important;
  float: right;
  color: #777;
  margin-left: 5px;
  margin-right: 5px;
  width: 11px;
  z-index: 10;
  text-align: center;
  width: auto;
}
[dir="rtl"] .indicator_area {
  float: left !important;
  float: left;
}
#kernel_indicator {
  float: right !important;
  float: right;
  color: #777;
  margin-left: 5px;
  margin-right: 5px;
  width: 11px;
  z-index: 10;
  text-align: center;
  width: auto;
  border-left: 1px solid;
}
#kernel_indicator .kernel_indicator_name {
  padding-left: 5px;
  padding-right: 5px;
}
[dir="rtl"] #kernel_indicator {
  float: left !important;
  float: left;
  border-left: 0;
  border-right: 1px solid;
}
#modal_indicator {
  float: right !important;
  float: right;
  color: #777;
  margin-left: 5px;
  margin-right: 5px;
  width: 11px;
  z-index: 10;
  text-align: center;
  width: auto;
}
[dir="rtl"] #modal_indicator {
  float: left !important;
  float: left;
}
#readonly-indicator {
  float: right !important;
  float: right;
  color: #777;
  margin-left: 5px;
  margin-right: 5px;
  width: 11px;
  z-index: 10;
  text-align: center;
  width: auto;
  margin-top: 2px;
  margin-bottom: 0px;
  margin-left: 0px;
  margin-right: 0px;
  display: none;
}
.modal_indicator:before {
  width: 1.28571429em;
  text-align: center;
}
.edit_mode .modal_indicator:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f040";
}
.edit_mode .modal_indicator:before.fa-pull-left {
  margin-right: .3em;
}
.edit_mode .modal_indicator:before.fa-pull-right {
  margin-left: .3em;
}
.edit_mode .modal_indicator:before.pull-left {
  margin-right: .3em;
}
.edit_mode .modal_indicator:before.pull-right {
  margin-left: .3em;
}
.command_mode .modal_indicator:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: ' ';
}
.command_mode .modal_indicator:before.fa-pull-left {
  margin-right: .3em;
}
.command_mode .modal_indicator:before.fa-pull-right {
  margin-left: .3em;
}
.command_mode .modal_indicator:before.pull-left {
  margin-right: .3em;
}
.command_mode .modal_indicator:before.pull-right {
  margin-left: .3em;
}
.kernel_idle_icon:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f10c";
}
.kernel_idle_icon:before.fa-pull-left {
  margin-right: .3em;
}
.kernel_idle_icon:before.fa-pull-right {
  margin-left: .3em;
}
.kernel_idle_icon:before.pull-left {
  margin-right: .3em;
}
.kernel_idle_icon:before.pull-right {
  margin-left: .3em;
}
.kernel_busy_icon:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f111";
}
.kernel_busy_icon:before.fa-pull-left {
  margin-right: .3em;
}
.kernel_busy_icon:before.fa-pull-right {
  margin-left: .3em;
}
.kernel_busy_icon:before.pull-left {
  margin-right: .3em;
}
.kernel_busy_icon:before.pull-right {
  margin-left: .3em;
}
.kernel_dead_icon:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f1e2";
}
.kernel_dead_icon:before.fa-pull-left {
  margin-right: .3em;
}
.kernel_dead_icon:before.fa-pull-right {
  margin-left: .3em;
}
.kernel_dead_icon:before.pull-left {
  margin-right: .3em;
}
.kernel_dead_icon:before.pull-right {
  margin-left: .3em;
}
.kernel_disconnected_icon:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f127";
}
.kernel_disconnected_icon:before.fa-pull-left {
  margin-right: .3em;
}
.kernel_disconnected_icon:before.fa-pull-right {
  margin-left: .3em;
}
.kernel_disconnected_icon:before.pull-left {
  margin-right: .3em;
}
.kernel_disconnected_icon:before.pull-right {
  margin-left: .3em;
}
.notification_widget {
  color: #777;
  z-index: 10;
  background: rgba(240, 240, 240, 0.5);
  margin-right: 4px;
  color: #333;
  background-color: #fff;
  border-color: #ccc;
}
.notification_widget:focus,
.notification_widget.focus {
  color: #333;
  background-color: #e6e6e6;
  border-color: #8c8c8c;
}
.notification_widget:hover {
  color: #333;
  background-color: #e6e6e6;
  border-color: #adadad;
}
.notification_widget:active,
.notification_widget.active,
.open > .dropdown-toggle.notification_widget {
  color: #333;
  background-color: #e6e6e6;
  border-color: #adadad;
}
.notification_widget:active:hover,
.notification_widget.active:hover,
.open > .dropdown-toggle.notification_widget:hover,
.notification_widget:active:focus,
.notification_widget.active:focus,
.open > .dropdown-toggle.notification_widget:focus,
.notification_widget:active.focus,
.notification_widget.active.focus,
.open > .dropdown-toggle.notification_widget.focus {
  color: #333;
  background-color: #d4d4d4;
  border-color: #8c8c8c;
}
.notification_widget:active,
.notification_widget.active,
.open > .dropdown-toggle.notification_widget {
  background-image: none;
}
.notification_widget.disabled:hover,
.notification_widget[disabled]:hover,
fieldset[disabled] .notification_widget:hover,
.notification_widget.disabled:focus,
.notification_widget[disabled]:focus,
fieldset[disabled] .notification_widget:focus,
.notification_widget.disabled.focus,
.notification_widget[disabled].focus,
fieldset[disabled] .notification_widget.focus {
  background-color: #fff;
  border-color: #ccc;
}
.notification_widget .badge {
  color: #fff;
  background-color: #333;
}
.notification_widget.warning {
  color: #fff;
  background-color: #f0ad4e;
  border-color: #eea236;
}
.notification_widget.warning:focus,
.notification_widget.warning.focus {
  color: #fff;
  background-color: #ec971f;
  border-color: #985f0d;
}
.notification_widget.warning:hover {
  color: #fff;
  background-color: #ec971f;
  border-color: #d58512;
}
.notification_widget.warning:active,
.notification_widget.warning.active,
.open > .dropdown-toggle.notification_widget.warning {
  color: #fff;
  background-color: #ec971f;
  border-color: #d58512;
}
.notification_widget.warning:active:hover,
.notification_widget.warning.active:hover,
.open > .dropdown-toggle.notification_widget.warning:hover,
.notification_widget.warning:active:focus,
.notification_widget.warning.active:focus,
.open > .dropdown-toggle.notification_widget.warning:focus,
.notification_widget.warning:active.focus,
.notification_widget.warning.active.focus,
.open > .dropdown-toggle.notification_widget.warning.focus {
  color: #fff;
  background-color: #d58512;
  border-color: #985f0d;
}
.notification_widget.warning:active,
.notification_widget.warning.active,
.open > .dropdown-toggle.notification_widget.warning {
  background-image: none;
}
.notification_widget.warning.disabled:hover,
.notification_widget.warning[disabled]:hover,
fieldset[disabled] .notification_widget.warning:hover,
.notification_widget.warning.disabled:focus,
.notification_widget.warning[disabled]:focus,
fieldset[disabled] .notification_widget.warning:focus,
.notification_widget.warning.disabled.focus,
.notification_widget.warning[disabled].focus,
fieldset[disabled] .notification_widget.warning.focus {
  background-color: #f0ad4e;
  border-color: #eea236;
}
.notification_widget.warning .badge {
  color: #f0ad4e;
  background-color: #fff;
}
.notification_widget.success {
  color: #fff;
  background-color: #5cb85c;
  border-color: #4cae4c;
}
.notification_widget.success:focus,
.notification_widget.success.focus {
  color: #fff;
  background-color: #449d44;
  border-color: #255625;
}
.notification_widget.success:hover {
  color: #fff;
  background-color: #449d44;
  border-color: #398439;
}
.notification_widget.success:active,
.notification_widget.success.active,
.open > .dropdown-toggle.notification_widget.success {
  color: #fff;
  background-color: #449d44;
  border-color: #398439;
}
.notification_widget.success:active:hover,
.notification_widget.success.active:hover,
.open > .dropdown-toggle.notification_widget.success:hover,
.notification_widget.success:active:focus,
.notification_widget.success.active:focus,
.open > .dropdown-toggle.notification_widget.success:focus,
.notification_widget.success:active.focus,
.notification_widget.success.active.focus,
.open > .dropdown-toggle.notification_widget.success.focus {
  color: #fff;
  background-color: #398439;
  border-color: #255625;
}
.notification_widget.success:active,
.notification_widget.success.active,
.open > .dropdown-toggle.notification_widget.success {
  background-image: none;
}
.notification_widget.success.disabled:hover,
.notification_widget.success[disabled]:hover,
fieldset[disabled] .notification_widget.success:hover,
.notification_widget.success.disabled:focus,
.notification_widget.success[disabled]:focus,
fieldset[disabled] .notification_widget.success:focus,
.notification_widget.success.disabled.focus,
.notification_widget.success[disabled].focus,
fieldset[disabled] .notification_widget.success.focus {
  background-color: #5cb85c;
  border-color: #4cae4c;
}
.notification_widget.success .badge {
  color: #5cb85c;
  background-color: #fff;
}
.notification_widget.info {
  color: #fff;
  background-color: #5bc0de;
  border-color: #46b8da;
}
.notification_widget.info:focus,
.notification_widget.info.focus {
  color: #fff;
  background-color: #31b0d5;
  border-color: #1b6d85;
}
.notification_widget.info:hover {
  color: #fff;
  background-color: #31b0d5;
  border-color: #269abc;
}
.notification_widget.info:active,
.notification_widget.info.active,
.open > .dropdown-toggle.notification_widget.info {
  color: #fff;
  background-color: #31b0d5;
  border-color: #269abc;
}
.notification_widget.info:active:hover,
.notification_widget.info.active:hover,
.open > .dropdown-toggle.notification_widget.info:hover,
.notification_widget.info:active:focus,
.notification_widget.info.active:focus,
.open > .dropdown-toggle.notification_widget.info:focus,
.notification_widget.info:active.focus,
.notification_widget.info.active.focus,
.open > .dropdown-toggle.notification_widget.info.focus {
  color: #fff;
  background-color: #269abc;
  border-color: #1b6d85;
}
.notification_widget.info:active,
.notification_widget.info.active,
.open > .dropdown-toggle.notification_widget.info {
  background-image: none;
}
.notification_widget.info.disabled:hover,
.notification_widget.info[disabled]:hover,
fieldset[disabled] .notification_widget.info:hover,
.notification_widget.info.disabled:focus,
.notification_widget.info[disabled]:focus,
fieldset[disabled] .notification_widget.info:focus,
.notification_widget.info.disabled.focus,
.notification_widget.info[disabled].focus,
fieldset[disabled] .notification_widget.info.focus {
  background-color: #5bc0de;
  border-color: #46b8da;
}
.notification_widget.info .badge {
  color: #5bc0de;
  background-color: #fff;
}
.notification_widget.danger {
  color: #fff;
  background-color: #d9534f;
  border-color: #d43f3a;
}
.notification_widget.danger:focus,
.notification_widget.danger.focus {
  color: #fff;
  background-color: #c9302c;
  border-color: #761c19;
}
.notification_widget.danger:hover {
  color: #fff;
  background-color: #c9302c;
  border-color: #ac2925;
}
.notification_widget.danger:active,
.notification_widget.danger.active,
.open > .dropdown-toggle.notification_widget.danger {
  color: #fff;
  background-color: #c9302c;
  border-color: #ac2925;
}
.notification_widget.danger:active:hover,
.notification_widget.danger.active:hover,
.open > .dropdown-toggle.notification_widget.danger:hover,
.notification_widget.danger:active:focus,
.notification_widget.danger.active:focus,
.open > .dropdown-toggle.notification_widget.danger:focus,
.notification_widget.danger:active.focus,
.notification_widget.danger.active.focus,
.open > .dropdown-toggle.notification_widget.danger.focus {
  color: #fff;
  background-color: #ac2925;
  border-color: #761c19;
}
.notification_widget.danger:active,
.notification_widget.danger.active,
.open > .dropdown-toggle.notification_widget.danger {
  background-image: none;
}
.notification_widget.danger.disabled:hover,
.notification_widget.danger[disabled]:hover,
fieldset[disabled] .notification_widget.danger:hover,
.notification_widget.danger.disabled:focus,
.notification_widget.danger[disabled]:focus,
fieldset[disabled] .notification_widget.danger:focus,
.notification_widget.danger.disabled.focus,
.notification_widget.danger[disabled].focus,
fieldset[disabled] .notification_widget.danger.focus {
  background-color: #d9534f;
  border-color: #d43f3a;
}
.notification_widget.danger .badge {
  color: #d9534f;
  background-color: #fff;
}
div#pager {
  background-color: #fff;
  font-size: 14px;
  line-height: 20px;
  overflow: hidden;
  display: none;
  position: fixed;
  bottom: 0px;
  width: 100%;
  max-height: 50%;
  padding-top: 8px;
  -webkit-box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
  box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
  /* Display over codemirror */
  z-index: 100;
  /* Hack which prevents jquery ui resizable from changing top. */
  top: auto !important;
}
div#pager pre {
  line-height: 1.21429em;
  color: #000;
  background-color: #f7f7f7;
  padding: 0.4em;
}
div#pager #pager-button-area {
  position: absolute;
  top: 8px;
  right: 20px;
}
div#pager #pager-contents {
  position: relative;
  overflow: auto;
  width: 100%;
  height: 100%;
}
div#pager #pager-contents #pager-container {
  position: relative;
  padding: 15px 0px;
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
}
div#pager .ui-resizable-handle {
  top: 0px;
  height: 8px;
  background: #f7f7f7;
  border-top: 1px solid #cfcfcf;
  border-bottom: 1px solid #cfcfcf;
  /* This injects handle bars (a short, wide = symbol) for 
        the resize handle. */
}
div#pager .ui-resizable-handle::after {
  content: '';
  top: 2px;
  left: 50%;
  height: 3px;
  width: 30px;
  margin-left: -15px;
  position: absolute;
  border-top: 1px solid #cfcfcf;
}
.quickhelp {
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: horizontal;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: horizontal;
  -moz-box-align: stretch;
  display: box;
  box-orient: horizontal;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: row;
  align-items: stretch;
  line-height: 1.8em;
}
.shortcut_key {
  display: inline-block;
  width: 21ex;
  text-align: right;
  font-family: monospace;
}
.shortcut_descr {
  display: inline-block;
  /* Old browsers */
  -webkit-box-flex: 1;
  -moz-box-flex: 1;
  box-flex: 1;
  /* Modern browsers */
  flex: 1;
}
span.save_widget {
  height: 30px;
  margin-top: 4px;
  display: flex;
  justify-content: flex-start;
  align-items: baseline;
  width: 50%;
  flex: 1;
}
span.save_widget span.filename {
  height: 100%;
  line-height: 1em;
  margin-left: 16px;
  border: none;
  font-size: 146.5%;
  text-overflow: ellipsis;
  overflow: hidden;
  white-space: nowrap;
  border-radius: 2px;
}
span.save_widget span.filename:hover {
  background-color: #e6e6e6;
}
[dir="rtl"] span.save_widget.pull-left {
  float: right !important;
  float: right;
}
[dir="rtl"] span.save_widget span.filename {
  margin-left: 0;
  margin-right: 16px;
}
span.checkpoint_status,
span.autosave_status {
  font-size: small;
  white-space: nowrap;
  padding: 0 5px;
}
@media (max-width: 767px) {
  span.save_widget {
    font-size: small;
    padding: 0 0 0 5px;
  }
  span.checkpoint_status,
  span.autosave_status {
    display: none;
  }
}
@media (min-width: 768px) and (max-width: 991px) {
  span.checkpoint_status {
    display: none;
  }
  span.autosave_status {
    font-size: x-small;
  }
}
.toolbar {
  padding: 0px;
  margin-left: -5px;
  margin-top: 2px;
  margin-bottom: 5px;
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
}
.toolbar select,
.toolbar label {
  width: auto;
  vertical-align: middle;
  margin-right: 2px;
  margin-bottom: 0px;
  display: inline;
  font-size: 92%;
  margin-left: 0.3em;
  margin-right: 0.3em;
  padding: 0px;
  padding-top: 3px;
}
.toolbar .btn {
  padding: 2px 8px;
}
.toolbar .btn-group {
  margin-top: 0px;
  margin-left: 5px;
}
.toolbar-btn-label {
  margin-left: 6px;
}
#maintoolbar {
  margin-bottom: -3px;
  margin-top: -8px;
  border: 0px;
  min-height: 27px;
  margin-left: 0px;
  padding-top: 11px;
  padding-bottom: 3px;
}
#maintoolbar .navbar-text {
  float: none;
  vertical-align: middle;
  text-align: right;
  margin-left: 5px;
  margin-right: 0px;
  margin-top: 0px;
}
.select-xs {
  height: 24px;
}
[dir="rtl"] .btn-group > .btn,
.btn-group-vertical > .btn {
  float: right;
}
.pulse,
.dropdown-menu > li > a.pulse,
li.pulse > a.dropdown-toggle,
li.pulse.open > a.dropdown-toggle {
  background-color: #F37626;
  color: white;
}
/**
 * Primary styles
 *
 * Author: Jupyter Development Team
 */
/** WARNING IF YOU ARE EDITTING THIS FILE, if this is a .css file, It has a lot
 * of chance of beeing generated from the ../less/[samename].less file, you can
 * try to get back the less file by reverting somme commit in history
 **/
/*
 * We'll try to get something pretty, so we
 * have some strange css to have the scroll bar on
 * the left with fix button on the top right of the tooltip
 */
@-moz-keyframes fadeOut {
  from {
    opacity: 1;
  }
  to {
    opacity: 0;
  }
}
@-webkit-keyframes fadeOut {
  from {
    opacity: 1;
  }
  to {
    opacity: 0;
  }
}
@-moz-keyframes fadeIn {
  from {
    opacity: 0;
  }
  to {
    opacity: 1;
  }
}
@-webkit-keyframes fadeIn {
  from {
    opacity: 0;
  }
  to {
    opacity: 1;
  }
}
/*properties of tooltip after "expand"*/
.bigtooltip {
  overflow: auto;
  height: 200px;
  -webkit-transition-property: height;
  -webkit-transition-duration: 500ms;
  -moz-transition-property: height;
  -moz-transition-duration: 500ms;
  transition-property: height;
  transition-duration: 500ms;
}
/*properties of tooltip before "expand"*/
.smalltooltip {
  -webkit-transition-property: height;
  -webkit-transition-duration: 500ms;
  -moz-transition-property: height;
  -moz-transition-duration: 500ms;
  transition-property: height;
  transition-duration: 500ms;
  text-overflow: ellipsis;
  overflow: hidden;
  height: 80px;
}
.tooltipbuttons {
  position: absolute;
  padding-right: 15px;
  top: 0px;
  right: 0px;
}
.tooltiptext {
  /*avoid the button to overlap on some docstring*/
  padding-right: 30px;
}
.ipython_tooltip {
  max-width: 700px;
  /*fade-in animation when inserted*/
  -webkit-animation: fadeOut 400ms;
  -moz-animation: fadeOut 400ms;
  animation: fadeOut 400ms;
  -webkit-animation: fadeIn 400ms;
  -moz-animation: fadeIn 400ms;
  animation: fadeIn 400ms;
  vertical-align: middle;
  background-color: #f7f7f7;
  overflow: visible;
  border: #ababab 1px solid;
  outline: none;
  padding: 3px;
  margin: 0px;
  padding-left: 7px;
  font-family: monospace;
  min-height: 50px;
  -moz-box-shadow: 0px 6px 10px -1px #adadad;
  -webkit-box-shadow: 0px 6px 10px -1px #adadad;
  box-shadow: 0px 6px 10px -1px #adadad;
  border-radius: 2px;
  position: absolute;
  z-index: 1000;
}
.ipython_tooltip a {
  float: right;
}
.ipython_tooltip .tooltiptext pre {
  border: 0;
  border-radius: 0;
  font-size: 100%;
  background-color: #f7f7f7;
}
.pretooltiparrow {
  left: 0px;
  margin: 0px;
  top: -16px;
  width: 40px;
  height: 16px;
  overflow: hidden;
  position: absolute;
}
.pretooltiparrow:before {
  background-color: #f7f7f7;
  border: 1px #ababab solid;
  z-index: 11;
  content: "";
  position: absolute;
  left: 15px;
  top: 10px;
  width: 25px;
  height: 25px;
  -webkit-transform: rotate(45deg);
  -moz-transform: rotate(45deg);
  -ms-transform: rotate(45deg);
  -o-transform: rotate(45deg);
}
ul.typeahead-list i {
  margin-left: -10px;
  width: 18px;
}
[dir="rtl"] ul.typeahead-list i {
  margin-left: 0;
  margin-right: -10px;
}
ul.typeahead-list {
  max-height: 80vh;
  overflow: auto;
}
ul.typeahead-list > li > a {
  /** Firefox bug **/
  /* see https://github.com/jupyter/notebook/issues/559 */
  white-space: normal;
}
ul.typeahead-list  > li > a.pull-right {
  float: left !important;
  float: left;
}
[dir="rtl"] .typeahead-list {
  text-align: right;
}
.cmd-palette .modal-body {
  padding: 7px;
}
.cmd-palette form {
  background: white;
}
.cmd-palette input {
  outline: none;
}
.no-shortcut {
  min-width: 20px;
  color: transparent;
}
[dir="rtl"] .no-shortcut.pull-right {
  float: left !important;
  float: left;
}
[dir="rtl"] .command-shortcut.pull-right {
  float: left !important;
  float: left;
}
.command-shortcut:before {
  content: "(command mode)";
  padding-right: 3px;
  color: #777777;
}
.edit-shortcut:before {
  content: "(edit)";
  padding-right: 3px;
  color: #777777;
}
[dir="rtl"] .edit-shortcut.pull-right {
  float: left !important;
  float: left;
}
#find-and-replace #replace-preview .match,
#find-and-replace #replace-preview .insert {
  background-color: #BBDEFB;
  border-color: #90CAF9;
  border-style: solid;
  border-width: 1px;
  border-radius: 0px;
}
[dir="ltr"] #find-and-replace .input-group-btn + .form-control {
  border-left: none;
}
[dir="rtl"] #find-and-replace .input-group-btn + .form-control {
  border-right: none;
}
#find-and-replace #replace-preview .replace .match {
  background-color: #FFCDD2;
  border-color: #EF9A9A;
  border-radius: 0px;
}
#find-and-replace #replace-preview .replace .insert {
  background-color: #C8E6C9;
  border-color: #A5D6A7;
  border-radius: 0px;
}
#find-and-replace #replace-preview {
  max-height: 60vh;
  overflow: auto;
}
#find-and-replace #replace-preview pre {
  padding: 5px 10px;
}
.terminal-app {
  background: #EEE;
}
.terminal-app #header {
  background: #fff;
  -webkit-box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
  box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
}
.terminal-app .terminal {
  width: 100%;
  float: left;
  font-family: monospace;
  color: white;
  background: black;
  padding: 0.4em;
  border-radius: 2px;
  -webkit-box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.4);
  box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.4);
}
.terminal-app .terminal,
.terminal-app .terminal dummy-screen {
  line-height: 1em;
  font-size: 14px;
}
.terminal-app .terminal .xterm-rows {
  padding: 10px;
}
.terminal-app .terminal-cursor {
  color: black;
  background: white;
}
.terminal-app #terminado-container {
  margin-top: 20px;
}
/*# sourceMappingURL=style.min.css.map */
    </style>
<style type="text/css">
    .highlight .hll { background-color: #ffffcc }
.highlight  { background: #f8f8f8; }
.highlight .c { color: #408080; font-style: italic } /* Comment */
.highlight .err { border: 1px solid #FF0000 } /* Error */
.highlight .k { color: #008000; font-weight: bold } /* Keyword */
.highlight .o { color: #666666 } /* Operator */
.highlight .ch { color: #408080; font-style: italic } /* Comment.Hashbang */
.highlight .cm { color: #408080; font-style: italic } /* Comment.Multiline */
.highlight .cp { color: #BC7A00 } /* Comment.Preproc */
.highlight .cpf { color: #408080; font-style: italic } /* Comment.PreprocFile */
.highlight .c1 { color: #408080; font-style: italic } /* Comment.Single */
.highlight .cs { color: #408080; font-style: italic } /* Comment.Special */
.highlight .gd { color: #A00000 } /* Generic.Deleted */
.highlight .ge { font-style: italic } /* Generic.Emph */
.highlight .gr { color: #FF0000 } /* Generic.Error */
.highlight .gh { color: #000080; font-weight: bold } /* Generic.Heading */
.highlight .gi { color: #00A000 } /* Generic.Inserted */
.highlight .go { color: #888888 } /* Generic.Output */
.highlight .gp { color: #000080; font-weight: bold } /* Generic.Prompt */
.highlight .gs { font-weight: bold } /* Generic.Strong */
.highlight .gu { color: #800080; font-weight: bold } /* Generic.Subheading */
.highlight .gt { color: #0044DD } /* Generic.Traceback */
.highlight .kc { color: #008000; font-weight: bold } /* Keyword.Constant */
.highlight .kd { color: #008000; font-weight: bold } /* Keyword.Declaration */
.highlight .kn { color: #008000; font-weight: bold } /* Keyword.Namespace */
.highlight .kp { color: #008000 } /* Keyword.Pseudo */
.highlight .kr { color: #008000; font-weight: bold } /* Keyword.Reserved */
.highlight .kt { color: #B00040 } /* Keyword.Type */
.highlight .m { color: #666666 } /* Literal.Number */
.highlight .s { color: #BA2121 } /* Literal.String */
.highlight .na { color: #7D9029 } /* Name.Attribute */
.highlight .nb { color: #008000 } /* Name.Builtin */
.highlight .nc { color: #0000FF; font-weight: bold } /* Name.Class */
.highlight .no { color: #880000 } /* Name.Constant */
.highlight .nd { color: #AA22FF } /* Name.Decorator */
.highlight .ni { color: #999999; font-weight: bold } /* Name.Entity */
.highlight .ne { color: #D2413A; font-weight: bold } /* Name.Exception */
.highlight .nf { color: #0000FF } /* Name.Function */
.highlight .nl { color: #A0A000 } /* Name.Label */
.highlight .nn { color: #0000FF; font-weight: bold } /* Name.Namespace */
.highlight .nt { color: #008000; font-weight: bold } /* Name.Tag */
.highlight .nv { color: #19177C } /* Name.Variable */
.highlight .ow { color: #AA22FF; font-weight: bold } /* Operator.Word */
.highlight .w { color: #bbbbbb } /* Text.Whitespace */
.highlight .mb { color: #666666 } /* Literal.Number.Bin */
.highlight .mf { color: #666666 } /* Literal.Number.Float */
.highlight .mh { color: #666666 } /* Literal.Number.Hex */
.highlight .mi { color: #666666 } /* Literal.Number.Integer */
.highlight .mo { color: #666666 } /* Literal.Number.Oct */
.highlight .sa { color: #BA2121 } /* Literal.String.Affix */
.highlight .sb { color: #BA2121 } /* Literal.String.Backtick */
.highlight .sc { color: #BA2121 } /* Literal.String.Char */
.highlight .dl { color: #BA2121 } /* Literal.String.Delimiter */
.highlight .sd { color: #BA2121; font-style: italic } /* Literal.String.Doc */
.highlight .s2 { color: #BA2121 } /* Literal.String.Double */
.highlight .se { color: #BB6622; font-weight: bold } /* Literal.String.Escape */
.highlight .sh { color: #BA2121 } /* Literal.String.Heredoc */
.highlight .si { color: #BB6688; font-weight: bold } /* Literal.String.Interpol */
.highlight .sx { color: #008000 } /* Literal.String.Other */
.highlight .sr { color: #BB6688 } /* Literal.String.Regex */
.highlight .s1 { color: #BA2121 } /* Literal.String.Single */
.highlight .ss { color: #19177C } /* Literal.String.Symbol */
.highlight .bp { color: #008000 } /* Name.Builtin.Pseudo */
.highlight .fm { color: #0000FF } /* Name.Function.Magic */
.highlight .vc { color: #19177C } /* Name.Variable.Class */
.highlight .vg { color: #19177C } /* Name.Variable.Global */
.highlight .vi { color: #19177C } /* Name.Variable.Instance */
.highlight .vm { color: #19177C } /* Name.Variable.Magic */
.highlight .il { color: #666666 } /* Literal.Number.Integer.Long */
    </style>
<style type="text/css">
    
/* Temporary definitions which will become obsolete with Notebook release 5.0 */
.ansi-black-fg { color: #3E424D; }
.ansi-black-bg { background-color: #3E424D; }
.ansi-black-intense-fg { color: #282C36; }
.ansi-black-intense-bg { background-color: #282C36; }
.ansi-red-fg { color: #E75C58; }
.ansi-red-bg { background-color: #E75C58; }
.ansi-red-intense-fg { color: #B22B31; }
.ansi-red-intense-bg { background-color: #B22B31; }
.ansi-green-fg { color: #00A250; }
.ansi-green-bg { background-color: #00A250; }
.ansi-green-intense-fg { color: #007427; }
.ansi-green-intense-bg { background-color: #007427; }
.ansi-yellow-fg { color: #DDB62B; }
.ansi-yellow-bg { background-color: #DDB62B; }
.ansi-yellow-intense-fg { color: #B27D12; }
.ansi-yellow-intense-bg { background-color: #B27D12; }
.ansi-blue-fg { color: #208FFB; }
.ansi-blue-bg { background-color: #208FFB; }
.ansi-blue-intense-fg { color: #0065CA; }
.ansi-blue-intense-bg { background-color: #0065CA; }
.ansi-magenta-fg { color: #D160C4; }
.ansi-magenta-bg { background-color: #D160C4; }
.ansi-magenta-intense-fg { color: #A03196; }
.ansi-magenta-intense-bg { background-color: #A03196; }
.ansi-cyan-fg { color: #60C6C8; }
.ansi-cyan-bg { background-color: #60C6C8; }
.ansi-cyan-intense-fg { color: #258F8F; }
.ansi-cyan-intense-bg { background-color: #258F8F; }
.ansi-white-fg { color: #C5C1B4; }
.ansi-white-bg { background-color: #C5C1B4; }
.ansi-white-intense-fg { color: #A1A6B2; }
.ansi-white-intense-bg { background-color: #A1A6B2; }

.ansi-bold { font-weight: bold; }

    </style>


<style type="text/css">
/* Overrides of notebook CSS for static HTML export */
body {
  overflow: visible;
  padding: 8px;
}

div#notebook {
  overflow: visible;
  border-top: none;
}@media print {
  div.cell {
    display: block;
    page-break-inside: avoid;
  } 
  div.output_wrapper { 
    display: block;
    page-break-inside: avoid; 
  }
  div.output { 
    display: block;
    page-break-inside: avoid; 
  }
}
</style>

<!-- Custom stylesheet, it must be in the same directory as the html file -->
<link rel="stylesheet" href="custom.css">

<!-- Loading mathjax macro -->
<!-- Load mathjax -->
    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/latest.js?config=TeX-AMS_HTML"></script>
    <!-- MathJax configuration -->
    <script type="text/x-mathjax-config">
    MathJax.Hub.Config({
        tex2jax: {
            inlineMath: [ ['$','$'], ["\\(","\\)"] ],
            displayMath: [ ['$$','$$'], ["\\[","\\]"] ],
            processEscapes: true,
            processEnvironments: true
        },
        // Center justify equations in code and markdown cells. Elsewhere
        // we use CSS to left justify single line equations in code cells.
        displayAlign: 'center',
        "HTML-CSS": {
            styles: {'.MathJax_Display': {"margin": 0}},
            linebreaks: { automatic: true }
        }
    });
    </script>
    <!-- End of mathjax configuration --></head>
<body>
  <div tabindex="-1" id="notebook" class="border-box-sizing">
    <div class="container" id="notebook-container">

<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[11]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="kn">from</span> <span class="nn">nltk</span> <span class="k">import</span> <span class="n">ngrams</span>

<span class="n">sentence</span> <span class="o">=</span> <span class="s1">&#39;Molecular Medicine Tri Conference Protein Engineering Peptalk Biocomputing SCOPE Summit for Clinical Trials Operations Executives bioproduction Discovery on Target PEGS Europe Drug Discovery Chemistry World Pharmaceutical Congress advanced diagnostics Advanced Automotive Battery Conference (AABC) Europe Florida Battery Conference Biomarkers Congress High Content Analysis Advanced Automotive Battery Conference (AABC) Immunogenicity CRA &amp; CRC Beginner Biopharmaceutical Change Control Beyond Genome Immunotherapy Alliance Management Strategies Targeted ImvacS Clinical Trials Molecular Medicine Marketplace Molecular Diagnostics Europe CRA Beginner AI World Data Driven Discovery R&amp;D Strategies Strategic Resource Allocation kinases Auditing Clinical Research Studies Accelerating Development &amp; Advancing Personalized Therapy X Gen Congress Biodefense &amp; Enabling POC Diagnostics &amp; Microarray Data Analysis Human Genome Project Biobanks Structure Based Design Batteries Portfolio Quantitative PCR Health Information Technology Auditing Techniques for Clinical Research Professionals Good Clinical Practice Question &amp; Answer REference Guide CFR/ICH GCP Immunotherapy Europe Gene Amplification PCR eStats: R&amp;D Statistical Sourcebook MicroRNA microarray data analysis Intelliigent Drug Discovery &amp; Development (now WPC) Monitoring Clinical Drug Studies: Beginner Comprehensive Monitoring for Medical Devices Introduction to Clinical Project Management Bioprocessing Summit Europe Oligonucleotide &amp; Peptide Summit World Pharma Week Prenatal Diagnostics Getting Optimized Targets Library Design &amp; Synthesis Clinical Project Management functional genomics bacterial infections Advanced Automotive Battery Conference (AABC) Asia Good Clinical Practice Q&amp;A Reference Guide Screening Transmissible spongiform encephalopathy TSE Biomarker Discovery Summit Clinical Genomics Sequencing ASAP Alliance Summit Bioterrorism microarrays Pharmaceutical Leadership Summit Circulating Cell-Free DNA Conducting Clinical Trials Under ICH GCP Bio IT Europe Trial Master File Biomarkers World Preclinical Congress Europe BioMEMS bioinformatics Genomic Partnering NMR nuclear magnetic resonance Clinical Data Management Biomarker Validation proteomics Statistics Sensors Global Summit New Drug Development A Regulatory Overview Drug Safety Pharmacy Diagnostics sample preparation Clinical Trial Design Pharmacovigilance Metabolic Profiling Digital PCR Good Clinical Practice for Clinical Trials Lab chips Europe Monitoring Clinical Drug Studies: Intermediate Preparing IND Submissions Antibody Engineering Asia Clinical Project Management: Intermediate phage display CELLutions Recombinant Antibodies imaging Biomarker Assay Development in silico biology Advanced Good Clinical Practice High Throughput Optimization of Culture Conditions for Bioprocessing High Throughput Technologies gene quantfication [real time PCR] From Gene Expression Profiling to Validated Biology Clinical Project Management: Advanced SCOPE Summit Europe CNS Partnering Genomics on Target R&amp;D Statistical Sourcebook MultiUser License Medical Device Development Biological ADME Protein Expression blood safety and screening Human Proteome Project Project Management high throughput organic synthesis Global Preclinical Development Clinical Research Coordinator Global Drug Development India Biomarker Diagnostics molecular diversity functional genomics Process R&amp;D Summit Cloud Computing bioinformatics Europe Target Validation Bispecific Antibodies Bridging Pharma and IT Green Fluorescent Proteins Quality Systems CRA Monitoring Drug Discovery &amp; Development AI in Government glycotechnology Baculovirus Drug Repurposing drug discovery and development Japan The CRA Manager Course State by State Clinical Trial Requirments Reference Guide Adverse Events: Managing &amp; Reporting for Medical Devices Good Laboratory Practice Process Chemistry Beyond Sequencing Process R&amp;D Summit with GLP Batteries Biomarkers Europe IT Infrastructure computer hardware Clinical Trials patient Recruitment Working with CROs Expediting Drugs and Biologics Development Tissue Sealants - One Day Protein Expression Europe Use of Note to Files in Clinical Trial Essential Documentation Antibody Engineering Korea RNAi for Pathway Analysis Advanced GCP Compliance Mechanisms of Cancer Business Diagnostics (Impact of New Diagnotics) Consumer Genomics Conference Recombinant Antibodies Europe Research Site Clinical Study Budgets and Contracts Proof of Concept Drug Development in China Future Diagnostics Medicinal Chemistry Combination Therapies CRA Training Series (1-7) Lab Chips Japan Human Genomes Europe Tissue Based Screening lead optimization Adverse Events Reimbursement Diagnostics labels signals and detection ASAP CHI Bio Pharm Alliance Summit forensic diagnostics Writing for Clinical Research Molecular Profiling with Cellular Resolution 10 Rules of Effective Report Writing pharmacogenomics europe Exploring Next Generation Sequencing conference Drug Development &amp; FDA Regulations HCA East Cancer Immunotherapies (formerly Cancer Vaccines) Biologics Development A Regulatory Overview Standard Operating Proces in Clinical Research molecular pharmacology RNA Interference Summit Clinical Training oligonucleotides Clinical Trial Protocols toxicology Immunogenicity Testing for Biologics Adaptive Clinical Trials ADME Stem Cells in Drug Discovery and Development Drug Pipeline Success (Pipeline Success Summit) stem cells Data Visualization Pharmacokinetics transgenic animal models Business Development Alliance Management Interface Monitoring Clinical Drug Studies: Advanced Digital Health Innovation Summit Data Management in the Electronic Data Capture Arena Case Report Forms Battery Safety Medical Devices GCP Overview Clinical Administrative Support Staff Alliance Management &amp; Project Management Pre-Implantation Diagnostics Eyesight Biomarker Diagnostics Biomarker Web Symposia Drug Approval Process Neglected Diseases Molecular Diagnostics Medical Device Approval Process Code of Federal Regulations for Medical Devices Clinical Research Associate G protein coupled receptors GPCRS Prenatal Diagnostics Europe Genomic Tools &amp; Technologies Biomarkers Europe Symyx Business Collaborative Innovation Source Documentation Mitochondria Comparative Genomic Hybridization Lithium Battery Power Writing Clinical Study Protocols Reimbursement Therapeutics genetic variations Business Investigator initiated trials Burrill Book Bio-IT Asia Compound Profiling cancer clinical trials Chemical Genomics Safety/Toxicity Biomarkers Cancer Diagnosis antibody engineering Drug Development in Asia West Coast Virtual Screening Point of Care Diagnostics Protein Formulation genetic diagnostics Bridging Discovery &amp; IT Biofuels Translational Medicine Personalized Medicine Clinical Research Organization Alliance Management Congress Europe New Drug Approval Risk Based Site Monitoring Root Cause Analysis Monitoring Phase I Clinical Trials Drug Development Latin America Licensing vaccines cancer genetics and genomics Marketing Reimbursement Metabolic Analytical Methods Difficult Clinical Research Sites Protein Chips/Arrays Monitoring Plan Development Genome Japan Immunogenicity Advances in Management and Reduction Clinical Auditing Clinical Informatics Antibody-Drug Conjugates Electronic Medical Records &amp; Source Document Verification Bridge to Pop Health East Informed Consent Pharma Future Microarray Data Analysis Europe Clinical Investigator Site Inspections Global Clinical Trials Protocol Deviations Immunotherapy West Cancer Therapies Recognize Attrition Earlier Electronic Data Capture Clinical Imaging Physical Chemistry Toll Like Receptors monoclonal antibodies Innate Immunity High Content Analysis Europe Negotiation Skills for Clinical Research Professionals Biotech Executive Forum CNP Partnering Europe nanotechnology Risk Management Clinical Trials for Medical Devices Adverse Event Monitoring for CRAs Vendor Management Report Writing for CRAs Symyx Europe Epigenetics Regulatory Compliance GCP Training for Investigators RECIST 1.0 and 1.1 Pharmacovigilance Audit Microfluidics yeast model organism Market Targets &amp; Compounds Critical Decision Points in Design &amp; Conduct of Patient Registries protein production formulation HCA Europe Idiosyncratic Toxicity Protein Informatics Conflict Resolution and Negotiation Regulatory Intelligence Bioresearch Monitoring Cryobiology signal transduction Emerging Companies Corrective Action Plans: Documentation of a Sites Response to GCP Deficiences Developing Clinical Study Budget Next Generation Sequencing Data Management Fraud in Clinical Research Biosimilars Dealmaking for Diagnostics Comprehensive CRC Training Cancer Cell Models Digital Health Patient Registry Programs crop genetics Glossary &amp; Acronyms Reference Biosensors Good Clinical Practice Essential Documentation in Clinical Trials at Research Sites Patient Centered Clinical Trials Proteins to Profits Europe Drug Metabolism International Drug Approval Regulatory Procedures Principal Investigator Training orthopedic tissue engineering Investigator Sites cardiovascular genomics Study Start Up Protein Folding Population Health Management Tissue Diagnostics GLP Bioanalysis Phase I Study Management Health Autonomous Driving Electronic Source Documentation Tools &amp; Metrics Congress Global GCP Monitoring Investigator Non-Compliance Global GCP Compliance Report Protein &amp; Peptide Arrays Europe Internet of Things Clinical Trials for Pharmaceuticals Introduction to Signal Detection and Data Mining Study Feasibility Clinical Investigation Monitoring Proteomics Europe Clinical Trials in Developing Regions Pediatric drug development Sponsor Monitoring Inspections Maximize Value of Drug Development protein structures cancer Microbial Genomics Translational Cancer Medicine Medical Terminalogy for Clinical Research Professionals Medical Devices Writing and Updating the Investigators Brochure Sunshine Act Sequencing for Drug Development Standard Operating Procedures Meeting International Safety Reporting Requirements Faciliation Skills for Clinical Research Professionals bioprocessing biologicals safety Regulatory Intelligence 101 Recent Trends in Noncompliance Briefings on Drug Safety Clinical research project mamangement essentials CRA Survival Kit Essential Documentation Extracellular RNA Successful Study Site Start-up Cell Based Therapies Web-Based Training Strategies data mining GLP Bioanalysis Clinical Trial Finance &amp; Management regulatory Site Relationship/Performance Management Introduction to FDA Regulatory Reporter Newsletter multiple sclerosis Data Integration Managing CRAs to Improve Performance &amp; Study Outcomes compounds Predictive Toxicity Surviving FDA Site Inspections: Best Practices for Site Personnel Phase III (3)/forecasting clinical outcomes Comparing FDA and Health Canada Regulations Medical Device Professionals Recombinant Therapeutics Tick Borne Diseases Writing and Maintaining the EU CTA Orphan Drugs Investigator Initiated Trials Orthopaedic Animal Models Auditing Sponsors and CROs Valuing &amp; Pricing Licensing Deals drug delivery Vendor Management for the Clinical Data Manager Data Quality Patient Engagement FDA Drug Approval Process HIPAA No 1 Team Training HIPAA &amp; Human Subjects Research  Q&amp;A Ubiquitin Europe Clinical Trial Data Monitoring Investigational Product Accountability Training for Research Site Personnel Adverse Event Reporting to IRBs Subject Recruitment for Clinical Research Sites Antibodies in Cancer Cost Management for Global Clinical Trials Portfolio Management Warning Letters Combination Products Observational Studies Molecular Medicine Asia CNS Central nervous system Discovery &amp; Development Collaboration Cross functional global teams Site Relationship Management peptides Investigator Oversight Writing SOPs pain web 2.0 Understanding FDAs new Draft Guidance Regarding Supervisory Repons Sponsors/CROs Preparing Clinical Research Sites for FDA Inspections eHealth Technologies Introduction to Data Management FDA Proposed rule 2010 Teambuilding for the Cross Functional Global Team Genomic Business Strategies Product Life Cycle RNA Interference Pharmacovigilance Signal Detection Foreign Clinical Trials Biotech Business Development genomics Portfolio Management Venue II Clinical Trial Design for Medical Devices Informed Consent Clinical Trial Study Wheel Biomarker Data Center Antibody Optimization &amp; Characterization Biologics Chronic Pain cardiovascular Risk based decisions for clinical site management Human Participant Protection Training Clinical Research Professionals CRC Role/Responsibilities Training Womens Health Current Developments in the Role of IRBs in the Conduct of Clinical Research Regulatory Compliance for Molecular Diagnostics infections Diabetes cancer partnering Preparing Medical Device 510K Submissions Monitoring Informed Consent Business of Biobanking Global Site Selection Boston Biomarkers of Drug Efficacy and Safety New Drug Approval in the European Union Protein Therapeutics Quality Improvement Strategies at Clinical Research Sites diagnostics bioprocessing viral hepatitis infections Advanced HIPAA Clinical Sequencing IRB Guidance regenerative healing cell culture Coronavirus Liver Disorders Big pharma Big Data HIPAA Electronic Medical Records blood Pharmaceutical Strategy Series Strategies for Accelearted Nonclinical Toxiciology &amp; Safety Assessment of Biologics New Drug Approval in Japan Artificial Intelligence Excel Spreadsheets-Step by Step Instructions for Compliance Chemistry R&amp;D Statistical Sourcebook Upgrade Medical Device Tracking Medical Devices Directive Facilitation Skills Autoimmune anticoagulants bone Clinical Antibodies gene therapy Newborn Diagnostics Real World Monitoring Allergies Performance Improvement Monitoring Model Institutional Review Board Health Outcomes Outsourcing R&amp;D Microbiome Key Opinion Leaders Chronic Obstructive Pulmonary Disorder Quality by Design Clinical Trials &amp; Translational Medicine Series Lupus Multi Drug Resistance Clinical Research Coordinator Tool Kit CRC &amp; PI Current Practice Update CRA Facilitator Training 21 CFR Part 11 Compliance for Electronic Records &amp; Signatures Cancer Diagnostics Electronic Health Record Chiral Intro to Combination Products Gastrointestinal Disorders Presentation skills for clinical research professionals inflammation Operational Modeling and Simulation in Clinical Trials Pharmaceutical &amp; Medical Device Industries Facilitation Skills for Clinical Research Team Members Diagnostics Partnering Mobile Health Wearables Pharmaceutical Discovery Data Management Medical device reporting Ubiquitin Medical Device Postmarketing Vigilance Blockchain Alzheimers high performance computing Innovative Preclinical &amp; Clinical Strategies GXP Good Practice Guides Writing and Maintaining Canadian CTA 3D Printing Key Information Gatherers Respiratory Five Keys to COTS Computer System Validation Next-Generation Sequencing Data Management Open Source Fibrosis/Scarring Biomarker Bridge Genomics 101 Dummy Keyword for DE lists w/more than 1 keyword or with no keywords FDA Form 1572 Antisense Accountable Care Orgnization ACE inhibitors AI Chips Antibody-Drug Conjugates  for PEGS Antibody Drug Conjugate Bioprocess Attention Deficit Hyperactivity Disorder Adjuvants ADMET (ADME &amp; Toxicology) adverse drug reactions Aerospace Advanced Energy Technology Congress Affordable Care affinity technologies Affinity Separation Antibody Fragments Agriculture  chemistry Aging Antibody Drug Targets Digital Farming angiogenesis AI Business Intelligence Artificial Intelligence Bioprocessing AI in Customer Analytics Intelligent Assistants and Bots AI in Cancer Enterprise AI Case Studies AI Executive Summit Machine Learning Artificial Intelligence Clinical &amp; Post Approval Artificial Intelligence Discovery &amp; Preclinical Implementing Enterprise AI AI Ethics Future of AI Cutting Edge Research for AI General AI Business Applications AI for Strategic Government Functions Cognitive Computing AI Partnering AI in Personalized Medicine Allosteric Modulators Amyotrophic lateral sclerosis Animal Models of Cancer Alternative Medicine Alliance Management Execution Asset Management Alliance Management Negotiation Animal Models of Pain Animal Models of Toxicity angina Anxiety cancer and apoptosis Active Pharmaceutical Ingredients Analytical Purification Apoptosis Anti Psychotics Alliances Rx Devices arrhythmias Assays for Antibodies Assays Affinity Assays and Allosteric Antagonism Immunogenicity Assay Development Assays Primary Cells Quantifying Receptor Activation and Agonism asthma Assays atherosclerosis Automotive Automotive Partnering Autophagy Autism Advisory Boards Bacterial Infections Consumer Electronic Battery Applications Defense Battery Applications Battery Data Science Flexible Battery Power Industrial Battery Applications Medical Device Battery Applications Battery Applications Stationary Battery Applications Automotive Battery Applications Bayesian Statistics Asia US Biotech Alliances Blood Brain Barrier Computational Biology for Bio IT BioIT Best Practices Battery Charging Cheminformatics for Bio IT Biomarker Clinical Applications Preclinical Biologic Development Breast Cancer Backup Compounds biological cancer treatments Biomarker Data Analysis Biological Database Discovery Informatics for Bio IT Delivery of Biologics Regulatory Business Diagnostics biodiversity screening E Clinical Research Battery Energy Storage Biofuels Alliance Biobank Informatics Flow Cell Technologies Cloud Computing for Data Science Biogenerics Business of Genomics biomaterials Bioinformatics for Cancer BIO IT World Battery Intellectual Property Bio IT World Web Resource Alert Bio IT World Monthly magazine IT &amp; Informatics Series Bio IT World Weekly Update Bookstore Biomarker Development Advanced Lead Acid Technology Manufacturing &amp; Process Economics Biopharm Executive Summit Biolaw Biomarker &amp; Diagnostics Series High-Througput Screen-Based Biomarker Discovery Battery Manufacturers Battery Manufacturing Battery Management Battery Manufacturing Machinery Battery Market Battery Machine Learning Biomarker Executive Think Tank Battery Materials, Recycling Biomarker Reverse Phase Assays Battery Materials, Solid State bone marrow transplants Biomarker Translational Biomarker Validation Bioinformatics Asia Bioinformatics Cloud Computing IT Infrastructure  for Bio IT Logistics and Sample of Biobanking Bioinformatics in the Genome Era Bioprocess Data Analysis Host Cell Protein Assays Bioproduction Continuous Processing biopurification Biological Pharmacokinetics Bioprocessing Quality Bioprocess &amp; Manufacturing Series Bioprocess Validation Bioreactor Design and Engineering Battery Regulatory Battery Raw Materials Brain Cancer Battery Repurposing Biological Therapeutics (biotherapeutics) Bispecific Antibodies for Immunotherapy Bispecifics for Cancer Business Strategies for Library Diversity blood safety Europe Battery Shipping Battery Simulation Biosensors bioseparation Biostabilization of Biospecimens Biomanufacturing Single Use Technologies Bioassays Battery Commercialization Flow Batteries Battery Materials Sci/Tech for Pharma &amp; Biotech Battery Safety Biotech tools Biotech Venture Forum Biomarkers for Molecular Diagnostics Biomarkers for Molecular Diagnostics Clinical Trials for Cancer Immunotherapy Artifical Intelligence in Clinical Trials cell adhesion molecules regulatory CANDA Computer Assisted New Drug Application Chimeric Antigen Receptor Chimeric Antigen Receptor Case Studies catalysis Cell Based Assays Cell Therapy CMC Cancer Biomarker Cell Therapy Production Cord Blood Stem Cells Cell Based Therapies Circulating Tumor Cells Cold Chain Colorectal Cancer cell cycle Collaborations Deals and Alliances Chemical Database Co-Development of Diagnostics and Drugs Cloud Computing Europe Case Histories Clinical Trials Consumer Electronics Cell Biology Clean Tech Solar Wind Comparative Effectiveness Research Ethical Considerations in Clinical Trials Continuing Education Units Circulating Cell-Free DNA Europe Agriculture  crop genetics Europe Cancer Genomics Europe congestive heart failure Chemistry Series Chinese Hamster Ovaries Clinical Research Conflicts of Interest cheminformatics competitive intelligence Cloud Computing Asia Integrating Clinical Lab Services in Clinical Trials Clinical Biospecimens and Central Lab Solutions Clinical Biospecimens and Central Lab Solutions Celiac Disease Cloud Extension Clinical Genomics Europe cellular all Conducting Clinical Trials in Asia Cloud Computing Project Management Cloud Computing Resource Management Cloud Computing Security Risks Software Development for Clinical Genomics Clinical Vaccines Cloud Computing West Comparability Chemistry Manufacturing and Controls Continuing Medical Education Communications Contract Manufacturing Cancer Microarray Application CNS Biomarkers Miscellaneous CHI conference CNS genetics/genomics CNS Disease Models Counterfeit Drugs Copy Number Variation Cognitive Disorders Battery Components capillary electrophoresis Cancer Prognostic Markers Clinical Pharmacology Clinical Proteomics Clinical Plasma Profiling Clinical Trial Platform Software Computer Vision cancer prevention CRA 8 Weeks Fundamental Training Cost Reduction w/o Increasing Regulatory or Business Risk Advanced Clinical Research Coordinator Critical Care Diagnostics Interviewing Skills for CRAs and CRCs Customer Relationship Management CRA Monitoring Clinical Research Training Week Clinical Research Training Week East Clinical Research Training Week West Drug-Device Combinations Peptides for Cancer Therapeutics Colony Stimulating Factors Cell Signaling Cancer Stem Cells Clinical Supply Chain Clinical Strategic Resource Allocation Country and Site Feasibility and Selection Mammalian Cell Culture Cloud Security Cybersecurity Clinical Data Management and eClinical Trials Asia Clinical Trials for the Drug Discoverer Clinical Trials Eastern Europe Clinical Trial Finance &amp; Management Re Engineering the Study Feasibility Assessment Process CRC Training Video &amp; Manual Clinical Trial Management Systems Cardiotoxicity Query Creation &amp; Processing clinical trials segmentation Neoantigens for Cancer Cardiovascular Diagnostics cardiovascular animal models Cardio Metabolic Drug Targets Targeting Cancer Diagnostics cytokines antagonists Cystic Fibrosis Cytogenetics cytokines Targeting Diabetes with Novel Therapeutics DBS Optimization of Cell drug discovery India Drug Discovery Map Drug Discovery Outsourcing Drug Discovery Technologies drug discovery and development Drug Discovery &amp; Development Series Dental Depression Detection non biological Treatments for Drug Abuse Drug Drug Interactions Digital Therapeutics Digitization Diabetes 2 Digital Healthcare &amp; Productivity web resource alert drug discovery Duchenne Muscular Dystrophy Drug Metabolism &amp; Pharmacokinetics Drug Discovery Informatics Europe Data Integrity Diagnostic Informatics DNA Repair Diversity Oriented Synthesis Digital Detection Europe Difficult to Express Proteins Executive Perspectives of Drug Safety downstream processing Europe Drug Safety Series downstream processing Dosing Selection Data Science/Analytics Direct to Consumer Marketing Data Management Drug Transporters Data Storage Digital Twins Drug Utilization Protein Devices Molecular and Companion Diagnostics Asia Clinical Adoption of Next Generation Diagnostics Difficult to Express Proteins Europe Globalization of Dx Diagnostics Immunoassays Diagnostics Automation Detection Informatics engineered animal models Hearing Ebola Diagnostics Evidence Based Medicine Ebola Therapeutics eCapacitors Electrochemistry E Coli Encoded Compound Libraries Ecommerce eCTD Validation of Disinfectant Efficacy Effective Drug Discovery Edge Computing Early Diagnosis Electronic Notebooks endothelium engineering Entertainment Enabling Technology in R&amp;D Environment Enzymes Economic Outcomes Executives on Target Epidemiology epilepsy Epigenetic Readers Epigenetic Targets Examining the Impact of the eCTD on the Regulatory Submissions Process Emerging Targets Diseases Ethics Emerging Technology Transfer Electric Vehicles Experimental Design Exhibitors Extractables/Leachables Exosomes Exome Sequencing Financial Analysts Hackathon Obesity Batteries France fibrin sealants Fine Chemicals FDA Meetings 101 Food Safety Financial Disclosure Foods FDA Website Functional Genomics Fragment Based Screening Surface Plasmon Resonance finance Flow Cytometry Influenza Financial Deal Structures Fintech Future of Healthcare Fraud Fertility Fibrin sealants Europe blood Fast Track Future Therapeutics fungal infections Follow Up Flow Chemistry Gamification gap junction channels Global Health Good Clinical Practice for Pediatric Research GCP Deficiencies Gene Cell Vectors Genomic Drug Discovery Genomic Data Integration Genetic Screening Wellness General Email Only Gene Editing Part 2 Gene Editing Gene Expression Monitoring Genomics Series Gene Expression growth factors Gene Identification genetic immunization vaccines gene interference Gene Knockouts Globalization Genome Links newsletter GLP Bioanalysis Leaders in Precision Medicine Good Manufacturing Practice Drugs introductory gene mutations genomic medicine Genotyping Government gene probes Genomic partnering Europe Greening of Pharma GPCR Targeted Therapies Grid Computing Genomic Service Providers Small GTPases (formerly Gene Town Pass) gene transcription gene therapy technologies Whole Genome Association Studies Humanized Antibodies high throughput analytical chemistry Health &amp; Beauty Aids Hepatitis B Virus High Content Analysis Course HIV and cancer Hematological Cancer Pipelines HIV clinical trials hepatitis C virus Heterocycle High Content Data Analysis HDAC Histone Demethylases Healing hematopoesis heat shock proteins Human Factors Engineering Health Information Systems HIV Healthcare Series Health Maintenance Organizations Human Tissue Huntingtons Disease hormones HIPAA #2 High Throughput Protein Purification High Performing Operation Human Papilloma Virus transgenics homologous recombinant Human Relations Health Insurance herpes virus HIV Surrogate Markers High Throughput Genomics Hit to Lead High Throughput Screening Hepatotoxicity Hybrid Computing hypertension Targeting Antigen Presenting Cells Inflammatory Bowel Disease imaging contrast agents interleukin converting enzymes ICE Improving Drug Safety diagnostics - infections Infections Diagnostics Europe engineering laboratories Integrated Fluidic Circuits for DOT Informatics for Genomic Medicine Infection Genomics Image Analysis Immunotherapy Biomarkers Immune Profiling in Cancer Complement-based Drug Discovery immunomodulation Imaging for WPC conference Imaging Informatics Immune Impurities Regulatory Immunogenicity Immunosequencing Immuno-Oncology Drug Developement Cancer Immunotherapy Oligonucleotides Cancer Immunotherapy Peptides Cancer Immunotherapy Small Molecules Informatics Partnering Insurance AI and IOT Investments Industrial Enzymes Immuno-Oncology Assays Immuno-Oncology Business Strategy Immuno-Oncology Clinical Trials Immuno-Oncology Models ion channels Protein Engineering for Immuno-oncology Immuno-Oncology Sequencing Immuno-Oncology Targets Legal Issues for Bioproduction Intellectual Property Pluripotent Stem Cells IRB Compliance and Oversight Considerations Adopting Integrated R&amp;D Informatics Systems India Re Engineering International Risk Management Drug Discovery Informatics Iron Chelation IT Infrastructure Software in situ hybridization Information Technology IT &amp; Informatics for Collaboration IT Infrastructure Europe Scalable IT &amp; Informatics IT Infrastructure computer hardware (part 2) IT Infrastructure computer hardware (part 3) IT Software for the Life Sciences IT Infrastructure Virtualization Interviewing Skills for Managers Investigator Sites Report 1 Investigator Sites Report 2 Imaging Week joints Job recruiters Kinase Chemistry KIN West Coast Kinases for DOT Knowledge Management chemokines HIV and Kaposis sarcoma Kinetics Structure Relationship laboratories Lead Acid Batteries Label Free Detection Drug Labeling Live Cell Imaging Laser Capture Microdissection Lung Cancer ligase chain reaction leukodepletion Laboratory Developed Tests leukemia Ontologies/Lexicons Legal drug liability screening libraries Life Sciences Protein Ligands lab information management systems LIMS Lipids Large Stationary Batteries Lyophilization Mergers &amp; Acquisitions Monoclonal Antibodies Forum Monoclonal Antibody Process Development Malaria Metabolism Targeted Cancer Therapeutics Microbiome in Immuno-Oncology Microbiome Metabolic Syndrome Medicinal Chemistry Part 2 Mucosal Immunity Microreactors Macrocycles Molecular Diagnostics Business Multidrug Resistance Cancer Medical Coding multidrug resistant infections Next Generation Non-Invasive Molecular Diagnostics Microdosing microbial infections Sequencing Based Molecular Diagnostics Molecular Diagnostics Forum Molecular Electronics Metabolic Engineering Melanoma BioMEMS memory enhancement cancer metastasis molecular evolution Mammalian Cell Line Development microfabrication Molecular Genetic Pro Management molecular medicine Novel bioactive high throughput screening europe Myocardial Infarction migraine microtiter plates Molecular Medicine Europe metalloproteinases Molecular Medicine Asia Managed Care Manufacturing Clinical Trial Monitoring Mechanism of Action Purifying Antibodies Meeting Planning Services Molecular Pathology Molecular Pathology Basic Molecular Pathology Advanced magnetic resonance imaging Multi Specific Antibodies Mass Spectrometry for Protein Biomarker Discovery Muscle Mass Spec Informatics Mass Spec Imaging Modeling and Simulation Mass spectrometry Mass Spec Diagnostics Metabolic Disorders Mental Health Materials Testing cellular matrix Multiplexed Assays Moelcular Diagnostics Europe Molecular Diagnostics for Cancer Molecular Diagnostics for Infectious Disease Next Generation Antibodies Next Generation Antibodies (for PGE) Nucleic Acid Europe National Academy of Sciences meeting natural products new antivirals Novel Cancer Informatics Non-Coding RNA Novel Strategies Cancer Novel Cancer Targets Neurodegenerative Nucleotide Delivery Internet New to Database comapny names Advances in Informatics nerve growth factors NF KB Nanofluidics Informatics Next-Generation Batteries Next Generation Batteries Portable Applications Next Generation Batteries Stationary Power Epigenetic Sequencing Next Generation Imaging Neurogenomics Nuclear Hormone Receptors Novel HIV Strategies Neurotech Industry neuroinjuries NK Cell Based Cancer Immunotherapy Natural Language Processing nuclear matrix Nanomedicine Nitric Oxide Network Pharmacology Energy Neurotoxicity New Drug Approval in the US nanotech self assembly Internet of Supply Chain Internet of Supply Chain Europe Neurostimulation Internet of Diagnostic Things Internet of Energy Internet of Energy Europe Internet of Things Infrastructure Internet of Health Internet of Insurance Internet of Insurance Europe Internet of Things Manufacturing Internet of Things Manufacturing Internet of Manufacturing Europe Smart Buildings Smart Cities Nephrotoxicity Nuclear Energy nutrition Optimizing Media organ and cell transplants Oncology Drug Targets Optical Diagnostics Oncogenomics Office of the Inspector General Oil and Gas oncogenes Oncolytic Viruses Oligo Production opportunistic infections Oligo Regulatory organs transplants oral drug delivery OSTEOARTHRITIS OTC over the counter Additional Conferences clinical trials outsourcing Oxygen Radicals oncogenes p53 Predictive ADME protein aggregation Protein Aggregation (for PTK) Packaging parasitic infections Process Analytical Technology Pharmacy Benefit Management Pharmaceutical BioProcess Basic Research &amp; Discovery track for PCG Clinical Operations track for PCG Preclinical Development track for PCG Bridgehead PCI book Preclinical Preclinical Preclinical prostate cancer Preclinical Outcome Predictions preclinical trials Point of Care West Protein Crystallography pediatric AIDS/HIV PDA Downloads from CHI website Process Development for Executives platelet derived growth factors protein drug delivery Preclinical Disease Models photodynamic therapies Phage Display for Vaccine Development Proteomic Tools for Diagnostics pediatric Pediatric trials for CRAS PEGS Virtual Interactive Global Summit Protein Expression Monitoring Protein Executive Summit Proof of Concept for Cancer Protein Function Enterprise Portfolio Management Portfolio Value Protein Aggregates Light Scattering Consumer Genomics/Personal Genomics Protein Engineering Partnering Particulate Screening Phage West Phase II/Reducing Attrition Phase IV Phase IV Pharmacies Phage Display Europe Pharmaceutical Half Life Phase Zero PI3K Phosphoinositide 3 Kinase Protein Identification Preclinical Imaging protease inhibitors enzymes PLA2 blood platelets Membrane Proteins Membrane Protein for DOT (part 1) Membrane Protein for DOT (part 2) Protein Manufacturing Clinical Project Management: Intermediate Preventive Medicine Pancreatic Cancer Preclinical Studies for IND Protein Computational Tools Prenatal Therapeutics Parenteral Point of Care Diagnostics Europe Cannabis Power Utilities protein characterization protein purification Protein Protein Interactions Protein Protein Interactions Part 2 Process Management Protein Process PepTalk Partnering Personalized Medicine Partnering Proteomics Analytics Predictive Analytics Pricing Parkinsons Predictive Biomedicine Proteins, Peptides &amp; Proteomics Series Protein Quantification Partnering Data Privacy Personalized Medicine Asia Product Service Announcement Production and Scale Up Pharma Services News schizophrenia antipsychotics Protein Antibodies Preclinical Toxicology Biologics Protein Technology Engineering Protein Therapeutics for Delivery Predictive Toxicity Europe Platform Software for R&amp;D Studies Phenotype to Genotype Pathology Protein drugs &amp; diagnostics Intellectual Property Post Translational Modifications Patient Registries Advancing Therapeutics Current Generation Protein Drug Delivery (part of PepTalk) Advancing Therapeutics Next Generation Biological Therapeutic Products Series Pathway/Networks Publications Protein Variations Powertrains Protein Characterization, Purification and Screening Protein Characterization, Purification and Screening Protein Expression Europe Beyond Protein Expression Europe Protein Expression Host Novel Protein Expression Systems Protein Engineering Vectors Preventive gene quantification Europe QS Regulation Recombinant Antibodies Recombinant Antibodies Recombinant Proteins Forum Radiation Rare Diseases Antibody Drug Products RBE track at PGE RBE track at PGE Antibody Screening Antibody Translational rapid compound characterization Clinical Enrollment Plan Clinical Recruitment Media Clinical Trials Patient Recruitment Winning Strategies for Clinical Recruitment Media Integrating R&amp;D and Marketing R&amp;D Productivity drug receptors Role of Business Process Managment in FDA Regulated Industry Worldwide Pharma Regulation Surviving FDA Site Inspections Real Estate Risk Evaluation and Mitigation Strategies Renal (kidney) Renewable Energy Storage System RFID Radiofrequency ID Reagents Gap Analysis rheumatoid arthritis gene therapy [RNA blocking] Ribonucleic Acid RNAi for Functional Screening RNAi   RNAInterference RNAi Discovery on Target RNAi Video on Request RNA Quality RNA Therapeutics Robotics Regional Organization Robotic Process Automation reperfusion Reproduction Gene Regulation and Regulatory Networks Restenosis Retail Real World Data Therapeutics Indications &amp; Drug Targets Series safety Screening 3D Models Sickle Cell Anemia Screening Informatics Sequencing and Cloud Computing supply chain management SCOPEs Clinical Research Leadership Forum Phenotypic Screening Phenotypic Screening clinical trials strategy IT Security Sequence Data Analysis Sequence Data Analysis Asia Sidec Executive Forum Sequence Data Analysis Europe Sleeper Disease Indications Sequencing Data Storage &amp; Management Screening Difficult Targets Source Document Verification Sequencing Data Analysis &amp; Storage second messengers sepsis infections Sequencing Forum Serotonin Sexual Small Fuel Cells selective immune suppression skin sleep Pharmaceutical Sales Biologics Small Molecular Comparisons Semiconductors small molecules simple model organisms Small Molecules Synthesis Semantic Web Sensor Applications Synthetic Biology Sensor Data Management Implantable Biomedical Sensors Sensor Materials Sensors Emerging Markets SNPs Sensor Systems Sensor Safety software Solubility Safety Pharmacology for Biologics Safety Pharmacology for Biologics Genomic Sample Preparation Speciality Pharmaceuticals Alternative Splicing Proteomic Sample Preparation High throughput screening partnering solid phase synthesis Subjective End Points Next Generation Sequencing Applications Sequencing Core Labs Next-Generation Data Generation Plant Sequencing RNA Sequencing Sequencing Solutions Deep Sequencing EU Site Selection, Study Activation, and Patient Recruitment Stability stroke Stem Cell Culture Stem Cell Research (part of MMTC) Statin Stem Cells Safety Screening Startup Public companies/stock exchanges CHI Surveys Services Systems Biology for BYG track synthesis Systems Biology Training &amp; Development Top 50 Big Pharmas Tissue Microarrays taxol  tamoxifen and other derivatives Tuberculosis Tobacco The Biotech Journal Email List Trust Building for Collaborative Innovation Tumor, Circulating Cells Technology Technology Consortium Target Driven Chemistry targeted drug delivery transgenic disease models Thrombotic Disease tissue engineering telomerases Battery Testing Transfection Toxicogenomics Target Prioritization Target Identification tissues Technology Platforms Immunotherapies Telecommunications Telemedicine Tumor Microenvironment Trial Master File for Sponsors (pharma) Trial Master File for Research Sites Theranostic Market Models tumor necrosis factors Therapeutics and Targets Therapeutics &amp; Targets Series immune tolerance Fibrinolytic (clot buster) Transgenic Production in Plants Synthetic Biology Transportation Translational Biomarkers Translational Informatics Drug/Disease Targets Drug Targets Series Genome Tri Conference Translation Services transgenics gene knockouts transgenic production Tumor Suppressor Genes tissue safety Technology &amp; Tools for the Life Sciences Technology &amp; Tools for Life Sciences Series Target Validation Text Mining Unmanned Aerial Vehicles Ubiquitin Uninterruptible Power Supplies upcoming conferences upcoming conferences Europe Urinary Incontinence New USP Initiatives and Standards for Biologics unstable triplets trinucleotide repeats Vaccines (for IMT) Vascular Vaccines Business Opportunities Venture Capital Business Opportunities Vaccines Voice Recognition Paperless Validation veterinary viral infections Vaccines Production &amp; Manufacturing Virtual Reality virtual business Virtual Teams Single Use Systems for Vaccine Manufacture well characterized biologicals Wellness Wiki wound management Wireless Change Record Change Record Mary Chitty Xenotransplantation Yeast Display Zika Vaccine Development&#39;</span>

<span class="n">n</span> <span class="o">=</span> <span class="mi">2</span>
<span class="n">trigrams</span> <span class="o">=</span> <span class="n">ngrams</span><span class="p">(</span><span class="n">sentence</span><span class="o">.</span><span class="n">split</span><span class="p">(),</span> <span class="n">n</span><span class="p">)</span>

<span class="k">for</span> <span class="n">grams</span> <span class="ow">in</span> <span class="n">trigrams</span><span class="p">:</span>
  <span class="nb">print</span> <span class="p">(</span><span class="n">grams</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>(&#39;Molecular&#39;, &#39;Medicine&#39;)
(&#39;Medicine&#39;, &#39;Tri&#39;)
(&#39;Tri&#39;, &#39;Conference&#39;)
(&#39;Conference&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Engineering&#39;)
(&#39;Engineering&#39;, &#39;Peptalk&#39;)
(&#39;Peptalk&#39;, &#39;Biocomputing&#39;)
(&#39;Biocomputing&#39;, &#39;SCOPE&#39;)
(&#39;SCOPE&#39;, &#39;Summit&#39;)
(&#39;Summit&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;Operations&#39;)
(&#39;Operations&#39;, &#39;Executives&#39;)
(&#39;Executives&#39;, &#39;bioproduction&#39;)
(&#39;bioproduction&#39;, &#39;Discovery&#39;)
(&#39;Discovery&#39;, &#39;on&#39;)
(&#39;on&#39;, &#39;Target&#39;)
(&#39;Target&#39;, &#39;PEGS&#39;)
(&#39;PEGS&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Discovery&#39;)
(&#39;Discovery&#39;, &#39;Chemistry&#39;)
(&#39;Chemistry&#39;, &#39;World&#39;)
(&#39;World&#39;, &#39;Pharmaceutical&#39;)
(&#39;Pharmaceutical&#39;, &#39;Congress&#39;)
(&#39;Congress&#39;, &#39;advanced&#39;)
(&#39;advanced&#39;, &#39;diagnostics&#39;)
(&#39;diagnostics&#39;, &#39;Advanced&#39;)
(&#39;Advanced&#39;, &#39;Automotive&#39;)
(&#39;Automotive&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Conference&#39;)
(&#39;Conference&#39;, &#39;(AABC)&#39;)
(&#39;(AABC)&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Florida&#39;)
(&#39;Florida&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Conference&#39;)
(&#39;Conference&#39;, &#39;Biomarkers&#39;)
(&#39;Biomarkers&#39;, &#39;Congress&#39;)
(&#39;Congress&#39;, &#39;High&#39;)
(&#39;High&#39;, &#39;Content&#39;)
(&#39;Content&#39;, &#39;Analysis&#39;)
(&#39;Analysis&#39;, &#39;Advanced&#39;)
(&#39;Advanced&#39;, &#39;Automotive&#39;)
(&#39;Automotive&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Conference&#39;)
(&#39;Conference&#39;, &#39;(AABC)&#39;)
(&#39;(AABC)&#39;, &#39;Immunogenicity&#39;)
(&#39;Immunogenicity&#39;, &#39;CRA&#39;)
(&#39;CRA&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;CRC&#39;)
(&#39;CRC&#39;, &#39;Beginner&#39;)
(&#39;Beginner&#39;, &#39;Biopharmaceutical&#39;)
(&#39;Biopharmaceutical&#39;, &#39;Change&#39;)
(&#39;Change&#39;, &#39;Control&#39;)
(&#39;Control&#39;, &#39;Beyond&#39;)
(&#39;Beyond&#39;, &#39;Genome&#39;)
(&#39;Genome&#39;, &#39;Immunotherapy&#39;)
(&#39;Immunotherapy&#39;, &#39;Alliance&#39;)
(&#39;Alliance&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Strategies&#39;)
(&#39;Strategies&#39;, &#39;Targeted&#39;)
(&#39;Targeted&#39;, &#39;ImvacS&#39;)
(&#39;ImvacS&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;Molecular&#39;)
(&#39;Molecular&#39;, &#39;Medicine&#39;)
(&#39;Medicine&#39;, &#39;Marketplace&#39;)
(&#39;Marketplace&#39;, &#39;Molecular&#39;)
(&#39;Molecular&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;CRA&#39;)
(&#39;CRA&#39;, &#39;Beginner&#39;)
(&#39;Beginner&#39;, &#39;AI&#39;)
(&#39;AI&#39;, &#39;World&#39;)
(&#39;World&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Driven&#39;)
(&#39;Driven&#39;, &#39;Discovery&#39;)
(&#39;Discovery&#39;, &#39;R&amp;D&#39;)
(&#39;R&amp;D&#39;, &#39;Strategies&#39;)
(&#39;Strategies&#39;, &#39;Strategic&#39;)
(&#39;Strategic&#39;, &#39;Resource&#39;)
(&#39;Resource&#39;, &#39;Allocation&#39;)
(&#39;Allocation&#39;, &#39;kinases&#39;)
(&#39;kinases&#39;, &#39;Auditing&#39;)
(&#39;Auditing&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Studies&#39;)
(&#39;Studies&#39;, &#39;Accelerating&#39;)
(&#39;Accelerating&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Advancing&#39;)
(&#39;Advancing&#39;, &#39;Personalized&#39;)
(&#39;Personalized&#39;, &#39;Therapy&#39;)
(&#39;Therapy&#39;, &#39;X&#39;)
(&#39;X&#39;, &#39;Gen&#39;)
(&#39;Gen&#39;, &#39;Congress&#39;)
(&#39;Congress&#39;, &#39;Biodefense&#39;)
(&#39;Biodefense&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Enabling&#39;)
(&#39;Enabling&#39;, &#39;POC&#39;)
(&#39;POC&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Microarray&#39;)
(&#39;Microarray&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Analysis&#39;)
(&#39;Analysis&#39;, &#39;Human&#39;)
(&#39;Human&#39;, &#39;Genome&#39;)
(&#39;Genome&#39;, &#39;Project&#39;)
(&#39;Project&#39;, &#39;Biobanks&#39;)
(&#39;Biobanks&#39;, &#39;Structure&#39;)
(&#39;Structure&#39;, &#39;Based&#39;)
(&#39;Based&#39;, &#39;Design&#39;)
(&#39;Design&#39;, &#39;Batteries&#39;)
(&#39;Batteries&#39;, &#39;Portfolio&#39;)
(&#39;Portfolio&#39;, &#39;Quantitative&#39;)
(&#39;Quantitative&#39;, &#39;PCR&#39;)
(&#39;PCR&#39;, &#39;Health&#39;)
(&#39;Health&#39;, &#39;Information&#39;)
(&#39;Information&#39;, &#39;Technology&#39;)
(&#39;Technology&#39;, &#39;Auditing&#39;)
(&#39;Auditing&#39;, &#39;Techniques&#39;)
(&#39;Techniques&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Professionals&#39;)
(&#39;Professionals&#39;, &#39;Good&#39;)
(&#39;Good&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Practice&#39;)
(&#39;Practice&#39;, &#39;Question&#39;)
(&#39;Question&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Answer&#39;)
(&#39;Answer&#39;, &#39;REference&#39;)
(&#39;REference&#39;, &#39;Guide&#39;)
(&#39;Guide&#39;, &#39;CFR/ICH&#39;)
(&#39;CFR/ICH&#39;, &#39;GCP&#39;)
(&#39;GCP&#39;, &#39;Immunotherapy&#39;)
(&#39;Immunotherapy&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Gene&#39;)
(&#39;Gene&#39;, &#39;Amplification&#39;)
(&#39;Amplification&#39;, &#39;PCR&#39;)
(&#39;PCR&#39;, &#39;eStats:&#39;)
(&#39;eStats:&#39;, &#39;R&amp;D&#39;)
(&#39;R&amp;D&#39;, &#39;Statistical&#39;)
(&#39;Statistical&#39;, &#39;Sourcebook&#39;)
(&#39;Sourcebook&#39;, &#39;MicroRNA&#39;)
(&#39;MicroRNA&#39;, &#39;microarray&#39;)
(&#39;microarray&#39;, &#39;data&#39;)
(&#39;data&#39;, &#39;analysis&#39;)
(&#39;analysis&#39;, &#39;Intelliigent&#39;)
(&#39;Intelliigent&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Discovery&#39;)
(&#39;Discovery&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;(now&#39;)
(&#39;(now&#39;, &#39;WPC)&#39;)
(&#39;WPC)&#39;, &#39;Monitoring&#39;)
(&#39;Monitoring&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Studies:&#39;)
(&#39;Studies:&#39;, &#39;Beginner&#39;)
(&#39;Beginner&#39;, &#39;Comprehensive&#39;)
(&#39;Comprehensive&#39;, &#39;Monitoring&#39;)
(&#39;Monitoring&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Medical&#39;)
(&#39;Medical&#39;, &#39;Devices&#39;)
(&#39;Devices&#39;, &#39;Introduction&#39;)
(&#39;Introduction&#39;, &#39;to&#39;)
(&#39;to&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Project&#39;)
(&#39;Project&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Bioprocessing&#39;)
(&#39;Bioprocessing&#39;, &#39;Summit&#39;)
(&#39;Summit&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Oligonucleotide&#39;)
(&#39;Oligonucleotide&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Peptide&#39;)
(&#39;Peptide&#39;, &#39;Summit&#39;)
(&#39;Summit&#39;, &#39;World&#39;)
(&#39;World&#39;, &#39;Pharma&#39;)
(&#39;Pharma&#39;, &#39;Week&#39;)
(&#39;Week&#39;, &#39;Prenatal&#39;)
(&#39;Prenatal&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Getting&#39;)
(&#39;Getting&#39;, &#39;Optimized&#39;)
(&#39;Optimized&#39;, &#39;Targets&#39;)
(&#39;Targets&#39;, &#39;Library&#39;)
(&#39;Library&#39;, &#39;Design&#39;)
(&#39;Design&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Synthesis&#39;)
(&#39;Synthesis&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Project&#39;)
(&#39;Project&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;functional&#39;)
(&#39;functional&#39;, &#39;genomics&#39;)
(&#39;genomics&#39;, &#39;bacterial&#39;)
(&#39;bacterial&#39;, &#39;infections&#39;)
(&#39;infections&#39;, &#39;Advanced&#39;)
(&#39;Advanced&#39;, &#39;Automotive&#39;)
(&#39;Automotive&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Conference&#39;)
(&#39;Conference&#39;, &#39;(AABC)&#39;)
(&#39;(AABC)&#39;, &#39;Asia&#39;)
(&#39;Asia&#39;, &#39;Good&#39;)
(&#39;Good&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Practice&#39;)
(&#39;Practice&#39;, &#39;Q&amp;A&#39;)
(&#39;Q&amp;A&#39;, &#39;Reference&#39;)
(&#39;Reference&#39;, &#39;Guide&#39;)
(&#39;Guide&#39;, &#39;Screening&#39;)
(&#39;Screening&#39;, &#39;Transmissible&#39;)
(&#39;Transmissible&#39;, &#39;spongiform&#39;)
(&#39;spongiform&#39;, &#39;encephalopathy&#39;)
(&#39;encephalopathy&#39;, &#39;TSE&#39;)
(&#39;TSE&#39;, &#39;Biomarker&#39;)
(&#39;Biomarker&#39;, &#39;Discovery&#39;)
(&#39;Discovery&#39;, &#39;Summit&#39;)
(&#39;Summit&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Genomics&#39;)
(&#39;Genomics&#39;, &#39;Sequencing&#39;)
(&#39;Sequencing&#39;, &#39;ASAP&#39;)
(&#39;ASAP&#39;, &#39;Alliance&#39;)
(&#39;Alliance&#39;, &#39;Summit&#39;)
(&#39;Summit&#39;, &#39;Bioterrorism&#39;)
(&#39;Bioterrorism&#39;, &#39;microarrays&#39;)
(&#39;microarrays&#39;, &#39;Pharmaceutical&#39;)
(&#39;Pharmaceutical&#39;, &#39;Leadership&#39;)
(&#39;Leadership&#39;, &#39;Summit&#39;)
(&#39;Summit&#39;, &#39;Circulating&#39;)
(&#39;Circulating&#39;, &#39;Cell-Free&#39;)
(&#39;Cell-Free&#39;, &#39;DNA&#39;)
(&#39;DNA&#39;, &#39;Conducting&#39;)
(&#39;Conducting&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;Under&#39;)
(&#39;Under&#39;, &#39;ICH&#39;)
(&#39;ICH&#39;, &#39;GCP&#39;)
(&#39;GCP&#39;, &#39;Bio&#39;)
(&#39;Bio&#39;, &#39;IT&#39;)
(&#39;IT&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Trial&#39;)
(&#39;Trial&#39;, &#39;Master&#39;)
(&#39;Master&#39;, &#39;File&#39;)
(&#39;File&#39;, &#39;Biomarkers&#39;)
(&#39;Biomarkers&#39;, &#39;World&#39;)
(&#39;World&#39;, &#39;Preclinical&#39;)
(&#39;Preclinical&#39;, &#39;Congress&#39;)
(&#39;Congress&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;BioMEMS&#39;)
(&#39;BioMEMS&#39;, &#39;bioinformatics&#39;)
(&#39;bioinformatics&#39;, &#39;Genomic&#39;)
(&#39;Genomic&#39;, &#39;Partnering&#39;)
(&#39;Partnering&#39;, &#39;NMR&#39;)
(&#39;NMR&#39;, &#39;nuclear&#39;)
(&#39;nuclear&#39;, &#39;magnetic&#39;)
(&#39;magnetic&#39;, &#39;resonance&#39;)
(&#39;resonance&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Biomarker&#39;)
(&#39;Biomarker&#39;, &#39;Validation&#39;)
(&#39;Validation&#39;, &#39;proteomics&#39;)
(&#39;proteomics&#39;, &#39;Statistics&#39;)
(&#39;Statistics&#39;, &#39;Sensors&#39;)
(&#39;Sensors&#39;, &#39;Global&#39;)
(&#39;Global&#39;, &#39;Summit&#39;)
(&#39;Summit&#39;, &#39;New&#39;)
(&#39;New&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;A&#39;)
(&#39;A&#39;, &#39;Regulatory&#39;)
(&#39;Regulatory&#39;, &#39;Overview&#39;)
(&#39;Overview&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Safety&#39;)
(&#39;Safety&#39;, &#39;Pharmacy&#39;)
(&#39;Pharmacy&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;sample&#39;)
(&#39;sample&#39;, &#39;preparation&#39;)
(&#39;preparation&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trial&#39;)
(&#39;Trial&#39;, &#39;Design&#39;)
(&#39;Design&#39;, &#39;Pharmacovigilance&#39;)
(&#39;Pharmacovigilance&#39;, &#39;Metabolic&#39;)
(&#39;Metabolic&#39;, &#39;Profiling&#39;)
(&#39;Profiling&#39;, &#39;Digital&#39;)
(&#39;Digital&#39;, &#39;PCR&#39;)
(&#39;PCR&#39;, &#39;Good&#39;)
(&#39;Good&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Practice&#39;)
(&#39;Practice&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;Lab&#39;)
(&#39;Lab&#39;, &#39;chips&#39;)
(&#39;chips&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Monitoring&#39;)
(&#39;Monitoring&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Studies:&#39;)
(&#39;Studies:&#39;, &#39;Intermediate&#39;)
(&#39;Intermediate&#39;, &#39;Preparing&#39;)
(&#39;Preparing&#39;, &#39;IND&#39;)
(&#39;IND&#39;, &#39;Submissions&#39;)
(&#39;Submissions&#39;, &#39;Antibody&#39;)
(&#39;Antibody&#39;, &#39;Engineering&#39;)
(&#39;Engineering&#39;, &#39;Asia&#39;)
(&#39;Asia&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Project&#39;)
(&#39;Project&#39;, &#39;Management:&#39;)
(&#39;Management:&#39;, &#39;Intermediate&#39;)
(&#39;Intermediate&#39;, &#39;phage&#39;)
(&#39;phage&#39;, &#39;display&#39;)
(&#39;display&#39;, &#39;CELLutions&#39;)
(&#39;CELLutions&#39;, &#39;Recombinant&#39;)
(&#39;Recombinant&#39;, &#39;Antibodies&#39;)
(&#39;Antibodies&#39;, &#39;imaging&#39;)
(&#39;imaging&#39;, &#39;Biomarker&#39;)
(&#39;Biomarker&#39;, &#39;Assay&#39;)
(&#39;Assay&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;silico&#39;)
(&#39;silico&#39;, &#39;biology&#39;)
(&#39;biology&#39;, &#39;Advanced&#39;)
(&#39;Advanced&#39;, &#39;Good&#39;)
(&#39;Good&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Practice&#39;)
(&#39;Practice&#39;, &#39;High&#39;)
(&#39;High&#39;, &#39;Throughput&#39;)
(&#39;Throughput&#39;, &#39;Optimization&#39;)
(&#39;Optimization&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Culture&#39;)
(&#39;Culture&#39;, &#39;Conditions&#39;)
(&#39;Conditions&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Bioprocessing&#39;)
(&#39;Bioprocessing&#39;, &#39;High&#39;)
(&#39;High&#39;, &#39;Throughput&#39;)
(&#39;Throughput&#39;, &#39;Technologies&#39;)
(&#39;Technologies&#39;, &#39;gene&#39;)
(&#39;gene&#39;, &#39;quantfication&#39;)
(&#39;quantfication&#39;, &#39;[real&#39;)
(&#39;[real&#39;, &#39;time&#39;)
(&#39;time&#39;, &#39;PCR]&#39;)
(&#39;PCR]&#39;, &#39;From&#39;)
(&#39;From&#39;, &#39;Gene&#39;)
(&#39;Gene&#39;, &#39;Expression&#39;)
(&#39;Expression&#39;, &#39;Profiling&#39;)
(&#39;Profiling&#39;, &#39;to&#39;)
(&#39;to&#39;, &#39;Validated&#39;)
(&#39;Validated&#39;, &#39;Biology&#39;)
(&#39;Biology&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Project&#39;)
(&#39;Project&#39;, &#39;Management:&#39;)
(&#39;Management:&#39;, &#39;Advanced&#39;)
(&#39;Advanced&#39;, &#39;SCOPE&#39;)
(&#39;SCOPE&#39;, &#39;Summit&#39;)
(&#39;Summit&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;CNS&#39;)
(&#39;CNS&#39;, &#39;Partnering&#39;)
(&#39;Partnering&#39;, &#39;Genomics&#39;)
(&#39;Genomics&#39;, &#39;on&#39;)
(&#39;on&#39;, &#39;Target&#39;)
(&#39;Target&#39;, &#39;R&amp;D&#39;)
(&#39;R&amp;D&#39;, &#39;Statistical&#39;)
(&#39;Statistical&#39;, &#39;Sourcebook&#39;)
(&#39;Sourcebook&#39;, &#39;MultiUser&#39;)
(&#39;MultiUser&#39;, &#39;License&#39;)
(&#39;License&#39;, &#39;Medical&#39;)
(&#39;Medical&#39;, &#39;Device&#39;)
(&#39;Device&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;Biological&#39;)
(&#39;Biological&#39;, &#39;ADME&#39;)
(&#39;ADME&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Expression&#39;)
(&#39;Expression&#39;, &#39;blood&#39;)
(&#39;blood&#39;, &#39;safety&#39;)
(&#39;safety&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;screening&#39;)
(&#39;screening&#39;, &#39;Human&#39;)
(&#39;Human&#39;, &#39;Proteome&#39;)
(&#39;Proteome&#39;, &#39;Project&#39;)
(&#39;Project&#39;, &#39;Project&#39;)
(&#39;Project&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;high&#39;)
(&#39;high&#39;, &#39;throughput&#39;)
(&#39;throughput&#39;, &#39;organic&#39;)
(&#39;organic&#39;, &#39;synthesis&#39;)
(&#39;synthesis&#39;, &#39;Global&#39;)
(&#39;Global&#39;, &#39;Preclinical&#39;)
(&#39;Preclinical&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Coordinator&#39;)
(&#39;Coordinator&#39;, &#39;Global&#39;)
(&#39;Global&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;India&#39;)
(&#39;India&#39;, &#39;Biomarker&#39;)
(&#39;Biomarker&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;molecular&#39;)
(&#39;molecular&#39;, &#39;diversity&#39;)
(&#39;diversity&#39;, &#39;functional&#39;)
(&#39;functional&#39;, &#39;genomics&#39;)
(&#39;genomics&#39;, &#39;Process&#39;)
(&#39;Process&#39;, &#39;R&amp;D&#39;)
(&#39;R&amp;D&#39;, &#39;Summit&#39;)
(&#39;Summit&#39;, &#39;Cloud&#39;)
(&#39;Cloud&#39;, &#39;Computing&#39;)
(&#39;Computing&#39;, &#39;bioinformatics&#39;)
(&#39;bioinformatics&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Target&#39;)
(&#39;Target&#39;, &#39;Validation&#39;)
(&#39;Validation&#39;, &#39;Bispecific&#39;)
(&#39;Bispecific&#39;, &#39;Antibodies&#39;)
(&#39;Antibodies&#39;, &#39;Bridging&#39;)
(&#39;Bridging&#39;, &#39;Pharma&#39;)
(&#39;Pharma&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;IT&#39;)
(&#39;IT&#39;, &#39;Green&#39;)
(&#39;Green&#39;, &#39;Fluorescent&#39;)
(&#39;Fluorescent&#39;, &#39;Proteins&#39;)
(&#39;Proteins&#39;, &#39;Quality&#39;)
(&#39;Quality&#39;, &#39;Systems&#39;)
(&#39;Systems&#39;, &#39;CRA&#39;)
(&#39;CRA&#39;, &#39;Monitoring&#39;)
(&#39;Monitoring&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Discovery&#39;)
(&#39;Discovery&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;AI&#39;)
(&#39;AI&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;Government&#39;)
(&#39;Government&#39;, &#39;glycotechnology&#39;)
(&#39;glycotechnology&#39;, &#39;Baculovirus&#39;)
(&#39;Baculovirus&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Repurposing&#39;)
(&#39;Repurposing&#39;, &#39;drug&#39;)
(&#39;drug&#39;, &#39;discovery&#39;)
(&#39;discovery&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;development&#39;)
(&#39;development&#39;, &#39;Japan&#39;)
(&#39;Japan&#39;, &#39;The&#39;)
(&#39;The&#39;, &#39;CRA&#39;)
(&#39;CRA&#39;, &#39;Manager&#39;)
(&#39;Manager&#39;, &#39;Course&#39;)
(&#39;Course&#39;, &#39;State&#39;)
(&#39;State&#39;, &#39;by&#39;)
(&#39;by&#39;, &#39;State&#39;)
(&#39;State&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trial&#39;)
(&#39;Trial&#39;, &#39;Requirments&#39;)
(&#39;Requirments&#39;, &#39;Reference&#39;)
(&#39;Reference&#39;, &#39;Guide&#39;)
(&#39;Guide&#39;, &#39;Adverse&#39;)
(&#39;Adverse&#39;, &#39;Events:&#39;)
(&#39;Events:&#39;, &#39;Managing&#39;)
(&#39;Managing&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Reporting&#39;)
(&#39;Reporting&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Medical&#39;)
(&#39;Medical&#39;, &#39;Devices&#39;)
(&#39;Devices&#39;, &#39;Good&#39;)
(&#39;Good&#39;, &#39;Laboratory&#39;)
(&#39;Laboratory&#39;, &#39;Practice&#39;)
(&#39;Practice&#39;, &#39;Process&#39;)
(&#39;Process&#39;, &#39;Chemistry&#39;)
(&#39;Chemistry&#39;, &#39;Beyond&#39;)
(&#39;Beyond&#39;, &#39;Sequencing&#39;)
(&#39;Sequencing&#39;, &#39;Process&#39;)
(&#39;Process&#39;, &#39;R&amp;D&#39;)
(&#39;R&amp;D&#39;, &#39;Summit&#39;)
(&#39;Summit&#39;, &#39;with&#39;)
(&#39;with&#39;, &#39;GLP&#39;)
(&#39;GLP&#39;, &#39;Batteries&#39;)
(&#39;Batteries&#39;, &#39;Biomarkers&#39;)
(&#39;Biomarkers&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;IT&#39;)
(&#39;IT&#39;, &#39;Infrastructure&#39;)
(&#39;Infrastructure&#39;, &#39;computer&#39;)
(&#39;computer&#39;, &#39;hardware&#39;)
(&#39;hardware&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;patient&#39;)
(&#39;patient&#39;, &#39;Recruitment&#39;)
(&#39;Recruitment&#39;, &#39;Working&#39;)
(&#39;Working&#39;, &#39;with&#39;)
(&#39;with&#39;, &#39;CROs&#39;)
(&#39;CROs&#39;, &#39;Expediting&#39;)
(&#39;Expediting&#39;, &#39;Drugs&#39;)
(&#39;Drugs&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Biologics&#39;)
(&#39;Biologics&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;Tissue&#39;)
(&#39;Tissue&#39;, &#39;Sealants&#39;)
(&#39;Sealants&#39;, &#39;-&#39;)
(&#39;-&#39;, &#39;One&#39;)
(&#39;One&#39;, &#39;Day&#39;)
(&#39;Day&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Expression&#39;)
(&#39;Expression&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Use&#39;)
(&#39;Use&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Note&#39;)
(&#39;Note&#39;, &#39;to&#39;)
(&#39;to&#39;, &#39;Files&#39;)
(&#39;Files&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trial&#39;)
(&#39;Trial&#39;, &#39;Essential&#39;)
(&#39;Essential&#39;, &#39;Documentation&#39;)
(&#39;Documentation&#39;, &#39;Antibody&#39;)
(&#39;Antibody&#39;, &#39;Engineering&#39;)
(&#39;Engineering&#39;, &#39;Korea&#39;)
(&#39;Korea&#39;, &#39;RNAi&#39;)
(&#39;RNAi&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Pathway&#39;)
(&#39;Pathway&#39;, &#39;Analysis&#39;)
(&#39;Analysis&#39;, &#39;Advanced&#39;)
(&#39;Advanced&#39;, &#39;GCP&#39;)
(&#39;GCP&#39;, &#39;Compliance&#39;)
(&#39;Compliance&#39;, &#39;Mechanisms&#39;)
(&#39;Mechanisms&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Business&#39;)
(&#39;Business&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;(Impact&#39;)
(&#39;(Impact&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;New&#39;)
(&#39;New&#39;, &#39;Diagnotics)&#39;)
(&#39;Diagnotics)&#39;, &#39;Consumer&#39;)
(&#39;Consumer&#39;, &#39;Genomics&#39;)
(&#39;Genomics&#39;, &#39;Conference&#39;)
(&#39;Conference&#39;, &#39;Recombinant&#39;)
(&#39;Recombinant&#39;, &#39;Antibodies&#39;)
(&#39;Antibodies&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Site&#39;)
(&#39;Site&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Study&#39;)
(&#39;Study&#39;, &#39;Budgets&#39;)
(&#39;Budgets&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Contracts&#39;)
(&#39;Contracts&#39;, &#39;Proof&#39;)
(&#39;Proof&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Concept&#39;)
(&#39;Concept&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;China&#39;)
(&#39;China&#39;, &#39;Future&#39;)
(&#39;Future&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Medicinal&#39;)
(&#39;Medicinal&#39;, &#39;Chemistry&#39;)
(&#39;Chemistry&#39;, &#39;Combination&#39;)
(&#39;Combination&#39;, &#39;Therapies&#39;)
(&#39;Therapies&#39;, &#39;CRA&#39;)
(&#39;CRA&#39;, &#39;Training&#39;)
(&#39;Training&#39;, &#39;Series&#39;)
(&#39;Series&#39;, &#39;(1-7)&#39;)
(&#39;(1-7)&#39;, &#39;Lab&#39;)
(&#39;Lab&#39;, &#39;Chips&#39;)
(&#39;Chips&#39;, &#39;Japan&#39;)
(&#39;Japan&#39;, &#39;Human&#39;)
(&#39;Human&#39;, &#39;Genomes&#39;)
(&#39;Genomes&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Tissue&#39;)
(&#39;Tissue&#39;, &#39;Based&#39;)
(&#39;Based&#39;, &#39;Screening&#39;)
(&#39;Screening&#39;, &#39;lead&#39;)
(&#39;lead&#39;, &#39;optimization&#39;)
(&#39;optimization&#39;, &#39;Adverse&#39;)
(&#39;Adverse&#39;, &#39;Events&#39;)
(&#39;Events&#39;, &#39;Reimbursement&#39;)
(&#39;Reimbursement&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;labels&#39;)
(&#39;labels&#39;, &#39;signals&#39;)
(&#39;signals&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;detection&#39;)
(&#39;detection&#39;, &#39;ASAP&#39;)
(&#39;ASAP&#39;, &#39;CHI&#39;)
(&#39;CHI&#39;, &#39;Bio&#39;)
(&#39;Bio&#39;, &#39;Pharm&#39;)
(&#39;Pharm&#39;, &#39;Alliance&#39;)
(&#39;Alliance&#39;, &#39;Summit&#39;)
(&#39;Summit&#39;, &#39;forensic&#39;)
(&#39;forensic&#39;, &#39;diagnostics&#39;)
(&#39;diagnostics&#39;, &#39;Writing&#39;)
(&#39;Writing&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Molecular&#39;)
(&#39;Molecular&#39;, &#39;Profiling&#39;)
(&#39;Profiling&#39;, &#39;with&#39;)
(&#39;with&#39;, &#39;Cellular&#39;)
(&#39;Cellular&#39;, &#39;Resolution&#39;)
(&#39;Resolution&#39;, &#39;10&#39;)
(&#39;10&#39;, &#39;Rules&#39;)
(&#39;Rules&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Effective&#39;)
(&#39;Effective&#39;, &#39;Report&#39;)
(&#39;Report&#39;, &#39;Writing&#39;)
(&#39;Writing&#39;, &#39;pharmacogenomics&#39;)
(&#39;pharmacogenomics&#39;, &#39;europe&#39;)
(&#39;europe&#39;, &#39;Exploring&#39;)
(&#39;Exploring&#39;, &#39;Next&#39;)
(&#39;Next&#39;, &#39;Generation&#39;)
(&#39;Generation&#39;, &#39;Sequencing&#39;)
(&#39;Sequencing&#39;, &#39;conference&#39;)
(&#39;conference&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;FDA&#39;)
(&#39;FDA&#39;, &#39;Regulations&#39;)
(&#39;Regulations&#39;, &#39;HCA&#39;)
(&#39;HCA&#39;, &#39;East&#39;)
(&#39;East&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Immunotherapies&#39;)
(&#39;Immunotherapies&#39;, &#39;(formerly&#39;)
(&#39;(formerly&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Vaccines)&#39;)
(&#39;Vaccines)&#39;, &#39;Biologics&#39;)
(&#39;Biologics&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;A&#39;)
(&#39;A&#39;, &#39;Regulatory&#39;)
(&#39;Regulatory&#39;, &#39;Overview&#39;)
(&#39;Overview&#39;, &#39;Standard&#39;)
(&#39;Standard&#39;, &#39;Operating&#39;)
(&#39;Operating&#39;, &#39;Proces&#39;)
(&#39;Proces&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;molecular&#39;)
(&#39;molecular&#39;, &#39;pharmacology&#39;)
(&#39;pharmacology&#39;, &#39;RNA&#39;)
(&#39;RNA&#39;, &#39;Interference&#39;)
(&#39;Interference&#39;, &#39;Summit&#39;)
(&#39;Summit&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Training&#39;)
(&#39;Training&#39;, &#39;oligonucleotides&#39;)
(&#39;oligonucleotides&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trial&#39;)
(&#39;Trial&#39;, &#39;Protocols&#39;)
(&#39;Protocols&#39;, &#39;toxicology&#39;)
(&#39;toxicology&#39;, &#39;Immunogenicity&#39;)
(&#39;Immunogenicity&#39;, &#39;Testing&#39;)
(&#39;Testing&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Biologics&#39;)
(&#39;Biologics&#39;, &#39;Adaptive&#39;)
(&#39;Adaptive&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;ADME&#39;)
(&#39;ADME&#39;, &#39;Stem&#39;)
(&#39;Stem&#39;, &#39;Cells&#39;)
(&#39;Cells&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Discovery&#39;)
(&#39;Discovery&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Pipeline&#39;)
(&#39;Pipeline&#39;, &#39;Success&#39;)
(&#39;Success&#39;, &#39;(Pipeline&#39;)
(&#39;(Pipeline&#39;, &#39;Success&#39;)
(&#39;Success&#39;, &#39;Summit)&#39;)
(&#39;Summit)&#39;, &#39;stem&#39;)
(&#39;stem&#39;, &#39;cells&#39;)
(&#39;cells&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Visualization&#39;)
(&#39;Visualization&#39;, &#39;Pharmacokinetics&#39;)
(&#39;Pharmacokinetics&#39;, &#39;transgenic&#39;)
(&#39;transgenic&#39;, &#39;animal&#39;)
(&#39;animal&#39;, &#39;models&#39;)
(&#39;models&#39;, &#39;Business&#39;)
(&#39;Business&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;Alliance&#39;)
(&#39;Alliance&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Interface&#39;)
(&#39;Interface&#39;, &#39;Monitoring&#39;)
(&#39;Monitoring&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Studies:&#39;)
(&#39;Studies:&#39;, &#39;Advanced&#39;)
(&#39;Advanced&#39;, &#39;Digital&#39;)
(&#39;Digital&#39;, &#39;Health&#39;)
(&#39;Health&#39;, &#39;Innovation&#39;)
(&#39;Innovation&#39;, &#39;Summit&#39;)
(&#39;Summit&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;the&#39;)
(&#39;the&#39;, &#39;Electronic&#39;)
(&#39;Electronic&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Capture&#39;)
(&#39;Capture&#39;, &#39;Arena&#39;)
(&#39;Arena&#39;, &#39;Case&#39;)
(&#39;Case&#39;, &#39;Report&#39;)
(&#39;Report&#39;, &#39;Forms&#39;)
(&#39;Forms&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Safety&#39;)
(&#39;Safety&#39;, &#39;Medical&#39;)
(&#39;Medical&#39;, &#39;Devices&#39;)
(&#39;Devices&#39;, &#39;GCP&#39;)
(&#39;GCP&#39;, &#39;Overview&#39;)
(&#39;Overview&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Administrative&#39;)
(&#39;Administrative&#39;, &#39;Support&#39;)
(&#39;Support&#39;, &#39;Staff&#39;)
(&#39;Staff&#39;, &#39;Alliance&#39;)
(&#39;Alliance&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Project&#39;)
(&#39;Project&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Pre-Implantation&#39;)
(&#39;Pre-Implantation&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Eyesight&#39;)
(&#39;Eyesight&#39;, &#39;Biomarker&#39;)
(&#39;Biomarker&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Biomarker&#39;)
(&#39;Biomarker&#39;, &#39;Web&#39;)
(&#39;Web&#39;, &#39;Symposia&#39;)
(&#39;Symposia&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Approval&#39;)
(&#39;Approval&#39;, &#39;Process&#39;)
(&#39;Process&#39;, &#39;Neglected&#39;)
(&#39;Neglected&#39;, &#39;Diseases&#39;)
(&#39;Diseases&#39;, &#39;Molecular&#39;)
(&#39;Molecular&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Medical&#39;)
(&#39;Medical&#39;, &#39;Device&#39;)
(&#39;Device&#39;, &#39;Approval&#39;)
(&#39;Approval&#39;, &#39;Process&#39;)
(&#39;Process&#39;, &#39;Code&#39;)
(&#39;Code&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Federal&#39;)
(&#39;Federal&#39;, &#39;Regulations&#39;)
(&#39;Regulations&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Medical&#39;)
(&#39;Medical&#39;, &#39;Devices&#39;)
(&#39;Devices&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Associate&#39;)
(&#39;Associate&#39;, &#39;G&#39;)
(&#39;G&#39;, &#39;protein&#39;)
(&#39;protein&#39;, &#39;coupled&#39;)
(&#39;coupled&#39;, &#39;receptors&#39;)
(&#39;receptors&#39;, &#39;GPCRS&#39;)
(&#39;GPCRS&#39;, &#39;Prenatal&#39;)
(&#39;Prenatal&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Genomic&#39;)
(&#39;Genomic&#39;, &#39;Tools&#39;)
(&#39;Tools&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Technologies&#39;)
(&#39;Technologies&#39;, &#39;Biomarkers&#39;)
(&#39;Biomarkers&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Symyx&#39;)
(&#39;Symyx&#39;, &#39;Business&#39;)
(&#39;Business&#39;, &#39;Collaborative&#39;)
(&#39;Collaborative&#39;, &#39;Innovation&#39;)
(&#39;Innovation&#39;, &#39;Source&#39;)
(&#39;Source&#39;, &#39;Documentation&#39;)
(&#39;Documentation&#39;, &#39;Mitochondria&#39;)
(&#39;Mitochondria&#39;, &#39;Comparative&#39;)
(&#39;Comparative&#39;, &#39;Genomic&#39;)
(&#39;Genomic&#39;, &#39;Hybridization&#39;)
(&#39;Hybridization&#39;, &#39;Lithium&#39;)
(&#39;Lithium&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Power&#39;)
(&#39;Power&#39;, &#39;Writing&#39;)
(&#39;Writing&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Study&#39;)
(&#39;Study&#39;, &#39;Protocols&#39;)
(&#39;Protocols&#39;, &#39;Reimbursement&#39;)
(&#39;Reimbursement&#39;, &#39;Therapeutics&#39;)
(&#39;Therapeutics&#39;, &#39;genetic&#39;)
(&#39;genetic&#39;, &#39;variations&#39;)
(&#39;variations&#39;, &#39;Business&#39;)
(&#39;Business&#39;, &#39;Investigator&#39;)
(&#39;Investigator&#39;, &#39;initiated&#39;)
(&#39;initiated&#39;, &#39;trials&#39;)
(&#39;trials&#39;, &#39;Burrill&#39;)
(&#39;Burrill&#39;, &#39;Book&#39;)
(&#39;Book&#39;, &#39;Bio-IT&#39;)
(&#39;Bio-IT&#39;, &#39;Asia&#39;)
(&#39;Asia&#39;, &#39;Compound&#39;)
(&#39;Compound&#39;, &#39;Profiling&#39;)
(&#39;Profiling&#39;, &#39;cancer&#39;)
(&#39;cancer&#39;, &#39;clinical&#39;)
(&#39;clinical&#39;, &#39;trials&#39;)
(&#39;trials&#39;, &#39;Chemical&#39;)
(&#39;Chemical&#39;, &#39;Genomics&#39;)
(&#39;Genomics&#39;, &#39;Safety/Toxicity&#39;)
(&#39;Safety/Toxicity&#39;, &#39;Biomarkers&#39;)
(&#39;Biomarkers&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Diagnosis&#39;)
(&#39;Diagnosis&#39;, &#39;antibody&#39;)
(&#39;antibody&#39;, &#39;engineering&#39;)
(&#39;engineering&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;Asia&#39;)
(&#39;Asia&#39;, &#39;West&#39;)
(&#39;West&#39;, &#39;Coast&#39;)
(&#39;Coast&#39;, &#39;Virtual&#39;)
(&#39;Virtual&#39;, &#39;Screening&#39;)
(&#39;Screening&#39;, &#39;Point&#39;)
(&#39;Point&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Care&#39;)
(&#39;Care&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Formulation&#39;)
(&#39;Formulation&#39;, &#39;genetic&#39;)
(&#39;genetic&#39;, &#39;diagnostics&#39;)
(&#39;diagnostics&#39;, &#39;Bridging&#39;)
(&#39;Bridging&#39;, &#39;Discovery&#39;)
(&#39;Discovery&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;IT&#39;)
(&#39;IT&#39;, &#39;Biofuels&#39;)
(&#39;Biofuels&#39;, &#39;Translational&#39;)
(&#39;Translational&#39;, &#39;Medicine&#39;)
(&#39;Medicine&#39;, &#39;Personalized&#39;)
(&#39;Personalized&#39;, &#39;Medicine&#39;)
(&#39;Medicine&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Organization&#39;)
(&#39;Organization&#39;, &#39;Alliance&#39;)
(&#39;Alliance&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Congress&#39;)
(&#39;Congress&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;New&#39;)
(&#39;New&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Approval&#39;)
(&#39;Approval&#39;, &#39;Risk&#39;)
(&#39;Risk&#39;, &#39;Based&#39;)
(&#39;Based&#39;, &#39;Site&#39;)
(&#39;Site&#39;, &#39;Monitoring&#39;)
(&#39;Monitoring&#39;, &#39;Root&#39;)
(&#39;Root&#39;, &#39;Cause&#39;)
(&#39;Cause&#39;, &#39;Analysis&#39;)
(&#39;Analysis&#39;, &#39;Monitoring&#39;)
(&#39;Monitoring&#39;, &#39;Phase&#39;)
(&#39;Phase&#39;, &#39;I&#39;)
(&#39;I&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;Latin&#39;)
(&#39;Latin&#39;, &#39;America&#39;)
(&#39;America&#39;, &#39;Licensing&#39;)
(&#39;Licensing&#39;, &#39;vaccines&#39;)
(&#39;vaccines&#39;, &#39;cancer&#39;)
(&#39;cancer&#39;, &#39;genetics&#39;)
(&#39;genetics&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;genomics&#39;)
(&#39;genomics&#39;, &#39;Marketing&#39;)
(&#39;Marketing&#39;, &#39;Reimbursement&#39;)
(&#39;Reimbursement&#39;, &#39;Metabolic&#39;)
(&#39;Metabolic&#39;, &#39;Analytical&#39;)
(&#39;Analytical&#39;, &#39;Methods&#39;)
(&#39;Methods&#39;, &#39;Difficult&#39;)
(&#39;Difficult&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Sites&#39;)
(&#39;Sites&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Chips/Arrays&#39;)
(&#39;Chips/Arrays&#39;, &#39;Monitoring&#39;)
(&#39;Monitoring&#39;, &#39;Plan&#39;)
(&#39;Plan&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;Genome&#39;)
(&#39;Genome&#39;, &#39;Japan&#39;)
(&#39;Japan&#39;, &#39;Immunogenicity&#39;)
(&#39;Immunogenicity&#39;, &#39;Advances&#39;)
(&#39;Advances&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Reduction&#39;)
(&#39;Reduction&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Auditing&#39;)
(&#39;Auditing&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Informatics&#39;)
(&#39;Informatics&#39;, &#39;Antibody-Drug&#39;)
(&#39;Antibody-Drug&#39;, &#39;Conjugates&#39;)
(&#39;Conjugates&#39;, &#39;Electronic&#39;)
(&#39;Electronic&#39;, &#39;Medical&#39;)
(&#39;Medical&#39;, &#39;Records&#39;)
(&#39;Records&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Source&#39;)
(&#39;Source&#39;, &#39;Document&#39;)
(&#39;Document&#39;, &#39;Verification&#39;)
(&#39;Verification&#39;, &#39;Bridge&#39;)
(&#39;Bridge&#39;, &#39;to&#39;)
(&#39;to&#39;, &#39;Pop&#39;)
(&#39;Pop&#39;, &#39;Health&#39;)
(&#39;Health&#39;, &#39;East&#39;)
(&#39;East&#39;, &#39;Informed&#39;)
(&#39;Informed&#39;, &#39;Consent&#39;)
(&#39;Consent&#39;, &#39;Pharma&#39;)
(&#39;Pharma&#39;, &#39;Future&#39;)
(&#39;Future&#39;, &#39;Microarray&#39;)
(&#39;Microarray&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Analysis&#39;)
(&#39;Analysis&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Investigator&#39;)
(&#39;Investigator&#39;, &#39;Site&#39;)
(&#39;Site&#39;, &#39;Inspections&#39;)
(&#39;Inspections&#39;, &#39;Global&#39;)
(&#39;Global&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;Protocol&#39;)
(&#39;Protocol&#39;, &#39;Deviations&#39;)
(&#39;Deviations&#39;, &#39;Immunotherapy&#39;)
(&#39;Immunotherapy&#39;, &#39;West&#39;)
(&#39;West&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Therapies&#39;)
(&#39;Therapies&#39;, &#39;Recognize&#39;)
(&#39;Recognize&#39;, &#39;Attrition&#39;)
(&#39;Attrition&#39;, &#39;Earlier&#39;)
(&#39;Earlier&#39;, &#39;Electronic&#39;)
(&#39;Electronic&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Capture&#39;)
(&#39;Capture&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Imaging&#39;)
(&#39;Imaging&#39;, &#39;Physical&#39;)
(&#39;Physical&#39;, &#39;Chemistry&#39;)
(&#39;Chemistry&#39;, &#39;Toll&#39;)
(&#39;Toll&#39;, &#39;Like&#39;)
(&#39;Like&#39;, &#39;Receptors&#39;)
(&#39;Receptors&#39;, &#39;monoclonal&#39;)
(&#39;monoclonal&#39;, &#39;antibodies&#39;)
(&#39;antibodies&#39;, &#39;Innate&#39;)
(&#39;Innate&#39;, &#39;Immunity&#39;)
(&#39;Immunity&#39;, &#39;High&#39;)
(&#39;High&#39;, &#39;Content&#39;)
(&#39;Content&#39;, &#39;Analysis&#39;)
(&#39;Analysis&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Negotiation&#39;)
(&#39;Negotiation&#39;, &#39;Skills&#39;)
(&#39;Skills&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Professionals&#39;)
(&#39;Professionals&#39;, &#39;Biotech&#39;)
(&#39;Biotech&#39;, &#39;Executive&#39;)
(&#39;Executive&#39;, &#39;Forum&#39;)
(&#39;Forum&#39;, &#39;CNP&#39;)
(&#39;CNP&#39;, &#39;Partnering&#39;)
(&#39;Partnering&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;nanotechnology&#39;)
(&#39;nanotechnology&#39;, &#39;Risk&#39;)
(&#39;Risk&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Medical&#39;)
(&#39;Medical&#39;, &#39;Devices&#39;)
(&#39;Devices&#39;, &#39;Adverse&#39;)
(&#39;Adverse&#39;, &#39;Event&#39;)
(&#39;Event&#39;, &#39;Monitoring&#39;)
(&#39;Monitoring&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;CRAs&#39;)
(&#39;CRAs&#39;, &#39;Vendor&#39;)
(&#39;Vendor&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Report&#39;)
(&#39;Report&#39;, &#39;Writing&#39;)
(&#39;Writing&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;CRAs&#39;)
(&#39;CRAs&#39;, &#39;Symyx&#39;)
(&#39;Symyx&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Epigenetics&#39;)
(&#39;Epigenetics&#39;, &#39;Regulatory&#39;)
(&#39;Regulatory&#39;, &#39;Compliance&#39;)
(&#39;Compliance&#39;, &#39;GCP&#39;)
(&#39;GCP&#39;, &#39;Training&#39;)
(&#39;Training&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Investigators&#39;)
(&#39;Investigators&#39;, &#39;RECIST&#39;)
(&#39;RECIST&#39;, &#39;1.0&#39;)
(&#39;1.0&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;1.1&#39;)
(&#39;1.1&#39;, &#39;Pharmacovigilance&#39;)
(&#39;Pharmacovigilance&#39;, &#39;Audit&#39;)
(&#39;Audit&#39;, &#39;Microfluidics&#39;)
(&#39;Microfluidics&#39;, &#39;yeast&#39;)
(&#39;yeast&#39;, &#39;model&#39;)
(&#39;model&#39;, &#39;organism&#39;)
(&#39;organism&#39;, &#39;Market&#39;)
(&#39;Market&#39;, &#39;Targets&#39;)
(&#39;Targets&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Compounds&#39;)
(&#39;Compounds&#39;, &#39;Critical&#39;)
(&#39;Critical&#39;, &#39;Decision&#39;)
(&#39;Decision&#39;, &#39;Points&#39;)
(&#39;Points&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;Design&#39;)
(&#39;Design&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Conduct&#39;)
(&#39;Conduct&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Patient&#39;)
(&#39;Patient&#39;, &#39;Registries&#39;)
(&#39;Registries&#39;, &#39;protein&#39;)
(&#39;protein&#39;, &#39;production&#39;)
(&#39;production&#39;, &#39;formulation&#39;)
(&#39;formulation&#39;, &#39;HCA&#39;)
(&#39;HCA&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Idiosyncratic&#39;)
(&#39;Idiosyncratic&#39;, &#39;Toxicity&#39;)
(&#39;Toxicity&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Informatics&#39;)
(&#39;Informatics&#39;, &#39;Conflict&#39;)
(&#39;Conflict&#39;, &#39;Resolution&#39;)
(&#39;Resolution&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Negotiation&#39;)
(&#39;Negotiation&#39;, &#39;Regulatory&#39;)
(&#39;Regulatory&#39;, &#39;Intelligence&#39;)
(&#39;Intelligence&#39;, &#39;Bioresearch&#39;)
(&#39;Bioresearch&#39;, &#39;Monitoring&#39;)
(&#39;Monitoring&#39;, &#39;Cryobiology&#39;)
(&#39;Cryobiology&#39;, &#39;signal&#39;)
(&#39;signal&#39;, &#39;transduction&#39;)
(&#39;transduction&#39;, &#39;Emerging&#39;)
(&#39;Emerging&#39;, &#39;Companies&#39;)
(&#39;Companies&#39;, &#39;Corrective&#39;)
(&#39;Corrective&#39;, &#39;Action&#39;)
(&#39;Action&#39;, &#39;Plans:&#39;)
(&#39;Plans:&#39;, &#39;Documentation&#39;)
(&#39;Documentation&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;a&#39;)
(&#39;a&#39;, &#39;Sites&#39;)
(&#39;Sites&#39;, &#39;Response&#39;)
(&#39;Response&#39;, &#39;to&#39;)
(&#39;to&#39;, &#39;GCP&#39;)
(&#39;GCP&#39;, &#39;Deficiences&#39;)
(&#39;Deficiences&#39;, &#39;Developing&#39;)
(&#39;Developing&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Study&#39;)
(&#39;Study&#39;, &#39;Budget&#39;)
(&#39;Budget&#39;, &#39;Next&#39;)
(&#39;Next&#39;, &#39;Generation&#39;)
(&#39;Generation&#39;, &#39;Sequencing&#39;)
(&#39;Sequencing&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Fraud&#39;)
(&#39;Fraud&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Biosimilars&#39;)
(&#39;Biosimilars&#39;, &#39;Dealmaking&#39;)
(&#39;Dealmaking&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Comprehensive&#39;)
(&#39;Comprehensive&#39;, &#39;CRC&#39;)
(&#39;CRC&#39;, &#39;Training&#39;)
(&#39;Training&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Cell&#39;)
(&#39;Cell&#39;, &#39;Models&#39;)
(&#39;Models&#39;, &#39;Digital&#39;)
(&#39;Digital&#39;, &#39;Health&#39;)
(&#39;Health&#39;, &#39;Patient&#39;)
(&#39;Patient&#39;, &#39;Registry&#39;)
(&#39;Registry&#39;, &#39;Programs&#39;)
(&#39;Programs&#39;, &#39;crop&#39;)
(&#39;crop&#39;, &#39;genetics&#39;)
(&#39;genetics&#39;, &#39;Glossary&#39;)
(&#39;Glossary&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Acronyms&#39;)
(&#39;Acronyms&#39;, &#39;Reference&#39;)
(&#39;Reference&#39;, &#39;Biosensors&#39;)
(&#39;Biosensors&#39;, &#39;Good&#39;)
(&#39;Good&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Practice&#39;)
(&#39;Practice&#39;, &#39;Essential&#39;)
(&#39;Essential&#39;, &#39;Documentation&#39;)
(&#39;Documentation&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;at&#39;)
(&#39;at&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Sites&#39;)
(&#39;Sites&#39;, &#39;Patient&#39;)
(&#39;Patient&#39;, &#39;Centered&#39;)
(&#39;Centered&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;Proteins&#39;)
(&#39;Proteins&#39;, &#39;to&#39;)
(&#39;to&#39;, &#39;Profits&#39;)
(&#39;Profits&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Metabolism&#39;)
(&#39;Metabolism&#39;, &#39;International&#39;)
(&#39;International&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Approval&#39;)
(&#39;Approval&#39;, &#39;Regulatory&#39;)
(&#39;Regulatory&#39;, &#39;Procedures&#39;)
(&#39;Procedures&#39;, &#39;Principal&#39;)
(&#39;Principal&#39;, &#39;Investigator&#39;)
(&#39;Investigator&#39;, &#39;Training&#39;)
(&#39;Training&#39;, &#39;orthopedic&#39;)
(&#39;orthopedic&#39;, &#39;tissue&#39;)
(&#39;tissue&#39;, &#39;engineering&#39;)
(&#39;engineering&#39;, &#39;Investigator&#39;)
(&#39;Investigator&#39;, &#39;Sites&#39;)
(&#39;Sites&#39;, &#39;cardiovascular&#39;)
(&#39;cardiovascular&#39;, &#39;genomics&#39;)
(&#39;genomics&#39;, &#39;Study&#39;)
(&#39;Study&#39;, &#39;Start&#39;)
(&#39;Start&#39;, &#39;Up&#39;)
(&#39;Up&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Folding&#39;)
(&#39;Folding&#39;, &#39;Population&#39;)
(&#39;Population&#39;, &#39;Health&#39;)
(&#39;Health&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Tissue&#39;)
(&#39;Tissue&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;GLP&#39;)
(&#39;GLP&#39;, &#39;Bioanalysis&#39;)
(&#39;Bioanalysis&#39;, &#39;Phase&#39;)
(&#39;Phase&#39;, &#39;I&#39;)
(&#39;I&#39;, &#39;Study&#39;)
(&#39;Study&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Health&#39;)
(&#39;Health&#39;, &#39;Autonomous&#39;)
(&#39;Autonomous&#39;, &#39;Driving&#39;)
(&#39;Driving&#39;, &#39;Electronic&#39;)
(&#39;Electronic&#39;, &#39;Source&#39;)
(&#39;Source&#39;, &#39;Documentation&#39;)
(&#39;Documentation&#39;, &#39;Tools&#39;)
(&#39;Tools&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Metrics&#39;)
(&#39;Metrics&#39;, &#39;Congress&#39;)
(&#39;Congress&#39;, &#39;Global&#39;)
(&#39;Global&#39;, &#39;GCP&#39;)
(&#39;GCP&#39;, &#39;Monitoring&#39;)
(&#39;Monitoring&#39;, &#39;Investigator&#39;)
(&#39;Investigator&#39;, &#39;Non-Compliance&#39;)
(&#39;Non-Compliance&#39;, &#39;Global&#39;)
(&#39;Global&#39;, &#39;GCP&#39;)
(&#39;GCP&#39;, &#39;Compliance&#39;)
(&#39;Compliance&#39;, &#39;Report&#39;)
(&#39;Report&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Peptide&#39;)
(&#39;Peptide&#39;, &#39;Arrays&#39;)
(&#39;Arrays&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Internet&#39;)
(&#39;Internet&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Things&#39;)
(&#39;Things&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Pharmaceuticals&#39;)
(&#39;Pharmaceuticals&#39;, &#39;Introduction&#39;)
(&#39;Introduction&#39;, &#39;to&#39;)
(&#39;to&#39;, &#39;Signal&#39;)
(&#39;Signal&#39;, &#39;Detection&#39;)
(&#39;Detection&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Mining&#39;)
(&#39;Mining&#39;, &#39;Study&#39;)
(&#39;Study&#39;, &#39;Feasibility&#39;)
(&#39;Feasibility&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Investigation&#39;)
(&#39;Investigation&#39;, &#39;Monitoring&#39;)
(&#39;Monitoring&#39;, &#39;Proteomics&#39;)
(&#39;Proteomics&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;Developing&#39;)
(&#39;Developing&#39;, &#39;Regions&#39;)
(&#39;Regions&#39;, &#39;Pediatric&#39;)
(&#39;Pediatric&#39;, &#39;drug&#39;)
(&#39;drug&#39;, &#39;development&#39;)
(&#39;development&#39;, &#39;Sponsor&#39;)
(&#39;Sponsor&#39;, &#39;Monitoring&#39;)
(&#39;Monitoring&#39;, &#39;Inspections&#39;)
(&#39;Inspections&#39;, &#39;Maximize&#39;)
(&#39;Maximize&#39;, &#39;Value&#39;)
(&#39;Value&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;protein&#39;)
(&#39;protein&#39;, &#39;structures&#39;)
(&#39;structures&#39;, &#39;cancer&#39;)
(&#39;cancer&#39;, &#39;Microbial&#39;)
(&#39;Microbial&#39;, &#39;Genomics&#39;)
(&#39;Genomics&#39;, &#39;Translational&#39;)
(&#39;Translational&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Medicine&#39;)
(&#39;Medicine&#39;, &#39;Medical&#39;)
(&#39;Medical&#39;, &#39;Terminalogy&#39;)
(&#39;Terminalogy&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Professionals&#39;)
(&#39;Professionals&#39;, &#39;Medical&#39;)
(&#39;Medical&#39;, &#39;Devices&#39;)
(&#39;Devices&#39;, &#39;Writing&#39;)
(&#39;Writing&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Updating&#39;)
(&#39;Updating&#39;, &#39;the&#39;)
(&#39;the&#39;, &#39;Investigators&#39;)
(&#39;Investigators&#39;, &#39;Brochure&#39;)
(&#39;Brochure&#39;, &#39;Sunshine&#39;)
(&#39;Sunshine&#39;, &#39;Act&#39;)
(&#39;Act&#39;, &#39;Sequencing&#39;)
(&#39;Sequencing&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;Standard&#39;)
(&#39;Standard&#39;, &#39;Operating&#39;)
(&#39;Operating&#39;, &#39;Procedures&#39;)
(&#39;Procedures&#39;, &#39;Meeting&#39;)
(&#39;Meeting&#39;, &#39;International&#39;)
(&#39;International&#39;, &#39;Safety&#39;)
(&#39;Safety&#39;, &#39;Reporting&#39;)
(&#39;Reporting&#39;, &#39;Requirements&#39;)
(&#39;Requirements&#39;, &#39;Faciliation&#39;)
(&#39;Faciliation&#39;, &#39;Skills&#39;)
(&#39;Skills&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Professionals&#39;)
(&#39;Professionals&#39;, &#39;bioprocessing&#39;)
(&#39;bioprocessing&#39;, &#39;biologicals&#39;)
(&#39;biologicals&#39;, &#39;safety&#39;)
(&#39;safety&#39;, &#39;Regulatory&#39;)
(&#39;Regulatory&#39;, &#39;Intelligence&#39;)
(&#39;Intelligence&#39;, &#39;101&#39;)
(&#39;101&#39;, &#39;Recent&#39;)
(&#39;Recent&#39;, &#39;Trends&#39;)
(&#39;Trends&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;Noncompliance&#39;)
(&#39;Noncompliance&#39;, &#39;Briefings&#39;)
(&#39;Briefings&#39;, &#39;on&#39;)
(&#39;on&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Safety&#39;)
(&#39;Safety&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;research&#39;)
(&#39;research&#39;, &#39;project&#39;)
(&#39;project&#39;, &#39;mamangement&#39;)
(&#39;mamangement&#39;, &#39;essentials&#39;)
(&#39;essentials&#39;, &#39;CRA&#39;)
(&#39;CRA&#39;, &#39;Survival&#39;)
(&#39;Survival&#39;, &#39;Kit&#39;)
(&#39;Kit&#39;, &#39;Essential&#39;)
(&#39;Essential&#39;, &#39;Documentation&#39;)
(&#39;Documentation&#39;, &#39;Extracellular&#39;)
(&#39;Extracellular&#39;, &#39;RNA&#39;)
(&#39;RNA&#39;, &#39;Successful&#39;)
(&#39;Successful&#39;, &#39;Study&#39;)
(&#39;Study&#39;, &#39;Site&#39;)
(&#39;Site&#39;, &#39;Start-up&#39;)
(&#39;Start-up&#39;, &#39;Cell&#39;)
(&#39;Cell&#39;, &#39;Based&#39;)
(&#39;Based&#39;, &#39;Therapies&#39;)
(&#39;Therapies&#39;, &#39;Web-Based&#39;)
(&#39;Web-Based&#39;, &#39;Training&#39;)
(&#39;Training&#39;, &#39;Strategies&#39;)
(&#39;Strategies&#39;, &#39;data&#39;)
(&#39;data&#39;, &#39;mining&#39;)
(&#39;mining&#39;, &#39;GLP&#39;)
(&#39;GLP&#39;, &#39;Bioanalysis&#39;)
(&#39;Bioanalysis&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trial&#39;)
(&#39;Trial&#39;, &#39;Finance&#39;)
(&#39;Finance&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;regulatory&#39;)
(&#39;regulatory&#39;, &#39;Site&#39;)
(&#39;Site&#39;, &#39;Relationship/Performance&#39;)
(&#39;Relationship/Performance&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Introduction&#39;)
(&#39;Introduction&#39;, &#39;to&#39;)
(&#39;to&#39;, &#39;FDA&#39;)
(&#39;FDA&#39;, &#39;Regulatory&#39;)
(&#39;Regulatory&#39;, &#39;Reporter&#39;)
(&#39;Reporter&#39;, &#39;Newsletter&#39;)
(&#39;Newsletter&#39;, &#39;multiple&#39;)
(&#39;multiple&#39;, &#39;sclerosis&#39;)
(&#39;sclerosis&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Integration&#39;)
(&#39;Integration&#39;, &#39;Managing&#39;)
(&#39;Managing&#39;, &#39;CRAs&#39;)
(&#39;CRAs&#39;, &#39;to&#39;)
(&#39;to&#39;, &#39;Improve&#39;)
(&#39;Improve&#39;, &#39;Performance&#39;)
(&#39;Performance&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Study&#39;)
(&#39;Study&#39;, &#39;Outcomes&#39;)
(&#39;Outcomes&#39;, &#39;compounds&#39;)
(&#39;compounds&#39;, &#39;Predictive&#39;)
(&#39;Predictive&#39;, &#39;Toxicity&#39;)
(&#39;Toxicity&#39;, &#39;Surviving&#39;)
(&#39;Surviving&#39;, &#39;FDA&#39;)
(&#39;FDA&#39;, &#39;Site&#39;)
(&#39;Site&#39;, &#39;Inspections:&#39;)
(&#39;Inspections:&#39;, &#39;Best&#39;)
(&#39;Best&#39;, &#39;Practices&#39;)
(&#39;Practices&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Site&#39;)
(&#39;Site&#39;, &#39;Personnel&#39;)
(&#39;Personnel&#39;, &#39;Phase&#39;)
(&#39;Phase&#39;, &#39;III&#39;)
(&#39;III&#39;, &#39;(3)/forecasting&#39;)
(&#39;(3)/forecasting&#39;, &#39;clinical&#39;)
(&#39;clinical&#39;, &#39;outcomes&#39;)
(&#39;outcomes&#39;, &#39;Comparing&#39;)
(&#39;Comparing&#39;, &#39;FDA&#39;)
(&#39;FDA&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Health&#39;)
(&#39;Health&#39;, &#39;Canada&#39;)
(&#39;Canada&#39;, &#39;Regulations&#39;)
(&#39;Regulations&#39;, &#39;Medical&#39;)
(&#39;Medical&#39;, &#39;Device&#39;)
(&#39;Device&#39;, &#39;Professionals&#39;)
(&#39;Professionals&#39;, &#39;Recombinant&#39;)
(&#39;Recombinant&#39;, &#39;Therapeutics&#39;)
(&#39;Therapeutics&#39;, &#39;Tick&#39;)
(&#39;Tick&#39;, &#39;Borne&#39;)
(&#39;Borne&#39;, &#39;Diseases&#39;)
(&#39;Diseases&#39;, &#39;Writing&#39;)
(&#39;Writing&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Maintaining&#39;)
(&#39;Maintaining&#39;, &#39;the&#39;)
(&#39;the&#39;, &#39;EU&#39;)
(&#39;EU&#39;, &#39;CTA&#39;)
(&#39;CTA&#39;, &#39;Orphan&#39;)
(&#39;Orphan&#39;, &#39;Drugs&#39;)
(&#39;Drugs&#39;, &#39;Investigator&#39;)
(&#39;Investigator&#39;, &#39;Initiated&#39;)
(&#39;Initiated&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;Orthopaedic&#39;)
(&#39;Orthopaedic&#39;, &#39;Animal&#39;)
(&#39;Animal&#39;, &#39;Models&#39;)
(&#39;Models&#39;, &#39;Auditing&#39;)
(&#39;Auditing&#39;, &#39;Sponsors&#39;)
(&#39;Sponsors&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;CROs&#39;)
(&#39;CROs&#39;, &#39;Valuing&#39;)
(&#39;Valuing&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Pricing&#39;)
(&#39;Pricing&#39;, &#39;Licensing&#39;)
(&#39;Licensing&#39;, &#39;Deals&#39;)
(&#39;Deals&#39;, &#39;drug&#39;)
(&#39;drug&#39;, &#39;delivery&#39;)
(&#39;delivery&#39;, &#39;Vendor&#39;)
(&#39;Vendor&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;the&#39;)
(&#39;the&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Manager&#39;)
(&#39;Manager&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Quality&#39;)
(&#39;Quality&#39;, &#39;Patient&#39;)
(&#39;Patient&#39;, &#39;Engagement&#39;)
(&#39;Engagement&#39;, &#39;FDA&#39;)
(&#39;FDA&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Approval&#39;)
(&#39;Approval&#39;, &#39;Process&#39;)
(&#39;Process&#39;, &#39;HIPAA&#39;)
(&#39;HIPAA&#39;, &#39;No&#39;)
(&#39;No&#39;, &#39;1&#39;)
(&#39;1&#39;, &#39;Team&#39;)
(&#39;Team&#39;, &#39;Training&#39;)
(&#39;Training&#39;, &#39;HIPAA&#39;)
(&#39;HIPAA&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Human&#39;)
(&#39;Human&#39;, &#39;Subjects&#39;)
(&#39;Subjects&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Q&amp;A&#39;)
(&#39;Q&amp;A&#39;, &#39;Ubiquitin&#39;)
(&#39;Ubiquitin&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trial&#39;)
(&#39;Trial&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Monitoring&#39;)
(&#39;Monitoring&#39;, &#39;Investigational&#39;)
(&#39;Investigational&#39;, &#39;Product&#39;)
(&#39;Product&#39;, &#39;Accountability&#39;)
(&#39;Accountability&#39;, &#39;Training&#39;)
(&#39;Training&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Site&#39;)
(&#39;Site&#39;, &#39;Personnel&#39;)
(&#39;Personnel&#39;, &#39;Adverse&#39;)
(&#39;Adverse&#39;, &#39;Event&#39;)
(&#39;Event&#39;, &#39;Reporting&#39;)
(&#39;Reporting&#39;, &#39;to&#39;)
(&#39;to&#39;, &#39;IRBs&#39;)
(&#39;IRBs&#39;, &#39;Subject&#39;)
(&#39;Subject&#39;, &#39;Recruitment&#39;)
(&#39;Recruitment&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Sites&#39;)
(&#39;Sites&#39;, &#39;Antibodies&#39;)
(&#39;Antibodies&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Cost&#39;)
(&#39;Cost&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Global&#39;)
(&#39;Global&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;Portfolio&#39;)
(&#39;Portfolio&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Warning&#39;)
(&#39;Warning&#39;, &#39;Letters&#39;)
(&#39;Letters&#39;, &#39;Combination&#39;)
(&#39;Combination&#39;, &#39;Products&#39;)
(&#39;Products&#39;, &#39;Observational&#39;)
(&#39;Observational&#39;, &#39;Studies&#39;)
(&#39;Studies&#39;, &#39;Molecular&#39;)
(&#39;Molecular&#39;, &#39;Medicine&#39;)
(&#39;Medicine&#39;, &#39;Asia&#39;)
(&#39;Asia&#39;, &#39;CNS&#39;)
(&#39;CNS&#39;, &#39;Central&#39;)
(&#39;Central&#39;, &#39;nervous&#39;)
(&#39;nervous&#39;, &#39;system&#39;)
(&#39;system&#39;, &#39;Discovery&#39;)
(&#39;Discovery&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;Collaboration&#39;)
(&#39;Collaboration&#39;, &#39;Cross&#39;)
(&#39;Cross&#39;, &#39;functional&#39;)
(&#39;functional&#39;, &#39;global&#39;)
(&#39;global&#39;, &#39;teams&#39;)
(&#39;teams&#39;, &#39;Site&#39;)
(&#39;Site&#39;, &#39;Relationship&#39;)
(&#39;Relationship&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;peptides&#39;)
(&#39;peptides&#39;, &#39;Investigator&#39;)
(&#39;Investigator&#39;, &#39;Oversight&#39;)
(&#39;Oversight&#39;, &#39;Writing&#39;)
(&#39;Writing&#39;, &#39;SOPs&#39;)
(&#39;SOPs&#39;, &#39;pain&#39;)
(&#39;pain&#39;, &#39;web&#39;)
(&#39;web&#39;, &#39;2.0&#39;)
(&#39;2.0&#39;, &#39;Understanding&#39;)
(&#39;Understanding&#39;, &#39;FDAs&#39;)
(&#39;FDAs&#39;, &#39;new&#39;)
(&#39;new&#39;, &#39;Draft&#39;)
(&#39;Draft&#39;, &#39;Guidance&#39;)
(&#39;Guidance&#39;, &#39;Regarding&#39;)
(&#39;Regarding&#39;, &#39;Supervisory&#39;)
(&#39;Supervisory&#39;, &#39;Repons&#39;)
(&#39;Repons&#39;, &#39;Sponsors/CROs&#39;)
(&#39;Sponsors/CROs&#39;, &#39;Preparing&#39;)
(&#39;Preparing&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Sites&#39;)
(&#39;Sites&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;FDA&#39;)
(&#39;FDA&#39;, &#39;Inspections&#39;)
(&#39;Inspections&#39;, &#39;eHealth&#39;)
(&#39;eHealth&#39;, &#39;Technologies&#39;)
(&#39;Technologies&#39;, &#39;Introduction&#39;)
(&#39;Introduction&#39;, &#39;to&#39;)
(&#39;to&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;FDA&#39;)
(&#39;FDA&#39;, &#39;Proposed&#39;)
(&#39;Proposed&#39;, &#39;rule&#39;)
(&#39;rule&#39;, &#39;2010&#39;)
(&#39;2010&#39;, &#39;Teambuilding&#39;)
(&#39;Teambuilding&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;the&#39;)
(&#39;the&#39;, &#39;Cross&#39;)
(&#39;Cross&#39;, &#39;Functional&#39;)
(&#39;Functional&#39;, &#39;Global&#39;)
(&#39;Global&#39;, &#39;Team&#39;)
(&#39;Team&#39;, &#39;Genomic&#39;)
(&#39;Genomic&#39;, &#39;Business&#39;)
(&#39;Business&#39;, &#39;Strategies&#39;)
(&#39;Strategies&#39;, &#39;Product&#39;)
(&#39;Product&#39;, &#39;Life&#39;)
(&#39;Life&#39;, &#39;Cycle&#39;)
(&#39;Cycle&#39;, &#39;RNA&#39;)
(&#39;RNA&#39;, &#39;Interference&#39;)
(&#39;Interference&#39;, &#39;Pharmacovigilance&#39;)
(&#39;Pharmacovigilance&#39;, &#39;Signal&#39;)
(&#39;Signal&#39;, &#39;Detection&#39;)
(&#39;Detection&#39;, &#39;Foreign&#39;)
(&#39;Foreign&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;Biotech&#39;)
(&#39;Biotech&#39;, &#39;Business&#39;)
(&#39;Business&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;genomics&#39;)
(&#39;genomics&#39;, &#39;Portfolio&#39;)
(&#39;Portfolio&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Venue&#39;)
(&#39;Venue&#39;, &#39;II&#39;)
(&#39;II&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trial&#39;)
(&#39;Trial&#39;, &#39;Design&#39;)
(&#39;Design&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Medical&#39;)
(&#39;Medical&#39;, &#39;Devices&#39;)
(&#39;Devices&#39;, &#39;Informed&#39;)
(&#39;Informed&#39;, &#39;Consent&#39;)
(&#39;Consent&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trial&#39;)
(&#39;Trial&#39;, &#39;Study&#39;)
(&#39;Study&#39;, &#39;Wheel&#39;)
(&#39;Wheel&#39;, &#39;Biomarker&#39;)
(&#39;Biomarker&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Center&#39;)
(&#39;Center&#39;, &#39;Antibody&#39;)
(&#39;Antibody&#39;, &#39;Optimization&#39;)
(&#39;Optimization&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Characterization&#39;)
(&#39;Characterization&#39;, &#39;Biologics&#39;)
(&#39;Biologics&#39;, &#39;Chronic&#39;)
(&#39;Chronic&#39;, &#39;Pain&#39;)
(&#39;Pain&#39;, &#39;cardiovascular&#39;)
(&#39;cardiovascular&#39;, &#39;Risk&#39;)
(&#39;Risk&#39;, &#39;based&#39;)
(&#39;based&#39;, &#39;decisions&#39;)
(&#39;decisions&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;clinical&#39;)
(&#39;clinical&#39;, &#39;site&#39;)
(&#39;site&#39;, &#39;management&#39;)
(&#39;management&#39;, &#39;Human&#39;)
(&#39;Human&#39;, &#39;Participant&#39;)
(&#39;Participant&#39;, &#39;Protection&#39;)
(&#39;Protection&#39;, &#39;Training&#39;)
(&#39;Training&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Professionals&#39;)
(&#39;Professionals&#39;, &#39;CRC&#39;)
(&#39;CRC&#39;, &#39;Role/Responsibilities&#39;)
(&#39;Role/Responsibilities&#39;, &#39;Training&#39;)
(&#39;Training&#39;, &#39;Womens&#39;)
(&#39;Womens&#39;, &#39;Health&#39;)
(&#39;Health&#39;, &#39;Current&#39;)
(&#39;Current&#39;, &#39;Developments&#39;)
(&#39;Developments&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;the&#39;)
(&#39;the&#39;, &#39;Role&#39;)
(&#39;Role&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;IRBs&#39;)
(&#39;IRBs&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;the&#39;)
(&#39;the&#39;, &#39;Conduct&#39;)
(&#39;Conduct&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Regulatory&#39;)
(&#39;Regulatory&#39;, &#39;Compliance&#39;)
(&#39;Compliance&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Molecular&#39;)
(&#39;Molecular&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;infections&#39;)
(&#39;infections&#39;, &#39;Diabetes&#39;)
(&#39;Diabetes&#39;, &#39;cancer&#39;)
(&#39;cancer&#39;, &#39;partnering&#39;)
(&#39;partnering&#39;, &#39;Preparing&#39;)
(&#39;Preparing&#39;, &#39;Medical&#39;)
(&#39;Medical&#39;, &#39;Device&#39;)
(&#39;Device&#39;, &#39;510K&#39;)
(&#39;510K&#39;, &#39;Submissions&#39;)
(&#39;Submissions&#39;, &#39;Monitoring&#39;)
(&#39;Monitoring&#39;, &#39;Informed&#39;)
(&#39;Informed&#39;, &#39;Consent&#39;)
(&#39;Consent&#39;, &#39;Business&#39;)
(&#39;Business&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Biobanking&#39;)
(&#39;Biobanking&#39;, &#39;Global&#39;)
(&#39;Global&#39;, &#39;Site&#39;)
(&#39;Site&#39;, &#39;Selection&#39;)
(&#39;Selection&#39;, &#39;Boston&#39;)
(&#39;Boston&#39;, &#39;Biomarkers&#39;)
(&#39;Biomarkers&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Efficacy&#39;)
(&#39;Efficacy&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Safety&#39;)
(&#39;Safety&#39;, &#39;New&#39;)
(&#39;New&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Approval&#39;)
(&#39;Approval&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;the&#39;)
(&#39;the&#39;, &#39;European&#39;)
(&#39;European&#39;, &#39;Union&#39;)
(&#39;Union&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Therapeutics&#39;)
(&#39;Therapeutics&#39;, &#39;Quality&#39;)
(&#39;Quality&#39;, &#39;Improvement&#39;)
(&#39;Improvement&#39;, &#39;Strategies&#39;)
(&#39;Strategies&#39;, &#39;at&#39;)
(&#39;at&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Sites&#39;)
(&#39;Sites&#39;, &#39;diagnostics&#39;)
(&#39;diagnostics&#39;, &#39;bioprocessing&#39;)
(&#39;bioprocessing&#39;, &#39;viral&#39;)
(&#39;viral&#39;, &#39;hepatitis&#39;)
(&#39;hepatitis&#39;, &#39;infections&#39;)
(&#39;infections&#39;, &#39;Advanced&#39;)
(&#39;Advanced&#39;, &#39;HIPAA&#39;)
(&#39;HIPAA&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Sequencing&#39;)
(&#39;Sequencing&#39;, &#39;IRB&#39;)
(&#39;IRB&#39;, &#39;Guidance&#39;)
(&#39;Guidance&#39;, &#39;regenerative&#39;)
(&#39;regenerative&#39;, &#39;healing&#39;)
(&#39;healing&#39;, &#39;cell&#39;)
(&#39;cell&#39;, &#39;culture&#39;)
(&#39;culture&#39;, &#39;Coronavirus&#39;)
(&#39;Coronavirus&#39;, &#39;Liver&#39;)
(&#39;Liver&#39;, &#39;Disorders&#39;)
(&#39;Disorders&#39;, &#39;Big&#39;)
(&#39;Big&#39;, &#39;pharma&#39;)
(&#39;pharma&#39;, &#39;Big&#39;)
(&#39;Big&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;HIPAA&#39;)
(&#39;HIPAA&#39;, &#39;Electronic&#39;)
(&#39;Electronic&#39;, &#39;Medical&#39;)
(&#39;Medical&#39;, &#39;Records&#39;)
(&#39;Records&#39;, &#39;blood&#39;)
(&#39;blood&#39;, &#39;Pharmaceutical&#39;)
(&#39;Pharmaceutical&#39;, &#39;Strategy&#39;)
(&#39;Strategy&#39;, &#39;Series&#39;)
(&#39;Series&#39;, &#39;Strategies&#39;)
(&#39;Strategies&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Accelearted&#39;)
(&#39;Accelearted&#39;, &#39;Nonclinical&#39;)
(&#39;Nonclinical&#39;, &#39;Toxiciology&#39;)
(&#39;Toxiciology&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Safety&#39;)
(&#39;Safety&#39;, &#39;Assessment&#39;)
(&#39;Assessment&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Biologics&#39;)
(&#39;Biologics&#39;, &#39;New&#39;)
(&#39;New&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Approval&#39;)
(&#39;Approval&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;Japan&#39;)
(&#39;Japan&#39;, &#39;Artificial&#39;)
(&#39;Artificial&#39;, &#39;Intelligence&#39;)
(&#39;Intelligence&#39;, &#39;Excel&#39;)
(&#39;Excel&#39;, &#39;Spreadsheets-Step&#39;)
(&#39;Spreadsheets-Step&#39;, &#39;by&#39;)
(&#39;by&#39;, &#39;Step&#39;)
(&#39;Step&#39;, &#39;Instructions&#39;)
(&#39;Instructions&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Compliance&#39;)
(&#39;Compliance&#39;, &#39;Chemistry&#39;)
(&#39;Chemistry&#39;, &#39;R&amp;D&#39;)
(&#39;R&amp;D&#39;, &#39;Statistical&#39;)
(&#39;Statistical&#39;, &#39;Sourcebook&#39;)
(&#39;Sourcebook&#39;, &#39;Upgrade&#39;)
(&#39;Upgrade&#39;, &#39;Medical&#39;)
(&#39;Medical&#39;, &#39;Device&#39;)
(&#39;Device&#39;, &#39;Tracking&#39;)
(&#39;Tracking&#39;, &#39;Medical&#39;)
(&#39;Medical&#39;, &#39;Devices&#39;)
(&#39;Devices&#39;, &#39;Directive&#39;)
(&#39;Directive&#39;, &#39;Facilitation&#39;)
(&#39;Facilitation&#39;, &#39;Skills&#39;)
(&#39;Skills&#39;, &#39;Autoimmune&#39;)
(&#39;Autoimmune&#39;, &#39;anticoagulants&#39;)
(&#39;anticoagulants&#39;, &#39;bone&#39;)
(&#39;bone&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Antibodies&#39;)
(&#39;Antibodies&#39;, &#39;gene&#39;)
(&#39;gene&#39;, &#39;therapy&#39;)
(&#39;therapy&#39;, &#39;Newborn&#39;)
(&#39;Newborn&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Real&#39;)
(&#39;Real&#39;, &#39;World&#39;)
(&#39;World&#39;, &#39;Monitoring&#39;)
(&#39;Monitoring&#39;, &#39;Allergies&#39;)
(&#39;Allergies&#39;, &#39;Performance&#39;)
(&#39;Performance&#39;, &#39;Improvement&#39;)
(&#39;Improvement&#39;, &#39;Monitoring&#39;)
(&#39;Monitoring&#39;, &#39;Model&#39;)
(&#39;Model&#39;, &#39;Institutional&#39;)
(&#39;Institutional&#39;, &#39;Review&#39;)
(&#39;Review&#39;, &#39;Board&#39;)
(&#39;Board&#39;, &#39;Health&#39;)
(&#39;Health&#39;, &#39;Outcomes&#39;)
(&#39;Outcomes&#39;, &#39;Outsourcing&#39;)
(&#39;Outsourcing&#39;, &#39;R&amp;D&#39;)
(&#39;R&amp;D&#39;, &#39;Microbiome&#39;)
(&#39;Microbiome&#39;, &#39;Key&#39;)
(&#39;Key&#39;, &#39;Opinion&#39;)
(&#39;Opinion&#39;, &#39;Leaders&#39;)
(&#39;Leaders&#39;, &#39;Chronic&#39;)
(&#39;Chronic&#39;, &#39;Obstructive&#39;)
(&#39;Obstructive&#39;, &#39;Pulmonary&#39;)
(&#39;Pulmonary&#39;, &#39;Disorder&#39;)
(&#39;Disorder&#39;, &#39;Quality&#39;)
(&#39;Quality&#39;, &#39;by&#39;)
(&#39;by&#39;, &#39;Design&#39;)
(&#39;Design&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Translational&#39;)
(&#39;Translational&#39;, &#39;Medicine&#39;)
(&#39;Medicine&#39;, &#39;Series&#39;)
(&#39;Series&#39;, &#39;Lupus&#39;)
(&#39;Lupus&#39;, &#39;Multi&#39;)
(&#39;Multi&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Resistance&#39;)
(&#39;Resistance&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Coordinator&#39;)
(&#39;Coordinator&#39;, &#39;Tool&#39;)
(&#39;Tool&#39;, &#39;Kit&#39;)
(&#39;Kit&#39;, &#39;CRC&#39;)
(&#39;CRC&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;PI&#39;)
(&#39;PI&#39;, &#39;Current&#39;)
(&#39;Current&#39;, &#39;Practice&#39;)
(&#39;Practice&#39;, &#39;Update&#39;)
(&#39;Update&#39;, &#39;CRA&#39;)
(&#39;CRA&#39;, &#39;Facilitator&#39;)
(&#39;Facilitator&#39;, &#39;Training&#39;)
(&#39;Training&#39;, &#39;21&#39;)
(&#39;21&#39;, &#39;CFR&#39;)
(&#39;CFR&#39;, &#39;Part&#39;)
(&#39;Part&#39;, &#39;11&#39;)
(&#39;11&#39;, &#39;Compliance&#39;)
(&#39;Compliance&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Electronic&#39;)
(&#39;Electronic&#39;, &#39;Records&#39;)
(&#39;Records&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Signatures&#39;)
(&#39;Signatures&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Electronic&#39;)
(&#39;Electronic&#39;, &#39;Health&#39;)
(&#39;Health&#39;, &#39;Record&#39;)
(&#39;Record&#39;, &#39;Chiral&#39;)
(&#39;Chiral&#39;, &#39;Intro&#39;)
(&#39;Intro&#39;, &#39;to&#39;)
(&#39;to&#39;, &#39;Combination&#39;)
(&#39;Combination&#39;, &#39;Products&#39;)
(&#39;Products&#39;, &#39;Gastrointestinal&#39;)
(&#39;Gastrointestinal&#39;, &#39;Disorders&#39;)
(&#39;Disorders&#39;, &#39;Presentation&#39;)
(&#39;Presentation&#39;, &#39;skills&#39;)
(&#39;skills&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;clinical&#39;)
(&#39;clinical&#39;, &#39;research&#39;)
(&#39;research&#39;, &#39;professionals&#39;)
(&#39;professionals&#39;, &#39;inflammation&#39;)
(&#39;inflammation&#39;, &#39;Operational&#39;)
(&#39;Operational&#39;, &#39;Modeling&#39;)
(&#39;Modeling&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Simulation&#39;)
(&#39;Simulation&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;Pharmaceutical&#39;)
(&#39;Pharmaceutical&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Medical&#39;)
(&#39;Medical&#39;, &#39;Device&#39;)
(&#39;Device&#39;, &#39;Industries&#39;)
(&#39;Industries&#39;, &#39;Facilitation&#39;)
(&#39;Facilitation&#39;, &#39;Skills&#39;)
(&#39;Skills&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Team&#39;)
(&#39;Team&#39;, &#39;Members&#39;)
(&#39;Members&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Partnering&#39;)
(&#39;Partnering&#39;, &#39;Mobile&#39;)
(&#39;Mobile&#39;, &#39;Health&#39;)
(&#39;Health&#39;, &#39;Wearables&#39;)
(&#39;Wearables&#39;, &#39;Pharmaceutical&#39;)
(&#39;Pharmaceutical&#39;, &#39;Discovery&#39;)
(&#39;Discovery&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Medical&#39;)
(&#39;Medical&#39;, &#39;device&#39;)
(&#39;device&#39;, &#39;reporting&#39;)
(&#39;reporting&#39;, &#39;Ubiquitin&#39;)
(&#39;Ubiquitin&#39;, &#39;Medical&#39;)
(&#39;Medical&#39;, &#39;Device&#39;)
(&#39;Device&#39;, &#39;Postmarketing&#39;)
(&#39;Postmarketing&#39;, &#39;Vigilance&#39;)
(&#39;Vigilance&#39;, &#39;Blockchain&#39;)
(&#39;Blockchain&#39;, &#39;Alzheimers&#39;)
(&#39;Alzheimers&#39;, &#39;high&#39;)
(&#39;high&#39;, &#39;performance&#39;)
(&#39;performance&#39;, &#39;computing&#39;)
(&#39;computing&#39;, &#39;Innovative&#39;)
(&#39;Innovative&#39;, &#39;Preclinical&#39;)
(&#39;Preclinical&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Strategies&#39;)
(&#39;Strategies&#39;, &#39;GXP&#39;)
(&#39;GXP&#39;, &#39;Good&#39;)
(&#39;Good&#39;, &#39;Practice&#39;)
(&#39;Practice&#39;, &#39;Guides&#39;)
(&#39;Guides&#39;, &#39;Writing&#39;)
(&#39;Writing&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Maintaining&#39;)
(&#39;Maintaining&#39;, &#39;Canadian&#39;)
(&#39;Canadian&#39;, &#39;CTA&#39;)
(&#39;CTA&#39;, &#39;3D&#39;)
(&#39;3D&#39;, &#39;Printing&#39;)
(&#39;Printing&#39;, &#39;Key&#39;)
(&#39;Key&#39;, &#39;Information&#39;)
(&#39;Information&#39;, &#39;Gatherers&#39;)
(&#39;Gatherers&#39;, &#39;Respiratory&#39;)
(&#39;Respiratory&#39;, &#39;Five&#39;)
(&#39;Five&#39;, &#39;Keys&#39;)
(&#39;Keys&#39;, &#39;to&#39;)
(&#39;to&#39;, &#39;COTS&#39;)
(&#39;COTS&#39;, &#39;Computer&#39;)
(&#39;Computer&#39;, &#39;System&#39;)
(&#39;System&#39;, &#39;Validation&#39;)
(&#39;Validation&#39;, &#39;Next-Generation&#39;)
(&#39;Next-Generation&#39;, &#39;Sequencing&#39;)
(&#39;Sequencing&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Open&#39;)
(&#39;Open&#39;, &#39;Source&#39;)
(&#39;Source&#39;, &#39;Fibrosis/Scarring&#39;)
(&#39;Fibrosis/Scarring&#39;, &#39;Biomarker&#39;)
(&#39;Biomarker&#39;, &#39;Bridge&#39;)
(&#39;Bridge&#39;, &#39;Genomics&#39;)
(&#39;Genomics&#39;, &#39;101&#39;)
(&#39;101&#39;, &#39;Dummy&#39;)
(&#39;Dummy&#39;, &#39;Keyword&#39;)
(&#39;Keyword&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;DE&#39;)
(&#39;DE&#39;, &#39;lists&#39;)
(&#39;lists&#39;, &#39;w/more&#39;)
(&#39;w/more&#39;, &#39;than&#39;)
(&#39;than&#39;, &#39;1&#39;)
(&#39;1&#39;, &#39;keyword&#39;)
(&#39;keyword&#39;, &#39;or&#39;)
(&#39;or&#39;, &#39;with&#39;)
(&#39;with&#39;, &#39;no&#39;)
(&#39;no&#39;, &#39;keywords&#39;)
(&#39;keywords&#39;, &#39;FDA&#39;)
(&#39;FDA&#39;, &#39;Form&#39;)
(&#39;Form&#39;, &#39;1572&#39;)
(&#39;1572&#39;, &#39;Antisense&#39;)
(&#39;Antisense&#39;, &#39;Accountable&#39;)
(&#39;Accountable&#39;, &#39;Care&#39;)
(&#39;Care&#39;, &#39;Orgnization&#39;)
(&#39;Orgnization&#39;, &#39;ACE&#39;)
(&#39;ACE&#39;, &#39;inhibitors&#39;)
(&#39;inhibitors&#39;, &#39;AI&#39;)
(&#39;AI&#39;, &#39;Chips&#39;)
(&#39;Chips&#39;, &#39;Antibody-Drug&#39;)
(&#39;Antibody-Drug&#39;, &#39;Conjugates&#39;)
(&#39;Conjugates&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;PEGS&#39;)
(&#39;PEGS&#39;, &#39;Antibody&#39;)
(&#39;Antibody&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Conjugate&#39;)
(&#39;Conjugate&#39;, &#39;Bioprocess&#39;)
(&#39;Bioprocess&#39;, &#39;Attention&#39;)
(&#39;Attention&#39;, &#39;Deficit&#39;)
(&#39;Deficit&#39;, &#39;Hyperactivity&#39;)
(&#39;Hyperactivity&#39;, &#39;Disorder&#39;)
(&#39;Disorder&#39;, &#39;Adjuvants&#39;)
(&#39;Adjuvants&#39;, &#39;ADMET&#39;)
(&#39;ADMET&#39;, &#39;(ADME&#39;)
(&#39;(ADME&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Toxicology)&#39;)
(&#39;Toxicology)&#39;, &#39;adverse&#39;)
(&#39;adverse&#39;, &#39;drug&#39;)
(&#39;drug&#39;, &#39;reactions&#39;)
(&#39;reactions&#39;, &#39;Aerospace&#39;)
(&#39;Aerospace&#39;, &#39;Advanced&#39;)
(&#39;Advanced&#39;, &#39;Energy&#39;)
(&#39;Energy&#39;, &#39;Technology&#39;)
(&#39;Technology&#39;, &#39;Congress&#39;)
(&#39;Congress&#39;, &#39;Affordable&#39;)
(&#39;Affordable&#39;, &#39;Care&#39;)
(&#39;Care&#39;, &#39;affinity&#39;)
(&#39;affinity&#39;, &#39;technologies&#39;)
(&#39;technologies&#39;, &#39;Affinity&#39;)
(&#39;Affinity&#39;, &#39;Separation&#39;)
(&#39;Separation&#39;, &#39;Antibody&#39;)
(&#39;Antibody&#39;, &#39;Fragments&#39;)
(&#39;Fragments&#39;, &#39;Agriculture&#39;)
(&#39;Agriculture&#39;, &#39;chemistry&#39;)
(&#39;chemistry&#39;, &#39;Aging&#39;)
(&#39;Aging&#39;, &#39;Antibody&#39;)
(&#39;Antibody&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Targets&#39;)
(&#39;Targets&#39;, &#39;Digital&#39;)
(&#39;Digital&#39;, &#39;Farming&#39;)
(&#39;Farming&#39;, &#39;angiogenesis&#39;)
(&#39;angiogenesis&#39;, &#39;AI&#39;)
(&#39;AI&#39;, &#39;Business&#39;)
(&#39;Business&#39;, &#39;Intelligence&#39;)
(&#39;Intelligence&#39;, &#39;Artificial&#39;)
(&#39;Artificial&#39;, &#39;Intelligence&#39;)
(&#39;Intelligence&#39;, &#39;Bioprocessing&#39;)
(&#39;Bioprocessing&#39;, &#39;AI&#39;)
(&#39;AI&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;Customer&#39;)
(&#39;Customer&#39;, &#39;Analytics&#39;)
(&#39;Analytics&#39;, &#39;Intelligent&#39;)
(&#39;Intelligent&#39;, &#39;Assistants&#39;)
(&#39;Assistants&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Bots&#39;)
(&#39;Bots&#39;, &#39;AI&#39;)
(&#39;AI&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Enterprise&#39;)
(&#39;Enterprise&#39;, &#39;AI&#39;)
(&#39;AI&#39;, &#39;Case&#39;)
(&#39;Case&#39;, &#39;Studies&#39;)
(&#39;Studies&#39;, &#39;AI&#39;)
(&#39;AI&#39;, &#39;Executive&#39;)
(&#39;Executive&#39;, &#39;Summit&#39;)
(&#39;Summit&#39;, &#39;Machine&#39;)
(&#39;Machine&#39;, &#39;Learning&#39;)
(&#39;Learning&#39;, &#39;Artificial&#39;)
(&#39;Artificial&#39;, &#39;Intelligence&#39;)
(&#39;Intelligence&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Post&#39;)
(&#39;Post&#39;, &#39;Approval&#39;)
(&#39;Approval&#39;, &#39;Artificial&#39;)
(&#39;Artificial&#39;, &#39;Intelligence&#39;)
(&#39;Intelligence&#39;, &#39;Discovery&#39;)
(&#39;Discovery&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Preclinical&#39;)
(&#39;Preclinical&#39;, &#39;Implementing&#39;)
(&#39;Implementing&#39;, &#39;Enterprise&#39;)
(&#39;Enterprise&#39;, &#39;AI&#39;)
(&#39;AI&#39;, &#39;AI&#39;)
(&#39;AI&#39;, &#39;Ethics&#39;)
(&#39;Ethics&#39;, &#39;Future&#39;)
(&#39;Future&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;AI&#39;)
(&#39;AI&#39;, &#39;Cutting&#39;)
(&#39;Cutting&#39;, &#39;Edge&#39;)
(&#39;Edge&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;AI&#39;)
(&#39;AI&#39;, &#39;General&#39;)
(&#39;General&#39;, &#39;AI&#39;)
(&#39;AI&#39;, &#39;Business&#39;)
(&#39;Business&#39;, &#39;Applications&#39;)
(&#39;Applications&#39;, &#39;AI&#39;)
(&#39;AI&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Strategic&#39;)
(&#39;Strategic&#39;, &#39;Government&#39;)
(&#39;Government&#39;, &#39;Functions&#39;)
(&#39;Functions&#39;, &#39;Cognitive&#39;)
(&#39;Cognitive&#39;, &#39;Computing&#39;)
(&#39;Computing&#39;, &#39;AI&#39;)
(&#39;AI&#39;, &#39;Partnering&#39;)
(&#39;Partnering&#39;, &#39;AI&#39;)
(&#39;AI&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;Personalized&#39;)
(&#39;Personalized&#39;, &#39;Medicine&#39;)
(&#39;Medicine&#39;, &#39;Allosteric&#39;)
(&#39;Allosteric&#39;, &#39;Modulators&#39;)
(&#39;Modulators&#39;, &#39;Amyotrophic&#39;)
(&#39;Amyotrophic&#39;, &#39;lateral&#39;)
(&#39;lateral&#39;, &#39;sclerosis&#39;)
(&#39;sclerosis&#39;, &#39;Animal&#39;)
(&#39;Animal&#39;, &#39;Models&#39;)
(&#39;Models&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Alternative&#39;)
(&#39;Alternative&#39;, &#39;Medicine&#39;)
(&#39;Medicine&#39;, &#39;Alliance&#39;)
(&#39;Alliance&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Execution&#39;)
(&#39;Execution&#39;, &#39;Asset&#39;)
(&#39;Asset&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Alliance&#39;)
(&#39;Alliance&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Negotiation&#39;)
(&#39;Negotiation&#39;, &#39;Animal&#39;)
(&#39;Animal&#39;, &#39;Models&#39;)
(&#39;Models&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Pain&#39;)
(&#39;Pain&#39;, &#39;Animal&#39;)
(&#39;Animal&#39;, &#39;Models&#39;)
(&#39;Models&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Toxicity&#39;)
(&#39;Toxicity&#39;, &#39;angina&#39;)
(&#39;angina&#39;, &#39;Anxiety&#39;)
(&#39;Anxiety&#39;, &#39;cancer&#39;)
(&#39;cancer&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;apoptosis&#39;)
(&#39;apoptosis&#39;, &#39;Active&#39;)
(&#39;Active&#39;, &#39;Pharmaceutical&#39;)
(&#39;Pharmaceutical&#39;, &#39;Ingredients&#39;)
(&#39;Ingredients&#39;, &#39;Analytical&#39;)
(&#39;Analytical&#39;, &#39;Purification&#39;)
(&#39;Purification&#39;, &#39;Apoptosis&#39;)
(&#39;Apoptosis&#39;, &#39;Anti&#39;)
(&#39;Anti&#39;, &#39;Psychotics&#39;)
(&#39;Psychotics&#39;, &#39;Alliances&#39;)
(&#39;Alliances&#39;, &#39;Rx&#39;)
(&#39;Rx&#39;, &#39;Devices&#39;)
(&#39;Devices&#39;, &#39;arrhythmias&#39;)
(&#39;arrhythmias&#39;, &#39;Assays&#39;)
(&#39;Assays&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Antibodies&#39;)
(&#39;Antibodies&#39;, &#39;Assays&#39;)
(&#39;Assays&#39;, &#39;Affinity&#39;)
(&#39;Affinity&#39;, &#39;Assays&#39;)
(&#39;Assays&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Allosteric&#39;)
(&#39;Allosteric&#39;, &#39;Antagonism&#39;)
(&#39;Antagonism&#39;, &#39;Immunogenicity&#39;)
(&#39;Immunogenicity&#39;, &#39;Assay&#39;)
(&#39;Assay&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;Assays&#39;)
(&#39;Assays&#39;, &#39;Primary&#39;)
(&#39;Primary&#39;, &#39;Cells&#39;)
(&#39;Cells&#39;, &#39;Quantifying&#39;)
(&#39;Quantifying&#39;, &#39;Receptor&#39;)
(&#39;Receptor&#39;, &#39;Activation&#39;)
(&#39;Activation&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Agonism&#39;)
(&#39;Agonism&#39;, &#39;asthma&#39;)
(&#39;asthma&#39;, &#39;Assays&#39;)
(&#39;Assays&#39;, &#39;atherosclerosis&#39;)
(&#39;atherosclerosis&#39;, &#39;Automotive&#39;)
(&#39;Automotive&#39;, &#39;Automotive&#39;)
(&#39;Automotive&#39;, &#39;Partnering&#39;)
(&#39;Partnering&#39;, &#39;Autophagy&#39;)
(&#39;Autophagy&#39;, &#39;Autism&#39;)
(&#39;Autism&#39;, &#39;Advisory&#39;)
(&#39;Advisory&#39;, &#39;Boards&#39;)
(&#39;Boards&#39;, &#39;Bacterial&#39;)
(&#39;Bacterial&#39;, &#39;Infections&#39;)
(&#39;Infections&#39;, &#39;Consumer&#39;)
(&#39;Consumer&#39;, &#39;Electronic&#39;)
(&#39;Electronic&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Applications&#39;)
(&#39;Applications&#39;, &#39;Defense&#39;)
(&#39;Defense&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Applications&#39;)
(&#39;Applications&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Science&#39;)
(&#39;Science&#39;, &#39;Flexible&#39;)
(&#39;Flexible&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Power&#39;)
(&#39;Power&#39;, &#39;Industrial&#39;)
(&#39;Industrial&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Applications&#39;)
(&#39;Applications&#39;, &#39;Medical&#39;)
(&#39;Medical&#39;, &#39;Device&#39;)
(&#39;Device&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Applications&#39;)
(&#39;Applications&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Applications&#39;)
(&#39;Applications&#39;, &#39;Stationary&#39;)
(&#39;Stationary&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Applications&#39;)
(&#39;Applications&#39;, &#39;Automotive&#39;)
(&#39;Automotive&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Applications&#39;)
(&#39;Applications&#39;, &#39;Bayesian&#39;)
(&#39;Bayesian&#39;, &#39;Statistics&#39;)
(&#39;Statistics&#39;, &#39;Asia&#39;)
(&#39;Asia&#39;, &#39;US&#39;)
(&#39;US&#39;, &#39;Biotech&#39;)
(&#39;Biotech&#39;, &#39;Alliances&#39;)
(&#39;Alliances&#39;, &#39;Blood&#39;)
(&#39;Blood&#39;, &#39;Brain&#39;)
(&#39;Brain&#39;, &#39;Barrier&#39;)
(&#39;Barrier&#39;, &#39;Computational&#39;)
(&#39;Computational&#39;, &#39;Biology&#39;)
(&#39;Biology&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Bio&#39;)
(&#39;Bio&#39;, &#39;IT&#39;)
(&#39;IT&#39;, &#39;BioIT&#39;)
(&#39;BioIT&#39;, &#39;Best&#39;)
(&#39;Best&#39;, &#39;Practices&#39;)
(&#39;Practices&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Charging&#39;)
(&#39;Charging&#39;, &#39;Cheminformatics&#39;)
(&#39;Cheminformatics&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Bio&#39;)
(&#39;Bio&#39;, &#39;IT&#39;)
(&#39;IT&#39;, &#39;Biomarker&#39;)
(&#39;Biomarker&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Applications&#39;)
(&#39;Applications&#39;, &#39;Preclinical&#39;)
(&#39;Preclinical&#39;, &#39;Biologic&#39;)
(&#39;Biologic&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;Breast&#39;)
(&#39;Breast&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Backup&#39;)
(&#39;Backup&#39;, &#39;Compounds&#39;)
(&#39;Compounds&#39;, &#39;biological&#39;)
(&#39;biological&#39;, &#39;cancer&#39;)
(&#39;cancer&#39;, &#39;treatments&#39;)
(&#39;treatments&#39;, &#39;Biomarker&#39;)
(&#39;Biomarker&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Analysis&#39;)
(&#39;Analysis&#39;, &#39;Biological&#39;)
(&#39;Biological&#39;, &#39;Database&#39;)
(&#39;Database&#39;, &#39;Discovery&#39;)
(&#39;Discovery&#39;, &#39;Informatics&#39;)
(&#39;Informatics&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Bio&#39;)
(&#39;Bio&#39;, &#39;IT&#39;)
(&#39;IT&#39;, &#39;Delivery&#39;)
(&#39;Delivery&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Biologics&#39;)
(&#39;Biologics&#39;, &#39;Regulatory&#39;)
(&#39;Regulatory&#39;, &#39;Business&#39;)
(&#39;Business&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;biodiversity&#39;)
(&#39;biodiversity&#39;, &#39;screening&#39;)
(&#39;screening&#39;, &#39;E&#39;)
(&#39;E&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Energy&#39;)
(&#39;Energy&#39;, &#39;Storage&#39;)
(&#39;Storage&#39;, &#39;Biofuels&#39;)
(&#39;Biofuels&#39;, &#39;Alliance&#39;)
(&#39;Alliance&#39;, &#39;Biobank&#39;)
(&#39;Biobank&#39;, &#39;Informatics&#39;)
(&#39;Informatics&#39;, &#39;Flow&#39;)
(&#39;Flow&#39;, &#39;Cell&#39;)
(&#39;Cell&#39;, &#39;Technologies&#39;)
(&#39;Technologies&#39;, &#39;Cloud&#39;)
(&#39;Cloud&#39;, &#39;Computing&#39;)
(&#39;Computing&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Science&#39;)
(&#39;Science&#39;, &#39;Biogenerics&#39;)
(&#39;Biogenerics&#39;, &#39;Business&#39;)
(&#39;Business&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Genomics&#39;)
(&#39;Genomics&#39;, &#39;biomaterials&#39;)
(&#39;biomaterials&#39;, &#39;Bioinformatics&#39;)
(&#39;Bioinformatics&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;BIO&#39;)
(&#39;BIO&#39;, &#39;IT&#39;)
(&#39;IT&#39;, &#39;World&#39;)
(&#39;World&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Intellectual&#39;)
(&#39;Intellectual&#39;, &#39;Property&#39;)
(&#39;Property&#39;, &#39;Bio&#39;)
(&#39;Bio&#39;, &#39;IT&#39;)
(&#39;IT&#39;, &#39;World&#39;)
(&#39;World&#39;, &#39;Web&#39;)
(&#39;Web&#39;, &#39;Resource&#39;)
(&#39;Resource&#39;, &#39;Alert&#39;)
(&#39;Alert&#39;, &#39;Bio&#39;)
(&#39;Bio&#39;, &#39;IT&#39;)
(&#39;IT&#39;, &#39;World&#39;)
(&#39;World&#39;, &#39;Monthly&#39;)
(&#39;Monthly&#39;, &#39;magazine&#39;)
(&#39;magazine&#39;, &#39;IT&#39;)
(&#39;IT&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Informatics&#39;)
(&#39;Informatics&#39;, &#39;Series&#39;)
(&#39;Series&#39;, &#39;Bio&#39;)
(&#39;Bio&#39;, &#39;IT&#39;)
(&#39;IT&#39;, &#39;World&#39;)
(&#39;World&#39;, &#39;Weekly&#39;)
(&#39;Weekly&#39;, &#39;Update&#39;)
(&#39;Update&#39;, &#39;Bookstore&#39;)
(&#39;Bookstore&#39;, &#39;Biomarker&#39;)
(&#39;Biomarker&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;Advanced&#39;)
(&#39;Advanced&#39;, &#39;Lead&#39;)
(&#39;Lead&#39;, &#39;Acid&#39;)
(&#39;Acid&#39;, &#39;Technology&#39;)
(&#39;Technology&#39;, &#39;Manufacturing&#39;)
(&#39;Manufacturing&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Process&#39;)
(&#39;Process&#39;, &#39;Economics&#39;)
(&#39;Economics&#39;, &#39;Biopharm&#39;)
(&#39;Biopharm&#39;, &#39;Executive&#39;)
(&#39;Executive&#39;, &#39;Summit&#39;)
(&#39;Summit&#39;, &#39;Biolaw&#39;)
(&#39;Biolaw&#39;, &#39;Biomarker&#39;)
(&#39;Biomarker&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Series&#39;)
(&#39;Series&#39;, &#39;High-Througput&#39;)
(&#39;High-Througput&#39;, &#39;Screen-Based&#39;)
(&#39;Screen-Based&#39;, &#39;Biomarker&#39;)
(&#39;Biomarker&#39;, &#39;Discovery&#39;)
(&#39;Discovery&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Manufacturers&#39;)
(&#39;Manufacturers&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Manufacturing&#39;)
(&#39;Manufacturing&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Manufacturing&#39;)
(&#39;Manufacturing&#39;, &#39;Machinery&#39;)
(&#39;Machinery&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Market&#39;)
(&#39;Market&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Machine&#39;)
(&#39;Machine&#39;, &#39;Learning&#39;)
(&#39;Learning&#39;, &#39;Biomarker&#39;)
(&#39;Biomarker&#39;, &#39;Executive&#39;)
(&#39;Executive&#39;, &#39;Think&#39;)
(&#39;Think&#39;, &#39;Tank&#39;)
(&#39;Tank&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Materials,&#39;)
(&#39;Materials,&#39;, &#39;Recycling&#39;)
(&#39;Recycling&#39;, &#39;Biomarker&#39;)
(&#39;Biomarker&#39;, &#39;Reverse&#39;)
(&#39;Reverse&#39;, &#39;Phase&#39;)
(&#39;Phase&#39;, &#39;Assays&#39;)
(&#39;Assays&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Materials,&#39;)
(&#39;Materials,&#39;, &#39;Solid&#39;)
(&#39;Solid&#39;, &#39;State&#39;)
(&#39;State&#39;, &#39;bone&#39;)
(&#39;bone&#39;, &#39;marrow&#39;)
(&#39;marrow&#39;, &#39;transplants&#39;)
(&#39;transplants&#39;, &#39;Biomarker&#39;)
(&#39;Biomarker&#39;, &#39;Translational&#39;)
(&#39;Translational&#39;, &#39;Biomarker&#39;)
(&#39;Biomarker&#39;, &#39;Validation&#39;)
(&#39;Validation&#39;, &#39;Bioinformatics&#39;)
(&#39;Bioinformatics&#39;, &#39;Asia&#39;)
(&#39;Asia&#39;, &#39;Bioinformatics&#39;)
(&#39;Bioinformatics&#39;, &#39;Cloud&#39;)
(&#39;Cloud&#39;, &#39;Computing&#39;)
(&#39;Computing&#39;, &#39;IT&#39;)
(&#39;IT&#39;, &#39;Infrastructure&#39;)
(&#39;Infrastructure&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Bio&#39;)
(&#39;Bio&#39;, &#39;IT&#39;)
(&#39;IT&#39;, &#39;Logistics&#39;)
(&#39;Logistics&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Sample&#39;)
(&#39;Sample&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Biobanking&#39;)
(&#39;Biobanking&#39;, &#39;Bioinformatics&#39;)
(&#39;Bioinformatics&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;the&#39;)
(&#39;the&#39;, &#39;Genome&#39;)
(&#39;Genome&#39;, &#39;Era&#39;)
(&#39;Era&#39;, &#39;Bioprocess&#39;)
(&#39;Bioprocess&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Analysis&#39;)
(&#39;Analysis&#39;, &#39;Host&#39;)
(&#39;Host&#39;, &#39;Cell&#39;)
(&#39;Cell&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Assays&#39;)
(&#39;Assays&#39;, &#39;Bioproduction&#39;)
(&#39;Bioproduction&#39;, &#39;Continuous&#39;)
(&#39;Continuous&#39;, &#39;Processing&#39;)
(&#39;Processing&#39;, &#39;biopurification&#39;)
(&#39;biopurification&#39;, &#39;Biological&#39;)
(&#39;Biological&#39;, &#39;Pharmacokinetics&#39;)
(&#39;Pharmacokinetics&#39;, &#39;Bioprocessing&#39;)
(&#39;Bioprocessing&#39;, &#39;Quality&#39;)
(&#39;Quality&#39;, &#39;Bioprocess&#39;)
(&#39;Bioprocess&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Manufacturing&#39;)
(&#39;Manufacturing&#39;, &#39;Series&#39;)
(&#39;Series&#39;, &#39;Bioprocess&#39;)
(&#39;Bioprocess&#39;, &#39;Validation&#39;)
(&#39;Validation&#39;, &#39;Bioreactor&#39;)
(&#39;Bioreactor&#39;, &#39;Design&#39;)
(&#39;Design&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Engineering&#39;)
(&#39;Engineering&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Regulatory&#39;)
(&#39;Regulatory&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Raw&#39;)
(&#39;Raw&#39;, &#39;Materials&#39;)
(&#39;Materials&#39;, &#39;Brain&#39;)
(&#39;Brain&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Repurposing&#39;)
(&#39;Repurposing&#39;, &#39;Biological&#39;)
(&#39;Biological&#39;, &#39;Therapeutics&#39;)
(&#39;Therapeutics&#39;, &#39;(biotherapeutics)&#39;)
(&#39;(biotherapeutics)&#39;, &#39;Bispecific&#39;)
(&#39;Bispecific&#39;, &#39;Antibodies&#39;)
(&#39;Antibodies&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Immunotherapy&#39;)
(&#39;Immunotherapy&#39;, &#39;Bispecifics&#39;)
(&#39;Bispecifics&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Business&#39;)
(&#39;Business&#39;, &#39;Strategies&#39;)
(&#39;Strategies&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Library&#39;)
(&#39;Library&#39;, &#39;Diversity&#39;)
(&#39;Diversity&#39;, &#39;blood&#39;)
(&#39;blood&#39;, &#39;safety&#39;)
(&#39;safety&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Shipping&#39;)
(&#39;Shipping&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Simulation&#39;)
(&#39;Simulation&#39;, &#39;Biosensors&#39;)
(&#39;Biosensors&#39;, &#39;bioseparation&#39;)
(&#39;bioseparation&#39;, &#39;Biostabilization&#39;)
(&#39;Biostabilization&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Biospecimens&#39;)
(&#39;Biospecimens&#39;, &#39;Biomanufacturing&#39;)
(&#39;Biomanufacturing&#39;, &#39;Single&#39;)
(&#39;Single&#39;, &#39;Use&#39;)
(&#39;Use&#39;, &#39;Technologies&#39;)
(&#39;Technologies&#39;, &#39;Bioassays&#39;)
(&#39;Bioassays&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Commercialization&#39;)
(&#39;Commercialization&#39;, &#39;Flow&#39;)
(&#39;Flow&#39;, &#39;Batteries&#39;)
(&#39;Batteries&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Materials&#39;)
(&#39;Materials&#39;, &#39;Sci/Tech&#39;)
(&#39;Sci/Tech&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Pharma&#39;)
(&#39;Pharma&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Biotech&#39;)
(&#39;Biotech&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Safety&#39;)
(&#39;Safety&#39;, &#39;Biotech&#39;)
(&#39;Biotech&#39;, &#39;tools&#39;)
(&#39;tools&#39;, &#39;Biotech&#39;)
(&#39;Biotech&#39;, &#39;Venture&#39;)
(&#39;Venture&#39;, &#39;Forum&#39;)
(&#39;Forum&#39;, &#39;Biomarkers&#39;)
(&#39;Biomarkers&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Molecular&#39;)
(&#39;Molecular&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Biomarkers&#39;)
(&#39;Biomarkers&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Molecular&#39;)
(&#39;Molecular&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Immunotherapy&#39;)
(&#39;Immunotherapy&#39;, &#39;Artifical&#39;)
(&#39;Artifical&#39;, &#39;Intelligence&#39;)
(&#39;Intelligence&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;cell&#39;)
(&#39;cell&#39;, &#39;adhesion&#39;)
(&#39;adhesion&#39;, &#39;molecules&#39;)
(&#39;molecules&#39;, &#39;regulatory&#39;)
(&#39;regulatory&#39;, &#39;CANDA&#39;)
(&#39;CANDA&#39;, &#39;Computer&#39;)
(&#39;Computer&#39;, &#39;Assisted&#39;)
(&#39;Assisted&#39;, &#39;New&#39;)
(&#39;New&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Application&#39;)
(&#39;Application&#39;, &#39;Chimeric&#39;)
(&#39;Chimeric&#39;, &#39;Antigen&#39;)
(&#39;Antigen&#39;, &#39;Receptor&#39;)
(&#39;Receptor&#39;, &#39;Chimeric&#39;)
(&#39;Chimeric&#39;, &#39;Antigen&#39;)
(&#39;Antigen&#39;, &#39;Receptor&#39;)
(&#39;Receptor&#39;, &#39;Case&#39;)
(&#39;Case&#39;, &#39;Studies&#39;)
(&#39;Studies&#39;, &#39;catalysis&#39;)
(&#39;catalysis&#39;, &#39;Cell&#39;)
(&#39;Cell&#39;, &#39;Based&#39;)
(&#39;Based&#39;, &#39;Assays&#39;)
(&#39;Assays&#39;, &#39;Cell&#39;)
(&#39;Cell&#39;, &#39;Therapy&#39;)
(&#39;Therapy&#39;, &#39;CMC&#39;)
(&#39;CMC&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Biomarker&#39;)
(&#39;Biomarker&#39;, &#39;Cell&#39;)
(&#39;Cell&#39;, &#39;Therapy&#39;)
(&#39;Therapy&#39;, &#39;Production&#39;)
(&#39;Production&#39;, &#39;Cord&#39;)
(&#39;Cord&#39;, &#39;Blood&#39;)
(&#39;Blood&#39;, &#39;Stem&#39;)
(&#39;Stem&#39;, &#39;Cells&#39;)
(&#39;Cells&#39;, &#39;Cell&#39;)
(&#39;Cell&#39;, &#39;Based&#39;)
(&#39;Based&#39;, &#39;Therapies&#39;)
(&#39;Therapies&#39;, &#39;Circulating&#39;)
(&#39;Circulating&#39;, &#39;Tumor&#39;)
(&#39;Tumor&#39;, &#39;Cells&#39;)
(&#39;Cells&#39;, &#39;Cold&#39;)
(&#39;Cold&#39;, &#39;Chain&#39;)
(&#39;Chain&#39;, &#39;Colorectal&#39;)
(&#39;Colorectal&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;cell&#39;)
(&#39;cell&#39;, &#39;cycle&#39;)
(&#39;cycle&#39;, &#39;Collaborations&#39;)
(&#39;Collaborations&#39;, &#39;Deals&#39;)
(&#39;Deals&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Alliances&#39;)
(&#39;Alliances&#39;, &#39;Chemical&#39;)
(&#39;Chemical&#39;, &#39;Database&#39;)
(&#39;Database&#39;, &#39;Co-Development&#39;)
(&#39;Co-Development&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Drugs&#39;)
(&#39;Drugs&#39;, &#39;Cloud&#39;)
(&#39;Cloud&#39;, &#39;Computing&#39;)
(&#39;Computing&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Case&#39;)
(&#39;Case&#39;, &#39;Histories&#39;)
(&#39;Histories&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;Consumer&#39;)
(&#39;Consumer&#39;, &#39;Electronics&#39;)
(&#39;Electronics&#39;, &#39;Cell&#39;)
(&#39;Cell&#39;, &#39;Biology&#39;)
(&#39;Biology&#39;, &#39;Clean&#39;)
(&#39;Clean&#39;, &#39;Tech&#39;)
(&#39;Tech&#39;, &#39;Solar&#39;)
(&#39;Solar&#39;, &#39;Wind&#39;)
(&#39;Wind&#39;, &#39;Comparative&#39;)
(&#39;Comparative&#39;, &#39;Effectiveness&#39;)
(&#39;Effectiveness&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Ethical&#39;)
(&#39;Ethical&#39;, &#39;Considerations&#39;)
(&#39;Considerations&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;Continuing&#39;)
(&#39;Continuing&#39;, &#39;Education&#39;)
(&#39;Education&#39;, &#39;Units&#39;)
(&#39;Units&#39;, &#39;Circulating&#39;)
(&#39;Circulating&#39;, &#39;Cell-Free&#39;)
(&#39;Cell-Free&#39;, &#39;DNA&#39;)
(&#39;DNA&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Agriculture&#39;)
(&#39;Agriculture&#39;, &#39;crop&#39;)
(&#39;crop&#39;, &#39;genetics&#39;)
(&#39;genetics&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Genomics&#39;)
(&#39;Genomics&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;congestive&#39;)
(&#39;congestive&#39;, &#39;heart&#39;)
(&#39;heart&#39;, &#39;failure&#39;)
(&#39;failure&#39;, &#39;Chemistry&#39;)
(&#39;Chemistry&#39;, &#39;Series&#39;)
(&#39;Series&#39;, &#39;Chinese&#39;)
(&#39;Chinese&#39;, &#39;Hamster&#39;)
(&#39;Hamster&#39;, &#39;Ovaries&#39;)
(&#39;Ovaries&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Conflicts&#39;)
(&#39;Conflicts&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Interest&#39;)
(&#39;Interest&#39;, &#39;cheminformatics&#39;)
(&#39;cheminformatics&#39;, &#39;competitive&#39;)
(&#39;competitive&#39;, &#39;intelligence&#39;)
(&#39;intelligence&#39;, &#39;Cloud&#39;)
(&#39;Cloud&#39;, &#39;Computing&#39;)
(&#39;Computing&#39;, &#39;Asia&#39;)
(&#39;Asia&#39;, &#39;Integrating&#39;)
(&#39;Integrating&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Lab&#39;)
(&#39;Lab&#39;, &#39;Services&#39;)
(&#39;Services&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Biospecimens&#39;)
(&#39;Biospecimens&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Central&#39;)
(&#39;Central&#39;, &#39;Lab&#39;)
(&#39;Lab&#39;, &#39;Solutions&#39;)
(&#39;Solutions&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Biospecimens&#39;)
(&#39;Biospecimens&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Central&#39;)
(&#39;Central&#39;, &#39;Lab&#39;)
(&#39;Lab&#39;, &#39;Solutions&#39;)
(&#39;Solutions&#39;, &#39;Celiac&#39;)
(&#39;Celiac&#39;, &#39;Disease&#39;)
(&#39;Disease&#39;, &#39;Cloud&#39;)
(&#39;Cloud&#39;, &#39;Extension&#39;)
(&#39;Extension&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Genomics&#39;)
(&#39;Genomics&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;cellular&#39;)
(&#39;cellular&#39;, &#39;all&#39;)
(&#39;all&#39;, &#39;Conducting&#39;)
(&#39;Conducting&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;Asia&#39;)
(&#39;Asia&#39;, &#39;Cloud&#39;)
(&#39;Cloud&#39;, &#39;Computing&#39;)
(&#39;Computing&#39;, &#39;Project&#39;)
(&#39;Project&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Cloud&#39;)
(&#39;Cloud&#39;, &#39;Computing&#39;)
(&#39;Computing&#39;, &#39;Resource&#39;)
(&#39;Resource&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Cloud&#39;)
(&#39;Cloud&#39;, &#39;Computing&#39;)
(&#39;Computing&#39;, &#39;Security&#39;)
(&#39;Security&#39;, &#39;Risks&#39;)
(&#39;Risks&#39;, &#39;Software&#39;)
(&#39;Software&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Genomics&#39;)
(&#39;Genomics&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Vaccines&#39;)
(&#39;Vaccines&#39;, &#39;Cloud&#39;)
(&#39;Cloud&#39;, &#39;Computing&#39;)
(&#39;Computing&#39;, &#39;West&#39;)
(&#39;West&#39;, &#39;Comparability&#39;)
(&#39;Comparability&#39;, &#39;Chemistry&#39;)
(&#39;Chemistry&#39;, &#39;Manufacturing&#39;)
(&#39;Manufacturing&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Controls&#39;)
(&#39;Controls&#39;, &#39;Continuing&#39;)
(&#39;Continuing&#39;, &#39;Medical&#39;)
(&#39;Medical&#39;, &#39;Education&#39;)
(&#39;Education&#39;, &#39;Communications&#39;)
(&#39;Communications&#39;, &#39;Contract&#39;)
(&#39;Contract&#39;, &#39;Manufacturing&#39;)
(&#39;Manufacturing&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Microarray&#39;)
(&#39;Microarray&#39;, &#39;Application&#39;)
(&#39;Application&#39;, &#39;CNS&#39;)
(&#39;CNS&#39;, &#39;Biomarkers&#39;)
(&#39;Biomarkers&#39;, &#39;Miscellaneous&#39;)
(&#39;Miscellaneous&#39;, &#39;CHI&#39;)
(&#39;CHI&#39;, &#39;conference&#39;)
(&#39;conference&#39;, &#39;CNS&#39;)
(&#39;CNS&#39;, &#39;genetics/genomics&#39;)
(&#39;genetics/genomics&#39;, &#39;CNS&#39;)
(&#39;CNS&#39;, &#39;Disease&#39;)
(&#39;Disease&#39;, &#39;Models&#39;)
(&#39;Models&#39;, &#39;Counterfeit&#39;)
(&#39;Counterfeit&#39;, &#39;Drugs&#39;)
(&#39;Drugs&#39;, &#39;Copy&#39;)
(&#39;Copy&#39;, &#39;Number&#39;)
(&#39;Number&#39;, &#39;Variation&#39;)
(&#39;Variation&#39;, &#39;Cognitive&#39;)
(&#39;Cognitive&#39;, &#39;Disorders&#39;)
(&#39;Disorders&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Components&#39;)
(&#39;Components&#39;, &#39;capillary&#39;)
(&#39;capillary&#39;, &#39;electrophoresis&#39;)
(&#39;electrophoresis&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Prognostic&#39;)
(&#39;Prognostic&#39;, &#39;Markers&#39;)
(&#39;Markers&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Pharmacology&#39;)
(&#39;Pharmacology&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Proteomics&#39;)
(&#39;Proteomics&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Plasma&#39;)
(&#39;Plasma&#39;, &#39;Profiling&#39;)
(&#39;Profiling&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trial&#39;)
(&#39;Trial&#39;, &#39;Platform&#39;)
(&#39;Platform&#39;, &#39;Software&#39;)
(&#39;Software&#39;, &#39;Computer&#39;)
(&#39;Computer&#39;, &#39;Vision&#39;)
(&#39;Vision&#39;, &#39;cancer&#39;)
(&#39;cancer&#39;, &#39;prevention&#39;)
(&#39;prevention&#39;, &#39;CRA&#39;)
(&#39;CRA&#39;, &#39;8&#39;)
(&#39;8&#39;, &#39;Weeks&#39;)
(&#39;Weeks&#39;, &#39;Fundamental&#39;)
(&#39;Fundamental&#39;, &#39;Training&#39;)
(&#39;Training&#39;, &#39;Cost&#39;)
(&#39;Cost&#39;, &#39;Reduction&#39;)
(&#39;Reduction&#39;, &#39;w/o&#39;)
(&#39;w/o&#39;, &#39;Increasing&#39;)
(&#39;Increasing&#39;, &#39;Regulatory&#39;)
(&#39;Regulatory&#39;, &#39;or&#39;)
(&#39;or&#39;, &#39;Business&#39;)
(&#39;Business&#39;, &#39;Risk&#39;)
(&#39;Risk&#39;, &#39;Advanced&#39;)
(&#39;Advanced&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Coordinator&#39;)
(&#39;Coordinator&#39;, &#39;Critical&#39;)
(&#39;Critical&#39;, &#39;Care&#39;)
(&#39;Care&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Interviewing&#39;)
(&#39;Interviewing&#39;, &#39;Skills&#39;)
(&#39;Skills&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;CRAs&#39;)
(&#39;CRAs&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;CRCs&#39;)
(&#39;CRCs&#39;, &#39;Customer&#39;)
(&#39;Customer&#39;, &#39;Relationship&#39;)
(&#39;Relationship&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;CRA&#39;)
(&#39;CRA&#39;, &#39;Monitoring&#39;)
(&#39;Monitoring&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Training&#39;)
(&#39;Training&#39;, &#39;Week&#39;)
(&#39;Week&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Training&#39;)
(&#39;Training&#39;, &#39;Week&#39;)
(&#39;Week&#39;, &#39;East&#39;)
(&#39;East&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Training&#39;)
(&#39;Training&#39;, &#39;Week&#39;)
(&#39;Week&#39;, &#39;West&#39;)
(&#39;West&#39;, &#39;Drug-Device&#39;)
(&#39;Drug-Device&#39;, &#39;Combinations&#39;)
(&#39;Combinations&#39;, &#39;Peptides&#39;)
(&#39;Peptides&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Therapeutics&#39;)
(&#39;Therapeutics&#39;, &#39;Colony&#39;)
(&#39;Colony&#39;, &#39;Stimulating&#39;)
(&#39;Stimulating&#39;, &#39;Factors&#39;)
(&#39;Factors&#39;, &#39;Cell&#39;)
(&#39;Cell&#39;, &#39;Signaling&#39;)
(&#39;Signaling&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Stem&#39;)
(&#39;Stem&#39;, &#39;Cells&#39;)
(&#39;Cells&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Supply&#39;)
(&#39;Supply&#39;, &#39;Chain&#39;)
(&#39;Chain&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Strategic&#39;)
(&#39;Strategic&#39;, &#39;Resource&#39;)
(&#39;Resource&#39;, &#39;Allocation&#39;)
(&#39;Allocation&#39;, &#39;Country&#39;)
(&#39;Country&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Site&#39;)
(&#39;Site&#39;, &#39;Feasibility&#39;)
(&#39;Feasibility&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Selection&#39;)
(&#39;Selection&#39;, &#39;Mammalian&#39;)
(&#39;Mammalian&#39;, &#39;Cell&#39;)
(&#39;Cell&#39;, &#39;Culture&#39;)
(&#39;Culture&#39;, &#39;Cloud&#39;)
(&#39;Cloud&#39;, &#39;Security&#39;)
(&#39;Security&#39;, &#39;Cybersecurity&#39;)
(&#39;Cybersecurity&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;eClinical&#39;)
(&#39;eClinical&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;Asia&#39;)
(&#39;Asia&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;the&#39;)
(&#39;the&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Discoverer&#39;)
(&#39;Discoverer&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;Eastern&#39;)
(&#39;Eastern&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trial&#39;)
(&#39;Trial&#39;, &#39;Finance&#39;)
(&#39;Finance&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Re&#39;)
(&#39;Re&#39;, &#39;Engineering&#39;)
(&#39;Engineering&#39;, &#39;the&#39;)
(&#39;the&#39;, &#39;Study&#39;)
(&#39;Study&#39;, &#39;Feasibility&#39;)
(&#39;Feasibility&#39;, &#39;Assessment&#39;)
(&#39;Assessment&#39;, &#39;Process&#39;)
(&#39;Process&#39;, &#39;CRC&#39;)
(&#39;CRC&#39;, &#39;Training&#39;)
(&#39;Training&#39;, &#39;Video&#39;)
(&#39;Video&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Manual&#39;)
(&#39;Manual&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trial&#39;)
(&#39;Trial&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Systems&#39;)
(&#39;Systems&#39;, &#39;Cardiotoxicity&#39;)
(&#39;Cardiotoxicity&#39;, &#39;Query&#39;)
(&#39;Query&#39;, &#39;Creation&#39;)
(&#39;Creation&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Processing&#39;)
(&#39;Processing&#39;, &#39;clinical&#39;)
(&#39;clinical&#39;, &#39;trials&#39;)
(&#39;trials&#39;, &#39;segmentation&#39;)
(&#39;segmentation&#39;, &#39;Neoantigens&#39;)
(&#39;Neoantigens&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Cardiovascular&#39;)
(&#39;Cardiovascular&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;cardiovascular&#39;)
(&#39;cardiovascular&#39;, &#39;animal&#39;)
(&#39;animal&#39;, &#39;models&#39;)
(&#39;models&#39;, &#39;Cardio&#39;)
(&#39;Cardio&#39;, &#39;Metabolic&#39;)
(&#39;Metabolic&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Targets&#39;)
(&#39;Targets&#39;, &#39;Targeting&#39;)
(&#39;Targeting&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;cytokines&#39;)
(&#39;cytokines&#39;, &#39;antagonists&#39;)
(&#39;antagonists&#39;, &#39;Cystic&#39;)
(&#39;Cystic&#39;, &#39;Fibrosis&#39;)
(&#39;Fibrosis&#39;, &#39;Cytogenetics&#39;)
(&#39;Cytogenetics&#39;, &#39;cytokines&#39;)
(&#39;cytokines&#39;, &#39;Targeting&#39;)
(&#39;Targeting&#39;, &#39;Diabetes&#39;)
(&#39;Diabetes&#39;, &#39;with&#39;)
(&#39;with&#39;, &#39;Novel&#39;)
(&#39;Novel&#39;, &#39;Therapeutics&#39;)
(&#39;Therapeutics&#39;, &#39;DBS&#39;)
(&#39;DBS&#39;, &#39;Optimization&#39;)
(&#39;Optimization&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Cell&#39;)
(&#39;Cell&#39;, &#39;drug&#39;)
(&#39;drug&#39;, &#39;discovery&#39;)
(&#39;discovery&#39;, &#39;India&#39;)
(&#39;India&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Discovery&#39;)
(&#39;Discovery&#39;, &#39;Map&#39;)
(&#39;Map&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Discovery&#39;)
(&#39;Discovery&#39;, &#39;Outsourcing&#39;)
(&#39;Outsourcing&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Discovery&#39;)
(&#39;Discovery&#39;, &#39;Technologies&#39;)
(&#39;Technologies&#39;, &#39;drug&#39;)
(&#39;drug&#39;, &#39;discovery&#39;)
(&#39;discovery&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;development&#39;)
(&#39;development&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Discovery&#39;)
(&#39;Discovery&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;Series&#39;)
(&#39;Series&#39;, &#39;Dental&#39;)
(&#39;Dental&#39;, &#39;Depression&#39;)
(&#39;Depression&#39;, &#39;Detection&#39;)
(&#39;Detection&#39;, &#39;non&#39;)
(&#39;non&#39;, &#39;biological&#39;)
(&#39;biological&#39;, &#39;Treatments&#39;)
(&#39;Treatments&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Abuse&#39;)
(&#39;Abuse&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Interactions&#39;)
(&#39;Interactions&#39;, &#39;Digital&#39;)
(&#39;Digital&#39;, &#39;Therapeutics&#39;)
(&#39;Therapeutics&#39;, &#39;Digitization&#39;)
(&#39;Digitization&#39;, &#39;Diabetes&#39;)
(&#39;Diabetes&#39;, &#39;2&#39;)
(&#39;2&#39;, &#39;Digital&#39;)
(&#39;Digital&#39;, &#39;Healthcare&#39;)
(&#39;Healthcare&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Productivity&#39;)
(&#39;Productivity&#39;, &#39;web&#39;)
(&#39;web&#39;, &#39;resource&#39;)
(&#39;resource&#39;, &#39;alert&#39;)
(&#39;alert&#39;, &#39;drug&#39;)
(&#39;drug&#39;, &#39;discovery&#39;)
(&#39;discovery&#39;, &#39;Duchenne&#39;)
(&#39;Duchenne&#39;, &#39;Muscular&#39;)
(&#39;Muscular&#39;, &#39;Dystrophy&#39;)
(&#39;Dystrophy&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Metabolism&#39;)
(&#39;Metabolism&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Pharmacokinetics&#39;)
(&#39;Pharmacokinetics&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Discovery&#39;)
(&#39;Discovery&#39;, &#39;Informatics&#39;)
(&#39;Informatics&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Integrity&#39;)
(&#39;Integrity&#39;, &#39;Diagnostic&#39;)
(&#39;Diagnostic&#39;, &#39;Informatics&#39;)
(&#39;Informatics&#39;, &#39;DNA&#39;)
(&#39;DNA&#39;, &#39;Repair&#39;)
(&#39;Repair&#39;, &#39;Diversity&#39;)
(&#39;Diversity&#39;, &#39;Oriented&#39;)
(&#39;Oriented&#39;, &#39;Synthesis&#39;)
(&#39;Synthesis&#39;, &#39;Digital&#39;)
(&#39;Digital&#39;, &#39;Detection&#39;)
(&#39;Detection&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Difficult&#39;)
(&#39;Difficult&#39;, &#39;to&#39;)
(&#39;to&#39;, &#39;Express&#39;)
(&#39;Express&#39;, &#39;Proteins&#39;)
(&#39;Proteins&#39;, &#39;Executive&#39;)
(&#39;Executive&#39;, &#39;Perspectives&#39;)
(&#39;Perspectives&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Safety&#39;)
(&#39;Safety&#39;, &#39;downstream&#39;)
(&#39;downstream&#39;, &#39;processing&#39;)
(&#39;processing&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Safety&#39;)
(&#39;Safety&#39;, &#39;Series&#39;)
(&#39;Series&#39;, &#39;downstream&#39;)
(&#39;downstream&#39;, &#39;processing&#39;)
(&#39;processing&#39;, &#39;Dosing&#39;)
(&#39;Dosing&#39;, &#39;Selection&#39;)
(&#39;Selection&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Science/Analytics&#39;)
(&#39;Science/Analytics&#39;, &#39;Direct&#39;)
(&#39;Direct&#39;, &#39;to&#39;)
(&#39;to&#39;, &#39;Consumer&#39;)
(&#39;Consumer&#39;, &#39;Marketing&#39;)
(&#39;Marketing&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Transporters&#39;)
(&#39;Transporters&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Storage&#39;)
(&#39;Storage&#39;, &#39;Digital&#39;)
(&#39;Digital&#39;, &#39;Twins&#39;)
(&#39;Twins&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Utilization&#39;)
(&#39;Utilization&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Devices&#39;)
(&#39;Devices&#39;, &#39;Molecular&#39;)
(&#39;Molecular&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Companion&#39;)
(&#39;Companion&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Asia&#39;)
(&#39;Asia&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Adoption&#39;)
(&#39;Adoption&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Next&#39;)
(&#39;Next&#39;, &#39;Generation&#39;)
(&#39;Generation&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Difficult&#39;)
(&#39;Difficult&#39;, &#39;to&#39;)
(&#39;to&#39;, &#39;Express&#39;)
(&#39;Express&#39;, &#39;Proteins&#39;)
(&#39;Proteins&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Globalization&#39;)
(&#39;Globalization&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Dx&#39;)
(&#39;Dx&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Immunoassays&#39;)
(&#39;Immunoassays&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Automation&#39;)
(&#39;Automation&#39;, &#39;Detection&#39;)
(&#39;Detection&#39;, &#39;Informatics&#39;)
(&#39;Informatics&#39;, &#39;engineered&#39;)
(&#39;engineered&#39;, &#39;animal&#39;)
(&#39;animal&#39;, &#39;models&#39;)
(&#39;models&#39;, &#39;Hearing&#39;)
(&#39;Hearing&#39;, &#39;Ebola&#39;)
(&#39;Ebola&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Evidence&#39;)
(&#39;Evidence&#39;, &#39;Based&#39;)
(&#39;Based&#39;, &#39;Medicine&#39;)
(&#39;Medicine&#39;, &#39;Ebola&#39;)
(&#39;Ebola&#39;, &#39;Therapeutics&#39;)
(&#39;Therapeutics&#39;, &#39;eCapacitors&#39;)
(&#39;eCapacitors&#39;, &#39;Electrochemistry&#39;)
(&#39;Electrochemistry&#39;, &#39;E&#39;)
(&#39;E&#39;, &#39;Coli&#39;)
(&#39;Coli&#39;, &#39;Encoded&#39;)
(&#39;Encoded&#39;, &#39;Compound&#39;)
(&#39;Compound&#39;, &#39;Libraries&#39;)
(&#39;Libraries&#39;, &#39;Ecommerce&#39;)
(&#39;Ecommerce&#39;, &#39;eCTD&#39;)
(&#39;eCTD&#39;, &#39;Validation&#39;)
(&#39;Validation&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Disinfectant&#39;)
(&#39;Disinfectant&#39;, &#39;Efficacy&#39;)
(&#39;Efficacy&#39;, &#39;Effective&#39;)
(&#39;Effective&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Discovery&#39;)
(&#39;Discovery&#39;, &#39;Edge&#39;)
(&#39;Edge&#39;, &#39;Computing&#39;)
(&#39;Computing&#39;, &#39;Early&#39;)
(&#39;Early&#39;, &#39;Diagnosis&#39;)
(&#39;Diagnosis&#39;, &#39;Electronic&#39;)
(&#39;Electronic&#39;, &#39;Notebooks&#39;)
(&#39;Notebooks&#39;, &#39;endothelium&#39;)
(&#39;endothelium&#39;, &#39;engineering&#39;)
(&#39;engineering&#39;, &#39;Entertainment&#39;)
(&#39;Entertainment&#39;, &#39;Enabling&#39;)
(&#39;Enabling&#39;, &#39;Technology&#39;)
(&#39;Technology&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;R&amp;D&#39;)
(&#39;R&amp;D&#39;, &#39;Environment&#39;)
(&#39;Environment&#39;, &#39;Enzymes&#39;)
(&#39;Enzymes&#39;, &#39;Economic&#39;)
(&#39;Economic&#39;, &#39;Outcomes&#39;)
(&#39;Outcomes&#39;, &#39;Executives&#39;)
(&#39;Executives&#39;, &#39;on&#39;)
(&#39;on&#39;, &#39;Target&#39;)
(&#39;Target&#39;, &#39;Epidemiology&#39;)
(&#39;Epidemiology&#39;, &#39;epilepsy&#39;)
(&#39;epilepsy&#39;, &#39;Epigenetic&#39;)
(&#39;Epigenetic&#39;, &#39;Readers&#39;)
(&#39;Readers&#39;, &#39;Epigenetic&#39;)
(&#39;Epigenetic&#39;, &#39;Targets&#39;)
(&#39;Targets&#39;, &#39;Examining&#39;)
(&#39;Examining&#39;, &#39;the&#39;)
(&#39;the&#39;, &#39;Impact&#39;)
(&#39;Impact&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;the&#39;)
(&#39;the&#39;, &#39;eCTD&#39;)
(&#39;eCTD&#39;, &#39;on&#39;)
(&#39;on&#39;, &#39;the&#39;)
(&#39;the&#39;, &#39;Regulatory&#39;)
(&#39;Regulatory&#39;, &#39;Submissions&#39;)
(&#39;Submissions&#39;, &#39;Process&#39;)
(&#39;Process&#39;, &#39;Emerging&#39;)
(&#39;Emerging&#39;, &#39;Targets&#39;)
(&#39;Targets&#39;, &#39;Diseases&#39;)
(&#39;Diseases&#39;, &#39;Ethics&#39;)
(&#39;Ethics&#39;, &#39;Emerging&#39;)
(&#39;Emerging&#39;, &#39;Technology&#39;)
(&#39;Technology&#39;, &#39;Transfer&#39;)
(&#39;Transfer&#39;, &#39;Electric&#39;)
(&#39;Electric&#39;, &#39;Vehicles&#39;)
(&#39;Vehicles&#39;, &#39;Experimental&#39;)
(&#39;Experimental&#39;, &#39;Design&#39;)
(&#39;Design&#39;, &#39;Exhibitors&#39;)
(&#39;Exhibitors&#39;, &#39;Extractables/Leachables&#39;)
(&#39;Extractables/Leachables&#39;, &#39;Exosomes&#39;)
(&#39;Exosomes&#39;, &#39;Exome&#39;)
(&#39;Exome&#39;, &#39;Sequencing&#39;)
(&#39;Sequencing&#39;, &#39;Financial&#39;)
(&#39;Financial&#39;, &#39;Analysts&#39;)
(&#39;Analysts&#39;, &#39;Hackathon&#39;)
(&#39;Hackathon&#39;, &#39;Obesity&#39;)
(&#39;Obesity&#39;, &#39;Batteries&#39;)
(&#39;Batteries&#39;, &#39;France&#39;)
(&#39;France&#39;, &#39;fibrin&#39;)
(&#39;fibrin&#39;, &#39;sealants&#39;)
(&#39;sealants&#39;, &#39;Fine&#39;)
(&#39;Fine&#39;, &#39;Chemicals&#39;)
(&#39;Chemicals&#39;, &#39;FDA&#39;)
(&#39;FDA&#39;, &#39;Meetings&#39;)
(&#39;Meetings&#39;, &#39;101&#39;)
(&#39;101&#39;, &#39;Food&#39;)
(&#39;Food&#39;, &#39;Safety&#39;)
(&#39;Safety&#39;, &#39;Financial&#39;)
(&#39;Financial&#39;, &#39;Disclosure&#39;)
(&#39;Disclosure&#39;, &#39;Foods&#39;)
(&#39;Foods&#39;, &#39;FDA&#39;)
(&#39;FDA&#39;, &#39;Website&#39;)
(&#39;Website&#39;, &#39;Functional&#39;)
(&#39;Functional&#39;, &#39;Genomics&#39;)
(&#39;Genomics&#39;, &#39;Fragment&#39;)
(&#39;Fragment&#39;, &#39;Based&#39;)
(&#39;Based&#39;, &#39;Screening&#39;)
(&#39;Screening&#39;, &#39;Surface&#39;)
(&#39;Surface&#39;, &#39;Plasmon&#39;)
(&#39;Plasmon&#39;, &#39;Resonance&#39;)
(&#39;Resonance&#39;, &#39;finance&#39;)
(&#39;finance&#39;, &#39;Flow&#39;)
(&#39;Flow&#39;, &#39;Cytometry&#39;)
(&#39;Cytometry&#39;, &#39;Influenza&#39;)
(&#39;Influenza&#39;, &#39;Financial&#39;)
(&#39;Financial&#39;, &#39;Deal&#39;)
(&#39;Deal&#39;, &#39;Structures&#39;)
(&#39;Structures&#39;, &#39;Fintech&#39;)
(&#39;Fintech&#39;, &#39;Future&#39;)
(&#39;Future&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Healthcare&#39;)
(&#39;Healthcare&#39;, &#39;Fraud&#39;)
(&#39;Fraud&#39;, &#39;Fertility&#39;)
(&#39;Fertility&#39;, &#39;Fibrin&#39;)
(&#39;Fibrin&#39;, &#39;sealants&#39;)
(&#39;sealants&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;blood&#39;)
(&#39;blood&#39;, &#39;Fast&#39;)
(&#39;Fast&#39;, &#39;Track&#39;)
(&#39;Track&#39;, &#39;Future&#39;)
(&#39;Future&#39;, &#39;Therapeutics&#39;)
(&#39;Therapeutics&#39;, &#39;fungal&#39;)
(&#39;fungal&#39;, &#39;infections&#39;)
(&#39;infections&#39;, &#39;Follow&#39;)
(&#39;Follow&#39;, &#39;Up&#39;)
(&#39;Up&#39;, &#39;Flow&#39;)
(&#39;Flow&#39;, &#39;Chemistry&#39;)
(&#39;Chemistry&#39;, &#39;Gamification&#39;)
(&#39;Gamification&#39;, &#39;gap&#39;)
(&#39;gap&#39;, &#39;junction&#39;)
(&#39;junction&#39;, &#39;channels&#39;)
(&#39;channels&#39;, &#39;Global&#39;)
(&#39;Global&#39;, &#39;Health&#39;)
(&#39;Health&#39;, &#39;Good&#39;)
(&#39;Good&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Practice&#39;)
(&#39;Practice&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Pediatric&#39;)
(&#39;Pediatric&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;GCP&#39;)
(&#39;GCP&#39;, &#39;Deficiencies&#39;)
(&#39;Deficiencies&#39;, &#39;Gene&#39;)
(&#39;Gene&#39;, &#39;Cell&#39;)
(&#39;Cell&#39;, &#39;Vectors&#39;)
(&#39;Vectors&#39;, &#39;Genomic&#39;)
(&#39;Genomic&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Discovery&#39;)
(&#39;Discovery&#39;, &#39;Genomic&#39;)
(&#39;Genomic&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Integration&#39;)
(&#39;Integration&#39;, &#39;Genetic&#39;)
(&#39;Genetic&#39;, &#39;Screening&#39;)
(&#39;Screening&#39;, &#39;Wellness&#39;)
(&#39;Wellness&#39;, &#39;General&#39;)
(&#39;General&#39;, &#39;Email&#39;)
(&#39;Email&#39;, &#39;Only&#39;)
(&#39;Only&#39;, &#39;Gene&#39;)
(&#39;Gene&#39;, &#39;Editing&#39;)
(&#39;Editing&#39;, &#39;Part&#39;)
(&#39;Part&#39;, &#39;2&#39;)
(&#39;2&#39;, &#39;Gene&#39;)
(&#39;Gene&#39;, &#39;Editing&#39;)
(&#39;Editing&#39;, &#39;Gene&#39;)
(&#39;Gene&#39;, &#39;Expression&#39;)
(&#39;Expression&#39;, &#39;Monitoring&#39;)
(&#39;Monitoring&#39;, &#39;Genomics&#39;)
(&#39;Genomics&#39;, &#39;Series&#39;)
(&#39;Series&#39;, &#39;Gene&#39;)
(&#39;Gene&#39;, &#39;Expression&#39;)
(&#39;Expression&#39;, &#39;growth&#39;)
(&#39;growth&#39;, &#39;factors&#39;)
(&#39;factors&#39;, &#39;Gene&#39;)
(&#39;Gene&#39;, &#39;Identification&#39;)
(&#39;Identification&#39;, &#39;genetic&#39;)
(&#39;genetic&#39;, &#39;immunization&#39;)
(&#39;immunization&#39;, &#39;vaccines&#39;)
(&#39;vaccines&#39;, &#39;gene&#39;)
(&#39;gene&#39;, &#39;interference&#39;)
(&#39;interference&#39;, &#39;Gene&#39;)
(&#39;Gene&#39;, &#39;Knockouts&#39;)
(&#39;Knockouts&#39;, &#39;Globalization&#39;)
(&#39;Globalization&#39;, &#39;Genome&#39;)
(&#39;Genome&#39;, &#39;Links&#39;)
(&#39;Links&#39;, &#39;newsletter&#39;)
(&#39;newsletter&#39;, &#39;GLP&#39;)
(&#39;GLP&#39;, &#39;Bioanalysis&#39;)
(&#39;Bioanalysis&#39;, &#39;Leaders&#39;)
(&#39;Leaders&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;Precision&#39;)
(&#39;Precision&#39;, &#39;Medicine&#39;)
(&#39;Medicine&#39;, &#39;Good&#39;)
(&#39;Good&#39;, &#39;Manufacturing&#39;)
(&#39;Manufacturing&#39;, &#39;Practice&#39;)
(&#39;Practice&#39;, &#39;Drugs&#39;)
(&#39;Drugs&#39;, &#39;introductory&#39;)
(&#39;introductory&#39;, &#39;gene&#39;)
(&#39;gene&#39;, &#39;mutations&#39;)
(&#39;mutations&#39;, &#39;genomic&#39;)
(&#39;genomic&#39;, &#39;medicine&#39;)
(&#39;medicine&#39;, &#39;Genotyping&#39;)
(&#39;Genotyping&#39;, &#39;Government&#39;)
(&#39;Government&#39;, &#39;gene&#39;)
(&#39;gene&#39;, &#39;probes&#39;)
(&#39;probes&#39;, &#39;Genomic&#39;)
(&#39;Genomic&#39;, &#39;partnering&#39;)
(&#39;partnering&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Greening&#39;)
(&#39;Greening&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Pharma&#39;)
(&#39;Pharma&#39;, &#39;GPCR&#39;)
(&#39;GPCR&#39;, &#39;Targeted&#39;)
(&#39;Targeted&#39;, &#39;Therapies&#39;)
(&#39;Therapies&#39;, &#39;Grid&#39;)
(&#39;Grid&#39;, &#39;Computing&#39;)
(&#39;Computing&#39;, &#39;Genomic&#39;)
(&#39;Genomic&#39;, &#39;Service&#39;)
(&#39;Service&#39;, &#39;Providers&#39;)
(&#39;Providers&#39;, &#39;Small&#39;)
(&#39;Small&#39;, &#39;GTPases&#39;)
(&#39;GTPases&#39;, &#39;(formerly&#39;)
(&#39;(formerly&#39;, &#39;Gene&#39;)
(&#39;Gene&#39;, &#39;Town&#39;)
(&#39;Town&#39;, &#39;Pass)&#39;)
(&#39;Pass)&#39;, &#39;gene&#39;)
(&#39;gene&#39;, &#39;transcription&#39;)
(&#39;transcription&#39;, &#39;gene&#39;)
(&#39;gene&#39;, &#39;therapy&#39;)
(&#39;therapy&#39;, &#39;technologies&#39;)
(&#39;technologies&#39;, &#39;Whole&#39;)
(&#39;Whole&#39;, &#39;Genome&#39;)
(&#39;Genome&#39;, &#39;Association&#39;)
(&#39;Association&#39;, &#39;Studies&#39;)
(&#39;Studies&#39;, &#39;Humanized&#39;)
(&#39;Humanized&#39;, &#39;Antibodies&#39;)
(&#39;Antibodies&#39;, &#39;high&#39;)
(&#39;high&#39;, &#39;throughput&#39;)
(&#39;throughput&#39;, &#39;analytical&#39;)
(&#39;analytical&#39;, &#39;chemistry&#39;)
(&#39;chemistry&#39;, &#39;Health&#39;)
(&#39;Health&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Beauty&#39;)
(&#39;Beauty&#39;, &#39;Aids&#39;)
(&#39;Aids&#39;, &#39;Hepatitis&#39;)
(&#39;Hepatitis&#39;, &#39;B&#39;)
(&#39;B&#39;, &#39;Virus&#39;)
(&#39;Virus&#39;, &#39;High&#39;)
(&#39;High&#39;, &#39;Content&#39;)
(&#39;Content&#39;, &#39;Analysis&#39;)
(&#39;Analysis&#39;, &#39;Course&#39;)
(&#39;Course&#39;, &#39;HIV&#39;)
(&#39;HIV&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;cancer&#39;)
(&#39;cancer&#39;, &#39;Hematological&#39;)
(&#39;Hematological&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Pipelines&#39;)
(&#39;Pipelines&#39;, &#39;HIV&#39;)
(&#39;HIV&#39;, &#39;clinical&#39;)
(&#39;clinical&#39;, &#39;trials&#39;)
(&#39;trials&#39;, &#39;hepatitis&#39;)
(&#39;hepatitis&#39;, &#39;C&#39;)
(&#39;C&#39;, &#39;virus&#39;)
(&#39;virus&#39;, &#39;Heterocycle&#39;)
(&#39;Heterocycle&#39;, &#39;High&#39;)
(&#39;High&#39;, &#39;Content&#39;)
(&#39;Content&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Analysis&#39;)
(&#39;Analysis&#39;, &#39;HDAC&#39;)
(&#39;HDAC&#39;, &#39;Histone&#39;)
(&#39;Histone&#39;, &#39;Demethylases&#39;)
(&#39;Demethylases&#39;, &#39;Healing&#39;)
(&#39;Healing&#39;, &#39;hematopoesis&#39;)
(&#39;hematopoesis&#39;, &#39;heat&#39;)
(&#39;heat&#39;, &#39;shock&#39;)
(&#39;shock&#39;, &#39;proteins&#39;)
(&#39;proteins&#39;, &#39;Human&#39;)
(&#39;Human&#39;, &#39;Factors&#39;)
(&#39;Factors&#39;, &#39;Engineering&#39;)
(&#39;Engineering&#39;, &#39;Health&#39;)
(&#39;Health&#39;, &#39;Information&#39;)
(&#39;Information&#39;, &#39;Systems&#39;)
(&#39;Systems&#39;, &#39;HIV&#39;)
(&#39;HIV&#39;, &#39;Healthcare&#39;)
(&#39;Healthcare&#39;, &#39;Series&#39;)
(&#39;Series&#39;, &#39;Health&#39;)
(&#39;Health&#39;, &#39;Maintenance&#39;)
(&#39;Maintenance&#39;, &#39;Organizations&#39;)
(&#39;Organizations&#39;, &#39;Human&#39;)
(&#39;Human&#39;, &#39;Tissue&#39;)
(&#39;Tissue&#39;, &#39;Huntingtons&#39;)
(&#39;Huntingtons&#39;, &#39;Disease&#39;)
(&#39;Disease&#39;, &#39;hormones&#39;)
(&#39;hormones&#39;, &#39;HIPAA&#39;)
(&#39;HIPAA&#39;, &#39;#2&#39;)
(&#39;#2&#39;, &#39;High&#39;)
(&#39;High&#39;, &#39;Throughput&#39;)
(&#39;Throughput&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Purification&#39;)
(&#39;Purification&#39;, &#39;High&#39;)
(&#39;High&#39;, &#39;Performing&#39;)
(&#39;Performing&#39;, &#39;Operation&#39;)
(&#39;Operation&#39;, &#39;Human&#39;)
(&#39;Human&#39;, &#39;Papilloma&#39;)
(&#39;Papilloma&#39;, &#39;Virus&#39;)
(&#39;Virus&#39;, &#39;transgenics&#39;)
(&#39;transgenics&#39;, &#39;homologous&#39;)
(&#39;homologous&#39;, &#39;recombinant&#39;)
(&#39;recombinant&#39;, &#39;Human&#39;)
(&#39;Human&#39;, &#39;Relations&#39;)
(&#39;Relations&#39;, &#39;Health&#39;)
(&#39;Health&#39;, &#39;Insurance&#39;)
(&#39;Insurance&#39;, &#39;herpes&#39;)
(&#39;herpes&#39;, &#39;virus&#39;)
(&#39;virus&#39;, &#39;HIV&#39;)
(&#39;HIV&#39;, &#39;Surrogate&#39;)
(&#39;Surrogate&#39;, &#39;Markers&#39;)
(&#39;Markers&#39;, &#39;High&#39;)
(&#39;High&#39;, &#39;Throughput&#39;)
(&#39;Throughput&#39;, &#39;Genomics&#39;)
(&#39;Genomics&#39;, &#39;Hit&#39;)
(&#39;Hit&#39;, &#39;to&#39;)
(&#39;to&#39;, &#39;Lead&#39;)
(&#39;Lead&#39;, &#39;High&#39;)
(&#39;High&#39;, &#39;Throughput&#39;)
(&#39;Throughput&#39;, &#39;Screening&#39;)
(&#39;Screening&#39;, &#39;Hepatotoxicity&#39;)
(&#39;Hepatotoxicity&#39;, &#39;Hybrid&#39;)
(&#39;Hybrid&#39;, &#39;Computing&#39;)
(&#39;Computing&#39;, &#39;hypertension&#39;)
(&#39;hypertension&#39;, &#39;Targeting&#39;)
(&#39;Targeting&#39;, &#39;Antigen&#39;)
(&#39;Antigen&#39;, &#39;Presenting&#39;)
(&#39;Presenting&#39;, &#39;Cells&#39;)
(&#39;Cells&#39;, &#39;Inflammatory&#39;)
(&#39;Inflammatory&#39;, &#39;Bowel&#39;)
(&#39;Bowel&#39;, &#39;Disease&#39;)
(&#39;Disease&#39;, &#39;imaging&#39;)
(&#39;imaging&#39;, &#39;contrast&#39;)
(&#39;contrast&#39;, &#39;agents&#39;)
(&#39;agents&#39;, &#39;interleukin&#39;)
(&#39;interleukin&#39;, &#39;converting&#39;)
(&#39;converting&#39;, &#39;enzymes&#39;)
(&#39;enzymes&#39;, &#39;ICE&#39;)
(&#39;ICE&#39;, &#39;Improving&#39;)
(&#39;Improving&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Safety&#39;)
(&#39;Safety&#39;, &#39;diagnostics&#39;)
(&#39;diagnostics&#39;, &#39;-&#39;)
(&#39;-&#39;, &#39;infections&#39;)
(&#39;infections&#39;, &#39;Infections&#39;)
(&#39;Infections&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;engineering&#39;)
(&#39;engineering&#39;, &#39;laboratories&#39;)
(&#39;laboratories&#39;, &#39;Integrated&#39;)
(&#39;Integrated&#39;, &#39;Fluidic&#39;)
(&#39;Fluidic&#39;, &#39;Circuits&#39;)
(&#39;Circuits&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;DOT&#39;)
(&#39;DOT&#39;, &#39;Informatics&#39;)
(&#39;Informatics&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Genomic&#39;)
(&#39;Genomic&#39;, &#39;Medicine&#39;)
(&#39;Medicine&#39;, &#39;Infection&#39;)
(&#39;Infection&#39;, &#39;Genomics&#39;)
(&#39;Genomics&#39;, &#39;Image&#39;)
(&#39;Image&#39;, &#39;Analysis&#39;)
(&#39;Analysis&#39;, &#39;Immunotherapy&#39;)
(&#39;Immunotherapy&#39;, &#39;Biomarkers&#39;)
(&#39;Biomarkers&#39;, &#39;Immune&#39;)
(&#39;Immune&#39;, &#39;Profiling&#39;)
(&#39;Profiling&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Complement-based&#39;)
(&#39;Complement-based&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Discovery&#39;)
(&#39;Discovery&#39;, &#39;immunomodulation&#39;)
(&#39;immunomodulation&#39;, &#39;Imaging&#39;)
(&#39;Imaging&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;WPC&#39;)
(&#39;WPC&#39;, &#39;conference&#39;)
(&#39;conference&#39;, &#39;Imaging&#39;)
(&#39;Imaging&#39;, &#39;Informatics&#39;)
(&#39;Informatics&#39;, &#39;Immune&#39;)
(&#39;Immune&#39;, &#39;Impurities&#39;)
(&#39;Impurities&#39;, &#39;Regulatory&#39;)
(&#39;Regulatory&#39;, &#39;Immunogenicity&#39;)
(&#39;Immunogenicity&#39;, &#39;Immunosequencing&#39;)
(&#39;Immunosequencing&#39;, &#39;Immuno-Oncology&#39;)
(&#39;Immuno-Oncology&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Developement&#39;)
(&#39;Developement&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Immunotherapy&#39;)
(&#39;Immunotherapy&#39;, &#39;Oligonucleotides&#39;)
(&#39;Oligonucleotides&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Immunotherapy&#39;)
(&#39;Immunotherapy&#39;, &#39;Peptides&#39;)
(&#39;Peptides&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Immunotherapy&#39;)
(&#39;Immunotherapy&#39;, &#39;Small&#39;)
(&#39;Small&#39;, &#39;Molecules&#39;)
(&#39;Molecules&#39;, &#39;Informatics&#39;)
(&#39;Informatics&#39;, &#39;Partnering&#39;)
(&#39;Partnering&#39;, &#39;Insurance&#39;)
(&#39;Insurance&#39;, &#39;AI&#39;)
(&#39;AI&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;IOT&#39;)
(&#39;IOT&#39;, &#39;Investments&#39;)
(&#39;Investments&#39;, &#39;Industrial&#39;)
(&#39;Industrial&#39;, &#39;Enzymes&#39;)
(&#39;Enzymes&#39;, &#39;Immuno-Oncology&#39;)
(&#39;Immuno-Oncology&#39;, &#39;Assays&#39;)
(&#39;Assays&#39;, &#39;Immuno-Oncology&#39;)
(&#39;Immuno-Oncology&#39;, &#39;Business&#39;)
(&#39;Business&#39;, &#39;Strategy&#39;)
(&#39;Strategy&#39;, &#39;Immuno-Oncology&#39;)
(&#39;Immuno-Oncology&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;Immuno-Oncology&#39;)
(&#39;Immuno-Oncology&#39;, &#39;Models&#39;)
(&#39;Models&#39;, &#39;ion&#39;)
(&#39;ion&#39;, &#39;channels&#39;)
(&#39;channels&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Engineering&#39;)
(&#39;Engineering&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Immuno-oncology&#39;)
(&#39;Immuno-oncology&#39;, &#39;Immuno-Oncology&#39;)
(&#39;Immuno-Oncology&#39;, &#39;Sequencing&#39;)
(&#39;Sequencing&#39;, &#39;Immuno-Oncology&#39;)
(&#39;Immuno-Oncology&#39;, &#39;Targets&#39;)
(&#39;Targets&#39;, &#39;Legal&#39;)
(&#39;Legal&#39;, &#39;Issues&#39;)
(&#39;Issues&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Bioproduction&#39;)
(&#39;Bioproduction&#39;, &#39;Intellectual&#39;)
(&#39;Intellectual&#39;, &#39;Property&#39;)
(&#39;Property&#39;, &#39;Pluripotent&#39;)
(&#39;Pluripotent&#39;, &#39;Stem&#39;)
(&#39;Stem&#39;, &#39;Cells&#39;)
(&#39;Cells&#39;, &#39;IRB&#39;)
(&#39;IRB&#39;, &#39;Compliance&#39;)
(&#39;Compliance&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Oversight&#39;)
(&#39;Oversight&#39;, &#39;Considerations&#39;)
(&#39;Considerations&#39;, &#39;Adopting&#39;)
(&#39;Adopting&#39;, &#39;Integrated&#39;)
(&#39;Integrated&#39;, &#39;R&amp;D&#39;)
(&#39;R&amp;D&#39;, &#39;Informatics&#39;)
(&#39;Informatics&#39;, &#39;Systems&#39;)
(&#39;Systems&#39;, &#39;India&#39;)
(&#39;India&#39;, &#39;Re&#39;)
(&#39;Re&#39;, &#39;Engineering&#39;)
(&#39;Engineering&#39;, &#39;International&#39;)
(&#39;International&#39;, &#39;Risk&#39;)
(&#39;Risk&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Discovery&#39;)
(&#39;Discovery&#39;, &#39;Informatics&#39;)
(&#39;Informatics&#39;, &#39;Iron&#39;)
(&#39;Iron&#39;, &#39;Chelation&#39;)
(&#39;Chelation&#39;, &#39;IT&#39;)
(&#39;IT&#39;, &#39;Infrastructure&#39;)
(&#39;Infrastructure&#39;, &#39;Software&#39;)
(&#39;Software&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;situ&#39;)
(&#39;situ&#39;, &#39;hybridization&#39;)
(&#39;hybridization&#39;, &#39;Information&#39;)
(&#39;Information&#39;, &#39;Technology&#39;)
(&#39;Technology&#39;, &#39;IT&#39;)
(&#39;IT&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Informatics&#39;)
(&#39;Informatics&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Collaboration&#39;)
(&#39;Collaboration&#39;, &#39;IT&#39;)
(&#39;IT&#39;, &#39;Infrastructure&#39;)
(&#39;Infrastructure&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Scalable&#39;)
(&#39;Scalable&#39;, &#39;IT&#39;)
(&#39;IT&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Informatics&#39;)
(&#39;Informatics&#39;, &#39;IT&#39;)
(&#39;IT&#39;, &#39;Infrastructure&#39;)
(&#39;Infrastructure&#39;, &#39;computer&#39;)
(&#39;computer&#39;, &#39;hardware&#39;)
(&#39;hardware&#39;, &#39;(part&#39;)
(&#39;(part&#39;, &#39;2)&#39;)
(&#39;2)&#39;, &#39;IT&#39;)
(&#39;IT&#39;, &#39;Infrastructure&#39;)
(&#39;Infrastructure&#39;, &#39;computer&#39;)
(&#39;computer&#39;, &#39;hardware&#39;)
(&#39;hardware&#39;, &#39;(part&#39;)
(&#39;(part&#39;, &#39;3)&#39;)
(&#39;3)&#39;, &#39;IT&#39;)
(&#39;IT&#39;, &#39;Software&#39;)
(&#39;Software&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;the&#39;)
(&#39;the&#39;, &#39;Life&#39;)
(&#39;Life&#39;, &#39;Sciences&#39;)
(&#39;Sciences&#39;, &#39;IT&#39;)
(&#39;IT&#39;, &#39;Infrastructure&#39;)
(&#39;Infrastructure&#39;, &#39;Virtualization&#39;)
(&#39;Virtualization&#39;, &#39;Interviewing&#39;)
(&#39;Interviewing&#39;, &#39;Skills&#39;)
(&#39;Skills&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Managers&#39;)
(&#39;Managers&#39;, &#39;Investigator&#39;)
(&#39;Investigator&#39;, &#39;Sites&#39;)
(&#39;Sites&#39;, &#39;Report&#39;)
(&#39;Report&#39;, &#39;1&#39;)
(&#39;1&#39;, &#39;Investigator&#39;)
(&#39;Investigator&#39;, &#39;Sites&#39;)
(&#39;Sites&#39;, &#39;Report&#39;)
(&#39;Report&#39;, &#39;2&#39;)
(&#39;2&#39;, &#39;Imaging&#39;)
(&#39;Imaging&#39;, &#39;Week&#39;)
(&#39;Week&#39;, &#39;joints&#39;)
(&#39;joints&#39;, &#39;Job&#39;)
(&#39;Job&#39;, &#39;recruiters&#39;)
(&#39;recruiters&#39;, &#39;Kinase&#39;)
(&#39;Kinase&#39;, &#39;Chemistry&#39;)
(&#39;Chemistry&#39;, &#39;KIN&#39;)
(&#39;KIN&#39;, &#39;West&#39;)
(&#39;West&#39;, &#39;Coast&#39;)
(&#39;Coast&#39;, &#39;Kinases&#39;)
(&#39;Kinases&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;DOT&#39;)
(&#39;DOT&#39;, &#39;Knowledge&#39;)
(&#39;Knowledge&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;chemokines&#39;)
(&#39;chemokines&#39;, &#39;HIV&#39;)
(&#39;HIV&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Kaposis&#39;)
(&#39;Kaposis&#39;, &#39;sarcoma&#39;)
(&#39;sarcoma&#39;, &#39;Kinetics&#39;)
(&#39;Kinetics&#39;, &#39;Structure&#39;)
(&#39;Structure&#39;, &#39;Relationship&#39;)
(&#39;Relationship&#39;, &#39;laboratories&#39;)
(&#39;laboratories&#39;, &#39;Lead&#39;)
(&#39;Lead&#39;, &#39;Acid&#39;)
(&#39;Acid&#39;, &#39;Batteries&#39;)
(&#39;Batteries&#39;, &#39;Label&#39;)
(&#39;Label&#39;, &#39;Free&#39;)
(&#39;Free&#39;, &#39;Detection&#39;)
(&#39;Detection&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Labeling&#39;)
(&#39;Labeling&#39;, &#39;Live&#39;)
(&#39;Live&#39;, &#39;Cell&#39;)
(&#39;Cell&#39;, &#39;Imaging&#39;)
(&#39;Imaging&#39;, &#39;Laser&#39;)
(&#39;Laser&#39;, &#39;Capture&#39;)
(&#39;Capture&#39;, &#39;Microdissection&#39;)
(&#39;Microdissection&#39;, &#39;Lung&#39;)
(&#39;Lung&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;ligase&#39;)
(&#39;ligase&#39;, &#39;chain&#39;)
(&#39;chain&#39;, &#39;reaction&#39;)
(&#39;reaction&#39;, &#39;leukodepletion&#39;)
(&#39;leukodepletion&#39;, &#39;Laboratory&#39;)
(&#39;Laboratory&#39;, &#39;Developed&#39;)
(&#39;Developed&#39;, &#39;Tests&#39;)
(&#39;Tests&#39;, &#39;leukemia&#39;)
(&#39;leukemia&#39;, &#39;Ontologies/Lexicons&#39;)
(&#39;Ontologies/Lexicons&#39;, &#39;Legal&#39;)
(&#39;Legal&#39;, &#39;drug&#39;)
(&#39;drug&#39;, &#39;liability&#39;)
(&#39;liability&#39;, &#39;screening&#39;)
(&#39;screening&#39;, &#39;libraries&#39;)
(&#39;libraries&#39;, &#39;Life&#39;)
(&#39;Life&#39;, &#39;Sciences&#39;)
(&#39;Sciences&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Ligands&#39;)
(&#39;Ligands&#39;, &#39;lab&#39;)
(&#39;lab&#39;, &#39;information&#39;)
(&#39;information&#39;, &#39;management&#39;)
(&#39;management&#39;, &#39;systems&#39;)
(&#39;systems&#39;, &#39;LIMS&#39;)
(&#39;LIMS&#39;, &#39;Lipids&#39;)
(&#39;Lipids&#39;, &#39;Large&#39;)
(&#39;Large&#39;, &#39;Stationary&#39;)
(&#39;Stationary&#39;, &#39;Batteries&#39;)
(&#39;Batteries&#39;, &#39;Lyophilization&#39;)
(&#39;Lyophilization&#39;, &#39;Mergers&#39;)
(&#39;Mergers&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Acquisitions&#39;)
(&#39;Acquisitions&#39;, &#39;Monoclonal&#39;)
(&#39;Monoclonal&#39;, &#39;Antibodies&#39;)
(&#39;Antibodies&#39;, &#39;Forum&#39;)
(&#39;Forum&#39;, &#39;Monoclonal&#39;)
(&#39;Monoclonal&#39;, &#39;Antibody&#39;)
(&#39;Antibody&#39;, &#39;Process&#39;)
(&#39;Process&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;Malaria&#39;)
(&#39;Malaria&#39;, &#39;Metabolism&#39;)
(&#39;Metabolism&#39;, &#39;Targeted&#39;)
(&#39;Targeted&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Therapeutics&#39;)
(&#39;Therapeutics&#39;, &#39;Microbiome&#39;)
(&#39;Microbiome&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;Immuno-Oncology&#39;)
(&#39;Immuno-Oncology&#39;, &#39;Microbiome&#39;)
(&#39;Microbiome&#39;, &#39;Metabolic&#39;)
(&#39;Metabolic&#39;, &#39;Syndrome&#39;)
(&#39;Syndrome&#39;, &#39;Medicinal&#39;)
(&#39;Medicinal&#39;, &#39;Chemistry&#39;)
(&#39;Chemistry&#39;, &#39;Part&#39;)
(&#39;Part&#39;, &#39;2&#39;)
(&#39;2&#39;, &#39;Mucosal&#39;)
(&#39;Mucosal&#39;, &#39;Immunity&#39;)
(&#39;Immunity&#39;, &#39;Microreactors&#39;)
(&#39;Microreactors&#39;, &#39;Macrocycles&#39;)
(&#39;Macrocycles&#39;, &#39;Molecular&#39;)
(&#39;Molecular&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Business&#39;)
(&#39;Business&#39;, &#39;Multidrug&#39;)
(&#39;Multidrug&#39;, &#39;Resistance&#39;)
(&#39;Resistance&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Medical&#39;)
(&#39;Medical&#39;, &#39;Coding&#39;)
(&#39;Coding&#39;, &#39;multidrug&#39;)
(&#39;multidrug&#39;, &#39;resistant&#39;)
(&#39;resistant&#39;, &#39;infections&#39;)
(&#39;infections&#39;, &#39;Next&#39;)
(&#39;Next&#39;, &#39;Generation&#39;)
(&#39;Generation&#39;, &#39;Non-Invasive&#39;)
(&#39;Non-Invasive&#39;, &#39;Molecular&#39;)
(&#39;Molecular&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Microdosing&#39;)
(&#39;Microdosing&#39;, &#39;microbial&#39;)
(&#39;microbial&#39;, &#39;infections&#39;)
(&#39;infections&#39;, &#39;Sequencing&#39;)
(&#39;Sequencing&#39;, &#39;Based&#39;)
(&#39;Based&#39;, &#39;Molecular&#39;)
(&#39;Molecular&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Molecular&#39;)
(&#39;Molecular&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Forum&#39;)
(&#39;Forum&#39;, &#39;Molecular&#39;)
(&#39;Molecular&#39;, &#39;Electronics&#39;)
(&#39;Electronics&#39;, &#39;Metabolic&#39;)
(&#39;Metabolic&#39;, &#39;Engineering&#39;)
(&#39;Engineering&#39;, &#39;Melanoma&#39;)
(&#39;Melanoma&#39;, &#39;BioMEMS&#39;)
(&#39;BioMEMS&#39;, &#39;memory&#39;)
(&#39;memory&#39;, &#39;enhancement&#39;)
(&#39;enhancement&#39;, &#39;cancer&#39;)
(&#39;cancer&#39;, &#39;metastasis&#39;)
(&#39;metastasis&#39;, &#39;molecular&#39;)
(&#39;molecular&#39;, &#39;evolution&#39;)
(&#39;evolution&#39;, &#39;Mammalian&#39;)
(&#39;Mammalian&#39;, &#39;Cell&#39;)
(&#39;Cell&#39;, &#39;Line&#39;)
(&#39;Line&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;microfabrication&#39;)
(&#39;microfabrication&#39;, &#39;Molecular&#39;)
(&#39;Molecular&#39;, &#39;Genetic&#39;)
(&#39;Genetic&#39;, &#39;Pro&#39;)
(&#39;Pro&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;molecular&#39;)
(&#39;molecular&#39;, &#39;medicine&#39;)
(&#39;medicine&#39;, &#39;Novel&#39;)
(&#39;Novel&#39;, &#39;bioactive&#39;)
(&#39;bioactive&#39;, &#39;high&#39;)
(&#39;high&#39;, &#39;throughput&#39;)
(&#39;throughput&#39;, &#39;screening&#39;)
(&#39;screening&#39;, &#39;europe&#39;)
(&#39;europe&#39;, &#39;Myocardial&#39;)
(&#39;Myocardial&#39;, &#39;Infarction&#39;)
(&#39;Infarction&#39;, &#39;migraine&#39;)
(&#39;migraine&#39;, &#39;microtiter&#39;)
(&#39;microtiter&#39;, &#39;plates&#39;)
(&#39;plates&#39;, &#39;Molecular&#39;)
(&#39;Molecular&#39;, &#39;Medicine&#39;)
(&#39;Medicine&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;metalloproteinases&#39;)
(&#39;metalloproteinases&#39;, &#39;Molecular&#39;)
(&#39;Molecular&#39;, &#39;Medicine&#39;)
(&#39;Medicine&#39;, &#39;Asia&#39;)
(&#39;Asia&#39;, &#39;Managed&#39;)
(&#39;Managed&#39;, &#39;Care&#39;)
(&#39;Care&#39;, &#39;Manufacturing&#39;)
(&#39;Manufacturing&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trial&#39;)
(&#39;Trial&#39;, &#39;Monitoring&#39;)
(&#39;Monitoring&#39;, &#39;Mechanism&#39;)
(&#39;Mechanism&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Action&#39;)
(&#39;Action&#39;, &#39;Purifying&#39;)
(&#39;Purifying&#39;, &#39;Antibodies&#39;)
(&#39;Antibodies&#39;, &#39;Meeting&#39;)
(&#39;Meeting&#39;, &#39;Planning&#39;)
(&#39;Planning&#39;, &#39;Services&#39;)
(&#39;Services&#39;, &#39;Molecular&#39;)
(&#39;Molecular&#39;, &#39;Pathology&#39;)
(&#39;Pathology&#39;, &#39;Molecular&#39;)
(&#39;Molecular&#39;, &#39;Pathology&#39;)
(&#39;Pathology&#39;, &#39;Basic&#39;)
(&#39;Basic&#39;, &#39;Molecular&#39;)
(&#39;Molecular&#39;, &#39;Pathology&#39;)
(&#39;Pathology&#39;, &#39;Advanced&#39;)
(&#39;Advanced&#39;, &#39;magnetic&#39;)
(&#39;magnetic&#39;, &#39;resonance&#39;)
(&#39;resonance&#39;, &#39;imaging&#39;)
(&#39;imaging&#39;, &#39;Multi&#39;)
(&#39;Multi&#39;, &#39;Specific&#39;)
(&#39;Specific&#39;, &#39;Antibodies&#39;)
(&#39;Antibodies&#39;, &#39;Mass&#39;)
(&#39;Mass&#39;, &#39;Spectrometry&#39;)
(&#39;Spectrometry&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Biomarker&#39;)
(&#39;Biomarker&#39;, &#39;Discovery&#39;)
(&#39;Discovery&#39;, &#39;Muscle&#39;)
(&#39;Muscle&#39;, &#39;Mass&#39;)
(&#39;Mass&#39;, &#39;Spec&#39;)
(&#39;Spec&#39;, &#39;Informatics&#39;)
(&#39;Informatics&#39;, &#39;Mass&#39;)
(&#39;Mass&#39;, &#39;Spec&#39;)
(&#39;Spec&#39;, &#39;Imaging&#39;)
(&#39;Imaging&#39;, &#39;Modeling&#39;)
(&#39;Modeling&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Simulation&#39;)
(&#39;Simulation&#39;, &#39;Mass&#39;)
(&#39;Mass&#39;, &#39;spectrometry&#39;)
(&#39;spectrometry&#39;, &#39;Mass&#39;)
(&#39;Mass&#39;, &#39;Spec&#39;)
(&#39;Spec&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Metabolic&#39;)
(&#39;Metabolic&#39;, &#39;Disorders&#39;)
(&#39;Disorders&#39;, &#39;Mental&#39;)
(&#39;Mental&#39;, &#39;Health&#39;)
(&#39;Health&#39;, &#39;Materials&#39;)
(&#39;Materials&#39;, &#39;Testing&#39;)
(&#39;Testing&#39;, &#39;cellular&#39;)
(&#39;cellular&#39;, &#39;matrix&#39;)
(&#39;matrix&#39;, &#39;Multiplexed&#39;)
(&#39;Multiplexed&#39;, &#39;Assays&#39;)
(&#39;Assays&#39;, &#39;Moelcular&#39;)
(&#39;Moelcular&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Molecular&#39;)
(&#39;Molecular&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Molecular&#39;)
(&#39;Molecular&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Infectious&#39;)
(&#39;Infectious&#39;, &#39;Disease&#39;)
(&#39;Disease&#39;, &#39;Next&#39;)
(&#39;Next&#39;, &#39;Generation&#39;)
(&#39;Generation&#39;, &#39;Antibodies&#39;)
(&#39;Antibodies&#39;, &#39;Next&#39;)
(&#39;Next&#39;, &#39;Generation&#39;)
(&#39;Generation&#39;, &#39;Antibodies&#39;)
(&#39;Antibodies&#39;, &#39;(for&#39;)
(&#39;(for&#39;, &#39;PGE)&#39;)
(&#39;PGE)&#39;, &#39;Nucleic&#39;)
(&#39;Nucleic&#39;, &#39;Acid&#39;)
(&#39;Acid&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;National&#39;)
(&#39;National&#39;, &#39;Academy&#39;)
(&#39;Academy&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Sciences&#39;)
(&#39;Sciences&#39;, &#39;meeting&#39;)
(&#39;meeting&#39;, &#39;natural&#39;)
(&#39;natural&#39;, &#39;products&#39;)
(&#39;products&#39;, &#39;new&#39;)
(&#39;new&#39;, &#39;antivirals&#39;)
(&#39;antivirals&#39;, &#39;Novel&#39;)
(&#39;Novel&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Informatics&#39;)
(&#39;Informatics&#39;, &#39;Non-Coding&#39;)
(&#39;Non-Coding&#39;, &#39;RNA&#39;)
(&#39;RNA&#39;, &#39;Novel&#39;)
(&#39;Novel&#39;, &#39;Strategies&#39;)
(&#39;Strategies&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Novel&#39;)
(&#39;Novel&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Targets&#39;)
(&#39;Targets&#39;, &#39;Neurodegenerative&#39;)
(&#39;Neurodegenerative&#39;, &#39;Nucleotide&#39;)
(&#39;Nucleotide&#39;, &#39;Delivery&#39;)
(&#39;Delivery&#39;, &#39;Internet&#39;)
(&#39;Internet&#39;, &#39;New&#39;)
(&#39;New&#39;, &#39;to&#39;)
(&#39;to&#39;, &#39;Database&#39;)
(&#39;Database&#39;, &#39;comapny&#39;)
(&#39;comapny&#39;, &#39;names&#39;)
(&#39;names&#39;, &#39;Advances&#39;)
(&#39;Advances&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;Informatics&#39;)
(&#39;Informatics&#39;, &#39;nerve&#39;)
(&#39;nerve&#39;, &#39;growth&#39;)
(&#39;growth&#39;, &#39;factors&#39;)
(&#39;factors&#39;, &#39;NF&#39;)
(&#39;NF&#39;, &#39;KB&#39;)
(&#39;KB&#39;, &#39;Nanofluidics&#39;)
(&#39;Nanofluidics&#39;, &#39;Informatics&#39;)
(&#39;Informatics&#39;, &#39;Next-Generation&#39;)
(&#39;Next-Generation&#39;, &#39;Batteries&#39;)
(&#39;Batteries&#39;, &#39;Next&#39;)
(&#39;Next&#39;, &#39;Generation&#39;)
(&#39;Generation&#39;, &#39;Batteries&#39;)
(&#39;Batteries&#39;, &#39;Portable&#39;)
(&#39;Portable&#39;, &#39;Applications&#39;)
(&#39;Applications&#39;, &#39;Next&#39;)
(&#39;Next&#39;, &#39;Generation&#39;)
(&#39;Generation&#39;, &#39;Batteries&#39;)
(&#39;Batteries&#39;, &#39;Stationary&#39;)
(&#39;Stationary&#39;, &#39;Power&#39;)
(&#39;Power&#39;, &#39;Epigenetic&#39;)
(&#39;Epigenetic&#39;, &#39;Sequencing&#39;)
(&#39;Sequencing&#39;, &#39;Next&#39;)
(&#39;Next&#39;, &#39;Generation&#39;)
(&#39;Generation&#39;, &#39;Imaging&#39;)
(&#39;Imaging&#39;, &#39;Neurogenomics&#39;)
(&#39;Neurogenomics&#39;, &#39;Nuclear&#39;)
(&#39;Nuclear&#39;, &#39;Hormone&#39;)
(&#39;Hormone&#39;, &#39;Receptors&#39;)
(&#39;Receptors&#39;, &#39;Novel&#39;)
(&#39;Novel&#39;, &#39;HIV&#39;)
(&#39;HIV&#39;, &#39;Strategies&#39;)
(&#39;Strategies&#39;, &#39;Neurotech&#39;)
(&#39;Neurotech&#39;, &#39;Industry&#39;)
(&#39;Industry&#39;, &#39;neuroinjuries&#39;)
(&#39;neuroinjuries&#39;, &#39;NK&#39;)
(&#39;NK&#39;, &#39;Cell&#39;)
(&#39;Cell&#39;, &#39;Based&#39;)
(&#39;Based&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Immunotherapy&#39;)
(&#39;Immunotherapy&#39;, &#39;Natural&#39;)
(&#39;Natural&#39;, &#39;Language&#39;)
(&#39;Language&#39;, &#39;Processing&#39;)
(&#39;Processing&#39;, &#39;nuclear&#39;)
(&#39;nuclear&#39;, &#39;matrix&#39;)
(&#39;matrix&#39;, &#39;Nanomedicine&#39;)
(&#39;Nanomedicine&#39;, &#39;Nitric&#39;)
(&#39;Nitric&#39;, &#39;Oxide&#39;)
(&#39;Oxide&#39;, &#39;Network&#39;)
(&#39;Network&#39;, &#39;Pharmacology&#39;)
(&#39;Pharmacology&#39;, &#39;Energy&#39;)
(&#39;Energy&#39;, &#39;Neurotoxicity&#39;)
(&#39;Neurotoxicity&#39;, &#39;New&#39;)
(&#39;New&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Approval&#39;)
(&#39;Approval&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;the&#39;)
(&#39;the&#39;, &#39;US&#39;)
(&#39;US&#39;, &#39;nanotech&#39;)
(&#39;nanotech&#39;, &#39;self&#39;)
(&#39;self&#39;, &#39;assembly&#39;)
(&#39;assembly&#39;, &#39;Internet&#39;)
(&#39;Internet&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Supply&#39;)
(&#39;Supply&#39;, &#39;Chain&#39;)
(&#39;Chain&#39;, &#39;Internet&#39;)
(&#39;Internet&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Supply&#39;)
(&#39;Supply&#39;, &#39;Chain&#39;)
(&#39;Chain&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Neurostimulation&#39;)
(&#39;Neurostimulation&#39;, &#39;Internet&#39;)
(&#39;Internet&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Diagnostic&#39;)
(&#39;Diagnostic&#39;, &#39;Things&#39;)
(&#39;Things&#39;, &#39;Internet&#39;)
(&#39;Internet&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Energy&#39;)
(&#39;Energy&#39;, &#39;Internet&#39;)
(&#39;Internet&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Energy&#39;)
(&#39;Energy&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Internet&#39;)
(&#39;Internet&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Things&#39;)
(&#39;Things&#39;, &#39;Infrastructure&#39;)
(&#39;Infrastructure&#39;, &#39;Internet&#39;)
(&#39;Internet&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Health&#39;)
(&#39;Health&#39;, &#39;Internet&#39;)
(&#39;Internet&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Insurance&#39;)
(&#39;Insurance&#39;, &#39;Internet&#39;)
(&#39;Internet&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Insurance&#39;)
(&#39;Insurance&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Internet&#39;)
(&#39;Internet&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Things&#39;)
(&#39;Things&#39;, &#39;Manufacturing&#39;)
(&#39;Manufacturing&#39;, &#39;Internet&#39;)
(&#39;Internet&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Things&#39;)
(&#39;Things&#39;, &#39;Manufacturing&#39;)
(&#39;Manufacturing&#39;, &#39;Internet&#39;)
(&#39;Internet&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Manufacturing&#39;)
(&#39;Manufacturing&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Smart&#39;)
(&#39;Smart&#39;, &#39;Buildings&#39;)
(&#39;Buildings&#39;, &#39;Smart&#39;)
(&#39;Smart&#39;, &#39;Cities&#39;)
(&#39;Cities&#39;, &#39;Nephrotoxicity&#39;)
(&#39;Nephrotoxicity&#39;, &#39;Nuclear&#39;)
(&#39;Nuclear&#39;, &#39;Energy&#39;)
(&#39;Energy&#39;, &#39;nutrition&#39;)
(&#39;nutrition&#39;, &#39;Optimizing&#39;)
(&#39;Optimizing&#39;, &#39;Media&#39;)
(&#39;Media&#39;, &#39;organ&#39;)
(&#39;organ&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;cell&#39;)
(&#39;cell&#39;, &#39;transplants&#39;)
(&#39;transplants&#39;, &#39;Oncology&#39;)
(&#39;Oncology&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Targets&#39;)
(&#39;Targets&#39;, &#39;Optical&#39;)
(&#39;Optical&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Oncogenomics&#39;)
(&#39;Oncogenomics&#39;, &#39;Office&#39;)
(&#39;Office&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;the&#39;)
(&#39;the&#39;, &#39;Inspector&#39;)
(&#39;Inspector&#39;, &#39;General&#39;)
(&#39;General&#39;, &#39;Oil&#39;)
(&#39;Oil&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Gas&#39;)
(&#39;Gas&#39;, &#39;oncogenes&#39;)
(&#39;oncogenes&#39;, &#39;Oncolytic&#39;)
(&#39;Oncolytic&#39;, &#39;Viruses&#39;)
(&#39;Viruses&#39;, &#39;Oligo&#39;)
(&#39;Oligo&#39;, &#39;Production&#39;)
(&#39;Production&#39;, &#39;opportunistic&#39;)
(&#39;opportunistic&#39;, &#39;infections&#39;)
(&#39;infections&#39;, &#39;Oligo&#39;)
(&#39;Oligo&#39;, &#39;Regulatory&#39;)
(&#39;Regulatory&#39;, &#39;organs&#39;)
(&#39;organs&#39;, &#39;transplants&#39;)
(&#39;transplants&#39;, &#39;oral&#39;)
(&#39;oral&#39;, &#39;drug&#39;)
(&#39;drug&#39;, &#39;delivery&#39;)
(&#39;delivery&#39;, &#39;OSTEOARTHRITIS&#39;)
(&#39;OSTEOARTHRITIS&#39;, &#39;OTC&#39;)
(&#39;OTC&#39;, &#39;over&#39;)
(&#39;over&#39;, &#39;the&#39;)
(&#39;the&#39;, &#39;counter&#39;)
(&#39;counter&#39;, &#39;Additional&#39;)
(&#39;Additional&#39;, &#39;Conferences&#39;)
(&#39;Conferences&#39;, &#39;clinical&#39;)
(&#39;clinical&#39;, &#39;trials&#39;)
(&#39;trials&#39;, &#39;outsourcing&#39;)
(&#39;outsourcing&#39;, &#39;Oxygen&#39;)
(&#39;Oxygen&#39;, &#39;Radicals&#39;)
(&#39;Radicals&#39;, &#39;oncogenes&#39;)
(&#39;oncogenes&#39;, &#39;p53&#39;)
(&#39;p53&#39;, &#39;Predictive&#39;)
(&#39;Predictive&#39;, &#39;ADME&#39;)
(&#39;ADME&#39;, &#39;protein&#39;)
(&#39;protein&#39;, &#39;aggregation&#39;)
(&#39;aggregation&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Aggregation&#39;)
(&#39;Aggregation&#39;, &#39;(for&#39;)
(&#39;(for&#39;, &#39;PTK)&#39;)
(&#39;PTK)&#39;, &#39;Packaging&#39;)
(&#39;Packaging&#39;, &#39;parasitic&#39;)
(&#39;parasitic&#39;, &#39;infections&#39;)
(&#39;infections&#39;, &#39;Process&#39;)
(&#39;Process&#39;, &#39;Analytical&#39;)
(&#39;Analytical&#39;, &#39;Technology&#39;)
(&#39;Technology&#39;, &#39;Pharmacy&#39;)
(&#39;Pharmacy&#39;, &#39;Benefit&#39;)
(&#39;Benefit&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Pharmaceutical&#39;)
(&#39;Pharmaceutical&#39;, &#39;BioProcess&#39;)
(&#39;BioProcess&#39;, &#39;Basic&#39;)
(&#39;Basic&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Discovery&#39;)
(&#39;Discovery&#39;, &#39;track&#39;)
(&#39;track&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;PCG&#39;)
(&#39;PCG&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Operations&#39;)
(&#39;Operations&#39;, &#39;track&#39;)
(&#39;track&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;PCG&#39;)
(&#39;PCG&#39;, &#39;Preclinical&#39;)
(&#39;Preclinical&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;track&#39;)
(&#39;track&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;PCG&#39;)
(&#39;PCG&#39;, &#39;Bridgehead&#39;)
(&#39;Bridgehead&#39;, &#39;PCI&#39;)
(&#39;PCI&#39;, &#39;book&#39;)
(&#39;book&#39;, &#39;Preclinical&#39;)
(&#39;Preclinical&#39;, &#39;Preclinical&#39;)
(&#39;Preclinical&#39;, &#39;Preclinical&#39;)
(&#39;Preclinical&#39;, &#39;prostate&#39;)
(&#39;prostate&#39;, &#39;cancer&#39;)
(&#39;cancer&#39;, &#39;Preclinical&#39;)
(&#39;Preclinical&#39;, &#39;Outcome&#39;)
(&#39;Outcome&#39;, &#39;Predictions&#39;)
(&#39;Predictions&#39;, &#39;preclinical&#39;)
(&#39;preclinical&#39;, &#39;trials&#39;)
(&#39;trials&#39;, &#39;Point&#39;)
(&#39;Point&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Care&#39;)
(&#39;Care&#39;, &#39;West&#39;)
(&#39;West&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Crystallography&#39;)
(&#39;Crystallography&#39;, &#39;pediatric&#39;)
(&#39;pediatric&#39;, &#39;AIDS/HIV&#39;)
(&#39;AIDS/HIV&#39;, &#39;PDA&#39;)
(&#39;PDA&#39;, &#39;Downloads&#39;)
(&#39;Downloads&#39;, &#39;from&#39;)
(&#39;from&#39;, &#39;CHI&#39;)
(&#39;CHI&#39;, &#39;website&#39;)
(&#39;website&#39;, &#39;Process&#39;)
(&#39;Process&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Executives&#39;)
(&#39;Executives&#39;, &#39;platelet&#39;)
(&#39;platelet&#39;, &#39;derived&#39;)
(&#39;derived&#39;, &#39;growth&#39;)
(&#39;growth&#39;, &#39;factors&#39;)
(&#39;factors&#39;, &#39;protein&#39;)
(&#39;protein&#39;, &#39;drug&#39;)
(&#39;drug&#39;, &#39;delivery&#39;)
(&#39;delivery&#39;, &#39;Preclinical&#39;)
(&#39;Preclinical&#39;, &#39;Disease&#39;)
(&#39;Disease&#39;, &#39;Models&#39;)
(&#39;Models&#39;, &#39;photodynamic&#39;)
(&#39;photodynamic&#39;, &#39;therapies&#39;)
(&#39;therapies&#39;, &#39;Phage&#39;)
(&#39;Phage&#39;, &#39;Display&#39;)
(&#39;Display&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Vaccine&#39;)
(&#39;Vaccine&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;Proteomic&#39;)
(&#39;Proteomic&#39;, &#39;Tools&#39;)
(&#39;Tools&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;pediatric&#39;)
(&#39;pediatric&#39;, &#39;Pediatric&#39;)
(&#39;Pediatric&#39;, &#39;trials&#39;)
(&#39;trials&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;CRAS&#39;)
(&#39;CRAS&#39;, &#39;PEGS&#39;)
(&#39;PEGS&#39;, &#39;Virtual&#39;)
(&#39;Virtual&#39;, &#39;Interactive&#39;)
(&#39;Interactive&#39;, &#39;Global&#39;)
(&#39;Global&#39;, &#39;Summit&#39;)
(&#39;Summit&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Expression&#39;)
(&#39;Expression&#39;, &#39;Monitoring&#39;)
(&#39;Monitoring&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Executive&#39;)
(&#39;Executive&#39;, &#39;Summit&#39;)
(&#39;Summit&#39;, &#39;Proof&#39;)
(&#39;Proof&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Concept&#39;)
(&#39;Concept&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Function&#39;)
(&#39;Function&#39;, &#39;Enterprise&#39;)
(&#39;Enterprise&#39;, &#39;Portfolio&#39;)
(&#39;Portfolio&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Portfolio&#39;)
(&#39;Portfolio&#39;, &#39;Value&#39;)
(&#39;Value&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Aggregates&#39;)
(&#39;Aggregates&#39;, &#39;Light&#39;)
(&#39;Light&#39;, &#39;Scattering&#39;)
(&#39;Scattering&#39;, &#39;Consumer&#39;)
(&#39;Consumer&#39;, &#39;Genomics/Personal&#39;)
(&#39;Genomics/Personal&#39;, &#39;Genomics&#39;)
(&#39;Genomics&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Engineering&#39;)
(&#39;Engineering&#39;, &#39;Partnering&#39;)
(&#39;Partnering&#39;, &#39;Particulate&#39;)
(&#39;Particulate&#39;, &#39;Screening&#39;)
(&#39;Screening&#39;, &#39;Phage&#39;)
(&#39;Phage&#39;, &#39;West&#39;)
(&#39;West&#39;, &#39;Phase&#39;)
(&#39;Phase&#39;, &#39;II/Reducing&#39;)
(&#39;II/Reducing&#39;, &#39;Attrition&#39;)
(&#39;Attrition&#39;, &#39;Phase&#39;)
(&#39;Phase&#39;, &#39;IV&#39;)
(&#39;IV&#39;, &#39;Phase&#39;)
(&#39;Phase&#39;, &#39;IV&#39;)
(&#39;IV&#39;, &#39;Pharmacies&#39;)
(&#39;Pharmacies&#39;, &#39;Phage&#39;)
(&#39;Phage&#39;, &#39;Display&#39;)
(&#39;Display&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Pharmaceutical&#39;)
(&#39;Pharmaceutical&#39;, &#39;Half&#39;)
(&#39;Half&#39;, &#39;Life&#39;)
(&#39;Life&#39;, &#39;Phase&#39;)
(&#39;Phase&#39;, &#39;Zero&#39;)
(&#39;Zero&#39;, &#39;PI3K&#39;)
(&#39;PI3K&#39;, &#39;Phosphoinositide&#39;)
(&#39;Phosphoinositide&#39;, &#39;3&#39;)
(&#39;3&#39;, &#39;Kinase&#39;)
(&#39;Kinase&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Identification&#39;)
(&#39;Identification&#39;, &#39;Preclinical&#39;)
(&#39;Preclinical&#39;, &#39;Imaging&#39;)
(&#39;Imaging&#39;, &#39;protease&#39;)
(&#39;protease&#39;, &#39;inhibitors&#39;)
(&#39;inhibitors&#39;, &#39;enzymes&#39;)
(&#39;enzymes&#39;, &#39;PLA2&#39;)
(&#39;PLA2&#39;, &#39;blood&#39;)
(&#39;blood&#39;, &#39;platelets&#39;)
(&#39;platelets&#39;, &#39;Membrane&#39;)
(&#39;Membrane&#39;, &#39;Proteins&#39;)
(&#39;Proteins&#39;, &#39;Membrane&#39;)
(&#39;Membrane&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;DOT&#39;)
(&#39;DOT&#39;, &#39;(part&#39;)
(&#39;(part&#39;, &#39;1)&#39;)
(&#39;1)&#39;, &#39;Membrane&#39;)
(&#39;Membrane&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;DOT&#39;)
(&#39;DOT&#39;, &#39;(part&#39;)
(&#39;(part&#39;, &#39;2)&#39;)
(&#39;2)&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Manufacturing&#39;)
(&#39;Manufacturing&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Project&#39;)
(&#39;Project&#39;, &#39;Management:&#39;)
(&#39;Management:&#39;, &#39;Intermediate&#39;)
(&#39;Intermediate&#39;, &#39;Preventive&#39;)
(&#39;Preventive&#39;, &#39;Medicine&#39;)
(&#39;Medicine&#39;, &#39;Pancreatic&#39;)
(&#39;Pancreatic&#39;, &#39;Cancer&#39;)
(&#39;Cancer&#39;, &#39;Preclinical&#39;)
(&#39;Preclinical&#39;, &#39;Studies&#39;)
(&#39;Studies&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;IND&#39;)
(&#39;IND&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Computational&#39;)
(&#39;Computational&#39;, &#39;Tools&#39;)
(&#39;Tools&#39;, &#39;Prenatal&#39;)
(&#39;Prenatal&#39;, &#39;Therapeutics&#39;)
(&#39;Therapeutics&#39;, &#39;Parenteral&#39;)
(&#39;Parenteral&#39;, &#39;Point&#39;)
(&#39;Point&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Care&#39;)
(&#39;Care&#39;, &#39;Diagnostics&#39;)
(&#39;Diagnostics&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Cannabis&#39;)
(&#39;Cannabis&#39;, &#39;Power&#39;)
(&#39;Power&#39;, &#39;Utilities&#39;)
(&#39;Utilities&#39;, &#39;protein&#39;)
(&#39;protein&#39;, &#39;characterization&#39;)
(&#39;characterization&#39;, &#39;protein&#39;)
(&#39;protein&#39;, &#39;purification&#39;)
(&#39;purification&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Interactions&#39;)
(&#39;Interactions&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Interactions&#39;)
(&#39;Interactions&#39;, &#39;Part&#39;)
(&#39;Part&#39;, &#39;2&#39;)
(&#39;2&#39;, &#39;Process&#39;)
(&#39;Process&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Process&#39;)
(&#39;Process&#39;, &#39;PepTalk&#39;)
(&#39;PepTalk&#39;, &#39;Partnering&#39;)
(&#39;Partnering&#39;, &#39;Personalized&#39;)
(&#39;Personalized&#39;, &#39;Medicine&#39;)
(&#39;Medicine&#39;, &#39;Partnering&#39;)
(&#39;Partnering&#39;, &#39;Proteomics&#39;)
(&#39;Proteomics&#39;, &#39;Analytics&#39;)
(&#39;Analytics&#39;, &#39;Predictive&#39;)
(&#39;Predictive&#39;, &#39;Analytics&#39;)
(&#39;Analytics&#39;, &#39;Pricing&#39;)
(&#39;Pricing&#39;, &#39;Parkinsons&#39;)
(&#39;Parkinsons&#39;, &#39;Predictive&#39;)
(&#39;Predictive&#39;, &#39;Biomedicine&#39;)
(&#39;Biomedicine&#39;, &#39;Proteins,&#39;)
(&#39;Proteins,&#39;, &#39;Peptides&#39;)
(&#39;Peptides&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Proteomics&#39;)
(&#39;Proteomics&#39;, &#39;Series&#39;)
(&#39;Series&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Quantification&#39;)
(&#39;Quantification&#39;, &#39;Partnering&#39;)
(&#39;Partnering&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Privacy&#39;)
(&#39;Privacy&#39;, &#39;Personalized&#39;)
(&#39;Personalized&#39;, &#39;Medicine&#39;)
(&#39;Medicine&#39;, &#39;Asia&#39;)
(&#39;Asia&#39;, &#39;Product&#39;)
(&#39;Product&#39;, &#39;Service&#39;)
(&#39;Service&#39;, &#39;Announcement&#39;)
(&#39;Announcement&#39;, &#39;Production&#39;)
(&#39;Production&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Scale&#39;)
(&#39;Scale&#39;, &#39;Up&#39;)
(&#39;Up&#39;, &#39;Pharma&#39;)
(&#39;Pharma&#39;, &#39;Services&#39;)
(&#39;Services&#39;, &#39;News&#39;)
(&#39;News&#39;, &#39;schizophrenia&#39;)
(&#39;schizophrenia&#39;, &#39;antipsychotics&#39;)
(&#39;antipsychotics&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Antibodies&#39;)
(&#39;Antibodies&#39;, &#39;Preclinical&#39;)
(&#39;Preclinical&#39;, &#39;Toxicology&#39;)
(&#39;Toxicology&#39;, &#39;Biologics&#39;)
(&#39;Biologics&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Technology&#39;)
(&#39;Technology&#39;, &#39;Engineering&#39;)
(&#39;Engineering&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Therapeutics&#39;)
(&#39;Therapeutics&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Delivery&#39;)
(&#39;Delivery&#39;, &#39;Predictive&#39;)
(&#39;Predictive&#39;, &#39;Toxicity&#39;)
(&#39;Toxicity&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Platform&#39;)
(&#39;Platform&#39;, &#39;Software&#39;)
(&#39;Software&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;R&amp;D&#39;)
(&#39;R&amp;D&#39;, &#39;Studies&#39;)
(&#39;Studies&#39;, &#39;Phenotype&#39;)
(&#39;Phenotype&#39;, &#39;to&#39;)
(&#39;to&#39;, &#39;Genotype&#39;)
(&#39;Genotype&#39;, &#39;Pathology&#39;)
(&#39;Pathology&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;drugs&#39;)
(&#39;drugs&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;diagnostics&#39;)
(&#39;diagnostics&#39;, &#39;Intellectual&#39;)
(&#39;Intellectual&#39;, &#39;Property&#39;)
(&#39;Property&#39;, &#39;Post&#39;)
(&#39;Post&#39;, &#39;Translational&#39;)
(&#39;Translational&#39;, &#39;Modifications&#39;)
(&#39;Modifications&#39;, &#39;Patient&#39;)
(&#39;Patient&#39;, &#39;Registries&#39;)
(&#39;Registries&#39;, &#39;Advancing&#39;)
(&#39;Advancing&#39;, &#39;Therapeutics&#39;)
(&#39;Therapeutics&#39;, &#39;Current&#39;)
(&#39;Current&#39;, &#39;Generation&#39;)
(&#39;Generation&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Delivery&#39;)
(&#39;Delivery&#39;, &#39;(part&#39;)
(&#39;(part&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;PepTalk)&#39;)
(&#39;PepTalk)&#39;, &#39;Advancing&#39;)
(&#39;Advancing&#39;, &#39;Therapeutics&#39;)
(&#39;Therapeutics&#39;, &#39;Next&#39;)
(&#39;Next&#39;, &#39;Generation&#39;)
(&#39;Generation&#39;, &#39;Biological&#39;)
(&#39;Biological&#39;, &#39;Therapeutic&#39;)
(&#39;Therapeutic&#39;, &#39;Products&#39;)
(&#39;Products&#39;, &#39;Series&#39;)
(&#39;Series&#39;, &#39;Pathway/Networks&#39;)
(&#39;Pathway/Networks&#39;, &#39;Publications&#39;)
(&#39;Publications&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Variations&#39;)
(&#39;Variations&#39;, &#39;Powertrains&#39;)
(&#39;Powertrains&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Characterization,&#39;)
(&#39;Characterization,&#39;, &#39;Purification&#39;)
(&#39;Purification&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Screening&#39;)
(&#39;Screening&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Characterization,&#39;)
(&#39;Characterization,&#39;, &#39;Purification&#39;)
(&#39;Purification&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Screening&#39;)
(&#39;Screening&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Expression&#39;)
(&#39;Expression&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Beyond&#39;)
(&#39;Beyond&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Expression&#39;)
(&#39;Expression&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Expression&#39;)
(&#39;Expression&#39;, &#39;Host&#39;)
(&#39;Host&#39;, &#39;Novel&#39;)
(&#39;Novel&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Expression&#39;)
(&#39;Expression&#39;, &#39;Systems&#39;)
(&#39;Systems&#39;, &#39;Protein&#39;)
(&#39;Protein&#39;, &#39;Engineering&#39;)
(&#39;Engineering&#39;, &#39;Vectors&#39;)
(&#39;Vectors&#39;, &#39;Preventive&#39;)
(&#39;Preventive&#39;, &#39;gene&#39;)
(&#39;gene&#39;, &#39;quantification&#39;)
(&#39;quantification&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;QS&#39;)
(&#39;QS&#39;, &#39;Regulation&#39;)
(&#39;Regulation&#39;, &#39;Recombinant&#39;)
(&#39;Recombinant&#39;, &#39;Antibodies&#39;)
(&#39;Antibodies&#39;, &#39;Recombinant&#39;)
(&#39;Recombinant&#39;, &#39;Antibodies&#39;)
(&#39;Antibodies&#39;, &#39;Recombinant&#39;)
(&#39;Recombinant&#39;, &#39;Proteins&#39;)
(&#39;Proteins&#39;, &#39;Forum&#39;)
(&#39;Forum&#39;, &#39;Radiation&#39;)
(&#39;Radiation&#39;, &#39;Rare&#39;)
(&#39;Rare&#39;, &#39;Diseases&#39;)
(&#39;Diseases&#39;, &#39;Antibody&#39;)
(&#39;Antibody&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Products&#39;)
(&#39;Products&#39;, &#39;RBE&#39;)
(&#39;RBE&#39;, &#39;track&#39;)
(&#39;track&#39;, &#39;at&#39;)
(&#39;at&#39;, &#39;PGE&#39;)
(&#39;PGE&#39;, &#39;RBE&#39;)
(&#39;RBE&#39;, &#39;track&#39;)
(&#39;track&#39;, &#39;at&#39;)
(&#39;at&#39;, &#39;PGE&#39;)
(&#39;PGE&#39;, &#39;Antibody&#39;)
(&#39;Antibody&#39;, &#39;Screening&#39;)
(&#39;Screening&#39;, &#39;Antibody&#39;)
(&#39;Antibody&#39;, &#39;Translational&#39;)
(&#39;Translational&#39;, &#39;rapid&#39;)
(&#39;rapid&#39;, &#39;compound&#39;)
(&#39;compound&#39;, &#39;characterization&#39;)
(&#39;characterization&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Enrollment&#39;)
(&#39;Enrollment&#39;, &#39;Plan&#39;)
(&#39;Plan&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Recruitment&#39;)
(&#39;Recruitment&#39;, &#39;Media&#39;)
(&#39;Media&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Trials&#39;)
(&#39;Trials&#39;, &#39;Patient&#39;)
(&#39;Patient&#39;, &#39;Recruitment&#39;)
(&#39;Recruitment&#39;, &#39;Winning&#39;)
(&#39;Winning&#39;, &#39;Strategies&#39;)
(&#39;Strategies&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Recruitment&#39;)
(&#39;Recruitment&#39;, &#39;Media&#39;)
(&#39;Media&#39;, &#39;Integrating&#39;)
(&#39;Integrating&#39;, &#39;R&amp;D&#39;)
(&#39;R&amp;D&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Marketing&#39;)
(&#39;Marketing&#39;, &#39;R&amp;D&#39;)
(&#39;R&amp;D&#39;, &#39;Productivity&#39;)
(&#39;Productivity&#39;, &#39;drug&#39;)
(&#39;drug&#39;, &#39;receptors&#39;)
(&#39;receptors&#39;, &#39;Role&#39;)
(&#39;Role&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;Business&#39;)
(&#39;Business&#39;, &#39;Process&#39;)
(&#39;Process&#39;, &#39;Managment&#39;)
(&#39;Managment&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;FDA&#39;)
(&#39;FDA&#39;, &#39;Regulated&#39;)
(&#39;Regulated&#39;, &#39;Industry&#39;)
(&#39;Industry&#39;, &#39;Worldwide&#39;)
(&#39;Worldwide&#39;, &#39;Pharma&#39;)
(&#39;Pharma&#39;, &#39;Regulation&#39;)
(&#39;Regulation&#39;, &#39;Surviving&#39;)
(&#39;Surviving&#39;, &#39;FDA&#39;)
(&#39;FDA&#39;, &#39;Site&#39;)
(&#39;Site&#39;, &#39;Inspections&#39;)
(&#39;Inspections&#39;, &#39;Real&#39;)
(&#39;Real&#39;, &#39;Estate&#39;)
(&#39;Estate&#39;, &#39;Risk&#39;)
(&#39;Risk&#39;, &#39;Evaluation&#39;)
(&#39;Evaluation&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Mitigation&#39;)
(&#39;Mitigation&#39;, &#39;Strategies&#39;)
(&#39;Strategies&#39;, &#39;Renal&#39;)
(&#39;Renal&#39;, &#39;(kidney)&#39;)
(&#39;(kidney)&#39;, &#39;Renewable&#39;)
(&#39;Renewable&#39;, &#39;Energy&#39;)
(&#39;Energy&#39;, &#39;Storage&#39;)
(&#39;Storage&#39;, &#39;System&#39;)
(&#39;System&#39;, &#39;RFID&#39;)
(&#39;RFID&#39;, &#39;Radiofrequency&#39;)
(&#39;Radiofrequency&#39;, &#39;ID&#39;)
(&#39;ID&#39;, &#39;Reagents&#39;)
(&#39;Reagents&#39;, &#39;Gap&#39;)
(&#39;Gap&#39;, &#39;Analysis&#39;)
(&#39;Analysis&#39;, &#39;rheumatoid&#39;)
(&#39;rheumatoid&#39;, &#39;arthritis&#39;)
(&#39;arthritis&#39;, &#39;gene&#39;)
(&#39;gene&#39;, &#39;therapy&#39;)
(&#39;therapy&#39;, &#39;[RNA&#39;)
(&#39;[RNA&#39;, &#39;blocking]&#39;)
(&#39;blocking]&#39;, &#39;Ribonucleic&#39;)
(&#39;Ribonucleic&#39;, &#39;Acid&#39;)
(&#39;Acid&#39;, &#39;RNAi&#39;)
(&#39;RNAi&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Functional&#39;)
(&#39;Functional&#39;, &#39;Screening&#39;)
(&#39;Screening&#39;, &#39;RNAi&#39;)
(&#39;RNAi&#39;, &#39;RNAInterference&#39;)
(&#39;RNAInterference&#39;, &#39;RNAi&#39;)
(&#39;RNAi&#39;, &#39;Discovery&#39;)
(&#39;Discovery&#39;, &#39;on&#39;)
(&#39;on&#39;, &#39;Target&#39;)
(&#39;Target&#39;, &#39;RNAi&#39;)
(&#39;RNAi&#39;, &#39;Video&#39;)
(&#39;Video&#39;, &#39;on&#39;)
(&#39;on&#39;, &#39;Request&#39;)
(&#39;Request&#39;, &#39;RNA&#39;)
(&#39;RNA&#39;, &#39;Quality&#39;)
(&#39;Quality&#39;, &#39;RNA&#39;)
(&#39;RNA&#39;, &#39;Therapeutics&#39;)
(&#39;Therapeutics&#39;, &#39;Robotics&#39;)
(&#39;Robotics&#39;, &#39;Regional&#39;)
(&#39;Regional&#39;, &#39;Organization&#39;)
(&#39;Organization&#39;, &#39;Robotic&#39;)
(&#39;Robotic&#39;, &#39;Process&#39;)
(&#39;Process&#39;, &#39;Automation&#39;)
(&#39;Automation&#39;, &#39;reperfusion&#39;)
(&#39;reperfusion&#39;, &#39;Reproduction&#39;)
(&#39;Reproduction&#39;, &#39;Gene&#39;)
(&#39;Gene&#39;, &#39;Regulation&#39;)
(&#39;Regulation&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Regulatory&#39;)
(&#39;Regulatory&#39;, &#39;Networks&#39;)
(&#39;Networks&#39;, &#39;Restenosis&#39;)
(&#39;Restenosis&#39;, &#39;Retail&#39;)
(&#39;Retail&#39;, &#39;Real&#39;)
(&#39;Real&#39;, &#39;World&#39;)
(&#39;World&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Therapeutics&#39;)
(&#39;Therapeutics&#39;, &#39;Indications&#39;)
(&#39;Indications&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Targets&#39;)
(&#39;Targets&#39;, &#39;Series&#39;)
(&#39;Series&#39;, &#39;safety&#39;)
(&#39;safety&#39;, &#39;Screening&#39;)
(&#39;Screening&#39;, &#39;3D&#39;)
(&#39;3D&#39;, &#39;Models&#39;)
(&#39;Models&#39;, &#39;Sickle&#39;)
(&#39;Sickle&#39;, &#39;Cell&#39;)
(&#39;Cell&#39;, &#39;Anemia&#39;)
(&#39;Anemia&#39;, &#39;Screening&#39;)
(&#39;Screening&#39;, &#39;Informatics&#39;)
(&#39;Informatics&#39;, &#39;Sequencing&#39;)
(&#39;Sequencing&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Cloud&#39;)
(&#39;Cloud&#39;, &#39;Computing&#39;)
(&#39;Computing&#39;, &#39;supply&#39;)
(&#39;supply&#39;, &#39;chain&#39;)
(&#39;chain&#39;, &#39;management&#39;)
(&#39;management&#39;, &#39;SCOPEs&#39;)
(&#39;SCOPEs&#39;, &#39;Clinical&#39;)
(&#39;Clinical&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Leadership&#39;)
(&#39;Leadership&#39;, &#39;Forum&#39;)
(&#39;Forum&#39;, &#39;Phenotypic&#39;)
(&#39;Phenotypic&#39;, &#39;Screening&#39;)
(&#39;Screening&#39;, &#39;Phenotypic&#39;)
(&#39;Phenotypic&#39;, &#39;Screening&#39;)
(&#39;Screening&#39;, &#39;clinical&#39;)
(&#39;clinical&#39;, &#39;trials&#39;)
(&#39;trials&#39;, &#39;strategy&#39;)
(&#39;strategy&#39;, &#39;IT&#39;)
(&#39;IT&#39;, &#39;Security&#39;)
(&#39;Security&#39;, &#39;Sequence&#39;)
(&#39;Sequence&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Analysis&#39;)
(&#39;Analysis&#39;, &#39;Sequence&#39;)
(&#39;Sequence&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Analysis&#39;)
(&#39;Analysis&#39;, &#39;Asia&#39;)
(&#39;Asia&#39;, &#39;Sidec&#39;)
(&#39;Sidec&#39;, &#39;Executive&#39;)
(&#39;Executive&#39;, &#39;Forum&#39;)
(&#39;Forum&#39;, &#39;Sequence&#39;)
(&#39;Sequence&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Analysis&#39;)
(&#39;Analysis&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Sleeper&#39;)
(&#39;Sleeper&#39;, &#39;Disease&#39;)
(&#39;Disease&#39;, &#39;Indications&#39;)
(&#39;Indications&#39;, &#39;Sequencing&#39;)
(&#39;Sequencing&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Storage&#39;)
(&#39;Storage&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Screening&#39;)
(&#39;Screening&#39;, &#39;Difficult&#39;)
(&#39;Difficult&#39;, &#39;Targets&#39;)
(&#39;Targets&#39;, &#39;Source&#39;)
(&#39;Source&#39;, &#39;Document&#39;)
(&#39;Document&#39;, &#39;Verification&#39;)
(&#39;Verification&#39;, &#39;Sequencing&#39;)
(&#39;Sequencing&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Analysis&#39;)
(&#39;Analysis&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Storage&#39;)
(&#39;Storage&#39;, &#39;second&#39;)
(&#39;second&#39;, &#39;messengers&#39;)
(&#39;messengers&#39;, &#39;sepsis&#39;)
(&#39;sepsis&#39;, &#39;infections&#39;)
(&#39;infections&#39;, &#39;Sequencing&#39;)
(&#39;Sequencing&#39;, &#39;Forum&#39;)
(&#39;Forum&#39;, &#39;Serotonin&#39;)
(&#39;Serotonin&#39;, &#39;Sexual&#39;)
(&#39;Sexual&#39;, &#39;Small&#39;)
(&#39;Small&#39;, &#39;Fuel&#39;)
(&#39;Fuel&#39;, &#39;Cells&#39;)
(&#39;Cells&#39;, &#39;selective&#39;)
(&#39;selective&#39;, &#39;immune&#39;)
(&#39;immune&#39;, &#39;suppression&#39;)
(&#39;suppression&#39;, &#39;skin&#39;)
(&#39;skin&#39;, &#39;sleep&#39;)
(&#39;sleep&#39;, &#39;Pharmaceutical&#39;)
(&#39;Pharmaceutical&#39;, &#39;Sales&#39;)
(&#39;Sales&#39;, &#39;Biologics&#39;)
(&#39;Biologics&#39;, &#39;Small&#39;)
(&#39;Small&#39;, &#39;Molecular&#39;)
(&#39;Molecular&#39;, &#39;Comparisons&#39;)
(&#39;Comparisons&#39;, &#39;Semiconductors&#39;)
(&#39;Semiconductors&#39;, &#39;small&#39;)
(&#39;small&#39;, &#39;molecules&#39;)
(&#39;molecules&#39;, &#39;simple&#39;)
(&#39;simple&#39;, &#39;model&#39;)
(&#39;model&#39;, &#39;organisms&#39;)
(&#39;organisms&#39;, &#39;Small&#39;)
(&#39;Small&#39;, &#39;Molecules&#39;)
(&#39;Molecules&#39;, &#39;Synthesis&#39;)
(&#39;Synthesis&#39;, &#39;Semantic&#39;)
(&#39;Semantic&#39;, &#39;Web&#39;)
(&#39;Web&#39;, &#39;Sensor&#39;)
(&#39;Sensor&#39;, &#39;Applications&#39;)
(&#39;Applications&#39;, &#39;Synthetic&#39;)
(&#39;Synthetic&#39;, &#39;Biology&#39;)
(&#39;Biology&#39;, &#39;Sensor&#39;)
(&#39;Sensor&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Management&#39;)
(&#39;Management&#39;, &#39;Implantable&#39;)
(&#39;Implantable&#39;, &#39;Biomedical&#39;)
(&#39;Biomedical&#39;, &#39;Sensors&#39;)
(&#39;Sensors&#39;, &#39;Sensor&#39;)
(&#39;Sensor&#39;, &#39;Materials&#39;)
(&#39;Materials&#39;, &#39;Sensors&#39;)
(&#39;Sensors&#39;, &#39;Emerging&#39;)
(&#39;Emerging&#39;, &#39;Markets&#39;)
(&#39;Markets&#39;, &#39;SNPs&#39;)
(&#39;SNPs&#39;, &#39;Sensor&#39;)
(&#39;Sensor&#39;, &#39;Systems&#39;)
(&#39;Systems&#39;, &#39;Sensor&#39;)
(&#39;Sensor&#39;, &#39;Safety&#39;)
(&#39;Safety&#39;, &#39;software&#39;)
(&#39;software&#39;, &#39;Solubility&#39;)
(&#39;Solubility&#39;, &#39;Safety&#39;)
(&#39;Safety&#39;, &#39;Pharmacology&#39;)
(&#39;Pharmacology&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Biologics&#39;)
(&#39;Biologics&#39;, &#39;Safety&#39;)
(&#39;Safety&#39;, &#39;Pharmacology&#39;)
(&#39;Pharmacology&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Biologics&#39;)
(&#39;Biologics&#39;, &#39;Genomic&#39;)
(&#39;Genomic&#39;, &#39;Sample&#39;)
(&#39;Sample&#39;, &#39;Preparation&#39;)
(&#39;Preparation&#39;, &#39;Speciality&#39;)
(&#39;Speciality&#39;, &#39;Pharmaceuticals&#39;)
(&#39;Pharmaceuticals&#39;, &#39;Alternative&#39;)
(&#39;Alternative&#39;, &#39;Splicing&#39;)
(&#39;Splicing&#39;, &#39;Proteomic&#39;)
(&#39;Proteomic&#39;, &#39;Sample&#39;)
(&#39;Sample&#39;, &#39;Preparation&#39;)
(&#39;Preparation&#39;, &#39;High&#39;)
(&#39;High&#39;, &#39;throughput&#39;)
(&#39;throughput&#39;, &#39;screening&#39;)
(&#39;screening&#39;, &#39;partnering&#39;)
(&#39;partnering&#39;, &#39;solid&#39;)
(&#39;solid&#39;, &#39;phase&#39;)
(&#39;phase&#39;, &#39;synthesis&#39;)
(&#39;synthesis&#39;, &#39;Subjective&#39;)
(&#39;Subjective&#39;, &#39;End&#39;)
(&#39;End&#39;, &#39;Points&#39;)
(&#39;Points&#39;, &#39;Next&#39;)
(&#39;Next&#39;, &#39;Generation&#39;)
(&#39;Generation&#39;, &#39;Sequencing&#39;)
(&#39;Sequencing&#39;, &#39;Applications&#39;)
(&#39;Applications&#39;, &#39;Sequencing&#39;)
(&#39;Sequencing&#39;, &#39;Core&#39;)
(&#39;Core&#39;, &#39;Labs&#39;)
(&#39;Labs&#39;, &#39;Next-Generation&#39;)
(&#39;Next-Generation&#39;, &#39;Data&#39;)
(&#39;Data&#39;, &#39;Generation&#39;)
(&#39;Generation&#39;, &#39;Plant&#39;)
(&#39;Plant&#39;, &#39;Sequencing&#39;)
(&#39;Sequencing&#39;, &#39;RNA&#39;)
(&#39;RNA&#39;, &#39;Sequencing&#39;)
(&#39;Sequencing&#39;, &#39;Sequencing&#39;)
(&#39;Sequencing&#39;, &#39;Solutions&#39;)
(&#39;Solutions&#39;, &#39;Deep&#39;)
(&#39;Deep&#39;, &#39;Sequencing&#39;)
(&#39;Sequencing&#39;, &#39;EU&#39;)
(&#39;EU&#39;, &#39;Site&#39;)
(&#39;Site&#39;, &#39;Selection,&#39;)
(&#39;Selection,&#39;, &#39;Study&#39;)
(&#39;Study&#39;, &#39;Activation,&#39;)
(&#39;Activation,&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Patient&#39;)
(&#39;Patient&#39;, &#39;Recruitment&#39;)
(&#39;Recruitment&#39;, &#39;Stability&#39;)
(&#39;Stability&#39;, &#39;stroke&#39;)
(&#39;stroke&#39;, &#39;Stem&#39;)
(&#39;Stem&#39;, &#39;Cell&#39;)
(&#39;Cell&#39;, &#39;Culture&#39;)
(&#39;Culture&#39;, &#39;Stem&#39;)
(&#39;Stem&#39;, &#39;Cell&#39;)
(&#39;Cell&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;(part&#39;)
(&#39;(part&#39;, &#39;of&#39;)
(&#39;of&#39;, &#39;MMTC)&#39;)
(&#39;MMTC)&#39;, &#39;Statin&#39;)
(&#39;Statin&#39;, &#39;Stem&#39;)
(&#39;Stem&#39;, &#39;Cells&#39;)
(&#39;Cells&#39;, &#39;Safety&#39;)
(&#39;Safety&#39;, &#39;Screening&#39;)
(&#39;Screening&#39;, &#39;Startup&#39;)
(&#39;Startup&#39;, &#39;Public&#39;)
(&#39;Public&#39;, &#39;companies/stock&#39;)
(&#39;companies/stock&#39;, &#39;exchanges&#39;)
(&#39;exchanges&#39;, &#39;CHI&#39;)
(&#39;CHI&#39;, &#39;Surveys&#39;)
(&#39;Surveys&#39;, &#39;Services&#39;)
(&#39;Services&#39;, &#39;Systems&#39;)
(&#39;Systems&#39;, &#39;Biology&#39;)
(&#39;Biology&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;BYG&#39;)
(&#39;BYG&#39;, &#39;track&#39;)
(&#39;track&#39;, &#39;synthesis&#39;)
(&#39;synthesis&#39;, &#39;Systems&#39;)
(&#39;Systems&#39;, &#39;Biology&#39;)
(&#39;Biology&#39;, &#39;Training&#39;)
(&#39;Training&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Development&#39;)
(&#39;Development&#39;, &#39;Top&#39;)
(&#39;Top&#39;, &#39;50&#39;)
(&#39;50&#39;, &#39;Big&#39;)
(&#39;Big&#39;, &#39;Pharmas&#39;)
(&#39;Pharmas&#39;, &#39;Tissue&#39;)
(&#39;Tissue&#39;, &#39;Microarrays&#39;)
(&#39;Microarrays&#39;, &#39;taxol&#39;)
(&#39;taxol&#39;, &#39;tamoxifen&#39;)
(&#39;tamoxifen&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;other&#39;)
(&#39;other&#39;, &#39;derivatives&#39;)
(&#39;derivatives&#39;, &#39;Tuberculosis&#39;)
(&#39;Tuberculosis&#39;, &#39;Tobacco&#39;)
(&#39;Tobacco&#39;, &#39;The&#39;)
(&#39;The&#39;, &#39;Biotech&#39;)
(&#39;Biotech&#39;, &#39;Journal&#39;)
(&#39;Journal&#39;, &#39;Email&#39;)
(&#39;Email&#39;, &#39;List&#39;)
(&#39;List&#39;, &#39;Trust&#39;)
(&#39;Trust&#39;, &#39;Building&#39;)
(&#39;Building&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Collaborative&#39;)
(&#39;Collaborative&#39;, &#39;Innovation&#39;)
(&#39;Innovation&#39;, &#39;Tumor,&#39;)
(&#39;Tumor,&#39;, &#39;Circulating&#39;)
(&#39;Circulating&#39;, &#39;Cells&#39;)
(&#39;Cells&#39;, &#39;Technology&#39;)
(&#39;Technology&#39;, &#39;Technology&#39;)
(&#39;Technology&#39;, &#39;Consortium&#39;)
(&#39;Consortium&#39;, &#39;Target&#39;)
(&#39;Target&#39;, &#39;Driven&#39;)
(&#39;Driven&#39;, &#39;Chemistry&#39;)
(&#39;Chemistry&#39;, &#39;targeted&#39;)
(&#39;targeted&#39;, &#39;drug&#39;)
(&#39;drug&#39;, &#39;delivery&#39;)
(&#39;delivery&#39;, &#39;transgenic&#39;)
(&#39;transgenic&#39;, &#39;disease&#39;)
(&#39;disease&#39;, &#39;models&#39;)
(&#39;models&#39;, &#39;Thrombotic&#39;)
(&#39;Thrombotic&#39;, &#39;Disease&#39;)
(&#39;Disease&#39;, &#39;tissue&#39;)
(&#39;tissue&#39;, &#39;engineering&#39;)
(&#39;engineering&#39;, &#39;telomerases&#39;)
(&#39;telomerases&#39;, &#39;Battery&#39;)
(&#39;Battery&#39;, &#39;Testing&#39;)
(&#39;Testing&#39;, &#39;Transfection&#39;)
(&#39;Transfection&#39;, &#39;Toxicogenomics&#39;)
(&#39;Toxicogenomics&#39;, &#39;Target&#39;)
(&#39;Target&#39;, &#39;Prioritization&#39;)
(&#39;Prioritization&#39;, &#39;Target&#39;)
(&#39;Target&#39;, &#39;Identification&#39;)
(&#39;Identification&#39;, &#39;tissues&#39;)
(&#39;tissues&#39;, &#39;Technology&#39;)
(&#39;Technology&#39;, &#39;Platforms&#39;)
(&#39;Platforms&#39;, &#39;Immunotherapies&#39;)
(&#39;Immunotherapies&#39;, &#39;Telecommunications&#39;)
(&#39;Telecommunications&#39;, &#39;Telemedicine&#39;)
(&#39;Telemedicine&#39;, &#39;Tumor&#39;)
(&#39;Tumor&#39;, &#39;Microenvironment&#39;)
(&#39;Microenvironment&#39;, &#39;Trial&#39;)
(&#39;Trial&#39;, &#39;Master&#39;)
(&#39;Master&#39;, &#39;File&#39;)
(&#39;File&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Sponsors&#39;)
(&#39;Sponsors&#39;, &#39;(pharma)&#39;)
(&#39;(pharma)&#39;, &#39;Trial&#39;)
(&#39;Trial&#39;, &#39;Master&#39;)
(&#39;Master&#39;, &#39;File&#39;)
(&#39;File&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Research&#39;)
(&#39;Research&#39;, &#39;Sites&#39;)
(&#39;Sites&#39;, &#39;Theranostic&#39;)
(&#39;Theranostic&#39;, &#39;Market&#39;)
(&#39;Market&#39;, &#39;Models&#39;)
(&#39;Models&#39;, &#39;tumor&#39;)
(&#39;tumor&#39;, &#39;necrosis&#39;)
(&#39;necrosis&#39;, &#39;factors&#39;)
(&#39;factors&#39;, &#39;Therapeutics&#39;)
(&#39;Therapeutics&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Targets&#39;)
(&#39;Targets&#39;, &#39;Therapeutics&#39;)
(&#39;Therapeutics&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Targets&#39;)
(&#39;Targets&#39;, &#39;Series&#39;)
(&#39;Series&#39;, &#39;immune&#39;)
(&#39;immune&#39;, &#39;tolerance&#39;)
(&#39;tolerance&#39;, &#39;Fibrinolytic&#39;)
(&#39;Fibrinolytic&#39;, &#39;(clot&#39;)
(&#39;(clot&#39;, &#39;buster)&#39;)
(&#39;buster)&#39;, &#39;Transgenic&#39;)
(&#39;Transgenic&#39;, &#39;Production&#39;)
(&#39;Production&#39;, &#39;in&#39;)
(&#39;in&#39;, &#39;Plants&#39;)
(&#39;Plants&#39;, &#39;Synthetic&#39;)
(&#39;Synthetic&#39;, &#39;Biology&#39;)
(&#39;Biology&#39;, &#39;Transportation&#39;)
(&#39;Transportation&#39;, &#39;Translational&#39;)
(&#39;Translational&#39;, &#39;Biomarkers&#39;)
(&#39;Biomarkers&#39;, &#39;Translational&#39;)
(&#39;Translational&#39;, &#39;Informatics&#39;)
(&#39;Informatics&#39;, &#39;Drug/Disease&#39;)
(&#39;Drug/Disease&#39;, &#39;Targets&#39;)
(&#39;Targets&#39;, &#39;Drug&#39;)
(&#39;Drug&#39;, &#39;Targets&#39;)
(&#39;Targets&#39;, &#39;Series&#39;)
(&#39;Series&#39;, &#39;Genome&#39;)
(&#39;Genome&#39;, &#39;Tri&#39;)
(&#39;Tri&#39;, &#39;Conference&#39;)
(&#39;Conference&#39;, &#39;Translation&#39;)
(&#39;Translation&#39;, &#39;Services&#39;)
(&#39;Services&#39;, &#39;transgenics&#39;)
(&#39;transgenics&#39;, &#39;gene&#39;)
(&#39;gene&#39;, &#39;knockouts&#39;)
(&#39;knockouts&#39;, &#39;transgenic&#39;)
(&#39;transgenic&#39;, &#39;production&#39;)
(&#39;production&#39;, &#39;Tumor&#39;)
(&#39;Tumor&#39;, &#39;Suppressor&#39;)
(&#39;Suppressor&#39;, &#39;Genes&#39;)
(&#39;Genes&#39;, &#39;tissue&#39;)
(&#39;tissue&#39;, &#39;safety&#39;)
(&#39;safety&#39;, &#39;Technology&#39;)
(&#39;Technology&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Tools&#39;)
(&#39;Tools&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;the&#39;)
(&#39;the&#39;, &#39;Life&#39;)
(&#39;Life&#39;, &#39;Sciences&#39;)
(&#39;Sciences&#39;, &#39;Technology&#39;)
(&#39;Technology&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Tools&#39;)
(&#39;Tools&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Life&#39;)
(&#39;Life&#39;, &#39;Sciences&#39;)
(&#39;Sciences&#39;, &#39;Series&#39;)
(&#39;Series&#39;, &#39;Target&#39;)
(&#39;Target&#39;, &#39;Validation&#39;)
(&#39;Validation&#39;, &#39;Text&#39;)
(&#39;Text&#39;, &#39;Mining&#39;)
(&#39;Mining&#39;, &#39;Unmanned&#39;)
(&#39;Unmanned&#39;, &#39;Aerial&#39;)
(&#39;Aerial&#39;, &#39;Vehicles&#39;)
(&#39;Vehicles&#39;, &#39;Ubiquitin&#39;)
(&#39;Ubiquitin&#39;, &#39;Uninterruptible&#39;)
(&#39;Uninterruptible&#39;, &#39;Power&#39;)
(&#39;Power&#39;, &#39;Supplies&#39;)
(&#39;Supplies&#39;, &#39;upcoming&#39;)
(&#39;upcoming&#39;, &#39;conferences&#39;)
(&#39;conferences&#39;, &#39;upcoming&#39;)
(&#39;upcoming&#39;, &#39;conferences&#39;)
(&#39;conferences&#39;, &#39;Europe&#39;)
(&#39;Europe&#39;, &#39;Urinary&#39;)
(&#39;Urinary&#39;, &#39;Incontinence&#39;)
(&#39;Incontinence&#39;, &#39;New&#39;)
(&#39;New&#39;, &#39;USP&#39;)
(&#39;USP&#39;, &#39;Initiatives&#39;)
(&#39;Initiatives&#39;, &#39;and&#39;)
(&#39;and&#39;, &#39;Standards&#39;)
(&#39;Standards&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Biologics&#39;)
(&#39;Biologics&#39;, &#39;unstable&#39;)
(&#39;unstable&#39;, &#39;triplets&#39;)
(&#39;triplets&#39;, &#39;trinucleotide&#39;)
(&#39;trinucleotide&#39;, &#39;repeats&#39;)
(&#39;repeats&#39;, &#39;Vaccines&#39;)
(&#39;Vaccines&#39;, &#39;(for&#39;)
(&#39;(for&#39;, &#39;IMT)&#39;)
(&#39;IMT)&#39;, &#39;Vascular&#39;)
(&#39;Vascular&#39;, &#39;Vaccines&#39;)
(&#39;Vaccines&#39;, &#39;Business&#39;)
(&#39;Business&#39;, &#39;Opportunities&#39;)
(&#39;Opportunities&#39;, &#39;Venture&#39;)
(&#39;Venture&#39;, &#39;Capital&#39;)
(&#39;Capital&#39;, &#39;Business&#39;)
(&#39;Business&#39;, &#39;Opportunities&#39;)
(&#39;Opportunities&#39;, &#39;Vaccines&#39;)
(&#39;Vaccines&#39;, &#39;Voice&#39;)
(&#39;Voice&#39;, &#39;Recognition&#39;)
(&#39;Recognition&#39;, &#39;Paperless&#39;)
(&#39;Paperless&#39;, &#39;Validation&#39;)
(&#39;Validation&#39;, &#39;veterinary&#39;)
(&#39;veterinary&#39;, &#39;viral&#39;)
(&#39;viral&#39;, &#39;infections&#39;)
(&#39;infections&#39;, &#39;Vaccines&#39;)
(&#39;Vaccines&#39;, &#39;Production&#39;)
(&#39;Production&#39;, &#39;&amp;&#39;)
(&#39;&amp;&#39;, &#39;Manufacturing&#39;)
(&#39;Manufacturing&#39;, &#39;Virtual&#39;)
(&#39;Virtual&#39;, &#39;Reality&#39;)
(&#39;Reality&#39;, &#39;virtual&#39;)
(&#39;virtual&#39;, &#39;business&#39;)
(&#39;business&#39;, &#39;Virtual&#39;)
(&#39;Virtual&#39;, &#39;Teams&#39;)
(&#39;Teams&#39;, &#39;Single&#39;)
(&#39;Single&#39;, &#39;Use&#39;)
(&#39;Use&#39;, &#39;Systems&#39;)
(&#39;Systems&#39;, &#39;for&#39;)
(&#39;for&#39;, &#39;Vaccine&#39;)
(&#39;Vaccine&#39;, &#39;Manufacture&#39;)
(&#39;Manufacture&#39;, &#39;well&#39;)
(&#39;well&#39;, &#39;characterized&#39;)
(&#39;characterized&#39;, &#39;biologicals&#39;)
(&#39;biologicals&#39;, &#39;Wellness&#39;)
(&#39;Wellness&#39;, &#39;Wiki&#39;)
(&#39;Wiki&#39;, &#39;wound&#39;)
(&#39;wound&#39;, &#39;management&#39;)
(&#39;management&#39;, &#39;Wireless&#39;)
(&#39;Wireless&#39;, &#39;Change&#39;)
(&#39;Change&#39;, &#39;Record&#39;)
(&#39;Record&#39;, &#39;Change&#39;)
(&#39;Change&#39;, &#39;Record&#39;)
(&#39;Record&#39;, &#39;Mary&#39;)
(&#39;Mary&#39;, &#39;Chitty&#39;)
(&#39;Chitty&#39;, &#39;Xenotransplantation&#39;)
(&#39;Xenotransplantation&#39;, &#39;Yeast&#39;)
(&#39;Yeast&#39;, &#39;Display&#39;)
(&#39;Display&#39;, &#39;Zika&#39;)
(&#39;Zika&#39;, &#39;Vaccine&#39;)
(&#39;Vaccine&#39;, &#39;Development&#39;)
</pre>
</div>
</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[12]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="kn">from</span> <span class="nn">spacy.lang.en</span> <span class="k">import</span> <span class="n">English</span>

<span class="c1"># Load English tokenizer, tagger, parser, NER and word vectors</span>
<span class="n">nlp</span> <span class="o">=</span> <span class="n">English</span><span class="p">()</span>

<span class="n">text</span> <span class="o">=</span> <span class="s2">&quot;&quot;&quot;Molecular Medicine Tri Conference Protein Engineering Peptalk Biocomputing SCOPE Summit for Clinical Trials Operations Executives bioproduction Discovery on Target PEGS Europe Drug Discovery Chemistry World Pharmaceutical Congress advanced diagnostics Advanced Automotive Battery Conference (AABC) Europe Florida Battery Conference Biomarkers Congress High Content Analysis Advanced Automotive Battery Conference (AABC) Immunogenicity CRA &amp; CRC Beginner Biopharmaceutical Change Control Beyond Genome Immunotherapy Alliance Management Strategies Targeted ImvacS Clinical Trials Molecular Medicine Marketplace Molecular Diagnostics Europe CRA Beginner AI World Data Driven Discovery R&amp;D Strategies Strategic Resource Allocation kinases Auditing Clinical Research Studies Accelerating Development &amp; Advancing Personalized Therapy X Gen Congress Biodefense &amp; Enabling POC Diagnostics &amp; Microarray Data Analysis Human Genome Project Biobanks Structure Based Design Batteries Portfolio Quantitative PCR Health Information Technology Auditing Techniques for Clinical Research Professionals Good Clinical Practice Question &amp; Answer REference Guide CFR/ICH GCP Immunotherapy Europe Gene Amplification PCR eStats: R&amp;D Statistical Sourcebook MicroRNA microarray data analysis Intelliigent Drug Discovery &amp; Development (now WPC) Monitoring Clinical Drug Studies: Beginner Comprehensive Monitoring for Medical Devices Introduction to Clinical Project Management Bioprocessing Summit Europe Oligonucleotide &amp; Peptide Summit World Pharma Week Prenatal Diagnostics Getting Optimized Targets Library Design &amp; Synthesis Clinical Project Management functional genomics bacterial infections Advanced Automotive Battery Conference (AABC) Asia Good Clinical Practice Q&amp;A Reference Guide Screening Transmissible spongiform encephalopathy TSE Biomarker Discovery Summit Clinical Genomics Sequencing ASAP Alliance Summit Bioterrorism microarrays Pharmaceutical Leadership Summit Circulating Cell-Free DNA Conducting Clinical Trials Under ICH GCP Bio IT Europe Trial Master File Biomarkers World Preclinical Congress Europe BioMEMS bioinformatics Genomic Partnering NMR nuclear magnetic resonance Clinical Data Management Biomarker Validation proteomics Statistics Sensors Global Summit New Drug Development A Regulatory Overview Drug Safety Pharmacy Diagnostics sample preparation Clinical Trial Design Pharmacovigilance Metabolic Profiling Digital PCR Good Clinical Practice for Clinical Trials Lab chips Europe Monitoring Clinical Drug Studies: Intermediate Preparing IND Submissions Antibody Engineering Asia Clinical Project Management: Intermediate phage display CELLutions Recombinant Antibodies imaging Biomarker Assay Development in silico biology Advanced Good Clinical Practice High Throughput Optimization of Culture Conditions for Bioprocessing High Throughput Technologies gene quantfication [real time PCR] From Gene Expression Profiling to Validated Biology Clinical Project Management: Advanced SCOPE Summit Europe CNS Partnering Genomics on Target R&amp;D Statistical Sourcebook MultiUser License Medical Device Development Biological ADME Protein Expression blood safety and screening Human Proteome Project Project Management high throughput organic synthesis Global Preclinical Development Clinical Research Coordinator Global Drug Development India Biomarker Diagnostics molecular diversity functional genomics Process R&amp;D Summit Cloud Computing bioinformatics Europe Target Validation Bispecific Antibodies Bridging Pharma and IT Green Fluorescent Proteins Quality Systems CRA Monitoring Drug Discovery &amp; Development AI in Government glycotechnology Baculovirus Drug Repurposing drug discovery and development Japan The CRA Manager Course State by State Clinical Trial Requirments Reference Guide Adverse Events: Managing &amp; Reporting for Medical Devices Good Laboratory Practice Process Chemistry Beyond Sequencing Process R&amp;D Summit with GLP Batteries Biomarkers Europe IT Infrastructure computer hardware Clinical Trials patient Recruitment Working with CROs Expediting Drugs and Biologics Development Tissue Sealants - One Day Protein Expression Europe Use of Note to Files in Clinical Trial Essential Documentation Antibody Engineering Korea RNAi for Pathway Analysis Advanced GCP Compliance Mechanisms of Cancer Business Diagnostics (Impact of New Diagnotics) Consumer Genomics Conference Recombinant Antibodies Europe Research Site Clinical Study Budgets and Contracts Proof of Concept Drug Development in China Future Diagnostics Medicinal Chemistry Combination Therapies CRA Training Series (1-7) Lab Chips Japan Human Genomes Europe Tissue Based Screening lead optimization Adverse Events Reimbursement Diagnostics labels signals and detection ASAP CHI Bio Pharm Alliance Summit forensic diagnostics Writing for Clinical Research Molecular Profiling with Cellular Resolution 10 Rules of Effective Report Writing pharmacogenomics europe Exploring Next Generation Sequencing conference Drug Development &amp; FDA Regulations HCA East Cancer Immunotherapies (formerly Cancer Vaccines) Biologics Development A Regulatory Overview Standard Operating Proces in Clinical Research molecular pharmacology RNA Interference Summit Clinical Training oligonucleotides Clinical Trial Protocols toxicology Immunogenicity Testing for Biologics Adaptive Clinical Trials ADME Stem Cells in Drug Discovery and Development Drug Pipeline Success (Pipeline Success Summit) stem cells Data Visualization Pharmacokinetics transgenic animal models Business Development Alliance Management Interface Monitoring Clinical Drug Studies: Advanced Digital Health Innovation Summit Data Management in the Electronic Data Capture Arena Case Report Forms Battery Safety Medical Devices GCP Overview Clinical Administrative Support Staff Alliance Management &amp; Project Management Pre-Implantation Diagnostics Eyesight Biomarker Diagnostics Biomarker Web Symposia Drug Approval Process Neglected Diseases Molecular Diagnostics Medical Device Approval Process Code of Federal Regulations for Medical Devices Clinical Research Associate G protein coupled receptors GPCRS Prenatal Diagnostics Europe Genomic Tools &amp; Technologies Biomarkers Europe Symyx Business Collaborative Innovation Source Documentation Mitochondria Comparative Genomic Hybridization Lithium Battery Power Writing Clinical Study Protocols Reimbursement Therapeutics genetic variations Business Investigator initiated trials Burrill Book Bio-IT Asia Compound Profiling cancer clinical trials Chemical Genomics Safety/Toxicity Biomarkers Cancer Diagnosis antibody engineering Drug Development in Asia West Coast Virtual Screening Point of Care Diagnostics Protein Formulation genetic diagnostics Bridging Discovery &amp; IT Biofuels Translational Medicine Personalized Medicine Clinical Research Organization Alliance Management Congress Europe New Drug Approval Risk Based Site Monitoring Root Cause Analysis Monitoring Phase I Clinical Trials Drug Development Latin America Licensing vaccines cancer genetics and genomics Marketing Reimbursement Metabolic Analytical Methods Difficult Clinical Research Sites Protein Chips/Arrays Monitoring Plan Development Genome Japan Immunogenicity Advances in Management and Reduction Clinical Auditing Clinical Informatics Antibody-Drug Conjugates Electronic Medical Records &amp; Source Document Verification Bridge to Pop Health East Informed Consent Pharma Future Microarray Data Analysis Europe Clinical Investigator Site Inspections Global Clinical Trials Protocol Deviations Immunotherapy West Cancer Therapies Recognize Attrition Earlier Electronic Data Capture Clinical Imaging Physical Chemistry Toll Like Receptors monoclonal antibodies Innate Immunity High Content Analysis Europe Negotiation Skills for Clinical Research Professionals Biotech Executive Forum CNP Partnering Europe nanotechnology Risk Management Clinical Trials for Medical Devices Adverse Event Monitoring for CRAs Vendor Management Report Writing for CRAs Symyx Europe Epigenetics Regulatory Compliance GCP Training for Investigators RECIST 1.0 and 1.1 Pharmacovigilance Audit Microfluidics yeast model organism Market Targets &amp; Compounds Critical Decision Points in Design &amp; Conduct of Patient Registries protein production formulation HCA Europe Idiosyncratic Toxicity Protein Informatics Conflict Resolution and Negotiation Regulatory Intelligence Bioresearch Monitoring Cryobiology signal transduction Emerging Companies Corrective Action Plans: Documentation of a Sites Response to GCP Deficiences Developing Clinical Study Budget Next Generation Sequencing Data Management Fraud in Clinical Research Biosimilars Dealmaking for Diagnostics Comprehensive CRC Training Cancer Cell Models Digital Health Patient Registry Programs crop genetics Glossary &amp; Acronyms Reference Biosensors Good Clinical Practice Essential Documentation in Clinical Trials at Research Sites Patient Centered Clinical Trials Proteins to Profits Europe Drug Metabolism International Drug Approval Regulatory Procedures Principal Investigator Training orthopedic tissue engineering Investigator Sites cardiovascular genomics Study Start Up Protein Folding Population Health Management Tissue Diagnostics GLP Bioanalysis Phase I Study Management Health Autonomous Driving Electronic Source Documentation Tools &amp; Metrics Congress Global GCP Monitoring Investigator Non-Compliance Global GCP Compliance Report Protein &amp; Peptide Arrays Europe Internet of Things Clinical Trials for Pharmaceuticals Introduction to Signal Detection and Data Mining Study Feasibility Clinical Investigation Monitoring Proteomics Europe Clinical Trials in Developing Regions Pediatric drug development Sponsor Monitoring Inspections Maximize Value of Drug Development protein structures cancer Microbial Genomics Translational Cancer Medicine Medical Terminalogy for Clinical Research Professionals Medical Devices Writing and Updating the Investigators Brochure Sunshine Act Sequencing for Drug Development Standard Operating Procedures Meeting International Safety Reporting Requirements Faciliation Skills for Clinical Research Professionals bioprocessing biologicals safety Regulatory Intelligence 101 Recent Trends in Noncompliance Briefings on Drug Safety Clinical research project mamangement essentials CRA Survival Kit Essential Documentation Extracellular RNA Successful Study Site Start-up Cell Based Therapies Web-Based Training Strategies data mining GLP Bioanalysis Clinical Trial Finance &amp; Management regulatory Site Relationship/Performance Management Introduction to FDA Regulatory Reporter Newsletter multiple sclerosis Data Integration Managing CRAs to Improve Performance &amp; Study Outcomes compounds Predictive Toxicity Surviving FDA Site Inspections: Best Practices for Site Personnel Phase III (3)/forecasting clinical outcomes Comparing FDA and Health Canada Regulations Medical Device Professionals Recombinant Therapeutics Tick Borne Diseases Writing and Maintaining the EU CTA Orphan Drugs Investigator Initiated Trials Orthopaedic Animal Models Auditing Sponsors and CROs Valuing &amp; Pricing Licensing Deals drug delivery Vendor Management for the Clinical Data Manager Data Quality Patient Engagement FDA Drug Approval Process HIPAA No 1 Team Training HIPAA &amp; Human Subjects Research  Q&amp;A Ubiquitin Europe Clinical Trial Data Monitoring Investigational Product Accountability Training for Research Site Personnel Adverse Event Reporting to IRBs Subject Recruitment for Clinical Research Sites Antibodies in Cancer Cost Management for Global Clinical Trials Portfolio Management Warning Letters Combination Products Observational Studies Molecular Medicine Asia CNS Central nervous system Discovery &amp; Development Collaboration Cross functional global teams Site Relationship Management peptides Investigator Oversight Writing SOPs pain web 2.0 Understanding FDAs new Draft Guidance Regarding Supervisory Repons Sponsors/CROs Preparing Clinical Research Sites for FDA Inspections eHealth Technologies Introduction to Data Management FDA Proposed rule 2010 Teambuilding for the Cross Functional Global Team Genomic Business Strategies Product Life Cycle RNA Interference Pharmacovigilance Signal Detection Foreign Clinical Trials Biotech Business Development genomics Portfolio Management Venue II Clinical Trial Design for Medical Devices Informed Consent Clinical Trial Study Wheel Biomarker Data Center Antibody Optimization &amp; Characterization Biologics Chronic Pain cardiovascular Risk based decisions for clinical site management Human Participant Protection Training Clinical Research Professionals CRC Role/Responsibilities Training Womens Health Current Developments in the Role of IRBs in the Conduct of Clinical Research Regulatory Compliance for Molecular Diagnostics infections Diabetes cancer partnering Preparing Medical Device 510K Submissions Monitoring Informed Consent Business of Biobanking Global Site Selection Boston Biomarkers of Drug Efficacy and Safety New Drug Approval in the European Union Protein Therapeutics Quality Improvement Strategies at Clinical Research Sites diagnostics bioprocessing viral hepatitis infections Advanced HIPAA Clinical Sequencing IRB Guidance regenerative healing cell culture Coronavirus Liver Disorders Big pharma Big Data HIPAA Electronic Medical Records blood Pharmaceutical Strategy Series Strategies for Accelearted Nonclinical Toxiciology &amp; Safety Assessment of Biologics New Drug Approval in Japan Artificial Intelligence Excel Spreadsheets-Step by Step Instructions for Compliance Chemistry R&amp;D Statistical Sourcebook Upgrade Medical Device Tracking Medical Devices Directive Facilitation Skills Autoimmune anticoagulants bone Clinical Antibodies gene therapy Newborn Diagnostics Real World Monitoring Allergies Performance Improvement Monitoring Model Institutional Review Board Health Outcomes Outsourcing R&amp;D Microbiome Key Opinion Leaders Chronic Obstructive Pulmonary Disorder Quality by Design Clinical Trials &amp; Translational Medicine Series Lupus Multi Drug Resistance Clinical Research Coordinator Tool Kit CRC &amp; PI Current Practice Update CRA Facilitator Training 21 CFR Part 11 Compliance for Electronic Records &amp; Signatures Cancer Diagnostics Electronic Health Record Chiral Intro to Combination Products Gastrointestinal Disorders Presentation skills for clinical research professionals inflammation Operational Modeling and Simulation in Clinical Trials Pharmaceutical &amp; Medical Device Industries Facilitation Skills for Clinical Research Team Members Diagnostics Partnering Mobile Health Wearables Pharmaceutical Discovery Data Management Medical device reporting Ubiquitin Medical Device Postmarketing Vigilance Blockchain Alzheimers high performance computing Innovative Preclinical &amp; Clinical Strategies GXP Good Practice Guides Writing and Maintaining Canadian CTA 3D Printing Key Information Gatherers Respiratory Five Keys to COTS Computer System Validation Next-Generation Sequencing Data Management Open Source Fibrosis/Scarring Biomarker Bridge Genomics 101 Dummy Keyword for DE lists w/more than 1 keyword or with no keywords FDA Form 1572 Antisense Accountable Care Orgnization ACE inhibitors AI Chips Antibody-Drug Conjugates  for PEGS Antibody Drug Conjugate Bioprocess Attention Deficit Hyperactivity Disorder Adjuvants ADMET (ADME &amp; Toxicology) adverse drug reactions Aerospace Advanced Energy Technology Congress Affordable Care affinity technologies Affinity Separation Antibody Fragments Agriculture  chemistry Aging Antibody Drug Targets Digital Farming angiogenesis AI Business Intelligence Artificial Intelligence Bioprocessing AI in Customer Analytics Intelligent Assistants and Bots AI in Cancer Enterprise AI Case Studies AI Executive Summit Machine Learning Artificial Intelligence Clinical &amp; Post Approval Artificial Intelligence Discovery &amp; Preclinical Implementing Enterprise AI AI Ethics Future of AI Cutting Edge Research for AI General AI Business Applications AI for Strategic Government Functions Cognitive Computing AI Partnering AI in Personalized Medicine Allosteric Modulators Amyotrophic lateral sclerosis Animal Models of Cancer Alternative Medicine Alliance Management Execution Asset Management Alliance Management Negotiation Animal Models of Pain Animal Models of Toxicity angina Anxiety cancer and apoptosis Active Pharmaceutical Ingredients Analytical Purification Apoptosis Anti Psychotics Alliances Rx Devices arrhythmias Assays for Antibodies Assays Affinity Assays and Allosteric Antagonism Immunogenicity Assay Development Assays Primary Cells Quantifying Receptor Activation and Agonism asthma Assays atherosclerosis Automotive Automotive Partnering Autophagy Autism Advisory Boards Bacterial Infections Consumer Electronic Battery Applications Defense Battery Applications Battery Data Science Flexible Battery Power Industrial Battery Applications Medical Device Battery Applications Battery Applications Stationary Battery Applications Automotive Battery Applications Bayesian Statistics Asia US Biotech Alliances Blood Brain Barrier Computational Biology for Bio IT BioIT Best Practices Battery Charging Cheminformatics for Bio IT Biomarker Clinical Applications Preclinical Biologic Development Breast Cancer Backup Compounds biological cancer treatments Biomarker Data Analysis Biological Database Discovery Informatics for Bio IT Delivery of Biologics Regulatory Business Diagnostics biodiversity screening E Clinical Research Battery Energy Storage Biofuels Alliance Biobank Informatics Flow Cell Technologies Cloud Computing for Data Science Biogenerics Business of Genomics biomaterials Bioinformatics for Cancer BIO IT World Battery Intellectual Property Bio IT World Web Resource Alert Bio IT World Monthly magazine IT &amp; Informatics Series Bio IT World Weekly Update Bookstore Biomarker Development Advanced Lead Acid Technology Manufacturing &amp; Process Economics Biopharm Executive Summit Biolaw Biomarker &amp; Diagnostics Series High-Througput Screen-Based Biomarker Discovery Battery Manufacturers Battery Manufacturing Battery Management Battery Manufacturing Machinery Battery Market Battery Machine Learning Biomarker Executive Think Tank Battery Materials, Recycling Biomarker Reverse Phase Assays Battery Materials, Solid State bone marrow transplants Biomarker Translational Biomarker Validation Bioinformatics Asia Bioinformatics Cloud Computing IT Infrastructure  for Bio IT Logistics and Sample of Biobanking Bioinformatics in the Genome Era Bioprocess Data Analysis Host Cell Protein Assays Bioproduction Continuous Processing biopurification Biological Pharmacokinetics Bioprocessing Quality Bioprocess &amp; Manufacturing Series Bioprocess Validation Bioreactor Design and Engineering Battery Regulatory Battery Raw Materials Brain Cancer Battery Repurposing Biological Therapeutics (biotherapeutics) Bispecific Antibodies for Immunotherapy Bispecifics for Cancer Business Strategies for Library Diversity blood safety Europe Battery Shipping Battery Simulation Biosensors bioseparation Biostabilization of Biospecimens Biomanufacturing Single Use Technologies Bioassays Battery Commercialization Flow Batteries Battery Materials Sci/Tech for Pharma &amp; Biotech Battery Safety Biotech tools Biotech Venture Forum Biomarkers for Molecular Diagnostics Biomarkers for Molecular Diagnostics Clinical Trials for Cancer Immunotherapy Artifical Intelligence in Clinical Trials cell adhesion molecules regulatory CANDA Computer Assisted New Drug Application Chimeric Antigen Receptor Chimeric Antigen Receptor Case Studies catalysis Cell Based Assays Cell Therapy CMC Cancer Biomarker Cell Therapy Production Cord Blood Stem Cells Cell Based Therapies Circulating Tumor Cells Cold Chain Colorectal Cancer cell cycle Collaborations Deals and Alliances Chemical Database Co-Development of Diagnostics and Drugs Cloud Computing Europe Case Histories Clinical Trials Consumer Electronics Cell Biology Clean Tech Solar Wind Comparative Effectiveness Research Ethical Considerations in Clinical Trials Continuing Education Units Circulating Cell-Free DNA Europe Agriculture  crop genetics Europe Cancer Genomics Europe congestive heart failure Chemistry Series Chinese Hamster Ovaries Clinical Research Conflicts of Interest cheminformatics competitive intelligence Cloud Computing Asia Integrating Clinical Lab Services in Clinical Trials Clinical Biospecimens and Central Lab Solutions Clinical Biospecimens and Central Lab Solutions Celiac Disease Cloud Extension Clinical Genomics Europe cellular all Conducting Clinical Trials in Asia Cloud Computing Project Management Cloud Computing Resource Management Cloud Computing Security Risks Software Development for Clinical Genomics Clinical Vaccines Cloud Computing West Comparability Chemistry Manufacturing and Controls Continuing Medical Education Communications Contract Manufacturing Cancer Microarray Application CNS Biomarkers Miscellaneous CHI conference CNS genetics/genomics CNS Disease Models Counterfeit Drugs Copy Number Variation Cognitive Disorders Battery Components capillary electrophoresis Cancer Prognostic Markers Clinical Pharmacology Clinical Proteomics Clinical Plasma Profiling Clinical Trial Platform Software Computer Vision cancer prevention CRA 8 Weeks Fundamental Training Cost Reduction w/o Increasing Regulatory or Business Risk Advanced Clinical Research Coordinator Critical Care Diagnostics Interviewing Skills for CRAs and CRCs Customer Relationship Management CRA Monitoring Clinical Research Training Week Clinical Research Training Week East Clinical Research Training Week West Drug-Device Combinations Peptides for Cancer Therapeutics Colony Stimulating Factors Cell Signaling Cancer Stem Cells Clinical Supply Chain Clinical Strategic Resource Allocation Country and Site Feasibility and Selection Mammalian Cell Culture Cloud Security Cybersecurity Clinical Data Management and eClinical Trials Asia Clinical Trials for the Drug Discoverer Clinical Trials Eastern Europe Clinical Trial Finance &amp; Management Re Engineering the Study Feasibility Assessment Process CRC Training Video &amp; Manual Clinical Trial Management Systems Cardiotoxicity Query Creation &amp; Processing clinical trials segmentation Neoantigens for Cancer Cardiovascular Diagnostics cardiovascular animal models Cardio Metabolic Drug Targets Targeting Cancer Diagnostics cytokines antagonists Cystic Fibrosis Cytogenetics cytokines Targeting Diabetes with Novel Therapeutics DBS Optimization of Cell drug discovery India Drug Discovery Map Drug Discovery Outsourcing Drug Discovery Technologies drug discovery and development Drug Discovery &amp; Development Series Dental Depression Detection non biological Treatments for Drug Abuse Drug Drug Interactions Digital Therapeutics Digitization Diabetes 2 Digital Healthcare &amp; Productivity web resource alert drug discovery Duchenne Muscular Dystrophy Drug Metabolism &amp; Pharmacokinetics Drug Discovery Informatics Europe Data Integrity Diagnostic Informatics DNA Repair Diversity Oriented Synthesis Digital Detection Europe Difficult to Express Proteins Executive Perspectives of Drug Safety downstream processing Europe Drug Safety Series downstream processing Dosing Selection Data Science/Analytics Direct to Consumer Marketing Data Management Drug Transporters Data Storage Digital Twins Drug Utilization Protein Devices Molecular and Companion Diagnostics Asia Clinical Adoption of Next Generation Diagnostics Difficult to Express Proteins Europe Globalization of Dx Diagnostics Immunoassays Diagnostics Automation Detection Informatics engineered animal models Hearing Ebola Diagnostics Evidence Based Medicine Ebola Therapeutics eCapacitors Electrochemistry E Coli Encoded Compound Libraries Ecommerce eCTD Validation of Disinfectant Efficacy Effective Drug Discovery Edge Computing Early Diagnosis Electronic Notebooks endothelium engineering Entertainment Enabling Technology in R&amp;D Environment Enzymes Economic Outcomes Executives on Target Epidemiology epilepsy Epigenetic Readers Epigenetic Targets Examining the Impact of the eCTD on the Regulatory Submissions Process Emerging Targets Diseases Ethics Emerging Technology Transfer Electric Vehicles Experimental Design Exhibitors Extractables/Leachables Exosomes Exome Sequencing Financial Analysts Hackathon Obesity Batteries France fibrin sealants Fine Chemicals FDA Meetings 101 Food Safety Financial Disclosure Foods FDA Website Functional Genomics Fragment Based Screening Surface Plasmon Resonance finance Flow Cytometry Influenza Financial Deal Structures Fintech Future of Healthcare Fraud Fertility Fibrin sealants Europe blood Fast Track Future Therapeutics fungal infections Follow Up Flow Chemistry Gamification gap junction channels Global Health Good Clinical Practice for Pediatric Research GCP Deficiencies Gene Cell Vectors Genomic Drug Discovery Genomic Data Integration Genetic Screening Wellness General Email Only Gene Editing Part 2 Gene Editing Gene Expression Monitoring Genomics Series Gene Expression growth factors Gene Identification genetic immunization vaccines gene interference Gene Knockouts Globalization Genome Links newsletter GLP Bioanalysis Leaders in Precision Medicine Good Manufacturing Practice Drugs introductory gene mutations genomic medicine Genotyping Government gene probes Genomic partnering Europe Greening of Pharma GPCR Targeted Therapies Grid Computing Genomic Service Providers Small GTPases (formerly Gene Town Pass) gene transcription gene therapy technologies Whole Genome Association Studies Humanized Antibodies high throughput analytical chemistry Health &amp; Beauty Aids Hepatitis B Virus High Content Analysis Course HIV and cancer Hematological Cancer Pipelines HIV clinical trials hepatitis C virus Heterocycle High Content Data Analysis HDAC Histone Demethylases Healing hematopoesis heat shock proteins Human Factors Engineering Health Information Systems HIV Healthcare Series Health Maintenance Organizations Human Tissue Huntingtons Disease hormones HIPAA #2 High Throughput Protein Purification High Performing Operation Human Papilloma Virus transgenics homologous recombinant Human Relations Health Insurance herpes virus HIV Surrogate Markers High Throughput Genomics Hit to Lead High Throughput Screening Hepatotoxicity Hybrid Computing hypertension Targeting Antigen Presenting Cells Inflammatory Bowel Disease imaging contrast agents interleukin converting enzymes ICE Improving Drug Safety diagnostics - infections Infections Diagnostics Europe engineering laboratories Integrated Fluidic Circuits for DOT Informatics for Genomic Medicine Infection Genomics Image Analysis Immunotherapy Biomarkers Immune Profiling in Cancer Complement-based Drug Discovery immunomodulation Imaging for WPC conference Imaging Informatics Immune Impurities Regulatory Immunogenicity Immunosequencing Immuno-Oncology Drug Developement Cancer Immunotherapy Oligonucleotides Cancer Immunotherapy Peptides Cancer Immunotherapy Small Molecules Informatics Partnering Insurance AI and IOT Investments Industrial Enzymes Immuno-Oncology Assays Immuno-Oncology Business Strategy Immuno-Oncology Clinical Trials Immuno-Oncology Models ion channels Protein Engineering for Immuno-oncology Immuno-Oncology Sequencing Immuno-Oncology Targets Legal Issues for Bioproduction Intellectual Property Pluripotent Stem Cells IRB Compliance and Oversight Considerations Adopting Integrated R&amp;D Informatics Systems India Re Engineering International Risk Management Drug Discovery Informatics Iron Chelation IT Infrastructure Software in situ hybridization Information Technology IT &amp; Informatics for Collaboration IT Infrastructure Europe Scalable IT &amp; Informatics IT Infrastructure computer hardware (part 2) IT Infrastructure computer hardware (part 3) IT Software for the Life Sciences IT Infrastructure Virtualization Interviewing Skills for Managers Investigator Sites Report 1 Investigator Sites Report 2 Imaging Week joints Job recruiters Kinase Chemistry KIN West Coast Kinases for DOT Knowledge Management chemokines HIV and Kaposis sarcoma Kinetics Structure Relationship laboratories Lead Acid Batteries Label Free Detection Drug Labeling Live Cell Imaging Laser Capture Microdissection Lung Cancer ligase chain reaction leukodepletion Laboratory Developed Tests leukemia Ontologies/Lexicons Legal drug liability screening libraries Life Sciences Protein Ligands lab information management systems LIMS Lipids Large Stationary Batteries Lyophilization Mergers &amp; Acquisitions Monoclonal Antibodies Forum Monoclonal Antibody Process Development Malaria Metabolism Targeted Cancer Therapeutics Microbiome in Immuno-Oncology Microbiome Metabolic Syndrome Medicinal Chemistry Part 2 Mucosal Immunity Microreactors Macrocycles Molecular Diagnostics Business Multidrug Resistance Cancer Medical Coding multidrug resistant infections Next Generation Non-Invasive Molecular Diagnostics Microdosing microbial infections Sequencing Based Molecular Diagnostics Molecular Diagnostics Forum Molecular Electronics Metabolic Engineering Melanoma BioMEMS memory enhancement cancer metastasis molecular evolution Mammalian Cell Line Development microfabrication Molecular Genetic Pro Management molecular medicine Novel bioactive high throughput screening europe Myocardial Infarction migraine microtiter plates Molecular Medicine Europe metalloproteinases Molecular Medicine Asia Managed Care Manufacturing Clinical Trial Monitoring Mechanism of Action Purifying Antibodies Meeting Planning Services Molecular Pathology Molecular Pathology Basic Molecular Pathology Advanced magnetic resonance imaging Multi Specific Antibodies Mass Spectrometry for Protein Biomarker Discovery Muscle Mass Spec Informatics Mass Spec Imaging Modeling and Simulation Mass spectrometry Mass Spec Diagnostics Metabolic Disorders Mental Health Materials Testing cellular matrix Multiplexed Assays Moelcular Diagnostics Europe Molecular Diagnostics for Cancer Molecular Diagnostics for Infectious Disease Next Generation Antibodies Next Generation Antibodies (for PGE) Nucleic Acid Europe National Academy of Sciences meeting natural products new antivirals Novel Cancer Informatics Non-Coding RNA Novel Strategies Cancer Novel Cancer Targets Neurodegenerative Nucleotide Delivery Internet New to Database comapny names Advances in Informatics nerve growth factors NF KB Nanofluidics Informatics Next-Generation Batteries Next Generation Batteries Portable Applications Next Generation Batteries Stationary Power Epigenetic Sequencing Next Generation Imaging Neurogenomics Nuclear Hormone Receptors Novel HIV Strategies Neurotech Industry neuroinjuries NK Cell Based Cancer Immunotherapy Natural Language Processing nuclear matrix Nanomedicine Nitric Oxide Network Pharmacology Energy Neurotoxicity New Drug Approval in the US nanotech self assembly Internet of Supply Chain Internet of Supply Chain Europe Neurostimulation Internet of Diagnostic Things Internet of Energy Internet of Energy Europe Internet of Things Infrastructure Internet of Health Internet of Insurance Internet of Insurance Europe Internet of Things Manufacturing Internet of Things Manufacturing Internet of Manufacturing Europe Smart Buildings Smart Cities Nephrotoxicity Nuclear Energy nutrition Optimizing Media organ and cell transplants Oncology Drug Targets Optical Diagnostics Oncogenomics Office of the Inspector General Oil and Gas oncogenes Oncolytic Viruses Oligo Production opportunistic infections Oligo Regulatory organs transplants oral drug delivery OSTEOARTHRITIS OTC over the counter Additional Conferences clinical trials outsourcing Oxygen Radicals oncogenes p53 Predictive ADME protein aggregation Protein Aggregation (for PTK) Packaging parasitic infections Process Analytical Technology Pharmacy Benefit Management Pharmaceutical BioProcess Basic Research &amp; Discovery track for PCG Clinical Operations track for PCG Preclinical Development track for PCG Bridgehead PCI book Preclinical Preclinical Preclinical prostate cancer Preclinical Outcome Predictions preclinical trials Point of Care West Protein Crystallography pediatric AIDS/HIV PDA Downloads from CHI website Process Development for Executives platelet derived growth factors protein drug delivery Preclinical Disease Models photodynamic therapies Phage Display for Vaccine Development Proteomic Tools for Diagnostics pediatric Pediatric trials for CRAS PEGS Virtual Interactive Global Summit Protein Expression Monitoring Protein Executive Summit Proof of Concept for Cancer Protein Function Enterprise Portfolio Management Portfolio Value Protein Aggregates Light Scattering Consumer Genomics/Personal Genomics Protein Engineering Partnering Particulate Screening Phage West Phase II/Reducing Attrition Phase IV Phase IV Pharmacies Phage Display Europe Pharmaceutical Half Life Phase Zero PI3K Phosphoinositide 3 Kinase Protein Identification Preclinical Imaging protease inhibitors enzymes PLA2 blood platelets Membrane Proteins Membrane Protein for DOT (part 1) Membrane Protein for DOT (part 2) Protein Manufacturing Clinical Project Management: Intermediate Preventive Medicine Pancreatic Cancer Preclinical Studies for IND Protein Computational Tools Prenatal Therapeutics Parenteral Point of Care Diagnostics Europe Cannabis Power Utilities protein characterization protein purification Protein Protein Interactions Protein Protein Interactions Part 2 Process Management Protein Process PepTalk Partnering Personalized Medicine Partnering Proteomics Analytics Predictive Analytics Pricing Parkinsons Predictive Biomedicine Proteins, Peptides &amp; Proteomics Series Protein Quantification Partnering Data Privacy Personalized Medicine Asia Product Service Announcement Production and Scale Up Pharma Services News schizophrenia antipsychotics Protein Antibodies Preclinical Toxicology Biologics Protein Technology Engineering Protein Therapeutics for Delivery Predictive Toxicity Europe Platform Software for R&amp;D Studies Phenotype to Genotype Pathology Protein drugs &amp; diagnostics Intellectual Property Post Translational Modifications Patient Registries Advancing Therapeutics Current Generation Protein Drug Delivery (part of PepTalk) Advancing Therapeutics Next Generation Biological Therapeutic Products Series Pathway/Networks Publications Protein Variations Powertrains Protein Characterization, Purification and Screening Protein Characterization, Purification and Screening Protein Expression Europe Beyond Protein Expression Europe Protein Expression Host Novel Protein Expression Systems Protein Engineering Vectors Preventive gene quantification Europe QS Regulation Recombinant Antibodies Recombinant Antibodies Recombinant Proteins Forum Radiation Rare Diseases Antibody Drug Products RBE track at PGE RBE track at PGE Antibody Screening Antibody Translational rapid compound characterization Clinical Enrollment Plan Clinical Recruitment Media Clinical Trials Patient Recruitment Winning Strategies for Clinical Recruitment Media Integrating R&amp;D and Marketing R&amp;D Productivity drug receptors Role of Business Process Managment in FDA Regulated Industry Worldwide Pharma Regulation Surviving FDA Site Inspections Real Estate Risk Evaluation and Mitigation Strategies Renal (kidney) Renewable Energy Storage System RFID Radiofrequency ID Reagents Gap Analysis rheumatoid arthritis gene therapy [RNA blocking] Ribonucleic Acid RNAi for Functional Screening RNAi   RNAInterference RNAi Discovery on Target RNAi Video on Request RNA Quality RNA Therapeutics Robotics Regional Organization Robotic Process Automation reperfusion Reproduction Gene Regulation and Regulatory Networks Restenosis Retail Real World Data Therapeutics Indications &amp; Drug Targets Series safety Screening 3D Models Sickle Cell Anemia Screening Informatics Sequencing and Cloud Computing supply chain management SCOPEs Clinical Research Leadership Forum Phenotypic Screening Phenotypic Screening clinical trials strategy IT Security Sequence Data Analysis Sequence Data Analysis Asia Sidec Executive Forum Sequence Data Analysis Europe Sleeper Disease Indications Sequencing Data Storage &amp; Management Screening Difficult Targets Source Document Verification Sequencing Data Analysis &amp; Storage second messengers sepsis infections Sequencing Forum Serotonin Sexual Small Fuel Cells selective immune suppression skin sleep Pharmaceutical Sales Biologics Small Molecular Comparisons Semiconductors small molecules simple model organisms Small Molecules Synthesis Semantic Web Sensor Applications Synthetic Biology Sensor Data Management Implantable Biomedical Sensors Sensor Materials Sensors Emerging Markets SNPs Sensor Systems Sensor Safety software Solubility Safety Pharmacology for Biologics Safety Pharmacology for Biologics Genomic Sample Preparation Speciality Pharmaceuticals Alternative Splicing Proteomic Sample Preparation High throughput screening partnering solid phase synthesis Subjective End Points Next Generation Sequencing Applications Sequencing Core Labs Next-Generation Data Generation Plant Sequencing RNA Sequencing Sequencing Solutions Deep Sequencing EU Site Selection, Study Activation, and Patient Recruitment Stability stroke Stem Cell Culture Stem Cell Research (part of MMTC) Statin Stem Cells Safety Screening Startup Public companies/stock exchanges CHI Surveys Services Systems Biology for BYG track synthesis Systems Biology Training &amp; Development Top 50 Big Pharmas Tissue Microarrays taxol  tamoxifen and other derivatives Tuberculosis Tobacco The Biotech Journal Email List Trust Building for Collaborative Innovation Tumor, Circulating Cells Technology Technology Consortium Target Driven Chemistry targeted drug delivery transgenic disease models Thrombotic Disease tissue engineering telomerases Battery Testing Transfection Toxicogenomics Target Prioritization Target Identification tissues Technology Platforms Immunotherapies Telecommunications Telemedicine Tumor Microenvironment Trial Master File for Sponsors (pharma) Trial Master File for Research Sites Theranostic Market Models tumor necrosis factors Therapeutics and Targets Therapeutics &amp; Targets Series immune tolerance Fibrinolytic (clot buster) Transgenic Production in Plants Synthetic Biology Transportation Translational Biomarkers Translational Informatics Drug/Disease Targets Drug Targets Series Genome Tri Conference Translation Services transgenics gene knockouts transgenic production Tumor Suppressor Genes tissue safety Technology &amp; Tools for the Life Sciences Technology &amp; Tools for Life Sciences Series Target Validation Text Mining Unmanned Aerial Vehicles Ubiquitin Uninterruptible Power Supplies upcoming conferences upcoming conferences Europe Urinary Incontinence New USP Initiatives and Standards for Biologics unstable triplets trinucleotide repeats Vaccines (for IMT) Vascular Vaccines Business Opportunities Venture Capital Business Opportunities Vaccines Voice Recognition Paperless Validation veterinary viral infections Vaccines Production &amp; Manufacturing Virtual Reality virtual business Virtual Teams Single Use Systems for Vaccine Manufacture well characterized biologicals Wellness Wiki wound management Wireless Change Record Change Record Mary Chitty Xenotransplantation Yeast Display Zika Vaccine Development&quot;&quot;&quot;</span>

<span class="c1">#  &quot;nlp&quot; Object is used to create documents with linguistic annotations.</span>
<span class="n">my_doc</span> <span class="o">=</span> <span class="n">nlp</span><span class="p">(</span><span class="n">text</span><span class="p">)</span>

<span class="c1"># Create list of word tokens</span>
<span class="n">token_list</span> <span class="o">=</span> <span class="p">[]</span>
<span class="k">for</span> <span class="n">token</span> <span class="ow">in</span> <span class="n">my_doc</span><span class="p">:</span>
    <span class="n">token_list</span><span class="o">.</span><span class="n">append</span><span class="p">(</span><span class="n">token</span><span class="o">.</span><span class="n">text</span><span class="p">)</span>
<span class="nb">print</span><span class="p">(</span><span class="n">token_list</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>[&#39;Molecular&#39;, &#39;Medicine&#39;, &#39;Tri&#39;, &#39;Conference&#39;, &#39;Protein&#39;, &#39;Engineering&#39;, &#39;Peptalk&#39;, &#39;Biocomputing&#39;, &#39;SCOPE&#39;, &#39;Summit&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Operations&#39;, &#39;Executives&#39;, &#39;bioproduction&#39;, &#39;Discovery&#39;, &#39;on&#39;, &#39;Target&#39;, &#39;PEGS&#39;, &#39;Europe&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Chemistry&#39;, &#39;World&#39;, &#39;Pharmaceutical&#39;, &#39;Congress&#39;, &#39;advanced&#39;, &#39;diagnostics&#39;, &#39;Advanced&#39;, &#39;Automotive&#39;, &#39;Battery&#39;, &#39;Conference&#39;, &#39;(&#39;, &#39;AABC&#39;, &#39;)&#39;, &#39;Europe&#39;, &#39;Florida&#39;, &#39;Battery&#39;, &#39;Conference&#39;, &#39;Biomarkers&#39;, &#39;Congress&#39;, &#39;High&#39;, &#39;Content&#39;, &#39;Analysis&#39;, &#39;Advanced&#39;, &#39;Automotive&#39;, &#39;Battery&#39;, &#39;Conference&#39;, &#39;(&#39;, &#39;AABC&#39;, &#39;)&#39;, &#39;Immunogenicity&#39;, &#39;CRA&#39;, &#39;&amp;&#39;, &#39;CRC&#39;, &#39;Beginner&#39;, &#39;Biopharmaceutical&#39;, &#39;Change&#39;, &#39;Control&#39;, &#39;Beyond&#39;, &#39;Genome&#39;, &#39;Immunotherapy&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;Strategies&#39;, &#39;Targeted&#39;, &#39;ImvacS&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Molecular&#39;, &#39;Medicine&#39;, &#39;Marketplace&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Europe&#39;, &#39;CRA&#39;, &#39;Beginner&#39;, &#39;AI&#39;, &#39;World&#39;, &#39;Data&#39;, &#39;Driven&#39;, &#39;Discovery&#39;, &#39;R&amp;D&#39;, &#39;Strategies&#39;, &#39;Strategic&#39;, &#39;Resource&#39;, &#39;Allocation&#39;, &#39;kinases&#39;, &#39;Auditing&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Studies&#39;, &#39;Accelerating&#39;, &#39;Development&#39;, &#39;&amp;&#39;, &#39;Advancing&#39;, &#39;Personalized&#39;, &#39;Therapy&#39;, &#39;X&#39;, &#39;Gen&#39;, &#39;Congress&#39;, &#39;Biodefense&#39;, &#39;&amp;&#39;, &#39;Enabling&#39;, &#39;POC&#39;, &#39;Diagnostics&#39;, &#39;&amp;&#39;, &#39;Microarray&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Human&#39;, &#39;Genome&#39;, &#39;Project&#39;, &#39;Biobanks&#39;, &#39;Structure&#39;, &#39;Based&#39;, &#39;Design&#39;, &#39;Batteries&#39;, &#39;Portfolio&#39;, &#39;Quantitative&#39;, &#39;PCR&#39;, &#39;Health&#39;, &#39;Information&#39;, &#39;Technology&#39;, &#39;Auditing&#39;, &#39;Techniques&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Professionals&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;Question&#39;, &#39;&amp;&#39;, &#39;Answer&#39;, &#39;REference&#39;, &#39;Guide&#39;, &#39;CFR&#39;, &#39;/&#39;, &#39;ICH&#39;, &#39;GCP&#39;, &#39;Immunotherapy&#39;, &#39;Europe&#39;, &#39;Gene&#39;, &#39;Amplification&#39;, &#39;PCR&#39;, &#39;eStats&#39;, &#39;:&#39;, &#39;R&amp;D&#39;, &#39;Statistical&#39;, &#39;Sourcebook&#39;, &#39;MicroRNA&#39;, &#39;microarray&#39;, &#39;data&#39;, &#39;analysis&#39;, &#39;Intelliigent&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;Development&#39;, &#39;(&#39;, &#39;now&#39;, &#39;WPC&#39;, &#39;)&#39;, &#39;Monitoring&#39;, &#39;Clinical&#39;, &#39;Drug&#39;, &#39;Studies&#39;, &#39;:&#39;, &#39;Beginner&#39;, &#39;Comprehensive&#39;, &#39;Monitoring&#39;, &#39;for&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Introduction&#39;, &#39;to&#39;, &#39;Clinical&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;Bioprocessing&#39;, &#39;Summit&#39;, &#39;Europe&#39;, &#39;Oligonucleotide&#39;, &#39;&amp;&#39;, &#39;Peptide&#39;, &#39;Summit&#39;, &#39;World&#39;, &#39;Pharma&#39;, &#39;Week&#39;, &#39;Prenatal&#39;, &#39;Diagnostics&#39;, &#39;Getting&#39;, &#39;Optimized&#39;, &#39;Targets&#39;, &#39;Library&#39;, &#39;Design&#39;, &#39;&amp;&#39;, &#39;Synthesis&#39;, &#39;Clinical&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;functional&#39;, &#39;genomics&#39;, &#39;bacterial&#39;, &#39;infections&#39;, &#39;Advanced&#39;, &#39;Automotive&#39;, &#39;Battery&#39;, &#39;Conference&#39;, &#39;(&#39;, &#39;AABC&#39;, &#39;)&#39;, &#39;Asia&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;Q&amp;A&#39;, &#39;Reference&#39;, &#39;Guide&#39;, &#39;Screening&#39;, &#39;Transmissible&#39;, &#39;spongiform&#39;, &#39;encephalopathy&#39;, &#39;TSE&#39;, &#39;Biomarker&#39;, &#39;Discovery&#39;, &#39;Summit&#39;, &#39;Clinical&#39;, &#39;Genomics&#39;, &#39;Sequencing&#39;, &#39;ASAP&#39;, &#39;Alliance&#39;, &#39;Summit&#39;, &#39;Bioterrorism&#39;, &#39;microarrays&#39;, &#39;Pharmaceutical&#39;, &#39;Leadership&#39;, &#39;Summit&#39;, &#39;Circulating&#39;, &#39;Cell&#39;, &#39;-&#39;, &#39;Free&#39;, &#39;DNA&#39;, &#39;Conducting&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Under&#39;, &#39;ICH&#39;, &#39;GCP&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;Europe&#39;, &#39;Trial&#39;, &#39;Master&#39;, &#39;File&#39;, &#39;Biomarkers&#39;, &#39;World&#39;, &#39;Preclinical&#39;, &#39;Congress&#39;, &#39;Europe&#39;, &#39;BioMEMS&#39;, &#39;bioinformatics&#39;, &#39;Genomic&#39;, &#39;Partnering&#39;, &#39;NMR&#39;, &#39;nuclear&#39;, &#39;magnetic&#39;, &#39;resonance&#39;, &#39;Clinical&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Biomarker&#39;, &#39;Validation&#39;, &#39;proteomics&#39;, &#39;Statistics&#39;, &#39;Sensors&#39;, &#39;Global&#39;, &#39;Summit&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;A&#39;, &#39;Regulatory&#39;, &#39;Overview&#39;, &#39;Drug&#39;, &#39;Safety&#39;, &#39;Pharmacy&#39;, &#39;Diagnostics&#39;, &#39;sample&#39;, &#39;preparation&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Design&#39;, &#39;Pharmacovigilance&#39;, &#39;Metabolic&#39;, &#39;Profiling&#39;, &#39;Digital&#39;, &#39;PCR&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Lab&#39;, &#39;chips&#39;, &#39;Europe&#39;, &#39;Monitoring&#39;, &#39;Clinical&#39;, &#39;Drug&#39;, &#39;Studies&#39;, &#39;:&#39;, &#39;Intermediate&#39;, &#39;Preparing&#39;, &#39;IND&#39;, &#39;Submissions&#39;, &#39;Antibody&#39;, &#39;Engineering&#39;, &#39;Asia&#39;, &#39;Clinical&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;:&#39;, &#39;Intermediate&#39;, &#39;phage&#39;, &#39;display&#39;, &#39;CELLutions&#39;, &#39;Recombinant&#39;, &#39;Antibodies&#39;, &#39;imaging&#39;, &#39;Biomarker&#39;, &#39;Assay&#39;, &#39;Development&#39;, &#39;in&#39;, &#39;silico&#39;, &#39;biology&#39;, &#39;Advanced&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;High&#39;, &#39;Throughput&#39;, &#39;Optimization&#39;, &#39;of&#39;, &#39;Culture&#39;, &#39;Conditions&#39;, &#39;for&#39;, &#39;Bioprocessing&#39;, &#39;High&#39;, &#39;Throughput&#39;, &#39;Technologies&#39;, &#39;gene&#39;, &#39;quantfication&#39;, &#39;[&#39;, &#39;real&#39;, &#39;time&#39;, &#39;PCR&#39;, &#39;]&#39;, &#39;From&#39;, &#39;Gene&#39;, &#39;Expression&#39;, &#39;Profiling&#39;, &#39;to&#39;, &#39;Validated&#39;, &#39;Biology&#39;, &#39;Clinical&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;:&#39;, &#39;Advanced&#39;, &#39;SCOPE&#39;, &#39;Summit&#39;, &#39;Europe&#39;, &#39;CNS&#39;, &#39;Partnering&#39;, &#39;Genomics&#39;, &#39;on&#39;, &#39;Target&#39;, &#39;R&amp;D&#39;, &#39;Statistical&#39;, &#39;Sourcebook&#39;, &#39;MultiUser&#39;, &#39;License&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Development&#39;, &#39;Biological&#39;, &#39;ADME&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;blood&#39;, &#39;safety&#39;, &#39;and&#39;, &#39;screening&#39;, &#39;Human&#39;, &#39;Proteome&#39;, &#39;Project&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;high&#39;, &#39;throughput&#39;, &#39;organic&#39;, &#39;synthesis&#39;, &#39;Global&#39;, &#39;Preclinical&#39;, &#39;Development&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Coordinator&#39;, &#39;Global&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;India&#39;, &#39;Biomarker&#39;, &#39;Diagnostics&#39;, &#39;molecular&#39;, &#39;diversity&#39;, &#39;functional&#39;, &#39;genomics&#39;, &#39;Process&#39;, &#39;R&amp;D&#39;, &#39;Summit&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;bioinformatics&#39;, &#39;Europe&#39;, &#39;Target&#39;, &#39;Validation&#39;, &#39;Bispecific&#39;, &#39;Antibodies&#39;, &#39;Bridging&#39;, &#39;Pharma&#39;, &#39;and&#39;, &#39;IT&#39;, &#39;Green&#39;, &#39;Fluorescent&#39;, &#39;Proteins&#39;, &#39;Quality&#39;, &#39;Systems&#39;, &#39;CRA&#39;, &#39;Monitoring&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;Development&#39;, &#39;AI&#39;, &#39;in&#39;, &#39;Government&#39;, &#39;glycotechnology&#39;, &#39;Baculovirus&#39;, &#39;Drug&#39;, &#39;Repurposing&#39;, &#39;drug&#39;, &#39;discovery&#39;, &#39;and&#39;, &#39;development&#39;, &#39;Japan&#39;, &#39;The&#39;, &#39;CRA&#39;, &#39;Manager&#39;, &#39;Course&#39;, &#39;State&#39;, &#39;by&#39;, &#39;State&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Requirments&#39;, &#39;Reference&#39;, &#39;Guide&#39;, &#39;Adverse&#39;, &#39;Events&#39;, &#39;:&#39;, &#39;Managing&#39;, &#39;&amp;&#39;, &#39;Reporting&#39;, &#39;for&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Good&#39;, &#39;Laboratory&#39;, &#39;Practice&#39;, &#39;Process&#39;, &#39;Chemistry&#39;, &#39;Beyond&#39;, &#39;Sequencing&#39;, &#39;Process&#39;, &#39;R&amp;D&#39;, &#39;Summit&#39;, &#39;with&#39;, &#39;GLP&#39;, &#39;Batteries&#39;, &#39;Biomarkers&#39;, &#39;Europe&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;computer&#39;, &#39;hardware&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;patient&#39;, &#39;Recruitment&#39;, &#39;Working&#39;, &#39;with&#39;, &#39;CROs&#39;, &#39;Expediting&#39;, &#39;Drugs&#39;, &#39;and&#39;, &#39;Biologics&#39;, &#39;Development&#39;, &#39;Tissue&#39;, &#39;Sealants&#39;, &#39;-&#39;, &#39;One&#39;, &#39;Day&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Europe&#39;, &#39;Use&#39;, &#39;of&#39;, &#39;Note&#39;, &#39;to&#39;, &#39;Files&#39;, &#39;in&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Essential&#39;, &#39;Documentation&#39;, &#39;Antibody&#39;, &#39;Engineering&#39;, &#39;Korea&#39;, &#39;RNAi&#39;, &#39;for&#39;, &#39;Pathway&#39;, &#39;Analysis&#39;, &#39;Advanced&#39;, &#39;GCP&#39;, &#39;Compliance&#39;, &#39;Mechanisms&#39;, &#39;of&#39;, &#39;Cancer&#39;, &#39;Business&#39;, &#39;Diagnostics&#39;, &#39;(&#39;, &#39;Impact&#39;, &#39;of&#39;, &#39;New&#39;, &#39;Diagnotics&#39;, &#39;)&#39;, &#39;Consumer&#39;, &#39;Genomics&#39;, &#39;Conference&#39;, &#39;Recombinant&#39;, &#39;Antibodies&#39;, &#39;Europe&#39;, &#39;Research&#39;, &#39;Site&#39;, &#39;Clinical&#39;, &#39;Study&#39;, &#39;Budgets&#39;, &#39;and&#39;, &#39;Contracts&#39;, &#39;Proof&#39;, &#39;of&#39;, &#39;Concept&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;in&#39;, &#39;China&#39;, &#39;Future&#39;, &#39;Diagnostics&#39;, &#39;Medicinal&#39;, &#39;Chemistry&#39;, &#39;Combination&#39;, &#39;Therapies&#39;, &#39;CRA&#39;, &#39;Training&#39;, &#39;Series&#39;, &#39;(&#39;, &#39;1&#39;, &#39;-&#39;, &#39;7&#39;, &#39;)&#39;, &#39;Lab&#39;, &#39;Chips&#39;, &#39;Japan&#39;, &#39;Human&#39;, &#39;Genomes&#39;, &#39;Europe&#39;, &#39;Tissue&#39;, &#39;Based&#39;, &#39;Screening&#39;, &#39;lead&#39;, &#39;optimization&#39;, &#39;Adverse&#39;, &#39;Events&#39;, &#39;Reimbursement&#39;, &#39;Diagnostics&#39;, &#39;labels&#39;, &#39;signals&#39;, &#39;and&#39;, &#39;detection&#39;, &#39;ASAP&#39;, &#39;CHI&#39;, &#39;Bio&#39;, &#39;Pharm&#39;, &#39;Alliance&#39;, &#39;Summit&#39;, &#39;forensic&#39;, &#39;diagnostics&#39;, &#39;Writing&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Molecular&#39;, &#39;Profiling&#39;, &#39;with&#39;, &#39;Cellular&#39;, &#39;Resolution&#39;, &#39;10&#39;, &#39;Rules&#39;, &#39;of&#39;, &#39;Effective&#39;, &#39;Report&#39;, &#39;Writing&#39;, &#39;pharmacogenomics&#39;, &#39;europe&#39;, &#39;Exploring&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Sequencing&#39;, &#39;conference&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;&amp;&#39;, &#39;FDA&#39;, &#39;Regulations&#39;, &#39;HCA&#39;, &#39;East&#39;, &#39;Cancer&#39;, &#39;Immunotherapies&#39;, &#39;(&#39;, &#39;formerly&#39;, &#39;Cancer&#39;, &#39;Vaccines&#39;, &#39;)&#39;, &#39;Biologics&#39;, &#39;Development&#39;, &#39;A&#39;, &#39;Regulatory&#39;, &#39;Overview&#39;, &#39;Standard&#39;, &#39;Operating&#39;, &#39;Proces&#39;, &#39;in&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;molecular&#39;, &#39;pharmacology&#39;, &#39;RNA&#39;, &#39;Interference&#39;, &#39;Summit&#39;, &#39;Clinical&#39;, &#39;Training&#39;, &#39;oligonucleotides&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Protocols&#39;, &#39;toxicology&#39;, &#39;Immunogenicity&#39;, &#39;Testing&#39;, &#39;for&#39;, &#39;Biologics&#39;, &#39;Adaptive&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;ADME&#39;, &#39;Stem&#39;, &#39;Cells&#39;, &#39;in&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;and&#39;, &#39;Development&#39;, &#39;Drug&#39;, &#39;Pipeline&#39;, &#39;Success&#39;, &#39;(&#39;, &#39;Pipeline&#39;, &#39;Success&#39;, &#39;Summit&#39;, &#39;)&#39;, &#39;stem&#39;, &#39;cells&#39;, &#39;Data&#39;, &#39;Visualization&#39;, &#39;Pharmacokinetics&#39;, &#39;transgenic&#39;, &#39;animal&#39;, &#39;models&#39;, &#39;Business&#39;, &#39;Development&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;Interface&#39;, &#39;Monitoring&#39;, &#39;Clinical&#39;, &#39;Drug&#39;, &#39;Studies&#39;, &#39;:&#39;, &#39;Advanced&#39;, &#39;Digital&#39;, &#39;Health&#39;, &#39;Innovation&#39;, &#39;Summit&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;in&#39;, &#39;the&#39;, &#39;Electronic&#39;, &#39;Data&#39;, &#39;Capture&#39;, &#39;Arena&#39;, &#39;Case&#39;, &#39;Report&#39;, &#39;Forms&#39;, &#39;Battery&#39;, &#39;Safety&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;GCP&#39;, &#39;Overview&#39;, &#39;Clinical&#39;, &#39;Administrative&#39;, &#39;Support&#39;, &#39;Staff&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;&amp;&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;Pre&#39;, &#39;-&#39;, &#39;Implantation&#39;, &#39;Diagnostics&#39;, &#39;Eyesight&#39;, &#39;Biomarker&#39;, &#39;Diagnostics&#39;, &#39;Biomarker&#39;, &#39;Web&#39;, &#39;Symposia&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;Process&#39;, &#39;Neglected&#39;, &#39;Diseases&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Approval&#39;, &#39;Process&#39;, &#39;Code&#39;, &#39;of&#39;, &#39;Federal&#39;, &#39;Regulations&#39;, &#39;for&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Associate&#39;, &#39;G&#39;, &#39;protein&#39;, &#39;coupled&#39;, &#39;receptors&#39;, &#39;GPCRS&#39;, &#39;Prenatal&#39;, &#39;Diagnostics&#39;, &#39;Europe&#39;, &#39;Genomic&#39;, &#39;Tools&#39;, &#39;&amp;&#39;, &#39;Technologies&#39;, &#39;Biomarkers&#39;, &#39;Europe&#39;, &#39;Symyx&#39;, &#39;Business&#39;, &#39;Collaborative&#39;, &#39;Innovation&#39;, &#39;Source&#39;, &#39;Documentation&#39;, &#39;Mitochondria&#39;, &#39;Comparative&#39;, &#39;Genomic&#39;, &#39;Hybridization&#39;, &#39;Lithium&#39;, &#39;Battery&#39;, &#39;Power&#39;, &#39;Writing&#39;, &#39;Clinical&#39;, &#39;Study&#39;, &#39;Protocols&#39;, &#39;Reimbursement&#39;, &#39;Therapeutics&#39;, &#39;genetic&#39;, &#39;variations&#39;, &#39;Business&#39;, &#39;Investigator&#39;, &#39;initiated&#39;, &#39;trials&#39;, &#39;Burrill&#39;, &#39;Book&#39;, &#39;Bio&#39;, &#39;-&#39;, &#39;IT&#39;, &#39;Asia&#39;, &#39;Compound&#39;, &#39;Profiling&#39;, &#39;cancer&#39;, &#39;clinical&#39;, &#39;trials&#39;, &#39;Chemical&#39;, &#39;Genomics&#39;, &#39;Safety&#39;, &#39;/&#39;, &#39;Toxicity&#39;, &#39;Biomarkers&#39;, &#39;Cancer&#39;, &#39;Diagnosis&#39;, &#39;antibody&#39;, &#39;engineering&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;in&#39;, &#39;Asia&#39;, &#39;West&#39;, &#39;Coast&#39;, &#39;Virtual&#39;, &#39;Screening&#39;, &#39;Point&#39;, &#39;of&#39;, &#39;Care&#39;, &#39;Diagnostics&#39;, &#39;Protein&#39;, &#39;Formulation&#39;, &#39;genetic&#39;, &#39;diagnostics&#39;, &#39;Bridging&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;IT&#39;, &#39;Biofuels&#39;, &#39;Translational&#39;, &#39;Medicine&#39;, &#39;Personalized&#39;, &#39;Medicine&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Organization&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;Congress&#39;, &#39;Europe&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;Risk&#39;, &#39;Based&#39;, &#39;Site&#39;, &#39;Monitoring&#39;, &#39;Root&#39;, &#39;Cause&#39;, &#39;Analysis&#39;, &#39;Monitoring&#39;, &#39;Phase&#39;, &#39;I&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;Latin&#39;, &#39;America&#39;, &#39;Licensing&#39;, &#39;vaccines&#39;, &#39;cancer&#39;, &#39;genetics&#39;, &#39;and&#39;, &#39;genomics&#39;, &#39;Marketing&#39;, &#39;Reimbursement&#39;, &#39;Metabolic&#39;, &#39;Analytical&#39;, &#39;Methods&#39;, &#39;Difficult&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;Protein&#39;, &#39;Chips&#39;, &#39;/&#39;, &#39;Arrays&#39;, &#39;Monitoring&#39;, &#39;Plan&#39;, &#39;Development&#39;, &#39;Genome&#39;, &#39;Japan&#39;, &#39;Immunogenicity&#39;, &#39;Advances&#39;, &#39;in&#39;, &#39;Management&#39;, &#39;and&#39;, &#39;Reduction&#39;, &#39;Clinical&#39;, &#39;Auditing&#39;, &#39;Clinical&#39;, &#39;Informatics&#39;, &#39;Antibody&#39;, &#39;-&#39;, &#39;Drug&#39;, &#39;Conjugates&#39;, &#39;Electronic&#39;, &#39;Medical&#39;, &#39;Records&#39;, &#39;&amp;&#39;, &#39;Source&#39;, &#39;Document&#39;, &#39;Verification&#39;, &#39;Bridge&#39;, &#39;to&#39;, &#39;Pop&#39;, &#39;Health&#39;, &#39;East&#39;, &#39;Informed&#39;, &#39;Consent&#39;, &#39;Pharma&#39;, &#39;Future&#39;, &#39;Microarray&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Europe&#39;, &#39;Clinical&#39;, &#39;Investigator&#39;, &#39;Site&#39;, &#39;Inspections&#39;, &#39;Global&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Protocol&#39;, &#39;Deviations&#39;, &#39;Immunotherapy&#39;, &#39;West&#39;, &#39;Cancer&#39;, &#39;Therapies&#39;, &#39;Recognize&#39;, &#39;Attrition&#39;, &#39;Earlier&#39;, &#39;Electronic&#39;, &#39;Data&#39;, &#39;Capture&#39;, &#39;Clinical&#39;, &#39;Imaging&#39;, &#39;Physical&#39;, &#39;Chemistry&#39;, &#39;Toll&#39;, &#39;Like&#39;, &#39;Receptors&#39;, &#39;monoclonal&#39;, &#39;antibodies&#39;, &#39;Innate&#39;, &#39;Immunity&#39;, &#39;High&#39;, &#39;Content&#39;, &#39;Analysis&#39;, &#39;Europe&#39;, &#39;Negotiation&#39;, &#39;Skills&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Professionals&#39;, &#39;Biotech&#39;, &#39;Executive&#39;, &#39;Forum&#39;, &#39;CNP&#39;, &#39;Partnering&#39;, &#39;Europe&#39;, &#39;nanotechnology&#39;, &#39;Risk&#39;, &#39;Management&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;for&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Adverse&#39;, &#39;Event&#39;, &#39;Monitoring&#39;, &#39;for&#39;, &#39;CRAs&#39;, &#39;Vendor&#39;, &#39;Management&#39;, &#39;Report&#39;, &#39;Writing&#39;, &#39;for&#39;, &#39;CRAs&#39;, &#39;Symyx&#39;, &#39;Europe&#39;, &#39;Epigenetics&#39;, &#39;Regulatory&#39;, &#39;Compliance&#39;, &#39;GCP&#39;, &#39;Training&#39;, &#39;for&#39;, &#39;Investigators&#39;, &#39;RECIST&#39;, &#39;1.0&#39;, &#39;and&#39;, &#39;1.1&#39;, &#39;Pharmacovigilance&#39;, &#39;Audit&#39;, &#39;Microfluidics&#39;, &#39;yeast&#39;, &#39;model&#39;, &#39;organism&#39;, &#39;Market&#39;, &#39;Targets&#39;, &#39;&amp;&#39;, &#39;Compounds&#39;, &#39;Critical&#39;, &#39;Decision&#39;, &#39;Points&#39;, &#39;in&#39;, &#39;Design&#39;, &#39;&amp;&#39;, &#39;Conduct&#39;, &#39;of&#39;, &#39;Patient&#39;, &#39;Registries&#39;, &#39;protein&#39;, &#39;production&#39;, &#39;formulation&#39;, &#39;HCA&#39;, &#39;Europe&#39;, &#39;Idiosyncratic&#39;, &#39;Toxicity&#39;, &#39;Protein&#39;, &#39;Informatics&#39;, &#39;Conflict&#39;, &#39;Resolution&#39;, &#39;and&#39;, &#39;Negotiation&#39;, &#39;Regulatory&#39;, &#39;Intelligence&#39;, &#39;Bioresearch&#39;, &#39;Monitoring&#39;, &#39;Cryobiology&#39;, &#39;signal&#39;, &#39;transduction&#39;, &#39;Emerging&#39;, &#39;Companies&#39;, &#39;Corrective&#39;, &#39;Action&#39;, &#39;Plans&#39;, &#39;:&#39;, &#39;Documentation&#39;, &#39;of&#39;, &#39;a&#39;, &#39;Sites&#39;, &#39;Response&#39;, &#39;to&#39;, &#39;GCP&#39;, &#39;Deficiences&#39;, &#39;Developing&#39;, &#39;Clinical&#39;, &#39;Study&#39;, &#39;Budget&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Sequencing&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Fraud&#39;, &#39;in&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Biosimilars&#39;, &#39;Dealmaking&#39;, &#39;for&#39;, &#39;Diagnostics&#39;, &#39;Comprehensive&#39;, &#39;CRC&#39;, &#39;Training&#39;, &#39;Cancer&#39;, &#39;Cell&#39;, &#39;Models&#39;, &#39;Digital&#39;, &#39;Health&#39;, &#39;Patient&#39;, &#39;Registry&#39;, &#39;Programs&#39;, &#39;crop&#39;, &#39;genetics&#39;, &#39;Glossary&#39;, &#39;&amp;&#39;, &#39;Acronyms&#39;, &#39;Reference&#39;, &#39;Biosensors&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;Essential&#39;, &#39;Documentation&#39;, &#39;in&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;at&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;Patient&#39;, &#39;Centered&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Proteins&#39;, &#39;to&#39;, &#39;Profits&#39;, &#39;Europe&#39;, &#39;Drug&#39;, &#39;Metabolism&#39;, &#39;International&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;Regulatory&#39;, &#39;Procedures&#39;, &#39;Principal&#39;, &#39;Investigator&#39;, &#39;Training&#39;, &#39;orthopedic&#39;, &#39;tissue&#39;, &#39;engineering&#39;, &#39;Investigator&#39;, &#39;Sites&#39;, &#39;cardiovascular&#39;, &#39;genomics&#39;, &#39;Study&#39;, &#39;Start&#39;, &#39;Up&#39;, &#39;Protein&#39;, &#39;Folding&#39;, &#39;Population&#39;, &#39;Health&#39;, &#39;Management&#39;, &#39;Tissue&#39;, &#39;Diagnostics&#39;, &#39;GLP&#39;, &#39;Bioanalysis&#39;, &#39;Phase&#39;, &#39;I&#39;, &#39;Study&#39;, &#39;Management&#39;, &#39;Health&#39;, &#39;Autonomous&#39;, &#39;Driving&#39;, &#39;Electronic&#39;, &#39;Source&#39;, &#39;Documentation&#39;, &#39;Tools&#39;, &#39;&amp;&#39;, &#39;Metrics&#39;, &#39;Congress&#39;, &#39;Global&#39;, &#39;GCP&#39;, &#39;Monitoring&#39;, &#39;Investigator&#39;, &#39;Non&#39;, &#39;-&#39;, &#39;Compliance&#39;, &#39;Global&#39;, &#39;GCP&#39;, &#39;Compliance&#39;, &#39;Report&#39;, &#39;Protein&#39;, &#39;&amp;&#39;, &#39;Peptide&#39;, &#39;Arrays&#39;, &#39;Europe&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Things&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;for&#39;, &#39;Pharmaceuticals&#39;, &#39;Introduction&#39;, &#39;to&#39;, &#39;Signal&#39;, &#39;Detection&#39;, &#39;and&#39;, &#39;Data&#39;, &#39;Mining&#39;, &#39;Study&#39;, &#39;Feasibility&#39;, &#39;Clinical&#39;, &#39;Investigation&#39;, &#39;Monitoring&#39;, &#39;Proteomics&#39;, &#39;Europe&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;in&#39;, &#39;Developing&#39;, &#39;Regions&#39;, &#39;Pediatric&#39;, &#39;drug&#39;, &#39;development&#39;, &#39;Sponsor&#39;, &#39;Monitoring&#39;, &#39;Inspections&#39;, &#39;Maximize&#39;, &#39;Value&#39;, &#39;of&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;protein&#39;, &#39;structures&#39;, &#39;cancer&#39;, &#39;Microbial&#39;, &#39;Genomics&#39;, &#39;Translational&#39;, &#39;Cancer&#39;, &#39;Medicine&#39;, &#39;Medical&#39;, &#39;Terminalogy&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Professionals&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Writing&#39;, &#39;and&#39;, &#39;Updating&#39;, &#39;the&#39;, &#39;Investigators&#39;, &#39;Brochure&#39;, &#39;Sunshine&#39;, &#39;Act&#39;, &#39;Sequencing&#39;, &#39;for&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;Standard&#39;, &#39;Operating&#39;, &#39;Procedures&#39;, &#39;Meeting&#39;, &#39;International&#39;, &#39;Safety&#39;, &#39;Reporting&#39;, &#39;Requirements&#39;, &#39;Faciliation&#39;, &#39;Skills&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Professionals&#39;, &#39;bioprocessing&#39;, &#39;biologicals&#39;, &#39;safety&#39;, &#39;Regulatory&#39;, &#39;Intelligence&#39;, &#39;101&#39;, &#39;Recent&#39;, &#39;Trends&#39;, &#39;in&#39;, &#39;Noncompliance&#39;, &#39;Briefings&#39;, &#39;on&#39;, &#39;Drug&#39;, &#39;Safety&#39;, &#39;Clinical&#39;, &#39;research&#39;, &#39;project&#39;, &#39;mamangement&#39;, &#39;essentials&#39;, &#39;CRA&#39;, &#39;Survival&#39;, &#39;Kit&#39;, &#39;Essential&#39;, &#39;Documentation&#39;, &#39;Extracellular&#39;, &#39;RNA&#39;, &#39;Successful&#39;, &#39;Study&#39;, &#39;Site&#39;, &#39;Start&#39;, &#39;-&#39;, &#39;up&#39;, &#39;Cell&#39;, &#39;Based&#39;, &#39;Therapies&#39;, &#39;Web&#39;, &#39;-&#39;, &#39;Based&#39;, &#39;Training&#39;, &#39;Strategies&#39;, &#39;data&#39;, &#39;mining&#39;, &#39;GLP&#39;, &#39;Bioanalysis&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Finance&#39;, &#39;&amp;&#39;, &#39;Management&#39;, &#39;regulatory&#39;, &#39;Site&#39;, &#39;Relationship&#39;, &#39;/&#39;, &#39;Performance&#39;, &#39;Management&#39;, &#39;Introduction&#39;, &#39;to&#39;, &#39;FDA&#39;, &#39;Regulatory&#39;, &#39;Reporter&#39;, &#39;Newsletter&#39;, &#39;multiple&#39;, &#39;sclerosis&#39;, &#39;Data&#39;, &#39;Integration&#39;, &#39;Managing&#39;, &#39;CRAs&#39;, &#39;to&#39;, &#39;Improve&#39;, &#39;Performance&#39;, &#39;&amp;&#39;, &#39;Study&#39;, &#39;Outcomes&#39;, &#39;compounds&#39;, &#39;Predictive&#39;, &#39;Toxicity&#39;, &#39;Surviving&#39;, &#39;FDA&#39;, &#39;Site&#39;, &#39;Inspections&#39;, &#39;:&#39;, &#39;Best&#39;, &#39;Practices&#39;, &#39;for&#39;, &#39;Site&#39;, &#39;Personnel&#39;, &#39;Phase&#39;, &#39;III&#39;, &#39;(&#39;, &#39;3)/forecasting&#39;, &#39;clinical&#39;, &#39;outcomes&#39;, &#39;Comparing&#39;, &#39;FDA&#39;, &#39;and&#39;, &#39;Health&#39;, &#39;Canada&#39;, &#39;Regulations&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Professionals&#39;, &#39;Recombinant&#39;, &#39;Therapeutics&#39;, &#39;Tick&#39;, &#39;Borne&#39;, &#39;Diseases&#39;, &#39;Writing&#39;, &#39;and&#39;, &#39;Maintaining&#39;, &#39;the&#39;, &#39;EU&#39;, &#39;CTA&#39;, &#39;Orphan&#39;, &#39;Drugs&#39;, &#39;Investigator&#39;, &#39;Initiated&#39;, &#39;Trials&#39;, &#39;Orthopaedic&#39;, &#39;Animal&#39;, &#39;Models&#39;, &#39;Auditing&#39;, &#39;Sponsors&#39;, &#39;and&#39;, &#39;CROs&#39;, &#39;Valuing&#39;, &#39;&amp;&#39;, &#39;Pricing&#39;, &#39;Licensing&#39;, &#39;Deals&#39;, &#39;drug&#39;, &#39;delivery&#39;, &#39;Vendor&#39;, &#39;Management&#39;, &#39;for&#39;, &#39;the&#39;, &#39;Clinical&#39;, &#39;Data&#39;, &#39;Manager&#39;, &#39;Data&#39;, &#39;Quality&#39;, &#39;Patient&#39;, &#39;Engagement&#39;, &#39;FDA&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;Process&#39;, &#39;HIPAA&#39;, &#39;No&#39;, &#39;1&#39;, &#39;Team&#39;, &#39;Training&#39;, &#39;HIPAA&#39;, &#39;&amp;&#39;, &#39;Human&#39;, &#39;Subjects&#39;, &#39;Research&#39;, &#39; &#39;, &#39;Q&amp;A&#39;, &#39;Ubiquitin&#39;, &#39;Europe&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Data&#39;, &#39;Monitoring&#39;, &#39;Investigational&#39;, &#39;Product&#39;, &#39;Accountability&#39;, &#39;Training&#39;, &#39;for&#39;, &#39;Research&#39;, &#39;Site&#39;, &#39;Personnel&#39;, &#39;Adverse&#39;, &#39;Event&#39;, &#39;Reporting&#39;, &#39;to&#39;, &#39;IRBs&#39;, &#39;Subject&#39;, &#39;Recruitment&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;Antibodies&#39;, &#39;in&#39;, &#39;Cancer&#39;, &#39;Cost&#39;, &#39;Management&#39;, &#39;for&#39;, &#39;Global&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Portfolio&#39;, &#39;Management&#39;, &#39;Warning&#39;, &#39;Letters&#39;, &#39;Combination&#39;, &#39;Products&#39;, &#39;Observational&#39;, &#39;Studies&#39;, &#39;Molecular&#39;, &#39;Medicine&#39;, &#39;Asia&#39;, &#39;CNS&#39;, &#39;Central&#39;, &#39;nervous&#39;, &#39;system&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;Development&#39;, &#39;Collaboration&#39;, &#39;Cross&#39;, &#39;functional&#39;, &#39;global&#39;, &#39;teams&#39;, &#39;Site&#39;, &#39;Relationship&#39;, &#39;Management&#39;, &#39;peptides&#39;, &#39;Investigator&#39;, &#39;Oversight&#39;, &#39;Writing&#39;, &#39;SOPs&#39;, &#39;pain&#39;, &#39;web&#39;, &#39;2.0&#39;, &#39;Understanding&#39;, &#39;FDAs&#39;, &#39;new&#39;, &#39;Draft&#39;, &#39;Guidance&#39;, &#39;Regarding&#39;, &#39;Supervisory&#39;, &#39;Repons&#39;, &#39;Sponsors&#39;, &#39;/&#39;, &#39;CROs&#39;, &#39;Preparing&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;for&#39;, &#39;FDA&#39;, &#39;Inspections&#39;, &#39;eHealth&#39;, &#39;Technologies&#39;, &#39;Introduction&#39;, &#39;to&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;FDA&#39;, &#39;Proposed&#39;, &#39;rule&#39;, &#39;2010&#39;, &#39;Teambuilding&#39;, &#39;for&#39;, &#39;the&#39;, &#39;Cross&#39;, &#39;Functional&#39;, &#39;Global&#39;, &#39;Team&#39;, &#39;Genomic&#39;, &#39;Business&#39;, &#39;Strategies&#39;, &#39;Product&#39;, &#39;Life&#39;, &#39;Cycle&#39;, &#39;RNA&#39;, &#39;Interference&#39;, &#39;Pharmacovigilance&#39;, &#39;Signal&#39;, &#39;Detection&#39;, &#39;Foreign&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Biotech&#39;, &#39;Business&#39;, &#39;Development&#39;, &#39;genomics&#39;, &#39;Portfolio&#39;, &#39;Management&#39;, &#39;Venue&#39;, &#39;II&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Design&#39;, &#39;for&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Informed&#39;, &#39;Consent&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Study&#39;, &#39;Wheel&#39;, &#39;Biomarker&#39;, &#39;Data&#39;, &#39;Center&#39;, &#39;Antibody&#39;, &#39;Optimization&#39;, &#39;&amp;&#39;, &#39;Characterization&#39;, &#39;Biologics&#39;, &#39;Chronic&#39;, &#39;Pain&#39;, &#39;cardiovascular&#39;, &#39;Risk&#39;, &#39;based&#39;, &#39;decisions&#39;, &#39;for&#39;, &#39;clinical&#39;, &#39;site&#39;, &#39;management&#39;, &#39;Human&#39;, &#39;Participant&#39;, &#39;Protection&#39;, &#39;Training&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Professionals&#39;, &#39;CRC&#39;, &#39;Role&#39;, &#39;/&#39;, &#39;Responsibilities&#39;, &#39;Training&#39;, &#39;Womens&#39;, &#39;Health&#39;, &#39;Current&#39;, &#39;Developments&#39;, &#39;in&#39;, &#39;the&#39;, &#39;Role&#39;, &#39;of&#39;, &#39;IRBs&#39;, &#39;in&#39;, &#39;the&#39;, &#39;Conduct&#39;, &#39;of&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Regulatory&#39;, &#39;Compliance&#39;, &#39;for&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;infections&#39;, &#39;Diabetes&#39;, &#39;cancer&#39;, &#39;partnering&#39;, &#39;Preparing&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;510&#39;, &#39;K&#39;, &#39;Submissions&#39;, &#39;Monitoring&#39;, &#39;Informed&#39;, &#39;Consent&#39;, &#39;Business&#39;, &#39;of&#39;, &#39;Biobanking&#39;, &#39;Global&#39;, &#39;Site&#39;, &#39;Selection&#39;, &#39;Boston&#39;, &#39;Biomarkers&#39;, &#39;of&#39;, &#39;Drug&#39;, &#39;Efficacy&#39;, &#39;and&#39;, &#39;Safety&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;in&#39;, &#39;the&#39;, &#39;European&#39;, &#39;Union&#39;, &#39;Protein&#39;, &#39;Therapeutics&#39;, &#39;Quality&#39;, &#39;Improvement&#39;, &#39;Strategies&#39;, &#39;at&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;diagnostics&#39;, &#39;bioprocessing&#39;, &#39;viral&#39;, &#39;hepatitis&#39;, &#39;infections&#39;, &#39;Advanced&#39;, &#39;HIPAA&#39;, &#39;Clinical&#39;, &#39;Sequencing&#39;, &#39;IRB&#39;, &#39;Guidance&#39;, &#39;regenerative&#39;, &#39;healing&#39;, &#39;cell&#39;, &#39;culture&#39;, &#39;Coronavirus&#39;, &#39;Liver&#39;, &#39;Disorders&#39;, &#39;Big&#39;, &#39;pharma&#39;, &#39;Big&#39;, &#39;Data&#39;, &#39;HIPAA&#39;, &#39;Electronic&#39;, &#39;Medical&#39;, &#39;Records&#39;, &#39;blood&#39;, &#39;Pharmaceutical&#39;, &#39;Strategy&#39;, &#39;Series&#39;, &#39;Strategies&#39;, &#39;for&#39;, &#39;Accelearted&#39;, &#39;Nonclinical&#39;, &#39;Toxiciology&#39;, &#39;&amp;&#39;, &#39;Safety&#39;, &#39;Assessment&#39;, &#39;of&#39;, &#39;Biologics&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;in&#39;, &#39;Japan&#39;, &#39;Artificial&#39;, &#39;Intelligence&#39;, &#39;Excel&#39;, &#39;Spreadsheets&#39;, &#39;-&#39;, &#39;Step&#39;, &#39;by&#39;, &#39;Step&#39;, &#39;Instructions&#39;, &#39;for&#39;, &#39;Compliance&#39;, &#39;Chemistry&#39;, &#39;R&amp;D&#39;, &#39;Statistical&#39;, &#39;Sourcebook&#39;, &#39;Upgrade&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Tracking&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Directive&#39;, &#39;Facilitation&#39;, &#39;Skills&#39;, &#39;Autoimmune&#39;, &#39;anticoagulants&#39;, &#39;bone&#39;, &#39;Clinical&#39;, &#39;Antibodies&#39;, &#39;gene&#39;, &#39;therapy&#39;, &#39;Newborn&#39;, &#39;Diagnostics&#39;, &#39;Real&#39;, &#39;World&#39;, &#39;Monitoring&#39;, &#39;Allergies&#39;, &#39;Performance&#39;, &#39;Improvement&#39;, &#39;Monitoring&#39;, &#39;Model&#39;, &#39;Institutional&#39;, &#39;Review&#39;, &#39;Board&#39;, &#39;Health&#39;, &#39;Outcomes&#39;, &#39;Outsourcing&#39;, &#39;R&amp;D&#39;, &#39;Microbiome&#39;, &#39;Key&#39;, &#39;Opinion&#39;, &#39;Leaders&#39;, &#39;Chronic&#39;, &#39;Obstructive&#39;, &#39;Pulmonary&#39;, &#39;Disorder&#39;, &#39;Quality&#39;, &#39;by&#39;, &#39;Design&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;&amp;&#39;, &#39;Translational&#39;, &#39;Medicine&#39;, &#39;Series&#39;, &#39;Lupus&#39;, &#39;Multi&#39;, &#39;Drug&#39;, &#39;Resistance&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Coordinator&#39;, &#39;Tool&#39;, &#39;Kit&#39;, &#39;CRC&#39;, &#39;&amp;&#39;, &#39;PI&#39;, &#39;Current&#39;, &#39;Practice&#39;, &#39;Update&#39;, &#39;CRA&#39;, &#39;Facilitator&#39;, &#39;Training&#39;, &#39;21&#39;, &#39;CFR&#39;, &#39;Part&#39;, &#39;11&#39;, &#39;Compliance&#39;, &#39;for&#39;, &#39;Electronic&#39;, &#39;Records&#39;, &#39;&amp;&#39;, &#39;Signatures&#39;, &#39;Cancer&#39;, &#39;Diagnostics&#39;, &#39;Electronic&#39;, &#39;Health&#39;, &#39;Record&#39;, &#39;Chiral&#39;, &#39;Intro&#39;, &#39;to&#39;, &#39;Combination&#39;, &#39;Products&#39;, &#39;Gastrointestinal&#39;, &#39;Disorders&#39;, &#39;Presentation&#39;, &#39;skills&#39;, &#39;for&#39;, &#39;clinical&#39;, &#39;research&#39;, &#39;professionals&#39;, &#39;inflammation&#39;, &#39;Operational&#39;, &#39;Modeling&#39;, &#39;and&#39;, &#39;Simulation&#39;, &#39;in&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Pharmaceutical&#39;, &#39;&amp;&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Industries&#39;, &#39;Facilitation&#39;, &#39;Skills&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Team&#39;, &#39;Members&#39;, &#39;Diagnostics&#39;, &#39;Partnering&#39;, &#39;Mobile&#39;, &#39;Health&#39;, &#39;Wearables&#39;, &#39;Pharmaceutical&#39;, &#39;Discovery&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Medical&#39;, &#39;device&#39;, &#39;reporting&#39;, &#39;Ubiquitin&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Postmarketing&#39;, &#39;Vigilance&#39;, &#39;Blockchain&#39;, &#39;Alzheimers&#39;, &#39;high&#39;, &#39;performance&#39;, &#39;computing&#39;, &#39;Innovative&#39;, &#39;Preclinical&#39;, &#39;&amp;&#39;, &#39;Clinical&#39;, &#39;Strategies&#39;, &#39;GXP&#39;, &#39;Good&#39;, &#39;Practice&#39;, &#39;Guides&#39;, &#39;Writing&#39;, &#39;and&#39;, &#39;Maintaining&#39;, &#39;Canadian&#39;, &#39;CTA&#39;, &#39;3D&#39;, &#39;Printing&#39;, &#39;Key&#39;, &#39;Information&#39;, &#39;Gatherers&#39;, &#39;Respiratory&#39;, &#39;Five&#39;, &#39;Keys&#39;, &#39;to&#39;, &#39;COTS&#39;, &#39;Computer&#39;, &#39;System&#39;, &#39;Validation&#39;, &#39;Next&#39;, &#39;-&#39;, &#39;Generation&#39;, &#39;Sequencing&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Open&#39;, &#39;Source&#39;, &#39;Fibrosis&#39;, &#39;/&#39;, &#39;Scarring&#39;, &#39;Biomarker&#39;, &#39;Bridge&#39;, &#39;Genomics&#39;, &#39;101&#39;, &#39;Dummy&#39;, &#39;Keyword&#39;, &#39;for&#39;, &#39;DE&#39;, &#39;lists&#39;, &#39;w&#39;, &#39;/&#39;, &#39;more&#39;, &#39;than&#39;, &#39;1&#39;, &#39;keyword&#39;, &#39;or&#39;, &#39;with&#39;, &#39;no&#39;, &#39;keywords&#39;, &#39;FDA&#39;, &#39;Form&#39;, &#39;1572&#39;, &#39;Antisense&#39;, &#39;Accountable&#39;, &#39;Care&#39;, &#39;Orgnization&#39;, &#39;ACE&#39;, &#39;inhibitors&#39;, &#39;AI&#39;, &#39;Chips&#39;, &#39;Antibody&#39;, &#39;-&#39;, &#39;Drug&#39;, &#39;Conjugates&#39;, &#39; &#39;, &#39;for&#39;, &#39;PEGS&#39;, &#39;Antibody&#39;, &#39;Drug&#39;, &#39;Conjugate&#39;, &#39;Bioprocess&#39;, &#39;Attention&#39;, &#39;Deficit&#39;, &#39;Hyperactivity&#39;, &#39;Disorder&#39;, &#39;Adjuvants&#39;, &#39;ADMET&#39;, &#39;(&#39;, &#39;ADME&#39;, &#39;&amp;&#39;, &#39;Toxicology&#39;, &#39;)&#39;, &#39;adverse&#39;, &#39;drug&#39;, &#39;reactions&#39;, &#39;Aerospace&#39;, &#39;Advanced&#39;, &#39;Energy&#39;, &#39;Technology&#39;, &#39;Congress&#39;, &#39;Affordable&#39;, &#39;Care&#39;, &#39;affinity&#39;, &#39;technologies&#39;, &#39;Affinity&#39;, &#39;Separation&#39;, &#39;Antibody&#39;, &#39;Fragments&#39;, &#39;Agriculture&#39;, &#39; &#39;, &#39;chemistry&#39;, &#39;Aging&#39;, &#39;Antibody&#39;, &#39;Drug&#39;, &#39;Targets&#39;, &#39;Digital&#39;, &#39;Farming&#39;, &#39;angiogenesis&#39;, &#39;AI&#39;, &#39;Business&#39;, &#39;Intelligence&#39;, &#39;Artificial&#39;, &#39;Intelligence&#39;, &#39;Bioprocessing&#39;, &#39;AI&#39;, &#39;in&#39;, &#39;Customer&#39;, &#39;Analytics&#39;, &#39;Intelligent&#39;, &#39;Assistants&#39;, &#39;and&#39;, &#39;Bots&#39;, &#39;AI&#39;, &#39;in&#39;, &#39;Cancer&#39;, &#39;Enterprise&#39;, &#39;AI&#39;, &#39;Case&#39;, &#39;Studies&#39;, &#39;AI&#39;, &#39;Executive&#39;, &#39;Summit&#39;, &#39;Machine&#39;, &#39;Learning&#39;, &#39;Artificial&#39;, &#39;Intelligence&#39;, &#39;Clinical&#39;, &#39;&amp;&#39;, &#39;Post&#39;, &#39;Approval&#39;, &#39;Artificial&#39;, &#39;Intelligence&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;Preclinical&#39;, &#39;Implementing&#39;, &#39;Enterprise&#39;, &#39;AI&#39;, &#39;AI&#39;, &#39;Ethics&#39;, &#39;Future&#39;, &#39;of&#39;, &#39;AI&#39;, &#39;Cutting&#39;, &#39;Edge&#39;, &#39;Research&#39;, &#39;for&#39;, &#39;AI&#39;, &#39;General&#39;, &#39;AI&#39;, &#39;Business&#39;, &#39;Applications&#39;, &#39;AI&#39;, &#39;for&#39;, &#39;Strategic&#39;, &#39;Government&#39;, &#39;Functions&#39;, &#39;Cognitive&#39;, &#39;Computing&#39;, &#39;AI&#39;, &#39;Partnering&#39;, &#39;AI&#39;, &#39;in&#39;, &#39;Personalized&#39;, &#39;Medicine&#39;, &#39;Allosteric&#39;, &#39;Modulators&#39;, &#39;Amyotrophic&#39;, &#39;lateral&#39;, &#39;sclerosis&#39;, &#39;Animal&#39;, &#39;Models&#39;, &#39;of&#39;, &#39;Cancer&#39;, &#39;Alternative&#39;, &#39;Medicine&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;Execution&#39;, &#39;Asset&#39;, &#39;Management&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;Negotiation&#39;, &#39;Animal&#39;, &#39;Models&#39;, &#39;of&#39;, &#39;Pain&#39;, &#39;Animal&#39;, &#39;Models&#39;, &#39;of&#39;, &#39;Toxicity&#39;, &#39;angina&#39;, &#39;Anxiety&#39;, &#39;cancer&#39;, &#39;and&#39;, &#39;apoptosis&#39;, &#39;Active&#39;, &#39;Pharmaceutical&#39;, &#39;Ingredients&#39;, &#39;Analytical&#39;, &#39;Purification&#39;, &#39;Apoptosis&#39;, &#39;Anti&#39;, &#39;Psychotics&#39;, &#39;Alliances&#39;, &#39;Rx&#39;, &#39;Devices&#39;, &#39;arrhythmias&#39;, &#39;Assays&#39;, &#39;for&#39;, &#39;Antibodies&#39;, &#39;Assays&#39;, &#39;Affinity&#39;, &#39;Assays&#39;, &#39;and&#39;, &#39;Allosteric&#39;, &#39;Antagonism&#39;, &#39;Immunogenicity&#39;, &#39;Assay&#39;, &#39;Development&#39;, &#39;Assays&#39;, &#39;Primary&#39;, &#39;Cells&#39;, &#39;Quantifying&#39;, &#39;Receptor&#39;, &#39;Activation&#39;, &#39;and&#39;, &#39;Agonism&#39;, &#39;asthma&#39;, &#39;Assays&#39;, &#39;atherosclerosis&#39;, &#39;Automotive&#39;, &#39;Automotive&#39;, &#39;Partnering&#39;, &#39;Autophagy&#39;, &#39;Autism&#39;, &#39;Advisory&#39;, &#39;Boards&#39;, &#39;Bacterial&#39;, &#39;Infections&#39;, &#39;Consumer&#39;, &#39;Electronic&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Defense&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Battery&#39;, &#39;Data&#39;, &#39;Science&#39;, &#39;Flexible&#39;, &#39;Battery&#39;, &#39;Power&#39;, &#39;Industrial&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Stationary&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Automotive&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Bayesian&#39;, &#39;Statistics&#39;, &#39;Asia&#39;, &#39;US&#39;, &#39;Biotech&#39;, &#39;Alliances&#39;, &#39;Blood&#39;, &#39;Brain&#39;, &#39;Barrier&#39;, &#39;Computational&#39;, &#39;Biology&#39;, &#39;for&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;BioIT&#39;, &#39;Best&#39;, &#39;Practices&#39;, &#39;Battery&#39;, &#39;Charging&#39;, &#39;Cheminformatics&#39;, &#39;for&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;Biomarker&#39;, &#39;Clinical&#39;, &#39;Applications&#39;, &#39;Preclinical&#39;, &#39;Biologic&#39;, &#39;Development&#39;, &#39;Breast&#39;, &#39;Cancer&#39;, &#39;Backup&#39;, &#39;Compounds&#39;, &#39;biological&#39;, &#39;cancer&#39;, &#39;treatments&#39;, &#39;Biomarker&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Biological&#39;, &#39;Database&#39;, &#39;Discovery&#39;, &#39;Informatics&#39;, &#39;for&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;Delivery&#39;, &#39;of&#39;, &#39;Biologics&#39;, &#39;Regulatory&#39;, &#39;Business&#39;, &#39;Diagnostics&#39;, &#39;biodiversity&#39;, &#39;screening&#39;, &#39;E&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Battery&#39;, &#39;Energy&#39;, &#39;Storage&#39;, &#39;Biofuels&#39;, &#39;Alliance&#39;, &#39;Biobank&#39;, &#39;Informatics&#39;, &#39;Flow&#39;, &#39;Cell&#39;, &#39;Technologies&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;for&#39;, &#39;Data&#39;, &#39;Science&#39;, &#39;Biogenerics&#39;, &#39;Business&#39;, &#39;of&#39;, &#39;Genomics&#39;, &#39;biomaterials&#39;, &#39;Bioinformatics&#39;, &#39;for&#39;, &#39;Cancer&#39;, &#39;BIO&#39;, &#39;IT&#39;, &#39;World&#39;, &#39;Battery&#39;, &#39;Intellectual&#39;, &#39;Property&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;World&#39;, &#39;Web&#39;, &#39;Resource&#39;, &#39;Alert&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;World&#39;, &#39;Monthly&#39;, &#39;magazine&#39;, &#39;IT&#39;, &#39;&amp;&#39;, &#39;Informatics&#39;, &#39;Series&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;World&#39;, &#39;Weekly&#39;, &#39;Update&#39;, &#39;Bookstore&#39;, &#39;Biomarker&#39;, &#39;Development&#39;, &#39;Advanced&#39;, &#39;Lead&#39;, &#39;Acid&#39;, &#39;Technology&#39;, &#39;Manufacturing&#39;, &#39;&amp;&#39;, &#39;Process&#39;, &#39;Economics&#39;, &#39;Biopharm&#39;, &#39;Executive&#39;, &#39;Summit&#39;, &#39;Biolaw&#39;, &#39;Biomarker&#39;, &#39;&amp;&#39;, &#39;Diagnostics&#39;, &#39;Series&#39;, &#39;High&#39;, &#39;-&#39;, &#39;Througput&#39;, &#39;Screen&#39;, &#39;-&#39;, &#39;Based&#39;, &#39;Biomarker&#39;, &#39;Discovery&#39;, &#39;Battery&#39;, &#39;Manufacturers&#39;, &#39;Battery&#39;, &#39;Manufacturing&#39;, &#39;Battery&#39;, &#39;Management&#39;, &#39;Battery&#39;, &#39;Manufacturing&#39;, &#39;Machinery&#39;, &#39;Battery&#39;, &#39;Market&#39;, &#39;Battery&#39;, &#39;Machine&#39;, &#39;Learning&#39;, &#39;Biomarker&#39;, &#39;Executive&#39;, &#39;Think&#39;, &#39;Tank&#39;, &#39;Battery&#39;, &#39;Materials&#39;, &#39;,&#39;, &#39;Recycling&#39;, &#39;Biomarker&#39;, &#39;Reverse&#39;, &#39;Phase&#39;, &#39;Assays&#39;, &#39;Battery&#39;, &#39;Materials&#39;, &#39;,&#39;, &#39;Solid&#39;, &#39;State&#39;, &#39;bone&#39;, &#39;marrow&#39;, &#39;transplants&#39;, &#39;Biomarker&#39;, &#39;Translational&#39;, &#39;Biomarker&#39;, &#39;Validation&#39;, &#39;Bioinformatics&#39;, &#39;Asia&#39;, &#39;Bioinformatics&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39; &#39;, &#39;for&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;Logistics&#39;, &#39;and&#39;, &#39;Sample&#39;, &#39;of&#39;, &#39;Biobanking&#39;, &#39;Bioinformatics&#39;, &#39;in&#39;, &#39;the&#39;, &#39;Genome&#39;, &#39;Era&#39;, &#39;Bioprocess&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Host&#39;, &#39;Cell&#39;, &#39;Protein&#39;, &#39;Assays&#39;, &#39;Bioproduction&#39;, &#39;Continuous&#39;, &#39;Processing&#39;, &#39;biopurification&#39;, &#39;Biological&#39;, &#39;Pharmacokinetics&#39;, &#39;Bioprocessing&#39;, &#39;Quality&#39;, &#39;Bioprocess&#39;, &#39;&amp;&#39;, &#39;Manufacturing&#39;, &#39;Series&#39;, &#39;Bioprocess&#39;, &#39;Validation&#39;, &#39;Bioreactor&#39;, &#39;Design&#39;, &#39;and&#39;, &#39;Engineering&#39;, &#39;Battery&#39;, &#39;Regulatory&#39;, &#39;Battery&#39;, &#39;Raw&#39;, &#39;Materials&#39;, &#39;Brain&#39;, &#39;Cancer&#39;, &#39;Battery&#39;, &#39;Repurposing&#39;, &#39;Biological&#39;, &#39;Therapeutics&#39;, &#39;(&#39;, &#39;biotherapeutics&#39;, &#39;)&#39;, &#39;Bispecific&#39;, &#39;Antibodies&#39;, &#39;for&#39;, &#39;Immunotherapy&#39;, &#39;Bispecifics&#39;, &#39;for&#39;, &#39;Cancer&#39;, &#39;Business&#39;, &#39;Strategies&#39;, &#39;for&#39;, &#39;Library&#39;, &#39;Diversity&#39;, &#39;blood&#39;, &#39;safety&#39;, &#39;Europe&#39;, &#39;Battery&#39;, &#39;Shipping&#39;, &#39;Battery&#39;, &#39;Simulation&#39;, &#39;Biosensors&#39;, &#39;bioseparation&#39;, &#39;Biostabilization&#39;, &#39;of&#39;, &#39;Biospecimens&#39;, &#39;Biomanufacturing&#39;, &#39;Single&#39;, &#39;Use&#39;, &#39;Technologies&#39;, &#39;Bioassays&#39;, &#39;Battery&#39;, &#39;Commercialization&#39;, &#39;Flow&#39;, &#39;Batteries&#39;, &#39;Battery&#39;, &#39;Materials&#39;, &#39;Sci&#39;, &#39;/&#39;, &#39;Tech&#39;, &#39;for&#39;, &#39;Pharma&#39;, &#39;&amp;&#39;, &#39;Biotech&#39;, &#39;Battery&#39;, &#39;Safety&#39;, &#39;Biotech&#39;, &#39;tools&#39;, &#39;Biotech&#39;, &#39;Venture&#39;, &#39;Forum&#39;, &#39;Biomarkers&#39;, &#39;for&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Biomarkers&#39;, &#39;for&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;for&#39;, &#39;Cancer&#39;, &#39;Immunotherapy&#39;, &#39;Artifical&#39;, &#39;Intelligence&#39;, &#39;in&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;cell&#39;, &#39;adhesion&#39;, &#39;molecules&#39;, &#39;regulatory&#39;, &#39;CANDA&#39;, &#39;Computer&#39;, &#39;Assisted&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Application&#39;, &#39;Chimeric&#39;, &#39;Antigen&#39;, &#39;Receptor&#39;, &#39;Chimeric&#39;, &#39;Antigen&#39;, &#39;Receptor&#39;, &#39;Case&#39;, &#39;Studies&#39;, &#39;catalysis&#39;, &#39;Cell&#39;, &#39;Based&#39;, &#39;Assays&#39;, &#39;Cell&#39;, &#39;Therapy&#39;, &#39;CMC&#39;, &#39;Cancer&#39;, &#39;Biomarker&#39;, &#39;Cell&#39;, &#39;Therapy&#39;, &#39;Production&#39;, &#39;Cord&#39;, &#39;Blood&#39;, &#39;Stem&#39;, &#39;Cells&#39;, &#39;Cell&#39;, &#39;Based&#39;, &#39;Therapies&#39;, &#39;Circulating&#39;, &#39;Tumor&#39;, &#39;Cells&#39;, &#39;Cold&#39;, &#39;Chain&#39;, &#39;Colorectal&#39;, &#39;Cancer&#39;, &#39;cell&#39;, &#39;cycle&#39;, &#39;Collaborations&#39;, &#39;Deals&#39;, &#39;and&#39;, &#39;Alliances&#39;, &#39;Chemical&#39;, &#39;Database&#39;, &#39;Co&#39;, &#39;-&#39;, &#39;Development&#39;, &#39;of&#39;, &#39;Diagnostics&#39;, &#39;and&#39;, &#39;Drugs&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;Europe&#39;, &#39;Case&#39;, &#39;Histories&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Consumer&#39;, &#39;Electronics&#39;, &#39;Cell&#39;, &#39;Biology&#39;, &#39;Clean&#39;, &#39;Tech&#39;, &#39;Solar&#39;, &#39;Wind&#39;, &#39;Comparative&#39;, &#39;Effectiveness&#39;, &#39;Research&#39;, &#39;Ethical&#39;, &#39;Considerations&#39;, &#39;in&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Continuing&#39;, &#39;Education&#39;, &#39;Units&#39;, &#39;Circulating&#39;, &#39;Cell&#39;, &#39;-&#39;, &#39;Free&#39;, &#39;DNA&#39;, &#39;Europe&#39;, &#39;Agriculture&#39;, &#39; &#39;, &#39;crop&#39;, &#39;genetics&#39;, &#39;Europe&#39;, &#39;Cancer&#39;, &#39;Genomics&#39;, &#39;Europe&#39;, &#39;congestive&#39;, &#39;heart&#39;, &#39;failure&#39;, &#39;Chemistry&#39;, &#39;Series&#39;, &#39;Chinese&#39;, &#39;Hamster&#39;, &#39;Ovaries&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Conflicts&#39;, &#39;of&#39;, &#39;Interest&#39;, &#39;cheminformatics&#39;, &#39;competitive&#39;, &#39;intelligence&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;Asia&#39;, &#39;Integrating&#39;, &#39;Clinical&#39;, &#39;Lab&#39;, &#39;Services&#39;, &#39;in&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Clinical&#39;, &#39;Biospecimens&#39;, &#39;and&#39;, &#39;Central&#39;, &#39;Lab&#39;, &#39;Solutions&#39;, &#39;Clinical&#39;, &#39;Biospecimens&#39;, &#39;and&#39;, &#39;Central&#39;, &#39;Lab&#39;, &#39;Solutions&#39;, &#39;Celiac&#39;, &#39;Disease&#39;, &#39;Cloud&#39;, &#39;Extension&#39;, &#39;Clinical&#39;, &#39;Genomics&#39;, &#39;Europe&#39;, &#39;cellular&#39;, &#39;all&#39;, &#39;Conducting&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;in&#39;, &#39;Asia&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;Resource&#39;, &#39;Management&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;Security&#39;, &#39;Risks&#39;, &#39;Software&#39;, &#39;Development&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Genomics&#39;, &#39;Clinical&#39;, &#39;Vaccines&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;West&#39;, &#39;Comparability&#39;, &#39;Chemistry&#39;, &#39;Manufacturing&#39;, &#39;and&#39;, &#39;Controls&#39;, &#39;Continuing&#39;, &#39;Medical&#39;, &#39;Education&#39;, &#39;Communications&#39;, &#39;Contract&#39;, &#39;Manufacturing&#39;, &#39;Cancer&#39;, &#39;Microarray&#39;, &#39;Application&#39;, &#39;CNS&#39;, &#39;Biomarkers&#39;, &#39;Miscellaneous&#39;, &#39;CHI&#39;, &#39;conference&#39;, &#39;CNS&#39;, &#39;genetics&#39;, &#39;/&#39;, &#39;genomics&#39;, &#39;CNS&#39;, &#39;Disease&#39;, &#39;Models&#39;, &#39;Counterfeit&#39;, &#39;Drugs&#39;, &#39;Copy&#39;, &#39;Number&#39;, &#39;Variation&#39;, &#39;Cognitive&#39;, &#39;Disorders&#39;, &#39;Battery&#39;, &#39;Components&#39;, &#39;capillary&#39;, &#39;electrophoresis&#39;, &#39;Cancer&#39;, &#39;Prognostic&#39;, &#39;Markers&#39;, &#39;Clinical&#39;, &#39;Pharmacology&#39;, &#39;Clinical&#39;, &#39;Proteomics&#39;, &#39;Clinical&#39;, &#39;Plasma&#39;, &#39;Profiling&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Platform&#39;, &#39;Software&#39;, &#39;Computer&#39;, &#39;Vision&#39;, &#39;cancer&#39;, &#39;prevention&#39;, &#39;CRA&#39;, &#39;8&#39;, &#39;Weeks&#39;, &#39;Fundamental&#39;, &#39;Training&#39;, &#39;Cost&#39;, &#39;Reduction&#39;, &#39;w/o&#39;, &#39;Increasing&#39;, &#39;Regulatory&#39;, &#39;or&#39;, &#39;Business&#39;, &#39;Risk&#39;, &#39;Advanced&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Coordinator&#39;, &#39;Critical&#39;, &#39;Care&#39;, &#39;Diagnostics&#39;, &#39;Interviewing&#39;, &#39;Skills&#39;, &#39;for&#39;, &#39;CRAs&#39;, &#39;and&#39;, &#39;CRCs&#39;, &#39;Customer&#39;, &#39;Relationship&#39;, &#39;Management&#39;, &#39;CRA&#39;, &#39;Monitoring&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Training&#39;, &#39;Week&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Training&#39;, &#39;Week&#39;, &#39;East&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Training&#39;, &#39;Week&#39;, &#39;West&#39;, &#39;Drug&#39;, &#39;-&#39;, &#39;Device&#39;, &#39;Combinations&#39;, &#39;Peptides&#39;, &#39;for&#39;, &#39;Cancer&#39;, &#39;Therapeutics&#39;, &#39;Colony&#39;, &#39;Stimulating&#39;, &#39;Factors&#39;, &#39;Cell&#39;, &#39;Signaling&#39;, &#39;Cancer&#39;, &#39;Stem&#39;, &#39;Cells&#39;, &#39;Clinical&#39;, &#39;Supply&#39;, &#39;Chain&#39;, &#39;Clinical&#39;, &#39;Strategic&#39;, &#39;Resource&#39;, &#39;Allocation&#39;, &#39;Country&#39;, &#39;and&#39;, &#39;Site&#39;, &#39;Feasibility&#39;, &#39;and&#39;, &#39;Selection&#39;, &#39;Mammalian&#39;, &#39;Cell&#39;, &#39;Culture&#39;, &#39;Cloud&#39;, &#39;Security&#39;, &#39;Cybersecurity&#39;, &#39;Clinical&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;and&#39;, &#39;eClinical&#39;, &#39;Trials&#39;, &#39;Asia&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;for&#39;, &#39;the&#39;, &#39;Drug&#39;, &#39;Discoverer&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Eastern&#39;, &#39;Europe&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Finance&#39;, &#39;&amp;&#39;, &#39;Management&#39;, &#39;Re&#39;, &#39;Engineering&#39;, &#39;the&#39;, &#39;Study&#39;, &#39;Feasibility&#39;, &#39;Assessment&#39;, &#39;Process&#39;, &#39;CRC&#39;, &#39;Training&#39;, &#39;Video&#39;, &#39;&amp;&#39;, &#39;Manual&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Management&#39;, &#39;Systems&#39;, &#39;Cardiotoxicity&#39;, &#39;Query&#39;, &#39;Creation&#39;, &#39;&amp;&#39;, &#39;Processing&#39;, &#39;clinical&#39;, &#39;trials&#39;, &#39;segmentation&#39;, &#39;Neoantigens&#39;, &#39;for&#39;, &#39;Cancer&#39;, &#39;Cardiovascular&#39;, &#39;Diagnostics&#39;, &#39;cardiovascular&#39;, &#39;animal&#39;, &#39;models&#39;, &#39;Cardio&#39;, &#39;Metabolic&#39;, &#39;Drug&#39;, &#39;Targets&#39;, &#39;Targeting&#39;, &#39;Cancer&#39;, &#39;Diagnostics&#39;, &#39;cytokines&#39;, &#39;antagonists&#39;, &#39;Cystic&#39;, &#39;Fibrosis&#39;, &#39;Cytogenetics&#39;, &#39;cytokines&#39;, &#39;Targeting&#39;, &#39;Diabetes&#39;, &#39;with&#39;, &#39;Novel&#39;, &#39;Therapeutics&#39;, &#39;DBS&#39;, &#39;Optimization&#39;, &#39;of&#39;, &#39;Cell&#39;, &#39;drug&#39;, &#39;discovery&#39;, &#39;India&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Map&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Outsourcing&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Technologies&#39;, &#39;drug&#39;, &#39;discovery&#39;, &#39;and&#39;, &#39;development&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;Development&#39;, &#39;Series&#39;, &#39;Dental&#39;, &#39;Depression&#39;, &#39;Detection&#39;, &#39;non&#39;, &#39;biological&#39;, &#39;Treatments&#39;, &#39;for&#39;, &#39;Drug&#39;, &#39;Abuse&#39;, &#39;Drug&#39;, &#39;Drug&#39;, &#39;Interactions&#39;, &#39;Digital&#39;, &#39;Therapeutics&#39;, &#39;Digitization&#39;, &#39;Diabetes&#39;, &#39;2&#39;, &#39;Digital&#39;, &#39;Healthcare&#39;, &#39;&amp;&#39;, &#39;Productivity&#39;, &#39;web&#39;, &#39;resource&#39;, &#39;alert&#39;, &#39;drug&#39;, &#39;discovery&#39;, &#39;Duchenne&#39;, &#39;Muscular&#39;, &#39;Dystrophy&#39;, &#39;Drug&#39;, &#39;Metabolism&#39;, &#39;&amp;&#39;, &#39;Pharmacokinetics&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Informatics&#39;, &#39;Europe&#39;, &#39;Data&#39;, &#39;Integrity&#39;, &#39;Diagnostic&#39;, &#39;Informatics&#39;, &#39;DNA&#39;, &#39;Repair&#39;, &#39;Diversity&#39;, &#39;Oriented&#39;, &#39;Synthesis&#39;, &#39;Digital&#39;, &#39;Detection&#39;, &#39;Europe&#39;, &#39;Difficult&#39;, &#39;to&#39;, &#39;Express&#39;, &#39;Proteins&#39;, &#39;Executive&#39;, &#39;Perspectives&#39;, &#39;of&#39;, &#39;Drug&#39;, &#39;Safety&#39;, &#39;downstream&#39;, &#39;processing&#39;, &#39;Europe&#39;, &#39;Drug&#39;, &#39;Safety&#39;, &#39;Series&#39;, &#39;downstream&#39;, &#39;processing&#39;, &#39;Dosing&#39;, &#39;Selection&#39;, &#39;Data&#39;, &#39;Science&#39;, &#39;/&#39;, &#39;Analytics&#39;, &#39;Direct&#39;, &#39;to&#39;, &#39;Consumer&#39;, &#39;Marketing&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Drug&#39;, &#39;Transporters&#39;, &#39;Data&#39;, &#39;Storage&#39;, &#39;Digital&#39;, &#39;Twins&#39;, &#39;Drug&#39;, &#39;Utilization&#39;, &#39;Protein&#39;, &#39;Devices&#39;, &#39;Molecular&#39;, &#39;and&#39;, &#39;Companion&#39;, &#39;Diagnostics&#39;, &#39;Asia&#39;, &#39;Clinical&#39;, &#39;Adoption&#39;, &#39;of&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Diagnostics&#39;, &#39;Difficult&#39;, &#39;to&#39;, &#39;Express&#39;, &#39;Proteins&#39;, &#39;Europe&#39;, &#39;Globalization&#39;, &#39;of&#39;, &#39;Dx&#39;, &#39;Diagnostics&#39;, &#39;Immunoassays&#39;, &#39;Diagnostics&#39;, &#39;Automation&#39;, &#39;Detection&#39;, &#39;Informatics&#39;, &#39;engineered&#39;, &#39;animal&#39;, &#39;models&#39;, &#39;Hearing&#39;, &#39;Ebola&#39;, &#39;Diagnostics&#39;, &#39;Evidence&#39;, &#39;Based&#39;, &#39;Medicine&#39;, &#39;Ebola&#39;, &#39;Therapeutics&#39;, &#39;eCapacitors&#39;, &#39;Electrochemistry&#39;, &#39;E&#39;, &#39;Coli&#39;, &#39;Encoded&#39;, &#39;Compound&#39;, &#39;Libraries&#39;, &#39;Ecommerce&#39;, &#39;eCTD&#39;, &#39;Validation&#39;, &#39;of&#39;, &#39;Disinfectant&#39;, &#39;Efficacy&#39;, &#39;Effective&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Edge&#39;, &#39;Computing&#39;, &#39;Early&#39;, &#39;Diagnosis&#39;, &#39;Electronic&#39;, &#39;Notebooks&#39;, &#39;endothelium&#39;, &#39;engineering&#39;, &#39;Entertainment&#39;, &#39;Enabling&#39;, &#39;Technology&#39;, &#39;in&#39;, &#39;R&amp;D&#39;, &#39;Environment&#39;, &#39;Enzymes&#39;, &#39;Economic&#39;, &#39;Outcomes&#39;, &#39;Executives&#39;, &#39;on&#39;, &#39;Target&#39;, &#39;Epidemiology&#39;, &#39;epilepsy&#39;, &#39;Epigenetic&#39;, &#39;Readers&#39;, &#39;Epigenetic&#39;, &#39;Targets&#39;, &#39;Examining&#39;, &#39;the&#39;, &#39;Impact&#39;, &#39;of&#39;, &#39;the&#39;, &#39;eCTD&#39;, &#39;on&#39;, &#39;the&#39;, &#39;Regulatory&#39;, &#39;Submissions&#39;, &#39;Process&#39;, &#39;Emerging&#39;, &#39;Targets&#39;, &#39;Diseases&#39;, &#39;Ethics&#39;, &#39;Emerging&#39;, &#39;Technology&#39;, &#39;Transfer&#39;, &#39;Electric&#39;, &#39;Vehicles&#39;, &#39;Experimental&#39;, &#39;Design&#39;, &#39;Exhibitors&#39;, &#39;Extractables&#39;, &#39;/&#39;, &#39;Leachables&#39;, &#39;Exosomes&#39;, &#39;Exome&#39;, &#39;Sequencing&#39;, &#39;Financial&#39;, &#39;Analysts&#39;, &#39;Hackathon&#39;, &#39;Obesity&#39;, &#39;Batteries&#39;, &#39;France&#39;, &#39;fibrin&#39;, &#39;sealants&#39;, &#39;Fine&#39;, &#39;Chemicals&#39;, &#39;FDA&#39;, &#39;Meetings&#39;, &#39;101&#39;, &#39;Food&#39;, &#39;Safety&#39;, &#39;Financial&#39;, &#39;Disclosure&#39;, &#39;Foods&#39;, &#39;FDA&#39;, &#39;Website&#39;, &#39;Functional&#39;, &#39;Genomics&#39;, &#39;Fragment&#39;, &#39;Based&#39;, &#39;Screening&#39;, &#39;Surface&#39;, &#39;Plasmon&#39;, &#39;Resonance&#39;, &#39;finance&#39;, &#39;Flow&#39;, &#39;Cytometry&#39;, &#39;Influenza&#39;, &#39;Financial&#39;, &#39;Deal&#39;, &#39;Structures&#39;, &#39;Fintech&#39;, &#39;Future&#39;, &#39;of&#39;, &#39;Healthcare&#39;, &#39;Fraud&#39;, &#39;Fertility&#39;, &#39;Fibrin&#39;, &#39;sealants&#39;, &#39;Europe&#39;, &#39;blood&#39;, &#39;Fast&#39;, &#39;Track&#39;, &#39;Future&#39;, &#39;Therapeutics&#39;, &#39;fungal&#39;, &#39;infections&#39;, &#39;Follow&#39;, &#39;Up&#39;, &#39;Flow&#39;, &#39;Chemistry&#39;, &#39;Gamification&#39;, &#39;gap&#39;, &#39;junction&#39;, &#39;channels&#39;, &#39;Global&#39;, &#39;Health&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;for&#39;, &#39;Pediatric&#39;, &#39;Research&#39;, &#39;GCP&#39;, &#39;Deficiencies&#39;, &#39;Gene&#39;, &#39;Cell&#39;, &#39;Vectors&#39;, &#39;Genomic&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Genomic&#39;, &#39;Data&#39;, &#39;Integration&#39;, &#39;Genetic&#39;, &#39;Screening&#39;, &#39;Wellness&#39;, &#39;General&#39;, &#39;Email&#39;, &#39;Only&#39;, &#39;Gene&#39;, &#39;Editing&#39;, &#39;Part&#39;, &#39;2&#39;, &#39;Gene&#39;, &#39;Editing&#39;, &#39;Gene&#39;, &#39;Expression&#39;, &#39;Monitoring&#39;, &#39;Genomics&#39;, &#39;Series&#39;, &#39;Gene&#39;, &#39;Expression&#39;, &#39;growth&#39;, &#39;factors&#39;, &#39;Gene&#39;, &#39;Identification&#39;, &#39;genetic&#39;, &#39;immunization&#39;, &#39;vaccines&#39;, &#39;gene&#39;, &#39;interference&#39;, &#39;Gene&#39;, &#39;Knockouts&#39;, &#39;Globalization&#39;, &#39;Genome&#39;, &#39;Links&#39;, &#39;newsletter&#39;, &#39;GLP&#39;, &#39;Bioanalysis&#39;, &#39;Leaders&#39;, &#39;in&#39;, &#39;Precision&#39;, &#39;Medicine&#39;, &#39;Good&#39;, &#39;Manufacturing&#39;, &#39;Practice&#39;, &#39;Drugs&#39;, &#39;introductory&#39;, &#39;gene&#39;, &#39;mutations&#39;, &#39;genomic&#39;, &#39;medicine&#39;, &#39;Genotyping&#39;, &#39;Government&#39;, &#39;gene&#39;, &#39;probes&#39;, &#39;Genomic&#39;, &#39;partnering&#39;, &#39;Europe&#39;, &#39;Greening&#39;, &#39;of&#39;, &#39;Pharma&#39;, &#39;GPCR&#39;, &#39;Targeted&#39;, &#39;Therapies&#39;, &#39;Grid&#39;, &#39;Computing&#39;, &#39;Genomic&#39;, &#39;Service&#39;, &#39;Providers&#39;, &#39;Small&#39;, &#39;GTPases&#39;, &#39;(&#39;, &#39;formerly&#39;, &#39;Gene&#39;, &#39;Town&#39;, &#39;Pass&#39;, &#39;)&#39;, &#39;gene&#39;, &#39;transcription&#39;, &#39;gene&#39;, &#39;therapy&#39;, &#39;technologies&#39;, &#39;Whole&#39;, &#39;Genome&#39;, &#39;Association&#39;, &#39;Studies&#39;, &#39;Humanized&#39;, &#39;Antibodies&#39;, &#39;high&#39;, &#39;throughput&#39;, &#39;analytical&#39;, &#39;chemistry&#39;, &#39;Health&#39;, &#39;&amp;&#39;, &#39;Beauty&#39;, &#39;Aids&#39;, &#39;Hepatitis&#39;, &#39;B&#39;, &#39;Virus&#39;, &#39;High&#39;, &#39;Content&#39;, &#39;Analysis&#39;, &#39;Course&#39;, &#39;HIV&#39;, &#39;and&#39;, &#39;cancer&#39;, &#39;Hematological&#39;, &#39;Cancer&#39;, &#39;Pipelines&#39;, &#39;HIV&#39;, &#39;clinical&#39;, &#39;trials&#39;, &#39;hepatitis&#39;, &#39;C&#39;, &#39;virus&#39;, &#39;Heterocycle&#39;, &#39;High&#39;, &#39;Content&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;HDAC&#39;, &#39;Histone&#39;, &#39;Demethylases&#39;, &#39;Healing&#39;, &#39;hematopoesis&#39;, &#39;heat&#39;, &#39;shock&#39;, &#39;proteins&#39;, &#39;Human&#39;, &#39;Factors&#39;, &#39;Engineering&#39;, &#39;Health&#39;, &#39;Information&#39;, &#39;Systems&#39;, &#39;HIV&#39;, &#39;Healthcare&#39;, &#39;Series&#39;, &#39;Health&#39;, &#39;Maintenance&#39;, &#39;Organizations&#39;, &#39;Human&#39;, &#39;Tissue&#39;, &#39;Huntingtons&#39;, &#39;Disease&#39;, &#39;hormones&#39;, &#39;HIPAA&#39;, &#39;#&#39;, &#39;2&#39;, &#39;High&#39;, &#39;Throughput&#39;, &#39;Protein&#39;, &#39;Purification&#39;, &#39;High&#39;, &#39;Performing&#39;, &#39;Operation&#39;, &#39;Human&#39;, &#39;Papilloma&#39;, &#39;Virus&#39;, &#39;transgenics&#39;, &#39;homologous&#39;, &#39;recombinant&#39;, &#39;Human&#39;, &#39;Relations&#39;, &#39;Health&#39;, &#39;Insurance&#39;, &#39;herpes&#39;, &#39;virus&#39;, &#39;HIV&#39;, &#39;Surrogate&#39;, &#39;Markers&#39;, &#39;High&#39;, &#39;Throughput&#39;, &#39;Genomics&#39;, &#39;Hit&#39;, &#39;to&#39;, &#39;Lead&#39;, &#39;High&#39;, &#39;Throughput&#39;, &#39;Screening&#39;, &#39;Hepatotoxicity&#39;, &#39;Hybrid&#39;, &#39;Computing&#39;, &#39;hypertension&#39;, &#39;Targeting&#39;, &#39;Antigen&#39;, &#39;Presenting&#39;, &#39;Cells&#39;, &#39;Inflammatory&#39;, &#39;Bowel&#39;, &#39;Disease&#39;, &#39;imaging&#39;, &#39;contrast&#39;, &#39;agents&#39;, &#39;interleukin&#39;, &#39;converting&#39;, &#39;enzymes&#39;, &#39;ICE&#39;, &#39;Improving&#39;, &#39;Drug&#39;, &#39;Safety&#39;, &#39;diagnostics&#39;, &#39;-&#39;, &#39;infections&#39;, &#39;Infections&#39;, &#39;Diagnostics&#39;, &#39;Europe&#39;, &#39;engineering&#39;, &#39;laboratories&#39;, &#39;Integrated&#39;, &#39;Fluidic&#39;, &#39;Circuits&#39;, &#39;for&#39;, &#39;DOT&#39;, &#39;Informatics&#39;, &#39;for&#39;, &#39;Genomic&#39;, &#39;Medicine&#39;, &#39;Infection&#39;, &#39;Genomics&#39;, &#39;Image&#39;, &#39;Analysis&#39;, &#39;Immunotherapy&#39;, &#39;Biomarkers&#39;, &#39;Immune&#39;, &#39;Profiling&#39;, &#39;in&#39;, &#39;Cancer&#39;, &#39;Complement&#39;, &#39;-&#39;, &#39;based&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;immunomodulation&#39;, &#39;Imaging&#39;, &#39;for&#39;, &#39;WPC&#39;, &#39;conference&#39;, &#39;Imaging&#39;, &#39;Informatics&#39;, &#39;Immune&#39;, &#39;Impurities&#39;, &#39;Regulatory&#39;, &#39;Immunogenicity&#39;, &#39;Immunosequencing&#39;, &#39;Immuno&#39;, &#39;-&#39;, &#39;Oncology&#39;, &#39;Drug&#39;, &#39;Developement&#39;, &#39;Cancer&#39;, &#39;Immunotherapy&#39;, &#39;Oligonucleotides&#39;, &#39;Cancer&#39;, &#39;Immunotherapy&#39;, &#39;Peptides&#39;, &#39;Cancer&#39;, &#39;Immunotherapy&#39;, &#39;Small&#39;, &#39;Molecules&#39;, &#39;Informatics&#39;, &#39;Partnering&#39;, &#39;Insurance&#39;, &#39;AI&#39;, &#39;and&#39;, &#39;IOT&#39;, &#39;Investments&#39;, &#39;Industrial&#39;, &#39;Enzymes&#39;, &#39;Immuno&#39;, &#39;-&#39;, &#39;Oncology&#39;, &#39;Assays&#39;, &#39;Immuno&#39;, &#39;-&#39;, &#39;Oncology&#39;, &#39;Business&#39;, &#39;Strategy&#39;, &#39;Immuno&#39;, &#39;-&#39;, &#39;Oncology&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Immuno&#39;, &#39;-&#39;, &#39;Oncology&#39;, &#39;Models&#39;, &#39;ion&#39;, &#39;channels&#39;, &#39;Protein&#39;, &#39;Engineering&#39;, &#39;for&#39;, &#39;Immuno&#39;, &#39;-&#39;, &#39;oncology&#39;, &#39;Immuno&#39;, &#39;-&#39;, &#39;Oncology&#39;, &#39;Sequencing&#39;, &#39;Immuno&#39;, &#39;-&#39;, &#39;Oncology&#39;, &#39;Targets&#39;, &#39;Legal&#39;, &#39;Issues&#39;, &#39;for&#39;, &#39;Bioproduction&#39;, &#39;Intellectual&#39;, &#39;Property&#39;, &#39;Pluripotent&#39;, &#39;Stem&#39;, &#39;Cells&#39;, &#39;IRB&#39;, &#39;Compliance&#39;, &#39;and&#39;, &#39;Oversight&#39;, &#39;Considerations&#39;, &#39;Adopting&#39;, &#39;Integrated&#39;, &#39;R&amp;D&#39;, &#39;Informatics&#39;, &#39;Systems&#39;, &#39;India&#39;, &#39;Re&#39;, &#39;Engineering&#39;, &#39;International&#39;, &#39;Risk&#39;, &#39;Management&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Informatics&#39;, &#39;Iron&#39;, &#39;Chelation&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;Software&#39;, &#39;in&#39;, &#39;situ&#39;, &#39;hybridization&#39;, &#39;Information&#39;, &#39;Technology&#39;, &#39;IT&#39;, &#39;&amp;&#39;, &#39;Informatics&#39;, &#39;for&#39;, &#39;Collaboration&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;Europe&#39;, &#39;Scalable&#39;, &#39;IT&#39;, &#39;&amp;&#39;, &#39;Informatics&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;computer&#39;, &#39;hardware&#39;, &#39;(&#39;, &#39;part&#39;, &#39;2&#39;, &#39;)&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;computer&#39;, &#39;hardware&#39;, &#39;(&#39;, &#39;part&#39;, &#39;3&#39;, &#39;)&#39;, &#39;IT&#39;, &#39;Software&#39;, &#39;for&#39;, &#39;the&#39;, &#39;Life&#39;, &#39;Sciences&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;Virtualization&#39;, &#39;Interviewing&#39;, &#39;Skills&#39;, &#39;for&#39;, &#39;Managers&#39;, &#39;Investigator&#39;, &#39;Sites&#39;, &#39;Report&#39;, &#39;1&#39;, &#39;Investigator&#39;, &#39;Sites&#39;, &#39;Report&#39;, &#39;2&#39;, &#39;Imaging&#39;, &#39;Week&#39;, &#39;joints&#39;, &#39;Job&#39;, &#39;recruiters&#39;, &#39;Kinase&#39;, &#39;Chemistry&#39;, &#39;KIN&#39;, &#39;West&#39;, &#39;Coast&#39;, &#39;Kinases&#39;, &#39;for&#39;, &#39;DOT&#39;, &#39;Knowledge&#39;, &#39;Management&#39;, &#39;chemokines&#39;, &#39;HIV&#39;, &#39;and&#39;, &#39;Kaposis&#39;, &#39;sarcoma&#39;, &#39;Kinetics&#39;, &#39;Structure&#39;, &#39;Relationship&#39;, &#39;laboratories&#39;, &#39;Lead&#39;, &#39;Acid&#39;, &#39;Batteries&#39;, &#39;Label&#39;, &#39;Free&#39;, &#39;Detection&#39;, &#39;Drug&#39;, &#39;Labeling&#39;, &#39;Live&#39;, &#39;Cell&#39;, &#39;Imaging&#39;, &#39;Laser&#39;, &#39;Capture&#39;, &#39;Microdissection&#39;, &#39;Lung&#39;, &#39;Cancer&#39;, &#39;ligase&#39;, &#39;chain&#39;, &#39;reaction&#39;, &#39;leukodepletion&#39;, &#39;Laboratory&#39;, &#39;Developed&#39;, &#39;Tests&#39;, &#39;leukemia&#39;, &#39;Ontologies&#39;, &#39;/&#39;, &#39;Lexicons&#39;, &#39;Legal&#39;, &#39;drug&#39;, &#39;liability&#39;, &#39;screening&#39;, &#39;libraries&#39;, &#39;Life&#39;, &#39;Sciences&#39;, &#39;Protein&#39;, &#39;Ligands&#39;, &#39;lab&#39;, &#39;information&#39;, &#39;management&#39;, &#39;systems&#39;, &#39;LIMS&#39;, &#39;Lipids&#39;, &#39;Large&#39;, &#39;Stationary&#39;, &#39;Batteries&#39;, &#39;Lyophilization&#39;, &#39;Mergers&#39;, &#39;&amp;&#39;, &#39;Acquisitions&#39;, &#39;Monoclonal&#39;, &#39;Antibodies&#39;, &#39;Forum&#39;, &#39;Monoclonal&#39;, &#39;Antibody&#39;, &#39;Process&#39;, &#39;Development&#39;, &#39;Malaria&#39;, &#39;Metabolism&#39;, &#39;Targeted&#39;, &#39;Cancer&#39;, &#39;Therapeutics&#39;, &#39;Microbiome&#39;, &#39;in&#39;, &#39;Immuno&#39;, &#39;-&#39;, &#39;Oncology&#39;, &#39;Microbiome&#39;, &#39;Metabolic&#39;, &#39;Syndrome&#39;, &#39;Medicinal&#39;, &#39;Chemistry&#39;, &#39;Part&#39;, &#39;2&#39;, &#39;Mucosal&#39;, &#39;Immunity&#39;, &#39;Microreactors&#39;, &#39;Macrocycles&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Business&#39;, &#39;Multidrug&#39;, &#39;Resistance&#39;, &#39;Cancer&#39;, &#39;Medical&#39;, &#39;Coding&#39;, &#39;multidrug&#39;, &#39;resistant&#39;, &#39;infections&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Non&#39;, &#39;-&#39;, &#39;Invasive&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Microdosing&#39;, &#39;microbial&#39;, &#39;infections&#39;, &#39;Sequencing&#39;, &#39;Based&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Forum&#39;, &#39;Molecular&#39;, &#39;Electronics&#39;, &#39;Metabolic&#39;, &#39;Engineering&#39;, &#39;Melanoma&#39;, &#39;BioMEMS&#39;, &#39;memory&#39;, &#39;enhancement&#39;, &#39;cancer&#39;, &#39;metastasis&#39;, &#39;molecular&#39;, &#39;evolution&#39;, &#39;Mammalian&#39;, &#39;Cell&#39;, &#39;Line&#39;, &#39;Development&#39;, &#39;microfabrication&#39;, &#39;Molecular&#39;, &#39;Genetic&#39;, &#39;Pro&#39;, &#39;Management&#39;, &#39;molecular&#39;, &#39;medicine&#39;, &#39;Novel&#39;, &#39;bioactive&#39;, &#39;high&#39;, &#39;throughput&#39;, &#39;screening&#39;, &#39;europe&#39;, &#39;Myocardial&#39;, &#39;Infarction&#39;, &#39;migraine&#39;, &#39;microtiter&#39;, &#39;plates&#39;, &#39;Molecular&#39;, &#39;Medicine&#39;, &#39;Europe&#39;, &#39;metalloproteinases&#39;, &#39;Molecular&#39;, &#39;Medicine&#39;, &#39;Asia&#39;, &#39;Managed&#39;, &#39;Care&#39;, &#39;Manufacturing&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Monitoring&#39;, &#39;Mechanism&#39;, &#39;of&#39;, &#39;Action&#39;, &#39;Purifying&#39;, &#39;Antibodies&#39;, &#39;Meeting&#39;, &#39;Planning&#39;, &#39;Services&#39;, &#39;Molecular&#39;, &#39;Pathology&#39;, &#39;Molecular&#39;, &#39;Pathology&#39;, &#39;Basic&#39;, &#39;Molecular&#39;, &#39;Pathology&#39;, &#39;Advanced&#39;, &#39;magnetic&#39;, &#39;resonance&#39;, &#39;imaging&#39;, &#39;Multi&#39;, &#39;Specific&#39;, &#39;Antibodies&#39;, &#39;Mass&#39;, &#39;Spectrometry&#39;, &#39;for&#39;, &#39;Protein&#39;, &#39;Biomarker&#39;, &#39;Discovery&#39;, &#39;Muscle&#39;, &#39;Mass&#39;, &#39;Spec&#39;, &#39;Informatics&#39;, &#39;Mass&#39;, &#39;Spec&#39;, &#39;Imaging&#39;, &#39;Modeling&#39;, &#39;and&#39;, &#39;Simulation&#39;, &#39;Mass&#39;, &#39;spectrometry&#39;, &#39;Mass&#39;, &#39;Spec&#39;, &#39;Diagnostics&#39;, &#39;Metabolic&#39;, &#39;Disorders&#39;, &#39;Mental&#39;, &#39;Health&#39;, &#39;Materials&#39;, &#39;Testing&#39;, &#39;cellular&#39;, &#39;matrix&#39;, &#39;Multiplexed&#39;, &#39;Assays&#39;, &#39;Moelcular&#39;, &#39;Diagnostics&#39;, &#39;Europe&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;for&#39;, &#39;Cancer&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;for&#39;, &#39;Infectious&#39;, &#39;Disease&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Antibodies&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Antibodies&#39;, &#39;(&#39;, &#39;for&#39;, &#39;PGE&#39;, &#39;)&#39;, &#39;Nucleic&#39;, &#39;Acid&#39;, &#39;Europe&#39;, &#39;National&#39;, &#39;Academy&#39;, &#39;of&#39;, &#39;Sciences&#39;, &#39;meeting&#39;, &#39;natural&#39;, &#39;products&#39;, &#39;new&#39;, &#39;antivirals&#39;, &#39;Novel&#39;, &#39;Cancer&#39;, &#39;Informatics&#39;, &#39;Non&#39;, &#39;-&#39;, &#39;Coding&#39;, &#39;RNA&#39;, &#39;Novel&#39;, &#39;Strategies&#39;, &#39;Cancer&#39;, &#39;Novel&#39;, &#39;Cancer&#39;, &#39;Targets&#39;, &#39;Neurodegenerative&#39;, &#39;Nucleotide&#39;, &#39;Delivery&#39;, &#39;Internet&#39;, &#39;New&#39;, &#39;to&#39;, &#39;Database&#39;, &#39;comapny&#39;, &#39;names&#39;, &#39;Advances&#39;, &#39;in&#39;, &#39;Informatics&#39;, &#39;nerve&#39;, &#39;growth&#39;, &#39;factors&#39;, &#39;NF&#39;, &#39;KB&#39;, &#39;Nanofluidics&#39;, &#39;Informatics&#39;, &#39;Next&#39;, &#39;-&#39;, &#39;Generation&#39;, &#39;Batteries&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Batteries&#39;, &#39;Portable&#39;, &#39;Applications&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Batteries&#39;, &#39;Stationary&#39;, &#39;Power&#39;, &#39;Epigenetic&#39;, &#39;Sequencing&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Imaging&#39;, &#39;Neurogenomics&#39;, &#39;Nuclear&#39;, &#39;Hormone&#39;, &#39;Receptors&#39;, &#39;Novel&#39;, &#39;HIV&#39;, &#39;Strategies&#39;, &#39;Neurotech&#39;, &#39;Industry&#39;, &#39;neuroinjuries&#39;, &#39;NK&#39;, &#39;Cell&#39;, &#39;Based&#39;, &#39;Cancer&#39;, &#39;Immunotherapy&#39;, &#39;Natural&#39;, &#39;Language&#39;, &#39;Processing&#39;, &#39;nuclear&#39;, &#39;matrix&#39;, &#39;Nanomedicine&#39;, &#39;Nitric&#39;, &#39;Oxide&#39;, &#39;Network&#39;, &#39;Pharmacology&#39;, &#39;Energy&#39;, &#39;Neurotoxicity&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;in&#39;, &#39;the&#39;, &#39;US&#39;, &#39;nanotech&#39;, &#39;self&#39;, &#39;assembly&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Supply&#39;, &#39;Chain&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Supply&#39;, &#39;Chain&#39;, &#39;Europe&#39;, &#39;Neurostimulation&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Diagnostic&#39;, &#39;Things&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Energy&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Energy&#39;, &#39;Europe&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Things&#39;, &#39;Infrastructure&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Health&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Insurance&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Insurance&#39;, &#39;Europe&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Things&#39;, &#39;Manufacturing&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Things&#39;, &#39;Manufacturing&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Manufacturing&#39;, &#39;Europe&#39;, &#39;Smart&#39;, &#39;Buildings&#39;, &#39;Smart&#39;, &#39;Cities&#39;, &#39;Nephrotoxicity&#39;, &#39;Nuclear&#39;, &#39;Energy&#39;, &#39;nutrition&#39;, &#39;Optimizing&#39;, &#39;Media&#39;, &#39;organ&#39;, &#39;and&#39;, &#39;cell&#39;, &#39;transplants&#39;, &#39;Oncology&#39;, &#39;Drug&#39;, &#39;Targets&#39;, &#39;Optical&#39;, &#39;Diagnostics&#39;, &#39;Oncogenomics&#39;, &#39;Office&#39;, &#39;of&#39;, &#39;the&#39;, &#39;Inspector&#39;, &#39;General&#39;, &#39;Oil&#39;, &#39;and&#39;, &#39;Gas&#39;, &#39;oncogenes&#39;, &#39;Oncolytic&#39;, &#39;Viruses&#39;, &#39;Oligo&#39;, &#39;Production&#39;, &#39;opportunistic&#39;, &#39;infections&#39;, &#39;Oligo&#39;, &#39;Regulatory&#39;, &#39;organs&#39;, &#39;transplants&#39;, &#39;oral&#39;, &#39;drug&#39;, &#39;delivery&#39;, &#39;OSTEOARTHRITIS&#39;, &#39;OTC&#39;, &#39;over&#39;, &#39;the&#39;, &#39;counter&#39;, &#39;Additional&#39;, &#39;Conferences&#39;, &#39;clinical&#39;, &#39;trials&#39;, &#39;outsourcing&#39;, &#39;Oxygen&#39;, &#39;Radicals&#39;, &#39;oncogenes&#39;, &#39;p53&#39;, &#39;Predictive&#39;, &#39;ADME&#39;, &#39;protein&#39;, &#39;aggregation&#39;, &#39;Protein&#39;, &#39;Aggregation&#39;, &#39;(&#39;, &#39;for&#39;, &#39;PTK&#39;, &#39;)&#39;, &#39;Packaging&#39;, &#39;parasitic&#39;, &#39;infections&#39;, &#39;Process&#39;, &#39;Analytical&#39;, &#39;Technology&#39;, &#39;Pharmacy&#39;, &#39;Benefit&#39;, &#39;Management&#39;, &#39;Pharmaceutical&#39;, &#39;BioProcess&#39;, &#39;Basic&#39;, &#39;Research&#39;, &#39;&amp;&#39;, &#39;Discovery&#39;, &#39;track&#39;, &#39;for&#39;, &#39;PCG&#39;, &#39;Clinical&#39;, &#39;Operations&#39;, &#39;track&#39;, &#39;for&#39;, &#39;PCG&#39;, &#39;Preclinical&#39;, &#39;Development&#39;, &#39;track&#39;, &#39;for&#39;, &#39;PCG&#39;, &#39;Bridgehead&#39;, &#39;PCI&#39;, &#39;book&#39;, &#39;Preclinical&#39;, &#39;Preclinical&#39;, &#39;Preclinical&#39;, &#39;prostate&#39;, &#39;cancer&#39;, &#39;Preclinical&#39;, &#39;Outcome&#39;, &#39;Predictions&#39;, &#39;preclinical&#39;, &#39;trials&#39;, &#39;Point&#39;, &#39;of&#39;, &#39;Care&#39;, &#39;West&#39;, &#39;Protein&#39;, &#39;Crystallography&#39;, &#39;pediatric&#39;, &#39;AIDS&#39;, &#39;/&#39;, &#39;HIV&#39;, &#39;PDA&#39;, &#39;Downloads&#39;, &#39;from&#39;, &#39;CHI&#39;, &#39;website&#39;, &#39;Process&#39;, &#39;Development&#39;, &#39;for&#39;, &#39;Executives&#39;, &#39;platelet&#39;, &#39;derived&#39;, &#39;growth&#39;, &#39;factors&#39;, &#39;protein&#39;, &#39;drug&#39;, &#39;delivery&#39;, &#39;Preclinical&#39;, &#39;Disease&#39;, &#39;Models&#39;, &#39;photodynamic&#39;, &#39;therapies&#39;, &#39;Phage&#39;, &#39;Display&#39;, &#39;for&#39;, &#39;Vaccine&#39;, &#39;Development&#39;, &#39;Proteomic&#39;, &#39;Tools&#39;, &#39;for&#39;, &#39;Diagnostics&#39;, &#39;pediatric&#39;, &#39;Pediatric&#39;, &#39;trials&#39;, &#39;for&#39;, &#39;CRAS&#39;, &#39;PEGS&#39;, &#39;Virtual&#39;, &#39;Interactive&#39;, &#39;Global&#39;, &#39;Summit&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Monitoring&#39;, &#39;Protein&#39;, &#39;Executive&#39;, &#39;Summit&#39;, &#39;Proof&#39;, &#39;of&#39;, &#39;Concept&#39;, &#39;for&#39;, &#39;Cancer&#39;, &#39;Protein&#39;, &#39;Function&#39;, &#39;Enterprise&#39;, &#39;Portfolio&#39;, &#39;Management&#39;, &#39;Portfolio&#39;, &#39;Value&#39;, &#39;Protein&#39;, &#39;Aggregates&#39;, &#39;Light&#39;, &#39;Scattering&#39;, &#39;Consumer&#39;, &#39;Genomics&#39;, &#39;/&#39;, &#39;Personal&#39;, &#39;Genomics&#39;, &#39;Protein&#39;, &#39;Engineering&#39;, &#39;Partnering&#39;, &#39;Particulate&#39;, &#39;Screening&#39;, &#39;Phage&#39;, &#39;West&#39;, &#39;Phase&#39;, &#39;II&#39;, &#39;/&#39;, &#39;Reducing&#39;, &#39;Attrition&#39;, &#39;Phase&#39;, &#39;IV&#39;, &#39;Phase&#39;, &#39;IV&#39;, &#39;Pharmacies&#39;, &#39;Phage&#39;, &#39;Display&#39;, &#39;Europe&#39;, &#39;Pharmaceutical&#39;, &#39;Half&#39;, &#39;Life&#39;, &#39;Phase&#39;, &#39;Zero&#39;, &#39;PI3&#39;, &#39;K&#39;, &#39;Phosphoinositide&#39;, &#39;3&#39;, &#39;Kinase&#39;, &#39;Protein&#39;, &#39;Identification&#39;, &#39;Preclinical&#39;, &#39;Imaging&#39;, &#39;protease&#39;, &#39;inhibitors&#39;, &#39;enzymes&#39;, &#39;PLA2&#39;, &#39;blood&#39;, &#39;platelets&#39;, &#39;Membrane&#39;, &#39;Proteins&#39;, &#39;Membrane&#39;, &#39;Protein&#39;, &#39;for&#39;, &#39;DOT&#39;, &#39;(&#39;, &#39;part&#39;, &#39;1&#39;, &#39;)&#39;, &#39;Membrane&#39;, &#39;Protein&#39;, &#39;for&#39;, &#39;DOT&#39;, &#39;(&#39;, &#39;part&#39;, &#39;2&#39;, &#39;)&#39;, &#39;Protein&#39;, &#39;Manufacturing&#39;, &#39;Clinical&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;:&#39;, &#39;Intermediate&#39;, &#39;Preventive&#39;, &#39;Medicine&#39;, &#39;Pancreatic&#39;, &#39;Cancer&#39;, &#39;Preclinical&#39;, &#39;Studies&#39;, &#39;for&#39;, &#39;IND&#39;, &#39;Protein&#39;, &#39;Computational&#39;, &#39;Tools&#39;, &#39;Prenatal&#39;, &#39;Therapeutics&#39;, &#39;Parenteral&#39;, &#39;Point&#39;, &#39;of&#39;, &#39;Care&#39;, &#39;Diagnostics&#39;, &#39;Europe&#39;, &#39;Cannabis&#39;, &#39;Power&#39;, &#39;Utilities&#39;, &#39;protein&#39;, &#39;characterization&#39;, &#39;protein&#39;, &#39;purification&#39;, &#39;Protein&#39;, &#39;Protein&#39;, &#39;Interactions&#39;, &#39;Protein&#39;, &#39;Protein&#39;, &#39;Interactions&#39;, &#39;Part&#39;, &#39;2&#39;, &#39;Process&#39;, &#39;Management&#39;, &#39;Protein&#39;, &#39;Process&#39;, &#39;PepTalk&#39;, &#39;Partnering&#39;, &#39;Personalized&#39;, &#39;Medicine&#39;, &#39;Partnering&#39;, &#39;Proteomics&#39;, &#39;Analytics&#39;, &#39;Predictive&#39;, &#39;Analytics&#39;, &#39;Pricing&#39;, &#39;Parkinsons&#39;, &#39;Predictive&#39;, &#39;Biomedicine&#39;, &#39;Proteins&#39;, &#39;,&#39;, &#39;Peptides&#39;, &#39;&amp;&#39;, &#39;Proteomics&#39;, &#39;Series&#39;, &#39;Protein&#39;, &#39;Quantification&#39;, &#39;Partnering&#39;, &#39;Data&#39;, &#39;Privacy&#39;, &#39;Personalized&#39;, &#39;Medicine&#39;, &#39;Asia&#39;, &#39;Product&#39;, &#39;Service&#39;, &#39;Announcement&#39;, &#39;Production&#39;, &#39;and&#39;, &#39;Scale&#39;, &#39;Up&#39;, &#39;Pharma&#39;, &#39;Services&#39;, &#39;News&#39;, &#39;schizophrenia&#39;, &#39;antipsychotics&#39;, &#39;Protein&#39;, &#39;Antibodies&#39;, &#39;Preclinical&#39;, &#39;Toxicology&#39;, &#39;Biologics&#39;, &#39;Protein&#39;, &#39;Technology&#39;, &#39;Engineering&#39;, &#39;Protein&#39;, &#39;Therapeutics&#39;, &#39;for&#39;, &#39;Delivery&#39;, &#39;Predictive&#39;, &#39;Toxicity&#39;, &#39;Europe&#39;, &#39;Platform&#39;, &#39;Software&#39;, &#39;for&#39;, &#39;R&amp;D&#39;, &#39;Studies&#39;, &#39;Phenotype&#39;, &#39;to&#39;, &#39;Genotype&#39;, &#39;Pathology&#39;, &#39;Protein&#39;, &#39;drugs&#39;, &#39;&amp;&#39;, &#39;diagnostics&#39;, &#39;Intellectual&#39;, &#39;Property&#39;, &#39;Post&#39;, &#39;Translational&#39;, &#39;Modifications&#39;, &#39;Patient&#39;, &#39;Registries&#39;, &#39;Advancing&#39;, &#39;Therapeutics&#39;, &#39;Current&#39;, &#39;Generation&#39;, &#39;Protein&#39;, &#39;Drug&#39;, &#39;Delivery&#39;, &#39;(&#39;, &#39;part&#39;, &#39;of&#39;, &#39;PepTalk&#39;, &#39;)&#39;, &#39;Advancing&#39;, &#39;Therapeutics&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Biological&#39;, &#39;Therapeutic&#39;, &#39;Products&#39;, &#39;Series&#39;, &#39;Pathway&#39;, &#39;/&#39;, &#39;Networks&#39;, &#39;Publications&#39;, &#39;Protein&#39;, &#39;Variations&#39;, &#39;Powertrains&#39;, &#39;Protein&#39;, &#39;Characterization&#39;, &#39;,&#39;, &#39;Purification&#39;, &#39;and&#39;, &#39;Screening&#39;, &#39;Protein&#39;, &#39;Characterization&#39;, &#39;,&#39;, &#39;Purification&#39;, &#39;and&#39;, &#39;Screening&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Europe&#39;, &#39;Beyond&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Europe&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Host&#39;, &#39;Novel&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Systems&#39;, &#39;Protein&#39;, &#39;Engineering&#39;, &#39;Vectors&#39;, &#39;Preventive&#39;, &#39;gene&#39;, &#39;quantification&#39;, &#39;Europe&#39;, &#39;QS&#39;, &#39;Regulation&#39;, &#39;Recombinant&#39;, &#39;Antibodies&#39;, &#39;Recombinant&#39;, &#39;Antibodies&#39;, &#39;Recombinant&#39;, &#39;Proteins&#39;, &#39;Forum&#39;, &#39;Radiation&#39;, &#39;Rare&#39;, &#39;Diseases&#39;, &#39;Antibody&#39;, &#39;Drug&#39;, &#39;Products&#39;, &#39;RBE&#39;, &#39;track&#39;, &#39;at&#39;, &#39;PGE&#39;, &#39;RBE&#39;, &#39;track&#39;, &#39;at&#39;, &#39;PGE&#39;, &#39;Antibody&#39;, &#39;Screening&#39;, &#39;Antibody&#39;, &#39;Translational&#39;, &#39;rapid&#39;, &#39;compound&#39;, &#39;characterization&#39;, &#39;Clinical&#39;, &#39;Enrollment&#39;, &#39;Plan&#39;, &#39;Clinical&#39;, &#39;Recruitment&#39;, &#39;Media&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Patient&#39;, &#39;Recruitment&#39;, &#39;Winning&#39;, &#39;Strategies&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Recruitment&#39;, &#39;Media&#39;, &#39;Integrating&#39;, &#39;R&amp;D&#39;, &#39;and&#39;, &#39;Marketing&#39;, &#39;R&amp;D&#39;, &#39;Productivity&#39;, &#39;drug&#39;, &#39;receptors&#39;, &#39;Role&#39;, &#39;of&#39;, &#39;Business&#39;, &#39;Process&#39;, &#39;Managment&#39;, &#39;in&#39;, &#39;FDA&#39;, &#39;Regulated&#39;, &#39;Industry&#39;, &#39;Worldwide&#39;, &#39;Pharma&#39;, &#39;Regulation&#39;, &#39;Surviving&#39;, &#39;FDA&#39;, &#39;Site&#39;, &#39;Inspections&#39;, &#39;Real&#39;, &#39;Estate&#39;, &#39;Risk&#39;, &#39;Evaluation&#39;, &#39;and&#39;, &#39;Mitigation&#39;, &#39;Strategies&#39;, &#39;Renal&#39;, &#39;(&#39;, &#39;kidney&#39;, &#39;)&#39;, &#39;Renewable&#39;, &#39;Energy&#39;, &#39;Storage&#39;, &#39;System&#39;, &#39;RFID&#39;, &#39;Radiofrequency&#39;, &#39;ID&#39;, &#39;Reagents&#39;, &#39;Gap&#39;, &#39;Analysis&#39;, &#39;rheumatoid&#39;, &#39;arthritis&#39;, &#39;gene&#39;, &#39;therapy&#39;, &#39;[&#39;, &#39;RNA&#39;, &#39;blocking&#39;, &#39;]&#39;, &#39;Ribonucleic&#39;, &#39;Acid&#39;, &#39;RNAi&#39;, &#39;for&#39;, &#39;Functional&#39;, &#39;Screening&#39;, &#39;RNAi&#39;, &#39;  &#39;, &#39;RNAInterference&#39;, &#39;RNAi&#39;, &#39;Discovery&#39;, &#39;on&#39;, &#39;Target&#39;, &#39;RNAi&#39;, &#39;Video&#39;, &#39;on&#39;, &#39;Request&#39;, &#39;RNA&#39;, &#39;Quality&#39;, &#39;RNA&#39;, &#39;Therapeutics&#39;, &#39;Robotics&#39;, &#39;Regional&#39;, &#39;Organization&#39;, &#39;Robotic&#39;, &#39;Process&#39;, &#39;Automation&#39;, &#39;reperfusion&#39;, &#39;Reproduction&#39;, &#39;Gene&#39;, &#39;Regulation&#39;, &#39;and&#39;, &#39;Regulatory&#39;, &#39;Networks&#39;, &#39;Restenosis&#39;, &#39;Retail&#39;, &#39;Real&#39;, &#39;World&#39;, &#39;Data&#39;, &#39;Therapeutics&#39;, &#39;Indications&#39;, &#39;&amp;&#39;, &#39;Drug&#39;, &#39;Targets&#39;, &#39;Series&#39;, &#39;safety&#39;, &#39;Screening&#39;, &#39;3D&#39;, &#39;Models&#39;, &#39;Sickle&#39;, &#39;Cell&#39;, &#39;Anemia&#39;, &#39;Screening&#39;, &#39;Informatics&#39;, &#39;Sequencing&#39;, &#39;and&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;supply&#39;, &#39;chain&#39;, &#39;management&#39;, &#39;SCOPEs&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Leadership&#39;, &#39;Forum&#39;, &#39;Phenotypic&#39;, &#39;Screening&#39;, &#39;Phenotypic&#39;, &#39;Screening&#39;, &#39;clinical&#39;, &#39;trials&#39;, &#39;strategy&#39;, &#39;IT&#39;, &#39;Security&#39;, &#39;Sequence&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Sequence&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Asia&#39;, &#39;Sidec&#39;, &#39;Executive&#39;, &#39;Forum&#39;, &#39;Sequence&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Europe&#39;, &#39;Sleeper&#39;, &#39;Disease&#39;, &#39;Indications&#39;, &#39;Sequencing&#39;, &#39;Data&#39;, &#39;Storage&#39;, &#39;&amp;&#39;, &#39;Management&#39;, &#39;Screening&#39;, &#39;Difficult&#39;, &#39;Targets&#39;, &#39;Source&#39;, &#39;Document&#39;, &#39;Verification&#39;, &#39;Sequencing&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;&amp;&#39;, &#39;Storage&#39;, &#39;second&#39;, &#39;messengers&#39;, &#39;sepsis&#39;, &#39;infections&#39;, &#39;Sequencing&#39;, &#39;Forum&#39;, &#39;Serotonin&#39;, &#39;Sexual&#39;, &#39;Small&#39;, &#39;Fuel&#39;, &#39;Cells&#39;, &#39;selective&#39;, &#39;immune&#39;, &#39;suppression&#39;, &#39;skin&#39;, &#39;sleep&#39;, &#39;Pharmaceutical&#39;, &#39;Sales&#39;, &#39;Biologics&#39;, &#39;Small&#39;, &#39;Molecular&#39;, &#39;Comparisons&#39;, &#39;Semiconductors&#39;, &#39;small&#39;, &#39;molecules&#39;, &#39;simple&#39;, &#39;model&#39;, &#39;organisms&#39;, &#39;Small&#39;, &#39;Molecules&#39;, &#39;Synthesis&#39;, &#39;Semantic&#39;, &#39;Web&#39;, &#39;Sensor&#39;, &#39;Applications&#39;, &#39;Synthetic&#39;, &#39;Biology&#39;, &#39;Sensor&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Implantable&#39;, &#39;Biomedical&#39;, &#39;Sensors&#39;, &#39;Sensor&#39;, &#39;Materials&#39;, &#39;Sensors&#39;, &#39;Emerging&#39;, &#39;Markets&#39;, &#39;SNPs&#39;, &#39;Sensor&#39;, &#39;Systems&#39;, &#39;Sensor&#39;, &#39;Safety&#39;, &#39;software&#39;, &#39;Solubility&#39;, &#39;Safety&#39;, &#39;Pharmacology&#39;, &#39;for&#39;, &#39;Biologics&#39;, &#39;Safety&#39;, &#39;Pharmacology&#39;, &#39;for&#39;, &#39;Biologics&#39;, &#39;Genomic&#39;, &#39;Sample&#39;, &#39;Preparation&#39;, &#39;Speciality&#39;, &#39;Pharmaceuticals&#39;, &#39;Alternative&#39;, &#39;Splicing&#39;, &#39;Proteomic&#39;, &#39;Sample&#39;, &#39;Preparation&#39;, &#39;High&#39;, &#39;throughput&#39;, &#39;screening&#39;, &#39;partnering&#39;, &#39;solid&#39;, &#39;phase&#39;, &#39;synthesis&#39;, &#39;Subjective&#39;, &#39;End&#39;, &#39;Points&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Sequencing&#39;, &#39;Applications&#39;, &#39;Sequencing&#39;, &#39;Core&#39;, &#39;Labs&#39;, &#39;Next&#39;, &#39;-&#39;, &#39;Generation&#39;, &#39;Data&#39;, &#39;Generation&#39;, &#39;Plant&#39;, &#39;Sequencing&#39;, &#39;RNA&#39;, &#39;Sequencing&#39;, &#39;Sequencing&#39;, &#39;Solutions&#39;, &#39;Deep&#39;, &#39;Sequencing&#39;, &#39;EU&#39;, &#39;Site&#39;, &#39;Selection&#39;, &#39;,&#39;, &#39;Study&#39;, &#39;Activation&#39;, &#39;,&#39;, &#39;and&#39;, &#39;Patient&#39;, &#39;Recruitment&#39;, &#39;Stability&#39;, &#39;stroke&#39;, &#39;Stem&#39;, &#39;Cell&#39;, &#39;Culture&#39;, &#39;Stem&#39;, &#39;Cell&#39;, &#39;Research&#39;, &#39;(&#39;, &#39;part&#39;, &#39;of&#39;, &#39;MMTC&#39;, &#39;)&#39;, &#39;Statin&#39;, &#39;Stem&#39;, &#39;Cells&#39;, &#39;Safety&#39;, &#39;Screening&#39;, &#39;Startup&#39;, &#39;Public&#39;, &#39;companies&#39;, &#39;/&#39;, &#39;stock&#39;, &#39;exchanges&#39;, &#39;CHI&#39;, &#39;Surveys&#39;, &#39;Services&#39;, &#39;Systems&#39;, &#39;Biology&#39;, &#39;for&#39;, &#39;BYG&#39;, &#39;track&#39;, &#39;synthesis&#39;, &#39;Systems&#39;, &#39;Biology&#39;, &#39;Training&#39;, &#39;&amp;&#39;, &#39;Development&#39;, &#39;Top&#39;, &#39;50&#39;, &#39;Big&#39;, &#39;Pharmas&#39;, &#39;Tissue&#39;, &#39;Microarrays&#39;, &#39;taxol&#39;, &#39; &#39;, &#39;tamoxifen&#39;, &#39;and&#39;, &#39;other&#39;, &#39;derivatives&#39;, &#39;Tuberculosis&#39;, &#39;Tobacco&#39;, &#39;The&#39;, &#39;Biotech&#39;, &#39;Journal&#39;, &#39;Email&#39;, &#39;List&#39;, &#39;Trust&#39;, &#39;Building&#39;, &#39;for&#39;, &#39;Collaborative&#39;, &#39;Innovation&#39;, &#39;Tumor&#39;, &#39;,&#39;, &#39;Circulating&#39;, &#39;Cells&#39;, &#39;Technology&#39;, &#39;Technology&#39;, &#39;Consortium&#39;, &#39;Target&#39;, &#39;Driven&#39;, &#39;Chemistry&#39;, &#39;targeted&#39;, &#39;drug&#39;, &#39;delivery&#39;, &#39;transgenic&#39;, &#39;disease&#39;, &#39;models&#39;, &#39;Thrombotic&#39;, &#39;Disease&#39;, &#39;tissue&#39;, &#39;engineering&#39;, &#39;telomerases&#39;, &#39;Battery&#39;, &#39;Testing&#39;, &#39;Transfection&#39;, &#39;Toxicogenomics&#39;, &#39;Target&#39;, &#39;Prioritization&#39;, &#39;Target&#39;, &#39;Identification&#39;, &#39;tissues&#39;, &#39;Technology&#39;, &#39;Platforms&#39;, &#39;Immunotherapies&#39;, &#39;Telecommunications&#39;, &#39;Telemedicine&#39;, &#39;Tumor&#39;, &#39;Microenvironment&#39;, &#39;Trial&#39;, &#39;Master&#39;, &#39;File&#39;, &#39;for&#39;, &#39;Sponsors&#39;, &#39;(&#39;, &#39;pharma&#39;, &#39;)&#39;, &#39;Trial&#39;, &#39;Master&#39;, &#39;File&#39;, &#39;for&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;Theranostic&#39;, &#39;Market&#39;, &#39;Models&#39;, &#39;tumor&#39;, &#39;necrosis&#39;, &#39;factors&#39;, &#39;Therapeutics&#39;, &#39;and&#39;, &#39;Targets&#39;, &#39;Therapeutics&#39;, &#39;&amp;&#39;, &#39;Targets&#39;, &#39;Series&#39;, &#39;immune&#39;, &#39;tolerance&#39;, &#39;Fibrinolytic&#39;, &#39;(&#39;, &#39;clot&#39;, &#39;buster&#39;, &#39;)&#39;, &#39;Transgenic&#39;, &#39;Production&#39;, &#39;in&#39;, &#39;Plants&#39;, &#39;Synthetic&#39;, &#39;Biology&#39;, &#39;Transportation&#39;, &#39;Translational&#39;, &#39;Biomarkers&#39;, &#39;Translational&#39;, &#39;Informatics&#39;, &#39;Drug&#39;, &#39;/&#39;, &#39;Disease&#39;, &#39;Targets&#39;, &#39;Drug&#39;, &#39;Targets&#39;, &#39;Series&#39;, &#39;Genome&#39;, &#39;Tri&#39;, &#39;Conference&#39;, &#39;Translation&#39;, &#39;Services&#39;, &#39;transgenics&#39;, &#39;gene&#39;, &#39;knockouts&#39;, &#39;transgenic&#39;, &#39;production&#39;, &#39;Tumor&#39;, &#39;Suppressor&#39;, &#39;Genes&#39;, &#39;tissue&#39;, &#39;safety&#39;, &#39;Technology&#39;, &#39;&amp;&#39;, &#39;Tools&#39;, &#39;for&#39;, &#39;the&#39;, &#39;Life&#39;, &#39;Sciences&#39;, &#39;Technology&#39;, &#39;&amp;&#39;, &#39;Tools&#39;, &#39;for&#39;, &#39;Life&#39;, &#39;Sciences&#39;, &#39;Series&#39;, &#39;Target&#39;, &#39;Validation&#39;, &#39;Text&#39;, &#39;Mining&#39;, &#39;Unmanned&#39;, &#39;Aerial&#39;, &#39;Vehicles&#39;, &#39;Ubiquitin&#39;, &#39;Uninterruptible&#39;, &#39;Power&#39;, &#39;Supplies&#39;, &#39;upcoming&#39;, &#39;conferences&#39;, &#39;upcoming&#39;, &#39;conferences&#39;, &#39;Europe&#39;, &#39;Urinary&#39;, &#39;Incontinence&#39;, &#39;New&#39;, &#39;USP&#39;, &#39;Initiatives&#39;, &#39;and&#39;, &#39;Standards&#39;, &#39;for&#39;, &#39;Biologics&#39;, &#39;unstable&#39;, &#39;triplets&#39;, &#39;trinucleotide&#39;, &#39;repeats&#39;, &#39;Vaccines&#39;, &#39;(&#39;, &#39;for&#39;, &#39;IMT&#39;, &#39;)&#39;, &#39;Vascular&#39;, &#39;Vaccines&#39;, &#39;Business&#39;, &#39;Opportunities&#39;, &#39;Venture&#39;, &#39;Capital&#39;, &#39;Business&#39;, &#39;Opportunities&#39;, &#39;Vaccines&#39;, &#39;Voice&#39;, &#39;Recognition&#39;, &#39;Paperless&#39;, &#39;Validation&#39;, &#39;veterinary&#39;, &#39;viral&#39;, &#39;infections&#39;, &#39;Vaccines&#39;, &#39;Production&#39;, &#39;&amp;&#39;, &#39;Manufacturing&#39;, &#39;Virtual&#39;, &#39;Reality&#39;, &#39;virtual&#39;, &#39;business&#39;, &#39;Virtual&#39;, &#39;Teams&#39;, &#39;Single&#39;, &#39;Use&#39;, &#39;Systems&#39;, &#39;for&#39;, &#39;Vaccine&#39;, &#39;Manufacture&#39;, &#39;well&#39;, &#39;characterized&#39;, &#39;biologicals&#39;, &#39;Wellness&#39;, &#39;Wiki&#39;, &#39;wound&#39;, &#39;management&#39;, &#39;Wireless&#39;, &#39;Change&#39;, &#39;Record&#39;, &#39;Change&#39;, &#39;Record&#39;, &#39;Mary&#39;, &#39;Chitty&#39;, &#39;Xenotransplantation&#39;, &#39;Yeast&#39;, &#39;Display&#39;, &#39;Zika&#39;, &#39;Vaccine&#39;, &#39;Development&#39;]
</pre>
</div>
</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[13]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="kn">from</span> <span class="nn">nltk.tokenize</span> <span class="k">import</span> <span class="n">word_tokenize</span>
<span class="n">tokenized_word</span><span class="o">=</span><span class="n">word_tokenize</span><span class="p">(</span><span class="s1">&#39;Molecular Medicine Tri Conference Protein Engineering Peptalk Biocomputing SCOPE Summit for Clinical Trials Operations Executives bioproduction Discovery on Target PEGS Europe Drug Discovery Chemistry World Pharmaceutical Congress advanced diagnostics Advanced Automotive Battery Conference (AABC) Europe Florida Battery Conference Biomarkers Congress High Content Analysis Advanced Automotive Battery Conference (AABC) Immunogenicity CRA &amp; CRC Beginner Biopharmaceutical Change Control Beyond Genome Immunotherapy Alliance Management Strategies Targeted ImvacS Clinical Trials Molecular Medicine Marketplace Molecular Diagnostics Europe CRA Beginner AI World Data Driven Discovery R&amp;D Strategies Strategic Resource Allocation kinases Auditing Clinical Research Studies Accelerating Development &amp; Advancing Personalized Therapy X Gen Congress Biodefense &amp; Enabling POC Diagnostics &amp; Microarray Data Analysis Human Genome Project Biobanks Structure Based Design Batteries Portfolio Quantitative PCR Health Information Technology Auditing Techniques for Clinical Research Professionals Good Clinical Practice Question &amp; Answer REference Guide CFR/ICH GCP Immunotherapy Europe Gene Amplification PCR eStats: R&amp;D Statistical Sourcebook MicroRNA microarray data analysis Intelliigent Drug Discovery &amp; Development (now WPC) Monitoring Clinical Drug Studies: Beginner Comprehensive Monitoring for Medical Devices Introduction to Clinical Project Management Bioprocessing Summit Europe Oligonucleotide &amp; Peptide Summit World Pharma Week Prenatal Diagnostics Getting Optimized Targets Library Design &amp; Synthesis Clinical Project Management functional genomics bacterial infections Advanced Automotive Battery Conference (AABC) Asia Good Clinical Practice Q&amp;A Reference Guide Screening Transmissible spongiform encephalopathy TSE Biomarker Discovery Summit Clinical Genomics Sequencing ASAP Alliance Summit Bioterrorism microarrays Pharmaceutical Leadership Summit Circulating Cell-Free DNA Conducting Clinical Trials Under ICH GCP Bio IT Europe Trial Master File Biomarkers World Preclinical Congress Europe BioMEMS bioinformatics Genomic Partnering NMR nuclear magnetic resonance Clinical Data Management Biomarker Validation proteomics Statistics Sensors Global Summit New Drug Development A Regulatory Overview Drug Safety Pharmacy Diagnostics sample preparation Clinical Trial Design Pharmacovigilance Metabolic Profiling Digital PCR Good Clinical Practice for Clinical Trials Lab chips Europe Monitoring Clinical Drug Studies: Intermediate Preparing IND Submissions Antibody Engineering Asia Clinical Project Management: Intermediate phage display CELLutions Recombinant Antibodies imaging Biomarker Assay Development in silico biology Advanced Good Clinical Practice High Throughput Optimization of Culture Conditions for Bioprocessing High Throughput Technologies gene quantfication [real time PCR] From Gene Expression Profiling to Validated Biology Clinical Project Management: Advanced SCOPE Summit Europe CNS Partnering Genomics on Target R&amp;D Statistical Sourcebook MultiUser License Medical Device Development Biological ADME Protein Expression blood safety and screening Human Proteome Project Project Management high throughput organic synthesis Global Preclinical Development Clinical Research Coordinator Global Drug Development India Biomarker Diagnostics molecular diversity functional genomics Process R&amp;D Summit Cloud Computing bioinformatics Europe Target Validation Bispecific Antibodies Bridging Pharma and IT Green Fluorescent Proteins Quality Systems CRA Monitoring Drug Discovery &amp; Development AI in Government glycotechnology Baculovirus Drug Repurposing drug discovery and development Japan The CRA Manager Course State by State Clinical Trial Requirments Reference Guide Adverse Events: Managing &amp; Reporting for Medical Devices Good Laboratory Practice Process Chemistry Beyond Sequencing Process R&amp;D Summit with GLP Batteries Biomarkers Europe IT Infrastructure computer hardware Clinical Trials patient Recruitment Working with CROs Expediting Drugs and Biologics Development Tissue Sealants - One Day Protein Expression Europe Use of Note to Files in Clinical Trial Essential Documentation Antibody Engineering Korea RNAi for Pathway Analysis Advanced GCP Compliance Mechanisms of Cancer Business Diagnostics (Impact of New Diagnotics) Consumer Genomics Conference Recombinant Antibodies Europe Research Site Clinical Study Budgets and Contracts Proof of Concept Drug Development in China Future Diagnostics Medicinal Chemistry Combination Therapies CRA Training Series (1-7) Lab Chips Japan Human Genomes Europe Tissue Based Screening lead optimization Adverse Events Reimbursement Diagnostics labels signals and detection ASAP CHI Bio Pharm Alliance Summit forensic diagnostics Writing for Clinical Research Molecular Profiling with Cellular Resolution 10 Rules of Effective Report Writing pharmacogenomics europe Exploring Next Generation Sequencing conference Drug Development &amp; FDA Regulations HCA East Cancer Immunotherapies (formerly Cancer Vaccines) Biologics Development A Regulatory Overview Standard Operating Proces in Clinical Research molecular pharmacology RNA Interference Summit Clinical Training oligonucleotides Clinical Trial Protocols toxicology Immunogenicity Testing for Biologics Adaptive Clinical Trials ADME Stem Cells in Drug Discovery and Development Drug Pipeline Success (Pipeline Success Summit) stem cells Data Visualization Pharmacokinetics transgenic animal models Business Development Alliance Management Interface Monitoring Clinical Drug Studies: Advanced Digital Health Innovation Summit Data Management in the Electronic Data Capture Arena Case Report Forms Battery Safety Medical Devices GCP Overview Clinical Administrative Support Staff Alliance Management &amp; Project Management Pre-Implantation Diagnostics Eyesight Biomarker Diagnostics Biomarker Web Symposia Drug Approval Process Neglected Diseases Molecular Diagnostics Medical Device Approval Process Code of Federal Regulations for Medical Devices Clinical Research Associate G protein coupled receptors GPCRS Prenatal Diagnostics Europe Genomic Tools &amp; Technologies Biomarkers Europe Symyx Business Collaborative Innovation Source Documentation Mitochondria Comparative Genomic Hybridization Lithium Battery Power Writing Clinical Study Protocols Reimbursement Therapeutics genetic variations Business Investigator initiated trials Burrill Book Bio-IT Asia Compound Profiling cancer clinical trials Chemical Genomics Safety/Toxicity Biomarkers Cancer Diagnosis antibody engineering Drug Development in Asia West Coast Virtual Screening Point of Care Diagnostics Protein Formulation genetic diagnostics Bridging Discovery &amp; IT Biofuels Translational Medicine Personalized Medicine Clinical Research Organization Alliance Management Congress Europe New Drug Approval Risk Based Site Monitoring Root Cause Analysis Monitoring Phase I Clinical Trials Drug Development Latin America Licensing vaccines cancer genetics and genomics Marketing Reimbursement Metabolic Analytical Methods Difficult Clinical Research Sites Protein Chips/Arrays Monitoring Plan Development Genome Japan Immunogenicity Advances in Management and Reduction Clinical Auditing Clinical Informatics Antibody-Drug Conjugates Electronic Medical Records &amp; Source Document Verification Bridge to Pop Health East Informed Consent Pharma Future Microarray Data Analysis Europe Clinical Investigator Site Inspections Global Clinical Trials Protocol Deviations Immunotherapy West Cancer Therapies Recognize Attrition Earlier Electronic Data Capture Clinical Imaging Physical Chemistry Toll Like Receptors monoclonal antibodies Innate Immunity High Content Analysis Europe Negotiation Skills for Clinical Research Professionals Biotech Executive Forum CNP Partnering Europe nanotechnology Risk Management Clinical Trials for Medical Devices Adverse Event Monitoring for CRAs Vendor Management Report Writing for CRAs Symyx Europe Epigenetics Regulatory Compliance GCP Training for Investigators RECIST 1.0 and 1.1 Pharmacovigilance Audit Microfluidics yeast model organism Market Targets &amp; Compounds Critical Decision Points in Design &amp; Conduct of Patient Registries protein production formulation HCA Europe Idiosyncratic Toxicity Protein Informatics Conflict Resolution and Negotiation Regulatory Intelligence Bioresearch Monitoring Cryobiology signal transduction Emerging Companies Corrective Action Plans: Documentation of a Sites Response to GCP Deficiences Developing Clinical Study Budget Next Generation Sequencing Data Management Fraud in Clinical Research Biosimilars Dealmaking for Diagnostics Comprehensive CRC Training Cancer Cell Models Digital Health Patient Registry Programs crop genetics Glossary &amp; Acronyms Reference Biosensors Good Clinical Practice Essential Documentation in Clinical Trials at Research Sites Patient Centered Clinical Trials Proteins to Profits Europe Drug Metabolism International Drug Approval Regulatory Procedures Principal Investigator Training orthopedic tissue engineering Investigator Sites cardiovascular genomics Study Start Up Protein Folding Population Health Management Tissue Diagnostics GLP Bioanalysis Phase I Study Management Health Autonomous Driving Electronic Source Documentation Tools &amp; Metrics Congress Global GCP Monitoring Investigator Non-Compliance Global GCP Compliance Report Protein &amp; Peptide Arrays Europe Internet of Things Clinical Trials for Pharmaceuticals Introduction to Signal Detection and Data Mining Study Feasibility Clinical Investigation Monitoring Proteomics Europe Clinical Trials in Developing Regions Pediatric drug development Sponsor Monitoring Inspections Maximize Value of Drug Development protein structures cancer Microbial Genomics Translational Cancer Medicine Medical Terminalogy for Clinical Research Professionals Medical Devices Writing and Updating the Investigators Brochure Sunshine Act Sequencing for Drug Development Standard Operating Procedures Meeting International Safety Reporting Requirements Faciliation Skills for Clinical Research Professionals bioprocessing biologicals safety Regulatory Intelligence 101 Recent Trends in Noncompliance Briefings on Drug Safety Clinical research project mamangement essentials CRA Survival Kit Essential Documentation Extracellular RNA Successful Study Site Start-up Cell Based Therapies Web-Based Training Strategies data mining GLP Bioanalysis Clinical Trial Finance &amp; Management regulatory Site Relationship/Performance Management Introduction to FDA Regulatory Reporter Newsletter multiple sclerosis Data Integration Managing CRAs to Improve Performance &amp; Study Outcomes compounds Predictive Toxicity Surviving FDA Site Inspections: Best Practices for Site Personnel Phase III (3)/forecasting clinical outcomes Comparing FDA and Health Canada Regulations Medical Device Professionals Recombinant Therapeutics Tick Borne Diseases Writing and Maintaining the EU CTA Orphan Drugs Investigator Initiated Trials Orthopaedic Animal Models Auditing Sponsors and CROs Valuing &amp; Pricing Licensing Deals drug delivery Vendor Management for the Clinical Data Manager Data Quality Patient Engagement FDA Drug Approval Process HIPAA No 1 Team Training HIPAA &amp; Human Subjects Research  Q&amp;A Ubiquitin Europe Clinical Trial Data Monitoring Investigational Product Accountability Training for Research Site Personnel Adverse Event Reporting to IRBs Subject Recruitment for Clinical Research Sites Antibodies in Cancer Cost Management for Global Clinical Trials Portfolio Management Warning Letters Combination Products Observational Studies Molecular Medicine Asia CNS Central nervous system Discovery &amp; Development Collaboration Cross functional global teams Site Relationship Management peptides Investigator Oversight Writing SOPs pain web 2.0 Understanding FDAs new Draft Guidance Regarding Supervisory Repons Sponsors/CROs Preparing Clinical Research Sites for FDA Inspections eHealth Technologies Introduction to Data Management FDA Proposed rule 2010 Teambuilding for the Cross Functional Global Team Genomic Business Strategies Product Life Cycle RNA Interference Pharmacovigilance Signal Detection Foreign Clinical Trials Biotech Business Development genomics Portfolio Management Venue II Clinical Trial Design for Medical Devices Informed Consent Clinical Trial Study Wheel Biomarker Data Center Antibody Optimization &amp; Characterization Biologics Chronic Pain cardiovascular Risk based decisions for clinical site management Human Participant Protection Training Clinical Research Professionals CRC Role/Responsibilities Training Womens Health Current Developments in the Role of IRBs in the Conduct of Clinical Research Regulatory Compliance for Molecular Diagnostics infections Diabetes cancer partnering Preparing Medical Device 510K Submissions Monitoring Informed Consent Business of Biobanking Global Site Selection Boston Biomarkers of Drug Efficacy and Safety New Drug Approval in the European Union Protein Therapeutics Quality Improvement Strategies at Clinical Research Sites diagnostics bioprocessing viral hepatitis infections Advanced HIPAA Clinical Sequencing IRB Guidance regenerative healing cell culture Coronavirus Liver Disorders Big pharma Big Data HIPAA Electronic Medical Records blood Pharmaceutical Strategy Series Strategies for Accelearted Nonclinical Toxiciology &amp; Safety Assessment of Biologics New Drug Approval in Japan Artificial Intelligence Excel Spreadsheets-Step by Step Instructions for Compliance Chemistry R&amp;D Statistical Sourcebook Upgrade Medical Device Tracking Medical Devices Directive Facilitation Skills Autoimmune anticoagulants bone Clinical Antibodies gene therapy Newborn Diagnostics Real World Monitoring Allergies Performance Improvement Monitoring Model Institutional Review Board Health Outcomes Outsourcing R&amp;D Microbiome Key Opinion Leaders Chronic Obstructive Pulmonary Disorder Quality by Design Clinical Trials &amp; Translational Medicine Series Lupus Multi Drug Resistance Clinical Research Coordinator Tool Kit CRC &amp; PI Current Practice Update CRA Facilitator Training 21 CFR Part 11 Compliance for Electronic Records &amp; Signatures Cancer Diagnostics Electronic Health Record Chiral Intro to Combination Products Gastrointestinal Disorders Presentation skills for clinical research professionals inflammation Operational Modeling and Simulation in Clinical Trials Pharmaceutical &amp; Medical Device Industries Facilitation Skills for Clinical Research Team Members Diagnostics Partnering Mobile Health Wearables Pharmaceutical Discovery Data Management Medical device reporting Ubiquitin Medical Device Postmarketing Vigilance Blockchain Alzheimers high performance computing Innovative Preclinical &amp; Clinical Strategies GXP Good Practice Guides Writing and Maintaining Canadian CTA 3D Printing Key Information Gatherers Respiratory Five Keys to COTS Computer System Validation Next-Generation Sequencing Data Management Open Source Fibrosis/Scarring Biomarker Bridge Genomics 101 Dummy Keyword for DE lists w/more than 1 keyword or with no keywords FDA Form 1572 Antisense Accountable Care Orgnization ACE inhibitors AI Chips Antibody-Drug Conjugates  for PEGS Antibody Drug Conjugate Bioprocess Attention Deficit Hyperactivity Disorder Adjuvants ADMET (ADME &amp; Toxicology) adverse drug reactions Aerospace Advanced Energy Technology Congress Affordable Care affinity technologies Affinity Separation Antibody Fragments Agriculture  chemistry Aging Antibody Drug Targets Digital Farming angiogenesis AI Business Intelligence Artificial Intelligence Bioprocessing AI in Customer Analytics Intelligent Assistants and Bots AI in Cancer Enterprise AI Case Studies AI Executive Summit Machine Learning Artificial Intelligence Clinical &amp; Post Approval Artificial Intelligence Discovery &amp; Preclinical Implementing Enterprise AI AI Ethics Future of AI Cutting Edge Research for AI General AI Business Applications AI for Strategic Government Functions Cognitive Computing AI Partnering AI in Personalized Medicine Allosteric Modulators Amyotrophic lateral sclerosis Animal Models of Cancer Alternative Medicine Alliance Management Execution Asset Management Alliance Management Negotiation Animal Models of Pain Animal Models of Toxicity angina Anxiety cancer and apoptosis Active Pharmaceutical Ingredients Analytical Purification Apoptosis Anti Psychotics Alliances Rx Devices arrhythmias Assays for Antibodies Assays Affinity Assays and Allosteric Antagonism Immunogenicity Assay Development Assays Primary Cells Quantifying Receptor Activation and Agonism asthma Assays atherosclerosis Automotive Automotive Partnering Autophagy Autism Advisory Boards Bacterial Infections Consumer Electronic Battery Applications Defense Battery Applications Battery Data Science Flexible Battery Power Industrial Battery Applications Medical Device Battery Applications Battery Applications Stationary Battery Applications Automotive Battery Applications Bayesian Statistics Asia US Biotech Alliances Blood Brain Barrier Computational Biology for Bio IT BioIT Best Practices Battery Charging Cheminformatics for Bio IT Biomarker Clinical Applications Preclinical Biologic Development Breast Cancer Backup Compounds biological cancer treatments Biomarker Data Analysis Biological Database Discovery Informatics for Bio IT Delivery of Biologics Regulatory Business Diagnostics biodiversity screening E Clinical Research Battery Energy Storage Biofuels Alliance Biobank Informatics Flow Cell Technologies Cloud Computing for Data Science Biogenerics Business of Genomics biomaterials Bioinformatics for Cancer BIO IT World Battery Intellectual Property Bio IT World Web Resource Alert Bio IT World Monthly magazine IT &amp; Informatics Series Bio IT World Weekly Update Bookstore Biomarker Development Advanced Lead Acid Technology Manufacturing &amp; Process Economics Biopharm Executive Summit Biolaw Biomarker &amp; Diagnostics Series High-Througput Screen-Based Biomarker Discovery Battery Manufacturers Battery Manufacturing Battery Management Battery Manufacturing Machinery Battery Market Battery Machine Learning Biomarker Executive Think Tank Battery Materials, Recycling Biomarker Reverse Phase Assays Battery Materials, Solid State bone marrow transplants Biomarker Translational Biomarker Validation Bioinformatics Asia Bioinformatics Cloud Computing IT Infrastructure  for Bio IT Logistics and Sample of Biobanking Bioinformatics in the Genome Era Bioprocess Data Analysis Host Cell Protein Assays Bioproduction Continuous Processing biopurification Biological Pharmacokinetics Bioprocessing Quality Bioprocess &amp; Manufacturing Series Bioprocess Validation Bioreactor Design and Engineering Battery Regulatory Battery Raw Materials Brain Cancer Battery Repurposing Biological Therapeutics (biotherapeutics) Bispecific Antibodies for Immunotherapy Bispecifics for Cancer Business Strategies for Library Diversity blood safety Europe Battery Shipping Battery Simulation Biosensors bioseparation Biostabilization of Biospecimens Biomanufacturing Single Use Technologies Bioassays Battery Commercialization Flow Batteries Battery Materials Sci/Tech for Pharma &amp; Biotech Battery Safety Biotech tools Biotech Venture Forum Biomarkers for Molecular Diagnostics Biomarkers for Molecular Diagnostics Clinical Trials for Cancer Immunotherapy Artifical Intelligence in Clinical Trials cell adhesion molecules regulatory CANDA Computer Assisted New Drug Application Chimeric Antigen Receptor Chimeric Antigen Receptor Case Studies catalysis Cell Based Assays Cell Therapy CMC Cancer Biomarker Cell Therapy Production Cord Blood Stem Cells Cell Based Therapies Circulating Tumor Cells Cold Chain Colorectal Cancer cell cycle Collaborations Deals and Alliances Chemical Database Co-Development of Diagnostics and Drugs Cloud Computing Europe Case Histories Clinical Trials Consumer Electronics Cell Biology Clean Tech Solar Wind Comparative Effectiveness Research Ethical Considerations in Clinical Trials Continuing Education Units Circulating Cell-Free DNA Europe Agriculture  crop genetics Europe Cancer Genomics Europe congestive heart failure Chemistry Series Chinese Hamster Ovaries Clinical Research Conflicts of Interest cheminformatics competitive intelligence Cloud Computing Asia Integrating Clinical Lab Services in Clinical Trials Clinical Biospecimens and Central Lab Solutions Clinical Biospecimens and Central Lab Solutions Celiac Disease Cloud Extension Clinical Genomics Europe cellular all Conducting Clinical Trials in Asia Cloud Computing Project Management Cloud Computing Resource Management Cloud Computing Security Risks Software Development for Clinical Genomics Clinical Vaccines Cloud Computing West Comparability Chemistry Manufacturing and Controls Continuing Medical Education Communications Contract Manufacturing Cancer Microarray Application CNS Biomarkers Miscellaneous CHI conference CNS genetics/genomics CNS Disease Models Counterfeit Drugs Copy Number Variation Cognitive Disorders Battery Components capillary electrophoresis Cancer Prognostic Markers Clinical Pharmacology Clinical Proteomics Clinical Plasma Profiling Clinical Trial Platform Software Computer Vision cancer prevention CRA 8 Weeks Fundamental Training Cost Reduction w/o Increasing Regulatory or Business Risk Advanced Clinical Research Coordinator Critical Care Diagnostics Interviewing Skills for CRAs and CRCs Customer Relationship Management CRA Monitoring Clinical Research Training Week Clinical Research Training Week East Clinical Research Training Week West Drug-Device Combinations Peptides for Cancer Therapeutics Colony Stimulating Factors Cell Signaling Cancer Stem Cells Clinical Supply Chain Clinical Strategic Resource Allocation Country and Site Feasibility and Selection Mammalian Cell Culture Cloud Security Cybersecurity Clinical Data Management and eClinical Trials Asia Clinical Trials for the Drug Discoverer Clinical Trials Eastern Europe Clinical Trial Finance &amp; Management Re Engineering the Study Feasibility Assessment Process CRC Training Video &amp; Manual Clinical Trial Management Systems Cardiotoxicity Query Creation &amp; Processing clinical trials segmentation Neoantigens for Cancer Cardiovascular Diagnostics cardiovascular animal models Cardio Metabolic Drug Targets Targeting Cancer Diagnostics cytokines antagonists Cystic Fibrosis Cytogenetics cytokines Targeting Diabetes with Novel Therapeutics DBS Optimization of Cell drug discovery India Drug Discovery Map Drug Discovery Outsourcing Drug Discovery Technologies drug discovery and development Drug Discovery &amp; Development Series Dental Depression Detection non biological Treatments for Drug Abuse Drug Drug Interactions Digital Therapeutics Digitization Diabetes 2 Digital Healthcare &amp; Productivity web resource alert drug discovery Duchenne Muscular Dystrophy Drug Metabolism &amp; Pharmacokinetics Drug Discovery Informatics Europe Data Integrity Diagnostic Informatics DNA Repair Diversity Oriented Synthesis Digital Detection Europe Difficult to Express Proteins Executive Perspectives of Drug Safety downstream processing Europe Drug Safety Series downstream processing Dosing Selection Data Science/Analytics Direct to Consumer Marketing Data Management Drug Transporters Data Storage Digital Twins Drug Utilization Protein Devices Molecular and Companion Diagnostics Asia Clinical Adoption of Next Generation Diagnostics Difficult to Express Proteins Europe Globalization of Dx Diagnostics Immunoassays Diagnostics Automation Detection Informatics engineered animal models Hearing Ebola Diagnostics Evidence Based Medicine Ebola Therapeutics eCapacitors Electrochemistry E Coli Encoded Compound Libraries Ecommerce eCTD Validation of Disinfectant Efficacy Effective Drug Discovery Edge Computing Early Diagnosis Electronic Notebooks endothelium engineering Entertainment Enabling Technology in R&amp;D Environment Enzymes Economic Outcomes Executives on Target Epidemiology epilepsy Epigenetic Readers Epigenetic Targets Examining the Impact of the eCTD on the Regulatory Submissions Process Emerging Targets Diseases Ethics Emerging Technology Transfer Electric Vehicles Experimental Design Exhibitors Extractables/Leachables Exosomes Exome Sequencing Financial Analysts Hackathon Obesity Batteries France fibrin sealants Fine Chemicals FDA Meetings 101 Food Safety Financial Disclosure Foods FDA Website Functional Genomics Fragment Based Screening Surface Plasmon Resonance finance Flow Cytometry Influenza Financial Deal Structures Fintech Future of Healthcare Fraud Fertility Fibrin sealants Europe blood Fast Track Future Therapeutics fungal infections Follow Up Flow Chemistry Gamification gap junction channels Global Health Good Clinical Practice for Pediatric Research GCP Deficiencies Gene Cell Vectors Genomic Drug Discovery Genomic Data Integration Genetic Screening Wellness General Email Only Gene Editing Part 2 Gene Editing Gene Expression Monitoring Genomics Series Gene Expression growth factors Gene Identification genetic immunization vaccines gene interference Gene Knockouts Globalization Genome Links newsletter GLP Bioanalysis Leaders in Precision Medicine Good Manufacturing Practice Drugs introductory gene mutations genomic medicine Genotyping Government gene probes Genomic partnering Europe Greening of Pharma GPCR Targeted Therapies Grid Computing Genomic Service Providers Small GTPases (formerly Gene Town Pass) gene transcription gene therapy technologies Whole Genome Association Studies Humanized Antibodies high throughput analytical chemistry Health &amp; Beauty Aids Hepatitis B Virus High Content Analysis Course HIV and cancer Hematological Cancer Pipelines HIV clinical trials hepatitis C virus Heterocycle High Content Data Analysis HDAC Histone Demethylases Healing hematopoesis heat shock proteins Human Factors Engineering Health Information Systems HIV Healthcare Series Health Maintenance Organizations Human Tissue Huntingtons Disease hormones HIPAA #2 High Throughput Protein Purification High Performing Operation Human Papilloma Virus transgenics homologous recombinant Human Relations Health Insurance herpes virus HIV Surrogate Markers High Throughput Genomics Hit to Lead High Throughput Screening Hepatotoxicity Hybrid Computing hypertension Targeting Antigen Presenting Cells Inflammatory Bowel Disease imaging contrast agents interleukin converting enzymes ICE Improving Drug Safety diagnostics - infections Infections Diagnostics Europe engineering laboratories Integrated Fluidic Circuits for DOT Informatics for Genomic Medicine Infection Genomics Image Analysis Immunotherapy Biomarkers Immune Profiling in Cancer Complement-based Drug Discovery immunomodulation Imaging for WPC conference Imaging Informatics Immune Impurities Regulatory Immunogenicity Immunosequencing Immuno-Oncology Drug Developement Cancer Immunotherapy Oligonucleotides Cancer Immunotherapy Peptides Cancer Immunotherapy Small Molecules Informatics Partnering Insurance AI and IOT Investments Industrial Enzymes Immuno-Oncology Assays Immuno-Oncology Business Strategy Immuno-Oncology Clinical Trials Immuno-Oncology Models ion channels Protein Engineering for Immuno-oncology Immuno-Oncology Sequencing Immuno-Oncology Targets Legal Issues for Bioproduction Intellectual Property Pluripotent Stem Cells IRB Compliance and Oversight Considerations Adopting Integrated R&amp;D Informatics Systems India Re Engineering International Risk Management Drug Discovery Informatics Iron Chelation IT Infrastructure Software in situ hybridization Information Technology IT &amp; Informatics for Collaboration IT Infrastructure Europe Scalable IT &amp; Informatics IT Infrastructure computer hardware (part 2) IT Infrastructure computer hardware (part 3) IT Software for the Life Sciences IT Infrastructure Virtualization Interviewing Skills for Managers Investigator Sites Report 1 Investigator Sites Report 2 Imaging Week joints Job recruiters Kinase Chemistry KIN West Coast Kinases for DOT Knowledge Management chemokines HIV and Kaposis sarcoma Kinetics Structure Relationship laboratories Lead Acid Batteries Label Free Detection Drug Labeling Live Cell Imaging Laser Capture Microdissection Lung Cancer ligase chain reaction leukodepletion Laboratory Developed Tests leukemia Ontologies/Lexicons Legal drug liability screening libraries Life Sciences Protein Ligands lab information management systems LIMS Lipids Large Stationary Batteries Lyophilization Mergers &amp; Acquisitions Monoclonal Antibodies Forum Monoclonal Antibody Process Development Malaria Metabolism Targeted Cancer Therapeutics Microbiome in Immuno-Oncology Microbiome Metabolic Syndrome Medicinal Chemistry Part 2 Mucosal Immunity Microreactors Macrocycles Molecular Diagnostics Business Multidrug Resistance Cancer Medical Coding multidrug resistant infections Next Generation Non-Invasive Molecular Diagnostics Microdosing microbial infections Sequencing Based Molecular Diagnostics Molecular Diagnostics Forum Molecular Electronics Metabolic Engineering Melanoma BioMEMS memory enhancement cancer metastasis molecular evolution Mammalian Cell Line Development microfabrication Molecular Genetic Pro Management molecular medicine Novel bioactive high throughput screening europe Myocardial Infarction migraine microtiter plates Molecular Medicine Europe metalloproteinases Molecular Medicine Asia Managed Care Manufacturing Clinical Trial Monitoring Mechanism of Action Purifying Antibodies Meeting Planning Services Molecular Pathology Molecular Pathology Basic Molecular Pathology Advanced magnetic resonance imaging Multi Specific Antibodies Mass Spectrometry for Protein Biomarker Discovery Muscle Mass Spec Informatics Mass Spec Imaging Modeling and Simulation Mass spectrometry Mass Spec Diagnostics Metabolic Disorders Mental Health Materials Testing cellular matrix Multiplexed Assays Moelcular Diagnostics Europe Molecular Diagnostics for Cancer Molecular Diagnostics for Infectious Disease Next Generation Antibodies Next Generation Antibodies (for PGE) Nucleic Acid Europe National Academy of Sciences meeting natural products new antivirals Novel Cancer Informatics Non-Coding RNA Novel Strategies Cancer Novel Cancer Targets Neurodegenerative Nucleotide Delivery Internet New to Database comapny names Advances in Informatics nerve growth factors NF KB Nanofluidics Informatics Next-Generation Batteries Next Generation Batteries Portable Applications Next Generation Batteries Stationary Power Epigenetic Sequencing Next Generation Imaging Neurogenomics Nuclear Hormone Receptors Novel HIV Strategies Neurotech Industry neuroinjuries NK Cell Based Cancer Immunotherapy Natural Language Processing nuclear matrix Nanomedicine Nitric Oxide Network Pharmacology Energy Neurotoxicity New Drug Approval in the US nanotech self assembly Internet of Supply Chain Internet of Supply Chain Europe Neurostimulation Internet of Diagnostic Things Internet of Energy Internet of Energy Europe Internet of Things Infrastructure Internet of Health Internet of Insurance Internet of Insurance Europe Internet of Things Manufacturing Internet of Things Manufacturing Internet of Manufacturing Europe Smart Buildings Smart Cities Nephrotoxicity Nuclear Energy nutrition Optimizing Media organ and cell transplants Oncology Drug Targets Optical Diagnostics Oncogenomics Office of the Inspector General Oil and Gas oncogenes Oncolytic Viruses Oligo Production opportunistic infections Oligo Regulatory organs transplants oral drug delivery OSTEOARTHRITIS OTC over the counter Additional Conferences clinical trials outsourcing Oxygen Radicals oncogenes p53 Predictive ADME protein aggregation Protein Aggregation (for PTK) Packaging parasitic infections Process Analytical Technology Pharmacy Benefit Management Pharmaceutical BioProcess Basic Research &amp; Discovery track for PCG Clinical Operations track for PCG Preclinical Development track for PCG Bridgehead PCI book Preclinical Preclinical Preclinical prostate cancer Preclinical Outcome Predictions preclinical trials Point of Care West Protein Crystallography pediatric AIDS/HIV PDA Downloads from CHI website Process Development for Executives platelet derived growth factors protein drug delivery Preclinical Disease Models photodynamic therapies Phage Display for Vaccine Development Proteomic Tools for Diagnostics pediatric Pediatric trials for CRAS PEGS Virtual Interactive Global Summit Protein Expression Monitoring Protein Executive Summit Proof of Concept for Cancer Protein Function Enterprise Portfolio Management Portfolio Value Protein Aggregates Light Scattering Consumer Genomics/Personal Genomics Protein Engineering Partnering Particulate Screening Phage West Phase II/Reducing Attrition Phase IV Phase IV Pharmacies Phage Display Europe Pharmaceutical Half Life Phase Zero PI3K Phosphoinositide 3 Kinase Protein Identification Preclinical Imaging protease inhibitors enzymes PLA2 blood platelets Membrane Proteins Membrane Protein for DOT (part 1) Membrane Protein for DOT (part 2) Protein Manufacturing Clinical Project Management: Intermediate Preventive Medicine Pancreatic Cancer Preclinical Studies for IND Protein Computational Tools Prenatal Therapeutics Parenteral Point of Care Diagnostics Europe Cannabis Power Utilities protein characterization protein purification Protein Protein Interactions Protein Protein Interactions Part 2 Process Management Protein Process PepTalk Partnering Personalized Medicine Partnering Proteomics Analytics Predictive Analytics Pricing Parkinsons Predictive Biomedicine Proteins, Peptides &amp; Proteomics Series Protein Quantification Partnering Data Privacy Personalized Medicine Asia Product Service Announcement Production and Scale Up Pharma Services News schizophrenia antipsychotics Protein Antibodies Preclinical Toxicology Biologics Protein Technology Engineering Protein Therapeutics for Delivery Predictive Toxicity Europe Platform Software for R&amp;D Studies Phenotype to Genotype Pathology Protein drugs &amp; diagnostics Intellectual Property Post Translational Modifications Patient Registries Advancing Therapeutics Current Generation Protein Drug Delivery (part of PepTalk) Advancing Therapeutics Next Generation Biological Therapeutic Products Series Pathway/Networks Publications Protein Variations Powertrains Protein Characterization, Purification and Screening Protein Characterization, Purification and Screening Protein Expression Europe Beyond Protein Expression Europe Protein Expression Host Novel Protein Expression Systems Protein Engineering Vectors Preventive gene quantification Europe QS Regulation Recombinant Antibodies Recombinant Antibodies Recombinant Proteins Forum Radiation Rare Diseases Antibody Drug Products RBE track at PGE RBE track at PGE Antibody Screening Antibody Translational rapid compound characterization Clinical Enrollment Plan Clinical Recruitment Media Clinical Trials Patient Recruitment Winning Strategies for Clinical Recruitment Media Integrating R&amp;D and Marketing R&amp;D Productivity drug receptors Role of Business Process Managment in FDA Regulated Industry Worldwide Pharma Regulation Surviving FDA Site Inspections Real Estate Risk Evaluation and Mitigation Strategies Renal (kidney) Renewable Energy Storage System RFID Radiofrequency ID Reagents Gap Analysis rheumatoid arthritis gene therapy [RNA blocking] Ribonucleic Acid RNAi for Functional Screening RNAi   RNAInterference RNAi Discovery on Target RNAi Video on Request RNA Quality RNA Therapeutics Robotics Regional Organization Robotic Process Automation reperfusion Reproduction Gene Regulation and Regulatory Networks Restenosis Retail Real World Data Therapeutics Indications &amp; Drug Targets Series safety Screening 3D Models Sickle Cell Anemia Screening Informatics Sequencing and Cloud Computing supply chain management SCOPEs Clinical Research Leadership Forum Phenotypic Screening Phenotypic Screening clinical trials strategy IT Security Sequence Data Analysis Sequence Data Analysis Asia Sidec Executive Forum Sequence Data Analysis Europe Sleeper Disease Indications Sequencing Data Storage &amp; Management Screening Difficult Targets Source Document Verification Sequencing Data Analysis &amp; Storage second messengers sepsis infections Sequencing Forum Serotonin Sexual Small Fuel Cells selective immune suppression skin sleep Pharmaceutical Sales Biologics Small Molecular Comparisons Semiconductors small molecules simple model organisms Small Molecules Synthesis Semantic Web Sensor Applications Synthetic Biology Sensor Data Management Implantable Biomedical Sensors Sensor Materials Sensors Emerging Markets SNPs Sensor Systems Sensor Safety software Solubility Safety Pharmacology for Biologics Safety Pharmacology for Biologics Genomic Sample Preparation Speciality Pharmaceuticals Alternative Splicing Proteomic Sample Preparation High throughput screening partnering solid phase synthesis Subjective End Points Next Generation Sequencing Applications Sequencing Core Labs Next-Generation Data Generation Plant Sequencing RNA Sequencing Sequencing Solutions Deep Sequencing EU Site Selection, Study Activation, and Patient Recruitment Stability stroke Stem Cell Culture Stem Cell Research (part of MMTC) Statin Stem Cells Safety Screening Startup Public companies/stock exchanges CHI Surveys Services Systems Biology for BYG track synthesis Systems Biology Training &amp; Development Top 50 Big Pharmas Tissue Microarrays taxol  tamoxifen and other derivatives Tuberculosis Tobacco The Biotech Journal Email List Trust Building for Collaborative Innovation Tumor, Circulating Cells Technology Technology Consortium Target Driven Chemistry targeted drug delivery transgenic disease models Thrombotic Disease tissue engineering telomerases Battery Testing Transfection Toxicogenomics Target Prioritization Target Identification tissues Technology Platforms Immunotherapies Telecommunications Telemedicine Tumor Microenvironment Trial Master File for Sponsors (pharma) Trial Master File for Research Sites Theranostic Market Models tumor necrosis factors Therapeutics and Targets Therapeutics &amp; Targets Series immune tolerance Fibrinolytic (clot buster) Transgenic Production in Plants Synthetic Biology Transportation Translational Biomarkers Translational Informatics Drug/Disease Targets Drug Targets Series Genome Tri Conference Translation Services transgenics gene knockouts transgenic production Tumor Suppressor Genes tissue safety Technology &amp; Tools for the Life Sciences Technology &amp; Tools for Life Sciences Series Target Validation Text Mining Unmanned Aerial Vehicles Ubiquitin Uninterruptible Power Supplies upcoming conferences upcoming conferences Europe Urinary Incontinence New USP Initiatives and Standards for Biologics unstable triplets trinucleotide repeats Vaccines (for IMT) Vascular Vaccines Business Opportunities Venture Capital Business Opportunities Vaccines Voice Recognition Paperless Validation veterinary viral infections Vaccines Production &amp; Manufacturing Virtual Reality virtual business Virtual Teams Single Use Systems for Vaccine Manufacture well characterized biologicals Wellness Wiki wound management Wireless Change Record Change Record Mary Chitty Xenotransplantation Yeast Display Zika Vaccine Development&#39;</span><span class="p">)</span>
<span class="nb">print</span><span class="p">(</span><span class="n">tokenized_word</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>[&#39;Molecular&#39;, &#39;Medicine&#39;, &#39;Tri&#39;, &#39;Conference&#39;, &#39;Protein&#39;, &#39;Engineering&#39;, &#39;Peptalk&#39;, &#39;Biocomputing&#39;, &#39;SCOPE&#39;, &#39;Summit&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Operations&#39;, &#39;Executives&#39;, &#39;bioproduction&#39;, &#39;Discovery&#39;, &#39;on&#39;, &#39;Target&#39;, &#39;PEGS&#39;, &#39;Europe&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Chemistry&#39;, &#39;World&#39;, &#39;Pharmaceutical&#39;, &#39;Congress&#39;, &#39;advanced&#39;, &#39;diagnostics&#39;, &#39;Advanced&#39;, &#39;Automotive&#39;, &#39;Battery&#39;, &#39;Conference&#39;, &#39;(&#39;, &#39;AABC&#39;, &#39;)&#39;, &#39;Europe&#39;, &#39;Florida&#39;, &#39;Battery&#39;, &#39;Conference&#39;, &#39;Biomarkers&#39;, &#39;Congress&#39;, &#39;High&#39;, &#39;Content&#39;, &#39;Analysis&#39;, &#39;Advanced&#39;, &#39;Automotive&#39;, &#39;Battery&#39;, &#39;Conference&#39;, &#39;(&#39;, &#39;AABC&#39;, &#39;)&#39;, &#39;Immunogenicity&#39;, &#39;CRA&#39;, &#39;&amp;&#39;, &#39;CRC&#39;, &#39;Beginner&#39;, &#39;Biopharmaceutical&#39;, &#39;Change&#39;, &#39;Control&#39;, &#39;Beyond&#39;, &#39;Genome&#39;, &#39;Immunotherapy&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;Strategies&#39;, &#39;Targeted&#39;, &#39;ImvacS&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Molecular&#39;, &#39;Medicine&#39;, &#39;Marketplace&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Europe&#39;, &#39;CRA&#39;, &#39;Beginner&#39;, &#39;AI&#39;, &#39;World&#39;, &#39;Data&#39;, &#39;Driven&#39;, &#39;Discovery&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Strategies&#39;, &#39;Strategic&#39;, &#39;Resource&#39;, &#39;Allocation&#39;, &#39;kinases&#39;, &#39;Auditing&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Studies&#39;, &#39;Accelerating&#39;, &#39;Development&#39;, &#39;&amp;&#39;, &#39;Advancing&#39;, &#39;Personalized&#39;, &#39;Therapy&#39;, &#39;X&#39;, &#39;Gen&#39;, &#39;Congress&#39;, &#39;Biodefense&#39;, &#39;&amp;&#39;, &#39;Enabling&#39;, &#39;POC&#39;, &#39;Diagnostics&#39;, &#39;&amp;&#39;, &#39;Microarray&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Human&#39;, &#39;Genome&#39;, &#39;Project&#39;, &#39;Biobanks&#39;, &#39;Structure&#39;, &#39;Based&#39;, &#39;Design&#39;, &#39;Batteries&#39;, &#39;Portfolio&#39;, &#39;Quantitative&#39;, &#39;PCR&#39;, &#39;Health&#39;, &#39;Information&#39;, &#39;Technology&#39;, &#39;Auditing&#39;, &#39;Techniques&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Professionals&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;Question&#39;, &#39;&amp;&#39;, &#39;Answer&#39;, &#39;REference&#39;, &#39;Guide&#39;, &#39;CFR/ICH&#39;, &#39;GCP&#39;, &#39;Immunotherapy&#39;, &#39;Europe&#39;, &#39;Gene&#39;, &#39;Amplification&#39;, &#39;PCR&#39;, &#39;eStats&#39;, &#39;:&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Statistical&#39;, &#39;Sourcebook&#39;, &#39;MicroRNA&#39;, &#39;microarray&#39;, &#39;data&#39;, &#39;analysis&#39;, &#39;Intelliigent&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;Development&#39;, &#39;(&#39;, &#39;now&#39;, &#39;WPC&#39;, &#39;)&#39;, &#39;Monitoring&#39;, &#39;Clinical&#39;, &#39;Drug&#39;, &#39;Studies&#39;, &#39;:&#39;, &#39;Beginner&#39;, &#39;Comprehensive&#39;, &#39;Monitoring&#39;, &#39;for&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Introduction&#39;, &#39;to&#39;, &#39;Clinical&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;Bioprocessing&#39;, &#39;Summit&#39;, &#39;Europe&#39;, &#39;Oligonucleotide&#39;, &#39;&amp;&#39;, &#39;Peptide&#39;, &#39;Summit&#39;, &#39;World&#39;, &#39;Pharma&#39;, &#39;Week&#39;, &#39;Prenatal&#39;, &#39;Diagnostics&#39;, &#39;Getting&#39;, &#39;Optimized&#39;, &#39;Targets&#39;, &#39;Library&#39;, &#39;Design&#39;, &#39;&amp;&#39;, &#39;Synthesis&#39;, &#39;Clinical&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;functional&#39;, &#39;genomics&#39;, &#39;bacterial&#39;, &#39;infections&#39;, &#39;Advanced&#39;, &#39;Automotive&#39;, &#39;Battery&#39;, &#39;Conference&#39;, &#39;(&#39;, &#39;AABC&#39;, &#39;)&#39;, &#39;Asia&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;Q&#39;, &#39;&amp;&#39;, &#39;A&#39;, &#39;Reference&#39;, &#39;Guide&#39;, &#39;Screening&#39;, &#39;Transmissible&#39;, &#39;spongiform&#39;, &#39;encephalopathy&#39;, &#39;TSE&#39;, &#39;Biomarker&#39;, &#39;Discovery&#39;, &#39;Summit&#39;, &#39;Clinical&#39;, &#39;Genomics&#39;, &#39;Sequencing&#39;, &#39;ASAP&#39;, &#39;Alliance&#39;, &#39;Summit&#39;, &#39;Bioterrorism&#39;, &#39;microarrays&#39;, &#39;Pharmaceutical&#39;, &#39;Leadership&#39;, &#39;Summit&#39;, &#39;Circulating&#39;, &#39;Cell-Free&#39;, &#39;DNA&#39;, &#39;Conducting&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Under&#39;, &#39;ICH&#39;, &#39;GCP&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;Europe&#39;, &#39;Trial&#39;, &#39;Master&#39;, &#39;File&#39;, &#39;Biomarkers&#39;, &#39;World&#39;, &#39;Preclinical&#39;, &#39;Congress&#39;, &#39;Europe&#39;, &#39;BioMEMS&#39;, &#39;bioinformatics&#39;, &#39;Genomic&#39;, &#39;Partnering&#39;, &#39;NMR&#39;, &#39;nuclear&#39;, &#39;magnetic&#39;, &#39;resonance&#39;, &#39;Clinical&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Biomarker&#39;, &#39;Validation&#39;, &#39;proteomics&#39;, &#39;Statistics&#39;, &#39;Sensors&#39;, &#39;Global&#39;, &#39;Summit&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;A&#39;, &#39;Regulatory&#39;, &#39;Overview&#39;, &#39;Drug&#39;, &#39;Safety&#39;, &#39;Pharmacy&#39;, &#39;Diagnostics&#39;, &#39;sample&#39;, &#39;preparation&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Design&#39;, &#39;Pharmacovigilance&#39;, &#39;Metabolic&#39;, &#39;Profiling&#39;, &#39;Digital&#39;, &#39;PCR&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Lab&#39;, &#39;chips&#39;, &#39;Europe&#39;, &#39;Monitoring&#39;, &#39;Clinical&#39;, &#39;Drug&#39;, &#39;Studies&#39;, &#39;:&#39;, &#39;Intermediate&#39;, &#39;Preparing&#39;, &#39;IND&#39;, &#39;Submissions&#39;, &#39;Antibody&#39;, &#39;Engineering&#39;, &#39;Asia&#39;, &#39;Clinical&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;:&#39;, &#39;Intermediate&#39;, &#39;phage&#39;, &#39;display&#39;, &#39;CELLutions&#39;, &#39;Recombinant&#39;, &#39;Antibodies&#39;, &#39;imaging&#39;, &#39;Biomarker&#39;, &#39;Assay&#39;, &#39;Development&#39;, &#39;in&#39;, &#39;silico&#39;, &#39;biology&#39;, &#39;Advanced&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;High&#39;, &#39;Throughput&#39;, &#39;Optimization&#39;, &#39;of&#39;, &#39;Culture&#39;, &#39;Conditions&#39;, &#39;for&#39;, &#39;Bioprocessing&#39;, &#39;High&#39;, &#39;Throughput&#39;, &#39;Technologies&#39;, &#39;gene&#39;, &#39;quantfication&#39;, &#39;[&#39;, &#39;real&#39;, &#39;time&#39;, &#39;PCR&#39;, &#39;]&#39;, &#39;From&#39;, &#39;Gene&#39;, &#39;Expression&#39;, &#39;Profiling&#39;, &#39;to&#39;, &#39;Validated&#39;, &#39;Biology&#39;, &#39;Clinical&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;:&#39;, &#39;Advanced&#39;, &#39;SCOPE&#39;, &#39;Summit&#39;, &#39;Europe&#39;, &#39;CNS&#39;, &#39;Partnering&#39;, &#39;Genomics&#39;, &#39;on&#39;, &#39;Target&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Statistical&#39;, &#39;Sourcebook&#39;, &#39;MultiUser&#39;, &#39;License&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Development&#39;, &#39;Biological&#39;, &#39;ADME&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;blood&#39;, &#39;safety&#39;, &#39;and&#39;, &#39;screening&#39;, &#39;Human&#39;, &#39;Proteome&#39;, &#39;Project&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;high&#39;, &#39;throughput&#39;, &#39;organic&#39;, &#39;synthesis&#39;, &#39;Global&#39;, &#39;Preclinical&#39;, &#39;Development&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Coordinator&#39;, &#39;Global&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;India&#39;, &#39;Biomarker&#39;, &#39;Diagnostics&#39;, &#39;molecular&#39;, &#39;diversity&#39;, &#39;functional&#39;, &#39;genomics&#39;, &#39;Process&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Summit&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;bioinformatics&#39;, &#39;Europe&#39;, &#39;Target&#39;, &#39;Validation&#39;, &#39;Bispecific&#39;, &#39;Antibodies&#39;, &#39;Bridging&#39;, &#39;Pharma&#39;, &#39;and&#39;, &#39;IT&#39;, &#39;Green&#39;, &#39;Fluorescent&#39;, &#39;Proteins&#39;, &#39;Quality&#39;, &#39;Systems&#39;, &#39;CRA&#39;, &#39;Monitoring&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;Development&#39;, &#39;AI&#39;, &#39;in&#39;, &#39;Government&#39;, &#39;glycotechnology&#39;, &#39;Baculovirus&#39;, &#39;Drug&#39;, &#39;Repurposing&#39;, &#39;drug&#39;, &#39;discovery&#39;, &#39;and&#39;, &#39;development&#39;, &#39;Japan&#39;, &#39;The&#39;, &#39;CRA&#39;, &#39;Manager&#39;, &#39;Course&#39;, &#39;State&#39;, &#39;by&#39;, &#39;State&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Requirments&#39;, &#39;Reference&#39;, &#39;Guide&#39;, &#39;Adverse&#39;, &#39;Events&#39;, &#39;:&#39;, &#39;Managing&#39;, &#39;&amp;&#39;, &#39;Reporting&#39;, &#39;for&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Good&#39;, &#39;Laboratory&#39;, &#39;Practice&#39;, &#39;Process&#39;, &#39;Chemistry&#39;, &#39;Beyond&#39;, &#39;Sequencing&#39;, &#39;Process&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Summit&#39;, &#39;with&#39;, &#39;GLP&#39;, &#39;Batteries&#39;, &#39;Biomarkers&#39;, &#39;Europe&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;computer&#39;, &#39;hardware&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;patient&#39;, &#39;Recruitment&#39;, &#39;Working&#39;, &#39;with&#39;, &#39;CROs&#39;, &#39;Expediting&#39;, &#39;Drugs&#39;, &#39;and&#39;, &#39;Biologics&#39;, &#39;Development&#39;, &#39;Tissue&#39;, &#39;Sealants&#39;, &#39;-&#39;, &#39;One&#39;, &#39;Day&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Europe&#39;, &#39;Use&#39;, &#39;of&#39;, &#39;Note&#39;, &#39;to&#39;, &#39;Files&#39;, &#39;in&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Essential&#39;, &#39;Documentation&#39;, &#39;Antibody&#39;, &#39;Engineering&#39;, &#39;Korea&#39;, &#39;RNAi&#39;, &#39;for&#39;, &#39;Pathway&#39;, &#39;Analysis&#39;, &#39;Advanced&#39;, &#39;GCP&#39;, &#39;Compliance&#39;, &#39;Mechanisms&#39;, &#39;of&#39;, &#39;Cancer&#39;, &#39;Business&#39;, &#39;Diagnostics&#39;, &#39;(&#39;, &#39;Impact&#39;, &#39;of&#39;, &#39;New&#39;, &#39;Diagnotics&#39;, &#39;)&#39;, &#39;Consumer&#39;, &#39;Genomics&#39;, &#39;Conference&#39;, &#39;Recombinant&#39;, &#39;Antibodies&#39;, &#39;Europe&#39;, &#39;Research&#39;, &#39;Site&#39;, &#39;Clinical&#39;, &#39;Study&#39;, &#39;Budgets&#39;, &#39;and&#39;, &#39;Contracts&#39;, &#39;Proof&#39;, &#39;of&#39;, &#39;Concept&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;in&#39;, &#39;China&#39;, &#39;Future&#39;, &#39;Diagnostics&#39;, &#39;Medicinal&#39;, &#39;Chemistry&#39;, &#39;Combination&#39;, &#39;Therapies&#39;, &#39;CRA&#39;, &#39;Training&#39;, &#39;Series&#39;, &#39;(&#39;, &#39;1-7&#39;, &#39;)&#39;, &#39;Lab&#39;, &#39;Chips&#39;, &#39;Japan&#39;, &#39;Human&#39;, &#39;Genomes&#39;, &#39;Europe&#39;, &#39;Tissue&#39;, &#39;Based&#39;, &#39;Screening&#39;, &#39;lead&#39;, &#39;optimization&#39;, &#39;Adverse&#39;, &#39;Events&#39;, &#39;Reimbursement&#39;, &#39;Diagnostics&#39;, &#39;labels&#39;, &#39;signals&#39;, &#39;and&#39;, &#39;detection&#39;, &#39;ASAP&#39;, &#39;CHI&#39;, &#39;Bio&#39;, &#39;Pharm&#39;, &#39;Alliance&#39;, &#39;Summit&#39;, &#39;forensic&#39;, &#39;diagnostics&#39;, &#39;Writing&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Molecular&#39;, &#39;Profiling&#39;, &#39;with&#39;, &#39;Cellular&#39;, &#39;Resolution&#39;, &#39;10&#39;, &#39;Rules&#39;, &#39;of&#39;, &#39;Effective&#39;, &#39;Report&#39;, &#39;Writing&#39;, &#39;pharmacogenomics&#39;, &#39;europe&#39;, &#39;Exploring&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Sequencing&#39;, &#39;conference&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;&amp;&#39;, &#39;FDA&#39;, &#39;Regulations&#39;, &#39;HCA&#39;, &#39;East&#39;, &#39;Cancer&#39;, &#39;Immunotherapies&#39;, &#39;(&#39;, &#39;formerly&#39;, &#39;Cancer&#39;, &#39;Vaccines&#39;, &#39;)&#39;, &#39;Biologics&#39;, &#39;Development&#39;, &#39;A&#39;, &#39;Regulatory&#39;, &#39;Overview&#39;, &#39;Standard&#39;, &#39;Operating&#39;, &#39;Proces&#39;, &#39;in&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;molecular&#39;, &#39;pharmacology&#39;, &#39;RNA&#39;, &#39;Interference&#39;, &#39;Summit&#39;, &#39;Clinical&#39;, &#39;Training&#39;, &#39;oligonucleotides&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Protocols&#39;, &#39;toxicology&#39;, &#39;Immunogenicity&#39;, &#39;Testing&#39;, &#39;for&#39;, &#39;Biologics&#39;, &#39;Adaptive&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;ADME&#39;, &#39;Stem&#39;, &#39;Cells&#39;, &#39;in&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;and&#39;, &#39;Development&#39;, &#39;Drug&#39;, &#39;Pipeline&#39;, &#39;Success&#39;, &#39;(&#39;, &#39;Pipeline&#39;, &#39;Success&#39;, &#39;Summit&#39;, &#39;)&#39;, &#39;stem&#39;, &#39;cells&#39;, &#39;Data&#39;, &#39;Visualization&#39;, &#39;Pharmacokinetics&#39;, &#39;transgenic&#39;, &#39;animal&#39;, &#39;models&#39;, &#39;Business&#39;, &#39;Development&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;Interface&#39;, &#39;Monitoring&#39;, &#39;Clinical&#39;, &#39;Drug&#39;, &#39;Studies&#39;, &#39;:&#39;, &#39;Advanced&#39;, &#39;Digital&#39;, &#39;Health&#39;, &#39;Innovation&#39;, &#39;Summit&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;in&#39;, &#39;the&#39;, &#39;Electronic&#39;, &#39;Data&#39;, &#39;Capture&#39;, &#39;Arena&#39;, &#39;Case&#39;, &#39;Report&#39;, &#39;Forms&#39;, &#39;Battery&#39;, &#39;Safety&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;GCP&#39;, &#39;Overview&#39;, &#39;Clinical&#39;, &#39;Administrative&#39;, &#39;Support&#39;, &#39;Staff&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;&amp;&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;Pre-Implantation&#39;, &#39;Diagnostics&#39;, &#39;Eyesight&#39;, &#39;Biomarker&#39;, &#39;Diagnostics&#39;, &#39;Biomarker&#39;, &#39;Web&#39;, &#39;Symposia&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;Process&#39;, &#39;Neglected&#39;, &#39;Diseases&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Approval&#39;, &#39;Process&#39;, &#39;Code&#39;, &#39;of&#39;, &#39;Federal&#39;, &#39;Regulations&#39;, &#39;for&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Associate&#39;, &#39;G&#39;, &#39;protein&#39;, &#39;coupled&#39;, &#39;receptors&#39;, &#39;GPCRS&#39;, &#39;Prenatal&#39;, &#39;Diagnostics&#39;, &#39;Europe&#39;, &#39;Genomic&#39;, &#39;Tools&#39;, &#39;&amp;&#39;, &#39;Technologies&#39;, &#39;Biomarkers&#39;, &#39;Europe&#39;, &#39;Symyx&#39;, &#39;Business&#39;, &#39;Collaborative&#39;, &#39;Innovation&#39;, &#39;Source&#39;, &#39;Documentation&#39;, &#39;Mitochondria&#39;, &#39;Comparative&#39;, &#39;Genomic&#39;, &#39;Hybridization&#39;, &#39;Lithium&#39;, &#39;Battery&#39;, &#39;Power&#39;, &#39;Writing&#39;, &#39;Clinical&#39;, &#39;Study&#39;, &#39;Protocols&#39;, &#39;Reimbursement&#39;, &#39;Therapeutics&#39;, &#39;genetic&#39;, &#39;variations&#39;, &#39;Business&#39;, &#39;Investigator&#39;, &#39;initiated&#39;, &#39;trials&#39;, &#39;Burrill&#39;, &#39;Book&#39;, &#39;Bio-IT&#39;, &#39;Asia&#39;, &#39;Compound&#39;, &#39;Profiling&#39;, &#39;cancer&#39;, &#39;clinical&#39;, &#39;trials&#39;, &#39;Chemical&#39;, &#39;Genomics&#39;, &#39;Safety/Toxicity&#39;, &#39;Biomarkers&#39;, &#39;Cancer&#39;, &#39;Diagnosis&#39;, &#39;antibody&#39;, &#39;engineering&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;in&#39;, &#39;Asia&#39;, &#39;West&#39;, &#39;Coast&#39;, &#39;Virtual&#39;, &#39;Screening&#39;, &#39;Point&#39;, &#39;of&#39;, &#39;Care&#39;, &#39;Diagnostics&#39;, &#39;Protein&#39;, &#39;Formulation&#39;, &#39;genetic&#39;, &#39;diagnostics&#39;, &#39;Bridging&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;IT&#39;, &#39;Biofuels&#39;, &#39;Translational&#39;, &#39;Medicine&#39;, &#39;Personalized&#39;, &#39;Medicine&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Organization&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;Congress&#39;, &#39;Europe&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;Risk&#39;, &#39;Based&#39;, &#39;Site&#39;, &#39;Monitoring&#39;, &#39;Root&#39;, &#39;Cause&#39;, &#39;Analysis&#39;, &#39;Monitoring&#39;, &#39;Phase&#39;, &#39;I&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;Latin&#39;, &#39;America&#39;, &#39;Licensing&#39;, &#39;vaccines&#39;, &#39;cancer&#39;, &#39;genetics&#39;, &#39;and&#39;, &#39;genomics&#39;, &#39;Marketing&#39;, &#39;Reimbursement&#39;, &#39;Metabolic&#39;, &#39;Analytical&#39;, &#39;Methods&#39;, &#39;Difficult&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;Protein&#39;, &#39;Chips/Arrays&#39;, &#39;Monitoring&#39;, &#39;Plan&#39;, &#39;Development&#39;, &#39;Genome&#39;, &#39;Japan&#39;, &#39;Immunogenicity&#39;, &#39;Advances&#39;, &#39;in&#39;, &#39;Management&#39;, &#39;and&#39;, &#39;Reduction&#39;, &#39;Clinical&#39;, &#39;Auditing&#39;, &#39;Clinical&#39;, &#39;Informatics&#39;, &#39;Antibody-Drug&#39;, &#39;Conjugates&#39;, &#39;Electronic&#39;, &#39;Medical&#39;, &#39;Records&#39;, &#39;&amp;&#39;, &#39;Source&#39;, &#39;Document&#39;, &#39;Verification&#39;, &#39;Bridge&#39;, &#39;to&#39;, &#39;Pop&#39;, &#39;Health&#39;, &#39;East&#39;, &#39;Informed&#39;, &#39;Consent&#39;, &#39;Pharma&#39;, &#39;Future&#39;, &#39;Microarray&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Europe&#39;, &#39;Clinical&#39;, &#39;Investigator&#39;, &#39;Site&#39;, &#39;Inspections&#39;, &#39;Global&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Protocol&#39;, &#39;Deviations&#39;, &#39;Immunotherapy&#39;, &#39;West&#39;, &#39;Cancer&#39;, &#39;Therapies&#39;, &#39;Recognize&#39;, &#39;Attrition&#39;, &#39;Earlier&#39;, &#39;Electronic&#39;, &#39;Data&#39;, &#39;Capture&#39;, &#39;Clinical&#39;, &#39;Imaging&#39;, &#39;Physical&#39;, &#39;Chemistry&#39;, &#39;Toll&#39;, &#39;Like&#39;, &#39;Receptors&#39;, &#39;monoclonal&#39;, &#39;antibodies&#39;, &#39;Innate&#39;, &#39;Immunity&#39;, &#39;High&#39;, &#39;Content&#39;, &#39;Analysis&#39;, &#39;Europe&#39;, &#39;Negotiation&#39;, &#39;Skills&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Professionals&#39;, &#39;Biotech&#39;, &#39;Executive&#39;, &#39;Forum&#39;, &#39;CNP&#39;, &#39;Partnering&#39;, &#39;Europe&#39;, &#39;nanotechnology&#39;, &#39;Risk&#39;, &#39;Management&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;for&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Adverse&#39;, &#39;Event&#39;, &#39;Monitoring&#39;, &#39;for&#39;, &#39;CRAs&#39;, &#39;Vendor&#39;, &#39;Management&#39;, &#39;Report&#39;, &#39;Writing&#39;, &#39;for&#39;, &#39;CRAs&#39;, &#39;Symyx&#39;, &#39;Europe&#39;, &#39;Epigenetics&#39;, &#39;Regulatory&#39;, &#39;Compliance&#39;, &#39;GCP&#39;, &#39;Training&#39;, &#39;for&#39;, &#39;Investigators&#39;, &#39;RECIST&#39;, &#39;1.0&#39;, &#39;and&#39;, &#39;1.1&#39;, &#39;Pharmacovigilance&#39;, &#39;Audit&#39;, &#39;Microfluidics&#39;, &#39;yeast&#39;, &#39;model&#39;, &#39;organism&#39;, &#39;Market&#39;, &#39;Targets&#39;, &#39;&amp;&#39;, &#39;Compounds&#39;, &#39;Critical&#39;, &#39;Decision&#39;, &#39;Points&#39;, &#39;in&#39;, &#39;Design&#39;, &#39;&amp;&#39;, &#39;Conduct&#39;, &#39;of&#39;, &#39;Patient&#39;, &#39;Registries&#39;, &#39;protein&#39;, &#39;production&#39;, &#39;formulation&#39;, &#39;HCA&#39;, &#39;Europe&#39;, &#39;Idiosyncratic&#39;, &#39;Toxicity&#39;, &#39;Protein&#39;, &#39;Informatics&#39;, &#39;Conflict&#39;, &#39;Resolution&#39;, &#39;and&#39;, &#39;Negotiation&#39;, &#39;Regulatory&#39;, &#39;Intelligence&#39;, &#39;Bioresearch&#39;, &#39;Monitoring&#39;, &#39;Cryobiology&#39;, &#39;signal&#39;, &#39;transduction&#39;, &#39;Emerging&#39;, &#39;Companies&#39;, &#39;Corrective&#39;, &#39;Action&#39;, &#39;Plans&#39;, &#39;:&#39;, &#39;Documentation&#39;, &#39;of&#39;, &#39;a&#39;, &#39;Sites&#39;, &#39;Response&#39;, &#39;to&#39;, &#39;GCP&#39;, &#39;Deficiences&#39;, &#39;Developing&#39;, &#39;Clinical&#39;, &#39;Study&#39;, &#39;Budget&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Sequencing&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Fraud&#39;, &#39;in&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Biosimilars&#39;, &#39;Dealmaking&#39;, &#39;for&#39;, &#39;Diagnostics&#39;, &#39;Comprehensive&#39;, &#39;CRC&#39;, &#39;Training&#39;, &#39;Cancer&#39;, &#39;Cell&#39;, &#39;Models&#39;, &#39;Digital&#39;, &#39;Health&#39;, &#39;Patient&#39;, &#39;Registry&#39;, &#39;Programs&#39;, &#39;crop&#39;, &#39;genetics&#39;, &#39;Glossary&#39;, &#39;&amp;&#39;, &#39;Acronyms&#39;, &#39;Reference&#39;, &#39;Biosensors&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;Essential&#39;, &#39;Documentation&#39;, &#39;in&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;at&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;Patient&#39;, &#39;Centered&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Proteins&#39;, &#39;to&#39;, &#39;Profits&#39;, &#39;Europe&#39;, &#39;Drug&#39;, &#39;Metabolism&#39;, &#39;International&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;Regulatory&#39;, &#39;Procedures&#39;, &#39;Principal&#39;, &#39;Investigator&#39;, &#39;Training&#39;, &#39;orthopedic&#39;, &#39;tissue&#39;, &#39;engineering&#39;, &#39;Investigator&#39;, &#39;Sites&#39;, &#39;cardiovascular&#39;, &#39;genomics&#39;, &#39;Study&#39;, &#39;Start&#39;, &#39;Up&#39;, &#39;Protein&#39;, &#39;Folding&#39;, &#39;Population&#39;, &#39;Health&#39;, &#39;Management&#39;, &#39;Tissue&#39;, &#39;Diagnostics&#39;, &#39;GLP&#39;, &#39;Bioanalysis&#39;, &#39;Phase&#39;, &#39;I&#39;, &#39;Study&#39;, &#39;Management&#39;, &#39;Health&#39;, &#39;Autonomous&#39;, &#39;Driving&#39;, &#39;Electronic&#39;, &#39;Source&#39;, &#39;Documentation&#39;, &#39;Tools&#39;, &#39;&amp;&#39;, &#39;Metrics&#39;, &#39;Congress&#39;, &#39;Global&#39;, &#39;GCP&#39;, &#39;Monitoring&#39;, &#39;Investigator&#39;, &#39;Non-Compliance&#39;, &#39;Global&#39;, &#39;GCP&#39;, &#39;Compliance&#39;, &#39;Report&#39;, &#39;Protein&#39;, &#39;&amp;&#39;, &#39;Peptide&#39;, &#39;Arrays&#39;, &#39;Europe&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Things&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;for&#39;, &#39;Pharmaceuticals&#39;, &#39;Introduction&#39;, &#39;to&#39;, &#39;Signal&#39;, &#39;Detection&#39;, &#39;and&#39;, &#39;Data&#39;, &#39;Mining&#39;, &#39;Study&#39;, &#39;Feasibility&#39;, &#39;Clinical&#39;, &#39;Investigation&#39;, &#39;Monitoring&#39;, &#39;Proteomics&#39;, &#39;Europe&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;in&#39;, &#39;Developing&#39;, &#39;Regions&#39;, &#39;Pediatric&#39;, &#39;drug&#39;, &#39;development&#39;, &#39;Sponsor&#39;, &#39;Monitoring&#39;, &#39;Inspections&#39;, &#39;Maximize&#39;, &#39;Value&#39;, &#39;of&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;protein&#39;, &#39;structures&#39;, &#39;cancer&#39;, &#39;Microbial&#39;, &#39;Genomics&#39;, &#39;Translational&#39;, &#39;Cancer&#39;, &#39;Medicine&#39;, &#39;Medical&#39;, &#39;Terminalogy&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Professionals&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Writing&#39;, &#39;and&#39;, &#39;Updating&#39;, &#39;the&#39;, &#39;Investigators&#39;, &#39;Brochure&#39;, &#39;Sunshine&#39;, &#39;Act&#39;, &#39;Sequencing&#39;, &#39;for&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;Standard&#39;, &#39;Operating&#39;, &#39;Procedures&#39;, &#39;Meeting&#39;, &#39;International&#39;, &#39;Safety&#39;, &#39;Reporting&#39;, &#39;Requirements&#39;, &#39;Faciliation&#39;, &#39;Skills&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Professionals&#39;, &#39;bioprocessing&#39;, &#39;biologicals&#39;, &#39;safety&#39;, &#39;Regulatory&#39;, &#39;Intelligence&#39;, &#39;101&#39;, &#39;Recent&#39;, &#39;Trends&#39;, &#39;in&#39;, &#39;Noncompliance&#39;, &#39;Briefings&#39;, &#39;on&#39;, &#39;Drug&#39;, &#39;Safety&#39;, &#39;Clinical&#39;, &#39;research&#39;, &#39;project&#39;, &#39;mamangement&#39;, &#39;essentials&#39;, &#39;CRA&#39;, &#39;Survival&#39;, &#39;Kit&#39;, &#39;Essential&#39;, &#39;Documentation&#39;, &#39;Extracellular&#39;, &#39;RNA&#39;, &#39;Successful&#39;, &#39;Study&#39;, &#39;Site&#39;, &#39;Start-up&#39;, &#39;Cell&#39;, &#39;Based&#39;, &#39;Therapies&#39;, &#39;Web-Based&#39;, &#39;Training&#39;, &#39;Strategies&#39;, &#39;data&#39;, &#39;mining&#39;, &#39;GLP&#39;, &#39;Bioanalysis&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Finance&#39;, &#39;&amp;&#39;, &#39;Management&#39;, &#39;regulatory&#39;, &#39;Site&#39;, &#39;Relationship/Performance&#39;, &#39;Management&#39;, &#39;Introduction&#39;, &#39;to&#39;, &#39;FDA&#39;, &#39;Regulatory&#39;, &#39;Reporter&#39;, &#39;Newsletter&#39;, &#39;multiple&#39;, &#39;sclerosis&#39;, &#39;Data&#39;, &#39;Integration&#39;, &#39;Managing&#39;, &#39;CRAs&#39;, &#39;to&#39;, &#39;Improve&#39;, &#39;Performance&#39;, &#39;&amp;&#39;, &#39;Study&#39;, &#39;Outcomes&#39;, &#39;compounds&#39;, &#39;Predictive&#39;, &#39;Toxicity&#39;, &#39;Surviving&#39;, &#39;FDA&#39;, &#39;Site&#39;, &#39;Inspections&#39;, &#39;:&#39;, &#39;Best&#39;, &#39;Practices&#39;, &#39;for&#39;, &#39;Site&#39;, &#39;Personnel&#39;, &#39;Phase&#39;, &#39;III&#39;, &#39;(&#39;, &#39;3&#39;, &#39;)&#39;, &#39;/forecasting&#39;, &#39;clinical&#39;, &#39;outcomes&#39;, &#39;Comparing&#39;, &#39;FDA&#39;, &#39;and&#39;, &#39;Health&#39;, &#39;Canada&#39;, &#39;Regulations&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Professionals&#39;, &#39;Recombinant&#39;, &#39;Therapeutics&#39;, &#39;Tick&#39;, &#39;Borne&#39;, &#39;Diseases&#39;, &#39;Writing&#39;, &#39;and&#39;, &#39;Maintaining&#39;, &#39;the&#39;, &#39;EU&#39;, &#39;CTA&#39;, &#39;Orphan&#39;, &#39;Drugs&#39;, &#39;Investigator&#39;, &#39;Initiated&#39;, &#39;Trials&#39;, &#39;Orthopaedic&#39;, &#39;Animal&#39;, &#39;Models&#39;, &#39;Auditing&#39;, &#39;Sponsors&#39;, &#39;and&#39;, &#39;CROs&#39;, &#39;Valuing&#39;, &#39;&amp;&#39;, &#39;Pricing&#39;, &#39;Licensing&#39;, &#39;Deals&#39;, &#39;drug&#39;, &#39;delivery&#39;, &#39;Vendor&#39;, &#39;Management&#39;, &#39;for&#39;, &#39;the&#39;, &#39;Clinical&#39;, &#39;Data&#39;, &#39;Manager&#39;, &#39;Data&#39;, &#39;Quality&#39;, &#39;Patient&#39;, &#39;Engagement&#39;, &#39;FDA&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;Process&#39;, &#39;HIPAA&#39;, &#39;No&#39;, &#39;1&#39;, &#39;Team&#39;, &#39;Training&#39;, &#39;HIPAA&#39;, &#39;&amp;&#39;, &#39;Human&#39;, &#39;Subjects&#39;, &#39;Research&#39;, &#39;Q&#39;, &#39;&amp;&#39;, &#39;A&#39;, &#39;Ubiquitin&#39;, &#39;Europe&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Data&#39;, &#39;Monitoring&#39;, &#39;Investigational&#39;, &#39;Product&#39;, &#39;Accountability&#39;, &#39;Training&#39;, &#39;for&#39;, &#39;Research&#39;, &#39;Site&#39;, &#39;Personnel&#39;, &#39;Adverse&#39;, &#39;Event&#39;, &#39;Reporting&#39;, &#39;to&#39;, &#39;IRBs&#39;, &#39;Subject&#39;, &#39;Recruitment&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;Antibodies&#39;, &#39;in&#39;, &#39;Cancer&#39;, &#39;Cost&#39;, &#39;Management&#39;, &#39;for&#39;, &#39;Global&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Portfolio&#39;, &#39;Management&#39;, &#39;Warning&#39;, &#39;Letters&#39;, &#39;Combination&#39;, &#39;Products&#39;, &#39;Observational&#39;, &#39;Studies&#39;, &#39;Molecular&#39;, &#39;Medicine&#39;, &#39;Asia&#39;, &#39;CNS&#39;, &#39;Central&#39;, &#39;nervous&#39;, &#39;system&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;Development&#39;, &#39;Collaboration&#39;, &#39;Cross&#39;, &#39;functional&#39;, &#39;global&#39;, &#39;teams&#39;, &#39;Site&#39;, &#39;Relationship&#39;, &#39;Management&#39;, &#39;peptides&#39;, &#39;Investigator&#39;, &#39;Oversight&#39;, &#39;Writing&#39;, &#39;SOPs&#39;, &#39;pain&#39;, &#39;web&#39;, &#39;2.0&#39;, &#39;Understanding&#39;, &#39;FDAs&#39;, &#39;new&#39;, &#39;Draft&#39;, &#39;Guidance&#39;, &#39;Regarding&#39;, &#39;Supervisory&#39;, &#39;Repons&#39;, &#39;Sponsors/CROs&#39;, &#39;Preparing&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;for&#39;, &#39;FDA&#39;, &#39;Inspections&#39;, &#39;eHealth&#39;, &#39;Technologies&#39;, &#39;Introduction&#39;, &#39;to&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;FDA&#39;, &#39;Proposed&#39;, &#39;rule&#39;, &#39;2010&#39;, &#39;Teambuilding&#39;, &#39;for&#39;, &#39;the&#39;, &#39;Cross&#39;, &#39;Functional&#39;, &#39;Global&#39;, &#39;Team&#39;, &#39;Genomic&#39;, &#39;Business&#39;, &#39;Strategies&#39;, &#39;Product&#39;, &#39;Life&#39;, &#39;Cycle&#39;, &#39;RNA&#39;, &#39;Interference&#39;, &#39;Pharmacovigilance&#39;, &#39;Signal&#39;, &#39;Detection&#39;, &#39;Foreign&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Biotech&#39;, &#39;Business&#39;, &#39;Development&#39;, &#39;genomics&#39;, &#39;Portfolio&#39;, &#39;Management&#39;, &#39;Venue&#39;, &#39;II&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Design&#39;, &#39;for&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Informed&#39;, &#39;Consent&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Study&#39;, &#39;Wheel&#39;, &#39;Biomarker&#39;, &#39;Data&#39;, &#39;Center&#39;, &#39;Antibody&#39;, &#39;Optimization&#39;, &#39;&amp;&#39;, &#39;Characterization&#39;, &#39;Biologics&#39;, &#39;Chronic&#39;, &#39;Pain&#39;, &#39;cardiovascular&#39;, &#39;Risk&#39;, &#39;based&#39;, &#39;decisions&#39;, &#39;for&#39;, &#39;clinical&#39;, &#39;site&#39;, &#39;management&#39;, &#39;Human&#39;, &#39;Participant&#39;, &#39;Protection&#39;, &#39;Training&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Professionals&#39;, &#39;CRC&#39;, &#39;Role/Responsibilities&#39;, &#39;Training&#39;, &#39;Womens&#39;, &#39;Health&#39;, &#39;Current&#39;, &#39;Developments&#39;, &#39;in&#39;, &#39;the&#39;, &#39;Role&#39;, &#39;of&#39;, &#39;IRBs&#39;, &#39;in&#39;, &#39;the&#39;, &#39;Conduct&#39;, &#39;of&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Regulatory&#39;, &#39;Compliance&#39;, &#39;for&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;infections&#39;, &#39;Diabetes&#39;, &#39;cancer&#39;, &#39;partnering&#39;, &#39;Preparing&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;510K&#39;, &#39;Submissions&#39;, &#39;Monitoring&#39;, &#39;Informed&#39;, &#39;Consent&#39;, &#39;Business&#39;, &#39;of&#39;, &#39;Biobanking&#39;, &#39;Global&#39;, &#39;Site&#39;, &#39;Selection&#39;, &#39;Boston&#39;, &#39;Biomarkers&#39;, &#39;of&#39;, &#39;Drug&#39;, &#39;Efficacy&#39;, &#39;and&#39;, &#39;Safety&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;in&#39;, &#39;the&#39;, &#39;European&#39;, &#39;Union&#39;, &#39;Protein&#39;, &#39;Therapeutics&#39;, &#39;Quality&#39;, &#39;Improvement&#39;, &#39;Strategies&#39;, &#39;at&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;diagnostics&#39;, &#39;bioprocessing&#39;, &#39;viral&#39;, &#39;hepatitis&#39;, &#39;infections&#39;, &#39;Advanced&#39;, &#39;HIPAA&#39;, &#39;Clinical&#39;, &#39;Sequencing&#39;, &#39;IRB&#39;, &#39;Guidance&#39;, &#39;regenerative&#39;, &#39;healing&#39;, &#39;cell&#39;, &#39;culture&#39;, &#39;Coronavirus&#39;, &#39;Liver&#39;, &#39;Disorders&#39;, &#39;Big&#39;, &#39;pharma&#39;, &#39;Big&#39;, &#39;Data&#39;, &#39;HIPAA&#39;, &#39;Electronic&#39;, &#39;Medical&#39;, &#39;Records&#39;, &#39;blood&#39;, &#39;Pharmaceutical&#39;, &#39;Strategy&#39;, &#39;Series&#39;, &#39;Strategies&#39;, &#39;for&#39;, &#39;Accelearted&#39;, &#39;Nonclinical&#39;, &#39;Toxiciology&#39;, &#39;&amp;&#39;, &#39;Safety&#39;, &#39;Assessment&#39;, &#39;of&#39;, &#39;Biologics&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;in&#39;, &#39;Japan&#39;, &#39;Artificial&#39;, &#39;Intelligence&#39;, &#39;Excel&#39;, &#39;Spreadsheets-Step&#39;, &#39;by&#39;, &#39;Step&#39;, &#39;Instructions&#39;, &#39;for&#39;, &#39;Compliance&#39;, &#39;Chemistry&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Statistical&#39;, &#39;Sourcebook&#39;, &#39;Upgrade&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Tracking&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Directive&#39;, &#39;Facilitation&#39;, &#39;Skills&#39;, &#39;Autoimmune&#39;, &#39;anticoagulants&#39;, &#39;bone&#39;, &#39;Clinical&#39;, &#39;Antibodies&#39;, &#39;gene&#39;, &#39;therapy&#39;, &#39;Newborn&#39;, &#39;Diagnostics&#39;, &#39;Real&#39;, &#39;World&#39;, &#39;Monitoring&#39;, &#39;Allergies&#39;, &#39;Performance&#39;, &#39;Improvement&#39;, &#39;Monitoring&#39;, &#39;Model&#39;, &#39;Institutional&#39;, &#39;Review&#39;, &#39;Board&#39;, &#39;Health&#39;, &#39;Outcomes&#39;, &#39;Outsourcing&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Microbiome&#39;, &#39;Key&#39;, &#39;Opinion&#39;, &#39;Leaders&#39;, &#39;Chronic&#39;, &#39;Obstructive&#39;, &#39;Pulmonary&#39;, &#39;Disorder&#39;, &#39;Quality&#39;, &#39;by&#39;, &#39;Design&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;&amp;&#39;, &#39;Translational&#39;, &#39;Medicine&#39;, &#39;Series&#39;, &#39;Lupus&#39;, &#39;Multi&#39;, &#39;Drug&#39;, &#39;Resistance&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Coordinator&#39;, &#39;Tool&#39;, &#39;Kit&#39;, &#39;CRC&#39;, &#39;&amp;&#39;, &#39;PI&#39;, &#39;Current&#39;, &#39;Practice&#39;, &#39;Update&#39;, &#39;CRA&#39;, &#39;Facilitator&#39;, &#39;Training&#39;, &#39;21&#39;, &#39;CFR&#39;, &#39;Part&#39;, &#39;11&#39;, &#39;Compliance&#39;, &#39;for&#39;, &#39;Electronic&#39;, &#39;Records&#39;, &#39;&amp;&#39;, &#39;Signatures&#39;, &#39;Cancer&#39;, &#39;Diagnostics&#39;, &#39;Electronic&#39;, &#39;Health&#39;, &#39;Record&#39;, &#39;Chiral&#39;, &#39;Intro&#39;, &#39;to&#39;, &#39;Combination&#39;, &#39;Products&#39;, &#39;Gastrointestinal&#39;, &#39;Disorders&#39;, &#39;Presentation&#39;, &#39;skills&#39;, &#39;for&#39;, &#39;clinical&#39;, &#39;research&#39;, &#39;professionals&#39;, &#39;inflammation&#39;, &#39;Operational&#39;, &#39;Modeling&#39;, &#39;and&#39;, &#39;Simulation&#39;, &#39;in&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Pharmaceutical&#39;, &#39;&amp;&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Industries&#39;, &#39;Facilitation&#39;, &#39;Skills&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Team&#39;, &#39;Members&#39;, &#39;Diagnostics&#39;, &#39;Partnering&#39;, &#39;Mobile&#39;, &#39;Health&#39;, &#39;Wearables&#39;, &#39;Pharmaceutical&#39;, &#39;Discovery&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Medical&#39;, &#39;device&#39;, &#39;reporting&#39;, &#39;Ubiquitin&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Postmarketing&#39;, &#39;Vigilance&#39;, &#39;Blockchain&#39;, &#39;Alzheimers&#39;, &#39;high&#39;, &#39;performance&#39;, &#39;computing&#39;, &#39;Innovative&#39;, &#39;Preclinical&#39;, &#39;&amp;&#39;, &#39;Clinical&#39;, &#39;Strategies&#39;, &#39;GXP&#39;, &#39;Good&#39;, &#39;Practice&#39;, &#39;Guides&#39;, &#39;Writing&#39;, &#39;and&#39;, &#39;Maintaining&#39;, &#39;Canadian&#39;, &#39;CTA&#39;, &#39;3D&#39;, &#39;Printing&#39;, &#39;Key&#39;, &#39;Information&#39;, &#39;Gatherers&#39;, &#39;Respiratory&#39;, &#39;Five&#39;, &#39;Keys&#39;, &#39;to&#39;, &#39;COTS&#39;, &#39;Computer&#39;, &#39;System&#39;, &#39;Validation&#39;, &#39;Next-Generation&#39;, &#39;Sequencing&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Open&#39;, &#39;Source&#39;, &#39;Fibrosis/Scarring&#39;, &#39;Biomarker&#39;, &#39;Bridge&#39;, &#39;Genomics&#39;, &#39;101&#39;, &#39;Dummy&#39;, &#39;Keyword&#39;, &#39;for&#39;, &#39;DE&#39;, &#39;lists&#39;, &#39;w/more&#39;, &#39;than&#39;, &#39;1&#39;, &#39;keyword&#39;, &#39;or&#39;, &#39;with&#39;, &#39;no&#39;, &#39;keywords&#39;, &#39;FDA&#39;, &#39;Form&#39;, &#39;1572&#39;, &#39;Antisense&#39;, &#39;Accountable&#39;, &#39;Care&#39;, &#39;Orgnization&#39;, &#39;ACE&#39;, &#39;inhibitors&#39;, &#39;AI&#39;, &#39;Chips&#39;, &#39;Antibody-Drug&#39;, &#39;Conjugates&#39;, &#39;for&#39;, &#39;PEGS&#39;, &#39;Antibody&#39;, &#39;Drug&#39;, &#39;Conjugate&#39;, &#39;Bioprocess&#39;, &#39;Attention&#39;, &#39;Deficit&#39;, &#39;Hyperactivity&#39;, &#39;Disorder&#39;, &#39;Adjuvants&#39;, &#39;ADMET&#39;, &#39;(&#39;, &#39;ADME&#39;, &#39;&amp;&#39;, &#39;Toxicology&#39;, &#39;)&#39;, &#39;adverse&#39;, &#39;drug&#39;, &#39;reactions&#39;, &#39;Aerospace&#39;, &#39;Advanced&#39;, &#39;Energy&#39;, &#39;Technology&#39;, &#39;Congress&#39;, &#39;Affordable&#39;, &#39;Care&#39;, &#39;affinity&#39;, &#39;technologies&#39;, &#39;Affinity&#39;, &#39;Separation&#39;, &#39;Antibody&#39;, &#39;Fragments&#39;, &#39;Agriculture&#39;, &#39;chemistry&#39;, &#39;Aging&#39;, &#39;Antibody&#39;, &#39;Drug&#39;, &#39;Targets&#39;, &#39;Digital&#39;, &#39;Farming&#39;, &#39;angiogenesis&#39;, &#39;AI&#39;, &#39;Business&#39;, &#39;Intelligence&#39;, &#39;Artificial&#39;, &#39;Intelligence&#39;, &#39;Bioprocessing&#39;, &#39;AI&#39;, &#39;in&#39;, &#39;Customer&#39;, &#39;Analytics&#39;, &#39;Intelligent&#39;, &#39;Assistants&#39;, &#39;and&#39;, &#39;Bots&#39;, &#39;AI&#39;, &#39;in&#39;, &#39;Cancer&#39;, &#39;Enterprise&#39;, &#39;AI&#39;, &#39;Case&#39;, &#39;Studies&#39;, &#39;AI&#39;, &#39;Executive&#39;, &#39;Summit&#39;, &#39;Machine&#39;, &#39;Learning&#39;, &#39;Artificial&#39;, &#39;Intelligence&#39;, &#39;Clinical&#39;, &#39;&amp;&#39;, &#39;Post&#39;, &#39;Approval&#39;, &#39;Artificial&#39;, &#39;Intelligence&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;Preclinical&#39;, &#39;Implementing&#39;, &#39;Enterprise&#39;, &#39;AI&#39;, &#39;AI&#39;, &#39;Ethics&#39;, &#39;Future&#39;, &#39;of&#39;, &#39;AI&#39;, &#39;Cutting&#39;, &#39;Edge&#39;, &#39;Research&#39;, &#39;for&#39;, &#39;AI&#39;, &#39;General&#39;, &#39;AI&#39;, &#39;Business&#39;, &#39;Applications&#39;, &#39;AI&#39;, &#39;for&#39;, &#39;Strategic&#39;, &#39;Government&#39;, &#39;Functions&#39;, &#39;Cognitive&#39;, &#39;Computing&#39;, &#39;AI&#39;, &#39;Partnering&#39;, &#39;AI&#39;, &#39;in&#39;, &#39;Personalized&#39;, &#39;Medicine&#39;, &#39;Allosteric&#39;, &#39;Modulators&#39;, &#39;Amyotrophic&#39;, &#39;lateral&#39;, &#39;sclerosis&#39;, &#39;Animal&#39;, &#39;Models&#39;, &#39;of&#39;, &#39;Cancer&#39;, &#39;Alternative&#39;, &#39;Medicine&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;Execution&#39;, &#39;Asset&#39;, &#39;Management&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;Negotiation&#39;, &#39;Animal&#39;, &#39;Models&#39;, &#39;of&#39;, &#39;Pain&#39;, &#39;Animal&#39;, &#39;Models&#39;, &#39;of&#39;, &#39;Toxicity&#39;, &#39;angina&#39;, &#39;Anxiety&#39;, &#39;cancer&#39;, &#39;and&#39;, &#39;apoptosis&#39;, &#39;Active&#39;, &#39;Pharmaceutical&#39;, &#39;Ingredients&#39;, &#39;Analytical&#39;, &#39;Purification&#39;, &#39;Apoptosis&#39;, &#39;Anti&#39;, &#39;Psychotics&#39;, &#39;Alliances&#39;, &#39;Rx&#39;, &#39;Devices&#39;, &#39;arrhythmias&#39;, &#39;Assays&#39;, &#39;for&#39;, &#39;Antibodies&#39;, &#39;Assays&#39;, &#39;Affinity&#39;, &#39;Assays&#39;, &#39;and&#39;, &#39;Allosteric&#39;, &#39;Antagonism&#39;, &#39;Immunogenicity&#39;, &#39;Assay&#39;, &#39;Development&#39;, &#39;Assays&#39;, &#39;Primary&#39;, &#39;Cells&#39;, &#39;Quantifying&#39;, &#39;Receptor&#39;, &#39;Activation&#39;, &#39;and&#39;, &#39;Agonism&#39;, &#39;asthma&#39;, &#39;Assays&#39;, &#39;atherosclerosis&#39;, &#39;Automotive&#39;, &#39;Automotive&#39;, &#39;Partnering&#39;, &#39;Autophagy&#39;, &#39;Autism&#39;, &#39;Advisory&#39;, &#39;Boards&#39;, &#39;Bacterial&#39;, &#39;Infections&#39;, &#39;Consumer&#39;, &#39;Electronic&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Defense&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Battery&#39;, &#39;Data&#39;, &#39;Science&#39;, &#39;Flexible&#39;, &#39;Battery&#39;, &#39;Power&#39;, &#39;Industrial&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Stationary&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Automotive&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Bayesian&#39;, &#39;Statistics&#39;, &#39;Asia&#39;, &#39;US&#39;, &#39;Biotech&#39;, &#39;Alliances&#39;, &#39;Blood&#39;, &#39;Brain&#39;, &#39;Barrier&#39;, &#39;Computational&#39;, &#39;Biology&#39;, &#39;for&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;BioIT&#39;, &#39;Best&#39;, &#39;Practices&#39;, &#39;Battery&#39;, &#39;Charging&#39;, &#39;Cheminformatics&#39;, &#39;for&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;Biomarker&#39;, &#39;Clinical&#39;, &#39;Applications&#39;, &#39;Preclinical&#39;, &#39;Biologic&#39;, &#39;Development&#39;, &#39;Breast&#39;, &#39;Cancer&#39;, &#39;Backup&#39;, &#39;Compounds&#39;, &#39;biological&#39;, &#39;cancer&#39;, &#39;treatments&#39;, &#39;Biomarker&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Biological&#39;, &#39;Database&#39;, &#39;Discovery&#39;, &#39;Informatics&#39;, &#39;for&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;Delivery&#39;, &#39;of&#39;, &#39;Biologics&#39;, &#39;Regulatory&#39;, &#39;Business&#39;, &#39;Diagnostics&#39;, &#39;biodiversity&#39;, &#39;screening&#39;, &#39;E&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Battery&#39;, &#39;Energy&#39;, &#39;Storage&#39;, &#39;Biofuels&#39;, &#39;Alliance&#39;, &#39;Biobank&#39;, &#39;Informatics&#39;, &#39;Flow&#39;, &#39;Cell&#39;, &#39;Technologies&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;for&#39;, &#39;Data&#39;, &#39;Science&#39;, &#39;Biogenerics&#39;, &#39;Business&#39;, &#39;of&#39;, &#39;Genomics&#39;, &#39;biomaterials&#39;, &#39;Bioinformatics&#39;, &#39;for&#39;, &#39;Cancer&#39;, &#39;BIO&#39;, &#39;IT&#39;, &#39;World&#39;, &#39;Battery&#39;, &#39;Intellectual&#39;, &#39;Property&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;World&#39;, &#39;Web&#39;, &#39;Resource&#39;, &#39;Alert&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;World&#39;, &#39;Monthly&#39;, &#39;magazine&#39;, &#39;IT&#39;, &#39;&amp;&#39;, &#39;Informatics&#39;, &#39;Series&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;World&#39;, &#39;Weekly&#39;, &#39;Update&#39;, &#39;Bookstore&#39;, &#39;Biomarker&#39;, &#39;Development&#39;, &#39;Advanced&#39;, &#39;Lead&#39;, &#39;Acid&#39;, &#39;Technology&#39;, &#39;Manufacturing&#39;, &#39;&amp;&#39;, &#39;Process&#39;, &#39;Economics&#39;, &#39;Biopharm&#39;, &#39;Executive&#39;, &#39;Summit&#39;, &#39;Biolaw&#39;, &#39;Biomarker&#39;, &#39;&amp;&#39;, &#39;Diagnostics&#39;, &#39;Series&#39;, &#39;High-Througput&#39;, &#39;Screen-Based&#39;, &#39;Biomarker&#39;, &#39;Discovery&#39;, &#39;Battery&#39;, &#39;Manufacturers&#39;, &#39;Battery&#39;, &#39;Manufacturing&#39;, &#39;Battery&#39;, &#39;Management&#39;, &#39;Battery&#39;, &#39;Manufacturing&#39;, &#39;Machinery&#39;, &#39;Battery&#39;, &#39;Market&#39;, &#39;Battery&#39;, &#39;Machine&#39;, &#39;Learning&#39;, &#39;Biomarker&#39;, &#39;Executive&#39;, &#39;Think&#39;, &#39;Tank&#39;, &#39;Battery&#39;, &#39;Materials&#39;, &#39;,&#39;, &#39;Recycling&#39;, &#39;Biomarker&#39;, &#39;Reverse&#39;, &#39;Phase&#39;, &#39;Assays&#39;, &#39;Battery&#39;, &#39;Materials&#39;, &#39;,&#39;, &#39;Solid&#39;, &#39;State&#39;, &#39;bone&#39;, &#39;marrow&#39;, &#39;transplants&#39;, &#39;Biomarker&#39;, &#39;Translational&#39;, &#39;Biomarker&#39;, &#39;Validation&#39;, &#39;Bioinformatics&#39;, &#39;Asia&#39;, &#39;Bioinformatics&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;for&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;Logistics&#39;, &#39;and&#39;, &#39;Sample&#39;, &#39;of&#39;, &#39;Biobanking&#39;, &#39;Bioinformatics&#39;, &#39;in&#39;, &#39;the&#39;, &#39;Genome&#39;, &#39;Era&#39;, &#39;Bioprocess&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Host&#39;, &#39;Cell&#39;, &#39;Protein&#39;, &#39;Assays&#39;, &#39;Bioproduction&#39;, &#39;Continuous&#39;, &#39;Processing&#39;, &#39;biopurification&#39;, &#39;Biological&#39;, &#39;Pharmacokinetics&#39;, &#39;Bioprocessing&#39;, &#39;Quality&#39;, &#39;Bioprocess&#39;, &#39;&amp;&#39;, &#39;Manufacturing&#39;, &#39;Series&#39;, &#39;Bioprocess&#39;, &#39;Validation&#39;, &#39;Bioreactor&#39;, &#39;Design&#39;, &#39;and&#39;, &#39;Engineering&#39;, &#39;Battery&#39;, &#39;Regulatory&#39;, &#39;Battery&#39;, &#39;Raw&#39;, &#39;Materials&#39;, &#39;Brain&#39;, &#39;Cancer&#39;, &#39;Battery&#39;, &#39;Repurposing&#39;, &#39;Biological&#39;, &#39;Therapeutics&#39;, &#39;(&#39;, &#39;biotherapeutics&#39;, &#39;)&#39;, &#39;Bispecific&#39;, &#39;Antibodies&#39;, &#39;for&#39;, &#39;Immunotherapy&#39;, &#39;Bispecifics&#39;, &#39;for&#39;, &#39;Cancer&#39;, &#39;Business&#39;, &#39;Strategies&#39;, &#39;for&#39;, &#39;Library&#39;, &#39;Diversity&#39;, &#39;blood&#39;, &#39;safety&#39;, &#39;Europe&#39;, &#39;Battery&#39;, &#39;Shipping&#39;, &#39;Battery&#39;, &#39;Simulation&#39;, &#39;Biosensors&#39;, &#39;bioseparation&#39;, &#39;Biostabilization&#39;, &#39;of&#39;, &#39;Biospecimens&#39;, &#39;Biomanufacturing&#39;, &#39;Single&#39;, &#39;Use&#39;, &#39;Technologies&#39;, &#39;Bioassays&#39;, &#39;Battery&#39;, &#39;Commercialization&#39;, &#39;Flow&#39;, &#39;Batteries&#39;, &#39;Battery&#39;, &#39;Materials&#39;, &#39;Sci/Tech&#39;, &#39;for&#39;, &#39;Pharma&#39;, &#39;&amp;&#39;, &#39;Biotech&#39;, &#39;Battery&#39;, &#39;Safety&#39;, &#39;Biotech&#39;, &#39;tools&#39;, &#39;Biotech&#39;, &#39;Venture&#39;, &#39;Forum&#39;, &#39;Biomarkers&#39;, &#39;for&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Biomarkers&#39;, &#39;for&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;for&#39;, &#39;Cancer&#39;, &#39;Immunotherapy&#39;, &#39;Artifical&#39;, &#39;Intelligence&#39;, &#39;in&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;cell&#39;, &#39;adhesion&#39;, &#39;molecules&#39;, &#39;regulatory&#39;, &#39;CANDA&#39;, &#39;Computer&#39;, &#39;Assisted&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Application&#39;, &#39;Chimeric&#39;, &#39;Antigen&#39;, &#39;Receptor&#39;, &#39;Chimeric&#39;, &#39;Antigen&#39;, &#39;Receptor&#39;, &#39;Case&#39;, &#39;Studies&#39;, &#39;catalysis&#39;, &#39;Cell&#39;, &#39;Based&#39;, &#39;Assays&#39;, &#39;Cell&#39;, &#39;Therapy&#39;, &#39;CMC&#39;, &#39;Cancer&#39;, &#39;Biomarker&#39;, &#39;Cell&#39;, &#39;Therapy&#39;, &#39;Production&#39;, &#39;Cord&#39;, &#39;Blood&#39;, &#39;Stem&#39;, &#39;Cells&#39;, &#39;Cell&#39;, &#39;Based&#39;, &#39;Therapies&#39;, &#39;Circulating&#39;, &#39;Tumor&#39;, &#39;Cells&#39;, &#39;Cold&#39;, &#39;Chain&#39;, &#39;Colorectal&#39;, &#39;Cancer&#39;, &#39;cell&#39;, &#39;cycle&#39;, &#39;Collaborations&#39;, &#39;Deals&#39;, &#39;and&#39;, &#39;Alliances&#39;, &#39;Chemical&#39;, &#39;Database&#39;, &#39;Co-Development&#39;, &#39;of&#39;, &#39;Diagnostics&#39;, &#39;and&#39;, &#39;Drugs&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;Europe&#39;, &#39;Case&#39;, &#39;Histories&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Consumer&#39;, &#39;Electronics&#39;, &#39;Cell&#39;, &#39;Biology&#39;, &#39;Clean&#39;, &#39;Tech&#39;, &#39;Solar&#39;, &#39;Wind&#39;, &#39;Comparative&#39;, &#39;Effectiveness&#39;, &#39;Research&#39;, &#39;Ethical&#39;, &#39;Considerations&#39;, &#39;in&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Continuing&#39;, &#39;Education&#39;, &#39;Units&#39;, &#39;Circulating&#39;, &#39;Cell-Free&#39;, &#39;DNA&#39;, &#39;Europe&#39;, &#39;Agriculture&#39;, &#39;crop&#39;, &#39;genetics&#39;, &#39;Europe&#39;, &#39;Cancer&#39;, &#39;Genomics&#39;, &#39;Europe&#39;, &#39;congestive&#39;, &#39;heart&#39;, &#39;failure&#39;, &#39;Chemistry&#39;, &#39;Series&#39;, &#39;Chinese&#39;, &#39;Hamster&#39;, &#39;Ovaries&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Conflicts&#39;, &#39;of&#39;, &#39;Interest&#39;, &#39;cheminformatics&#39;, &#39;competitive&#39;, &#39;intelligence&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;Asia&#39;, &#39;Integrating&#39;, &#39;Clinical&#39;, &#39;Lab&#39;, &#39;Services&#39;, &#39;in&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Clinical&#39;, &#39;Biospecimens&#39;, &#39;and&#39;, &#39;Central&#39;, &#39;Lab&#39;, &#39;Solutions&#39;, &#39;Clinical&#39;, &#39;Biospecimens&#39;, &#39;and&#39;, &#39;Central&#39;, &#39;Lab&#39;, &#39;Solutions&#39;, &#39;Celiac&#39;, &#39;Disease&#39;, &#39;Cloud&#39;, &#39;Extension&#39;, &#39;Clinical&#39;, &#39;Genomics&#39;, &#39;Europe&#39;, &#39;cellular&#39;, &#39;all&#39;, &#39;Conducting&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;in&#39;, &#39;Asia&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;Resource&#39;, &#39;Management&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;Security&#39;, &#39;Risks&#39;, &#39;Software&#39;, &#39;Development&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Genomics&#39;, &#39;Clinical&#39;, &#39;Vaccines&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;West&#39;, &#39;Comparability&#39;, &#39;Chemistry&#39;, &#39;Manufacturing&#39;, &#39;and&#39;, &#39;Controls&#39;, &#39;Continuing&#39;, &#39;Medical&#39;, &#39;Education&#39;, &#39;Communications&#39;, &#39;Contract&#39;, &#39;Manufacturing&#39;, &#39;Cancer&#39;, &#39;Microarray&#39;, &#39;Application&#39;, &#39;CNS&#39;, &#39;Biomarkers&#39;, &#39;Miscellaneous&#39;, &#39;CHI&#39;, &#39;conference&#39;, &#39;CNS&#39;, &#39;genetics/genomics&#39;, &#39;CNS&#39;, &#39;Disease&#39;, &#39;Models&#39;, &#39;Counterfeit&#39;, &#39;Drugs&#39;, &#39;Copy&#39;, &#39;Number&#39;, &#39;Variation&#39;, &#39;Cognitive&#39;, &#39;Disorders&#39;, &#39;Battery&#39;, &#39;Components&#39;, &#39;capillary&#39;, &#39;electrophoresis&#39;, &#39;Cancer&#39;, &#39;Prognostic&#39;, &#39;Markers&#39;, &#39;Clinical&#39;, &#39;Pharmacology&#39;, &#39;Clinical&#39;, &#39;Proteomics&#39;, &#39;Clinical&#39;, &#39;Plasma&#39;, &#39;Profiling&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Platform&#39;, &#39;Software&#39;, &#39;Computer&#39;, &#39;Vision&#39;, &#39;cancer&#39;, &#39;prevention&#39;, &#39;CRA&#39;, &#39;8&#39;, &#39;Weeks&#39;, &#39;Fundamental&#39;, &#39;Training&#39;, &#39;Cost&#39;, &#39;Reduction&#39;, &#39;w/o&#39;, &#39;Increasing&#39;, &#39;Regulatory&#39;, &#39;or&#39;, &#39;Business&#39;, &#39;Risk&#39;, &#39;Advanced&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Coordinator&#39;, &#39;Critical&#39;, &#39;Care&#39;, &#39;Diagnostics&#39;, &#39;Interviewing&#39;, &#39;Skills&#39;, &#39;for&#39;, &#39;CRAs&#39;, &#39;and&#39;, &#39;CRCs&#39;, &#39;Customer&#39;, &#39;Relationship&#39;, &#39;Management&#39;, &#39;CRA&#39;, &#39;Monitoring&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Training&#39;, &#39;Week&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Training&#39;, &#39;Week&#39;, &#39;East&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Training&#39;, &#39;Week&#39;, &#39;West&#39;, &#39;Drug-Device&#39;, &#39;Combinations&#39;, &#39;Peptides&#39;, &#39;for&#39;, &#39;Cancer&#39;, &#39;Therapeutics&#39;, &#39;Colony&#39;, &#39;Stimulating&#39;, &#39;Factors&#39;, &#39;Cell&#39;, &#39;Signaling&#39;, &#39;Cancer&#39;, &#39;Stem&#39;, &#39;Cells&#39;, &#39;Clinical&#39;, &#39;Supply&#39;, &#39;Chain&#39;, &#39;Clinical&#39;, &#39;Strategic&#39;, &#39;Resource&#39;, &#39;Allocation&#39;, &#39;Country&#39;, &#39;and&#39;, &#39;Site&#39;, &#39;Feasibility&#39;, &#39;and&#39;, &#39;Selection&#39;, &#39;Mammalian&#39;, &#39;Cell&#39;, &#39;Culture&#39;, &#39;Cloud&#39;, &#39;Security&#39;, &#39;Cybersecurity&#39;, &#39;Clinical&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;and&#39;, &#39;eClinical&#39;, &#39;Trials&#39;, &#39;Asia&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;for&#39;, &#39;the&#39;, &#39;Drug&#39;, &#39;Discoverer&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Eastern&#39;, &#39;Europe&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Finance&#39;, &#39;&amp;&#39;, &#39;Management&#39;, &#39;Re&#39;, &#39;Engineering&#39;, &#39;the&#39;, &#39;Study&#39;, &#39;Feasibility&#39;, &#39;Assessment&#39;, &#39;Process&#39;, &#39;CRC&#39;, &#39;Training&#39;, &#39;Video&#39;, &#39;&amp;&#39;, &#39;Manual&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Management&#39;, &#39;Systems&#39;, &#39;Cardiotoxicity&#39;, &#39;Query&#39;, &#39;Creation&#39;, &#39;&amp;&#39;, &#39;Processing&#39;, &#39;clinical&#39;, &#39;trials&#39;, &#39;segmentation&#39;, &#39;Neoantigens&#39;, &#39;for&#39;, &#39;Cancer&#39;, &#39;Cardiovascular&#39;, &#39;Diagnostics&#39;, &#39;cardiovascular&#39;, &#39;animal&#39;, &#39;models&#39;, &#39;Cardio&#39;, &#39;Metabolic&#39;, &#39;Drug&#39;, &#39;Targets&#39;, &#39;Targeting&#39;, &#39;Cancer&#39;, &#39;Diagnostics&#39;, &#39;cytokines&#39;, &#39;antagonists&#39;, &#39;Cystic&#39;, &#39;Fibrosis&#39;, &#39;Cytogenetics&#39;, &#39;cytokines&#39;, &#39;Targeting&#39;, &#39;Diabetes&#39;, &#39;with&#39;, &#39;Novel&#39;, &#39;Therapeutics&#39;, &#39;DBS&#39;, &#39;Optimization&#39;, &#39;of&#39;, &#39;Cell&#39;, &#39;drug&#39;, &#39;discovery&#39;, &#39;India&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Map&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Outsourcing&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Technologies&#39;, &#39;drug&#39;, &#39;discovery&#39;, &#39;and&#39;, &#39;development&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;Development&#39;, &#39;Series&#39;, &#39;Dental&#39;, &#39;Depression&#39;, &#39;Detection&#39;, &#39;non&#39;, &#39;biological&#39;, &#39;Treatments&#39;, &#39;for&#39;, &#39;Drug&#39;, &#39;Abuse&#39;, &#39;Drug&#39;, &#39;Drug&#39;, &#39;Interactions&#39;, &#39;Digital&#39;, &#39;Therapeutics&#39;, &#39;Digitization&#39;, &#39;Diabetes&#39;, &#39;2&#39;, &#39;Digital&#39;, &#39;Healthcare&#39;, &#39;&amp;&#39;, &#39;Productivity&#39;, &#39;web&#39;, &#39;resource&#39;, &#39;alert&#39;, &#39;drug&#39;, &#39;discovery&#39;, &#39;Duchenne&#39;, &#39;Muscular&#39;, &#39;Dystrophy&#39;, &#39;Drug&#39;, &#39;Metabolism&#39;, &#39;&amp;&#39;, &#39;Pharmacokinetics&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Informatics&#39;, &#39;Europe&#39;, &#39;Data&#39;, &#39;Integrity&#39;, &#39;Diagnostic&#39;, &#39;Informatics&#39;, &#39;DNA&#39;, &#39;Repair&#39;, &#39;Diversity&#39;, &#39;Oriented&#39;, &#39;Synthesis&#39;, &#39;Digital&#39;, &#39;Detection&#39;, &#39;Europe&#39;, &#39;Difficult&#39;, &#39;to&#39;, &#39;Express&#39;, &#39;Proteins&#39;, &#39;Executive&#39;, &#39;Perspectives&#39;, &#39;of&#39;, &#39;Drug&#39;, &#39;Safety&#39;, &#39;downstream&#39;, &#39;processing&#39;, &#39;Europe&#39;, &#39;Drug&#39;, &#39;Safety&#39;, &#39;Series&#39;, &#39;downstream&#39;, &#39;processing&#39;, &#39;Dosing&#39;, &#39;Selection&#39;, &#39;Data&#39;, &#39;Science/Analytics&#39;, &#39;Direct&#39;, &#39;to&#39;, &#39;Consumer&#39;, &#39;Marketing&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Drug&#39;, &#39;Transporters&#39;, &#39;Data&#39;, &#39;Storage&#39;, &#39;Digital&#39;, &#39;Twins&#39;, &#39;Drug&#39;, &#39;Utilization&#39;, &#39;Protein&#39;, &#39;Devices&#39;, &#39;Molecular&#39;, &#39;and&#39;, &#39;Companion&#39;, &#39;Diagnostics&#39;, &#39;Asia&#39;, &#39;Clinical&#39;, &#39;Adoption&#39;, &#39;of&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Diagnostics&#39;, &#39;Difficult&#39;, &#39;to&#39;, &#39;Express&#39;, &#39;Proteins&#39;, &#39;Europe&#39;, &#39;Globalization&#39;, &#39;of&#39;, &#39;Dx&#39;, &#39;Diagnostics&#39;, &#39;Immunoassays&#39;, &#39;Diagnostics&#39;, &#39;Automation&#39;, &#39;Detection&#39;, &#39;Informatics&#39;, &#39;engineered&#39;, &#39;animal&#39;, &#39;models&#39;, &#39;Hearing&#39;, &#39;Ebola&#39;, &#39;Diagnostics&#39;, &#39;Evidence&#39;, &#39;Based&#39;, &#39;Medicine&#39;, &#39;Ebola&#39;, &#39;Therapeutics&#39;, &#39;eCapacitors&#39;, &#39;Electrochemistry&#39;, &#39;E&#39;, &#39;Coli&#39;, &#39;Encoded&#39;, &#39;Compound&#39;, &#39;Libraries&#39;, &#39;Ecommerce&#39;, &#39;eCTD&#39;, &#39;Validation&#39;, &#39;of&#39;, &#39;Disinfectant&#39;, &#39;Efficacy&#39;, &#39;Effective&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Edge&#39;, &#39;Computing&#39;, &#39;Early&#39;, &#39;Diagnosis&#39;, &#39;Electronic&#39;, &#39;Notebooks&#39;, &#39;endothelium&#39;, &#39;engineering&#39;, &#39;Entertainment&#39;, &#39;Enabling&#39;, &#39;Technology&#39;, &#39;in&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Environment&#39;, &#39;Enzymes&#39;, &#39;Economic&#39;, &#39;Outcomes&#39;, &#39;Executives&#39;, &#39;on&#39;, &#39;Target&#39;, &#39;Epidemiology&#39;, &#39;epilepsy&#39;, &#39;Epigenetic&#39;, &#39;Readers&#39;, &#39;Epigenetic&#39;, &#39;Targets&#39;, &#39;Examining&#39;, &#39;the&#39;, &#39;Impact&#39;, &#39;of&#39;, &#39;the&#39;, &#39;eCTD&#39;, &#39;on&#39;, &#39;the&#39;, &#39;Regulatory&#39;, &#39;Submissions&#39;, &#39;Process&#39;, &#39;Emerging&#39;, &#39;Targets&#39;, &#39;Diseases&#39;, &#39;Ethics&#39;, &#39;Emerging&#39;, &#39;Technology&#39;, &#39;Transfer&#39;, &#39;Electric&#39;, &#39;Vehicles&#39;, &#39;Experimental&#39;, &#39;Design&#39;, &#39;Exhibitors&#39;, &#39;Extractables/Leachables&#39;, &#39;Exosomes&#39;, &#39;Exome&#39;, &#39;Sequencing&#39;, &#39;Financial&#39;, &#39;Analysts&#39;, &#39;Hackathon&#39;, &#39;Obesity&#39;, &#39;Batteries&#39;, &#39;France&#39;, &#39;fibrin&#39;, &#39;sealants&#39;, &#39;Fine&#39;, &#39;Chemicals&#39;, &#39;FDA&#39;, &#39;Meetings&#39;, &#39;101&#39;, &#39;Food&#39;, &#39;Safety&#39;, &#39;Financial&#39;, &#39;Disclosure&#39;, &#39;Foods&#39;, &#39;FDA&#39;, &#39;Website&#39;, &#39;Functional&#39;, &#39;Genomics&#39;, &#39;Fragment&#39;, &#39;Based&#39;, &#39;Screening&#39;, &#39;Surface&#39;, &#39;Plasmon&#39;, &#39;Resonance&#39;, &#39;finance&#39;, &#39;Flow&#39;, &#39;Cytometry&#39;, &#39;Influenza&#39;, &#39;Financial&#39;, &#39;Deal&#39;, &#39;Structures&#39;, &#39;Fintech&#39;, &#39;Future&#39;, &#39;of&#39;, &#39;Healthcare&#39;, &#39;Fraud&#39;, &#39;Fertility&#39;, &#39;Fibrin&#39;, &#39;sealants&#39;, &#39;Europe&#39;, &#39;blood&#39;, &#39;Fast&#39;, &#39;Track&#39;, &#39;Future&#39;, &#39;Therapeutics&#39;, &#39;fungal&#39;, &#39;infections&#39;, &#39;Follow&#39;, &#39;Up&#39;, &#39;Flow&#39;, &#39;Chemistry&#39;, &#39;Gamification&#39;, &#39;gap&#39;, &#39;junction&#39;, &#39;channels&#39;, &#39;Global&#39;, &#39;Health&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;for&#39;, &#39;Pediatric&#39;, &#39;Research&#39;, &#39;GCP&#39;, &#39;Deficiencies&#39;, &#39;Gene&#39;, &#39;Cell&#39;, &#39;Vectors&#39;, &#39;Genomic&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Genomic&#39;, &#39;Data&#39;, &#39;Integration&#39;, &#39;Genetic&#39;, &#39;Screening&#39;, &#39;Wellness&#39;, &#39;General&#39;, &#39;Email&#39;, &#39;Only&#39;, &#39;Gene&#39;, &#39;Editing&#39;, &#39;Part&#39;, &#39;2&#39;, &#39;Gene&#39;, &#39;Editing&#39;, &#39;Gene&#39;, &#39;Expression&#39;, &#39;Monitoring&#39;, &#39;Genomics&#39;, &#39;Series&#39;, &#39;Gene&#39;, &#39;Expression&#39;, &#39;growth&#39;, &#39;factors&#39;, &#39;Gene&#39;, &#39;Identification&#39;, &#39;genetic&#39;, &#39;immunization&#39;, &#39;vaccines&#39;, &#39;gene&#39;, &#39;interference&#39;, &#39;Gene&#39;, &#39;Knockouts&#39;, &#39;Globalization&#39;, &#39;Genome&#39;, &#39;Links&#39;, &#39;newsletter&#39;, &#39;GLP&#39;, &#39;Bioanalysis&#39;, &#39;Leaders&#39;, &#39;in&#39;, &#39;Precision&#39;, &#39;Medicine&#39;, &#39;Good&#39;, &#39;Manufacturing&#39;, &#39;Practice&#39;, &#39;Drugs&#39;, &#39;introductory&#39;, &#39;gene&#39;, &#39;mutations&#39;, &#39;genomic&#39;, &#39;medicine&#39;, &#39;Genotyping&#39;, &#39;Government&#39;, &#39;gene&#39;, &#39;probes&#39;, &#39;Genomic&#39;, &#39;partnering&#39;, &#39;Europe&#39;, &#39;Greening&#39;, &#39;of&#39;, &#39;Pharma&#39;, &#39;GPCR&#39;, &#39;Targeted&#39;, &#39;Therapies&#39;, &#39;Grid&#39;, &#39;Computing&#39;, &#39;Genomic&#39;, &#39;Service&#39;, &#39;Providers&#39;, &#39;Small&#39;, &#39;GTPases&#39;, &#39;(&#39;, &#39;formerly&#39;, &#39;Gene&#39;, &#39;Town&#39;, &#39;Pass&#39;, &#39;)&#39;, &#39;gene&#39;, &#39;transcription&#39;, &#39;gene&#39;, &#39;therapy&#39;, &#39;technologies&#39;, &#39;Whole&#39;, &#39;Genome&#39;, &#39;Association&#39;, &#39;Studies&#39;, &#39;Humanized&#39;, &#39;Antibodies&#39;, &#39;high&#39;, &#39;throughput&#39;, &#39;analytical&#39;, &#39;chemistry&#39;, &#39;Health&#39;, &#39;&amp;&#39;, &#39;Beauty&#39;, &#39;Aids&#39;, &#39;Hepatitis&#39;, &#39;B&#39;, &#39;Virus&#39;, &#39;High&#39;, &#39;Content&#39;, &#39;Analysis&#39;, &#39;Course&#39;, &#39;HIV&#39;, &#39;and&#39;, &#39;cancer&#39;, &#39;Hematological&#39;, &#39;Cancer&#39;, &#39;Pipelines&#39;, &#39;HIV&#39;, &#39;clinical&#39;, &#39;trials&#39;, &#39;hepatitis&#39;, &#39;C&#39;, &#39;virus&#39;, &#39;Heterocycle&#39;, &#39;High&#39;, &#39;Content&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;HDAC&#39;, &#39;Histone&#39;, &#39;Demethylases&#39;, &#39;Healing&#39;, &#39;hematopoesis&#39;, &#39;heat&#39;, &#39;shock&#39;, &#39;proteins&#39;, &#39;Human&#39;, &#39;Factors&#39;, &#39;Engineering&#39;, &#39;Health&#39;, &#39;Information&#39;, &#39;Systems&#39;, &#39;HIV&#39;, &#39;Healthcare&#39;, &#39;Series&#39;, &#39;Health&#39;, &#39;Maintenance&#39;, &#39;Organizations&#39;, &#39;Human&#39;, &#39;Tissue&#39;, &#39;Huntingtons&#39;, &#39;Disease&#39;, &#39;hormones&#39;, &#39;HIPAA&#39;, &#39;#&#39;, &#39;2&#39;, &#39;High&#39;, &#39;Throughput&#39;, &#39;Protein&#39;, &#39;Purification&#39;, &#39;High&#39;, &#39;Performing&#39;, &#39;Operation&#39;, &#39;Human&#39;, &#39;Papilloma&#39;, &#39;Virus&#39;, &#39;transgenics&#39;, &#39;homologous&#39;, &#39;recombinant&#39;, &#39;Human&#39;, &#39;Relations&#39;, &#39;Health&#39;, &#39;Insurance&#39;, &#39;herpes&#39;, &#39;virus&#39;, &#39;HIV&#39;, &#39;Surrogate&#39;, &#39;Markers&#39;, &#39;High&#39;, &#39;Throughput&#39;, &#39;Genomics&#39;, &#39;Hit&#39;, &#39;to&#39;, &#39;Lead&#39;, &#39;High&#39;, &#39;Throughput&#39;, &#39;Screening&#39;, &#39;Hepatotoxicity&#39;, &#39;Hybrid&#39;, &#39;Computing&#39;, &#39;hypertension&#39;, &#39;Targeting&#39;, &#39;Antigen&#39;, &#39;Presenting&#39;, &#39;Cells&#39;, &#39;Inflammatory&#39;, &#39;Bowel&#39;, &#39;Disease&#39;, &#39;imaging&#39;, &#39;contrast&#39;, &#39;agents&#39;, &#39;interleukin&#39;, &#39;converting&#39;, &#39;enzymes&#39;, &#39;ICE&#39;, &#39;Improving&#39;, &#39;Drug&#39;, &#39;Safety&#39;, &#39;diagnostics&#39;, &#39;-&#39;, &#39;infections&#39;, &#39;Infections&#39;, &#39;Diagnostics&#39;, &#39;Europe&#39;, &#39;engineering&#39;, &#39;laboratories&#39;, &#39;Integrated&#39;, &#39;Fluidic&#39;, &#39;Circuits&#39;, &#39;for&#39;, &#39;DOT&#39;, &#39;Informatics&#39;, &#39;for&#39;, &#39;Genomic&#39;, &#39;Medicine&#39;, &#39;Infection&#39;, &#39;Genomics&#39;, &#39;Image&#39;, &#39;Analysis&#39;, &#39;Immunotherapy&#39;, &#39;Biomarkers&#39;, &#39;Immune&#39;, &#39;Profiling&#39;, &#39;in&#39;, &#39;Cancer&#39;, &#39;Complement-based&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;immunomodulation&#39;, &#39;Imaging&#39;, &#39;for&#39;, &#39;WPC&#39;, &#39;conference&#39;, &#39;Imaging&#39;, &#39;Informatics&#39;, &#39;Immune&#39;, &#39;Impurities&#39;, &#39;Regulatory&#39;, &#39;Immunogenicity&#39;, &#39;Immunosequencing&#39;, &#39;Immuno-Oncology&#39;, &#39;Drug&#39;, &#39;Developement&#39;, &#39;Cancer&#39;, &#39;Immunotherapy&#39;, &#39;Oligonucleotides&#39;, &#39;Cancer&#39;, &#39;Immunotherapy&#39;, &#39;Peptides&#39;, &#39;Cancer&#39;, &#39;Immunotherapy&#39;, &#39;Small&#39;, &#39;Molecules&#39;, &#39;Informatics&#39;, &#39;Partnering&#39;, &#39;Insurance&#39;, &#39;AI&#39;, &#39;and&#39;, &#39;IOT&#39;, &#39;Investments&#39;, &#39;Industrial&#39;, &#39;Enzymes&#39;, &#39;Immuno-Oncology&#39;, &#39;Assays&#39;, &#39;Immuno-Oncology&#39;, &#39;Business&#39;, &#39;Strategy&#39;, &#39;Immuno-Oncology&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Immuno-Oncology&#39;, &#39;Models&#39;, &#39;ion&#39;, &#39;channels&#39;, &#39;Protein&#39;, &#39;Engineering&#39;, &#39;for&#39;, &#39;Immuno-oncology&#39;, &#39;Immuno-Oncology&#39;, &#39;Sequencing&#39;, &#39;Immuno-Oncology&#39;, &#39;Targets&#39;, &#39;Legal&#39;, &#39;Issues&#39;, &#39;for&#39;, &#39;Bioproduction&#39;, &#39;Intellectual&#39;, &#39;Property&#39;, &#39;Pluripotent&#39;, &#39;Stem&#39;, &#39;Cells&#39;, &#39;IRB&#39;, &#39;Compliance&#39;, &#39;and&#39;, &#39;Oversight&#39;, &#39;Considerations&#39;, &#39;Adopting&#39;, &#39;Integrated&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Informatics&#39;, &#39;Systems&#39;, &#39;India&#39;, &#39;Re&#39;, &#39;Engineering&#39;, &#39;International&#39;, &#39;Risk&#39;, &#39;Management&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Informatics&#39;, &#39;Iron&#39;, &#39;Chelation&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;Software&#39;, &#39;in&#39;, &#39;situ&#39;, &#39;hybridization&#39;, &#39;Information&#39;, &#39;Technology&#39;, &#39;IT&#39;, &#39;&amp;&#39;, &#39;Informatics&#39;, &#39;for&#39;, &#39;Collaboration&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;Europe&#39;, &#39;Scalable&#39;, &#39;IT&#39;, &#39;&amp;&#39;, &#39;Informatics&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;computer&#39;, &#39;hardware&#39;, &#39;(&#39;, &#39;part&#39;, &#39;2&#39;, &#39;)&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;computer&#39;, &#39;hardware&#39;, &#39;(&#39;, &#39;part&#39;, &#39;3&#39;, &#39;)&#39;, &#39;IT&#39;, &#39;Software&#39;, &#39;for&#39;, &#39;the&#39;, &#39;Life&#39;, &#39;Sciences&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;Virtualization&#39;, &#39;Interviewing&#39;, &#39;Skills&#39;, &#39;for&#39;, &#39;Managers&#39;, &#39;Investigator&#39;, &#39;Sites&#39;, &#39;Report&#39;, &#39;1&#39;, &#39;Investigator&#39;, &#39;Sites&#39;, &#39;Report&#39;, &#39;2&#39;, &#39;Imaging&#39;, &#39;Week&#39;, &#39;joints&#39;, &#39;Job&#39;, &#39;recruiters&#39;, &#39;Kinase&#39;, &#39;Chemistry&#39;, &#39;KIN&#39;, &#39;West&#39;, &#39;Coast&#39;, &#39;Kinases&#39;, &#39;for&#39;, &#39;DOT&#39;, &#39;Knowledge&#39;, &#39;Management&#39;, &#39;chemokines&#39;, &#39;HIV&#39;, &#39;and&#39;, &#39;Kaposis&#39;, &#39;sarcoma&#39;, &#39;Kinetics&#39;, &#39;Structure&#39;, &#39;Relationship&#39;, &#39;laboratories&#39;, &#39;Lead&#39;, &#39;Acid&#39;, &#39;Batteries&#39;, &#39;Label&#39;, &#39;Free&#39;, &#39;Detection&#39;, &#39;Drug&#39;, &#39;Labeling&#39;, &#39;Live&#39;, &#39;Cell&#39;, &#39;Imaging&#39;, &#39;Laser&#39;, &#39;Capture&#39;, &#39;Microdissection&#39;, &#39;Lung&#39;, &#39;Cancer&#39;, &#39;ligase&#39;, &#39;chain&#39;, &#39;reaction&#39;, &#39;leukodepletion&#39;, &#39;Laboratory&#39;, &#39;Developed&#39;, &#39;Tests&#39;, &#39;leukemia&#39;, &#39;Ontologies/Lexicons&#39;, &#39;Legal&#39;, &#39;drug&#39;, &#39;liability&#39;, &#39;screening&#39;, &#39;libraries&#39;, &#39;Life&#39;, &#39;Sciences&#39;, &#39;Protein&#39;, &#39;Ligands&#39;, &#39;lab&#39;, &#39;information&#39;, &#39;management&#39;, &#39;systems&#39;, &#39;LIMS&#39;, &#39;Lipids&#39;, &#39;Large&#39;, &#39;Stationary&#39;, &#39;Batteries&#39;, &#39;Lyophilization&#39;, &#39;Mergers&#39;, &#39;&amp;&#39;, &#39;Acquisitions&#39;, &#39;Monoclonal&#39;, &#39;Antibodies&#39;, &#39;Forum&#39;, &#39;Monoclonal&#39;, &#39;Antibody&#39;, &#39;Process&#39;, &#39;Development&#39;, &#39;Malaria&#39;, &#39;Metabolism&#39;, &#39;Targeted&#39;, &#39;Cancer&#39;, &#39;Therapeutics&#39;, &#39;Microbiome&#39;, &#39;in&#39;, &#39;Immuno-Oncology&#39;, &#39;Microbiome&#39;, &#39;Metabolic&#39;, &#39;Syndrome&#39;, &#39;Medicinal&#39;, &#39;Chemistry&#39;, &#39;Part&#39;, &#39;2&#39;, &#39;Mucosal&#39;, &#39;Immunity&#39;, &#39;Microreactors&#39;, &#39;Macrocycles&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Business&#39;, &#39;Multidrug&#39;, &#39;Resistance&#39;, &#39;Cancer&#39;, &#39;Medical&#39;, &#39;Coding&#39;, &#39;multidrug&#39;, &#39;resistant&#39;, &#39;infections&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Non-Invasive&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Microdosing&#39;, &#39;microbial&#39;, &#39;infections&#39;, &#39;Sequencing&#39;, &#39;Based&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Forum&#39;, &#39;Molecular&#39;, &#39;Electronics&#39;, &#39;Metabolic&#39;, &#39;Engineering&#39;, &#39;Melanoma&#39;, &#39;BioMEMS&#39;, &#39;memory&#39;, &#39;enhancement&#39;, &#39;cancer&#39;, &#39;metastasis&#39;, &#39;molecular&#39;, &#39;evolution&#39;, &#39;Mammalian&#39;, &#39;Cell&#39;, &#39;Line&#39;, &#39;Development&#39;, &#39;microfabrication&#39;, &#39;Molecular&#39;, &#39;Genetic&#39;, &#39;Pro&#39;, &#39;Management&#39;, &#39;molecular&#39;, &#39;medicine&#39;, &#39;Novel&#39;, &#39;bioactive&#39;, &#39;high&#39;, &#39;throughput&#39;, &#39;screening&#39;, &#39;europe&#39;, &#39;Myocardial&#39;, &#39;Infarction&#39;, &#39;migraine&#39;, &#39;microtiter&#39;, &#39;plates&#39;, &#39;Molecular&#39;, &#39;Medicine&#39;, &#39;Europe&#39;, &#39;metalloproteinases&#39;, &#39;Molecular&#39;, &#39;Medicine&#39;, &#39;Asia&#39;, &#39;Managed&#39;, &#39;Care&#39;, &#39;Manufacturing&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Monitoring&#39;, &#39;Mechanism&#39;, &#39;of&#39;, &#39;Action&#39;, &#39;Purifying&#39;, &#39;Antibodies&#39;, &#39;Meeting&#39;, &#39;Planning&#39;, &#39;Services&#39;, &#39;Molecular&#39;, &#39;Pathology&#39;, &#39;Molecular&#39;, &#39;Pathology&#39;, &#39;Basic&#39;, &#39;Molecular&#39;, &#39;Pathology&#39;, &#39;Advanced&#39;, &#39;magnetic&#39;, &#39;resonance&#39;, &#39;imaging&#39;, &#39;Multi&#39;, &#39;Specific&#39;, &#39;Antibodies&#39;, &#39;Mass&#39;, &#39;Spectrometry&#39;, &#39;for&#39;, &#39;Protein&#39;, &#39;Biomarker&#39;, &#39;Discovery&#39;, &#39;Muscle&#39;, &#39;Mass&#39;, &#39;Spec&#39;, &#39;Informatics&#39;, &#39;Mass&#39;, &#39;Spec&#39;, &#39;Imaging&#39;, &#39;Modeling&#39;, &#39;and&#39;, &#39;Simulation&#39;, &#39;Mass&#39;, &#39;spectrometry&#39;, &#39;Mass&#39;, &#39;Spec&#39;, &#39;Diagnostics&#39;, &#39;Metabolic&#39;, &#39;Disorders&#39;, &#39;Mental&#39;, &#39;Health&#39;, &#39;Materials&#39;, &#39;Testing&#39;, &#39;cellular&#39;, &#39;matrix&#39;, &#39;Multiplexed&#39;, &#39;Assays&#39;, &#39;Moelcular&#39;, &#39;Diagnostics&#39;, &#39;Europe&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;for&#39;, &#39;Cancer&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;for&#39;, &#39;Infectious&#39;, &#39;Disease&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Antibodies&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Antibodies&#39;, &#39;(&#39;, &#39;for&#39;, &#39;PGE&#39;, &#39;)&#39;, &#39;Nucleic&#39;, &#39;Acid&#39;, &#39;Europe&#39;, &#39;National&#39;, &#39;Academy&#39;, &#39;of&#39;, &#39;Sciences&#39;, &#39;meeting&#39;, &#39;natural&#39;, &#39;products&#39;, &#39;new&#39;, &#39;antivirals&#39;, &#39;Novel&#39;, &#39;Cancer&#39;, &#39;Informatics&#39;, &#39;Non-Coding&#39;, &#39;RNA&#39;, &#39;Novel&#39;, &#39;Strategies&#39;, &#39;Cancer&#39;, &#39;Novel&#39;, &#39;Cancer&#39;, &#39;Targets&#39;, &#39;Neurodegenerative&#39;, &#39;Nucleotide&#39;, &#39;Delivery&#39;, &#39;Internet&#39;, &#39;New&#39;, &#39;to&#39;, &#39;Database&#39;, &#39;comapny&#39;, &#39;names&#39;, &#39;Advances&#39;, &#39;in&#39;, &#39;Informatics&#39;, &#39;nerve&#39;, &#39;growth&#39;, &#39;factors&#39;, &#39;NF&#39;, &#39;KB&#39;, &#39;Nanofluidics&#39;, &#39;Informatics&#39;, &#39;Next-Generation&#39;, &#39;Batteries&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Batteries&#39;, &#39;Portable&#39;, &#39;Applications&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Batteries&#39;, &#39;Stationary&#39;, &#39;Power&#39;, &#39;Epigenetic&#39;, &#39;Sequencing&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Imaging&#39;, &#39;Neurogenomics&#39;, &#39;Nuclear&#39;, &#39;Hormone&#39;, &#39;Receptors&#39;, &#39;Novel&#39;, &#39;HIV&#39;, &#39;Strategies&#39;, &#39;Neurotech&#39;, &#39;Industry&#39;, &#39;neuroinjuries&#39;, &#39;NK&#39;, &#39;Cell&#39;, &#39;Based&#39;, &#39;Cancer&#39;, &#39;Immunotherapy&#39;, &#39;Natural&#39;, &#39;Language&#39;, &#39;Processing&#39;, &#39;nuclear&#39;, &#39;matrix&#39;, &#39;Nanomedicine&#39;, &#39;Nitric&#39;, &#39;Oxide&#39;, &#39;Network&#39;, &#39;Pharmacology&#39;, &#39;Energy&#39;, &#39;Neurotoxicity&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;in&#39;, &#39;the&#39;, &#39;US&#39;, &#39;nanotech&#39;, &#39;self&#39;, &#39;assembly&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Supply&#39;, &#39;Chain&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Supply&#39;, &#39;Chain&#39;, &#39;Europe&#39;, &#39;Neurostimulation&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Diagnostic&#39;, &#39;Things&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Energy&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Energy&#39;, &#39;Europe&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Things&#39;, &#39;Infrastructure&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Health&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Insurance&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Insurance&#39;, &#39;Europe&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Things&#39;, &#39;Manufacturing&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Things&#39;, &#39;Manufacturing&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Manufacturing&#39;, &#39;Europe&#39;, &#39;Smart&#39;, &#39;Buildings&#39;, &#39;Smart&#39;, &#39;Cities&#39;, &#39;Nephrotoxicity&#39;, &#39;Nuclear&#39;, &#39;Energy&#39;, &#39;nutrition&#39;, &#39;Optimizing&#39;, &#39;Media&#39;, &#39;organ&#39;, &#39;and&#39;, &#39;cell&#39;, &#39;transplants&#39;, &#39;Oncology&#39;, &#39;Drug&#39;, &#39;Targets&#39;, &#39;Optical&#39;, &#39;Diagnostics&#39;, &#39;Oncogenomics&#39;, &#39;Office&#39;, &#39;of&#39;, &#39;the&#39;, &#39;Inspector&#39;, &#39;General&#39;, &#39;Oil&#39;, &#39;and&#39;, &#39;Gas&#39;, &#39;oncogenes&#39;, &#39;Oncolytic&#39;, &#39;Viruses&#39;, &#39;Oligo&#39;, &#39;Production&#39;, &#39;opportunistic&#39;, &#39;infections&#39;, &#39;Oligo&#39;, &#39;Regulatory&#39;, &#39;organs&#39;, &#39;transplants&#39;, &#39;oral&#39;, &#39;drug&#39;, &#39;delivery&#39;, &#39;OSTEOARTHRITIS&#39;, &#39;OTC&#39;, &#39;over&#39;, &#39;the&#39;, &#39;counter&#39;, &#39;Additional&#39;, &#39;Conferences&#39;, &#39;clinical&#39;, &#39;trials&#39;, &#39;outsourcing&#39;, &#39;Oxygen&#39;, &#39;Radicals&#39;, &#39;oncogenes&#39;, &#39;p53&#39;, &#39;Predictive&#39;, &#39;ADME&#39;, &#39;protein&#39;, &#39;aggregation&#39;, &#39;Protein&#39;, &#39;Aggregation&#39;, &#39;(&#39;, &#39;for&#39;, &#39;PTK&#39;, &#39;)&#39;, &#39;Packaging&#39;, &#39;parasitic&#39;, &#39;infections&#39;, &#39;Process&#39;, &#39;Analytical&#39;, &#39;Technology&#39;, &#39;Pharmacy&#39;, &#39;Benefit&#39;, &#39;Management&#39;, &#39;Pharmaceutical&#39;, &#39;BioProcess&#39;, &#39;Basic&#39;, &#39;Research&#39;, &#39;&amp;&#39;, &#39;Discovery&#39;, &#39;track&#39;, &#39;for&#39;, &#39;PCG&#39;, &#39;Clinical&#39;, &#39;Operations&#39;, &#39;track&#39;, &#39;for&#39;, &#39;PCG&#39;, &#39;Preclinical&#39;, &#39;Development&#39;, &#39;track&#39;, &#39;for&#39;, &#39;PCG&#39;, &#39;Bridgehead&#39;, &#39;PCI&#39;, &#39;book&#39;, &#39;Preclinical&#39;, &#39;Preclinical&#39;, &#39;Preclinical&#39;, &#39;prostate&#39;, &#39;cancer&#39;, &#39;Preclinical&#39;, &#39;Outcome&#39;, &#39;Predictions&#39;, &#39;preclinical&#39;, &#39;trials&#39;, &#39;Point&#39;, &#39;of&#39;, &#39;Care&#39;, &#39;West&#39;, &#39;Protein&#39;, &#39;Crystallography&#39;, &#39;pediatric&#39;, &#39;AIDS/HIV&#39;, &#39;PDA&#39;, &#39;Downloads&#39;, &#39;from&#39;, &#39;CHI&#39;, &#39;website&#39;, &#39;Process&#39;, &#39;Development&#39;, &#39;for&#39;, &#39;Executives&#39;, &#39;platelet&#39;, &#39;derived&#39;, &#39;growth&#39;, &#39;factors&#39;, &#39;protein&#39;, &#39;drug&#39;, &#39;delivery&#39;, &#39;Preclinical&#39;, &#39;Disease&#39;, &#39;Models&#39;, &#39;photodynamic&#39;, &#39;therapies&#39;, &#39;Phage&#39;, &#39;Display&#39;, &#39;for&#39;, &#39;Vaccine&#39;, &#39;Development&#39;, &#39;Proteomic&#39;, &#39;Tools&#39;, &#39;for&#39;, &#39;Diagnostics&#39;, &#39;pediatric&#39;, &#39;Pediatric&#39;, &#39;trials&#39;, &#39;for&#39;, &#39;CRAS&#39;, &#39;PEGS&#39;, &#39;Virtual&#39;, &#39;Interactive&#39;, &#39;Global&#39;, &#39;Summit&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Monitoring&#39;, &#39;Protein&#39;, &#39;Executive&#39;, &#39;Summit&#39;, &#39;Proof&#39;, &#39;of&#39;, &#39;Concept&#39;, &#39;for&#39;, &#39;Cancer&#39;, &#39;Protein&#39;, &#39;Function&#39;, &#39;Enterprise&#39;, &#39;Portfolio&#39;, &#39;Management&#39;, &#39;Portfolio&#39;, &#39;Value&#39;, &#39;Protein&#39;, &#39;Aggregates&#39;, &#39;Light&#39;, &#39;Scattering&#39;, &#39;Consumer&#39;, &#39;Genomics/Personal&#39;, &#39;Genomics&#39;, &#39;Protein&#39;, &#39;Engineering&#39;, &#39;Partnering&#39;, &#39;Particulate&#39;, &#39;Screening&#39;, &#39;Phage&#39;, &#39;West&#39;, &#39;Phase&#39;, &#39;II/Reducing&#39;, &#39;Attrition&#39;, &#39;Phase&#39;, &#39;IV&#39;, &#39;Phase&#39;, &#39;IV&#39;, &#39;Pharmacies&#39;, &#39;Phage&#39;, &#39;Display&#39;, &#39;Europe&#39;, &#39;Pharmaceutical&#39;, &#39;Half&#39;, &#39;Life&#39;, &#39;Phase&#39;, &#39;Zero&#39;, &#39;PI3K&#39;, &#39;Phosphoinositide&#39;, &#39;3&#39;, &#39;Kinase&#39;, &#39;Protein&#39;, &#39;Identification&#39;, &#39;Preclinical&#39;, &#39;Imaging&#39;, &#39;protease&#39;, &#39;inhibitors&#39;, &#39;enzymes&#39;, &#39;PLA2&#39;, &#39;blood&#39;, &#39;platelets&#39;, &#39;Membrane&#39;, &#39;Proteins&#39;, &#39;Membrane&#39;, &#39;Protein&#39;, &#39;for&#39;, &#39;DOT&#39;, &#39;(&#39;, &#39;part&#39;, &#39;1&#39;, &#39;)&#39;, &#39;Membrane&#39;, &#39;Protein&#39;, &#39;for&#39;, &#39;DOT&#39;, &#39;(&#39;, &#39;part&#39;, &#39;2&#39;, &#39;)&#39;, &#39;Protein&#39;, &#39;Manufacturing&#39;, &#39;Clinical&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;:&#39;, &#39;Intermediate&#39;, &#39;Preventive&#39;, &#39;Medicine&#39;, &#39;Pancreatic&#39;, &#39;Cancer&#39;, &#39;Preclinical&#39;, &#39;Studies&#39;, &#39;for&#39;, &#39;IND&#39;, &#39;Protein&#39;, &#39;Computational&#39;, &#39;Tools&#39;, &#39;Prenatal&#39;, &#39;Therapeutics&#39;, &#39;Parenteral&#39;, &#39;Point&#39;, &#39;of&#39;, &#39;Care&#39;, &#39;Diagnostics&#39;, &#39;Europe&#39;, &#39;Cannabis&#39;, &#39;Power&#39;, &#39;Utilities&#39;, &#39;protein&#39;, &#39;characterization&#39;, &#39;protein&#39;, &#39;purification&#39;, &#39;Protein&#39;, &#39;Protein&#39;, &#39;Interactions&#39;, &#39;Protein&#39;, &#39;Protein&#39;, &#39;Interactions&#39;, &#39;Part&#39;, &#39;2&#39;, &#39;Process&#39;, &#39;Management&#39;, &#39;Protein&#39;, &#39;Process&#39;, &#39;PepTalk&#39;, &#39;Partnering&#39;, &#39;Personalized&#39;, &#39;Medicine&#39;, &#39;Partnering&#39;, &#39;Proteomics&#39;, &#39;Analytics&#39;, &#39;Predictive&#39;, &#39;Analytics&#39;, &#39;Pricing&#39;, &#39;Parkinsons&#39;, &#39;Predictive&#39;, &#39;Biomedicine&#39;, &#39;Proteins&#39;, &#39;,&#39;, &#39;Peptides&#39;, &#39;&amp;&#39;, &#39;Proteomics&#39;, &#39;Series&#39;, &#39;Protein&#39;, &#39;Quantification&#39;, &#39;Partnering&#39;, &#39;Data&#39;, &#39;Privacy&#39;, &#39;Personalized&#39;, &#39;Medicine&#39;, &#39;Asia&#39;, &#39;Product&#39;, &#39;Service&#39;, &#39;Announcement&#39;, &#39;Production&#39;, &#39;and&#39;, &#39;Scale&#39;, &#39;Up&#39;, &#39;Pharma&#39;, &#39;Services&#39;, &#39;News&#39;, &#39;schizophrenia&#39;, &#39;antipsychotics&#39;, &#39;Protein&#39;, &#39;Antibodies&#39;, &#39;Preclinical&#39;, &#39;Toxicology&#39;, &#39;Biologics&#39;, &#39;Protein&#39;, &#39;Technology&#39;, &#39;Engineering&#39;, &#39;Protein&#39;, &#39;Therapeutics&#39;, &#39;for&#39;, &#39;Delivery&#39;, &#39;Predictive&#39;, &#39;Toxicity&#39;, &#39;Europe&#39;, &#39;Platform&#39;, &#39;Software&#39;, &#39;for&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Studies&#39;, &#39;Phenotype&#39;, &#39;to&#39;, &#39;Genotype&#39;, &#39;Pathology&#39;, &#39;Protein&#39;, &#39;drugs&#39;, &#39;&amp;&#39;, &#39;diagnostics&#39;, &#39;Intellectual&#39;, &#39;Property&#39;, &#39;Post&#39;, &#39;Translational&#39;, &#39;Modifications&#39;, &#39;Patient&#39;, &#39;Registries&#39;, &#39;Advancing&#39;, &#39;Therapeutics&#39;, &#39;Current&#39;, &#39;Generation&#39;, &#39;Protein&#39;, &#39;Drug&#39;, &#39;Delivery&#39;, &#39;(&#39;, &#39;part&#39;, &#39;of&#39;, &#39;PepTalk&#39;, &#39;)&#39;, &#39;Advancing&#39;, &#39;Therapeutics&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Biological&#39;, &#39;Therapeutic&#39;, &#39;Products&#39;, &#39;Series&#39;, &#39;Pathway/Networks&#39;, &#39;Publications&#39;, &#39;Protein&#39;, &#39;Variations&#39;, &#39;Powertrains&#39;, &#39;Protein&#39;, &#39;Characterization&#39;, &#39;,&#39;, &#39;Purification&#39;, &#39;and&#39;, &#39;Screening&#39;, &#39;Protein&#39;, &#39;Characterization&#39;, &#39;,&#39;, &#39;Purification&#39;, &#39;and&#39;, &#39;Screening&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Europe&#39;, &#39;Beyond&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Europe&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Host&#39;, &#39;Novel&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Systems&#39;, &#39;Protein&#39;, &#39;Engineering&#39;, &#39;Vectors&#39;, &#39;Preventive&#39;, &#39;gene&#39;, &#39;quantification&#39;, &#39;Europe&#39;, &#39;QS&#39;, &#39;Regulation&#39;, &#39;Recombinant&#39;, &#39;Antibodies&#39;, &#39;Recombinant&#39;, &#39;Antibodies&#39;, &#39;Recombinant&#39;, &#39;Proteins&#39;, &#39;Forum&#39;, &#39;Radiation&#39;, &#39;Rare&#39;, &#39;Diseases&#39;, &#39;Antibody&#39;, &#39;Drug&#39;, &#39;Products&#39;, &#39;RBE&#39;, &#39;track&#39;, &#39;at&#39;, &#39;PGE&#39;, &#39;RBE&#39;, &#39;track&#39;, &#39;at&#39;, &#39;PGE&#39;, &#39;Antibody&#39;, &#39;Screening&#39;, &#39;Antibody&#39;, &#39;Translational&#39;, &#39;rapid&#39;, &#39;compound&#39;, &#39;characterization&#39;, &#39;Clinical&#39;, &#39;Enrollment&#39;, &#39;Plan&#39;, &#39;Clinical&#39;, &#39;Recruitment&#39;, &#39;Media&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Patient&#39;, &#39;Recruitment&#39;, &#39;Winning&#39;, &#39;Strategies&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Recruitment&#39;, &#39;Media&#39;, &#39;Integrating&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;and&#39;, &#39;Marketing&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Productivity&#39;, &#39;drug&#39;, &#39;receptors&#39;, &#39;Role&#39;, &#39;of&#39;, &#39;Business&#39;, &#39;Process&#39;, &#39;Managment&#39;, &#39;in&#39;, &#39;FDA&#39;, &#39;Regulated&#39;, &#39;Industry&#39;, &#39;Worldwide&#39;, &#39;Pharma&#39;, &#39;Regulation&#39;, &#39;Surviving&#39;, &#39;FDA&#39;, &#39;Site&#39;, &#39;Inspections&#39;, &#39;Real&#39;, &#39;Estate&#39;, &#39;Risk&#39;, &#39;Evaluation&#39;, &#39;and&#39;, &#39;Mitigation&#39;, &#39;Strategies&#39;, &#39;Renal&#39;, &#39;(&#39;, &#39;kidney&#39;, &#39;)&#39;, &#39;Renewable&#39;, &#39;Energy&#39;, &#39;Storage&#39;, &#39;System&#39;, &#39;RFID&#39;, &#39;Radiofrequency&#39;, &#39;ID&#39;, &#39;Reagents&#39;, &#39;Gap&#39;, &#39;Analysis&#39;, &#39;rheumatoid&#39;, &#39;arthritis&#39;, &#39;gene&#39;, &#39;therapy&#39;, &#39;[&#39;, &#39;RNA&#39;, &#39;blocking&#39;, &#39;]&#39;, &#39;Ribonucleic&#39;, &#39;Acid&#39;, &#39;RNAi&#39;, &#39;for&#39;, &#39;Functional&#39;, &#39;Screening&#39;, &#39;RNAi&#39;, &#39;RNAInterference&#39;, &#39;RNAi&#39;, &#39;Discovery&#39;, &#39;on&#39;, &#39;Target&#39;, &#39;RNAi&#39;, &#39;Video&#39;, &#39;on&#39;, &#39;Request&#39;, &#39;RNA&#39;, &#39;Quality&#39;, &#39;RNA&#39;, &#39;Therapeutics&#39;, &#39;Robotics&#39;, &#39;Regional&#39;, &#39;Organization&#39;, &#39;Robotic&#39;, &#39;Process&#39;, &#39;Automation&#39;, &#39;reperfusion&#39;, &#39;Reproduction&#39;, &#39;Gene&#39;, &#39;Regulation&#39;, &#39;and&#39;, &#39;Regulatory&#39;, &#39;Networks&#39;, &#39;Restenosis&#39;, &#39;Retail&#39;, &#39;Real&#39;, &#39;World&#39;, &#39;Data&#39;, &#39;Therapeutics&#39;, &#39;Indications&#39;, &#39;&amp;&#39;, &#39;Drug&#39;, &#39;Targets&#39;, &#39;Series&#39;, &#39;safety&#39;, &#39;Screening&#39;, &#39;3D&#39;, &#39;Models&#39;, &#39;Sickle&#39;, &#39;Cell&#39;, &#39;Anemia&#39;, &#39;Screening&#39;, &#39;Informatics&#39;, &#39;Sequencing&#39;, &#39;and&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;supply&#39;, &#39;chain&#39;, &#39;management&#39;, &#39;SCOPEs&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Leadership&#39;, &#39;Forum&#39;, &#39;Phenotypic&#39;, &#39;Screening&#39;, &#39;Phenotypic&#39;, &#39;Screening&#39;, &#39;clinical&#39;, &#39;trials&#39;, &#39;strategy&#39;, &#39;IT&#39;, &#39;Security&#39;, &#39;Sequence&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Sequence&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Asia&#39;, &#39;Sidec&#39;, &#39;Executive&#39;, &#39;Forum&#39;, &#39;Sequence&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Europe&#39;, &#39;Sleeper&#39;, &#39;Disease&#39;, &#39;Indications&#39;, &#39;Sequencing&#39;, &#39;Data&#39;, &#39;Storage&#39;, &#39;&amp;&#39;, &#39;Management&#39;, &#39;Screening&#39;, &#39;Difficult&#39;, &#39;Targets&#39;, &#39;Source&#39;, &#39;Document&#39;, &#39;Verification&#39;, &#39;Sequencing&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;&amp;&#39;, &#39;Storage&#39;, &#39;second&#39;, &#39;messengers&#39;, &#39;sepsis&#39;, &#39;infections&#39;, &#39;Sequencing&#39;, &#39;Forum&#39;, &#39;Serotonin&#39;, &#39;Sexual&#39;, &#39;Small&#39;, &#39;Fuel&#39;, &#39;Cells&#39;, &#39;selective&#39;, &#39;immune&#39;, &#39;suppression&#39;, &#39;skin&#39;, &#39;sleep&#39;, &#39;Pharmaceutical&#39;, &#39;Sales&#39;, &#39;Biologics&#39;, &#39;Small&#39;, &#39;Molecular&#39;, &#39;Comparisons&#39;, &#39;Semiconductors&#39;, &#39;small&#39;, &#39;molecules&#39;, &#39;simple&#39;, &#39;model&#39;, &#39;organisms&#39;, &#39;Small&#39;, &#39;Molecules&#39;, &#39;Synthesis&#39;, &#39;Semantic&#39;, &#39;Web&#39;, &#39;Sensor&#39;, &#39;Applications&#39;, &#39;Synthetic&#39;, &#39;Biology&#39;, &#39;Sensor&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Implantable&#39;, &#39;Biomedical&#39;, &#39;Sensors&#39;, &#39;Sensor&#39;, &#39;Materials&#39;, &#39;Sensors&#39;, &#39;Emerging&#39;, &#39;Markets&#39;, &#39;SNPs&#39;, &#39;Sensor&#39;, &#39;Systems&#39;, &#39;Sensor&#39;, &#39;Safety&#39;, &#39;software&#39;, &#39;Solubility&#39;, &#39;Safety&#39;, &#39;Pharmacology&#39;, &#39;for&#39;, &#39;Biologics&#39;, &#39;Safety&#39;, &#39;Pharmacology&#39;, &#39;for&#39;, &#39;Biologics&#39;, &#39;Genomic&#39;, &#39;Sample&#39;, &#39;Preparation&#39;, &#39;Speciality&#39;, &#39;Pharmaceuticals&#39;, &#39;Alternative&#39;, &#39;Splicing&#39;, &#39;Proteomic&#39;, &#39;Sample&#39;, &#39;Preparation&#39;, &#39;High&#39;, &#39;throughput&#39;, &#39;screening&#39;, &#39;partnering&#39;, &#39;solid&#39;, &#39;phase&#39;, &#39;synthesis&#39;, &#39;Subjective&#39;, &#39;End&#39;, &#39;Points&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Sequencing&#39;, &#39;Applications&#39;, &#39;Sequencing&#39;, &#39;Core&#39;, &#39;Labs&#39;, &#39;Next-Generation&#39;, &#39;Data&#39;, &#39;Generation&#39;, &#39;Plant&#39;, &#39;Sequencing&#39;, &#39;RNA&#39;, &#39;Sequencing&#39;, &#39;Sequencing&#39;, &#39;Solutions&#39;, &#39;Deep&#39;, &#39;Sequencing&#39;, &#39;EU&#39;, &#39;Site&#39;, &#39;Selection&#39;, &#39;,&#39;, &#39;Study&#39;, &#39;Activation&#39;, &#39;,&#39;, &#39;and&#39;, &#39;Patient&#39;, &#39;Recruitment&#39;, &#39;Stability&#39;, &#39;stroke&#39;, &#39;Stem&#39;, &#39;Cell&#39;, &#39;Culture&#39;, &#39;Stem&#39;, &#39;Cell&#39;, &#39;Research&#39;, &#39;(&#39;, &#39;part&#39;, &#39;of&#39;, &#39;MMTC&#39;, &#39;)&#39;, &#39;Statin&#39;, &#39;Stem&#39;, &#39;Cells&#39;, &#39;Safety&#39;, &#39;Screening&#39;, &#39;Startup&#39;, &#39;Public&#39;, &#39;companies/stock&#39;, &#39;exchanges&#39;, &#39;CHI&#39;, &#39;Surveys&#39;, &#39;Services&#39;, &#39;Systems&#39;, &#39;Biology&#39;, &#39;for&#39;, &#39;BYG&#39;, &#39;track&#39;, &#39;synthesis&#39;, &#39;Systems&#39;, &#39;Biology&#39;, &#39;Training&#39;, &#39;&amp;&#39;, &#39;Development&#39;, &#39;Top&#39;, &#39;50&#39;, &#39;Big&#39;, &#39;Pharmas&#39;, &#39;Tissue&#39;, &#39;Microarrays&#39;, &#39;taxol&#39;, &#39;tamoxifen&#39;, &#39;and&#39;, &#39;other&#39;, &#39;derivatives&#39;, &#39;Tuberculosis&#39;, &#39;Tobacco&#39;, &#39;The&#39;, &#39;Biotech&#39;, &#39;Journal&#39;, &#39;Email&#39;, &#39;List&#39;, &#39;Trust&#39;, &#39;Building&#39;, &#39;for&#39;, &#39;Collaborative&#39;, &#39;Innovation&#39;, &#39;Tumor&#39;, &#39;,&#39;, &#39;Circulating&#39;, &#39;Cells&#39;, &#39;Technology&#39;, &#39;Technology&#39;, &#39;Consortium&#39;, &#39;Target&#39;, &#39;Driven&#39;, &#39;Chemistry&#39;, &#39;targeted&#39;, &#39;drug&#39;, &#39;delivery&#39;, &#39;transgenic&#39;, &#39;disease&#39;, &#39;models&#39;, &#39;Thrombotic&#39;, &#39;Disease&#39;, &#39;tissue&#39;, &#39;engineering&#39;, &#39;telomerases&#39;, &#39;Battery&#39;, &#39;Testing&#39;, &#39;Transfection&#39;, &#39;Toxicogenomics&#39;, &#39;Target&#39;, &#39;Prioritization&#39;, &#39;Target&#39;, &#39;Identification&#39;, &#39;tissues&#39;, &#39;Technology&#39;, &#39;Platforms&#39;, &#39;Immunotherapies&#39;, &#39;Telecommunications&#39;, &#39;Telemedicine&#39;, &#39;Tumor&#39;, &#39;Microenvironment&#39;, &#39;Trial&#39;, &#39;Master&#39;, &#39;File&#39;, &#39;for&#39;, &#39;Sponsors&#39;, &#39;(&#39;, &#39;pharma&#39;, &#39;)&#39;, &#39;Trial&#39;, &#39;Master&#39;, &#39;File&#39;, &#39;for&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;Theranostic&#39;, &#39;Market&#39;, &#39;Models&#39;, &#39;tumor&#39;, &#39;necrosis&#39;, &#39;factors&#39;, &#39;Therapeutics&#39;, &#39;and&#39;, &#39;Targets&#39;, &#39;Therapeutics&#39;, &#39;&amp;&#39;, &#39;Targets&#39;, &#39;Series&#39;, &#39;immune&#39;, &#39;tolerance&#39;, &#39;Fibrinolytic&#39;, &#39;(&#39;, &#39;clot&#39;, &#39;buster&#39;, &#39;)&#39;, &#39;Transgenic&#39;, &#39;Production&#39;, &#39;in&#39;, &#39;Plants&#39;, &#39;Synthetic&#39;, &#39;Biology&#39;, &#39;Transportation&#39;, &#39;Translational&#39;, &#39;Biomarkers&#39;, &#39;Translational&#39;, &#39;Informatics&#39;, &#39;Drug/Disease&#39;, &#39;Targets&#39;, &#39;Drug&#39;, &#39;Targets&#39;, &#39;Series&#39;, &#39;Genome&#39;, &#39;Tri&#39;, &#39;Conference&#39;, &#39;Translation&#39;, &#39;Services&#39;, &#39;transgenics&#39;, &#39;gene&#39;, &#39;knockouts&#39;, &#39;transgenic&#39;, &#39;production&#39;, &#39;Tumor&#39;, &#39;Suppressor&#39;, &#39;Genes&#39;, &#39;tissue&#39;, &#39;safety&#39;, &#39;Technology&#39;, &#39;&amp;&#39;, &#39;Tools&#39;, &#39;for&#39;, &#39;the&#39;, &#39;Life&#39;, &#39;Sciences&#39;, &#39;Technology&#39;, &#39;&amp;&#39;, &#39;Tools&#39;, &#39;for&#39;, &#39;Life&#39;, &#39;Sciences&#39;, &#39;Series&#39;, &#39;Target&#39;, &#39;Validation&#39;, &#39;Text&#39;, &#39;Mining&#39;, &#39;Unmanned&#39;, &#39;Aerial&#39;, &#39;Vehicles&#39;, &#39;Ubiquitin&#39;, &#39;Uninterruptible&#39;, &#39;Power&#39;, &#39;Supplies&#39;, &#39;upcoming&#39;, &#39;conferences&#39;, &#39;upcoming&#39;, &#39;conferences&#39;, &#39;Europe&#39;, &#39;Urinary&#39;, &#39;Incontinence&#39;, &#39;New&#39;, &#39;USP&#39;, &#39;Initiatives&#39;, &#39;and&#39;, &#39;Standards&#39;, &#39;for&#39;, &#39;Biologics&#39;, &#39;unstable&#39;, &#39;triplets&#39;, &#39;trinucleotide&#39;, &#39;repeats&#39;, &#39;Vaccines&#39;, &#39;(&#39;, &#39;for&#39;, &#39;IMT&#39;, &#39;)&#39;, &#39;Vascular&#39;, &#39;Vaccines&#39;, &#39;Business&#39;, &#39;Opportunities&#39;, &#39;Venture&#39;, &#39;Capital&#39;, &#39;Business&#39;, &#39;Opportunities&#39;, &#39;Vaccines&#39;, &#39;Voice&#39;, &#39;Recognition&#39;, &#39;Paperless&#39;, &#39;Validation&#39;, &#39;veterinary&#39;, &#39;viral&#39;, &#39;infections&#39;, &#39;Vaccines&#39;, &#39;Production&#39;, &#39;&amp;&#39;, &#39;Manufacturing&#39;, &#39;Virtual&#39;, &#39;Reality&#39;, &#39;virtual&#39;, &#39;business&#39;, &#39;Virtual&#39;, &#39;Teams&#39;, &#39;Single&#39;, &#39;Use&#39;, &#39;Systems&#39;, &#39;for&#39;, &#39;Vaccine&#39;, &#39;Manufacture&#39;, &#39;well&#39;, &#39;characterized&#39;, &#39;biologicals&#39;, &#39;Wellness&#39;, &#39;Wiki&#39;, &#39;wound&#39;, &#39;management&#39;, &#39;Wireless&#39;, &#39;Change&#39;, &#39;Record&#39;, &#39;Change&#39;, &#39;Record&#39;, &#39;Mary&#39;, &#39;Chitty&#39;, &#39;Xenotransplantation&#39;, &#39;Yeast&#39;, &#39;Display&#39;, &#39;Zika&#39;, &#39;Vaccine&#39;, &#39;Development&#39;]
</pre>
</div>
</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[14]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="kn">from</span> <span class="nn">nltk.probability</span> <span class="k">import</span> <span class="n">FreqDist</span>
<span class="n">fdist</span> <span class="o">=</span> <span class="n">FreqDist</span><span class="p">(</span><span class="n">tokenized_word</span><span class="p">)</span>
<span class="nb">print</span><span class="p">(</span><span class="n">fdist</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>&lt;FreqDist with 1710 samples and 4829 outcomes&gt;
</pre>
</div>
</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[15]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">fdist</span><span class="o">.</span><span class="n">most_common</span><span class="p">(</span><span class="mi">10</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt output_prompt">Out[15]:</div>




<div class="output_text output_subarea output_execute_result">
<pre>[(&#39;Clinical&#39;, 115),
 (&#39;for&#39;, 100),
 (&#39;&amp;&#39;, 75),
 (&#39;Drug&#39;, 59),
 (&#39;Europe&#39;, 56),
 (&#39;of&#39;, 56),
 (&#39;and&#39;, 54),
 (&#39;Management&#39;, 48),
 (&#39;Protein&#39;, 46),
 (&#39;Diagnostics&#39;, 44)]</pre>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[25]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="kn">import</span> <span class="nn">matplotlib.pyplot</span> <span class="k">as</span> <span class="nn">plt</span>
<span class="n">fdist</span><span class="o">.</span><span class="n">plot</span><span class="p">(</span><span class="mi">10</span><span class="p">,</span><span class="n">cumulative</span><span class="o">=</span><span class="kc">False</span><span class="p">)</span>
<span class="n">plt</span><span class="o">.</span><span class="n">show</span><span class="p">()</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>




<div class="output_png output_subarea ">
<img src="data:image/png;base64,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
"
>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[26]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="kn">from</span> <span class="nn">nltk.corpus</span> <span class="k">import</span> <span class="n">stopwords</span>
</pre></div>

    </div>
</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[28]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="kn">import</span> <span class="nn">nltk</span>
<span class="n">nltk</span><span class="o">.</span><span class="n">download</span><span class="p">(</span><span class="s1">&#39;stopwords&#39;</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stderr output_text">
<pre>[nltk_data] Downloading package stopwords to
[nltk_data]     C:\Users\vmohite\AppData\Roaming\nltk_data...
[nltk_data]   Unzipping corpora\stopwords.zip.
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt output_prompt">Out[28]:</div>




<div class="output_text output_subarea output_execute_result">
<pre>True</pre>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[29]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="kn">from</span> <span class="nn">nltk.corpus</span> <span class="k">import</span> <span class="n">stopwords</span>
<span class="n">stop_words</span><span class="o">=</span><span class="nb">set</span><span class="p">(</span><span class="n">stopwords</span><span class="o">.</span><span class="n">words</span><span class="p">(</span><span class="s2">&quot;english&quot;</span><span class="p">))</span>
<span class="nb">print</span><span class="p">(</span><span class="n">stop_words</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>{&#39;is&#39;, &#39;but&#39;, &#39;once&#39;, &#39;myself&#39;, &#39;out&#39;, &#39;what&#39;, &#34;you&#39;ve&#34;, &#39;both&#39;, &#34;hadn&#39;t&#34;, &#34;haven&#39;t&#34;, &#39;needn&#39;, &#39;couldn&#39;, &#39;same&#39;, &#39;very&#39;, &#34;doesn&#39;t&#34;, &#39;he&#39;, &#39;a&#39;, &#39;being&#39;, &#39;or&#39;, &#39;between&#39;, &#39;up&#39;, &#34;you&#39;re&#34;, &#39;them&#39;, &#34;couldn&#39;t&#34;, &#39;yourself&#39;, &#39;were&#39;, &#39;didn&#39;, &#39;few&#39;, &#39;him&#39;, &#34;hasn&#39;t&#34;, &#39;herself&#39;, &#39;before&#39;, &#39;down&#39;, &#39;re&#39;, &#39;can&#39;, &#39;aren&#39;, &#39;should&#39;, &#39;won&#39;, &#34;isn&#39;t&#34;, &#39;now&#39;, &#39;his&#39;, &#39;and&#39;, &#39;there&#39;, &#39;don&#39;, &#39;who&#39;, &#39;m&#39;, &#39;any&#39;, &#39;hers&#39;, &#39;she&#39;, &#39;these&#39;, &#39;me&#39;, &#39;than&#39;, &#39;over&#39;, &#39;why&#39;, &#39;ain&#39;, &#39;whom&#39;, &#34;didn&#39;t&#34;, &#39;do&#39;, &#39;yourselves&#39;, &#39;on&#39;, &#39;as&#39;, &#39;which&#39;, &#39;have&#39;, &#34;you&#39;ll&#34;, &#39;just&#39;, &#39;y&#39;, &#39;mightn&#39;, &#34;mustn&#39;t&#34;, &#39;for&#39;, &#34;wouldn&#39;t&#34;, &#39;haven&#39;, &#34;shouldn&#39;t&#34;, &#34;mightn&#39;t&#34;, &#34;don&#39;t&#34;, &#39;ourselves&#39;, &#39;s&#39;, &#39;ve&#39;, &#39;its&#39;, &#39;am&#39;, &#39;we&#39;, &#39;did&#39;, &#39;when&#39;, &#39;some&#39;, &#39;above&#39;, &#39;hasn&#39;, &#39;wasn&#39;, &#39;are&#39;, &#39;has&#39;, &#39;then&#39;, &#39;that&#39;, &#39;hadn&#39;, &#39;your&#39;, &#39;nor&#39;, &#39;d&#39;, &#39;her&#39;, &#34;needn&#39;t&#34;, &#39;you&#39;, &#39;theirs&#39;, &#39;doing&#39;, &#39;had&#39;, &#39;been&#39;, &#34;it&#39;s&#34;, &#39;other&#39;, &#39;by&#39;, &#39;o&#39;, &#39;ma&#39;, &#39;an&#39;, &#39;in&#39;, &#39;here&#39;, &#39;their&#39;, &#39;through&#39;, &#34;weren&#39;t&#34;, &#39;into&#39;, &#39;own&#39;, &#39;most&#39;, &#34;won&#39;t&#34;, &#39;t&#39;, &#39;itself&#39;, &#39;of&#39;, &#39;it&#39;, &#34;wasn&#39;t&#34;, &#39;mustn&#39;, &#39;not&#39;, &#39;himself&#39;, &#34;should&#39;ve&#34;, &#39;doesn&#39;, &#39;i&#39;, &#39;the&#39;, &#39;so&#39;, &#39;themselves&#39;, &#39;all&#39;, &#39;during&#39;, &#39;after&#39;, &#39;ll&#39;, &#39;wouldn&#39;, &#39;ours&#39;, &#39;more&#39;, &#39;weren&#39;, &#39;because&#39;, &#39;such&#39;, &#39;until&#39;, &#34;she&#39;s&#34;, &#39;from&#39;, &#39;where&#39;, &#39;about&#39;, &#39;if&#39;, &#39;shouldn&#39;, &#39;below&#39;, &#39;each&#39;, &#39;isn&#39;, &#34;shan&#39;t&#34;, &#39;shan&#39;, &#39;with&#39;, &#39;will&#39;, &#34;you&#39;d&#34;, &#39;yours&#39;, &#39;those&#39;, &#39;under&#39;, &#34;aren&#39;t&#34;, &#39;while&#39;, &#39;again&#39;, &#39;this&#39;, &#39;to&#39;, &#39;further&#39;, &#39;our&#39;, &#39;my&#39;, &#39;against&#39;, &#39;they&#39;, &#39;at&#39;, &#39;does&#39;, &#39;was&#39;, &#39;too&#39;, &#34;that&#39;ll&#34;, &#39;how&#39;, &#39;only&#39;, &#39;no&#39;, &#39;off&#39;, &#39;having&#39;, &#39;be&#39;}
</pre>
</div>
</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[32]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">filtered_sent</span><span class="o">=</span><span class="p">[]</span>
<span class="k">for</span> <span class="n">w</span> <span class="ow">in</span> <span class="n">tokenized_word</span><span class="p">:</span>
    <span class="k">if</span> <span class="n">w</span> <span class="ow">not</span> <span class="ow">in</span> <span class="n">stop_words</span><span class="p">:</span>
        <span class="n">filtered_sent</span><span class="o">.</span><span class="n">append</span><span class="p">(</span><span class="n">w</span><span class="p">)</span>
<span class="nb">print</span><span class="p">(</span><span class="s2">&quot;Tokenized Sentence:&quot;</span><span class="p">,</span><span class="n">tokenized_word</span><span class="p">)</span>
<span class="nb">print</span><span class="p">(</span><span class="s2">&quot;Filterd Sentence:&quot;</span><span class="p">,</span><span class="n">filtered_sent</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>Tokenized Sentence: [&#39;Molecular&#39;, &#39;Medicine&#39;, &#39;Tri&#39;, &#39;Conference&#39;, &#39;Protein&#39;, &#39;Engineering&#39;, &#39;Peptalk&#39;, &#39;Biocomputing&#39;, &#39;SCOPE&#39;, &#39;Summit&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Operations&#39;, &#39;Executives&#39;, &#39;bioproduction&#39;, &#39;Discovery&#39;, &#39;on&#39;, &#39;Target&#39;, &#39;PEGS&#39;, &#39;Europe&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Chemistry&#39;, &#39;World&#39;, &#39;Pharmaceutical&#39;, &#39;Congress&#39;, &#39;advanced&#39;, &#39;diagnostics&#39;, &#39;Advanced&#39;, &#39;Automotive&#39;, &#39;Battery&#39;, &#39;Conference&#39;, &#39;(&#39;, &#39;AABC&#39;, &#39;)&#39;, &#39;Europe&#39;, &#39;Florida&#39;, &#39;Battery&#39;, &#39;Conference&#39;, &#39;Biomarkers&#39;, &#39;Congress&#39;, &#39;High&#39;, &#39;Content&#39;, &#39;Analysis&#39;, &#39;Advanced&#39;, &#39;Automotive&#39;, &#39;Battery&#39;, &#39;Conference&#39;, &#39;(&#39;, &#39;AABC&#39;, &#39;)&#39;, &#39;Immunogenicity&#39;, &#39;CRA&#39;, &#39;&amp;&#39;, &#39;CRC&#39;, &#39;Beginner&#39;, &#39;Biopharmaceutical&#39;, &#39;Change&#39;, &#39;Control&#39;, &#39;Beyond&#39;, &#39;Genome&#39;, &#39;Immunotherapy&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;Strategies&#39;, &#39;Targeted&#39;, &#39;ImvacS&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Molecular&#39;, &#39;Medicine&#39;, &#39;Marketplace&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Europe&#39;, &#39;CRA&#39;, &#39;Beginner&#39;, &#39;AI&#39;, &#39;World&#39;, &#39;Data&#39;, &#39;Driven&#39;, &#39;Discovery&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Strategies&#39;, &#39;Strategic&#39;, &#39;Resource&#39;, &#39;Allocation&#39;, &#39;kinases&#39;, &#39;Auditing&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Studies&#39;, &#39;Accelerating&#39;, &#39;Development&#39;, &#39;&amp;&#39;, &#39;Advancing&#39;, &#39;Personalized&#39;, &#39;Therapy&#39;, &#39;X&#39;, &#39;Gen&#39;, &#39;Congress&#39;, &#39;Biodefense&#39;, &#39;&amp;&#39;, &#39;Enabling&#39;, &#39;POC&#39;, &#39;Diagnostics&#39;, &#39;&amp;&#39;, &#39;Microarray&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Human&#39;, &#39;Genome&#39;, &#39;Project&#39;, &#39;Biobanks&#39;, &#39;Structure&#39;, &#39;Based&#39;, &#39;Design&#39;, &#39;Batteries&#39;, &#39;Portfolio&#39;, &#39;Quantitative&#39;, &#39;PCR&#39;, &#39;Health&#39;, &#39;Information&#39;, &#39;Technology&#39;, &#39;Auditing&#39;, &#39;Techniques&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Professionals&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;Question&#39;, &#39;&amp;&#39;, &#39;Answer&#39;, &#39;REference&#39;, &#39;Guide&#39;, &#39;CFR/ICH&#39;, &#39;GCP&#39;, &#39;Immunotherapy&#39;, &#39;Europe&#39;, &#39;Gene&#39;, &#39;Amplification&#39;, &#39;PCR&#39;, &#39;eStats&#39;, &#39;:&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Statistical&#39;, &#39;Sourcebook&#39;, &#39;MicroRNA&#39;, &#39;microarray&#39;, &#39;data&#39;, &#39;analysis&#39;, &#39;Intelliigent&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;Development&#39;, &#39;(&#39;, &#39;now&#39;, &#39;WPC&#39;, &#39;)&#39;, &#39;Monitoring&#39;, &#39;Clinical&#39;, &#39;Drug&#39;, &#39;Studies&#39;, &#39;:&#39;, &#39;Beginner&#39;, &#39;Comprehensive&#39;, &#39;Monitoring&#39;, &#39;for&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Introduction&#39;, &#39;to&#39;, &#39;Clinical&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;Bioprocessing&#39;, &#39;Summit&#39;, &#39;Europe&#39;, &#39;Oligonucleotide&#39;, &#39;&amp;&#39;, &#39;Peptide&#39;, &#39;Summit&#39;, &#39;World&#39;, &#39;Pharma&#39;, &#39;Week&#39;, &#39;Prenatal&#39;, &#39;Diagnostics&#39;, &#39;Getting&#39;, &#39;Optimized&#39;, &#39;Targets&#39;, &#39;Library&#39;, &#39;Design&#39;, &#39;&amp;&#39;, &#39;Synthesis&#39;, &#39;Clinical&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;functional&#39;, &#39;genomics&#39;, &#39;bacterial&#39;, &#39;infections&#39;, &#39;Advanced&#39;, &#39;Automotive&#39;, &#39;Battery&#39;, &#39;Conference&#39;, &#39;(&#39;, &#39;AABC&#39;, &#39;)&#39;, &#39;Asia&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;Q&#39;, &#39;&amp;&#39;, &#39;A&#39;, &#39;Reference&#39;, &#39;Guide&#39;, &#39;Screening&#39;, &#39;Transmissible&#39;, &#39;spongiform&#39;, &#39;encephalopathy&#39;, &#39;TSE&#39;, &#39;Biomarker&#39;, &#39;Discovery&#39;, &#39;Summit&#39;, &#39;Clinical&#39;, &#39;Genomics&#39;, &#39;Sequencing&#39;, &#39;ASAP&#39;, &#39;Alliance&#39;, &#39;Summit&#39;, &#39;Bioterrorism&#39;, &#39;microarrays&#39;, &#39;Pharmaceutical&#39;, &#39;Leadership&#39;, &#39;Summit&#39;, &#39;Circulating&#39;, &#39;Cell-Free&#39;, &#39;DNA&#39;, &#39;Conducting&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Under&#39;, &#39;ICH&#39;, &#39;GCP&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;Europe&#39;, &#39;Trial&#39;, &#39;Master&#39;, &#39;File&#39;, &#39;Biomarkers&#39;, &#39;World&#39;, &#39;Preclinical&#39;, &#39;Congress&#39;, &#39;Europe&#39;, &#39;BioMEMS&#39;, &#39;bioinformatics&#39;, &#39;Genomic&#39;, &#39;Partnering&#39;, &#39;NMR&#39;, &#39;nuclear&#39;, &#39;magnetic&#39;, &#39;resonance&#39;, &#39;Clinical&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Biomarker&#39;, &#39;Validation&#39;, &#39;proteomics&#39;, &#39;Statistics&#39;, &#39;Sensors&#39;, &#39;Global&#39;, &#39;Summit&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;A&#39;, &#39;Regulatory&#39;, &#39;Overview&#39;, &#39;Drug&#39;, &#39;Safety&#39;, &#39;Pharmacy&#39;, &#39;Diagnostics&#39;, &#39;sample&#39;, &#39;preparation&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Design&#39;, &#39;Pharmacovigilance&#39;, &#39;Metabolic&#39;, &#39;Profiling&#39;, &#39;Digital&#39;, &#39;PCR&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Lab&#39;, &#39;chips&#39;, &#39;Europe&#39;, &#39;Monitoring&#39;, &#39;Clinical&#39;, &#39;Drug&#39;, &#39;Studies&#39;, &#39;:&#39;, &#39;Intermediate&#39;, &#39;Preparing&#39;, &#39;IND&#39;, &#39;Submissions&#39;, &#39;Antibody&#39;, &#39;Engineering&#39;, &#39;Asia&#39;, &#39;Clinical&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;:&#39;, &#39;Intermediate&#39;, &#39;phage&#39;, &#39;display&#39;, &#39;CELLutions&#39;, &#39;Recombinant&#39;, &#39;Antibodies&#39;, &#39;imaging&#39;, &#39;Biomarker&#39;, &#39;Assay&#39;, &#39;Development&#39;, &#39;in&#39;, &#39;silico&#39;, &#39;biology&#39;, &#39;Advanced&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;High&#39;, &#39;Throughput&#39;, &#39;Optimization&#39;, &#39;of&#39;, &#39;Culture&#39;, &#39;Conditions&#39;, &#39;for&#39;, &#39;Bioprocessing&#39;, &#39;High&#39;, &#39;Throughput&#39;, &#39;Technologies&#39;, &#39;gene&#39;, &#39;quantfication&#39;, &#39;[&#39;, &#39;real&#39;, &#39;time&#39;, &#39;PCR&#39;, &#39;]&#39;, &#39;From&#39;, &#39;Gene&#39;, &#39;Expression&#39;, &#39;Profiling&#39;, &#39;to&#39;, &#39;Validated&#39;, &#39;Biology&#39;, &#39;Clinical&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;:&#39;, &#39;Advanced&#39;, &#39;SCOPE&#39;, &#39;Summit&#39;, &#39;Europe&#39;, &#39;CNS&#39;, &#39;Partnering&#39;, &#39;Genomics&#39;, &#39;on&#39;, &#39;Target&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Statistical&#39;, &#39;Sourcebook&#39;, &#39;MultiUser&#39;, &#39;License&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Development&#39;, &#39;Biological&#39;, &#39;ADME&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;blood&#39;, &#39;safety&#39;, &#39;and&#39;, &#39;screening&#39;, &#39;Human&#39;, &#39;Proteome&#39;, &#39;Project&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;high&#39;, &#39;throughput&#39;, &#39;organic&#39;, &#39;synthesis&#39;, &#39;Global&#39;, &#39;Preclinical&#39;, &#39;Development&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Coordinator&#39;, &#39;Global&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;India&#39;, &#39;Biomarker&#39;, &#39;Diagnostics&#39;, &#39;molecular&#39;, &#39;diversity&#39;, &#39;functional&#39;, &#39;genomics&#39;, &#39;Process&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Summit&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;bioinformatics&#39;, &#39;Europe&#39;, &#39;Target&#39;, &#39;Validation&#39;, &#39;Bispecific&#39;, &#39;Antibodies&#39;, &#39;Bridging&#39;, &#39;Pharma&#39;, &#39;and&#39;, &#39;IT&#39;, &#39;Green&#39;, &#39;Fluorescent&#39;, &#39;Proteins&#39;, &#39;Quality&#39;, &#39;Systems&#39;, &#39;CRA&#39;, &#39;Monitoring&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;Development&#39;, &#39;AI&#39;, &#39;in&#39;, &#39;Government&#39;, &#39;glycotechnology&#39;, &#39;Baculovirus&#39;, &#39;Drug&#39;, &#39;Repurposing&#39;, &#39;drug&#39;, &#39;discovery&#39;, &#39;and&#39;, &#39;development&#39;, &#39;Japan&#39;, &#39;The&#39;, &#39;CRA&#39;, &#39;Manager&#39;, &#39;Course&#39;, &#39;State&#39;, &#39;by&#39;, &#39;State&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Requirments&#39;, &#39;Reference&#39;, &#39;Guide&#39;, &#39;Adverse&#39;, &#39;Events&#39;, &#39;:&#39;, &#39;Managing&#39;, &#39;&amp;&#39;, &#39;Reporting&#39;, &#39;for&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Good&#39;, &#39;Laboratory&#39;, &#39;Practice&#39;, &#39;Process&#39;, &#39;Chemistry&#39;, &#39;Beyond&#39;, &#39;Sequencing&#39;, &#39;Process&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Summit&#39;, &#39;with&#39;, &#39;GLP&#39;, &#39;Batteries&#39;, &#39;Biomarkers&#39;, &#39;Europe&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;computer&#39;, &#39;hardware&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;patient&#39;, &#39;Recruitment&#39;, &#39;Working&#39;, &#39;with&#39;, &#39;CROs&#39;, &#39;Expediting&#39;, &#39;Drugs&#39;, &#39;and&#39;, &#39;Biologics&#39;, &#39;Development&#39;, &#39;Tissue&#39;, &#39;Sealants&#39;, &#39;-&#39;, &#39;One&#39;, &#39;Day&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Europe&#39;, &#39;Use&#39;, &#39;of&#39;, &#39;Note&#39;, &#39;to&#39;, &#39;Files&#39;, &#39;in&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Essential&#39;, &#39;Documentation&#39;, &#39;Antibody&#39;, &#39;Engineering&#39;, &#39;Korea&#39;, &#39;RNAi&#39;, &#39;for&#39;, &#39;Pathway&#39;, &#39;Analysis&#39;, &#39;Advanced&#39;, &#39;GCP&#39;, &#39;Compliance&#39;, &#39;Mechanisms&#39;, &#39;of&#39;, &#39;Cancer&#39;, &#39;Business&#39;, &#39;Diagnostics&#39;, &#39;(&#39;, &#39;Impact&#39;, &#39;of&#39;, &#39;New&#39;, &#39;Diagnotics&#39;, &#39;)&#39;, &#39;Consumer&#39;, &#39;Genomics&#39;, &#39;Conference&#39;, &#39;Recombinant&#39;, &#39;Antibodies&#39;, &#39;Europe&#39;, &#39;Research&#39;, &#39;Site&#39;, &#39;Clinical&#39;, &#39;Study&#39;, &#39;Budgets&#39;, &#39;and&#39;, &#39;Contracts&#39;, &#39;Proof&#39;, &#39;of&#39;, &#39;Concept&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;in&#39;, &#39;China&#39;, &#39;Future&#39;, &#39;Diagnostics&#39;, &#39;Medicinal&#39;, &#39;Chemistry&#39;, &#39;Combination&#39;, &#39;Therapies&#39;, &#39;CRA&#39;, &#39;Training&#39;, &#39;Series&#39;, &#39;(&#39;, &#39;1-7&#39;, &#39;)&#39;, &#39;Lab&#39;, &#39;Chips&#39;, &#39;Japan&#39;, &#39;Human&#39;, &#39;Genomes&#39;, &#39;Europe&#39;, &#39;Tissue&#39;, &#39;Based&#39;, &#39;Screening&#39;, &#39;lead&#39;, &#39;optimization&#39;, &#39;Adverse&#39;, &#39;Events&#39;, &#39;Reimbursement&#39;, &#39;Diagnostics&#39;, &#39;labels&#39;, &#39;signals&#39;, &#39;and&#39;, &#39;detection&#39;, &#39;ASAP&#39;, &#39;CHI&#39;, &#39;Bio&#39;, &#39;Pharm&#39;, &#39;Alliance&#39;, &#39;Summit&#39;, &#39;forensic&#39;, &#39;diagnostics&#39;, &#39;Writing&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Molecular&#39;, &#39;Profiling&#39;, &#39;with&#39;, &#39;Cellular&#39;, &#39;Resolution&#39;, &#39;10&#39;, &#39;Rules&#39;, &#39;of&#39;, &#39;Effective&#39;, &#39;Report&#39;, &#39;Writing&#39;, &#39;pharmacogenomics&#39;, &#39;europe&#39;, &#39;Exploring&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Sequencing&#39;, &#39;conference&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;&amp;&#39;, &#39;FDA&#39;, &#39;Regulations&#39;, &#39;HCA&#39;, &#39;East&#39;, &#39;Cancer&#39;, &#39;Immunotherapies&#39;, &#39;(&#39;, &#39;formerly&#39;, &#39;Cancer&#39;, &#39;Vaccines&#39;, &#39;)&#39;, &#39;Biologics&#39;, &#39;Development&#39;, &#39;A&#39;, &#39;Regulatory&#39;, &#39;Overview&#39;, &#39;Standard&#39;, &#39;Operating&#39;, &#39;Proces&#39;, &#39;in&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;molecular&#39;, &#39;pharmacology&#39;, &#39;RNA&#39;, &#39;Interference&#39;, &#39;Summit&#39;, &#39;Clinical&#39;, &#39;Training&#39;, &#39;oligonucleotides&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Protocols&#39;, &#39;toxicology&#39;, &#39;Immunogenicity&#39;, &#39;Testing&#39;, &#39;for&#39;, &#39;Biologics&#39;, &#39;Adaptive&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;ADME&#39;, &#39;Stem&#39;, &#39;Cells&#39;, &#39;in&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;and&#39;, &#39;Development&#39;, &#39;Drug&#39;, &#39;Pipeline&#39;, &#39;Success&#39;, &#39;(&#39;, &#39;Pipeline&#39;, &#39;Success&#39;, &#39;Summit&#39;, &#39;)&#39;, &#39;stem&#39;, &#39;cells&#39;, &#39;Data&#39;, &#39;Visualization&#39;, &#39;Pharmacokinetics&#39;, &#39;transgenic&#39;, &#39;animal&#39;, &#39;models&#39;, &#39;Business&#39;, &#39;Development&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;Interface&#39;, &#39;Monitoring&#39;, &#39;Clinical&#39;, &#39;Drug&#39;, &#39;Studies&#39;, &#39;:&#39;, &#39;Advanced&#39;, &#39;Digital&#39;, &#39;Health&#39;, &#39;Innovation&#39;, &#39;Summit&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;in&#39;, &#39;the&#39;, &#39;Electronic&#39;, &#39;Data&#39;, &#39;Capture&#39;, &#39;Arena&#39;, &#39;Case&#39;, &#39;Report&#39;, &#39;Forms&#39;, &#39;Battery&#39;, &#39;Safety&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;GCP&#39;, &#39;Overview&#39;, &#39;Clinical&#39;, &#39;Administrative&#39;, &#39;Support&#39;, &#39;Staff&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;&amp;&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;Pre-Implantation&#39;, &#39;Diagnostics&#39;, &#39;Eyesight&#39;, &#39;Biomarker&#39;, &#39;Diagnostics&#39;, &#39;Biomarker&#39;, &#39;Web&#39;, &#39;Symposia&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;Process&#39;, &#39;Neglected&#39;, &#39;Diseases&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Approval&#39;, &#39;Process&#39;, &#39;Code&#39;, &#39;of&#39;, &#39;Federal&#39;, &#39;Regulations&#39;, &#39;for&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Associate&#39;, &#39;G&#39;, &#39;protein&#39;, &#39;coupled&#39;, &#39;receptors&#39;, &#39;GPCRS&#39;, &#39;Prenatal&#39;, &#39;Diagnostics&#39;, &#39;Europe&#39;, &#39;Genomic&#39;, &#39;Tools&#39;, &#39;&amp;&#39;, &#39;Technologies&#39;, &#39;Biomarkers&#39;, &#39;Europe&#39;, &#39;Symyx&#39;, &#39;Business&#39;, &#39;Collaborative&#39;, &#39;Innovation&#39;, &#39;Source&#39;, &#39;Documentation&#39;, &#39;Mitochondria&#39;, &#39;Comparative&#39;, &#39;Genomic&#39;, &#39;Hybridization&#39;, &#39;Lithium&#39;, &#39;Battery&#39;, &#39;Power&#39;, &#39;Writing&#39;, &#39;Clinical&#39;, &#39;Study&#39;, &#39;Protocols&#39;, &#39;Reimbursement&#39;, &#39;Therapeutics&#39;, &#39;genetic&#39;, &#39;variations&#39;, &#39;Business&#39;, &#39;Investigator&#39;, &#39;initiated&#39;, &#39;trials&#39;, &#39;Burrill&#39;, &#39;Book&#39;, &#39;Bio-IT&#39;, &#39;Asia&#39;, &#39;Compound&#39;, &#39;Profiling&#39;, &#39;cancer&#39;, &#39;clinical&#39;, &#39;trials&#39;, &#39;Chemical&#39;, &#39;Genomics&#39;, &#39;Safety/Toxicity&#39;, &#39;Biomarkers&#39;, &#39;Cancer&#39;, &#39;Diagnosis&#39;, &#39;antibody&#39;, &#39;engineering&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;in&#39;, &#39;Asia&#39;, &#39;West&#39;, &#39;Coast&#39;, &#39;Virtual&#39;, &#39;Screening&#39;, &#39;Point&#39;, &#39;of&#39;, &#39;Care&#39;, &#39;Diagnostics&#39;, &#39;Protein&#39;, &#39;Formulation&#39;, &#39;genetic&#39;, &#39;diagnostics&#39;, &#39;Bridging&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;IT&#39;, &#39;Biofuels&#39;, &#39;Translational&#39;, &#39;Medicine&#39;, &#39;Personalized&#39;, &#39;Medicine&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Organization&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;Congress&#39;, &#39;Europe&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;Risk&#39;, &#39;Based&#39;, &#39;Site&#39;, &#39;Monitoring&#39;, &#39;Root&#39;, &#39;Cause&#39;, &#39;Analysis&#39;, &#39;Monitoring&#39;, &#39;Phase&#39;, &#39;I&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;Latin&#39;, &#39;America&#39;, &#39;Licensing&#39;, &#39;vaccines&#39;, &#39;cancer&#39;, &#39;genetics&#39;, &#39;and&#39;, &#39;genomics&#39;, &#39;Marketing&#39;, &#39;Reimbursement&#39;, &#39;Metabolic&#39;, &#39;Analytical&#39;, &#39;Methods&#39;, &#39;Difficult&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;Protein&#39;, &#39;Chips/Arrays&#39;, &#39;Monitoring&#39;, &#39;Plan&#39;, &#39;Development&#39;, &#39;Genome&#39;, &#39;Japan&#39;, &#39;Immunogenicity&#39;, &#39;Advances&#39;, &#39;in&#39;, &#39;Management&#39;, &#39;and&#39;, &#39;Reduction&#39;, &#39;Clinical&#39;, &#39;Auditing&#39;, &#39;Clinical&#39;, &#39;Informatics&#39;, &#39;Antibody-Drug&#39;, &#39;Conjugates&#39;, &#39;Electronic&#39;, &#39;Medical&#39;, &#39;Records&#39;, &#39;&amp;&#39;, &#39;Source&#39;, &#39;Document&#39;, &#39;Verification&#39;, &#39;Bridge&#39;, &#39;to&#39;, &#39;Pop&#39;, &#39;Health&#39;, &#39;East&#39;, &#39;Informed&#39;, &#39;Consent&#39;, &#39;Pharma&#39;, &#39;Future&#39;, &#39;Microarray&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Europe&#39;, &#39;Clinical&#39;, &#39;Investigator&#39;, &#39;Site&#39;, &#39;Inspections&#39;, &#39;Global&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Protocol&#39;, &#39;Deviations&#39;, &#39;Immunotherapy&#39;, &#39;West&#39;, &#39;Cancer&#39;, &#39;Therapies&#39;, &#39;Recognize&#39;, &#39;Attrition&#39;, &#39;Earlier&#39;, &#39;Electronic&#39;, &#39;Data&#39;, &#39;Capture&#39;, &#39;Clinical&#39;, &#39;Imaging&#39;, &#39;Physical&#39;, &#39;Chemistry&#39;, &#39;Toll&#39;, &#39;Like&#39;, &#39;Receptors&#39;, &#39;monoclonal&#39;, &#39;antibodies&#39;, &#39;Innate&#39;, &#39;Immunity&#39;, &#39;High&#39;, &#39;Content&#39;, &#39;Analysis&#39;, &#39;Europe&#39;, &#39;Negotiation&#39;, &#39;Skills&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Professionals&#39;, &#39;Biotech&#39;, &#39;Executive&#39;, &#39;Forum&#39;, &#39;CNP&#39;, &#39;Partnering&#39;, &#39;Europe&#39;, &#39;nanotechnology&#39;, &#39;Risk&#39;, &#39;Management&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;for&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Adverse&#39;, &#39;Event&#39;, &#39;Monitoring&#39;, &#39;for&#39;, &#39;CRAs&#39;, &#39;Vendor&#39;, &#39;Management&#39;, &#39;Report&#39;, &#39;Writing&#39;, &#39;for&#39;, &#39;CRAs&#39;, &#39;Symyx&#39;, &#39;Europe&#39;, &#39;Epigenetics&#39;, &#39;Regulatory&#39;, &#39;Compliance&#39;, &#39;GCP&#39;, &#39;Training&#39;, &#39;for&#39;, &#39;Investigators&#39;, &#39;RECIST&#39;, &#39;1.0&#39;, &#39;and&#39;, &#39;1.1&#39;, &#39;Pharmacovigilance&#39;, &#39;Audit&#39;, &#39;Microfluidics&#39;, &#39;yeast&#39;, &#39;model&#39;, &#39;organism&#39;, &#39;Market&#39;, &#39;Targets&#39;, &#39;&amp;&#39;, &#39;Compounds&#39;, &#39;Critical&#39;, &#39;Decision&#39;, &#39;Points&#39;, &#39;in&#39;, &#39;Design&#39;, &#39;&amp;&#39;, &#39;Conduct&#39;, &#39;of&#39;, &#39;Patient&#39;, &#39;Registries&#39;, &#39;protein&#39;, &#39;production&#39;, &#39;formulation&#39;, &#39;HCA&#39;, &#39;Europe&#39;, &#39;Idiosyncratic&#39;, &#39;Toxicity&#39;, &#39;Protein&#39;, &#39;Informatics&#39;, &#39;Conflict&#39;, &#39;Resolution&#39;, &#39;and&#39;, &#39;Negotiation&#39;, &#39;Regulatory&#39;, &#39;Intelligence&#39;, &#39;Bioresearch&#39;, &#39;Monitoring&#39;, &#39;Cryobiology&#39;, &#39;signal&#39;, &#39;transduction&#39;, &#39;Emerging&#39;, &#39;Companies&#39;, &#39;Corrective&#39;, &#39;Action&#39;, &#39;Plans&#39;, &#39;:&#39;, &#39;Documentation&#39;, &#39;of&#39;, &#39;a&#39;, &#39;Sites&#39;, &#39;Response&#39;, &#39;to&#39;, &#39;GCP&#39;, &#39;Deficiences&#39;, &#39;Developing&#39;, &#39;Clinical&#39;, &#39;Study&#39;, &#39;Budget&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Sequencing&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Fraud&#39;, &#39;in&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Biosimilars&#39;, &#39;Dealmaking&#39;, &#39;for&#39;, &#39;Diagnostics&#39;, &#39;Comprehensive&#39;, &#39;CRC&#39;, &#39;Training&#39;, &#39;Cancer&#39;, &#39;Cell&#39;, &#39;Models&#39;, &#39;Digital&#39;, &#39;Health&#39;, &#39;Patient&#39;, &#39;Registry&#39;, &#39;Programs&#39;, &#39;crop&#39;, &#39;genetics&#39;, &#39;Glossary&#39;, &#39;&amp;&#39;, &#39;Acronyms&#39;, &#39;Reference&#39;, &#39;Biosensors&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;Essential&#39;, &#39;Documentation&#39;, &#39;in&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;at&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;Patient&#39;, &#39;Centered&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Proteins&#39;, &#39;to&#39;, &#39;Profits&#39;, &#39;Europe&#39;, &#39;Drug&#39;, &#39;Metabolism&#39;, &#39;International&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;Regulatory&#39;, &#39;Procedures&#39;, &#39;Principal&#39;, &#39;Investigator&#39;, &#39;Training&#39;, &#39;orthopedic&#39;, &#39;tissue&#39;, &#39;engineering&#39;, &#39;Investigator&#39;, &#39;Sites&#39;, &#39;cardiovascular&#39;, &#39;genomics&#39;, &#39;Study&#39;, &#39;Start&#39;, &#39;Up&#39;, &#39;Protein&#39;, &#39;Folding&#39;, &#39;Population&#39;, &#39;Health&#39;, &#39;Management&#39;, &#39;Tissue&#39;, &#39;Diagnostics&#39;, &#39;GLP&#39;, &#39;Bioanalysis&#39;, &#39;Phase&#39;, &#39;I&#39;, &#39;Study&#39;, &#39;Management&#39;, &#39;Health&#39;, &#39;Autonomous&#39;, &#39;Driving&#39;, &#39;Electronic&#39;, &#39;Source&#39;, &#39;Documentation&#39;, &#39;Tools&#39;, &#39;&amp;&#39;, &#39;Metrics&#39;, &#39;Congress&#39;, &#39;Global&#39;, &#39;GCP&#39;, &#39;Monitoring&#39;, &#39;Investigator&#39;, &#39;Non-Compliance&#39;, &#39;Global&#39;, &#39;GCP&#39;, &#39;Compliance&#39;, &#39;Report&#39;, &#39;Protein&#39;, &#39;&amp;&#39;, &#39;Peptide&#39;, &#39;Arrays&#39;, &#39;Europe&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Things&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;for&#39;, &#39;Pharmaceuticals&#39;, &#39;Introduction&#39;, &#39;to&#39;, &#39;Signal&#39;, &#39;Detection&#39;, &#39;and&#39;, &#39;Data&#39;, &#39;Mining&#39;, &#39;Study&#39;, &#39;Feasibility&#39;, &#39;Clinical&#39;, &#39;Investigation&#39;, &#39;Monitoring&#39;, &#39;Proteomics&#39;, &#39;Europe&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;in&#39;, &#39;Developing&#39;, &#39;Regions&#39;, &#39;Pediatric&#39;, &#39;drug&#39;, &#39;development&#39;, &#39;Sponsor&#39;, &#39;Monitoring&#39;, &#39;Inspections&#39;, &#39;Maximize&#39;, &#39;Value&#39;, &#39;of&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;protein&#39;, &#39;structures&#39;, &#39;cancer&#39;, &#39;Microbial&#39;, &#39;Genomics&#39;, &#39;Translational&#39;, &#39;Cancer&#39;, &#39;Medicine&#39;, &#39;Medical&#39;, &#39;Terminalogy&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Professionals&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Writing&#39;, &#39;and&#39;, &#39;Updating&#39;, &#39;the&#39;, &#39;Investigators&#39;, &#39;Brochure&#39;, &#39;Sunshine&#39;, &#39;Act&#39;, &#39;Sequencing&#39;, &#39;for&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;Standard&#39;, &#39;Operating&#39;, &#39;Procedures&#39;, &#39;Meeting&#39;, &#39;International&#39;, &#39;Safety&#39;, &#39;Reporting&#39;, &#39;Requirements&#39;, &#39;Faciliation&#39;, &#39;Skills&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Professionals&#39;, &#39;bioprocessing&#39;, &#39;biologicals&#39;, &#39;safety&#39;, &#39;Regulatory&#39;, &#39;Intelligence&#39;, &#39;101&#39;, &#39;Recent&#39;, &#39;Trends&#39;, &#39;in&#39;, &#39;Noncompliance&#39;, &#39;Briefings&#39;, &#39;on&#39;, &#39;Drug&#39;, &#39;Safety&#39;, &#39;Clinical&#39;, &#39;research&#39;, &#39;project&#39;, &#39;mamangement&#39;, &#39;essentials&#39;, &#39;CRA&#39;, &#39;Survival&#39;, &#39;Kit&#39;, &#39;Essential&#39;, &#39;Documentation&#39;, &#39;Extracellular&#39;, &#39;RNA&#39;, &#39;Successful&#39;, &#39;Study&#39;, &#39;Site&#39;, &#39;Start-up&#39;, &#39;Cell&#39;, &#39;Based&#39;, &#39;Therapies&#39;, &#39;Web-Based&#39;, &#39;Training&#39;, &#39;Strategies&#39;, &#39;data&#39;, &#39;mining&#39;, &#39;GLP&#39;, &#39;Bioanalysis&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Finance&#39;, &#39;&amp;&#39;, &#39;Management&#39;, &#39;regulatory&#39;, &#39;Site&#39;, &#39;Relationship/Performance&#39;, &#39;Management&#39;, &#39;Introduction&#39;, &#39;to&#39;, &#39;FDA&#39;, &#39;Regulatory&#39;, &#39;Reporter&#39;, &#39;Newsletter&#39;, &#39;multiple&#39;, &#39;sclerosis&#39;, &#39;Data&#39;, &#39;Integration&#39;, &#39;Managing&#39;, &#39;CRAs&#39;, &#39;to&#39;, &#39;Improve&#39;, &#39;Performance&#39;, &#39;&amp;&#39;, &#39;Study&#39;, &#39;Outcomes&#39;, &#39;compounds&#39;, &#39;Predictive&#39;, &#39;Toxicity&#39;, &#39;Surviving&#39;, &#39;FDA&#39;, &#39;Site&#39;, &#39;Inspections&#39;, &#39;:&#39;, &#39;Best&#39;, &#39;Practices&#39;, &#39;for&#39;, &#39;Site&#39;, &#39;Personnel&#39;, &#39;Phase&#39;, &#39;III&#39;, &#39;(&#39;, &#39;3&#39;, &#39;)&#39;, &#39;/forecasting&#39;, &#39;clinical&#39;, &#39;outcomes&#39;, &#39;Comparing&#39;, &#39;FDA&#39;, &#39;and&#39;, &#39;Health&#39;, &#39;Canada&#39;, &#39;Regulations&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Professionals&#39;, &#39;Recombinant&#39;, &#39;Therapeutics&#39;, &#39;Tick&#39;, &#39;Borne&#39;, &#39;Diseases&#39;, &#39;Writing&#39;, &#39;and&#39;, &#39;Maintaining&#39;, &#39;the&#39;, &#39;EU&#39;, &#39;CTA&#39;, &#39;Orphan&#39;, &#39;Drugs&#39;, &#39;Investigator&#39;, &#39;Initiated&#39;, &#39;Trials&#39;, &#39;Orthopaedic&#39;, &#39;Animal&#39;, &#39;Models&#39;, &#39;Auditing&#39;, &#39;Sponsors&#39;, &#39;and&#39;, &#39;CROs&#39;, &#39;Valuing&#39;, &#39;&amp;&#39;, &#39;Pricing&#39;, &#39;Licensing&#39;, &#39;Deals&#39;, &#39;drug&#39;, &#39;delivery&#39;, &#39;Vendor&#39;, &#39;Management&#39;, &#39;for&#39;, &#39;the&#39;, &#39;Clinical&#39;, &#39;Data&#39;, &#39;Manager&#39;, &#39;Data&#39;, &#39;Quality&#39;, &#39;Patient&#39;, &#39;Engagement&#39;, &#39;FDA&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;Process&#39;, &#39;HIPAA&#39;, &#39;No&#39;, &#39;1&#39;, &#39;Team&#39;, &#39;Training&#39;, &#39;HIPAA&#39;, &#39;&amp;&#39;, &#39;Human&#39;, &#39;Subjects&#39;, &#39;Research&#39;, &#39;Q&#39;, &#39;&amp;&#39;, &#39;A&#39;, &#39;Ubiquitin&#39;, &#39;Europe&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Data&#39;, &#39;Monitoring&#39;, &#39;Investigational&#39;, &#39;Product&#39;, &#39;Accountability&#39;, &#39;Training&#39;, &#39;for&#39;, &#39;Research&#39;, &#39;Site&#39;, &#39;Personnel&#39;, &#39;Adverse&#39;, &#39;Event&#39;, &#39;Reporting&#39;, &#39;to&#39;, &#39;IRBs&#39;, &#39;Subject&#39;, &#39;Recruitment&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;Antibodies&#39;, &#39;in&#39;, &#39;Cancer&#39;, &#39;Cost&#39;, &#39;Management&#39;, &#39;for&#39;, &#39;Global&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Portfolio&#39;, &#39;Management&#39;, &#39;Warning&#39;, &#39;Letters&#39;, &#39;Combination&#39;, &#39;Products&#39;, &#39;Observational&#39;, &#39;Studies&#39;, &#39;Molecular&#39;, &#39;Medicine&#39;, &#39;Asia&#39;, &#39;CNS&#39;, &#39;Central&#39;, &#39;nervous&#39;, &#39;system&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;Development&#39;, &#39;Collaboration&#39;, &#39;Cross&#39;, &#39;functional&#39;, &#39;global&#39;, &#39;teams&#39;, &#39;Site&#39;, &#39;Relationship&#39;, &#39;Management&#39;, &#39;peptides&#39;, &#39;Investigator&#39;, &#39;Oversight&#39;, &#39;Writing&#39;, &#39;SOPs&#39;, &#39;pain&#39;, &#39;web&#39;, &#39;2.0&#39;, &#39;Understanding&#39;, &#39;FDAs&#39;, &#39;new&#39;, &#39;Draft&#39;, &#39;Guidance&#39;, &#39;Regarding&#39;, &#39;Supervisory&#39;, &#39;Repons&#39;, &#39;Sponsors/CROs&#39;, &#39;Preparing&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;for&#39;, &#39;FDA&#39;, &#39;Inspections&#39;, &#39;eHealth&#39;, &#39;Technologies&#39;, &#39;Introduction&#39;, &#39;to&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;FDA&#39;, &#39;Proposed&#39;, &#39;rule&#39;, &#39;2010&#39;, &#39;Teambuilding&#39;, &#39;for&#39;, &#39;the&#39;, &#39;Cross&#39;, &#39;Functional&#39;, &#39;Global&#39;, &#39;Team&#39;, &#39;Genomic&#39;, &#39;Business&#39;, &#39;Strategies&#39;, &#39;Product&#39;, &#39;Life&#39;, &#39;Cycle&#39;, &#39;RNA&#39;, &#39;Interference&#39;, &#39;Pharmacovigilance&#39;, &#39;Signal&#39;, &#39;Detection&#39;, &#39;Foreign&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Biotech&#39;, &#39;Business&#39;, &#39;Development&#39;, &#39;genomics&#39;, &#39;Portfolio&#39;, &#39;Management&#39;, &#39;Venue&#39;, &#39;II&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Design&#39;, &#39;for&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Informed&#39;, &#39;Consent&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Study&#39;, &#39;Wheel&#39;, &#39;Biomarker&#39;, &#39;Data&#39;, &#39;Center&#39;, &#39;Antibody&#39;, &#39;Optimization&#39;, &#39;&amp;&#39;, &#39;Characterization&#39;, &#39;Biologics&#39;, &#39;Chronic&#39;, &#39;Pain&#39;, &#39;cardiovascular&#39;, &#39;Risk&#39;, &#39;based&#39;, &#39;decisions&#39;, &#39;for&#39;, &#39;clinical&#39;, &#39;site&#39;, &#39;management&#39;, &#39;Human&#39;, &#39;Participant&#39;, &#39;Protection&#39;, &#39;Training&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Professionals&#39;, &#39;CRC&#39;, &#39;Role/Responsibilities&#39;, &#39;Training&#39;, &#39;Womens&#39;, &#39;Health&#39;, &#39;Current&#39;, &#39;Developments&#39;, &#39;in&#39;, &#39;the&#39;, &#39;Role&#39;, &#39;of&#39;, &#39;IRBs&#39;, &#39;in&#39;, &#39;the&#39;, &#39;Conduct&#39;, &#39;of&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Regulatory&#39;, &#39;Compliance&#39;, &#39;for&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;infections&#39;, &#39;Diabetes&#39;, &#39;cancer&#39;, &#39;partnering&#39;, &#39;Preparing&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;510K&#39;, &#39;Submissions&#39;, &#39;Monitoring&#39;, &#39;Informed&#39;, &#39;Consent&#39;, &#39;Business&#39;, &#39;of&#39;, &#39;Biobanking&#39;, &#39;Global&#39;, &#39;Site&#39;, &#39;Selection&#39;, &#39;Boston&#39;, &#39;Biomarkers&#39;, &#39;of&#39;, &#39;Drug&#39;, &#39;Efficacy&#39;, &#39;and&#39;, &#39;Safety&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;in&#39;, &#39;the&#39;, &#39;European&#39;, &#39;Union&#39;, &#39;Protein&#39;, &#39;Therapeutics&#39;, &#39;Quality&#39;, &#39;Improvement&#39;, &#39;Strategies&#39;, &#39;at&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;diagnostics&#39;, &#39;bioprocessing&#39;, &#39;viral&#39;, &#39;hepatitis&#39;, &#39;infections&#39;, &#39;Advanced&#39;, &#39;HIPAA&#39;, &#39;Clinical&#39;, &#39;Sequencing&#39;, &#39;IRB&#39;, &#39;Guidance&#39;, &#39;regenerative&#39;, &#39;healing&#39;, &#39;cell&#39;, &#39;culture&#39;, &#39;Coronavirus&#39;, &#39;Liver&#39;, &#39;Disorders&#39;, &#39;Big&#39;, &#39;pharma&#39;, &#39;Big&#39;, &#39;Data&#39;, &#39;HIPAA&#39;, &#39;Electronic&#39;, &#39;Medical&#39;, &#39;Records&#39;, &#39;blood&#39;, &#39;Pharmaceutical&#39;, &#39;Strategy&#39;, &#39;Series&#39;, &#39;Strategies&#39;, &#39;for&#39;, &#39;Accelearted&#39;, &#39;Nonclinical&#39;, &#39;Toxiciology&#39;, &#39;&amp;&#39;, &#39;Safety&#39;, &#39;Assessment&#39;, &#39;of&#39;, &#39;Biologics&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;in&#39;, &#39;Japan&#39;, &#39;Artificial&#39;, &#39;Intelligence&#39;, &#39;Excel&#39;, &#39;Spreadsheets-Step&#39;, &#39;by&#39;, &#39;Step&#39;, &#39;Instructions&#39;, &#39;for&#39;, &#39;Compliance&#39;, &#39;Chemistry&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Statistical&#39;, &#39;Sourcebook&#39;, &#39;Upgrade&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Tracking&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Directive&#39;, &#39;Facilitation&#39;, &#39;Skills&#39;, &#39;Autoimmune&#39;, &#39;anticoagulants&#39;, &#39;bone&#39;, &#39;Clinical&#39;, &#39;Antibodies&#39;, &#39;gene&#39;, &#39;therapy&#39;, &#39;Newborn&#39;, &#39;Diagnostics&#39;, &#39;Real&#39;, &#39;World&#39;, &#39;Monitoring&#39;, &#39;Allergies&#39;, &#39;Performance&#39;, &#39;Improvement&#39;, &#39;Monitoring&#39;, &#39;Model&#39;, &#39;Institutional&#39;, &#39;Review&#39;, &#39;Board&#39;, &#39;Health&#39;, &#39;Outcomes&#39;, &#39;Outsourcing&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Microbiome&#39;, &#39;Key&#39;, &#39;Opinion&#39;, &#39;Leaders&#39;, &#39;Chronic&#39;, &#39;Obstructive&#39;, &#39;Pulmonary&#39;, &#39;Disorder&#39;, &#39;Quality&#39;, &#39;by&#39;, &#39;Design&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;&amp;&#39;, &#39;Translational&#39;, &#39;Medicine&#39;, &#39;Series&#39;, &#39;Lupus&#39;, &#39;Multi&#39;, &#39;Drug&#39;, &#39;Resistance&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Coordinator&#39;, &#39;Tool&#39;, &#39;Kit&#39;, &#39;CRC&#39;, &#39;&amp;&#39;, &#39;PI&#39;, &#39;Current&#39;, &#39;Practice&#39;, &#39;Update&#39;, &#39;CRA&#39;, &#39;Facilitator&#39;, &#39;Training&#39;, &#39;21&#39;, &#39;CFR&#39;, &#39;Part&#39;, &#39;11&#39;, &#39;Compliance&#39;, &#39;for&#39;, &#39;Electronic&#39;, &#39;Records&#39;, &#39;&amp;&#39;, &#39;Signatures&#39;, &#39;Cancer&#39;, &#39;Diagnostics&#39;, &#39;Electronic&#39;, &#39;Health&#39;, &#39;Record&#39;, &#39;Chiral&#39;, &#39;Intro&#39;, &#39;to&#39;, &#39;Combination&#39;, &#39;Products&#39;, &#39;Gastrointestinal&#39;, &#39;Disorders&#39;, &#39;Presentation&#39;, &#39;skills&#39;, &#39;for&#39;, &#39;clinical&#39;, &#39;research&#39;, &#39;professionals&#39;, &#39;inflammation&#39;, &#39;Operational&#39;, &#39;Modeling&#39;, &#39;and&#39;, &#39;Simulation&#39;, &#39;in&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Pharmaceutical&#39;, &#39;&amp;&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Industries&#39;, &#39;Facilitation&#39;, &#39;Skills&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Team&#39;, &#39;Members&#39;, &#39;Diagnostics&#39;, &#39;Partnering&#39;, &#39;Mobile&#39;, &#39;Health&#39;, &#39;Wearables&#39;, &#39;Pharmaceutical&#39;, &#39;Discovery&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Medical&#39;, &#39;device&#39;, &#39;reporting&#39;, &#39;Ubiquitin&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Postmarketing&#39;, &#39;Vigilance&#39;, &#39;Blockchain&#39;, &#39;Alzheimers&#39;, &#39;high&#39;, &#39;performance&#39;, &#39;computing&#39;, &#39;Innovative&#39;, &#39;Preclinical&#39;, &#39;&amp;&#39;, &#39;Clinical&#39;, &#39;Strategies&#39;, &#39;GXP&#39;, &#39;Good&#39;, &#39;Practice&#39;, &#39;Guides&#39;, &#39;Writing&#39;, &#39;and&#39;, &#39;Maintaining&#39;, &#39;Canadian&#39;, &#39;CTA&#39;, &#39;3D&#39;, &#39;Printing&#39;, &#39;Key&#39;, &#39;Information&#39;, &#39;Gatherers&#39;, &#39;Respiratory&#39;, &#39;Five&#39;, &#39;Keys&#39;, &#39;to&#39;, &#39;COTS&#39;, &#39;Computer&#39;, &#39;System&#39;, &#39;Validation&#39;, &#39;Next-Generation&#39;, &#39;Sequencing&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Open&#39;, &#39;Source&#39;, &#39;Fibrosis/Scarring&#39;, &#39;Biomarker&#39;, &#39;Bridge&#39;, &#39;Genomics&#39;, &#39;101&#39;, &#39;Dummy&#39;, &#39;Keyword&#39;, &#39;for&#39;, &#39;DE&#39;, &#39;lists&#39;, &#39;w/more&#39;, &#39;than&#39;, &#39;1&#39;, &#39;keyword&#39;, &#39;or&#39;, &#39;with&#39;, &#39;no&#39;, &#39;keywords&#39;, &#39;FDA&#39;, &#39;Form&#39;, &#39;1572&#39;, &#39;Antisense&#39;, &#39;Accountable&#39;, &#39;Care&#39;, &#39;Orgnization&#39;, &#39;ACE&#39;, &#39;inhibitors&#39;, &#39;AI&#39;, &#39;Chips&#39;, &#39;Antibody-Drug&#39;, &#39;Conjugates&#39;, &#39;for&#39;, &#39;PEGS&#39;, &#39;Antibody&#39;, &#39;Drug&#39;, &#39;Conjugate&#39;, &#39;Bioprocess&#39;, &#39;Attention&#39;, &#39;Deficit&#39;, &#39;Hyperactivity&#39;, &#39;Disorder&#39;, &#39;Adjuvants&#39;, &#39;ADMET&#39;, &#39;(&#39;, &#39;ADME&#39;, &#39;&amp;&#39;, &#39;Toxicology&#39;, &#39;)&#39;, &#39;adverse&#39;, &#39;drug&#39;, &#39;reactions&#39;, &#39;Aerospace&#39;, &#39;Advanced&#39;, &#39;Energy&#39;, &#39;Technology&#39;, &#39;Congress&#39;, &#39;Affordable&#39;, &#39;Care&#39;, &#39;affinity&#39;, &#39;technologies&#39;, &#39;Affinity&#39;, &#39;Separation&#39;, &#39;Antibody&#39;, &#39;Fragments&#39;, &#39;Agriculture&#39;, &#39;chemistry&#39;, &#39;Aging&#39;, &#39;Antibody&#39;, &#39;Drug&#39;, &#39;Targets&#39;, &#39;Digital&#39;, &#39;Farming&#39;, &#39;angiogenesis&#39;, &#39;AI&#39;, &#39;Business&#39;, &#39;Intelligence&#39;, &#39;Artificial&#39;, &#39;Intelligence&#39;, &#39;Bioprocessing&#39;, &#39;AI&#39;, &#39;in&#39;, &#39;Customer&#39;, &#39;Analytics&#39;, &#39;Intelligent&#39;, &#39;Assistants&#39;, &#39;and&#39;, &#39;Bots&#39;, &#39;AI&#39;, &#39;in&#39;, &#39;Cancer&#39;, &#39;Enterprise&#39;, &#39;AI&#39;, &#39;Case&#39;, &#39;Studies&#39;, &#39;AI&#39;, &#39;Executive&#39;, &#39;Summit&#39;, &#39;Machine&#39;, &#39;Learning&#39;, &#39;Artificial&#39;, &#39;Intelligence&#39;, &#39;Clinical&#39;, &#39;&amp;&#39;, &#39;Post&#39;, &#39;Approval&#39;, &#39;Artificial&#39;, &#39;Intelligence&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;Preclinical&#39;, &#39;Implementing&#39;, &#39;Enterprise&#39;, &#39;AI&#39;, &#39;AI&#39;, &#39;Ethics&#39;, &#39;Future&#39;, &#39;of&#39;, &#39;AI&#39;, &#39;Cutting&#39;, &#39;Edge&#39;, &#39;Research&#39;, &#39;for&#39;, &#39;AI&#39;, &#39;General&#39;, &#39;AI&#39;, &#39;Business&#39;, &#39;Applications&#39;, &#39;AI&#39;, &#39;for&#39;, &#39;Strategic&#39;, &#39;Government&#39;, &#39;Functions&#39;, &#39;Cognitive&#39;, &#39;Computing&#39;, &#39;AI&#39;, &#39;Partnering&#39;, &#39;AI&#39;, &#39;in&#39;, &#39;Personalized&#39;, &#39;Medicine&#39;, &#39;Allosteric&#39;, &#39;Modulators&#39;, &#39;Amyotrophic&#39;, &#39;lateral&#39;, &#39;sclerosis&#39;, &#39;Animal&#39;, &#39;Models&#39;, &#39;of&#39;, &#39;Cancer&#39;, &#39;Alternative&#39;, &#39;Medicine&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;Execution&#39;, &#39;Asset&#39;, &#39;Management&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;Negotiation&#39;, &#39;Animal&#39;, &#39;Models&#39;, &#39;of&#39;, &#39;Pain&#39;, &#39;Animal&#39;, &#39;Models&#39;, &#39;of&#39;, &#39;Toxicity&#39;, &#39;angina&#39;, &#39;Anxiety&#39;, &#39;cancer&#39;, &#39;and&#39;, &#39;apoptosis&#39;, &#39;Active&#39;, &#39;Pharmaceutical&#39;, &#39;Ingredients&#39;, &#39;Analytical&#39;, &#39;Purification&#39;, &#39;Apoptosis&#39;, &#39;Anti&#39;, &#39;Psychotics&#39;, &#39;Alliances&#39;, &#39;Rx&#39;, &#39;Devices&#39;, &#39;arrhythmias&#39;, &#39;Assays&#39;, &#39;for&#39;, &#39;Antibodies&#39;, &#39;Assays&#39;, &#39;Affinity&#39;, &#39;Assays&#39;, &#39;and&#39;, &#39;Allosteric&#39;, &#39;Antagonism&#39;, &#39;Immunogenicity&#39;, &#39;Assay&#39;, &#39;Development&#39;, &#39;Assays&#39;, &#39;Primary&#39;, &#39;Cells&#39;, &#39;Quantifying&#39;, &#39;Receptor&#39;, &#39;Activation&#39;, &#39;and&#39;, &#39;Agonism&#39;, &#39;asthma&#39;, &#39;Assays&#39;, &#39;atherosclerosis&#39;, &#39;Automotive&#39;, &#39;Automotive&#39;, &#39;Partnering&#39;, &#39;Autophagy&#39;, &#39;Autism&#39;, &#39;Advisory&#39;, &#39;Boards&#39;, &#39;Bacterial&#39;, &#39;Infections&#39;, &#39;Consumer&#39;, &#39;Electronic&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Defense&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Battery&#39;, &#39;Data&#39;, &#39;Science&#39;, &#39;Flexible&#39;, &#39;Battery&#39;, &#39;Power&#39;, &#39;Industrial&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Stationary&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Automotive&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Bayesian&#39;, &#39;Statistics&#39;, &#39;Asia&#39;, &#39;US&#39;, &#39;Biotech&#39;, &#39;Alliances&#39;, &#39;Blood&#39;, &#39;Brain&#39;, &#39;Barrier&#39;, &#39;Computational&#39;, &#39;Biology&#39;, &#39;for&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;BioIT&#39;, &#39;Best&#39;, &#39;Practices&#39;, &#39;Battery&#39;, &#39;Charging&#39;, &#39;Cheminformatics&#39;, &#39;for&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;Biomarker&#39;, &#39;Clinical&#39;, &#39;Applications&#39;, &#39;Preclinical&#39;, &#39;Biologic&#39;, &#39;Development&#39;, &#39;Breast&#39;, &#39;Cancer&#39;, &#39;Backup&#39;, &#39;Compounds&#39;, &#39;biological&#39;, &#39;cancer&#39;, &#39;treatments&#39;, &#39;Biomarker&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Biological&#39;, &#39;Database&#39;, &#39;Discovery&#39;, &#39;Informatics&#39;, &#39;for&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;Delivery&#39;, &#39;of&#39;, &#39;Biologics&#39;, &#39;Regulatory&#39;, &#39;Business&#39;, &#39;Diagnostics&#39;, &#39;biodiversity&#39;, &#39;screening&#39;, &#39;E&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Battery&#39;, &#39;Energy&#39;, &#39;Storage&#39;, &#39;Biofuels&#39;, &#39;Alliance&#39;, &#39;Biobank&#39;, &#39;Informatics&#39;, &#39;Flow&#39;, &#39;Cell&#39;, &#39;Technologies&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;for&#39;, &#39;Data&#39;, &#39;Science&#39;, &#39;Biogenerics&#39;, &#39;Business&#39;, &#39;of&#39;, &#39;Genomics&#39;, &#39;biomaterials&#39;, &#39;Bioinformatics&#39;, &#39;for&#39;, &#39;Cancer&#39;, &#39;BIO&#39;, &#39;IT&#39;, &#39;World&#39;, &#39;Battery&#39;, &#39;Intellectual&#39;, &#39;Property&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;World&#39;, &#39;Web&#39;, &#39;Resource&#39;, &#39;Alert&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;World&#39;, &#39;Monthly&#39;, &#39;magazine&#39;, &#39;IT&#39;, &#39;&amp;&#39;, &#39;Informatics&#39;, &#39;Series&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;World&#39;, &#39;Weekly&#39;, &#39;Update&#39;, &#39;Bookstore&#39;, &#39;Biomarker&#39;, &#39;Development&#39;, &#39;Advanced&#39;, &#39;Lead&#39;, &#39;Acid&#39;, &#39;Technology&#39;, &#39;Manufacturing&#39;, &#39;&amp;&#39;, &#39;Process&#39;, &#39;Economics&#39;, &#39;Biopharm&#39;, &#39;Executive&#39;, &#39;Summit&#39;, &#39;Biolaw&#39;, &#39;Biomarker&#39;, &#39;&amp;&#39;, &#39;Diagnostics&#39;, &#39;Series&#39;, &#39;High-Througput&#39;, &#39;Screen-Based&#39;, &#39;Biomarker&#39;, &#39;Discovery&#39;, &#39;Battery&#39;, &#39;Manufacturers&#39;, &#39;Battery&#39;, &#39;Manufacturing&#39;, &#39;Battery&#39;, &#39;Management&#39;, &#39;Battery&#39;, &#39;Manufacturing&#39;, &#39;Machinery&#39;, &#39;Battery&#39;, &#39;Market&#39;, &#39;Battery&#39;, &#39;Machine&#39;, &#39;Learning&#39;, &#39;Biomarker&#39;, &#39;Executive&#39;, &#39;Think&#39;, &#39;Tank&#39;, &#39;Battery&#39;, &#39;Materials&#39;, &#39;,&#39;, &#39;Recycling&#39;, &#39;Biomarker&#39;, &#39;Reverse&#39;, &#39;Phase&#39;, &#39;Assays&#39;, &#39;Battery&#39;, &#39;Materials&#39;, &#39;,&#39;, &#39;Solid&#39;, &#39;State&#39;, &#39;bone&#39;, &#39;marrow&#39;, &#39;transplants&#39;, &#39;Biomarker&#39;, &#39;Translational&#39;, &#39;Biomarker&#39;, &#39;Validation&#39;, &#39;Bioinformatics&#39;, &#39;Asia&#39;, &#39;Bioinformatics&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;for&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;Logistics&#39;, &#39;and&#39;, &#39;Sample&#39;, &#39;of&#39;, &#39;Biobanking&#39;, &#39;Bioinformatics&#39;, &#39;in&#39;, &#39;the&#39;, &#39;Genome&#39;, &#39;Era&#39;, &#39;Bioprocess&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Host&#39;, &#39;Cell&#39;, &#39;Protein&#39;, &#39;Assays&#39;, &#39;Bioproduction&#39;, &#39;Continuous&#39;, &#39;Processing&#39;, &#39;biopurification&#39;, &#39;Biological&#39;, &#39;Pharmacokinetics&#39;, &#39;Bioprocessing&#39;, &#39;Quality&#39;, &#39;Bioprocess&#39;, &#39;&amp;&#39;, &#39;Manufacturing&#39;, &#39;Series&#39;, &#39;Bioprocess&#39;, &#39;Validation&#39;, &#39;Bioreactor&#39;, &#39;Design&#39;, &#39;and&#39;, &#39;Engineering&#39;, &#39;Battery&#39;, &#39;Regulatory&#39;, &#39;Battery&#39;, &#39;Raw&#39;, &#39;Materials&#39;, &#39;Brain&#39;, &#39;Cancer&#39;, &#39;Battery&#39;, &#39;Repurposing&#39;, &#39;Biological&#39;, &#39;Therapeutics&#39;, &#39;(&#39;, &#39;biotherapeutics&#39;, &#39;)&#39;, &#39;Bispecific&#39;, &#39;Antibodies&#39;, &#39;for&#39;, &#39;Immunotherapy&#39;, &#39;Bispecifics&#39;, &#39;for&#39;, &#39;Cancer&#39;, &#39;Business&#39;, &#39;Strategies&#39;, &#39;for&#39;, &#39;Library&#39;, &#39;Diversity&#39;, &#39;blood&#39;, &#39;safety&#39;, &#39;Europe&#39;, &#39;Battery&#39;, &#39;Shipping&#39;, &#39;Battery&#39;, &#39;Simulation&#39;, &#39;Biosensors&#39;, &#39;bioseparation&#39;, &#39;Biostabilization&#39;, &#39;of&#39;, &#39;Biospecimens&#39;, &#39;Biomanufacturing&#39;, &#39;Single&#39;, &#39;Use&#39;, &#39;Technologies&#39;, &#39;Bioassays&#39;, &#39;Battery&#39;, &#39;Commercialization&#39;, &#39;Flow&#39;, &#39;Batteries&#39;, &#39;Battery&#39;, &#39;Materials&#39;, &#39;Sci/Tech&#39;, &#39;for&#39;, &#39;Pharma&#39;, &#39;&amp;&#39;, &#39;Biotech&#39;, &#39;Battery&#39;, &#39;Safety&#39;, &#39;Biotech&#39;, &#39;tools&#39;, &#39;Biotech&#39;, &#39;Venture&#39;, &#39;Forum&#39;, &#39;Biomarkers&#39;, &#39;for&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Biomarkers&#39;, &#39;for&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;for&#39;, &#39;Cancer&#39;, &#39;Immunotherapy&#39;, &#39;Artifical&#39;, &#39;Intelligence&#39;, &#39;in&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;cell&#39;, &#39;adhesion&#39;, &#39;molecules&#39;, &#39;regulatory&#39;, &#39;CANDA&#39;, &#39;Computer&#39;, &#39;Assisted&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Application&#39;, &#39;Chimeric&#39;, &#39;Antigen&#39;, &#39;Receptor&#39;, &#39;Chimeric&#39;, &#39;Antigen&#39;, &#39;Receptor&#39;, &#39;Case&#39;, &#39;Studies&#39;, &#39;catalysis&#39;, &#39;Cell&#39;, &#39;Based&#39;, &#39;Assays&#39;, &#39;Cell&#39;, &#39;Therapy&#39;, &#39;CMC&#39;, &#39;Cancer&#39;, &#39;Biomarker&#39;, &#39;Cell&#39;, &#39;Therapy&#39;, &#39;Production&#39;, &#39;Cord&#39;, &#39;Blood&#39;, &#39;Stem&#39;, &#39;Cells&#39;, &#39;Cell&#39;, &#39;Based&#39;, &#39;Therapies&#39;, &#39;Circulating&#39;, &#39;Tumor&#39;, &#39;Cells&#39;, &#39;Cold&#39;, &#39;Chain&#39;, &#39;Colorectal&#39;, &#39;Cancer&#39;, &#39;cell&#39;, &#39;cycle&#39;, &#39;Collaborations&#39;, &#39;Deals&#39;, &#39;and&#39;, &#39;Alliances&#39;, &#39;Chemical&#39;, &#39;Database&#39;, &#39;Co-Development&#39;, &#39;of&#39;, &#39;Diagnostics&#39;, &#39;and&#39;, &#39;Drugs&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;Europe&#39;, &#39;Case&#39;, &#39;Histories&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Consumer&#39;, &#39;Electronics&#39;, &#39;Cell&#39;, &#39;Biology&#39;, &#39;Clean&#39;, &#39;Tech&#39;, &#39;Solar&#39;, &#39;Wind&#39;, &#39;Comparative&#39;, &#39;Effectiveness&#39;, &#39;Research&#39;, &#39;Ethical&#39;, &#39;Considerations&#39;, &#39;in&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Continuing&#39;, &#39;Education&#39;, &#39;Units&#39;, &#39;Circulating&#39;, &#39;Cell-Free&#39;, &#39;DNA&#39;, &#39;Europe&#39;, &#39;Agriculture&#39;, &#39;crop&#39;, &#39;genetics&#39;, &#39;Europe&#39;, &#39;Cancer&#39;, &#39;Genomics&#39;, &#39;Europe&#39;, &#39;congestive&#39;, &#39;heart&#39;, &#39;failure&#39;, &#39;Chemistry&#39;, &#39;Series&#39;, &#39;Chinese&#39;, &#39;Hamster&#39;, &#39;Ovaries&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Conflicts&#39;, &#39;of&#39;, &#39;Interest&#39;, &#39;cheminformatics&#39;, &#39;competitive&#39;, &#39;intelligence&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;Asia&#39;, &#39;Integrating&#39;, &#39;Clinical&#39;, &#39;Lab&#39;, &#39;Services&#39;, &#39;in&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Clinical&#39;, &#39;Biospecimens&#39;, &#39;and&#39;, &#39;Central&#39;, &#39;Lab&#39;, &#39;Solutions&#39;, &#39;Clinical&#39;, &#39;Biospecimens&#39;, &#39;and&#39;, &#39;Central&#39;, &#39;Lab&#39;, &#39;Solutions&#39;, &#39;Celiac&#39;, &#39;Disease&#39;, &#39;Cloud&#39;, &#39;Extension&#39;, &#39;Clinical&#39;, &#39;Genomics&#39;, &#39;Europe&#39;, &#39;cellular&#39;, &#39;all&#39;, &#39;Conducting&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;in&#39;, &#39;Asia&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;Resource&#39;, &#39;Management&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;Security&#39;, &#39;Risks&#39;, &#39;Software&#39;, &#39;Development&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Genomics&#39;, &#39;Clinical&#39;, &#39;Vaccines&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;West&#39;, &#39;Comparability&#39;, &#39;Chemistry&#39;, &#39;Manufacturing&#39;, &#39;and&#39;, &#39;Controls&#39;, &#39;Continuing&#39;, &#39;Medical&#39;, &#39;Education&#39;, &#39;Communications&#39;, &#39;Contract&#39;, &#39;Manufacturing&#39;, &#39;Cancer&#39;, &#39;Microarray&#39;, &#39;Application&#39;, &#39;CNS&#39;, &#39;Biomarkers&#39;, &#39;Miscellaneous&#39;, &#39;CHI&#39;, &#39;conference&#39;, &#39;CNS&#39;, &#39;genetics/genomics&#39;, &#39;CNS&#39;, &#39;Disease&#39;, &#39;Models&#39;, &#39;Counterfeit&#39;, &#39;Drugs&#39;, &#39;Copy&#39;, &#39;Number&#39;, &#39;Variation&#39;, &#39;Cognitive&#39;, &#39;Disorders&#39;, &#39;Battery&#39;, &#39;Components&#39;, &#39;capillary&#39;, &#39;electrophoresis&#39;, &#39;Cancer&#39;, &#39;Prognostic&#39;, &#39;Markers&#39;, &#39;Clinical&#39;, &#39;Pharmacology&#39;, &#39;Clinical&#39;, &#39;Proteomics&#39;, &#39;Clinical&#39;, &#39;Plasma&#39;, &#39;Profiling&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Platform&#39;, &#39;Software&#39;, &#39;Computer&#39;, &#39;Vision&#39;, &#39;cancer&#39;, &#39;prevention&#39;, &#39;CRA&#39;, &#39;8&#39;, &#39;Weeks&#39;, &#39;Fundamental&#39;, &#39;Training&#39;, &#39;Cost&#39;, &#39;Reduction&#39;, &#39;w/o&#39;, &#39;Increasing&#39;, &#39;Regulatory&#39;, &#39;or&#39;, &#39;Business&#39;, &#39;Risk&#39;, &#39;Advanced&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Coordinator&#39;, &#39;Critical&#39;, &#39;Care&#39;, &#39;Diagnostics&#39;, &#39;Interviewing&#39;, &#39;Skills&#39;, &#39;for&#39;, &#39;CRAs&#39;, &#39;and&#39;, &#39;CRCs&#39;, &#39;Customer&#39;, &#39;Relationship&#39;, &#39;Management&#39;, &#39;CRA&#39;, &#39;Monitoring&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Training&#39;, &#39;Week&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Training&#39;, &#39;Week&#39;, &#39;East&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Training&#39;, &#39;Week&#39;, &#39;West&#39;, &#39;Drug-Device&#39;, &#39;Combinations&#39;, &#39;Peptides&#39;, &#39;for&#39;, &#39;Cancer&#39;, &#39;Therapeutics&#39;, &#39;Colony&#39;, &#39;Stimulating&#39;, &#39;Factors&#39;, &#39;Cell&#39;, &#39;Signaling&#39;, &#39;Cancer&#39;, &#39;Stem&#39;, &#39;Cells&#39;, &#39;Clinical&#39;, &#39;Supply&#39;, &#39;Chain&#39;, &#39;Clinical&#39;, &#39;Strategic&#39;, &#39;Resource&#39;, &#39;Allocation&#39;, &#39;Country&#39;, &#39;and&#39;, &#39;Site&#39;, &#39;Feasibility&#39;, &#39;and&#39;, &#39;Selection&#39;, &#39;Mammalian&#39;, &#39;Cell&#39;, &#39;Culture&#39;, &#39;Cloud&#39;, &#39;Security&#39;, &#39;Cybersecurity&#39;, &#39;Clinical&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;and&#39;, &#39;eClinical&#39;, &#39;Trials&#39;, &#39;Asia&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;for&#39;, &#39;the&#39;, &#39;Drug&#39;, &#39;Discoverer&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Eastern&#39;, &#39;Europe&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Finance&#39;, &#39;&amp;&#39;, &#39;Management&#39;, &#39;Re&#39;, &#39;Engineering&#39;, &#39;the&#39;, &#39;Study&#39;, &#39;Feasibility&#39;, &#39;Assessment&#39;, &#39;Process&#39;, &#39;CRC&#39;, &#39;Training&#39;, &#39;Video&#39;, &#39;&amp;&#39;, &#39;Manual&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Management&#39;, &#39;Systems&#39;, &#39;Cardiotoxicity&#39;, &#39;Query&#39;, &#39;Creation&#39;, &#39;&amp;&#39;, &#39;Processing&#39;, &#39;clinical&#39;, &#39;trials&#39;, &#39;segmentation&#39;, &#39;Neoantigens&#39;, &#39;for&#39;, &#39;Cancer&#39;, &#39;Cardiovascular&#39;, &#39;Diagnostics&#39;, &#39;cardiovascular&#39;, &#39;animal&#39;, &#39;models&#39;, &#39;Cardio&#39;, &#39;Metabolic&#39;, &#39;Drug&#39;, &#39;Targets&#39;, &#39;Targeting&#39;, &#39;Cancer&#39;, &#39;Diagnostics&#39;, &#39;cytokines&#39;, &#39;antagonists&#39;, &#39;Cystic&#39;, &#39;Fibrosis&#39;, &#39;Cytogenetics&#39;, &#39;cytokines&#39;, &#39;Targeting&#39;, &#39;Diabetes&#39;, &#39;with&#39;, &#39;Novel&#39;, &#39;Therapeutics&#39;, &#39;DBS&#39;, &#39;Optimization&#39;, &#39;of&#39;, &#39;Cell&#39;, &#39;drug&#39;, &#39;discovery&#39;, &#39;India&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Map&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Outsourcing&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Technologies&#39;, &#39;drug&#39;, &#39;discovery&#39;, &#39;and&#39;, &#39;development&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;Development&#39;, &#39;Series&#39;, &#39;Dental&#39;, &#39;Depression&#39;, &#39;Detection&#39;, &#39;non&#39;, &#39;biological&#39;, &#39;Treatments&#39;, &#39;for&#39;, &#39;Drug&#39;, &#39;Abuse&#39;, &#39;Drug&#39;, &#39;Drug&#39;, &#39;Interactions&#39;, &#39;Digital&#39;, &#39;Therapeutics&#39;, &#39;Digitization&#39;, &#39;Diabetes&#39;, &#39;2&#39;, &#39;Digital&#39;, &#39;Healthcare&#39;, &#39;&amp;&#39;, &#39;Productivity&#39;, &#39;web&#39;, &#39;resource&#39;, &#39;alert&#39;, &#39;drug&#39;, &#39;discovery&#39;, &#39;Duchenne&#39;, &#39;Muscular&#39;, &#39;Dystrophy&#39;, &#39;Drug&#39;, &#39;Metabolism&#39;, &#39;&amp;&#39;, &#39;Pharmacokinetics&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Informatics&#39;, &#39;Europe&#39;, &#39;Data&#39;, &#39;Integrity&#39;, &#39;Diagnostic&#39;, &#39;Informatics&#39;, &#39;DNA&#39;, &#39;Repair&#39;, &#39;Diversity&#39;, &#39;Oriented&#39;, &#39;Synthesis&#39;, &#39;Digital&#39;, &#39;Detection&#39;, &#39;Europe&#39;, &#39;Difficult&#39;, &#39;to&#39;, &#39;Express&#39;, &#39;Proteins&#39;, &#39;Executive&#39;, &#39;Perspectives&#39;, &#39;of&#39;, &#39;Drug&#39;, &#39;Safety&#39;, &#39;downstream&#39;, &#39;processing&#39;, &#39;Europe&#39;, &#39;Drug&#39;, &#39;Safety&#39;, &#39;Series&#39;, &#39;downstream&#39;, &#39;processing&#39;, &#39;Dosing&#39;, &#39;Selection&#39;, &#39;Data&#39;, &#39;Science/Analytics&#39;, &#39;Direct&#39;, &#39;to&#39;, &#39;Consumer&#39;, &#39;Marketing&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Drug&#39;, &#39;Transporters&#39;, &#39;Data&#39;, &#39;Storage&#39;, &#39;Digital&#39;, &#39;Twins&#39;, &#39;Drug&#39;, &#39;Utilization&#39;, &#39;Protein&#39;, &#39;Devices&#39;, &#39;Molecular&#39;, &#39;and&#39;, &#39;Companion&#39;, &#39;Diagnostics&#39;, &#39;Asia&#39;, &#39;Clinical&#39;, &#39;Adoption&#39;, &#39;of&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Diagnostics&#39;, &#39;Difficult&#39;, &#39;to&#39;, &#39;Express&#39;, &#39;Proteins&#39;, &#39;Europe&#39;, &#39;Globalization&#39;, &#39;of&#39;, &#39;Dx&#39;, &#39;Diagnostics&#39;, &#39;Immunoassays&#39;, &#39;Diagnostics&#39;, &#39;Automation&#39;, &#39;Detection&#39;, &#39;Informatics&#39;, &#39;engineered&#39;, &#39;animal&#39;, &#39;models&#39;, &#39;Hearing&#39;, &#39;Ebola&#39;, &#39;Diagnostics&#39;, &#39;Evidence&#39;, &#39;Based&#39;, &#39;Medicine&#39;, &#39;Ebola&#39;, &#39;Therapeutics&#39;, &#39;eCapacitors&#39;, &#39;Electrochemistry&#39;, &#39;E&#39;, &#39;Coli&#39;, &#39;Encoded&#39;, &#39;Compound&#39;, &#39;Libraries&#39;, &#39;Ecommerce&#39;, &#39;eCTD&#39;, &#39;Validation&#39;, &#39;of&#39;, &#39;Disinfectant&#39;, &#39;Efficacy&#39;, &#39;Effective&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Edge&#39;, &#39;Computing&#39;, &#39;Early&#39;, &#39;Diagnosis&#39;, &#39;Electronic&#39;, &#39;Notebooks&#39;, &#39;endothelium&#39;, &#39;engineering&#39;, &#39;Entertainment&#39;, &#39;Enabling&#39;, &#39;Technology&#39;, &#39;in&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Environment&#39;, &#39;Enzymes&#39;, &#39;Economic&#39;, &#39;Outcomes&#39;, &#39;Executives&#39;, &#39;on&#39;, &#39;Target&#39;, &#39;Epidemiology&#39;, &#39;epilepsy&#39;, &#39;Epigenetic&#39;, &#39;Readers&#39;, &#39;Epigenetic&#39;, &#39;Targets&#39;, &#39;Examining&#39;, &#39;the&#39;, &#39;Impact&#39;, &#39;of&#39;, &#39;the&#39;, &#39;eCTD&#39;, &#39;on&#39;, &#39;the&#39;, &#39;Regulatory&#39;, &#39;Submissions&#39;, &#39;Process&#39;, &#39;Emerging&#39;, &#39;Targets&#39;, &#39;Diseases&#39;, &#39;Ethics&#39;, &#39;Emerging&#39;, &#39;Technology&#39;, &#39;Transfer&#39;, &#39;Electric&#39;, &#39;Vehicles&#39;, &#39;Experimental&#39;, &#39;Design&#39;, &#39;Exhibitors&#39;, &#39;Extractables/Leachables&#39;, &#39;Exosomes&#39;, &#39;Exome&#39;, &#39;Sequencing&#39;, &#39;Financial&#39;, &#39;Analysts&#39;, &#39;Hackathon&#39;, &#39;Obesity&#39;, &#39;Batteries&#39;, &#39;France&#39;, &#39;fibrin&#39;, &#39;sealants&#39;, &#39;Fine&#39;, &#39;Chemicals&#39;, &#39;FDA&#39;, &#39;Meetings&#39;, &#39;101&#39;, &#39;Food&#39;, &#39;Safety&#39;, &#39;Financial&#39;, &#39;Disclosure&#39;, &#39;Foods&#39;, &#39;FDA&#39;, &#39;Website&#39;, &#39;Functional&#39;, &#39;Genomics&#39;, &#39;Fragment&#39;, &#39;Based&#39;, &#39;Screening&#39;, &#39;Surface&#39;, &#39;Plasmon&#39;, &#39;Resonance&#39;, &#39;finance&#39;, &#39;Flow&#39;, &#39;Cytometry&#39;, &#39;Influenza&#39;, &#39;Financial&#39;, &#39;Deal&#39;, &#39;Structures&#39;, &#39;Fintech&#39;, &#39;Future&#39;, &#39;of&#39;, &#39;Healthcare&#39;, &#39;Fraud&#39;, &#39;Fertility&#39;, &#39;Fibrin&#39;, &#39;sealants&#39;, &#39;Europe&#39;, &#39;blood&#39;, &#39;Fast&#39;, &#39;Track&#39;, &#39;Future&#39;, &#39;Therapeutics&#39;, &#39;fungal&#39;, &#39;infections&#39;, &#39;Follow&#39;, &#39;Up&#39;, &#39;Flow&#39;, &#39;Chemistry&#39;, &#39;Gamification&#39;, &#39;gap&#39;, &#39;junction&#39;, &#39;channels&#39;, &#39;Global&#39;, &#39;Health&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;for&#39;, &#39;Pediatric&#39;, &#39;Research&#39;, &#39;GCP&#39;, &#39;Deficiencies&#39;, &#39;Gene&#39;, &#39;Cell&#39;, &#39;Vectors&#39;, &#39;Genomic&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Genomic&#39;, &#39;Data&#39;, &#39;Integration&#39;, &#39;Genetic&#39;, &#39;Screening&#39;, &#39;Wellness&#39;, &#39;General&#39;, &#39;Email&#39;, &#39;Only&#39;, &#39;Gene&#39;, &#39;Editing&#39;, &#39;Part&#39;, &#39;2&#39;, &#39;Gene&#39;, &#39;Editing&#39;, &#39;Gene&#39;, &#39;Expression&#39;, &#39;Monitoring&#39;, &#39;Genomics&#39;, &#39;Series&#39;, &#39;Gene&#39;, &#39;Expression&#39;, &#39;growth&#39;, &#39;factors&#39;, &#39;Gene&#39;, &#39;Identification&#39;, &#39;genetic&#39;, &#39;immunization&#39;, &#39;vaccines&#39;, &#39;gene&#39;, &#39;interference&#39;, &#39;Gene&#39;, &#39;Knockouts&#39;, &#39;Globalization&#39;, &#39;Genome&#39;, &#39;Links&#39;, &#39;newsletter&#39;, &#39;GLP&#39;, &#39;Bioanalysis&#39;, &#39;Leaders&#39;, &#39;in&#39;, &#39;Precision&#39;, &#39;Medicine&#39;, &#39;Good&#39;, &#39;Manufacturing&#39;, &#39;Practice&#39;, &#39;Drugs&#39;, &#39;introductory&#39;, &#39;gene&#39;, &#39;mutations&#39;, &#39;genomic&#39;, &#39;medicine&#39;, &#39;Genotyping&#39;, &#39;Government&#39;, &#39;gene&#39;, &#39;probes&#39;, &#39;Genomic&#39;, &#39;partnering&#39;, &#39;Europe&#39;, &#39;Greening&#39;, &#39;of&#39;, &#39;Pharma&#39;, &#39;GPCR&#39;, &#39;Targeted&#39;, &#39;Therapies&#39;, &#39;Grid&#39;, &#39;Computing&#39;, &#39;Genomic&#39;, &#39;Service&#39;, &#39;Providers&#39;, &#39;Small&#39;, &#39;GTPases&#39;, &#39;(&#39;, &#39;formerly&#39;, &#39;Gene&#39;, &#39;Town&#39;, &#39;Pass&#39;, &#39;)&#39;, &#39;gene&#39;, &#39;transcription&#39;, &#39;gene&#39;, &#39;therapy&#39;, &#39;technologies&#39;, &#39;Whole&#39;, &#39;Genome&#39;, &#39;Association&#39;, &#39;Studies&#39;, &#39;Humanized&#39;, &#39;Antibodies&#39;, &#39;high&#39;, &#39;throughput&#39;, &#39;analytical&#39;, &#39;chemistry&#39;, &#39;Health&#39;, &#39;&amp;&#39;, &#39;Beauty&#39;, &#39;Aids&#39;, &#39;Hepatitis&#39;, &#39;B&#39;, &#39;Virus&#39;, &#39;High&#39;, &#39;Content&#39;, &#39;Analysis&#39;, &#39;Course&#39;, &#39;HIV&#39;, &#39;and&#39;, &#39;cancer&#39;, &#39;Hematological&#39;, &#39;Cancer&#39;, &#39;Pipelines&#39;, &#39;HIV&#39;, &#39;clinical&#39;, &#39;trials&#39;, &#39;hepatitis&#39;, &#39;C&#39;, &#39;virus&#39;, &#39;Heterocycle&#39;, &#39;High&#39;, &#39;Content&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;HDAC&#39;, &#39;Histone&#39;, &#39;Demethylases&#39;, &#39;Healing&#39;, &#39;hematopoesis&#39;, &#39;heat&#39;, &#39;shock&#39;, &#39;proteins&#39;, &#39;Human&#39;, &#39;Factors&#39;, &#39;Engineering&#39;, &#39;Health&#39;, &#39;Information&#39;, &#39;Systems&#39;, &#39;HIV&#39;, &#39;Healthcare&#39;, &#39;Series&#39;, &#39;Health&#39;, &#39;Maintenance&#39;, &#39;Organizations&#39;, &#39;Human&#39;, &#39;Tissue&#39;, &#39;Huntingtons&#39;, &#39;Disease&#39;, &#39;hormones&#39;, &#39;HIPAA&#39;, &#39;#&#39;, &#39;2&#39;, &#39;High&#39;, &#39;Throughput&#39;, &#39;Protein&#39;, &#39;Purification&#39;, &#39;High&#39;, &#39;Performing&#39;, &#39;Operation&#39;, &#39;Human&#39;, &#39;Papilloma&#39;, &#39;Virus&#39;, &#39;transgenics&#39;, &#39;homologous&#39;, &#39;recombinant&#39;, &#39;Human&#39;, &#39;Relations&#39;, &#39;Health&#39;, &#39;Insurance&#39;, &#39;herpes&#39;, &#39;virus&#39;, &#39;HIV&#39;, &#39;Surrogate&#39;, &#39;Markers&#39;, &#39;High&#39;, &#39;Throughput&#39;, &#39;Genomics&#39;, &#39;Hit&#39;, &#39;to&#39;, &#39;Lead&#39;, &#39;High&#39;, &#39;Throughput&#39;, &#39;Screening&#39;, &#39;Hepatotoxicity&#39;, &#39;Hybrid&#39;, &#39;Computing&#39;, &#39;hypertension&#39;, &#39;Targeting&#39;, &#39;Antigen&#39;, &#39;Presenting&#39;, &#39;Cells&#39;, &#39;Inflammatory&#39;, &#39;Bowel&#39;, &#39;Disease&#39;, &#39;imaging&#39;, &#39;contrast&#39;, &#39;agents&#39;, &#39;interleukin&#39;, &#39;converting&#39;, &#39;enzymes&#39;, &#39;ICE&#39;, &#39;Improving&#39;, &#39;Drug&#39;, &#39;Safety&#39;, &#39;diagnostics&#39;, &#39;-&#39;, &#39;infections&#39;, &#39;Infections&#39;, &#39;Diagnostics&#39;, &#39;Europe&#39;, &#39;engineering&#39;, &#39;laboratories&#39;, &#39;Integrated&#39;, &#39;Fluidic&#39;, &#39;Circuits&#39;, &#39;for&#39;, &#39;DOT&#39;, &#39;Informatics&#39;, &#39;for&#39;, &#39;Genomic&#39;, &#39;Medicine&#39;, &#39;Infection&#39;, &#39;Genomics&#39;, &#39;Image&#39;, &#39;Analysis&#39;, &#39;Immunotherapy&#39;, &#39;Biomarkers&#39;, &#39;Immune&#39;, &#39;Profiling&#39;, &#39;in&#39;, &#39;Cancer&#39;, &#39;Complement-based&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;immunomodulation&#39;, &#39;Imaging&#39;, &#39;for&#39;, &#39;WPC&#39;, &#39;conference&#39;, &#39;Imaging&#39;, &#39;Informatics&#39;, &#39;Immune&#39;, &#39;Impurities&#39;, &#39;Regulatory&#39;, &#39;Immunogenicity&#39;, &#39;Immunosequencing&#39;, &#39;Immuno-Oncology&#39;, &#39;Drug&#39;, &#39;Developement&#39;, &#39;Cancer&#39;, &#39;Immunotherapy&#39;, &#39;Oligonucleotides&#39;, &#39;Cancer&#39;, &#39;Immunotherapy&#39;, &#39;Peptides&#39;, &#39;Cancer&#39;, &#39;Immunotherapy&#39;, &#39;Small&#39;, &#39;Molecules&#39;, &#39;Informatics&#39;, &#39;Partnering&#39;, &#39;Insurance&#39;, &#39;AI&#39;, &#39;and&#39;, &#39;IOT&#39;, &#39;Investments&#39;, &#39;Industrial&#39;, &#39;Enzymes&#39;, &#39;Immuno-Oncology&#39;, &#39;Assays&#39;, &#39;Immuno-Oncology&#39;, &#39;Business&#39;, &#39;Strategy&#39;, &#39;Immuno-Oncology&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Immuno-Oncology&#39;, &#39;Models&#39;, &#39;ion&#39;, &#39;channels&#39;, &#39;Protein&#39;, &#39;Engineering&#39;, &#39;for&#39;, &#39;Immuno-oncology&#39;, &#39;Immuno-Oncology&#39;, &#39;Sequencing&#39;, &#39;Immuno-Oncology&#39;, &#39;Targets&#39;, &#39;Legal&#39;, &#39;Issues&#39;, &#39;for&#39;, &#39;Bioproduction&#39;, &#39;Intellectual&#39;, &#39;Property&#39;, &#39;Pluripotent&#39;, &#39;Stem&#39;, &#39;Cells&#39;, &#39;IRB&#39;, &#39;Compliance&#39;, &#39;and&#39;, &#39;Oversight&#39;, &#39;Considerations&#39;, &#39;Adopting&#39;, &#39;Integrated&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Informatics&#39;, &#39;Systems&#39;, &#39;India&#39;, &#39;Re&#39;, &#39;Engineering&#39;, &#39;International&#39;, &#39;Risk&#39;, &#39;Management&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Informatics&#39;, &#39;Iron&#39;, &#39;Chelation&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;Software&#39;, &#39;in&#39;, &#39;situ&#39;, &#39;hybridization&#39;, &#39;Information&#39;, &#39;Technology&#39;, &#39;IT&#39;, &#39;&amp;&#39;, &#39;Informatics&#39;, &#39;for&#39;, &#39;Collaboration&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;Europe&#39;, &#39;Scalable&#39;, &#39;IT&#39;, &#39;&amp;&#39;, &#39;Informatics&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;computer&#39;, &#39;hardware&#39;, &#39;(&#39;, &#39;part&#39;, &#39;2&#39;, &#39;)&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;computer&#39;, &#39;hardware&#39;, &#39;(&#39;, &#39;part&#39;, &#39;3&#39;, &#39;)&#39;, &#39;IT&#39;, &#39;Software&#39;, &#39;for&#39;, &#39;the&#39;, &#39;Life&#39;, &#39;Sciences&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;Virtualization&#39;, &#39;Interviewing&#39;, &#39;Skills&#39;, &#39;for&#39;, &#39;Managers&#39;, &#39;Investigator&#39;, &#39;Sites&#39;, &#39;Report&#39;, &#39;1&#39;, &#39;Investigator&#39;, &#39;Sites&#39;, &#39;Report&#39;, &#39;2&#39;, &#39;Imaging&#39;, &#39;Week&#39;, &#39;joints&#39;, &#39;Job&#39;, &#39;recruiters&#39;, &#39;Kinase&#39;, &#39;Chemistry&#39;, &#39;KIN&#39;, &#39;West&#39;, &#39;Coast&#39;, &#39;Kinases&#39;, &#39;for&#39;, &#39;DOT&#39;, &#39;Knowledge&#39;, &#39;Management&#39;, &#39;chemokines&#39;, &#39;HIV&#39;, &#39;and&#39;, &#39;Kaposis&#39;, &#39;sarcoma&#39;, &#39;Kinetics&#39;, &#39;Structure&#39;, &#39;Relationship&#39;, &#39;laboratories&#39;, &#39;Lead&#39;, &#39;Acid&#39;, &#39;Batteries&#39;, &#39;Label&#39;, &#39;Free&#39;, &#39;Detection&#39;, &#39;Drug&#39;, &#39;Labeling&#39;, &#39;Live&#39;, &#39;Cell&#39;, &#39;Imaging&#39;, &#39;Laser&#39;, &#39;Capture&#39;, &#39;Microdissection&#39;, &#39;Lung&#39;, &#39;Cancer&#39;, &#39;ligase&#39;, &#39;chain&#39;, &#39;reaction&#39;, &#39;leukodepletion&#39;, &#39;Laboratory&#39;, &#39;Developed&#39;, &#39;Tests&#39;, &#39;leukemia&#39;, &#39;Ontologies/Lexicons&#39;, &#39;Legal&#39;, &#39;drug&#39;, &#39;liability&#39;, &#39;screening&#39;, &#39;libraries&#39;, &#39;Life&#39;, &#39;Sciences&#39;, &#39;Protein&#39;, &#39;Ligands&#39;, &#39;lab&#39;, &#39;information&#39;, &#39;management&#39;, &#39;systems&#39;, &#39;LIMS&#39;, &#39;Lipids&#39;, &#39;Large&#39;, &#39;Stationary&#39;, &#39;Batteries&#39;, &#39;Lyophilization&#39;, &#39;Mergers&#39;, &#39;&amp;&#39;, &#39;Acquisitions&#39;, &#39;Monoclonal&#39;, &#39;Antibodies&#39;, &#39;Forum&#39;, &#39;Monoclonal&#39;, &#39;Antibody&#39;, &#39;Process&#39;, &#39;Development&#39;, &#39;Malaria&#39;, &#39;Metabolism&#39;, &#39;Targeted&#39;, &#39;Cancer&#39;, &#39;Therapeutics&#39;, &#39;Microbiome&#39;, &#39;in&#39;, &#39;Immuno-Oncology&#39;, &#39;Microbiome&#39;, &#39;Metabolic&#39;, &#39;Syndrome&#39;, &#39;Medicinal&#39;, &#39;Chemistry&#39;, &#39;Part&#39;, &#39;2&#39;, &#39;Mucosal&#39;, &#39;Immunity&#39;, &#39;Microreactors&#39;, &#39;Macrocycles&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Business&#39;, &#39;Multidrug&#39;, &#39;Resistance&#39;, &#39;Cancer&#39;, &#39;Medical&#39;, &#39;Coding&#39;, &#39;multidrug&#39;, &#39;resistant&#39;, &#39;infections&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Non-Invasive&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Microdosing&#39;, &#39;microbial&#39;, &#39;infections&#39;, &#39;Sequencing&#39;, &#39;Based&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Forum&#39;, &#39;Molecular&#39;, &#39;Electronics&#39;, &#39;Metabolic&#39;, &#39;Engineering&#39;, &#39;Melanoma&#39;, &#39;BioMEMS&#39;, &#39;memory&#39;, &#39;enhancement&#39;, &#39;cancer&#39;, &#39;metastasis&#39;, &#39;molecular&#39;, &#39;evolution&#39;, &#39;Mammalian&#39;, &#39;Cell&#39;, &#39;Line&#39;, &#39;Development&#39;, &#39;microfabrication&#39;, &#39;Molecular&#39;, &#39;Genetic&#39;, &#39;Pro&#39;, &#39;Management&#39;, &#39;molecular&#39;, &#39;medicine&#39;, &#39;Novel&#39;, &#39;bioactive&#39;, &#39;high&#39;, &#39;throughput&#39;, &#39;screening&#39;, &#39;europe&#39;, &#39;Myocardial&#39;, &#39;Infarction&#39;, &#39;migraine&#39;, &#39;microtiter&#39;, &#39;plates&#39;, &#39;Molecular&#39;, &#39;Medicine&#39;, &#39;Europe&#39;, &#39;metalloproteinases&#39;, &#39;Molecular&#39;, &#39;Medicine&#39;, &#39;Asia&#39;, &#39;Managed&#39;, &#39;Care&#39;, &#39;Manufacturing&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Monitoring&#39;, &#39;Mechanism&#39;, &#39;of&#39;, &#39;Action&#39;, &#39;Purifying&#39;, &#39;Antibodies&#39;, &#39;Meeting&#39;, &#39;Planning&#39;, &#39;Services&#39;, &#39;Molecular&#39;, &#39;Pathology&#39;, &#39;Molecular&#39;, &#39;Pathology&#39;, &#39;Basic&#39;, &#39;Molecular&#39;, &#39;Pathology&#39;, &#39;Advanced&#39;, &#39;magnetic&#39;, &#39;resonance&#39;, &#39;imaging&#39;, &#39;Multi&#39;, &#39;Specific&#39;, &#39;Antibodies&#39;, &#39;Mass&#39;, &#39;Spectrometry&#39;, &#39;for&#39;, &#39;Protein&#39;, &#39;Biomarker&#39;, &#39;Discovery&#39;, &#39;Muscle&#39;, &#39;Mass&#39;, &#39;Spec&#39;, &#39;Informatics&#39;, &#39;Mass&#39;, &#39;Spec&#39;, &#39;Imaging&#39;, &#39;Modeling&#39;, &#39;and&#39;, &#39;Simulation&#39;, &#39;Mass&#39;, &#39;spectrometry&#39;, &#39;Mass&#39;, &#39;Spec&#39;, &#39;Diagnostics&#39;, &#39;Metabolic&#39;, &#39;Disorders&#39;, &#39;Mental&#39;, &#39;Health&#39;, &#39;Materials&#39;, &#39;Testing&#39;, &#39;cellular&#39;, &#39;matrix&#39;, &#39;Multiplexed&#39;, &#39;Assays&#39;, &#39;Moelcular&#39;, &#39;Diagnostics&#39;, &#39;Europe&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;for&#39;, &#39;Cancer&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;for&#39;, &#39;Infectious&#39;, &#39;Disease&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Antibodies&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Antibodies&#39;, &#39;(&#39;, &#39;for&#39;, &#39;PGE&#39;, &#39;)&#39;, &#39;Nucleic&#39;, &#39;Acid&#39;, &#39;Europe&#39;, &#39;National&#39;, &#39;Academy&#39;, &#39;of&#39;, &#39;Sciences&#39;, &#39;meeting&#39;, &#39;natural&#39;, &#39;products&#39;, &#39;new&#39;, &#39;antivirals&#39;, &#39;Novel&#39;, &#39;Cancer&#39;, &#39;Informatics&#39;, &#39;Non-Coding&#39;, &#39;RNA&#39;, &#39;Novel&#39;, &#39;Strategies&#39;, &#39;Cancer&#39;, &#39;Novel&#39;, &#39;Cancer&#39;, &#39;Targets&#39;, &#39;Neurodegenerative&#39;, &#39;Nucleotide&#39;, &#39;Delivery&#39;, &#39;Internet&#39;, &#39;New&#39;, &#39;to&#39;, &#39;Database&#39;, &#39;comapny&#39;, &#39;names&#39;, &#39;Advances&#39;, &#39;in&#39;, &#39;Informatics&#39;, &#39;nerve&#39;, &#39;growth&#39;, &#39;factors&#39;, &#39;NF&#39;, &#39;KB&#39;, &#39;Nanofluidics&#39;, &#39;Informatics&#39;, &#39;Next-Generation&#39;, &#39;Batteries&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Batteries&#39;, &#39;Portable&#39;, &#39;Applications&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Batteries&#39;, &#39;Stationary&#39;, &#39;Power&#39;, &#39;Epigenetic&#39;, &#39;Sequencing&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Imaging&#39;, &#39;Neurogenomics&#39;, &#39;Nuclear&#39;, &#39;Hormone&#39;, &#39;Receptors&#39;, &#39;Novel&#39;, &#39;HIV&#39;, &#39;Strategies&#39;, &#39;Neurotech&#39;, &#39;Industry&#39;, &#39;neuroinjuries&#39;, &#39;NK&#39;, &#39;Cell&#39;, &#39;Based&#39;, &#39;Cancer&#39;, &#39;Immunotherapy&#39;, &#39;Natural&#39;, &#39;Language&#39;, &#39;Processing&#39;, &#39;nuclear&#39;, &#39;matrix&#39;, &#39;Nanomedicine&#39;, &#39;Nitric&#39;, &#39;Oxide&#39;, &#39;Network&#39;, &#39;Pharmacology&#39;, &#39;Energy&#39;, &#39;Neurotoxicity&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;in&#39;, &#39;the&#39;, &#39;US&#39;, &#39;nanotech&#39;, &#39;self&#39;, &#39;assembly&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Supply&#39;, &#39;Chain&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Supply&#39;, &#39;Chain&#39;, &#39;Europe&#39;, &#39;Neurostimulation&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Diagnostic&#39;, &#39;Things&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Energy&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Energy&#39;, &#39;Europe&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Things&#39;, &#39;Infrastructure&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Health&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Insurance&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Insurance&#39;, &#39;Europe&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Things&#39;, &#39;Manufacturing&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Things&#39;, &#39;Manufacturing&#39;, &#39;Internet&#39;, &#39;of&#39;, &#39;Manufacturing&#39;, &#39;Europe&#39;, &#39;Smart&#39;, &#39;Buildings&#39;, &#39;Smart&#39;, &#39;Cities&#39;, &#39;Nephrotoxicity&#39;, &#39;Nuclear&#39;, &#39;Energy&#39;, &#39;nutrition&#39;, &#39;Optimizing&#39;, &#39;Media&#39;, &#39;organ&#39;, &#39;and&#39;, &#39;cell&#39;, &#39;transplants&#39;, &#39;Oncology&#39;, &#39;Drug&#39;, &#39;Targets&#39;, &#39;Optical&#39;, &#39;Diagnostics&#39;, &#39;Oncogenomics&#39;, &#39;Office&#39;, &#39;of&#39;, &#39;the&#39;, &#39;Inspector&#39;, &#39;General&#39;, &#39;Oil&#39;, &#39;and&#39;, &#39;Gas&#39;, &#39;oncogenes&#39;, &#39;Oncolytic&#39;, &#39;Viruses&#39;, &#39;Oligo&#39;, &#39;Production&#39;, &#39;opportunistic&#39;, &#39;infections&#39;, &#39;Oligo&#39;, &#39;Regulatory&#39;, &#39;organs&#39;, &#39;transplants&#39;, &#39;oral&#39;, &#39;drug&#39;, &#39;delivery&#39;, &#39;OSTEOARTHRITIS&#39;, &#39;OTC&#39;, &#39;over&#39;, &#39;the&#39;, &#39;counter&#39;, &#39;Additional&#39;, &#39;Conferences&#39;, &#39;clinical&#39;, &#39;trials&#39;, &#39;outsourcing&#39;, &#39;Oxygen&#39;, &#39;Radicals&#39;, &#39;oncogenes&#39;, &#39;p53&#39;, &#39;Predictive&#39;, &#39;ADME&#39;, &#39;protein&#39;, &#39;aggregation&#39;, &#39;Protein&#39;, &#39;Aggregation&#39;, &#39;(&#39;, &#39;for&#39;, &#39;PTK&#39;, &#39;)&#39;, &#39;Packaging&#39;, &#39;parasitic&#39;, &#39;infections&#39;, &#39;Process&#39;, &#39;Analytical&#39;, &#39;Technology&#39;, &#39;Pharmacy&#39;, &#39;Benefit&#39;, &#39;Management&#39;, &#39;Pharmaceutical&#39;, &#39;BioProcess&#39;, &#39;Basic&#39;, &#39;Research&#39;, &#39;&amp;&#39;, &#39;Discovery&#39;, &#39;track&#39;, &#39;for&#39;, &#39;PCG&#39;, &#39;Clinical&#39;, &#39;Operations&#39;, &#39;track&#39;, &#39;for&#39;, &#39;PCG&#39;, &#39;Preclinical&#39;, &#39;Development&#39;, &#39;track&#39;, &#39;for&#39;, &#39;PCG&#39;, &#39;Bridgehead&#39;, &#39;PCI&#39;, &#39;book&#39;, &#39;Preclinical&#39;, &#39;Preclinical&#39;, &#39;Preclinical&#39;, &#39;prostate&#39;, &#39;cancer&#39;, &#39;Preclinical&#39;, &#39;Outcome&#39;, &#39;Predictions&#39;, &#39;preclinical&#39;, &#39;trials&#39;, &#39;Point&#39;, &#39;of&#39;, &#39;Care&#39;, &#39;West&#39;, &#39;Protein&#39;, &#39;Crystallography&#39;, &#39;pediatric&#39;, &#39;AIDS/HIV&#39;, &#39;PDA&#39;, &#39;Downloads&#39;, &#39;from&#39;, &#39;CHI&#39;, &#39;website&#39;, &#39;Process&#39;, &#39;Development&#39;, &#39;for&#39;, &#39;Executives&#39;, &#39;platelet&#39;, &#39;derived&#39;, &#39;growth&#39;, &#39;factors&#39;, &#39;protein&#39;, &#39;drug&#39;, &#39;delivery&#39;, &#39;Preclinical&#39;, &#39;Disease&#39;, &#39;Models&#39;, &#39;photodynamic&#39;, &#39;therapies&#39;, &#39;Phage&#39;, &#39;Display&#39;, &#39;for&#39;, &#39;Vaccine&#39;, &#39;Development&#39;, &#39;Proteomic&#39;, &#39;Tools&#39;, &#39;for&#39;, &#39;Diagnostics&#39;, &#39;pediatric&#39;, &#39;Pediatric&#39;, &#39;trials&#39;, &#39;for&#39;, &#39;CRAS&#39;, &#39;PEGS&#39;, &#39;Virtual&#39;, &#39;Interactive&#39;, &#39;Global&#39;, &#39;Summit&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Monitoring&#39;, &#39;Protein&#39;, &#39;Executive&#39;, &#39;Summit&#39;, &#39;Proof&#39;, &#39;of&#39;, &#39;Concept&#39;, &#39;for&#39;, &#39;Cancer&#39;, &#39;Protein&#39;, &#39;Function&#39;, &#39;Enterprise&#39;, &#39;Portfolio&#39;, &#39;Management&#39;, &#39;Portfolio&#39;, &#39;Value&#39;, &#39;Protein&#39;, &#39;Aggregates&#39;, &#39;Light&#39;, &#39;Scattering&#39;, &#39;Consumer&#39;, &#39;Genomics/Personal&#39;, &#39;Genomics&#39;, &#39;Protein&#39;, &#39;Engineering&#39;, &#39;Partnering&#39;, &#39;Particulate&#39;, &#39;Screening&#39;, &#39;Phage&#39;, &#39;West&#39;, &#39;Phase&#39;, &#39;II/Reducing&#39;, &#39;Attrition&#39;, &#39;Phase&#39;, &#39;IV&#39;, &#39;Phase&#39;, &#39;IV&#39;, &#39;Pharmacies&#39;, &#39;Phage&#39;, &#39;Display&#39;, &#39;Europe&#39;, &#39;Pharmaceutical&#39;, &#39;Half&#39;, &#39;Life&#39;, &#39;Phase&#39;, &#39;Zero&#39;, &#39;PI3K&#39;, &#39;Phosphoinositide&#39;, &#39;3&#39;, &#39;Kinase&#39;, &#39;Protein&#39;, &#39;Identification&#39;, &#39;Preclinical&#39;, &#39;Imaging&#39;, &#39;protease&#39;, &#39;inhibitors&#39;, &#39;enzymes&#39;, &#39;PLA2&#39;, &#39;blood&#39;, &#39;platelets&#39;, &#39;Membrane&#39;, &#39;Proteins&#39;, &#39;Membrane&#39;, &#39;Protein&#39;, &#39;for&#39;, &#39;DOT&#39;, &#39;(&#39;, &#39;part&#39;, &#39;1&#39;, &#39;)&#39;, &#39;Membrane&#39;, &#39;Protein&#39;, &#39;for&#39;, &#39;DOT&#39;, &#39;(&#39;, &#39;part&#39;, &#39;2&#39;, &#39;)&#39;, &#39;Protein&#39;, &#39;Manufacturing&#39;, &#39;Clinical&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;:&#39;, &#39;Intermediate&#39;, &#39;Preventive&#39;, &#39;Medicine&#39;, &#39;Pancreatic&#39;, &#39;Cancer&#39;, &#39;Preclinical&#39;, &#39;Studies&#39;, &#39;for&#39;, &#39;IND&#39;, &#39;Protein&#39;, &#39;Computational&#39;, &#39;Tools&#39;, &#39;Prenatal&#39;, &#39;Therapeutics&#39;, &#39;Parenteral&#39;, &#39;Point&#39;, &#39;of&#39;, &#39;Care&#39;, &#39;Diagnostics&#39;, &#39;Europe&#39;, &#39;Cannabis&#39;, &#39;Power&#39;, &#39;Utilities&#39;, &#39;protein&#39;, &#39;characterization&#39;, &#39;protein&#39;, &#39;purification&#39;, &#39;Protein&#39;, &#39;Protein&#39;, &#39;Interactions&#39;, &#39;Protein&#39;, &#39;Protein&#39;, &#39;Interactions&#39;, &#39;Part&#39;, &#39;2&#39;, &#39;Process&#39;, &#39;Management&#39;, &#39;Protein&#39;, &#39;Process&#39;, &#39;PepTalk&#39;, &#39;Partnering&#39;, &#39;Personalized&#39;, &#39;Medicine&#39;, &#39;Partnering&#39;, &#39;Proteomics&#39;, &#39;Analytics&#39;, &#39;Predictive&#39;, &#39;Analytics&#39;, &#39;Pricing&#39;, &#39;Parkinsons&#39;, &#39;Predictive&#39;, &#39;Biomedicine&#39;, &#39;Proteins&#39;, &#39;,&#39;, &#39;Peptides&#39;, &#39;&amp;&#39;, &#39;Proteomics&#39;, &#39;Series&#39;, &#39;Protein&#39;, &#39;Quantification&#39;, &#39;Partnering&#39;, &#39;Data&#39;, &#39;Privacy&#39;, &#39;Personalized&#39;, &#39;Medicine&#39;, &#39;Asia&#39;, &#39;Product&#39;, &#39;Service&#39;, &#39;Announcement&#39;, &#39;Production&#39;, &#39;and&#39;, &#39;Scale&#39;, &#39;Up&#39;, &#39;Pharma&#39;, &#39;Services&#39;, &#39;News&#39;, &#39;schizophrenia&#39;, &#39;antipsychotics&#39;, &#39;Protein&#39;, &#39;Antibodies&#39;, &#39;Preclinical&#39;, &#39;Toxicology&#39;, &#39;Biologics&#39;, &#39;Protein&#39;, &#39;Technology&#39;, &#39;Engineering&#39;, &#39;Protein&#39;, &#39;Therapeutics&#39;, &#39;for&#39;, &#39;Delivery&#39;, &#39;Predictive&#39;, &#39;Toxicity&#39;, &#39;Europe&#39;, &#39;Platform&#39;, &#39;Software&#39;, &#39;for&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Studies&#39;, &#39;Phenotype&#39;, &#39;to&#39;, &#39;Genotype&#39;, &#39;Pathology&#39;, &#39;Protein&#39;, &#39;drugs&#39;, &#39;&amp;&#39;, &#39;diagnostics&#39;, &#39;Intellectual&#39;, &#39;Property&#39;, &#39;Post&#39;, &#39;Translational&#39;, &#39;Modifications&#39;, &#39;Patient&#39;, &#39;Registries&#39;, &#39;Advancing&#39;, &#39;Therapeutics&#39;, &#39;Current&#39;, &#39;Generation&#39;, &#39;Protein&#39;, &#39;Drug&#39;, &#39;Delivery&#39;, &#39;(&#39;, &#39;part&#39;, &#39;of&#39;, &#39;PepTalk&#39;, &#39;)&#39;, &#39;Advancing&#39;, &#39;Therapeutics&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Biological&#39;, &#39;Therapeutic&#39;, &#39;Products&#39;, &#39;Series&#39;, &#39;Pathway/Networks&#39;, &#39;Publications&#39;, &#39;Protein&#39;, &#39;Variations&#39;, &#39;Powertrains&#39;, &#39;Protein&#39;, &#39;Characterization&#39;, &#39;,&#39;, &#39;Purification&#39;, &#39;and&#39;, &#39;Screening&#39;, &#39;Protein&#39;, &#39;Characterization&#39;, &#39;,&#39;, &#39;Purification&#39;, &#39;and&#39;, &#39;Screening&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Europe&#39;, &#39;Beyond&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Europe&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Host&#39;, &#39;Novel&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Systems&#39;, &#39;Protein&#39;, &#39;Engineering&#39;, &#39;Vectors&#39;, &#39;Preventive&#39;, &#39;gene&#39;, &#39;quantification&#39;, &#39;Europe&#39;, &#39;QS&#39;, &#39;Regulation&#39;, &#39;Recombinant&#39;, &#39;Antibodies&#39;, &#39;Recombinant&#39;, &#39;Antibodies&#39;, &#39;Recombinant&#39;, &#39;Proteins&#39;, &#39;Forum&#39;, &#39;Radiation&#39;, &#39;Rare&#39;, &#39;Diseases&#39;, &#39;Antibody&#39;, &#39;Drug&#39;, &#39;Products&#39;, &#39;RBE&#39;, &#39;track&#39;, &#39;at&#39;, &#39;PGE&#39;, &#39;RBE&#39;, &#39;track&#39;, &#39;at&#39;, &#39;PGE&#39;, &#39;Antibody&#39;, &#39;Screening&#39;, &#39;Antibody&#39;, &#39;Translational&#39;, &#39;rapid&#39;, &#39;compound&#39;, &#39;characterization&#39;, &#39;Clinical&#39;, &#39;Enrollment&#39;, &#39;Plan&#39;, &#39;Clinical&#39;, &#39;Recruitment&#39;, &#39;Media&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Patient&#39;, &#39;Recruitment&#39;, &#39;Winning&#39;, &#39;Strategies&#39;, &#39;for&#39;, &#39;Clinical&#39;, &#39;Recruitment&#39;, &#39;Media&#39;, &#39;Integrating&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;and&#39;, &#39;Marketing&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Productivity&#39;, &#39;drug&#39;, &#39;receptors&#39;, &#39;Role&#39;, &#39;of&#39;, &#39;Business&#39;, &#39;Process&#39;, &#39;Managment&#39;, &#39;in&#39;, &#39;FDA&#39;, &#39;Regulated&#39;, &#39;Industry&#39;, &#39;Worldwide&#39;, &#39;Pharma&#39;, &#39;Regulation&#39;, &#39;Surviving&#39;, &#39;FDA&#39;, &#39;Site&#39;, &#39;Inspections&#39;, &#39;Real&#39;, &#39;Estate&#39;, &#39;Risk&#39;, &#39;Evaluation&#39;, &#39;and&#39;, &#39;Mitigation&#39;, &#39;Strategies&#39;, &#39;Renal&#39;, &#39;(&#39;, &#39;kidney&#39;, &#39;)&#39;, &#39;Renewable&#39;, &#39;Energy&#39;, &#39;Storage&#39;, &#39;System&#39;, &#39;RFID&#39;, &#39;Radiofrequency&#39;, &#39;ID&#39;, &#39;Reagents&#39;, &#39;Gap&#39;, &#39;Analysis&#39;, &#39;rheumatoid&#39;, &#39;arthritis&#39;, &#39;gene&#39;, &#39;therapy&#39;, &#39;[&#39;, &#39;RNA&#39;, &#39;blocking&#39;, &#39;]&#39;, &#39;Ribonucleic&#39;, &#39;Acid&#39;, &#39;RNAi&#39;, &#39;for&#39;, &#39;Functional&#39;, &#39;Screening&#39;, &#39;RNAi&#39;, &#39;RNAInterference&#39;, &#39;RNAi&#39;, &#39;Discovery&#39;, &#39;on&#39;, &#39;Target&#39;, &#39;RNAi&#39;, &#39;Video&#39;, &#39;on&#39;, &#39;Request&#39;, &#39;RNA&#39;, &#39;Quality&#39;, &#39;RNA&#39;, &#39;Therapeutics&#39;, &#39;Robotics&#39;, &#39;Regional&#39;, &#39;Organization&#39;, &#39;Robotic&#39;, &#39;Process&#39;, &#39;Automation&#39;, &#39;reperfusion&#39;, &#39;Reproduction&#39;, &#39;Gene&#39;, &#39;Regulation&#39;, &#39;and&#39;, &#39;Regulatory&#39;, &#39;Networks&#39;, &#39;Restenosis&#39;, &#39;Retail&#39;, &#39;Real&#39;, &#39;World&#39;, &#39;Data&#39;, &#39;Therapeutics&#39;, &#39;Indications&#39;, &#39;&amp;&#39;, &#39;Drug&#39;, &#39;Targets&#39;, &#39;Series&#39;, &#39;safety&#39;, &#39;Screening&#39;, &#39;3D&#39;, &#39;Models&#39;, &#39;Sickle&#39;, &#39;Cell&#39;, &#39;Anemia&#39;, &#39;Screening&#39;, &#39;Informatics&#39;, &#39;Sequencing&#39;, &#39;and&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;supply&#39;, &#39;chain&#39;, &#39;management&#39;, &#39;SCOPEs&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Leadership&#39;, &#39;Forum&#39;, &#39;Phenotypic&#39;, &#39;Screening&#39;, &#39;Phenotypic&#39;, &#39;Screening&#39;, &#39;clinical&#39;, &#39;trials&#39;, &#39;strategy&#39;, &#39;IT&#39;, &#39;Security&#39;, &#39;Sequence&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Sequence&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Asia&#39;, &#39;Sidec&#39;, &#39;Executive&#39;, &#39;Forum&#39;, &#39;Sequence&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Europe&#39;, &#39;Sleeper&#39;, &#39;Disease&#39;, &#39;Indications&#39;, &#39;Sequencing&#39;, &#39;Data&#39;, &#39;Storage&#39;, &#39;&amp;&#39;, &#39;Management&#39;, &#39;Screening&#39;, &#39;Difficult&#39;, &#39;Targets&#39;, &#39;Source&#39;, &#39;Document&#39;, &#39;Verification&#39;, &#39;Sequencing&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;&amp;&#39;, &#39;Storage&#39;, &#39;second&#39;, &#39;messengers&#39;, &#39;sepsis&#39;, &#39;infections&#39;, &#39;Sequencing&#39;, &#39;Forum&#39;, &#39;Serotonin&#39;, &#39;Sexual&#39;, &#39;Small&#39;, &#39;Fuel&#39;, &#39;Cells&#39;, &#39;selective&#39;, &#39;immune&#39;, &#39;suppression&#39;, &#39;skin&#39;, &#39;sleep&#39;, &#39;Pharmaceutical&#39;, &#39;Sales&#39;, &#39;Biologics&#39;, &#39;Small&#39;, &#39;Molecular&#39;, &#39;Comparisons&#39;, &#39;Semiconductors&#39;, &#39;small&#39;, &#39;molecules&#39;, &#39;simple&#39;, &#39;model&#39;, &#39;organisms&#39;, &#39;Small&#39;, &#39;Molecules&#39;, &#39;Synthesis&#39;, &#39;Semantic&#39;, &#39;Web&#39;, &#39;Sensor&#39;, &#39;Applications&#39;, &#39;Synthetic&#39;, &#39;Biology&#39;, &#39;Sensor&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Implantable&#39;, &#39;Biomedical&#39;, &#39;Sensors&#39;, &#39;Sensor&#39;, &#39;Materials&#39;, &#39;Sensors&#39;, &#39;Emerging&#39;, &#39;Markets&#39;, &#39;SNPs&#39;, &#39;Sensor&#39;, &#39;Systems&#39;, &#39;Sensor&#39;, &#39;Safety&#39;, &#39;software&#39;, &#39;Solubility&#39;, &#39;Safety&#39;, &#39;Pharmacology&#39;, &#39;for&#39;, &#39;Biologics&#39;, &#39;Safety&#39;, &#39;Pharmacology&#39;, &#39;for&#39;, &#39;Biologics&#39;, &#39;Genomic&#39;, &#39;Sample&#39;, &#39;Preparation&#39;, &#39;Speciality&#39;, &#39;Pharmaceuticals&#39;, &#39;Alternative&#39;, &#39;Splicing&#39;, &#39;Proteomic&#39;, &#39;Sample&#39;, &#39;Preparation&#39;, &#39;High&#39;, &#39;throughput&#39;, &#39;screening&#39;, &#39;partnering&#39;, &#39;solid&#39;, &#39;phase&#39;, &#39;synthesis&#39;, &#39;Subjective&#39;, &#39;End&#39;, &#39;Points&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Sequencing&#39;, &#39;Applications&#39;, &#39;Sequencing&#39;, &#39;Core&#39;, &#39;Labs&#39;, &#39;Next-Generation&#39;, &#39;Data&#39;, &#39;Generation&#39;, &#39;Plant&#39;, &#39;Sequencing&#39;, &#39;RNA&#39;, &#39;Sequencing&#39;, &#39;Sequencing&#39;, &#39;Solutions&#39;, &#39;Deep&#39;, &#39;Sequencing&#39;, &#39;EU&#39;, &#39;Site&#39;, &#39;Selection&#39;, &#39;,&#39;, &#39;Study&#39;, &#39;Activation&#39;, &#39;,&#39;, &#39;and&#39;, &#39;Patient&#39;, &#39;Recruitment&#39;, &#39;Stability&#39;, &#39;stroke&#39;, &#39;Stem&#39;, &#39;Cell&#39;, &#39;Culture&#39;, &#39;Stem&#39;, &#39;Cell&#39;, &#39;Research&#39;, &#39;(&#39;, &#39;part&#39;, &#39;of&#39;, &#39;MMTC&#39;, &#39;)&#39;, &#39;Statin&#39;, &#39;Stem&#39;, &#39;Cells&#39;, &#39;Safety&#39;, &#39;Screening&#39;, &#39;Startup&#39;, &#39;Public&#39;, &#39;companies/stock&#39;, &#39;exchanges&#39;, &#39;CHI&#39;, &#39;Surveys&#39;, &#39;Services&#39;, &#39;Systems&#39;, &#39;Biology&#39;, &#39;for&#39;, &#39;BYG&#39;, &#39;track&#39;, &#39;synthesis&#39;, &#39;Systems&#39;, &#39;Biology&#39;, &#39;Training&#39;, &#39;&amp;&#39;, &#39;Development&#39;, &#39;Top&#39;, &#39;50&#39;, &#39;Big&#39;, &#39;Pharmas&#39;, &#39;Tissue&#39;, &#39;Microarrays&#39;, &#39;taxol&#39;, &#39;tamoxifen&#39;, &#39;and&#39;, &#39;other&#39;, &#39;derivatives&#39;, &#39;Tuberculosis&#39;, &#39;Tobacco&#39;, &#39;The&#39;, &#39;Biotech&#39;, &#39;Journal&#39;, &#39;Email&#39;, &#39;List&#39;, &#39;Trust&#39;, &#39;Building&#39;, &#39;for&#39;, &#39;Collaborative&#39;, &#39;Innovation&#39;, &#39;Tumor&#39;, &#39;,&#39;, &#39;Circulating&#39;, &#39;Cells&#39;, &#39;Technology&#39;, &#39;Technology&#39;, &#39;Consortium&#39;, &#39;Target&#39;, &#39;Driven&#39;, &#39;Chemistry&#39;, &#39;targeted&#39;, &#39;drug&#39;, &#39;delivery&#39;, &#39;transgenic&#39;, &#39;disease&#39;, &#39;models&#39;, &#39;Thrombotic&#39;, &#39;Disease&#39;, &#39;tissue&#39;, &#39;engineering&#39;, &#39;telomerases&#39;, &#39;Battery&#39;, &#39;Testing&#39;, &#39;Transfection&#39;, &#39;Toxicogenomics&#39;, &#39;Target&#39;, &#39;Prioritization&#39;, &#39;Target&#39;, &#39;Identification&#39;, &#39;tissues&#39;, &#39;Technology&#39;, &#39;Platforms&#39;, &#39;Immunotherapies&#39;, &#39;Telecommunications&#39;, &#39;Telemedicine&#39;, &#39;Tumor&#39;, &#39;Microenvironment&#39;, &#39;Trial&#39;, &#39;Master&#39;, &#39;File&#39;, &#39;for&#39;, &#39;Sponsors&#39;, &#39;(&#39;, &#39;pharma&#39;, &#39;)&#39;, &#39;Trial&#39;, &#39;Master&#39;, &#39;File&#39;, &#39;for&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;Theranostic&#39;, &#39;Market&#39;, &#39;Models&#39;, &#39;tumor&#39;, &#39;necrosis&#39;, &#39;factors&#39;, &#39;Therapeutics&#39;, &#39;and&#39;, &#39;Targets&#39;, &#39;Therapeutics&#39;, &#39;&amp;&#39;, &#39;Targets&#39;, &#39;Series&#39;, &#39;immune&#39;, &#39;tolerance&#39;, &#39;Fibrinolytic&#39;, &#39;(&#39;, &#39;clot&#39;, &#39;buster&#39;, &#39;)&#39;, &#39;Transgenic&#39;, &#39;Production&#39;, &#39;in&#39;, &#39;Plants&#39;, &#39;Synthetic&#39;, &#39;Biology&#39;, &#39;Transportation&#39;, &#39;Translational&#39;, &#39;Biomarkers&#39;, &#39;Translational&#39;, &#39;Informatics&#39;, &#39;Drug/Disease&#39;, &#39;Targets&#39;, &#39;Drug&#39;, &#39;Targets&#39;, &#39;Series&#39;, &#39;Genome&#39;, &#39;Tri&#39;, &#39;Conference&#39;, &#39;Translation&#39;, &#39;Services&#39;, &#39;transgenics&#39;, &#39;gene&#39;, &#39;knockouts&#39;, &#39;transgenic&#39;, &#39;production&#39;, &#39;Tumor&#39;, &#39;Suppressor&#39;, &#39;Genes&#39;, &#39;tissue&#39;, &#39;safety&#39;, &#39;Technology&#39;, &#39;&amp;&#39;, &#39;Tools&#39;, &#39;for&#39;, &#39;the&#39;, &#39;Life&#39;, &#39;Sciences&#39;, &#39;Technology&#39;, &#39;&amp;&#39;, &#39;Tools&#39;, &#39;for&#39;, &#39;Life&#39;, &#39;Sciences&#39;, &#39;Series&#39;, &#39;Target&#39;, &#39;Validation&#39;, &#39;Text&#39;, &#39;Mining&#39;, &#39;Unmanned&#39;, &#39;Aerial&#39;, &#39;Vehicles&#39;, &#39;Ubiquitin&#39;, &#39;Uninterruptible&#39;, &#39;Power&#39;, &#39;Supplies&#39;, &#39;upcoming&#39;, &#39;conferences&#39;, &#39;upcoming&#39;, &#39;conferences&#39;, &#39;Europe&#39;, &#39;Urinary&#39;, &#39;Incontinence&#39;, &#39;New&#39;, &#39;USP&#39;, &#39;Initiatives&#39;, &#39;and&#39;, &#39;Standards&#39;, &#39;for&#39;, &#39;Biologics&#39;, &#39;unstable&#39;, &#39;triplets&#39;, &#39;trinucleotide&#39;, &#39;repeats&#39;, &#39;Vaccines&#39;, &#39;(&#39;, &#39;for&#39;, &#39;IMT&#39;, &#39;)&#39;, &#39;Vascular&#39;, &#39;Vaccines&#39;, &#39;Business&#39;, &#39;Opportunities&#39;, &#39;Venture&#39;, &#39;Capital&#39;, &#39;Business&#39;, &#39;Opportunities&#39;, &#39;Vaccines&#39;, &#39;Voice&#39;, &#39;Recognition&#39;, &#39;Paperless&#39;, &#39;Validation&#39;, &#39;veterinary&#39;, &#39;viral&#39;, &#39;infections&#39;, &#39;Vaccines&#39;, &#39;Production&#39;, &#39;&amp;&#39;, &#39;Manufacturing&#39;, &#39;Virtual&#39;, &#39;Reality&#39;, &#39;virtual&#39;, &#39;business&#39;, &#39;Virtual&#39;, &#39;Teams&#39;, &#39;Single&#39;, &#39;Use&#39;, &#39;Systems&#39;, &#39;for&#39;, &#39;Vaccine&#39;, &#39;Manufacture&#39;, &#39;well&#39;, &#39;characterized&#39;, &#39;biologicals&#39;, &#39;Wellness&#39;, &#39;Wiki&#39;, &#39;wound&#39;, &#39;management&#39;, &#39;Wireless&#39;, &#39;Change&#39;, &#39;Record&#39;, &#39;Change&#39;, &#39;Record&#39;, &#39;Mary&#39;, &#39;Chitty&#39;, &#39;Xenotransplantation&#39;, &#39;Yeast&#39;, &#39;Display&#39;, &#39;Zika&#39;, &#39;Vaccine&#39;, &#39;Development&#39;]
Filterd Sentence: [&#39;Molecular&#39;, &#39;Medicine&#39;, &#39;Tri&#39;, &#39;Conference&#39;, &#39;Protein&#39;, &#39;Engineering&#39;, &#39;Peptalk&#39;, &#39;Biocomputing&#39;, &#39;SCOPE&#39;, &#39;Summit&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Operations&#39;, &#39;Executives&#39;, &#39;bioproduction&#39;, &#39;Discovery&#39;, &#39;Target&#39;, &#39;PEGS&#39;, &#39;Europe&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Chemistry&#39;, &#39;World&#39;, &#39;Pharmaceutical&#39;, &#39;Congress&#39;, &#39;advanced&#39;, &#39;diagnostics&#39;, &#39;Advanced&#39;, &#39;Automotive&#39;, &#39;Battery&#39;, &#39;Conference&#39;, &#39;(&#39;, &#39;AABC&#39;, &#39;)&#39;, &#39;Europe&#39;, &#39;Florida&#39;, &#39;Battery&#39;, &#39;Conference&#39;, &#39;Biomarkers&#39;, &#39;Congress&#39;, &#39;High&#39;, &#39;Content&#39;, &#39;Analysis&#39;, &#39;Advanced&#39;, &#39;Automotive&#39;, &#39;Battery&#39;, &#39;Conference&#39;, &#39;(&#39;, &#39;AABC&#39;, &#39;)&#39;, &#39;Immunogenicity&#39;, &#39;CRA&#39;, &#39;&amp;&#39;, &#39;CRC&#39;, &#39;Beginner&#39;, &#39;Biopharmaceutical&#39;, &#39;Change&#39;, &#39;Control&#39;, &#39;Beyond&#39;, &#39;Genome&#39;, &#39;Immunotherapy&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;Strategies&#39;, &#39;Targeted&#39;, &#39;ImvacS&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Molecular&#39;, &#39;Medicine&#39;, &#39;Marketplace&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Europe&#39;, &#39;CRA&#39;, &#39;Beginner&#39;, &#39;AI&#39;, &#39;World&#39;, &#39;Data&#39;, &#39;Driven&#39;, &#39;Discovery&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Strategies&#39;, &#39;Strategic&#39;, &#39;Resource&#39;, &#39;Allocation&#39;, &#39;kinases&#39;, &#39;Auditing&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Studies&#39;, &#39;Accelerating&#39;, &#39;Development&#39;, &#39;&amp;&#39;, &#39;Advancing&#39;, &#39;Personalized&#39;, &#39;Therapy&#39;, &#39;X&#39;, &#39;Gen&#39;, &#39;Congress&#39;, &#39;Biodefense&#39;, &#39;&amp;&#39;, &#39;Enabling&#39;, &#39;POC&#39;, &#39;Diagnostics&#39;, &#39;&amp;&#39;, &#39;Microarray&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Human&#39;, &#39;Genome&#39;, &#39;Project&#39;, &#39;Biobanks&#39;, &#39;Structure&#39;, &#39;Based&#39;, &#39;Design&#39;, &#39;Batteries&#39;, &#39;Portfolio&#39;, &#39;Quantitative&#39;, &#39;PCR&#39;, &#39;Health&#39;, &#39;Information&#39;, &#39;Technology&#39;, &#39;Auditing&#39;, &#39;Techniques&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Professionals&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;Question&#39;, &#39;&amp;&#39;, &#39;Answer&#39;, &#39;REference&#39;, &#39;Guide&#39;, &#39;CFR/ICH&#39;, &#39;GCP&#39;, &#39;Immunotherapy&#39;, &#39;Europe&#39;, &#39;Gene&#39;, &#39;Amplification&#39;, &#39;PCR&#39;, &#39;eStats&#39;, &#39;:&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Statistical&#39;, &#39;Sourcebook&#39;, &#39;MicroRNA&#39;, &#39;microarray&#39;, &#39;data&#39;, &#39;analysis&#39;, &#39;Intelliigent&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;Development&#39;, &#39;(&#39;, &#39;WPC&#39;, &#39;)&#39;, &#39;Monitoring&#39;, &#39;Clinical&#39;, &#39;Drug&#39;, &#39;Studies&#39;, &#39;:&#39;, &#39;Beginner&#39;, &#39;Comprehensive&#39;, &#39;Monitoring&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Introduction&#39;, &#39;Clinical&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;Bioprocessing&#39;, &#39;Summit&#39;, &#39;Europe&#39;, &#39;Oligonucleotide&#39;, &#39;&amp;&#39;, &#39;Peptide&#39;, &#39;Summit&#39;, &#39;World&#39;, &#39;Pharma&#39;, &#39;Week&#39;, &#39;Prenatal&#39;, &#39;Diagnostics&#39;, &#39;Getting&#39;, &#39;Optimized&#39;, &#39;Targets&#39;, &#39;Library&#39;, &#39;Design&#39;, &#39;&amp;&#39;, &#39;Synthesis&#39;, &#39;Clinical&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;functional&#39;, &#39;genomics&#39;, &#39;bacterial&#39;, &#39;infections&#39;, &#39;Advanced&#39;, &#39;Automotive&#39;, &#39;Battery&#39;, &#39;Conference&#39;, &#39;(&#39;, &#39;AABC&#39;, &#39;)&#39;, &#39;Asia&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;Q&#39;, &#39;&amp;&#39;, &#39;A&#39;, &#39;Reference&#39;, &#39;Guide&#39;, &#39;Screening&#39;, &#39;Transmissible&#39;, &#39;spongiform&#39;, &#39;encephalopathy&#39;, &#39;TSE&#39;, &#39;Biomarker&#39;, &#39;Discovery&#39;, &#39;Summit&#39;, &#39;Clinical&#39;, &#39;Genomics&#39;, &#39;Sequencing&#39;, &#39;ASAP&#39;, &#39;Alliance&#39;, &#39;Summit&#39;, &#39;Bioterrorism&#39;, &#39;microarrays&#39;, &#39;Pharmaceutical&#39;, &#39;Leadership&#39;, &#39;Summit&#39;, &#39;Circulating&#39;, &#39;Cell-Free&#39;, &#39;DNA&#39;, &#39;Conducting&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Under&#39;, &#39;ICH&#39;, &#39;GCP&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;Europe&#39;, &#39;Trial&#39;, &#39;Master&#39;, &#39;File&#39;, &#39;Biomarkers&#39;, &#39;World&#39;, &#39;Preclinical&#39;, &#39;Congress&#39;, &#39;Europe&#39;, &#39;BioMEMS&#39;, &#39;bioinformatics&#39;, &#39;Genomic&#39;, &#39;Partnering&#39;, &#39;NMR&#39;, &#39;nuclear&#39;, &#39;magnetic&#39;, &#39;resonance&#39;, &#39;Clinical&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Biomarker&#39;, &#39;Validation&#39;, &#39;proteomics&#39;, &#39;Statistics&#39;, &#39;Sensors&#39;, &#39;Global&#39;, &#39;Summit&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;A&#39;, &#39;Regulatory&#39;, &#39;Overview&#39;, &#39;Drug&#39;, &#39;Safety&#39;, &#39;Pharmacy&#39;, &#39;Diagnostics&#39;, &#39;sample&#39;, &#39;preparation&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Design&#39;, &#39;Pharmacovigilance&#39;, &#39;Metabolic&#39;, &#39;Profiling&#39;, &#39;Digital&#39;, &#39;PCR&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Lab&#39;, &#39;chips&#39;, &#39;Europe&#39;, &#39;Monitoring&#39;, &#39;Clinical&#39;, &#39;Drug&#39;, &#39;Studies&#39;, &#39;:&#39;, &#39;Intermediate&#39;, &#39;Preparing&#39;, &#39;IND&#39;, &#39;Submissions&#39;, &#39;Antibody&#39;, &#39;Engineering&#39;, &#39;Asia&#39;, &#39;Clinical&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;:&#39;, &#39;Intermediate&#39;, &#39;phage&#39;, &#39;display&#39;, &#39;CELLutions&#39;, &#39;Recombinant&#39;, &#39;Antibodies&#39;, &#39;imaging&#39;, &#39;Biomarker&#39;, &#39;Assay&#39;, &#39;Development&#39;, &#39;silico&#39;, &#39;biology&#39;, &#39;Advanced&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;High&#39;, &#39;Throughput&#39;, &#39;Optimization&#39;, &#39;Culture&#39;, &#39;Conditions&#39;, &#39;Bioprocessing&#39;, &#39;High&#39;, &#39;Throughput&#39;, &#39;Technologies&#39;, &#39;gene&#39;, &#39;quantfication&#39;, &#39;[&#39;, &#39;real&#39;, &#39;time&#39;, &#39;PCR&#39;, &#39;]&#39;, &#39;From&#39;, &#39;Gene&#39;, &#39;Expression&#39;, &#39;Profiling&#39;, &#39;Validated&#39;, &#39;Biology&#39;, &#39;Clinical&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;:&#39;, &#39;Advanced&#39;, &#39;SCOPE&#39;, &#39;Summit&#39;, &#39;Europe&#39;, &#39;CNS&#39;, &#39;Partnering&#39;, &#39;Genomics&#39;, &#39;Target&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Statistical&#39;, &#39;Sourcebook&#39;, &#39;MultiUser&#39;, &#39;License&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Development&#39;, &#39;Biological&#39;, &#39;ADME&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;blood&#39;, &#39;safety&#39;, &#39;screening&#39;, &#39;Human&#39;, &#39;Proteome&#39;, &#39;Project&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;high&#39;, &#39;throughput&#39;, &#39;organic&#39;, &#39;synthesis&#39;, &#39;Global&#39;, &#39;Preclinical&#39;, &#39;Development&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Coordinator&#39;, &#39;Global&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;India&#39;, &#39;Biomarker&#39;, &#39;Diagnostics&#39;, &#39;molecular&#39;, &#39;diversity&#39;, &#39;functional&#39;, &#39;genomics&#39;, &#39;Process&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Summit&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;bioinformatics&#39;, &#39;Europe&#39;, &#39;Target&#39;, &#39;Validation&#39;, &#39;Bispecific&#39;, &#39;Antibodies&#39;, &#39;Bridging&#39;, &#39;Pharma&#39;, &#39;IT&#39;, &#39;Green&#39;, &#39;Fluorescent&#39;, &#39;Proteins&#39;, &#39;Quality&#39;, &#39;Systems&#39;, &#39;CRA&#39;, &#39;Monitoring&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;Development&#39;, &#39;AI&#39;, &#39;Government&#39;, &#39;glycotechnology&#39;, &#39;Baculovirus&#39;, &#39;Drug&#39;, &#39;Repurposing&#39;, &#39;drug&#39;, &#39;discovery&#39;, &#39;development&#39;, &#39;Japan&#39;, &#39;The&#39;, &#39;CRA&#39;, &#39;Manager&#39;, &#39;Course&#39;, &#39;State&#39;, &#39;State&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Requirments&#39;, &#39;Reference&#39;, &#39;Guide&#39;, &#39;Adverse&#39;, &#39;Events&#39;, &#39;:&#39;, &#39;Managing&#39;, &#39;&amp;&#39;, &#39;Reporting&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Good&#39;, &#39;Laboratory&#39;, &#39;Practice&#39;, &#39;Process&#39;, &#39;Chemistry&#39;, &#39;Beyond&#39;, &#39;Sequencing&#39;, &#39;Process&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Summit&#39;, &#39;GLP&#39;, &#39;Batteries&#39;, &#39;Biomarkers&#39;, &#39;Europe&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;computer&#39;, &#39;hardware&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;patient&#39;, &#39;Recruitment&#39;, &#39;Working&#39;, &#39;CROs&#39;, &#39;Expediting&#39;, &#39;Drugs&#39;, &#39;Biologics&#39;, &#39;Development&#39;, &#39;Tissue&#39;, &#39;Sealants&#39;, &#39;-&#39;, &#39;One&#39;, &#39;Day&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Europe&#39;, &#39;Use&#39;, &#39;Note&#39;, &#39;Files&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Essential&#39;, &#39;Documentation&#39;, &#39;Antibody&#39;, &#39;Engineering&#39;, &#39;Korea&#39;, &#39;RNAi&#39;, &#39;Pathway&#39;, &#39;Analysis&#39;, &#39;Advanced&#39;, &#39;GCP&#39;, &#39;Compliance&#39;, &#39;Mechanisms&#39;, &#39;Cancer&#39;, &#39;Business&#39;, &#39;Diagnostics&#39;, &#39;(&#39;, &#39;Impact&#39;, &#39;New&#39;, &#39;Diagnotics&#39;, &#39;)&#39;, &#39;Consumer&#39;, &#39;Genomics&#39;, &#39;Conference&#39;, &#39;Recombinant&#39;, &#39;Antibodies&#39;, &#39;Europe&#39;, &#39;Research&#39;, &#39;Site&#39;, &#39;Clinical&#39;, &#39;Study&#39;, &#39;Budgets&#39;, &#39;Contracts&#39;, &#39;Proof&#39;, &#39;Concept&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;China&#39;, &#39;Future&#39;, &#39;Diagnostics&#39;, &#39;Medicinal&#39;, &#39;Chemistry&#39;, &#39;Combination&#39;, &#39;Therapies&#39;, &#39;CRA&#39;, &#39;Training&#39;, &#39;Series&#39;, &#39;(&#39;, &#39;1-7&#39;, &#39;)&#39;, &#39;Lab&#39;, &#39;Chips&#39;, &#39;Japan&#39;, &#39;Human&#39;, &#39;Genomes&#39;, &#39;Europe&#39;, &#39;Tissue&#39;, &#39;Based&#39;, &#39;Screening&#39;, &#39;lead&#39;, &#39;optimization&#39;, &#39;Adverse&#39;, &#39;Events&#39;, &#39;Reimbursement&#39;, &#39;Diagnostics&#39;, &#39;labels&#39;, &#39;signals&#39;, &#39;detection&#39;, &#39;ASAP&#39;, &#39;CHI&#39;, &#39;Bio&#39;, &#39;Pharm&#39;, &#39;Alliance&#39;, &#39;Summit&#39;, &#39;forensic&#39;, &#39;diagnostics&#39;, &#39;Writing&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Molecular&#39;, &#39;Profiling&#39;, &#39;Cellular&#39;, &#39;Resolution&#39;, &#39;10&#39;, &#39;Rules&#39;, &#39;Effective&#39;, &#39;Report&#39;, &#39;Writing&#39;, &#39;pharmacogenomics&#39;, &#39;europe&#39;, &#39;Exploring&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Sequencing&#39;, &#39;conference&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;&amp;&#39;, &#39;FDA&#39;, &#39;Regulations&#39;, &#39;HCA&#39;, &#39;East&#39;, &#39;Cancer&#39;, &#39;Immunotherapies&#39;, &#39;(&#39;, &#39;formerly&#39;, &#39;Cancer&#39;, &#39;Vaccines&#39;, &#39;)&#39;, &#39;Biologics&#39;, &#39;Development&#39;, &#39;A&#39;, &#39;Regulatory&#39;, &#39;Overview&#39;, &#39;Standard&#39;, &#39;Operating&#39;, &#39;Proces&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;molecular&#39;, &#39;pharmacology&#39;, &#39;RNA&#39;, &#39;Interference&#39;, &#39;Summit&#39;, &#39;Clinical&#39;, &#39;Training&#39;, &#39;oligonucleotides&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Protocols&#39;, &#39;toxicology&#39;, &#39;Immunogenicity&#39;, &#39;Testing&#39;, &#39;Biologics&#39;, &#39;Adaptive&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;ADME&#39;, &#39;Stem&#39;, &#39;Cells&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Development&#39;, &#39;Drug&#39;, &#39;Pipeline&#39;, &#39;Success&#39;, &#39;(&#39;, &#39;Pipeline&#39;, &#39;Success&#39;, &#39;Summit&#39;, &#39;)&#39;, &#39;stem&#39;, &#39;cells&#39;, &#39;Data&#39;, &#39;Visualization&#39;, &#39;Pharmacokinetics&#39;, &#39;transgenic&#39;, &#39;animal&#39;, &#39;models&#39;, &#39;Business&#39;, &#39;Development&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;Interface&#39;, &#39;Monitoring&#39;, &#39;Clinical&#39;, &#39;Drug&#39;, &#39;Studies&#39;, &#39;:&#39;, &#39;Advanced&#39;, &#39;Digital&#39;, &#39;Health&#39;, &#39;Innovation&#39;, &#39;Summit&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Electronic&#39;, &#39;Data&#39;, &#39;Capture&#39;, &#39;Arena&#39;, &#39;Case&#39;, &#39;Report&#39;, &#39;Forms&#39;, &#39;Battery&#39;, &#39;Safety&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;GCP&#39;, &#39;Overview&#39;, &#39;Clinical&#39;, &#39;Administrative&#39;, &#39;Support&#39;, &#39;Staff&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;&amp;&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;Pre-Implantation&#39;, &#39;Diagnostics&#39;, &#39;Eyesight&#39;, &#39;Biomarker&#39;, &#39;Diagnostics&#39;, &#39;Biomarker&#39;, &#39;Web&#39;, &#39;Symposia&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;Process&#39;, &#39;Neglected&#39;, &#39;Diseases&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Approval&#39;, &#39;Process&#39;, &#39;Code&#39;, &#39;Federal&#39;, &#39;Regulations&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Associate&#39;, &#39;G&#39;, &#39;protein&#39;, &#39;coupled&#39;, &#39;receptors&#39;, &#39;GPCRS&#39;, &#39;Prenatal&#39;, &#39;Diagnostics&#39;, &#39;Europe&#39;, &#39;Genomic&#39;, &#39;Tools&#39;, &#39;&amp;&#39;, &#39;Technologies&#39;, &#39;Biomarkers&#39;, &#39;Europe&#39;, &#39;Symyx&#39;, &#39;Business&#39;, &#39;Collaborative&#39;, &#39;Innovation&#39;, &#39;Source&#39;, &#39;Documentation&#39;, &#39;Mitochondria&#39;, &#39;Comparative&#39;, &#39;Genomic&#39;, &#39;Hybridization&#39;, &#39;Lithium&#39;, &#39;Battery&#39;, &#39;Power&#39;, &#39;Writing&#39;, &#39;Clinical&#39;, &#39;Study&#39;, &#39;Protocols&#39;, &#39;Reimbursement&#39;, &#39;Therapeutics&#39;, &#39;genetic&#39;, &#39;variations&#39;, &#39;Business&#39;, &#39;Investigator&#39;, &#39;initiated&#39;, &#39;trials&#39;, &#39;Burrill&#39;, &#39;Book&#39;, &#39;Bio-IT&#39;, &#39;Asia&#39;, &#39;Compound&#39;, &#39;Profiling&#39;, &#39;cancer&#39;, &#39;clinical&#39;, &#39;trials&#39;, &#39;Chemical&#39;, &#39;Genomics&#39;, &#39;Safety/Toxicity&#39;, &#39;Biomarkers&#39;, &#39;Cancer&#39;, &#39;Diagnosis&#39;, &#39;antibody&#39;, &#39;engineering&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;Asia&#39;, &#39;West&#39;, &#39;Coast&#39;, &#39;Virtual&#39;, &#39;Screening&#39;, &#39;Point&#39;, &#39;Care&#39;, &#39;Diagnostics&#39;, &#39;Protein&#39;, &#39;Formulation&#39;, &#39;genetic&#39;, &#39;diagnostics&#39;, &#39;Bridging&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;IT&#39;, &#39;Biofuels&#39;, &#39;Translational&#39;, &#39;Medicine&#39;, &#39;Personalized&#39;, &#39;Medicine&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Organization&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;Congress&#39;, &#39;Europe&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;Risk&#39;, &#39;Based&#39;, &#39;Site&#39;, &#39;Monitoring&#39;, &#39;Root&#39;, &#39;Cause&#39;, &#39;Analysis&#39;, &#39;Monitoring&#39;, &#39;Phase&#39;, &#39;I&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;Latin&#39;, &#39;America&#39;, &#39;Licensing&#39;, &#39;vaccines&#39;, &#39;cancer&#39;, &#39;genetics&#39;, &#39;genomics&#39;, &#39;Marketing&#39;, &#39;Reimbursement&#39;, &#39;Metabolic&#39;, &#39;Analytical&#39;, &#39;Methods&#39;, &#39;Difficult&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;Protein&#39;, &#39;Chips/Arrays&#39;, &#39;Monitoring&#39;, &#39;Plan&#39;, &#39;Development&#39;, &#39;Genome&#39;, &#39;Japan&#39;, &#39;Immunogenicity&#39;, &#39;Advances&#39;, &#39;Management&#39;, &#39;Reduction&#39;, &#39;Clinical&#39;, &#39;Auditing&#39;, &#39;Clinical&#39;, &#39;Informatics&#39;, &#39;Antibody-Drug&#39;, &#39;Conjugates&#39;, &#39;Electronic&#39;, &#39;Medical&#39;, &#39;Records&#39;, &#39;&amp;&#39;, &#39;Source&#39;, &#39;Document&#39;, &#39;Verification&#39;, &#39;Bridge&#39;, &#39;Pop&#39;, &#39;Health&#39;, &#39;East&#39;, &#39;Informed&#39;, &#39;Consent&#39;, &#39;Pharma&#39;, &#39;Future&#39;, &#39;Microarray&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Europe&#39;, &#39;Clinical&#39;, &#39;Investigator&#39;, &#39;Site&#39;, &#39;Inspections&#39;, &#39;Global&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Protocol&#39;, &#39;Deviations&#39;, &#39;Immunotherapy&#39;, &#39;West&#39;, &#39;Cancer&#39;, &#39;Therapies&#39;, &#39;Recognize&#39;, &#39;Attrition&#39;, &#39;Earlier&#39;, &#39;Electronic&#39;, &#39;Data&#39;, &#39;Capture&#39;, &#39;Clinical&#39;, &#39;Imaging&#39;, &#39;Physical&#39;, &#39;Chemistry&#39;, &#39;Toll&#39;, &#39;Like&#39;, &#39;Receptors&#39;, &#39;monoclonal&#39;, &#39;antibodies&#39;, &#39;Innate&#39;, &#39;Immunity&#39;, &#39;High&#39;, &#39;Content&#39;, &#39;Analysis&#39;, &#39;Europe&#39;, &#39;Negotiation&#39;, &#39;Skills&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Professionals&#39;, &#39;Biotech&#39;, &#39;Executive&#39;, &#39;Forum&#39;, &#39;CNP&#39;, &#39;Partnering&#39;, &#39;Europe&#39;, &#39;nanotechnology&#39;, &#39;Risk&#39;, &#39;Management&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Adverse&#39;, &#39;Event&#39;, &#39;Monitoring&#39;, &#39;CRAs&#39;, &#39;Vendor&#39;, &#39;Management&#39;, &#39;Report&#39;, &#39;Writing&#39;, &#39;CRAs&#39;, &#39;Symyx&#39;, &#39;Europe&#39;, &#39;Epigenetics&#39;, &#39;Regulatory&#39;, &#39;Compliance&#39;, &#39;GCP&#39;, &#39;Training&#39;, &#39;Investigators&#39;, &#39;RECIST&#39;, &#39;1.0&#39;, &#39;1.1&#39;, &#39;Pharmacovigilance&#39;, &#39;Audit&#39;, &#39;Microfluidics&#39;, &#39;yeast&#39;, &#39;model&#39;, &#39;organism&#39;, &#39;Market&#39;, &#39;Targets&#39;, &#39;&amp;&#39;, &#39;Compounds&#39;, &#39;Critical&#39;, &#39;Decision&#39;, &#39;Points&#39;, &#39;Design&#39;, &#39;&amp;&#39;, &#39;Conduct&#39;, &#39;Patient&#39;, &#39;Registries&#39;, &#39;protein&#39;, &#39;production&#39;, &#39;formulation&#39;, &#39;HCA&#39;, &#39;Europe&#39;, &#39;Idiosyncratic&#39;, &#39;Toxicity&#39;, &#39;Protein&#39;, &#39;Informatics&#39;, &#39;Conflict&#39;, &#39;Resolution&#39;, &#39;Negotiation&#39;, &#39;Regulatory&#39;, &#39;Intelligence&#39;, &#39;Bioresearch&#39;, &#39;Monitoring&#39;, &#39;Cryobiology&#39;, &#39;signal&#39;, &#39;transduction&#39;, &#39;Emerging&#39;, &#39;Companies&#39;, &#39;Corrective&#39;, &#39;Action&#39;, &#39;Plans&#39;, &#39;:&#39;, &#39;Documentation&#39;, &#39;Sites&#39;, &#39;Response&#39;, &#39;GCP&#39;, &#39;Deficiences&#39;, &#39;Developing&#39;, &#39;Clinical&#39;, &#39;Study&#39;, &#39;Budget&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Sequencing&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Fraud&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Biosimilars&#39;, &#39;Dealmaking&#39;, &#39;Diagnostics&#39;, &#39;Comprehensive&#39;, &#39;CRC&#39;, &#39;Training&#39;, &#39;Cancer&#39;, &#39;Cell&#39;, &#39;Models&#39;, &#39;Digital&#39;, &#39;Health&#39;, &#39;Patient&#39;, &#39;Registry&#39;, &#39;Programs&#39;, &#39;crop&#39;, &#39;genetics&#39;, &#39;Glossary&#39;, &#39;&amp;&#39;, &#39;Acronyms&#39;, &#39;Reference&#39;, &#39;Biosensors&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;Essential&#39;, &#39;Documentation&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;Patient&#39;, &#39;Centered&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Proteins&#39;, &#39;Profits&#39;, &#39;Europe&#39;, &#39;Drug&#39;, &#39;Metabolism&#39;, &#39;International&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;Regulatory&#39;, &#39;Procedures&#39;, &#39;Principal&#39;, &#39;Investigator&#39;, &#39;Training&#39;, &#39;orthopedic&#39;, &#39;tissue&#39;, &#39;engineering&#39;, &#39;Investigator&#39;, &#39;Sites&#39;, &#39;cardiovascular&#39;, &#39;genomics&#39;, &#39;Study&#39;, &#39;Start&#39;, &#39;Up&#39;, &#39;Protein&#39;, &#39;Folding&#39;, &#39;Population&#39;, &#39;Health&#39;, &#39;Management&#39;, &#39;Tissue&#39;, &#39;Diagnostics&#39;, &#39;GLP&#39;, &#39;Bioanalysis&#39;, &#39;Phase&#39;, &#39;I&#39;, &#39;Study&#39;, &#39;Management&#39;, &#39;Health&#39;, &#39;Autonomous&#39;, &#39;Driving&#39;, &#39;Electronic&#39;, &#39;Source&#39;, &#39;Documentation&#39;, &#39;Tools&#39;, &#39;&amp;&#39;, &#39;Metrics&#39;, &#39;Congress&#39;, &#39;Global&#39;, &#39;GCP&#39;, &#39;Monitoring&#39;, &#39;Investigator&#39;, &#39;Non-Compliance&#39;, &#39;Global&#39;, &#39;GCP&#39;, &#39;Compliance&#39;, &#39;Report&#39;, &#39;Protein&#39;, &#39;&amp;&#39;, &#39;Peptide&#39;, &#39;Arrays&#39;, &#39;Europe&#39;, &#39;Internet&#39;, &#39;Things&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Pharmaceuticals&#39;, &#39;Introduction&#39;, &#39;Signal&#39;, &#39;Detection&#39;, &#39;Data&#39;, &#39;Mining&#39;, &#39;Study&#39;, &#39;Feasibility&#39;, &#39;Clinical&#39;, &#39;Investigation&#39;, &#39;Monitoring&#39;, &#39;Proteomics&#39;, &#39;Europe&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Developing&#39;, &#39;Regions&#39;, &#39;Pediatric&#39;, &#39;drug&#39;, &#39;development&#39;, &#39;Sponsor&#39;, &#39;Monitoring&#39;, &#39;Inspections&#39;, &#39;Maximize&#39;, &#39;Value&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;protein&#39;, &#39;structures&#39;, &#39;cancer&#39;, &#39;Microbial&#39;, &#39;Genomics&#39;, &#39;Translational&#39;, &#39;Cancer&#39;, &#39;Medicine&#39;, &#39;Medical&#39;, &#39;Terminalogy&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Professionals&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Writing&#39;, &#39;Updating&#39;, &#39;Investigators&#39;, &#39;Brochure&#39;, &#39;Sunshine&#39;, &#39;Act&#39;, &#39;Sequencing&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;Standard&#39;, &#39;Operating&#39;, &#39;Procedures&#39;, &#39;Meeting&#39;, &#39;International&#39;, &#39;Safety&#39;, &#39;Reporting&#39;, &#39;Requirements&#39;, &#39;Faciliation&#39;, &#39;Skills&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Professionals&#39;, &#39;bioprocessing&#39;, &#39;biologicals&#39;, &#39;safety&#39;, &#39;Regulatory&#39;, &#39;Intelligence&#39;, &#39;101&#39;, &#39;Recent&#39;, &#39;Trends&#39;, &#39;Noncompliance&#39;, &#39;Briefings&#39;, &#39;Drug&#39;, &#39;Safety&#39;, &#39;Clinical&#39;, &#39;research&#39;, &#39;project&#39;, &#39;mamangement&#39;, &#39;essentials&#39;, &#39;CRA&#39;, &#39;Survival&#39;, &#39;Kit&#39;, &#39;Essential&#39;, &#39;Documentation&#39;, &#39;Extracellular&#39;, &#39;RNA&#39;, &#39;Successful&#39;, &#39;Study&#39;, &#39;Site&#39;, &#39;Start-up&#39;, &#39;Cell&#39;, &#39;Based&#39;, &#39;Therapies&#39;, &#39;Web-Based&#39;, &#39;Training&#39;, &#39;Strategies&#39;, &#39;data&#39;, &#39;mining&#39;, &#39;GLP&#39;, &#39;Bioanalysis&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Finance&#39;, &#39;&amp;&#39;, &#39;Management&#39;, &#39;regulatory&#39;, &#39;Site&#39;, &#39;Relationship/Performance&#39;, &#39;Management&#39;, &#39;Introduction&#39;, &#39;FDA&#39;, &#39;Regulatory&#39;, &#39;Reporter&#39;, &#39;Newsletter&#39;, &#39;multiple&#39;, &#39;sclerosis&#39;, &#39;Data&#39;, &#39;Integration&#39;, &#39;Managing&#39;, &#39;CRAs&#39;, &#39;Improve&#39;, &#39;Performance&#39;, &#39;&amp;&#39;, &#39;Study&#39;, &#39;Outcomes&#39;, &#39;compounds&#39;, &#39;Predictive&#39;, &#39;Toxicity&#39;, &#39;Surviving&#39;, &#39;FDA&#39;, &#39;Site&#39;, &#39;Inspections&#39;, &#39;:&#39;, &#39;Best&#39;, &#39;Practices&#39;, &#39;Site&#39;, &#39;Personnel&#39;, &#39;Phase&#39;, &#39;III&#39;, &#39;(&#39;, &#39;3&#39;, &#39;)&#39;, &#39;/forecasting&#39;, &#39;clinical&#39;, &#39;outcomes&#39;, &#39;Comparing&#39;, &#39;FDA&#39;, &#39;Health&#39;, &#39;Canada&#39;, &#39;Regulations&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Professionals&#39;, &#39;Recombinant&#39;, &#39;Therapeutics&#39;, &#39;Tick&#39;, &#39;Borne&#39;, &#39;Diseases&#39;, &#39;Writing&#39;, &#39;Maintaining&#39;, &#39;EU&#39;, &#39;CTA&#39;, &#39;Orphan&#39;, &#39;Drugs&#39;, &#39;Investigator&#39;, &#39;Initiated&#39;, &#39;Trials&#39;, &#39;Orthopaedic&#39;, &#39;Animal&#39;, &#39;Models&#39;, &#39;Auditing&#39;, &#39;Sponsors&#39;, &#39;CROs&#39;, &#39;Valuing&#39;, &#39;&amp;&#39;, &#39;Pricing&#39;, &#39;Licensing&#39;, &#39;Deals&#39;, &#39;drug&#39;, &#39;delivery&#39;, &#39;Vendor&#39;, &#39;Management&#39;, &#39;Clinical&#39;, &#39;Data&#39;, &#39;Manager&#39;, &#39;Data&#39;, &#39;Quality&#39;, &#39;Patient&#39;, &#39;Engagement&#39;, &#39;FDA&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;Process&#39;, &#39;HIPAA&#39;, &#39;No&#39;, &#39;1&#39;, &#39;Team&#39;, &#39;Training&#39;, &#39;HIPAA&#39;, &#39;&amp;&#39;, &#39;Human&#39;, &#39;Subjects&#39;, &#39;Research&#39;, &#39;Q&#39;, &#39;&amp;&#39;, &#39;A&#39;, &#39;Ubiquitin&#39;, &#39;Europe&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Data&#39;, &#39;Monitoring&#39;, &#39;Investigational&#39;, &#39;Product&#39;, &#39;Accountability&#39;, &#39;Training&#39;, &#39;Research&#39;, &#39;Site&#39;, &#39;Personnel&#39;, &#39;Adverse&#39;, &#39;Event&#39;, &#39;Reporting&#39;, &#39;IRBs&#39;, &#39;Subject&#39;, &#39;Recruitment&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;Antibodies&#39;, &#39;Cancer&#39;, &#39;Cost&#39;, &#39;Management&#39;, &#39;Global&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Portfolio&#39;, &#39;Management&#39;, &#39;Warning&#39;, &#39;Letters&#39;, &#39;Combination&#39;, &#39;Products&#39;, &#39;Observational&#39;, &#39;Studies&#39;, &#39;Molecular&#39;, &#39;Medicine&#39;, &#39;Asia&#39;, &#39;CNS&#39;, &#39;Central&#39;, &#39;nervous&#39;, &#39;system&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;Development&#39;, &#39;Collaboration&#39;, &#39;Cross&#39;, &#39;functional&#39;, &#39;global&#39;, &#39;teams&#39;, &#39;Site&#39;, &#39;Relationship&#39;, &#39;Management&#39;, &#39;peptides&#39;, &#39;Investigator&#39;, &#39;Oversight&#39;, &#39;Writing&#39;, &#39;SOPs&#39;, &#39;pain&#39;, &#39;web&#39;, &#39;2.0&#39;, &#39;Understanding&#39;, &#39;FDAs&#39;, &#39;new&#39;, &#39;Draft&#39;, &#39;Guidance&#39;, &#39;Regarding&#39;, &#39;Supervisory&#39;, &#39;Repons&#39;, &#39;Sponsors/CROs&#39;, &#39;Preparing&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;FDA&#39;, &#39;Inspections&#39;, &#39;eHealth&#39;, &#39;Technologies&#39;, &#39;Introduction&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;FDA&#39;, &#39;Proposed&#39;, &#39;rule&#39;, &#39;2010&#39;, &#39;Teambuilding&#39;, &#39;Cross&#39;, &#39;Functional&#39;, &#39;Global&#39;, &#39;Team&#39;, &#39;Genomic&#39;, &#39;Business&#39;, &#39;Strategies&#39;, &#39;Product&#39;, &#39;Life&#39;, &#39;Cycle&#39;, &#39;RNA&#39;, &#39;Interference&#39;, &#39;Pharmacovigilance&#39;, &#39;Signal&#39;, &#39;Detection&#39;, &#39;Foreign&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Biotech&#39;, &#39;Business&#39;, &#39;Development&#39;, &#39;genomics&#39;, &#39;Portfolio&#39;, &#39;Management&#39;, &#39;Venue&#39;, &#39;II&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Design&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Informed&#39;, &#39;Consent&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Study&#39;, &#39;Wheel&#39;, &#39;Biomarker&#39;, &#39;Data&#39;, &#39;Center&#39;, &#39;Antibody&#39;, &#39;Optimization&#39;, &#39;&amp;&#39;, &#39;Characterization&#39;, &#39;Biologics&#39;, &#39;Chronic&#39;, &#39;Pain&#39;, &#39;cardiovascular&#39;, &#39;Risk&#39;, &#39;based&#39;, &#39;decisions&#39;, &#39;clinical&#39;, &#39;site&#39;, &#39;management&#39;, &#39;Human&#39;, &#39;Participant&#39;, &#39;Protection&#39;, &#39;Training&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Professionals&#39;, &#39;CRC&#39;, &#39;Role/Responsibilities&#39;, &#39;Training&#39;, &#39;Womens&#39;, &#39;Health&#39;, &#39;Current&#39;, &#39;Developments&#39;, &#39;Role&#39;, &#39;IRBs&#39;, &#39;Conduct&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Regulatory&#39;, &#39;Compliance&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;infections&#39;, &#39;Diabetes&#39;, &#39;cancer&#39;, &#39;partnering&#39;, &#39;Preparing&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;510K&#39;, &#39;Submissions&#39;, &#39;Monitoring&#39;, &#39;Informed&#39;, &#39;Consent&#39;, &#39;Business&#39;, &#39;Biobanking&#39;, &#39;Global&#39;, &#39;Site&#39;, &#39;Selection&#39;, &#39;Boston&#39;, &#39;Biomarkers&#39;, &#39;Drug&#39;, &#39;Efficacy&#39;, &#39;Safety&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;European&#39;, &#39;Union&#39;, &#39;Protein&#39;, &#39;Therapeutics&#39;, &#39;Quality&#39;, &#39;Improvement&#39;, &#39;Strategies&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;diagnostics&#39;, &#39;bioprocessing&#39;, &#39;viral&#39;, &#39;hepatitis&#39;, &#39;infections&#39;, &#39;Advanced&#39;, &#39;HIPAA&#39;, &#39;Clinical&#39;, &#39;Sequencing&#39;, &#39;IRB&#39;, &#39;Guidance&#39;, &#39;regenerative&#39;, &#39;healing&#39;, &#39;cell&#39;, &#39;culture&#39;, &#39;Coronavirus&#39;, &#39;Liver&#39;, &#39;Disorders&#39;, &#39;Big&#39;, &#39;pharma&#39;, &#39;Big&#39;, &#39;Data&#39;, &#39;HIPAA&#39;, &#39;Electronic&#39;, &#39;Medical&#39;, &#39;Records&#39;, &#39;blood&#39;, &#39;Pharmaceutical&#39;, &#39;Strategy&#39;, &#39;Series&#39;, &#39;Strategies&#39;, &#39;Accelearted&#39;, &#39;Nonclinical&#39;, &#39;Toxiciology&#39;, &#39;&amp;&#39;, &#39;Safety&#39;, &#39;Assessment&#39;, &#39;Biologics&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;Japan&#39;, &#39;Artificial&#39;, &#39;Intelligence&#39;, &#39;Excel&#39;, &#39;Spreadsheets-Step&#39;, &#39;Step&#39;, &#39;Instructions&#39;, &#39;Compliance&#39;, &#39;Chemistry&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Statistical&#39;, &#39;Sourcebook&#39;, &#39;Upgrade&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Tracking&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Directive&#39;, &#39;Facilitation&#39;, &#39;Skills&#39;, &#39;Autoimmune&#39;, &#39;anticoagulants&#39;, &#39;bone&#39;, &#39;Clinical&#39;, &#39;Antibodies&#39;, &#39;gene&#39;, &#39;therapy&#39;, &#39;Newborn&#39;, &#39;Diagnostics&#39;, &#39;Real&#39;, &#39;World&#39;, &#39;Monitoring&#39;, &#39;Allergies&#39;, &#39;Performance&#39;, &#39;Improvement&#39;, &#39;Monitoring&#39;, &#39;Model&#39;, &#39;Institutional&#39;, &#39;Review&#39;, &#39;Board&#39;, &#39;Health&#39;, &#39;Outcomes&#39;, &#39;Outsourcing&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Microbiome&#39;, &#39;Key&#39;, &#39;Opinion&#39;, &#39;Leaders&#39;, &#39;Chronic&#39;, &#39;Obstructive&#39;, &#39;Pulmonary&#39;, &#39;Disorder&#39;, &#39;Quality&#39;, &#39;Design&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;&amp;&#39;, &#39;Translational&#39;, &#39;Medicine&#39;, &#39;Series&#39;, &#39;Lupus&#39;, &#39;Multi&#39;, &#39;Drug&#39;, &#39;Resistance&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Coordinator&#39;, &#39;Tool&#39;, &#39;Kit&#39;, &#39;CRC&#39;, &#39;&amp;&#39;, &#39;PI&#39;, &#39;Current&#39;, &#39;Practice&#39;, &#39;Update&#39;, &#39;CRA&#39;, &#39;Facilitator&#39;, &#39;Training&#39;, &#39;21&#39;, &#39;CFR&#39;, &#39;Part&#39;, &#39;11&#39;, &#39;Compliance&#39;, &#39;Electronic&#39;, &#39;Records&#39;, &#39;&amp;&#39;, &#39;Signatures&#39;, &#39;Cancer&#39;, &#39;Diagnostics&#39;, &#39;Electronic&#39;, &#39;Health&#39;, &#39;Record&#39;, &#39;Chiral&#39;, &#39;Intro&#39;, &#39;Combination&#39;, &#39;Products&#39;, &#39;Gastrointestinal&#39;, &#39;Disorders&#39;, &#39;Presentation&#39;, &#39;skills&#39;, &#39;clinical&#39;, &#39;research&#39;, &#39;professionals&#39;, &#39;inflammation&#39;, &#39;Operational&#39;, &#39;Modeling&#39;, &#39;Simulation&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Pharmaceutical&#39;, &#39;&amp;&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Industries&#39;, &#39;Facilitation&#39;, &#39;Skills&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Team&#39;, &#39;Members&#39;, &#39;Diagnostics&#39;, &#39;Partnering&#39;, &#39;Mobile&#39;, &#39;Health&#39;, &#39;Wearables&#39;, &#39;Pharmaceutical&#39;, &#39;Discovery&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Medical&#39;, &#39;device&#39;, &#39;reporting&#39;, &#39;Ubiquitin&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Postmarketing&#39;, &#39;Vigilance&#39;, &#39;Blockchain&#39;, &#39;Alzheimers&#39;, &#39;high&#39;, &#39;performance&#39;, &#39;computing&#39;, &#39;Innovative&#39;, &#39;Preclinical&#39;, &#39;&amp;&#39;, &#39;Clinical&#39;, &#39;Strategies&#39;, &#39;GXP&#39;, &#39;Good&#39;, &#39;Practice&#39;, &#39;Guides&#39;, &#39;Writing&#39;, &#39;Maintaining&#39;, &#39;Canadian&#39;, &#39;CTA&#39;, &#39;3D&#39;, &#39;Printing&#39;, &#39;Key&#39;, &#39;Information&#39;, &#39;Gatherers&#39;, &#39;Respiratory&#39;, &#39;Five&#39;, &#39;Keys&#39;, &#39;COTS&#39;, &#39;Computer&#39;, &#39;System&#39;, &#39;Validation&#39;, &#39;Next-Generation&#39;, &#39;Sequencing&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Open&#39;, &#39;Source&#39;, &#39;Fibrosis/Scarring&#39;, &#39;Biomarker&#39;, &#39;Bridge&#39;, &#39;Genomics&#39;, &#39;101&#39;, &#39;Dummy&#39;, &#39;Keyword&#39;, &#39;DE&#39;, &#39;lists&#39;, &#39;w/more&#39;, &#39;1&#39;, &#39;keyword&#39;, &#39;keywords&#39;, &#39;FDA&#39;, &#39;Form&#39;, &#39;1572&#39;, &#39;Antisense&#39;, &#39;Accountable&#39;, &#39;Care&#39;, &#39;Orgnization&#39;, &#39;ACE&#39;, &#39;inhibitors&#39;, &#39;AI&#39;, &#39;Chips&#39;, &#39;Antibody-Drug&#39;, &#39;Conjugates&#39;, &#39;PEGS&#39;, &#39;Antibody&#39;, &#39;Drug&#39;, &#39;Conjugate&#39;, &#39;Bioprocess&#39;, &#39;Attention&#39;, &#39;Deficit&#39;, &#39;Hyperactivity&#39;, &#39;Disorder&#39;, &#39;Adjuvants&#39;, &#39;ADMET&#39;, &#39;(&#39;, &#39;ADME&#39;, &#39;&amp;&#39;, &#39;Toxicology&#39;, &#39;)&#39;, &#39;adverse&#39;, &#39;drug&#39;, &#39;reactions&#39;, &#39;Aerospace&#39;, &#39;Advanced&#39;, &#39;Energy&#39;, &#39;Technology&#39;, &#39;Congress&#39;, &#39;Affordable&#39;, &#39;Care&#39;, &#39;affinity&#39;, &#39;technologies&#39;, &#39;Affinity&#39;, &#39;Separation&#39;, &#39;Antibody&#39;, &#39;Fragments&#39;, &#39;Agriculture&#39;, &#39;chemistry&#39;, &#39;Aging&#39;, &#39;Antibody&#39;, &#39;Drug&#39;, &#39;Targets&#39;, &#39;Digital&#39;, &#39;Farming&#39;, &#39;angiogenesis&#39;, &#39;AI&#39;, &#39;Business&#39;, &#39;Intelligence&#39;, &#39;Artificial&#39;, &#39;Intelligence&#39;, &#39;Bioprocessing&#39;, &#39;AI&#39;, &#39;Customer&#39;, &#39;Analytics&#39;, &#39;Intelligent&#39;, &#39;Assistants&#39;, &#39;Bots&#39;, &#39;AI&#39;, &#39;Cancer&#39;, &#39;Enterprise&#39;, &#39;AI&#39;, &#39;Case&#39;, &#39;Studies&#39;, &#39;AI&#39;, &#39;Executive&#39;, &#39;Summit&#39;, &#39;Machine&#39;, &#39;Learning&#39;, &#39;Artificial&#39;, &#39;Intelligence&#39;, &#39;Clinical&#39;, &#39;&amp;&#39;, &#39;Post&#39;, &#39;Approval&#39;, &#39;Artificial&#39;, &#39;Intelligence&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;Preclinical&#39;, &#39;Implementing&#39;, &#39;Enterprise&#39;, &#39;AI&#39;, &#39;AI&#39;, &#39;Ethics&#39;, &#39;Future&#39;, &#39;AI&#39;, &#39;Cutting&#39;, &#39;Edge&#39;, &#39;Research&#39;, &#39;AI&#39;, &#39;General&#39;, &#39;AI&#39;, &#39;Business&#39;, &#39;Applications&#39;, &#39;AI&#39;, &#39;Strategic&#39;, &#39;Government&#39;, &#39;Functions&#39;, &#39;Cognitive&#39;, &#39;Computing&#39;, &#39;AI&#39;, &#39;Partnering&#39;, &#39;AI&#39;, &#39;Personalized&#39;, &#39;Medicine&#39;, &#39;Allosteric&#39;, &#39;Modulators&#39;, &#39;Amyotrophic&#39;, &#39;lateral&#39;, &#39;sclerosis&#39;, &#39;Animal&#39;, &#39;Models&#39;, &#39;Cancer&#39;, &#39;Alternative&#39;, &#39;Medicine&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;Execution&#39;, &#39;Asset&#39;, &#39;Management&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;Negotiation&#39;, &#39;Animal&#39;, &#39;Models&#39;, &#39;Pain&#39;, &#39;Animal&#39;, &#39;Models&#39;, &#39;Toxicity&#39;, &#39;angina&#39;, &#39;Anxiety&#39;, &#39;cancer&#39;, &#39;apoptosis&#39;, &#39;Active&#39;, &#39;Pharmaceutical&#39;, &#39;Ingredients&#39;, &#39;Analytical&#39;, &#39;Purification&#39;, &#39;Apoptosis&#39;, &#39;Anti&#39;, &#39;Psychotics&#39;, &#39;Alliances&#39;, &#39;Rx&#39;, &#39;Devices&#39;, &#39;arrhythmias&#39;, &#39;Assays&#39;, &#39;Antibodies&#39;, &#39;Assays&#39;, &#39;Affinity&#39;, &#39;Assays&#39;, &#39;Allosteric&#39;, &#39;Antagonism&#39;, &#39;Immunogenicity&#39;, &#39;Assay&#39;, &#39;Development&#39;, &#39;Assays&#39;, &#39;Primary&#39;, &#39;Cells&#39;, &#39;Quantifying&#39;, &#39;Receptor&#39;, &#39;Activation&#39;, &#39;Agonism&#39;, &#39;asthma&#39;, &#39;Assays&#39;, &#39;atherosclerosis&#39;, &#39;Automotive&#39;, &#39;Automotive&#39;, &#39;Partnering&#39;, &#39;Autophagy&#39;, &#39;Autism&#39;, &#39;Advisory&#39;, &#39;Boards&#39;, &#39;Bacterial&#39;, &#39;Infections&#39;, &#39;Consumer&#39;, &#39;Electronic&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Defense&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Battery&#39;, &#39;Data&#39;, &#39;Science&#39;, &#39;Flexible&#39;, &#39;Battery&#39;, &#39;Power&#39;, &#39;Industrial&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Stationary&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Automotive&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Bayesian&#39;, &#39;Statistics&#39;, &#39;Asia&#39;, &#39;US&#39;, &#39;Biotech&#39;, &#39;Alliances&#39;, &#39;Blood&#39;, &#39;Brain&#39;, &#39;Barrier&#39;, &#39;Computational&#39;, &#39;Biology&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;BioIT&#39;, &#39;Best&#39;, &#39;Practices&#39;, &#39;Battery&#39;, &#39;Charging&#39;, &#39;Cheminformatics&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;Biomarker&#39;, &#39;Clinical&#39;, &#39;Applications&#39;, &#39;Preclinical&#39;, &#39;Biologic&#39;, &#39;Development&#39;, &#39;Breast&#39;, &#39;Cancer&#39;, &#39;Backup&#39;, &#39;Compounds&#39;, &#39;biological&#39;, &#39;cancer&#39;, &#39;treatments&#39;, &#39;Biomarker&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Biological&#39;, &#39;Database&#39;, &#39;Discovery&#39;, &#39;Informatics&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;Delivery&#39;, &#39;Biologics&#39;, &#39;Regulatory&#39;, &#39;Business&#39;, &#39;Diagnostics&#39;, &#39;biodiversity&#39;, &#39;screening&#39;, &#39;E&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Battery&#39;, &#39;Energy&#39;, &#39;Storage&#39;, &#39;Biofuels&#39;, &#39;Alliance&#39;, &#39;Biobank&#39;, &#39;Informatics&#39;, &#39;Flow&#39;, &#39;Cell&#39;, &#39;Technologies&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;Data&#39;, &#39;Science&#39;, &#39;Biogenerics&#39;, &#39;Business&#39;, &#39;Genomics&#39;, &#39;biomaterials&#39;, &#39;Bioinformatics&#39;, &#39;Cancer&#39;, &#39;BIO&#39;, &#39;IT&#39;, &#39;World&#39;, &#39;Battery&#39;, &#39;Intellectual&#39;, &#39;Property&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;World&#39;, &#39;Web&#39;, &#39;Resource&#39;, &#39;Alert&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;World&#39;, &#39;Monthly&#39;, &#39;magazine&#39;, &#39;IT&#39;, &#39;&amp;&#39;, &#39;Informatics&#39;, &#39;Series&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;World&#39;, &#39;Weekly&#39;, &#39;Update&#39;, &#39;Bookstore&#39;, &#39;Biomarker&#39;, &#39;Development&#39;, &#39;Advanced&#39;, &#39;Lead&#39;, &#39;Acid&#39;, &#39;Technology&#39;, &#39;Manufacturing&#39;, &#39;&amp;&#39;, &#39;Process&#39;, &#39;Economics&#39;, &#39;Biopharm&#39;, &#39;Executive&#39;, &#39;Summit&#39;, &#39;Biolaw&#39;, &#39;Biomarker&#39;, &#39;&amp;&#39;, &#39;Diagnostics&#39;, &#39;Series&#39;, &#39;High-Througput&#39;, &#39;Screen-Based&#39;, &#39;Biomarker&#39;, &#39;Discovery&#39;, &#39;Battery&#39;, &#39;Manufacturers&#39;, &#39;Battery&#39;, &#39;Manufacturing&#39;, &#39;Battery&#39;, &#39;Management&#39;, &#39;Battery&#39;, &#39;Manufacturing&#39;, &#39;Machinery&#39;, &#39;Battery&#39;, &#39;Market&#39;, &#39;Battery&#39;, &#39;Machine&#39;, &#39;Learning&#39;, &#39;Biomarker&#39;, &#39;Executive&#39;, &#39;Think&#39;, &#39;Tank&#39;, &#39;Battery&#39;, &#39;Materials&#39;, &#39;,&#39;, &#39;Recycling&#39;, &#39;Biomarker&#39;, &#39;Reverse&#39;, &#39;Phase&#39;, &#39;Assays&#39;, &#39;Battery&#39;, &#39;Materials&#39;, &#39;,&#39;, &#39;Solid&#39;, &#39;State&#39;, &#39;bone&#39;, &#39;marrow&#39;, &#39;transplants&#39;, &#39;Biomarker&#39;, &#39;Translational&#39;, &#39;Biomarker&#39;, &#39;Validation&#39;, &#39;Bioinformatics&#39;, &#39;Asia&#39;, &#39;Bioinformatics&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;Logistics&#39;, &#39;Sample&#39;, &#39;Biobanking&#39;, &#39;Bioinformatics&#39;, &#39;Genome&#39;, &#39;Era&#39;, &#39;Bioprocess&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Host&#39;, &#39;Cell&#39;, &#39;Protein&#39;, &#39;Assays&#39;, &#39;Bioproduction&#39;, &#39;Continuous&#39;, &#39;Processing&#39;, &#39;biopurification&#39;, &#39;Biological&#39;, &#39;Pharmacokinetics&#39;, &#39;Bioprocessing&#39;, &#39;Quality&#39;, &#39;Bioprocess&#39;, &#39;&amp;&#39;, &#39;Manufacturing&#39;, &#39;Series&#39;, &#39;Bioprocess&#39;, &#39;Validation&#39;, &#39;Bioreactor&#39;, &#39;Design&#39;, &#39;Engineering&#39;, &#39;Battery&#39;, &#39;Regulatory&#39;, &#39;Battery&#39;, &#39;Raw&#39;, &#39;Materials&#39;, &#39;Brain&#39;, &#39;Cancer&#39;, &#39;Battery&#39;, &#39;Repurposing&#39;, &#39;Biological&#39;, &#39;Therapeutics&#39;, &#39;(&#39;, &#39;biotherapeutics&#39;, &#39;)&#39;, &#39;Bispecific&#39;, &#39;Antibodies&#39;, &#39;Immunotherapy&#39;, &#39;Bispecifics&#39;, &#39;Cancer&#39;, &#39;Business&#39;, &#39;Strategies&#39;, &#39;Library&#39;, &#39;Diversity&#39;, &#39;blood&#39;, &#39;safety&#39;, &#39;Europe&#39;, &#39;Battery&#39;, &#39;Shipping&#39;, &#39;Battery&#39;, &#39;Simulation&#39;, &#39;Biosensors&#39;, &#39;bioseparation&#39;, &#39;Biostabilization&#39;, &#39;Biospecimens&#39;, &#39;Biomanufacturing&#39;, &#39;Single&#39;, &#39;Use&#39;, &#39;Technologies&#39;, &#39;Bioassays&#39;, &#39;Battery&#39;, &#39;Commercialization&#39;, &#39;Flow&#39;, &#39;Batteries&#39;, &#39;Battery&#39;, &#39;Materials&#39;, &#39;Sci/Tech&#39;, &#39;Pharma&#39;, &#39;&amp;&#39;, &#39;Biotech&#39;, &#39;Battery&#39;, &#39;Safety&#39;, &#39;Biotech&#39;, &#39;tools&#39;, &#39;Biotech&#39;, &#39;Venture&#39;, &#39;Forum&#39;, &#39;Biomarkers&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Biomarkers&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Cancer&#39;, &#39;Immunotherapy&#39;, &#39;Artifical&#39;, &#39;Intelligence&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;cell&#39;, &#39;adhesion&#39;, &#39;molecules&#39;, &#39;regulatory&#39;, &#39;CANDA&#39;, &#39;Computer&#39;, &#39;Assisted&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Application&#39;, &#39;Chimeric&#39;, &#39;Antigen&#39;, &#39;Receptor&#39;, &#39;Chimeric&#39;, &#39;Antigen&#39;, &#39;Receptor&#39;, &#39;Case&#39;, &#39;Studies&#39;, &#39;catalysis&#39;, &#39;Cell&#39;, &#39;Based&#39;, &#39;Assays&#39;, &#39;Cell&#39;, &#39;Therapy&#39;, &#39;CMC&#39;, &#39;Cancer&#39;, &#39;Biomarker&#39;, &#39;Cell&#39;, &#39;Therapy&#39;, &#39;Production&#39;, &#39;Cord&#39;, &#39;Blood&#39;, &#39;Stem&#39;, &#39;Cells&#39;, &#39;Cell&#39;, &#39;Based&#39;, &#39;Therapies&#39;, &#39;Circulating&#39;, &#39;Tumor&#39;, &#39;Cells&#39;, &#39;Cold&#39;, &#39;Chain&#39;, &#39;Colorectal&#39;, &#39;Cancer&#39;, &#39;cell&#39;, &#39;cycle&#39;, &#39;Collaborations&#39;, &#39;Deals&#39;, &#39;Alliances&#39;, &#39;Chemical&#39;, &#39;Database&#39;, &#39;Co-Development&#39;, &#39;Diagnostics&#39;, &#39;Drugs&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;Europe&#39;, &#39;Case&#39;, &#39;Histories&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Consumer&#39;, &#39;Electronics&#39;, &#39;Cell&#39;, &#39;Biology&#39;, &#39;Clean&#39;, &#39;Tech&#39;, &#39;Solar&#39;, &#39;Wind&#39;, &#39;Comparative&#39;, &#39;Effectiveness&#39;, &#39;Research&#39;, &#39;Ethical&#39;, &#39;Considerations&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Continuing&#39;, &#39;Education&#39;, &#39;Units&#39;, &#39;Circulating&#39;, &#39;Cell-Free&#39;, &#39;DNA&#39;, &#39;Europe&#39;, &#39;Agriculture&#39;, &#39;crop&#39;, &#39;genetics&#39;, &#39;Europe&#39;, &#39;Cancer&#39;, &#39;Genomics&#39;, &#39;Europe&#39;, &#39;congestive&#39;, &#39;heart&#39;, &#39;failure&#39;, &#39;Chemistry&#39;, &#39;Series&#39;, &#39;Chinese&#39;, &#39;Hamster&#39;, &#39;Ovaries&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Conflicts&#39;, &#39;Interest&#39;, &#39;cheminformatics&#39;, &#39;competitive&#39;, &#39;intelligence&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;Asia&#39;, &#39;Integrating&#39;, &#39;Clinical&#39;, &#39;Lab&#39;, &#39;Services&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Clinical&#39;, &#39;Biospecimens&#39;, &#39;Central&#39;, &#39;Lab&#39;, &#39;Solutions&#39;, &#39;Clinical&#39;, &#39;Biospecimens&#39;, &#39;Central&#39;, &#39;Lab&#39;, &#39;Solutions&#39;, &#39;Celiac&#39;, &#39;Disease&#39;, &#39;Cloud&#39;, &#39;Extension&#39;, &#39;Clinical&#39;, &#39;Genomics&#39;, &#39;Europe&#39;, &#39;cellular&#39;, &#39;Conducting&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Asia&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;Resource&#39;, &#39;Management&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;Security&#39;, &#39;Risks&#39;, &#39;Software&#39;, &#39;Development&#39;, &#39;Clinical&#39;, &#39;Genomics&#39;, &#39;Clinical&#39;, &#39;Vaccines&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;West&#39;, &#39;Comparability&#39;, &#39;Chemistry&#39;, &#39;Manufacturing&#39;, &#39;Controls&#39;, &#39;Continuing&#39;, &#39;Medical&#39;, &#39;Education&#39;, &#39;Communications&#39;, &#39;Contract&#39;, &#39;Manufacturing&#39;, &#39;Cancer&#39;, &#39;Microarray&#39;, &#39;Application&#39;, &#39;CNS&#39;, &#39;Biomarkers&#39;, &#39;Miscellaneous&#39;, &#39;CHI&#39;, &#39;conference&#39;, &#39;CNS&#39;, &#39;genetics/genomics&#39;, &#39;CNS&#39;, &#39;Disease&#39;, &#39;Models&#39;, &#39;Counterfeit&#39;, &#39;Drugs&#39;, &#39;Copy&#39;, &#39;Number&#39;, &#39;Variation&#39;, &#39;Cognitive&#39;, &#39;Disorders&#39;, &#39;Battery&#39;, &#39;Components&#39;, &#39;capillary&#39;, &#39;electrophoresis&#39;, &#39;Cancer&#39;, &#39;Prognostic&#39;, &#39;Markers&#39;, &#39;Clinical&#39;, &#39;Pharmacology&#39;, &#39;Clinical&#39;, &#39;Proteomics&#39;, &#39;Clinical&#39;, &#39;Plasma&#39;, &#39;Profiling&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Platform&#39;, &#39;Software&#39;, &#39;Computer&#39;, &#39;Vision&#39;, &#39;cancer&#39;, &#39;prevention&#39;, &#39;CRA&#39;, &#39;8&#39;, &#39;Weeks&#39;, &#39;Fundamental&#39;, &#39;Training&#39;, &#39;Cost&#39;, &#39;Reduction&#39;, &#39;w/o&#39;, &#39;Increasing&#39;, &#39;Regulatory&#39;, &#39;Business&#39;, &#39;Risk&#39;, &#39;Advanced&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Coordinator&#39;, &#39;Critical&#39;, &#39;Care&#39;, &#39;Diagnostics&#39;, &#39;Interviewing&#39;, &#39;Skills&#39;, &#39;CRAs&#39;, &#39;CRCs&#39;, &#39;Customer&#39;, &#39;Relationship&#39;, &#39;Management&#39;, &#39;CRA&#39;, &#39;Monitoring&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Training&#39;, &#39;Week&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Training&#39;, &#39;Week&#39;, &#39;East&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Training&#39;, &#39;Week&#39;, &#39;West&#39;, &#39;Drug-Device&#39;, &#39;Combinations&#39;, &#39;Peptides&#39;, &#39;Cancer&#39;, &#39;Therapeutics&#39;, &#39;Colony&#39;, &#39;Stimulating&#39;, &#39;Factors&#39;, &#39;Cell&#39;, &#39;Signaling&#39;, &#39;Cancer&#39;, &#39;Stem&#39;, &#39;Cells&#39;, &#39;Clinical&#39;, &#39;Supply&#39;, &#39;Chain&#39;, &#39;Clinical&#39;, &#39;Strategic&#39;, &#39;Resource&#39;, &#39;Allocation&#39;, &#39;Country&#39;, &#39;Site&#39;, &#39;Feasibility&#39;, &#39;Selection&#39;, &#39;Mammalian&#39;, &#39;Cell&#39;, &#39;Culture&#39;, &#39;Cloud&#39;, &#39;Security&#39;, &#39;Cybersecurity&#39;, &#39;Clinical&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;eClinical&#39;, &#39;Trials&#39;, &#39;Asia&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Drug&#39;, &#39;Discoverer&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Eastern&#39;, &#39;Europe&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Finance&#39;, &#39;&amp;&#39;, &#39;Management&#39;, &#39;Re&#39;, &#39;Engineering&#39;, &#39;Study&#39;, &#39;Feasibility&#39;, &#39;Assessment&#39;, &#39;Process&#39;, &#39;CRC&#39;, &#39;Training&#39;, &#39;Video&#39;, &#39;&amp;&#39;, &#39;Manual&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Management&#39;, &#39;Systems&#39;, &#39;Cardiotoxicity&#39;, &#39;Query&#39;, &#39;Creation&#39;, &#39;&amp;&#39;, &#39;Processing&#39;, &#39;clinical&#39;, &#39;trials&#39;, &#39;segmentation&#39;, &#39;Neoantigens&#39;, &#39;Cancer&#39;, &#39;Cardiovascular&#39;, &#39;Diagnostics&#39;, &#39;cardiovascular&#39;, &#39;animal&#39;, &#39;models&#39;, &#39;Cardio&#39;, &#39;Metabolic&#39;, &#39;Drug&#39;, &#39;Targets&#39;, &#39;Targeting&#39;, &#39;Cancer&#39;, &#39;Diagnostics&#39;, &#39;cytokines&#39;, &#39;antagonists&#39;, &#39;Cystic&#39;, &#39;Fibrosis&#39;, &#39;Cytogenetics&#39;, &#39;cytokines&#39;, &#39;Targeting&#39;, &#39;Diabetes&#39;, &#39;Novel&#39;, &#39;Therapeutics&#39;, &#39;DBS&#39;, &#39;Optimization&#39;, &#39;Cell&#39;, &#39;drug&#39;, &#39;discovery&#39;, &#39;India&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Map&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Outsourcing&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Technologies&#39;, &#39;drug&#39;, &#39;discovery&#39;, &#39;development&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;Development&#39;, &#39;Series&#39;, &#39;Dental&#39;, &#39;Depression&#39;, &#39;Detection&#39;, &#39;non&#39;, &#39;biological&#39;, &#39;Treatments&#39;, &#39;Drug&#39;, &#39;Abuse&#39;, &#39;Drug&#39;, &#39;Drug&#39;, &#39;Interactions&#39;, &#39;Digital&#39;, &#39;Therapeutics&#39;, &#39;Digitization&#39;, &#39;Diabetes&#39;, &#39;2&#39;, &#39;Digital&#39;, &#39;Healthcare&#39;, &#39;&amp;&#39;, &#39;Productivity&#39;, &#39;web&#39;, &#39;resource&#39;, &#39;alert&#39;, &#39;drug&#39;, &#39;discovery&#39;, &#39;Duchenne&#39;, &#39;Muscular&#39;, &#39;Dystrophy&#39;, &#39;Drug&#39;, &#39;Metabolism&#39;, &#39;&amp;&#39;, &#39;Pharmacokinetics&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Informatics&#39;, &#39;Europe&#39;, &#39;Data&#39;, &#39;Integrity&#39;, &#39;Diagnostic&#39;, &#39;Informatics&#39;, &#39;DNA&#39;, &#39;Repair&#39;, &#39;Diversity&#39;, &#39;Oriented&#39;, &#39;Synthesis&#39;, &#39;Digital&#39;, &#39;Detection&#39;, &#39;Europe&#39;, &#39;Difficult&#39;, &#39;Express&#39;, &#39;Proteins&#39;, &#39;Executive&#39;, &#39;Perspectives&#39;, &#39;Drug&#39;, &#39;Safety&#39;, &#39;downstream&#39;, &#39;processing&#39;, &#39;Europe&#39;, &#39;Drug&#39;, &#39;Safety&#39;, &#39;Series&#39;, &#39;downstream&#39;, &#39;processing&#39;, &#39;Dosing&#39;, &#39;Selection&#39;, &#39;Data&#39;, &#39;Science/Analytics&#39;, &#39;Direct&#39;, &#39;Consumer&#39;, &#39;Marketing&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Drug&#39;, &#39;Transporters&#39;, &#39;Data&#39;, &#39;Storage&#39;, &#39;Digital&#39;, &#39;Twins&#39;, &#39;Drug&#39;, &#39;Utilization&#39;, &#39;Protein&#39;, &#39;Devices&#39;, &#39;Molecular&#39;, &#39;Companion&#39;, &#39;Diagnostics&#39;, &#39;Asia&#39;, &#39;Clinical&#39;, &#39;Adoption&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Diagnostics&#39;, &#39;Difficult&#39;, &#39;Express&#39;, &#39;Proteins&#39;, &#39;Europe&#39;, &#39;Globalization&#39;, &#39;Dx&#39;, &#39;Diagnostics&#39;, &#39;Immunoassays&#39;, &#39;Diagnostics&#39;, &#39;Automation&#39;, &#39;Detection&#39;, &#39;Informatics&#39;, &#39;engineered&#39;, &#39;animal&#39;, &#39;models&#39;, &#39;Hearing&#39;, &#39;Ebola&#39;, &#39;Diagnostics&#39;, &#39;Evidence&#39;, &#39;Based&#39;, &#39;Medicine&#39;, &#39;Ebola&#39;, &#39;Therapeutics&#39;, &#39;eCapacitors&#39;, &#39;Electrochemistry&#39;, &#39;E&#39;, &#39;Coli&#39;, &#39;Encoded&#39;, &#39;Compound&#39;, &#39;Libraries&#39;, &#39;Ecommerce&#39;, &#39;eCTD&#39;, &#39;Validation&#39;, &#39;Disinfectant&#39;, &#39;Efficacy&#39;, &#39;Effective&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Edge&#39;, &#39;Computing&#39;, &#39;Early&#39;, &#39;Diagnosis&#39;, &#39;Electronic&#39;, &#39;Notebooks&#39;, &#39;endothelium&#39;, &#39;engineering&#39;, &#39;Entertainment&#39;, &#39;Enabling&#39;, &#39;Technology&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Environment&#39;, &#39;Enzymes&#39;, &#39;Economic&#39;, &#39;Outcomes&#39;, &#39;Executives&#39;, &#39;Target&#39;, &#39;Epidemiology&#39;, &#39;epilepsy&#39;, &#39;Epigenetic&#39;, &#39;Readers&#39;, &#39;Epigenetic&#39;, &#39;Targets&#39;, &#39;Examining&#39;, &#39;Impact&#39;, &#39;eCTD&#39;, &#39;Regulatory&#39;, &#39;Submissions&#39;, &#39;Process&#39;, &#39;Emerging&#39;, &#39;Targets&#39;, &#39;Diseases&#39;, &#39;Ethics&#39;, &#39;Emerging&#39;, &#39;Technology&#39;, &#39;Transfer&#39;, &#39;Electric&#39;, &#39;Vehicles&#39;, &#39;Experimental&#39;, &#39;Design&#39;, &#39;Exhibitors&#39;, &#39;Extractables/Leachables&#39;, &#39;Exosomes&#39;, &#39;Exome&#39;, &#39;Sequencing&#39;, &#39;Financial&#39;, &#39;Analysts&#39;, &#39;Hackathon&#39;, &#39;Obesity&#39;, &#39;Batteries&#39;, &#39;France&#39;, &#39;fibrin&#39;, &#39;sealants&#39;, &#39;Fine&#39;, &#39;Chemicals&#39;, &#39;FDA&#39;, &#39;Meetings&#39;, &#39;101&#39;, &#39;Food&#39;, &#39;Safety&#39;, &#39;Financial&#39;, &#39;Disclosure&#39;, &#39;Foods&#39;, &#39;FDA&#39;, &#39;Website&#39;, &#39;Functional&#39;, &#39;Genomics&#39;, &#39;Fragment&#39;, &#39;Based&#39;, &#39;Screening&#39;, &#39;Surface&#39;, &#39;Plasmon&#39;, &#39;Resonance&#39;, &#39;finance&#39;, &#39;Flow&#39;, &#39;Cytometry&#39;, &#39;Influenza&#39;, &#39;Financial&#39;, &#39;Deal&#39;, &#39;Structures&#39;, &#39;Fintech&#39;, &#39;Future&#39;, &#39;Healthcare&#39;, &#39;Fraud&#39;, &#39;Fertility&#39;, &#39;Fibrin&#39;, &#39;sealants&#39;, &#39;Europe&#39;, &#39;blood&#39;, &#39;Fast&#39;, &#39;Track&#39;, &#39;Future&#39;, &#39;Therapeutics&#39;, &#39;fungal&#39;, &#39;infections&#39;, &#39;Follow&#39;, &#39;Up&#39;, &#39;Flow&#39;, &#39;Chemistry&#39;, &#39;Gamification&#39;, &#39;gap&#39;, &#39;junction&#39;, &#39;channels&#39;, &#39;Global&#39;, &#39;Health&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;Pediatric&#39;, &#39;Research&#39;, &#39;GCP&#39;, &#39;Deficiencies&#39;, &#39;Gene&#39;, &#39;Cell&#39;, &#39;Vectors&#39;, &#39;Genomic&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Genomic&#39;, &#39;Data&#39;, &#39;Integration&#39;, &#39;Genetic&#39;, &#39;Screening&#39;, &#39;Wellness&#39;, &#39;General&#39;, &#39;Email&#39;, &#39;Only&#39;, &#39;Gene&#39;, &#39;Editing&#39;, &#39;Part&#39;, &#39;2&#39;, &#39;Gene&#39;, &#39;Editing&#39;, &#39;Gene&#39;, &#39;Expression&#39;, &#39;Monitoring&#39;, &#39;Genomics&#39;, &#39;Series&#39;, &#39;Gene&#39;, &#39;Expression&#39;, &#39;growth&#39;, &#39;factors&#39;, &#39;Gene&#39;, &#39;Identification&#39;, &#39;genetic&#39;, &#39;immunization&#39;, &#39;vaccines&#39;, &#39;gene&#39;, &#39;interference&#39;, &#39;Gene&#39;, &#39;Knockouts&#39;, &#39;Globalization&#39;, &#39;Genome&#39;, &#39;Links&#39;, &#39;newsletter&#39;, &#39;GLP&#39;, &#39;Bioanalysis&#39;, &#39;Leaders&#39;, &#39;Precision&#39;, &#39;Medicine&#39;, &#39;Good&#39;, &#39;Manufacturing&#39;, &#39;Practice&#39;, &#39;Drugs&#39;, &#39;introductory&#39;, &#39;gene&#39;, &#39;mutations&#39;, &#39;genomic&#39;, &#39;medicine&#39;, &#39;Genotyping&#39;, &#39;Government&#39;, &#39;gene&#39;, &#39;probes&#39;, &#39;Genomic&#39;, &#39;partnering&#39;, &#39;Europe&#39;, &#39;Greening&#39;, &#39;Pharma&#39;, &#39;GPCR&#39;, &#39;Targeted&#39;, &#39;Therapies&#39;, &#39;Grid&#39;, &#39;Computing&#39;, &#39;Genomic&#39;, &#39;Service&#39;, &#39;Providers&#39;, &#39;Small&#39;, &#39;GTPases&#39;, &#39;(&#39;, &#39;formerly&#39;, &#39;Gene&#39;, &#39;Town&#39;, &#39;Pass&#39;, &#39;)&#39;, &#39;gene&#39;, &#39;transcription&#39;, &#39;gene&#39;, &#39;therapy&#39;, &#39;technologies&#39;, &#39;Whole&#39;, &#39;Genome&#39;, &#39;Association&#39;, &#39;Studies&#39;, &#39;Humanized&#39;, &#39;Antibodies&#39;, &#39;high&#39;, &#39;throughput&#39;, &#39;analytical&#39;, &#39;chemistry&#39;, &#39;Health&#39;, &#39;&amp;&#39;, &#39;Beauty&#39;, &#39;Aids&#39;, &#39;Hepatitis&#39;, &#39;B&#39;, &#39;Virus&#39;, &#39;High&#39;, &#39;Content&#39;, &#39;Analysis&#39;, &#39;Course&#39;, &#39;HIV&#39;, &#39;cancer&#39;, &#39;Hematological&#39;, &#39;Cancer&#39;, &#39;Pipelines&#39;, &#39;HIV&#39;, &#39;clinical&#39;, &#39;trials&#39;, &#39;hepatitis&#39;, &#39;C&#39;, &#39;virus&#39;, &#39;Heterocycle&#39;, &#39;High&#39;, &#39;Content&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;HDAC&#39;, &#39;Histone&#39;, &#39;Demethylases&#39;, &#39;Healing&#39;, &#39;hematopoesis&#39;, &#39;heat&#39;, &#39;shock&#39;, &#39;proteins&#39;, &#39;Human&#39;, &#39;Factors&#39;, &#39;Engineering&#39;, &#39;Health&#39;, &#39;Information&#39;, &#39;Systems&#39;, &#39;HIV&#39;, &#39;Healthcare&#39;, &#39;Series&#39;, &#39;Health&#39;, &#39;Maintenance&#39;, &#39;Organizations&#39;, &#39;Human&#39;, &#39;Tissue&#39;, &#39;Huntingtons&#39;, &#39;Disease&#39;, &#39;hormones&#39;, &#39;HIPAA&#39;, &#39;#&#39;, &#39;2&#39;, &#39;High&#39;, &#39;Throughput&#39;, &#39;Protein&#39;, &#39;Purification&#39;, &#39;High&#39;, &#39;Performing&#39;, &#39;Operation&#39;, &#39;Human&#39;, &#39;Papilloma&#39;, &#39;Virus&#39;, &#39;transgenics&#39;, &#39;homologous&#39;, &#39;recombinant&#39;, &#39;Human&#39;, &#39;Relations&#39;, &#39;Health&#39;, &#39;Insurance&#39;, &#39;herpes&#39;, &#39;virus&#39;, &#39;HIV&#39;, &#39;Surrogate&#39;, &#39;Markers&#39;, &#39;High&#39;, &#39;Throughput&#39;, &#39;Genomics&#39;, &#39;Hit&#39;, &#39;Lead&#39;, &#39;High&#39;, &#39;Throughput&#39;, &#39;Screening&#39;, &#39;Hepatotoxicity&#39;, &#39;Hybrid&#39;, &#39;Computing&#39;, &#39;hypertension&#39;, &#39;Targeting&#39;, &#39;Antigen&#39;, &#39;Presenting&#39;, &#39;Cells&#39;, &#39;Inflammatory&#39;, &#39;Bowel&#39;, &#39;Disease&#39;, &#39;imaging&#39;, &#39;contrast&#39;, &#39;agents&#39;, &#39;interleukin&#39;, &#39;converting&#39;, &#39;enzymes&#39;, &#39;ICE&#39;, &#39;Improving&#39;, &#39;Drug&#39;, &#39;Safety&#39;, &#39;diagnostics&#39;, &#39;-&#39;, &#39;infections&#39;, &#39;Infections&#39;, &#39;Diagnostics&#39;, &#39;Europe&#39;, &#39;engineering&#39;, &#39;laboratories&#39;, &#39;Integrated&#39;, &#39;Fluidic&#39;, &#39;Circuits&#39;, &#39;DOT&#39;, &#39;Informatics&#39;, &#39;Genomic&#39;, &#39;Medicine&#39;, &#39;Infection&#39;, &#39;Genomics&#39;, &#39;Image&#39;, &#39;Analysis&#39;, &#39;Immunotherapy&#39;, &#39;Biomarkers&#39;, &#39;Immune&#39;, &#39;Profiling&#39;, &#39;Cancer&#39;, &#39;Complement-based&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;immunomodulation&#39;, &#39;Imaging&#39;, &#39;WPC&#39;, &#39;conference&#39;, &#39;Imaging&#39;, &#39;Informatics&#39;, &#39;Immune&#39;, &#39;Impurities&#39;, &#39;Regulatory&#39;, &#39;Immunogenicity&#39;, &#39;Immunosequencing&#39;, &#39;Immuno-Oncology&#39;, &#39;Drug&#39;, &#39;Developement&#39;, &#39;Cancer&#39;, &#39;Immunotherapy&#39;, &#39;Oligonucleotides&#39;, &#39;Cancer&#39;, &#39;Immunotherapy&#39;, &#39;Peptides&#39;, &#39;Cancer&#39;, &#39;Immunotherapy&#39;, &#39;Small&#39;, &#39;Molecules&#39;, &#39;Informatics&#39;, &#39;Partnering&#39;, &#39;Insurance&#39;, &#39;AI&#39;, &#39;IOT&#39;, &#39;Investments&#39;, &#39;Industrial&#39;, &#39;Enzymes&#39;, &#39;Immuno-Oncology&#39;, &#39;Assays&#39;, &#39;Immuno-Oncology&#39;, &#39;Business&#39;, &#39;Strategy&#39;, &#39;Immuno-Oncology&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Immuno-Oncology&#39;, &#39;Models&#39;, &#39;ion&#39;, &#39;channels&#39;, &#39;Protein&#39;, &#39;Engineering&#39;, &#39;Immuno-oncology&#39;, &#39;Immuno-Oncology&#39;, &#39;Sequencing&#39;, &#39;Immuno-Oncology&#39;, &#39;Targets&#39;, &#39;Legal&#39;, &#39;Issues&#39;, &#39;Bioproduction&#39;, &#39;Intellectual&#39;, &#39;Property&#39;, &#39;Pluripotent&#39;, &#39;Stem&#39;, &#39;Cells&#39;, &#39;IRB&#39;, &#39;Compliance&#39;, &#39;Oversight&#39;, &#39;Considerations&#39;, &#39;Adopting&#39;, &#39;Integrated&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Informatics&#39;, &#39;Systems&#39;, &#39;India&#39;, &#39;Re&#39;, &#39;Engineering&#39;, &#39;International&#39;, &#39;Risk&#39;, &#39;Management&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Informatics&#39;, &#39;Iron&#39;, &#39;Chelation&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;Software&#39;, &#39;situ&#39;, &#39;hybridization&#39;, &#39;Information&#39;, &#39;Technology&#39;, &#39;IT&#39;, &#39;&amp;&#39;, &#39;Informatics&#39;, &#39;Collaboration&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;Europe&#39;, &#39;Scalable&#39;, &#39;IT&#39;, &#39;&amp;&#39;, &#39;Informatics&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;computer&#39;, &#39;hardware&#39;, &#39;(&#39;, &#39;part&#39;, &#39;2&#39;, &#39;)&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;computer&#39;, &#39;hardware&#39;, &#39;(&#39;, &#39;part&#39;, &#39;3&#39;, &#39;)&#39;, &#39;IT&#39;, &#39;Software&#39;, &#39;Life&#39;, &#39;Sciences&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;Virtualization&#39;, &#39;Interviewing&#39;, &#39;Skills&#39;, &#39;Managers&#39;, &#39;Investigator&#39;, &#39;Sites&#39;, &#39;Report&#39;, &#39;1&#39;, &#39;Investigator&#39;, &#39;Sites&#39;, &#39;Report&#39;, &#39;2&#39;, &#39;Imaging&#39;, &#39;Week&#39;, &#39;joints&#39;, &#39;Job&#39;, &#39;recruiters&#39;, &#39;Kinase&#39;, &#39;Chemistry&#39;, &#39;KIN&#39;, &#39;West&#39;, &#39;Coast&#39;, &#39;Kinases&#39;, &#39;DOT&#39;, &#39;Knowledge&#39;, &#39;Management&#39;, &#39;chemokines&#39;, &#39;HIV&#39;, &#39;Kaposis&#39;, &#39;sarcoma&#39;, &#39;Kinetics&#39;, &#39;Structure&#39;, &#39;Relationship&#39;, &#39;laboratories&#39;, &#39;Lead&#39;, &#39;Acid&#39;, &#39;Batteries&#39;, &#39;Label&#39;, &#39;Free&#39;, &#39;Detection&#39;, &#39;Drug&#39;, &#39;Labeling&#39;, &#39;Live&#39;, &#39;Cell&#39;, &#39;Imaging&#39;, &#39;Laser&#39;, &#39;Capture&#39;, &#39;Microdissection&#39;, &#39;Lung&#39;, &#39;Cancer&#39;, &#39;ligase&#39;, &#39;chain&#39;, &#39;reaction&#39;, &#39;leukodepletion&#39;, &#39;Laboratory&#39;, &#39;Developed&#39;, &#39;Tests&#39;, &#39;leukemia&#39;, &#39;Ontologies/Lexicons&#39;, &#39;Legal&#39;, &#39;drug&#39;, &#39;liability&#39;, &#39;screening&#39;, &#39;libraries&#39;, &#39;Life&#39;, &#39;Sciences&#39;, &#39;Protein&#39;, &#39;Ligands&#39;, &#39;lab&#39;, &#39;information&#39;, &#39;management&#39;, &#39;systems&#39;, &#39;LIMS&#39;, &#39;Lipids&#39;, &#39;Large&#39;, &#39;Stationary&#39;, &#39;Batteries&#39;, &#39;Lyophilization&#39;, &#39;Mergers&#39;, &#39;&amp;&#39;, &#39;Acquisitions&#39;, &#39;Monoclonal&#39;, &#39;Antibodies&#39;, &#39;Forum&#39;, &#39;Monoclonal&#39;, &#39;Antibody&#39;, &#39;Process&#39;, &#39;Development&#39;, &#39;Malaria&#39;, &#39;Metabolism&#39;, &#39;Targeted&#39;, &#39;Cancer&#39;, &#39;Therapeutics&#39;, &#39;Microbiome&#39;, &#39;Immuno-Oncology&#39;, &#39;Microbiome&#39;, &#39;Metabolic&#39;, &#39;Syndrome&#39;, &#39;Medicinal&#39;, &#39;Chemistry&#39;, &#39;Part&#39;, &#39;2&#39;, &#39;Mucosal&#39;, &#39;Immunity&#39;, &#39;Microreactors&#39;, &#39;Macrocycles&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Business&#39;, &#39;Multidrug&#39;, &#39;Resistance&#39;, &#39;Cancer&#39;, &#39;Medical&#39;, &#39;Coding&#39;, &#39;multidrug&#39;, &#39;resistant&#39;, &#39;infections&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Non-Invasive&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Microdosing&#39;, &#39;microbial&#39;, &#39;infections&#39;, &#39;Sequencing&#39;, &#39;Based&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Forum&#39;, &#39;Molecular&#39;, &#39;Electronics&#39;, &#39;Metabolic&#39;, &#39;Engineering&#39;, &#39;Melanoma&#39;, &#39;BioMEMS&#39;, &#39;memory&#39;, &#39;enhancement&#39;, &#39;cancer&#39;, &#39;metastasis&#39;, &#39;molecular&#39;, &#39;evolution&#39;, &#39;Mammalian&#39;, &#39;Cell&#39;, &#39;Line&#39;, &#39;Development&#39;, &#39;microfabrication&#39;, &#39;Molecular&#39;, &#39;Genetic&#39;, &#39;Pro&#39;, &#39;Management&#39;, &#39;molecular&#39;, &#39;medicine&#39;, &#39;Novel&#39;, &#39;bioactive&#39;, &#39;high&#39;, &#39;throughput&#39;, &#39;screening&#39;, &#39;europe&#39;, &#39;Myocardial&#39;, &#39;Infarction&#39;, &#39;migraine&#39;, &#39;microtiter&#39;, &#39;plates&#39;, &#39;Molecular&#39;, &#39;Medicine&#39;, &#39;Europe&#39;, &#39;metalloproteinases&#39;, &#39;Molecular&#39;, &#39;Medicine&#39;, &#39;Asia&#39;, &#39;Managed&#39;, &#39;Care&#39;, &#39;Manufacturing&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Monitoring&#39;, &#39;Mechanism&#39;, &#39;Action&#39;, &#39;Purifying&#39;, &#39;Antibodies&#39;, &#39;Meeting&#39;, &#39;Planning&#39;, &#39;Services&#39;, &#39;Molecular&#39;, &#39;Pathology&#39;, &#39;Molecular&#39;, &#39;Pathology&#39;, &#39;Basic&#39;, &#39;Molecular&#39;, &#39;Pathology&#39;, &#39;Advanced&#39;, &#39;magnetic&#39;, &#39;resonance&#39;, &#39;imaging&#39;, &#39;Multi&#39;, &#39;Specific&#39;, &#39;Antibodies&#39;, &#39;Mass&#39;, &#39;Spectrometry&#39;, &#39;Protein&#39;, &#39;Biomarker&#39;, &#39;Discovery&#39;, &#39;Muscle&#39;, &#39;Mass&#39;, &#39;Spec&#39;, &#39;Informatics&#39;, &#39;Mass&#39;, &#39;Spec&#39;, &#39;Imaging&#39;, &#39;Modeling&#39;, &#39;Simulation&#39;, &#39;Mass&#39;, &#39;spectrometry&#39;, &#39;Mass&#39;, &#39;Spec&#39;, &#39;Diagnostics&#39;, &#39;Metabolic&#39;, &#39;Disorders&#39;, &#39;Mental&#39;, &#39;Health&#39;, &#39;Materials&#39;, &#39;Testing&#39;, &#39;cellular&#39;, &#39;matrix&#39;, &#39;Multiplexed&#39;, &#39;Assays&#39;, &#39;Moelcular&#39;, &#39;Diagnostics&#39;, &#39;Europe&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Cancer&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Infectious&#39;, &#39;Disease&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Antibodies&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Antibodies&#39;, &#39;(&#39;, &#39;PGE&#39;, &#39;)&#39;, &#39;Nucleic&#39;, &#39;Acid&#39;, &#39;Europe&#39;, &#39;National&#39;, &#39;Academy&#39;, &#39;Sciences&#39;, &#39;meeting&#39;, &#39;natural&#39;, &#39;products&#39;, &#39;new&#39;, &#39;antivirals&#39;, &#39;Novel&#39;, &#39;Cancer&#39;, &#39;Informatics&#39;, &#39;Non-Coding&#39;, &#39;RNA&#39;, &#39;Novel&#39;, &#39;Strategies&#39;, &#39;Cancer&#39;, &#39;Novel&#39;, &#39;Cancer&#39;, &#39;Targets&#39;, &#39;Neurodegenerative&#39;, &#39;Nucleotide&#39;, &#39;Delivery&#39;, &#39;Internet&#39;, &#39;New&#39;, &#39;Database&#39;, &#39;comapny&#39;, &#39;names&#39;, &#39;Advances&#39;, &#39;Informatics&#39;, &#39;nerve&#39;, &#39;growth&#39;, &#39;factors&#39;, &#39;NF&#39;, &#39;KB&#39;, &#39;Nanofluidics&#39;, &#39;Informatics&#39;, &#39;Next-Generation&#39;, &#39;Batteries&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Batteries&#39;, &#39;Portable&#39;, &#39;Applications&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Batteries&#39;, &#39;Stationary&#39;, &#39;Power&#39;, &#39;Epigenetic&#39;, &#39;Sequencing&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Imaging&#39;, &#39;Neurogenomics&#39;, &#39;Nuclear&#39;, &#39;Hormone&#39;, &#39;Receptors&#39;, &#39;Novel&#39;, &#39;HIV&#39;, &#39;Strategies&#39;, &#39;Neurotech&#39;, &#39;Industry&#39;, &#39;neuroinjuries&#39;, &#39;NK&#39;, &#39;Cell&#39;, &#39;Based&#39;, &#39;Cancer&#39;, &#39;Immunotherapy&#39;, &#39;Natural&#39;, &#39;Language&#39;, &#39;Processing&#39;, &#39;nuclear&#39;, &#39;matrix&#39;, &#39;Nanomedicine&#39;, &#39;Nitric&#39;, &#39;Oxide&#39;, &#39;Network&#39;, &#39;Pharmacology&#39;, &#39;Energy&#39;, &#39;Neurotoxicity&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;US&#39;, &#39;nanotech&#39;, &#39;self&#39;, &#39;assembly&#39;, &#39;Internet&#39;, &#39;Supply&#39;, &#39;Chain&#39;, &#39;Internet&#39;, &#39;Supply&#39;, &#39;Chain&#39;, &#39;Europe&#39;, &#39;Neurostimulation&#39;, &#39;Internet&#39;, &#39;Diagnostic&#39;, &#39;Things&#39;, &#39;Internet&#39;, &#39;Energy&#39;, &#39;Internet&#39;, &#39;Energy&#39;, &#39;Europe&#39;, &#39;Internet&#39;, &#39;Things&#39;, &#39;Infrastructure&#39;, &#39;Internet&#39;, &#39;Health&#39;, &#39;Internet&#39;, &#39;Insurance&#39;, &#39;Internet&#39;, &#39;Insurance&#39;, &#39;Europe&#39;, &#39;Internet&#39;, &#39;Things&#39;, &#39;Manufacturing&#39;, &#39;Internet&#39;, &#39;Things&#39;, &#39;Manufacturing&#39;, &#39;Internet&#39;, &#39;Manufacturing&#39;, &#39;Europe&#39;, &#39;Smart&#39;, &#39;Buildings&#39;, &#39;Smart&#39;, &#39;Cities&#39;, &#39;Nephrotoxicity&#39;, &#39;Nuclear&#39;, &#39;Energy&#39;, &#39;nutrition&#39;, &#39;Optimizing&#39;, &#39;Media&#39;, &#39;organ&#39;, &#39;cell&#39;, &#39;transplants&#39;, &#39;Oncology&#39;, &#39;Drug&#39;, &#39;Targets&#39;, &#39;Optical&#39;, &#39;Diagnostics&#39;, &#39;Oncogenomics&#39;, &#39;Office&#39;, &#39;Inspector&#39;, &#39;General&#39;, &#39;Oil&#39;, &#39;Gas&#39;, &#39;oncogenes&#39;, &#39;Oncolytic&#39;, &#39;Viruses&#39;, &#39;Oligo&#39;, &#39;Production&#39;, &#39;opportunistic&#39;, &#39;infections&#39;, &#39;Oligo&#39;, &#39;Regulatory&#39;, &#39;organs&#39;, &#39;transplants&#39;, &#39;oral&#39;, &#39;drug&#39;, &#39;delivery&#39;, &#39;OSTEOARTHRITIS&#39;, &#39;OTC&#39;, &#39;counter&#39;, &#39;Additional&#39;, &#39;Conferences&#39;, &#39;clinical&#39;, &#39;trials&#39;, &#39;outsourcing&#39;, &#39;Oxygen&#39;, &#39;Radicals&#39;, &#39;oncogenes&#39;, &#39;p53&#39;, &#39;Predictive&#39;, &#39;ADME&#39;, &#39;protein&#39;, &#39;aggregation&#39;, &#39;Protein&#39;, &#39;Aggregation&#39;, &#39;(&#39;, &#39;PTK&#39;, &#39;)&#39;, &#39;Packaging&#39;, &#39;parasitic&#39;, &#39;infections&#39;, &#39;Process&#39;, &#39;Analytical&#39;, &#39;Technology&#39;, &#39;Pharmacy&#39;, &#39;Benefit&#39;, &#39;Management&#39;, &#39;Pharmaceutical&#39;, &#39;BioProcess&#39;, &#39;Basic&#39;, &#39;Research&#39;, &#39;&amp;&#39;, &#39;Discovery&#39;, &#39;track&#39;, &#39;PCG&#39;, &#39;Clinical&#39;, &#39;Operations&#39;, &#39;track&#39;, &#39;PCG&#39;, &#39;Preclinical&#39;, &#39;Development&#39;, &#39;track&#39;, &#39;PCG&#39;, &#39;Bridgehead&#39;, &#39;PCI&#39;, &#39;book&#39;, &#39;Preclinical&#39;, &#39;Preclinical&#39;, &#39;Preclinical&#39;, &#39;prostate&#39;, &#39;cancer&#39;, &#39;Preclinical&#39;, &#39;Outcome&#39;, &#39;Predictions&#39;, &#39;preclinical&#39;, &#39;trials&#39;, &#39;Point&#39;, &#39;Care&#39;, &#39;West&#39;, &#39;Protein&#39;, &#39;Crystallography&#39;, &#39;pediatric&#39;, &#39;AIDS/HIV&#39;, &#39;PDA&#39;, &#39;Downloads&#39;, &#39;CHI&#39;, &#39;website&#39;, &#39;Process&#39;, &#39;Development&#39;, &#39;Executives&#39;, &#39;platelet&#39;, &#39;derived&#39;, &#39;growth&#39;, &#39;factors&#39;, &#39;protein&#39;, &#39;drug&#39;, &#39;delivery&#39;, &#39;Preclinical&#39;, &#39;Disease&#39;, &#39;Models&#39;, &#39;photodynamic&#39;, &#39;therapies&#39;, &#39;Phage&#39;, &#39;Display&#39;, &#39;Vaccine&#39;, &#39;Development&#39;, &#39;Proteomic&#39;, &#39;Tools&#39;, &#39;Diagnostics&#39;, &#39;pediatric&#39;, &#39;Pediatric&#39;, &#39;trials&#39;, &#39;CRAS&#39;, &#39;PEGS&#39;, &#39;Virtual&#39;, &#39;Interactive&#39;, &#39;Global&#39;, &#39;Summit&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Monitoring&#39;, &#39;Protein&#39;, &#39;Executive&#39;, &#39;Summit&#39;, &#39;Proof&#39;, &#39;Concept&#39;, &#39;Cancer&#39;, &#39;Protein&#39;, &#39;Function&#39;, &#39;Enterprise&#39;, &#39;Portfolio&#39;, &#39;Management&#39;, &#39;Portfolio&#39;, &#39;Value&#39;, &#39;Protein&#39;, &#39;Aggregates&#39;, &#39;Light&#39;, &#39;Scattering&#39;, &#39;Consumer&#39;, &#39;Genomics/Personal&#39;, &#39;Genomics&#39;, &#39;Protein&#39;, &#39;Engineering&#39;, &#39;Partnering&#39;, &#39;Particulate&#39;, &#39;Screening&#39;, &#39;Phage&#39;, &#39;West&#39;, &#39;Phase&#39;, &#39;II/Reducing&#39;, &#39;Attrition&#39;, &#39;Phase&#39;, &#39;IV&#39;, &#39;Phase&#39;, &#39;IV&#39;, &#39;Pharmacies&#39;, &#39;Phage&#39;, &#39;Display&#39;, &#39;Europe&#39;, &#39;Pharmaceutical&#39;, &#39;Half&#39;, &#39;Life&#39;, &#39;Phase&#39;, &#39;Zero&#39;, &#39;PI3K&#39;, &#39;Phosphoinositide&#39;, &#39;3&#39;, &#39;Kinase&#39;, &#39;Protein&#39;, &#39;Identification&#39;, &#39;Preclinical&#39;, &#39;Imaging&#39;, &#39;protease&#39;, &#39;inhibitors&#39;, &#39;enzymes&#39;, &#39;PLA2&#39;, &#39;blood&#39;, &#39;platelets&#39;, &#39;Membrane&#39;, &#39;Proteins&#39;, &#39;Membrane&#39;, &#39;Protein&#39;, &#39;DOT&#39;, &#39;(&#39;, &#39;part&#39;, &#39;1&#39;, &#39;)&#39;, &#39;Membrane&#39;, &#39;Protein&#39;, &#39;DOT&#39;, &#39;(&#39;, &#39;part&#39;, &#39;2&#39;, &#39;)&#39;, &#39;Protein&#39;, &#39;Manufacturing&#39;, &#39;Clinical&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;:&#39;, &#39;Intermediate&#39;, &#39;Preventive&#39;, &#39;Medicine&#39;, &#39;Pancreatic&#39;, &#39;Cancer&#39;, &#39;Preclinical&#39;, &#39;Studies&#39;, &#39;IND&#39;, &#39;Protein&#39;, &#39;Computational&#39;, &#39;Tools&#39;, &#39;Prenatal&#39;, &#39;Therapeutics&#39;, &#39;Parenteral&#39;, &#39;Point&#39;, &#39;Care&#39;, &#39;Diagnostics&#39;, &#39;Europe&#39;, &#39;Cannabis&#39;, &#39;Power&#39;, &#39;Utilities&#39;, &#39;protein&#39;, &#39;characterization&#39;, &#39;protein&#39;, &#39;purification&#39;, &#39;Protein&#39;, &#39;Protein&#39;, &#39;Interactions&#39;, &#39;Protein&#39;, &#39;Protein&#39;, &#39;Interactions&#39;, &#39;Part&#39;, &#39;2&#39;, &#39;Process&#39;, &#39;Management&#39;, &#39;Protein&#39;, &#39;Process&#39;, &#39;PepTalk&#39;, &#39;Partnering&#39;, &#39;Personalized&#39;, &#39;Medicine&#39;, &#39;Partnering&#39;, &#39;Proteomics&#39;, &#39;Analytics&#39;, &#39;Predictive&#39;, &#39;Analytics&#39;, &#39;Pricing&#39;, &#39;Parkinsons&#39;, &#39;Predictive&#39;, &#39;Biomedicine&#39;, &#39;Proteins&#39;, &#39;,&#39;, &#39;Peptides&#39;, &#39;&amp;&#39;, &#39;Proteomics&#39;, &#39;Series&#39;, &#39;Protein&#39;, &#39;Quantification&#39;, &#39;Partnering&#39;, &#39;Data&#39;, &#39;Privacy&#39;, &#39;Personalized&#39;, &#39;Medicine&#39;, &#39;Asia&#39;, &#39;Product&#39;, &#39;Service&#39;, &#39;Announcement&#39;, &#39;Production&#39;, &#39;Scale&#39;, &#39;Up&#39;, &#39;Pharma&#39;, &#39;Services&#39;, &#39;News&#39;, &#39;schizophrenia&#39;, &#39;antipsychotics&#39;, &#39;Protein&#39;, &#39;Antibodies&#39;, &#39;Preclinical&#39;, &#39;Toxicology&#39;, &#39;Biologics&#39;, &#39;Protein&#39;, &#39;Technology&#39;, &#39;Engineering&#39;, &#39;Protein&#39;, &#39;Therapeutics&#39;, &#39;Delivery&#39;, &#39;Predictive&#39;, &#39;Toxicity&#39;, &#39;Europe&#39;, &#39;Platform&#39;, &#39;Software&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Studies&#39;, &#39;Phenotype&#39;, &#39;Genotype&#39;, &#39;Pathology&#39;, &#39;Protein&#39;, &#39;drugs&#39;, &#39;&amp;&#39;, &#39;diagnostics&#39;, &#39;Intellectual&#39;, &#39;Property&#39;, &#39;Post&#39;, &#39;Translational&#39;, &#39;Modifications&#39;, &#39;Patient&#39;, &#39;Registries&#39;, &#39;Advancing&#39;, &#39;Therapeutics&#39;, &#39;Current&#39;, &#39;Generation&#39;, &#39;Protein&#39;, &#39;Drug&#39;, &#39;Delivery&#39;, &#39;(&#39;, &#39;part&#39;, &#39;PepTalk&#39;, &#39;)&#39;, &#39;Advancing&#39;, &#39;Therapeutics&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Biological&#39;, &#39;Therapeutic&#39;, &#39;Products&#39;, &#39;Series&#39;, &#39;Pathway/Networks&#39;, &#39;Publications&#39;, &#39;Protein&#39;, &#39;Variations&#39;, &#39;Powertrains&#39;, &#39;Protein&#39;, &#39;Characterization&#39;, &#39;,&#39;, &#39;Purification&#39;, &#39;Screening&#39;, &#39;Protein&#39;, &#39;Characterization&#39;, &#39;,&#39;, &#39;Purification&#39;, &#39;Screening&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Europe&#39;, &#39;Beyond&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Europe&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Host&#39;, &#39;Novel&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Systems&#39;, &#39;Protein&#39;, &#39;Engineering&#39;, &#39;Vectors&#39;, &#39;Preventive&#39;, &#39;gene&#39;, &#39;quantification&#39;, &#39;Europe&#39;, &#39;QS&#39;, &#39;Regulation&#39;, &#39;Recombinant&#39;, &#39;Antibodies&#39;, &#39;Recombinant&#39;, &#39;Antibodies&#39;, &#39;Recombinant&#39;, &#39;Proteins&#39;, &#39;Forum&#39;, &#39;Radiation&#39;, &#39;Rare&#39;, &#39;Diseases&#39;, &#39;Antibody&#39;, &#39;Drug&#39;, &#39;Products&#39;, &#39;RBE&#39;, &#39;track&#39;, &#39;PGE&#39;, &#39;RBE&#39;, &#39;track&#39;, &#39;PGE&#39;, &#39;Antibody&#39;, &#39;Screening&#39;, &#39;Antibody&#39;, &#39;Translational&#39;, &#39;rapid&#39;, &#39;compound&#39;, &#39;characterization&#39;, &#39;Clinical&#39;, &#39;Enrollment&#39;, &#39;Plan&#39;, &#39;Clinical&#39;, &#39;Recruitment&#39;, &#39;Media&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Patient&#39;, &#39;Recruitment&#39;, &#39;Winning&#39;, &#39;Strategies&#39;, &#39;Clinical&#39;, &#39;Recruitment&#39;, &#39;Media&#39;, &#39;Integrating&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Marketing&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Productivity&#39;, &#39;drug&#39;, &#39;receptors&#39;, &#39;Role&#39;, &#39;Business&#39;, &#39;Process&#39;, &#39;Managment&#39;, &#39;FDA&#39;, &#39;Regulated&#39;, &#39;Industry&#39;, &#39;Worldwide&#39;, &#39;Pharma&#39;, &#39;Regulation&#39;, &#39;Surviving&#39;, &#39;FDA&#39;, &#39;Site&#39;, &#39;Inspections&#39;, &#39;Real&#39;, &#39;Estate&#39;, &#39;Risk&#39;, &#39;Evaluation&#39;, &#39;Mitigation&#39;, &#39;Strategies&#39;, &#39;Renal&#39;, &#39;(&#39;, &#39;kidney&#39;, &#39;)&#39;, &#39;Renewable&#39;, &#39;Energy&#39;, &#39;Storage&#39;, &#39;System&#39;, &#39;RFID&#39;, &#39;Radiofrequency&#39;, &#39;ID&#39;, &#39;Reagents&#39;, &#39;Gap&#39;, &#39;Analysis&#39;, &#39;rheumatoid&#39;, &#39;arthritis&#39;, &#39;gene&#39;, &#39;therapy&#39;, &#39;[&#39;, &#39;RNA&#39;, &#39;blocking&#39;, &#39;]&#39;, &#39;Ribonucleic&#39;, &#39;Acid&#39;, &#39;RNAi&#39;, &#39;Functional&#39;, &#39;Screening&#39;, &#39;RNAi&#39;, &#39;RNAInterference&#39;, &#39;RNAi&#39;, &#39;Discovery&#39;, &#39;Target&#39;, &#39;RNAi&#39;, &#39;Video&#39;, &#39;Request&#39;, &#39;RNA&#39;, &#39;Quality&#39;, &#39;RNA&#39;, &#39;Therapeutics&#39;, &#39;Robotics&#39;, &#39;Regional&#39;, &#39;Organization&#39;, &#39;Robotic&#39;, &#39;Process&#39;, &#39;Automation&#39;, &#39;reperfusion&#39;, &#39;Reproduction&#39;, &#39;Gene&#39;, &#39;Regulation&#39;, &#39;Regulatory&#39;, &#39;Networks&#39;, &#39;Restenosis&#39;, &#39;Retail&#39;, &#39;Real&#39;, &#39;World&#39;, &#39;Data&#39;, &#39;Therapeutics&#39;, &#39;Indications&#39;, &#39;&amp;&#39;, &#39;Drug&#39;, &#39;Targets&#39;, &#39;Series&#39;, &#39;safety&#39;, &#39;Screening&#39;, &#39;3D&#39;, &#39;Models&#39;, &#39;Sickle&#39;, &#39;Cell&#39;, &#39;Anemia&#39;, &#39;Screening&#39;, &#39;Informatics&#39;, &#39;Sequencing&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;supply&#39;, &#39;chain&#39;, &#39;management&#39;, &#39;SCOPEs&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Leadership&#39;, &#39;Forum&#39;, &#39;Phenotypic&#39;, &#39;Screening&#39;, &#39;Phenotypic&#39;, &#39;Screening&#39;, &#39;clinical&#39;, &#39;trials&#39;, &#39;strategy&#39;, &#39;IT&#39;, &#39;Security&#39;, &#39;Sequence&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Sequence&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Asia&#39;, &#39;Sidec&#39;, &#39;Executive&#39;, &#39;Forum&#39;, &#39;Sequence&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Europe&#39;, &#39;Sleeper&#39;, &#39;Disease&#39;, &#39;Indications&#39;, &#39;Sequencing&#39;, &#39;Data&#39;, &#39;Storage&#39;, &#39;&amp;&#39;, &#39;Management&#39;, &#39;Screening&#39;, &#39;Difficult&#39;, &#39;Targets&#39;, &#39;Source&#39;, &#39;Document&#39;, &#39;Verification&#39;, &#39;Sequencing&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;&amp;&#39;, &#39;Storage&#39;, &#39;second&#39;, &#39;messengers&#39;, &#39;sepsis&#39;, &#39;infections&#39;, &#39;Sequencing&#39;, &#39;Forum&#39;, &#39;Serotonin&#39;, &#39;Sexual&#39;, &#39;Small&#39;, &#39;Fuel&#39;, &#39;Cells&#39;, &#39;selective&#39;, &#39;immune&#39;, &#39;suppression&#39;, &#39;skin&#39;, &#39;sleep&#39;, &#39;Pharmaceutical&#39;, &#39;Sales&#39;, &#39;Biologics&#39;, &#39;Small&#39;, &#39;Molecular&#39;, &#39;Comparisons&#39;, &#39;Semiconductors&#39;, &#39;small&#39;, &#39;molecules&#39;, &#39;simple&#39;, &#39;model&#39;, &#39;organisms&#39;, &#39;Small&#39;, &#39;Molecules&#39;, &#39;Synthesis&#39;, &#39;Semantic&#39;, &#39;Web&#39;, &#39;Sensor&#39;, &#39;Applications&#39;, &#39;Synthetic&#39;, &#39;Biology&#39;, &#39;Sensor&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Implantable&#39;, &#39;Biomedical&#39;, &#39;Sensors&#39;, &#39;Sensor&#39;, &#39;Materials&#39;, &#39;Sensors&#39;, &#39;Emerging&#39;, &#39;Markets&#39;, &#39;SNPs&#39;, &#39;Sensor&#39;, &#39;Systems&#39;, &#39;Sensor&#39;, &#39;Safety&#39;, &#39;software&#39;, &#39;Solubility&#39;, &#39;Safety&#39;, &#39;Pharmacology&#39;, &#39;Biologics&#39;, &#39;Safety&#39;, &#39;Pharmacology&#39;, &#39;Biologics&#39;, &#39;Genomic&#39;, &#39;Sample&#39;, &#39;Preparation&#39;, &#39;Speciality&#39;, &#39;Pharmaceuticals&#39;, &#39;Alternative&#39;, &#39;Splicing&#39;, &#39;Proteomic&#39;, &#39;Sample&#39;, &#39;Preparation&#39;, &#39;High&#39;, &#39;throughput&#39;, &#39;screening&#39;, &#39;partnering&#39;, &#39;solid&#39;, &#39;phase&#39;, &#39;synthesis&#39;, &#39;Subjective&#39;, &#39;End&#39;, &#39;Points&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Sequencing&#39;, &#39;Applications&#39;, &#39;Sequencing&#39;, &#39;Core&#39;, &#39;Labs&#39;, &#39;Next-Generation&#39;, &#39;Data&#39;, &#39;Generation&#39;, &#39;Plant&#39;, &#39;Sequencing&#39;, &#39;RNA&#39;, &#39;Sequencing&#39;, &#39;Sequencing&#39;, &#39;Solutions&#39;, &#39;Deep&#39;, &#39;Sequencing&#39;, &#39;EU&#39;, &#39;Site&#39;, &#39;Selection&#39;, &#39;,&#39;, &#39;Study&#39;, &#39;Activation&#39;, &#39;,&#39;, &#39;Patient&#39;, &#39;Recruitment&#39;, &#39;Stability&#39;, &#39;stroke&#39;, &#39;Stem&#39;, &#39;Cell&#39;, &#39;Culture&#39;, &#39;Stem&#39;, &#39;Cell&#39;, &#39;Research&#39;, &#39;(&#39;, &#39;part&#39;, &#39;MMTC&#39;, &#39;)&#39;, &#39;Statin&#39;, &#39;Stem&#39;, &#39;Cells&#39;, &#39;Safety&#39;, &#39;Screening&#39;, &#39;Startup&#39;, &#39;Public&#39;, &#39;companies/stock&#39;, &#39;exchanges&#39;, &#39;CHI&#39;, &#39;Surveys&#39;, &#39;Services&#39;, &#39;Systems&#39;, &#39;Biology&#39;, &#39;BYG&#39;, &#39;track&#39;, &#39;synthesis&#39;, &#39;Systems&#39;, &#39;Biology&#39;, &#39;Training&#39;, &#39;&amp;&#39;, &#39;Development&#39;, &#39;Top&#39;, &#39;50&#39;, &#39;Big&#39;, &#39;Pharmas&#39;, &#39;Tissue&#39;, &#39;Microarrays&#39;, &#39;taxol&#39;, &#39;tamoxifen&#39;, &#39;derivatives&#39;, &#39;Tuberculosis&#39;, &#39;Tobacco&#39;, &#39;The&#39;, &#39;Biotech&#39;, &#39;Journal&#39;, &#39;Email&#39;, &#39;List&#39;, &#39;Trust&#39;, &#39;Building&#39;, &#39;Collaborative&#39;, &#39;Innovation&#39;, &#39;Tumor&#39;, &#39;,&#39;, &#39;Circulating&#39;, &#39;Cells&#39;, &#39;Technology&#39;, &#39;Technology&#39;, &#39;Consortium&#39;, &#39;Target&#39;, &#39;Driven&#39;, &#39;Chemistry&#39;, &#39;targeted&#39;, &#39;drug&#39;, &#39;delivery&#39;, &#39;transgenic&#39;, &#39;disease&#39;, &#39;models&#39;, &#39;Thrombotic&#39;, &#39;Disease&#39;, &#39;tissue&#39;, &#39;engineering&#39;, &#39;telomerases&#39;, &#39;Battery&#39;, &#39;Testing&#39;, &#39;Transfection&#39;, &#39;Toxicogenomics&#39;, &#39;Target&#39;, &#39;Prioritization&#39;, &#39;Target&#39;, &#39;Identification&#39;, &#39;tissues&#39;, &#39;Technology&#39;, &#39;Platforms&#39;, &#39;Immunotherapies&#39;, &#39;Telecommunications&#39;, &#39;Telemedicine&#39;, &#39;Tumor&#39;, &#39;Microenvironment&#39;, &#39;Trial&#39;, &#39;Master&#39;, &#39;File&#39;, &#39;Sponsors&#39;, &#39;(&#39;, &#39;pharma&#39;, &#39;)&#39;, &#39;Trial&#39;, &#39;Master&#39;, &#39;File&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;Theranostic&#39;, &#39;Market&#39;, &#39;Models&#39;, &#39;tumor&#39;, &#39;necrosis&#39;, &#39;factors&#39;, &#39;Therapeutics&#39;, &#39;Targets&#39;, &#39;Therapeutics&#39;, &#39;&amp;&#39;, &#39;Targets&#39;, &#39;Series&#39;, &#39;immune&#39;, &#39;tolerance&#39;, &#39;Fibrinolytic&#39;, &#39;(&#39;, &#39;clot&#39;, &#39;buster&#39;, &#39;)&#39;, &#39;Transgenic&#39;, &#39;Production&#39;, &#39;Plants&#39;, &#39;Synthetic&#39;, &#39;Biology&#39;, &#39;Transportation&#39;, &#39;Translational&#39;, &#39;Biomarkers&#39;, &#39;Translational&#39;, &#39;Informatics&#39;, &#39;Drug/Disease&#39;, &#39;Targets&#39;, &#39;Drug&#39;, &#39;Targets&#39;, &#39;Series&#39;, &#39;Genome&#39;, &#39;Tri&#39;, &#39;Conference&#39;, &#39;Translation&#39;, &#39;Services&#39;, &#39;transgenics&#39;, &#39;gene&#39;, &#39;knockouts&#39;, &#39;transgenic&#39;, &#39;production&#39;, &#39;Tumor&#39;, &#39;Suppressor&#39;, &#39;Genes&#39;, &#39;tissue&#39;, &#39;safety&#39;, &#39;Technology&#39;, &#39;&amp;&#39;, &#39;Tools&#39;, &#39;Life&#39;, &#39;Sciences&#39;, &#39;Technology&#39;, &#39;&amp;&#39;, &#39;Tools&#39;, &#39;Life&#39;, &#39;Sciences&#39;, &#39;Series&#39;, &#39;Target&#39;, &#39;Validation&#39;, &#39;Text&#39;, &#39;Mining&#39;, &#39;Unmanned&#39;, &#39;Aerial&#39;, &#39;Vehicles&#39;, &#39;Ubiquitin&#39;, &#39;Uninterruptible&#39;, &#39;Power&#39;, &#39;Supplies&#39;, &#39;upcoming&#39;, &#39;conferences&#39;, &#39;upcoming&#39;, &#39;conferences&#39;, &#39;Europe&#39;, &#39;Urinary&#39;, &#39;Incontinence&#39;, &#39;New&#39;, &#39;USP&#39;, &#39;Initiatives&#39;, &#39;Standards&#39;, &#39;Biologics&#39;, &#39;unstable&#39;, &#39;triplets&#39;, &#39;trinucleotide&#39;, &#39;repeats&#39;, &#39;Vaccines&#39;, &#39;(&#39;, &#39;IMT&#39;, &#39;)&#39;, &#39;Vascular&#39;, &#39;Vaccines&#39;, &#39;Business&#39;, &#39;Opportunities&#39;, &#39;Venture&#39;, &#39;Capital&#39;, &#39;Business&#39;, &#39;Opportunities&#39;, &#39;Vaccines&#39;, &#39;Voice&#39;, &#39;Recognition&#39;, &#39;Paperless&#39;, &#39;Validation&#39;, &#39;veterinary&#39;, &#39;viral&#39;, &#39;infections&#39;, &#39;Vaccines&#39;, &#39;Production&#39;, &#39;&amp;&#39;, &#39;Manufacturing&#39;, &#39;Virtual&#39;, &#39;Reality&#39;, &#39;virtual&#39;, &#39;business&#39;, &#39;Virtual&#39;, &#39;Teams&#39;, &#39;Single&#39;, &#39;Use&#39;, &#39;Systems&#39;, &#39;Vaccine&#39;, &#39;Manufacture&#39;, &#39;well&#39;, &#39;characterized&#39;, &#39;biologicals&#39;, &#39;Wellness&#39;, &#39;Wiki&#39;, &#39;wound&#39;, &#39;management&#39;, &#39;Wireless&#39;, &#39;Change&#39;, &#39;Record&#39;, &#39;Change&#39;, &#39;Record&#39;, &#39;Mary&#39;, &#39;Chitty&#39;, &#39;Xenotransplantation&#39;, &#39;Yeast&#39;, &#39;Display&#39;, &#39;Zika&#39;, &#39;Vaccine&#39;, &#39;Development&#39;]
</pre>
</div>
</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[33]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="kn">from</span> <span class="nn">nltk.stem</span> <span class="k">import</span> <span class="n">PorterStemmer</span>
<span class="kn">from</span> <span class="nn">nltk.tokenize</span> <span class="k">import</span> <span class="n">sent_tokenize</span><span class="p">,</span> <span class="n">word_tokenize</span>

<span class="n">ps</span> <span class="o">=</span> <span class="n">PorterStemmer</span><span class="p">()</span>

<span class="n">stemmed_words</span><span class="o">=</span><span class="p">[]</span>
<span class="k">for</span> <span class="n">w</span> <span class="ow">in</span> <span class="n">filtered_sent</span><span class="p">:</span>
    <span class="n">stemmed_words</span><span class="o">.</span><span class="n">append</span><span class="p">(</span><span class="n">ps</span><span class="o">.</span><span class="n">stem</span><span class="p">(</span><span class="n">w</span><span class="p">))</span>

<span class="nb">print</span><span class="p">(</span><span class="s2">&quot;Filtered Sentence:&quot;</span><span class="p">,</span><span class="n">filtered_sent</span><span class="p">)</span>
<span class="nb">print</span><span class="p">(</span><span class="s2">&quot;Stemmed Sentence:&quot;</span><span class="p">,</span><span class="n">stemmed_words</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>Filtered Sentence: [&#39;Molecular&#39;, &#39;Medicine&#39;, &#39;Tri&#39;, &#39;Conference&#39;, &#39;Protein&#39;, &#39;Engineering&#39;, &#39;Peptalk&#39;, &#39;Biocomputing&#39;, &#39;SCOPE&#39;, &#39;Summit&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Operations&#39;, &#39;Executives&#39;, &#39;bioproduction&#39;, &#39;Discovery&#39;, &#39;Target&#39;, &#39;PEGS&#39;, &#39;Europe&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Chemistry&#39;, &#39;World&#39;, &#39;Pharmaceutical&#39;, &#39;Congress&#39;, &#39;advanced&#39;, &#39;diagnostics&#39;, &#39;Advanced&#39;, &#39;Automotive&#39;, &#39;Battery&#39;, &#39;Conference&#39;, &#39;(&#39;, &#39;AABC&#39;, &#39;)&#39;, &#39;Europe&#39;, &#39;Florida&#39;, &#39;Battery&#39;, &#39;Conference&#39;, &#39;Biomarkers&#39;, &#39;Congress&#39;, &#39;High&#39;, &#39;Content&#39;, &#39;Analysis&#39;, &#39;Advanced&#39;, &#39;Automotive&#39;, &#39;Battery&#39;, &#39;Conference&#39;, &#39;(&#39;, &#39;AABC&#39;, &#39;)&#39;, &#39;Immunogenicity&#39;, &#39;CRA&#39;, &#39;&amp;&#39;, &#39;CRC&#39;, &#39;Beginner&#39;, &#39;Biopharmaceutical&#39;, &#39;Change&#39;, &#39;Control&#39;, &#39;Beyond&#39;, &#39;Genome&#39;, &#39;Immunotherapy&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;Strategies&#39;, &#39;Targeted&#39;, &#39;ImvacS&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Molecular&#39;, &#39;Medicine&#39;, &#39;Marketplace&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Europe&#39;, &#39;CRA&#39;, &#39;Beginner&#39;, &#39;AI&#39;, &#39;World&#39;, &#39;Data&#39;, &#39;Driven&#39;, &#39;Discovery&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Strategies&#39;, &#39;Strategic&#39;, &#39;Resource&#39;, &#39;Allocation&#39;, &#39;kinases&#39;, &#39;Auditing&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Studies&#39;, &#39;Accelerating&#39;, &#39;Development&#39;, &#39;&amp;&#39;, &#39;Advancing&#39;, &#39;Personalized&#39;, &#39;Therapy&#39;, &#39;X&#39;, &#39;Gen&#39;, &#39;Congress&#39;, &#39;Biodefense&#39;, &#39;&amp;&#39;, &#39;Enabling&#39;, &#39;POC&#39;, &#39;Diagnostics&#39;, &#39;&amp;&#39;, &#39;Microarray&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Human&#39;, &#39;Genome&#39;, &#39;Project&#39;, &#39;Biobanks&#39;, &#39;Structure&#39;, &#39;Based&#39;, &#39;Design&#39;, &#39;Batteries&#39;, &#39;Portfolio&#39;, &#39;Quantitative&#39;, &#39;PCR&#39;, &#39;Health&#39;, &#39;Information&#39;, &#39;Technology&#39;, &#39;Auditing&#39;, &#39;Techniques&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Professionals&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;Question&#39;, &#39;&amp;&#39;, &#39;Answer&#39;, &#39;REference&#39;, &#39;Guide&#39;, &#39;CFR/ICH&#39;, &#39;GCP&#39;, &#39;Immunotherapy&#39;, &#39;Europe&#39;, &#39;Gene&#39;, &#39;Amplification&#39;, &#39;PCR&#39;, &#39;eStats&#39;, &#39;:&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Statistical&#39;, &#39;Sourcebook&#39;, &#39;MicroRNA&#39;, &#39;microarray&#39;, &#39;data&#39;, &#39;analysis&#39;, &#39;Intelliigent&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;Development&#39;, &#39;(&#39;, &#39;WPC&#39;, &#39;)&#39;, &#39;Monitoring&#39;, &#39;Clinical&#39;, &#39;Drug&#39;, &#39;Studies&#39;, &#39;:&#39;, &#39;Beginner&#39;, &#39;Comprehensive&#39;, &#39;Monitoring&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Introduction&#39;, &#39;Clinical&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;Bioprocessing&#39;, &#39;Summit&#39;, &#39;Europe&#39;, &#39;Oligonucleotide&#39;, &#39;&amp;&#39;, &#39;Peptide&#39;, &#39;Summit&#39;, &#39;World&#39;, &#39;Pharma&#39;, &#39;Week&#39;, &#39;Prenatal&#39;, &#39;Diagnostics&#39;, &#39;Getting&#39;, &#39;Optimized&#39;, &#39;Targets&#39;, &#39;Library&#39;, &#39;Design&#39;, &#39;&amp;&#39;, &#39;Synthesis&#39;, &#39;Clinical&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;functional&#39;, &#39;genomics&#39;, &#39;bacterial&#39;, &#39;infections&#39;, &#39;Advanced&#39;, &#39;Automotive&#39;, &#39;Battery&#39;, &#39;Conference&#39;, &#39;(&#39;, &#39;AABC&#39;, &#39;)&#39;, &#39;Asia&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;Q&#39;, &#39;&amp;&#39;, &#39;A&#39;, &#39;Reference&#39;, &#39;Guide&#39;, &#39;Screening&#39;, &#39;Transmissible&#39;, &#39;spongiform&#39;, &#39;encephalopathy&#39;, &#39;TSE&#39;, &#39;Biomarker&#39;, &#39;Discovery&#39;, &#39;Summit&#39;, &#39;Clinical&#39;, &#39;Genomics&#39;, &#39;Sequencing&#39;, &#39;ASAP&#39;, &#39;Alliance&#39;, &#39;Summit&#39;, &#39;Bioterrorism&#39;, &#39;microarrays&#39;, &#39;Pharmaceutical&#39;, &#39;Leadership&#39;, &#39;Summit&#39;, &#39;Circulating&#39;, &#39;Cell-Free&#39;, &#39;DNA&#39;, &#39;Conducting&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Under&#39;, &#39;ICH&#39;, &#39;GCP&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;Europe&#39;, &#39;Trial&#39;, &#39;Master&#39;, &#39;File&#39;, &#39;Biomarkers&#39;, &#39;World&#39;, &#39;Preclinical&#39;, &#39;Congress&#39;, &#39;Europe&#39;, &#39;BioMEMS&#39;, &#39;bioinformatics&#39;, &#39;Genomic&#39;, &#39;Partnering&#39;, &#39;NMR&#39;, &#39;nuclear&#39;, &#39;magnetic&#39;, &#39;resonance&#39;, &#39;Clinical&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Biomarker&#39;, &#39;Validation&#39;, &#39;proteomics&#39;, &#39;Statistics&#39;, &#39;Sensors&#39;, &#39;Global&#39;, &#39;Summit&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;A&#39;, &#39;Regulatory&#39;, &#39;Overview&#39;, &#39;Drug&#39;, &#39;Safety&#39;, &#39;Pharmacy&#39;, &#39;Diagnostics&#39;, &#39;sample&#39;, &#39;preparation&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Design&#39;, &#39;Pharmacovigilance&#39;, &#39;Metabolic&#39;, &#39;Profiling&#39;, &#39;Digital&#39;, &#39;PCR&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Lab&#39;, &#39;chips&#39;, &#39;Europe&#39;, &#39;Monitoring&#39;, &#39;Clinical&#39;, &#39;Drug&#39;, &#39;Studies&#39;, &#39;:&#39;, &#39;Intermediate&#39;, &#39;Preparing&#39;, &#39;IND&#39;, &#39;Submissions&#39;, &#39;Antibody&#39;, &#39;Engineering&#39;, &#39;Asia&#39;, &#39;Clinical&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;:&#39;, &#39;Intermediate&#39;, &#39;phage&#39;, &#39;display&#39;, &#39;CELLutions&#39;, &#39;Recombinant&#39;, &#39;Antibodies&#39;, &#39;imaging&#39;, &#39;Biomarker&#39;, &#39;Assay&#39;, &#39;Development&#39;, &#39;silico&#39;, &#39;biology&#39;, &#39;Advanced&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;High&#39;, &#39;Throughput&#39;, &#39;Optimization&#39;, &#39;Culture&#39;, &#39;Conditions&#39;, &#39;Bioprocessing&#39;, &#39;High&#39;, &#39;Throughput&#39;, &#39;Technologies&#39;, &#39;gene&#39;, &#39;quantfication&#39;, &#39;[&#39;, &#39;real&#39;, &#39;time&#39;, &#39;PCR&#39;, &#39;]&#39;, &#39;From&#39;, &#39;Gene&#39;, &#39;Expression&#39;, &#39;Profiling&#39;, &#39;Validated&#39;, &#39;Biology&#39;, &#39;Clinical&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;:&#39;, &#39;Advanced&#39;, &#39;SCOPE&#39;, &#39;Summit&#39;, &#39;Europe&#39;, &#39;CNS&#39;, &#39;Partnering&#39;, &#39;Genomics&#39;, &#39;Target&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Statistical&#39;, &#39;Sourcebook&#39;, &#39;MultiUser&#39;, &#39;License&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Development&#39;, &#39;Biological&#39;, &#39;ADME&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;blood&#39;, &#39;safety&#39;, &#39;screening&#39;, &#39;Human&#39;, &#39;Proteome&#39;, &#39;Project&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;high&#39;, &#39;throughput&#39;, &#39;organic&#39;, &#39;synthesis&#39;, &#39;Global&#39;, &#39;Preclinical&#39;, &#39;Development&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Coordinator&#39;, &#39;Global&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;India&#39;, &#39;Biomarker&#39;, &#39;Diagnostics&#39;, &#39;molecular&#39;, &#39;diversity&#39;, &#39;functional&#39;, &#39;genomics&#39;, &#39;Process&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Summit&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;bioinformatics&#39;, &#39;Europe&#39;, &#39;Target&#39;, &#39;Validation&#39;, &#39;Bispecific&#39;, &#39;Antibodies&#39;, &#39;Bridging&#39;, &#39;Pharma&#39;, &#39;IT&#39;, &#39;Green&#39;, &#39;Fluorescent&#39;, &#39;Proteins&#39;, &#39;Quality&#39;, &#39;Systems&#39;, &#39;CRA&#39;, &#39;Monitoring&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;Development&#39;, &#39;AI&#39;, &#39;Government&#39;, &#39;glycotechnology&#39;, &#39;Baculovirus&#39;, &#39;Drug&#39;, &#39;Repurposing&#39;, &#39;drug&#39;, &#39;discovery&#39;, &#39;development&#39;, &#39;Japan&#39;, &#39;The&#39;, &#39;CRA&#39;, &#39;Manager&#39;, &#39;Course&#39;, &#39;State&#39;, &#39;State&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Requirments&#39;, &#39;Reference&#39;, &#39;Guide&#39;, &#39;Adverse&#39;, &#39;Events&#39;, &#39;:&#39;, &#39;Managing&#39;, &#39;&amp;&#39;, &#39;Reporting&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Good&#39;, &#39;Laboratory&#39;, &#39;Practice&#39;, &#39;Process&#39;, &#39;Chemistry&#39;, &#39;Beyond&#39;, &#39;Sequencing&#39;, &#39;Process&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Summit&#39;, &#39;GLP&#39;, &#39;Batteries&#39;, &#39;Biomarkers&#39;, &#39;Europe&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;computer&#39;, &#39;hardware&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;patient&#39;, &#39;Recruitment&#39;, &#39;Working&#39;, &#39;CROs&#39;, &#39;Expediting&#39;, &#39;Drugs&#39;, &#39;Biologics&#39;, &#39;Development&#39;, &#39;Tissue&#39;, &#39;Sealants&#39;, &#39;-&#39;, &#39;One&#39;, &#39;Day&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Europe&#39;, &#39;Use&#39;, &#39;Note&#39;, &#39;Files&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Essential&#39;, &#39;Documentation&#39;, &#39;Antibody&#39;, &#39;Engineering&#39;, &#39;Korea&#39;, &#39;RNAi&#39;, &#39;Pathway&#39;, &#39;Analysis&#39;, &#39;Advanced&#39;, &#39;GCP&#39;, &#39;Compliance&#39;, &#39;Mechanisms&#39;, &#39;Cancer&#39;, &#39;Business&#39;, &#39;Diagnostics&#39;, &#39;(&#39;, &#39;Impact&#39;, &#39;New&#39;, &#39;Diagnotics&#39;, &#39;)&#39;, &#39;Consumer&#39;, &#39;Genomics&#39;, &#39;Conference&#39;, &#39;Recombinant&#39;, &#39;Antibodies&#39;, &#39;Europe&#39;, &#39;Research&#39;, &#39;Site&#39;, &#39;Clinical&#39;, &#39;Study&#39;, &#39;Budgets&#39;, &#39;Contracts&#39;, &#39;Proof&#39;, &#39;Concept&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;China&#39;, &#39;Future&#39;, &#39;Diagnostics&#39;, &#39;Medicinal&#39;, &#39;Chemistry&#39;, &#39;Combination&#39;, &#39;Therapies&#39;, &#39;CRA&#39;, &#39;Training&#39;, &#39;Series&#39;, &#39;(&#39;, &#39;1-7&#39;, &#39;)&#39;, &#39;Lab&#39;, &#39;Chips&#39;, &#39;Japan&#39;, &#39;Human&#39;, &#39;Genomes&#39;, &#39;Europe&#39;, &#39;Tissue&#39;, &#39;Based&#39;, &#39;Screening&#39;, &#39;lead&#39;, &#39;optimization&#39;, &#39;Adverse&#39;, &#39;Events&#39;, &#39;Reimbursement&#39;, &#39;Diagnostics&#39;, &#39;labels&#39;, &#39;signals&#39;, &#39;detection&#39;, &#39;ASAP&#39;, &#39;CHI&#39;, &#39;Bio&#39;, &#39;Pharm&#39;, &#39;Alliance&#39;, &#39;Summit&#39;, &#39;forensic&#39;, &#39;diagnostics&#39;, &#39;Writing&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Molecular&#39;, &#39;Profiling&#39;, &#39;Cellular&#39;, &#39;Resolution&#39;, &#39;10&#39;, &#39;Rules&#39;, &#39;Effective&#39;, &#39;Report&#39;, &#39;Writing&#39;, &#39;pharmacogenomics&#39;, &#39;europe&#39;, &#39;Exploring&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Sequencing&#39;, &#39;conference&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;&amp;&#39;, &#39;FDA&#39;, &#39;Regulations&#39;, &#39;HCA&#39;, &#39;East&#39;, &#39;Cancer&#39;, &#39;Immunotherapies&#39;, &#39;(&#39;, &#39;formerly&#39;, &#39;Cancer&#39;, &#39;Vaccines&#39;, &#39;)&#39;, &#39;Biologics&#39;, &#39;Development&#39;, &#39;A&#39;, &#39;Regulatory&#39;, &#39;Overview&#39;, &#39;Standard&#39;, &#39;Operating&#39;, &#39;Proces&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;molecular&#39;, &#39;pharmacology&#39;, &#39;RNA&#39;, &#39;Interference&#39;, &#39;Summit&#39;, &#39;Clinical&#39;, &#39;Training&#39;, &#39;oligonucleotides&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Protocols&#39;, &#39;toxicology&#39;, &#39;Immunogenicity&#39;, &#39;Testing&#39;, &#39;Biologics&#39;, &#39;Adaptive&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;ADME&#39;, &#39;Stem&#39;, &#39;Cells&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Development&#39;, &#39;Drug&#39;, &#39;Pipeline&#39;, &#39;Success&#39;, &#39;(&#39;, &#39;Pipeline&#39;, &#39;Success&#39;, &#39;Summit&#39;, &#39;)&#39;, &#39;stem&#39;, &#39;cells&#39;, &#39;Data&#39;, &#39;Visualization&#39;, &#39;Pharmacokinetics&#39;, &#39;transgenic&#39;, &#39;animal&#39;, &#39;models&#39;, &#39;Business&#39;, &#39;Development&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;Interface&#39;, &#39;Monitoring&#39;, &#39;Clinical&#39;, &#39;Drug&#39;, &#39;Studies&#39;, &#39;:&#39;, &#39;Advanced&#39;, &#39;Digital&#39;, &#39;Health&#39;, &#39;Innovation&#39;, &#39;Summit&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Electronic&#39;, &#39;Data&#39;, &#39;Capture&#39;, &#39;Arena&#39;, &#39;Case&#39;, &#39;Report&#39;, &#39;Forms&#39;, &#39;Battery&#39;, &#39;Safety&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;GCP&#39;, &#39;Overview&#39;, &#39;Clinical&#39;, &#39;Administrative&#39;, &#39;Support&#39;, &#39;Staff&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;&amp;&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;Pre-Implantation&#39;, &#39;Diagnostics&#39;, &#39;Eyesight&#39;, &#39;Biomarker&#39;, &#39;Diagnostics&#39;, &#39;Biomarker&#39;, &#39;Web&#39;, &#39;Symposia&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;Process&#39;, &#39;Neglected&#39;, &#39;Diseases&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Approval&#39;, &#39;Process&#39;, &#39;Code&#39;, &#39;Federal&#39;, &#39;Regulations&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Associate&#39;, &#39;G&#39;, &#39;protein&#39;, &#39;coupled&#39;, &#39;receptors&#39;, &#39;GPCRS&#39;, &#39;Prenatal&#39;, &#39;Diagnostics&#39;, &#39;Europe&#39;, &#39;Genomic&#39;, &#39;Tools&#39;, &#39;&amp;&#39;, &#39;Technologies&#39;, &#39;Biomarkers&#39;, &#39;Europe&#39;, &#39;Symyx&#39;, &#39;Business&#39;, &#39;Collaborative&#39;, &#39;Innovation&#39;, &#39;Source&#39;, &#39;Documentation&#39;, &#39;Mitochondria&#39;, &#39;Comparative&#39;, &#39;Genomic&#39;, &#39;Hybridization&#39;, &#39;Lithium&#39;, &#39;Battery&#39;, &#39;Power&#39;, &#39;Writing&#39;, &#39;Clinical&#39;, &#39;Study&#39;, &#39;Protocols&#39;, &#39;Reimbursement&#39;, &#39;Therapeutics&#39;, &#39;genetic&#39;, &#39;variations&#39;, &#39;Business&#39;, &#39;Investigator&#39;, &#39;initiated&#39;, &#39;trials&#39;, &#39;Burrill&#39;, &#39;Book&#39;, &#39;Bio-IT&#39;, &#39;Asia&#39;, &#39;Compound&#39;, &#39;Profiling&#39;, &#39;cancer&#39;, &#39;clinical&#39;, &#39;trials&#39;, &#39;Chemical&#39;, &#39;Genomics&#39;, &#39;Safety/Toxicity&#39;, &#39;Biomarkers&#39;, &#39;Cancer&#39;, &#39;Diagnosis&#39;, &#39;antibody&#39;, &#39;engineering&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;Asia&#39;, &#39;West&#39;, &#39;Coast&#39;, &#39;Virtual&#39;, &#39;Screening&#39;, &#39;Point&#39;, &#39;Care&#39;, &#39;Diagnostics&#39;, &#39;Protein&#39;, &#39;Formulation&#39;, &#39;genetic&#39;, &#39;diagnostics&#39;, &#39;Bridging&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;IT&#39;, &#39;Biofuels&#39;, &#39;Translational&#39;, &#39;Medicine&#39;, &#39;Personalized&#39;, &#39;Medicine&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Organization&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;Congress&#39;, &#39;Europe&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;Risk&#39;, &#39;Based&#39;, &#39;Site&#39;, &#39;Monitoring&#39;, &#39;Root&#39;, &#39;Cause&#39;, &#39;Analysis&#39;, &#39;Monitoring&#39;, &#39;Phase&#39;, &#39;I&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;Latin&#39;, &#39;America&#39;, &#39;Licensing&#39;, &#39;vaccines&#39;, &#39;cancer&#39;, &#39;genetics&#39;, &#39;genomics&#39;, &#39;Marketing&#39;, &#39;Reimbursement&#39;, &#39;Metabolic&#39;, &#39;Analytical&#39;, &#39;Methods&#39;, &#39;Difficult&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;Protein&#39;, &#39;Chips/Arrays&#39;, &#39;Monitoring&#39;, &#39;Plan&#39;, &#39;Development&#39;, &#39;Genome&#39;, &#39;Japan&#39;, &#39;Immunogenicity&#39;, &#39;Advances&#39;, &#39;Management&#39;, &#39;Reduction&#39;, &#39;Clinical&#39;, &#39;Auditing&#39;, &#39;Clinical&#39;, &#39;Informatics&#39;, &#39;Antibody-Drug&#39;, &#39;Conjugates&#39;, &#39;Electronic&#39;, &#39;Medical&#39;, &#39;Records&#39;, &#39;&amp;&#39;, &#39;Source&#39;, &#39;Document&#39;, &#39;Verification&#39;, &#39;Bridge&#39;, &#39;Pop&#39;, &#39;Health&#39;, &#39;East&#39;, &#39;Informed&#39;, &#39;Consent&#39;, &#39;Pharma&#39;, &#39;Future&#39;, &#39;Microarray&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Europe&#39;, &#39;Clinical&#39;, &#39;Investigator&#39;, &#39;Site&#39;, &#39;Inspections&#39;, &#39;Global&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Protocol&#39;, &#39;Deviations&#39;, &#39;Immunotherapy&#39;, &#39;West&#39;, &#39;Cancer&#39;, &#39;Therapies&#39;, &#39;Recognize&#39;, &#39;Attrition&#39;, &#39;Earlier&#39;, &#39;Electronic&#39;, &#39;Data&#39;, &#39;Capture&#39;, &#39;Clinical&#39;, &#39;Imaging&#39;, &#39;Physical&#39;, &#39;Chemistry&#39;, &#39;Toll&#39;, &#39;Like&#39;, &#39;Receptors&#39;, &#39;monoclonal&#39;, &#39;antibodies&#39;, &#39;Innate&#39;, &#39;Immunity&#39;, &#39;High&#39;, &#39;Content&#39;, &#39;Analysis&#39;, &#39;Europe&#39;, &#39;Negotiation&#39;, &#39;Skills&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Professionals&#39;, &#39;Biotech&#39;, &#39;Executive&#39;, &#39;Forum&#39;, &#39;CNP&#39;, &#39;Partnering&#39;, &#39;Europe&#39;, &#39;nanotechnology&#39;, &#39;Risk&#39;, &#39;Management&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Adverse&#39;, &#39;Event&#39;, &#39;Monitoring&#39;, &#39;CRAs&#39;, &#39;Vendor&#39;, &#39;Management&#39;, &#39;Report&#39;, &#39;Writing&#39;, &#39;CRAs&#39;, &#39;Symyx&#39;, &#39;Europe&#39;, &#39;Epigenetics&#39;, &#39;Regulatory&#39;, &#39;Compliance&#39;, &#39;GCP&#39;, &#39;Training&#39;, &#39;Investigators&#39;, &#39;RECIST&#39;, &#39;1.0&#39;, &#39;1.1&#39;, &#39;Pharmacovigilance&#39;, &#39;Audit&#39;, &#39;Microfluidics&#39;, &#39;yeast&#39;, &#39;model&#39;, &#39;organism&#39;, &#39;Market&#39;, &#39;Targets&#39;, &#39;&amp;&#39;, &#39;Compounds&#39;, &#39;Critical&#39;, &#39;Decision&#39;, &#39;Points&#39;, &#39;Design&#39;, &#39;&amp;&#39;, &#39;Conduct&#39;, &#39;Patient&#39;, &#39;Registries&#39;, &#39;protein&#39;, &#39;production&#39;, &#39;formulation&#39;, &#39;HCA&#39;, &#39;Europe&#39;, &#39;Idiosyncratic&#39;, &#39;Toxicity&#39;, &#39;Protein&#39;, &#39;Informatics&#39;, &#39;Conflict&#39;, &#39;Resolution&#39;, &#39;Negotiation&#39;, &#39;Regulatory&#39;, &#39;Intelligence&#39;, &#39;Bioresearch&#39;, &#39;Monitoring&#39;, &#39;Cryobiology&#39;, &#39;signal&#39;, &#39;transduction&#39;, &#39;Emerging&#39;, &#39;Companies&#39;, &#39;Corrective&#39;, &#39;Action&#39;, &#39;Plans&#39;, &#39;:&#39;, &#39;Documentation&#39;, &#39;Sites&#39;, &#39;Response&#39;, &#39;GCP&#39;, &#39;Deficiences&#39;, &#39;Developing&#39;, &#39;Clinical&#39;, &#39;Study&#39;, &#39;Budget&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Sequencing&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Fraud&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Biosimilars&#39;, &#39;Dealmaking&#39;, &#39;Diagnostics&#39;, &#39;Comprehensive&#39;, &#39;CRC&#39;, &#39;Training&#39;, &#39;Cancer&#39;, &#39;Cell&#39;, &#39;Models&#39;, &#39;Digital&#39;, &#39;Health&#39;, &#39;Patient&#39;, &#39;Registry&#39;, &#39;Programs&#39;, &#39;crop&#39;, &#39;genetics&#39;, &#39;Glossary&#39;, &#39;&amp;&#39;, &#39;Acronyms&#39;, &#39;Reference&#39;, &#39;Biosensors&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;Essential&#39;, &#39;Documentation&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;Patient&#39;, &#39;Centered&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Proteins&#39;, &#39;Profits&#39;, &#39;Europe&#39;, &#39;Drug&#39;, &#39;Metabolism&#39;, &#39;International&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;Regulatory&#39;, &#39;Procedures&#39;, &#39;Principal&#39;, &#39;Investigator&#39;, &#39;Training&#39;, &#39;orthopedic&#39;, &#39;tissue&#39;, &#39;engineering&#39;, &#39;Investigator&#39;, &#39;Sites&#39;, &#39;cardiovascular&#39;, &#39;genomics&#39;, &#39;Study&#39;, &#39;Start&#39;, &#39;Up&#39;, &#39;Protein&#39;, &#39;Folding&#39;, &#39;Population&#39;, &#39;Health&#39;, &#39;Management&#39;, &#39;Tissue&#39;, &#39;Diagnostics&#39;, &#39;GLP&#39;, &#39;Bioanalysis&#39;, &#39;Phase&#39;, &#39;I&#39;, &#39;Study&#39;, &#39;Management&#39;, &#39;Health&#39;, &#39;Autonomous&#39;, &#39;Driving&#39;, &#39;Electronic&#39;, &#39;Source&#39;, &#39;Documentation&#39;, &#39;Tools&#39;, &#39;&amp;&#39;, &#39;Metrics&#39;, &#39;Congress&#39;, &#39;Global&#39;, &#39;GCP&#39;, &#39;Monitoring&#39;, &#39;Investigator&#39;, &#39;Non-Compliance&#39;, &#39;Global&#39;, &#39;GCP&#39;, &#39;Compliance&#39;, &#39;Report&#39;, &#39;Protein&#39;, &#39;&amp;&#39;, &#39;Peptide&#39;, &#39;Arrays&#39;, &#39;Europe&#39;, &#39;Internet&#39;, &#39;Things&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Pharmaceuticals&#39;, &#39;Introduction&#39;, &#39;Signal&#39;, &#39;Detection&#39;, &#39;Data&#39;, &#39;Mining&#39;, &#39;Study&#39;, &#39;Feasibility&#39;, &#39;Clinical&#39;, &#39;Investigation&#39;, &#39;Monitoring&#39;, &#39;Proteomics&#39;, &#39;Europe&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Developing&#39;, &#39;Regions&#39;, &#39;Pediatric&#39;, &#39;drug&#39;, &#39;development&#39;, &#39;Sponsor&#39;, &#39;Monitoring&#39;, &#39;Inspections&#39;, &#39;Maximize&#39;, &#39;Value&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;protein&#39;, &#39;structures&#39;, &#39;cancer&#39;, &#39;Microbial&#39;, &#39;Genomics&#39;, &#39;Translational&#39;, &#39;Cancer&#39;, &#39;Medicine&#39;, &#39;Medical&#39;, &#39;Terminalogy&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Professionals&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Writing&#39;, &#39;Updating&#39;, &#39;Investigators&#39;, &#39;Brochure&#39;, &#39;Sunshine&#39;, &#39;Act&#39;, &#39;Sequencing&#39;, &#39;Drug&#39;, &#39;Development&#39;, &#39;Standard&#39;, &#39;Operating&#39;, &#39;Procedures&#39;, &#39;Meeting&#39;, &#39;International&#39;, &#39;Safety&#39;, &#39;Reporting&#39;, &#39;Requirements&#39;, &#39;Faciliation&#39;, &#39;Skills&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Professionals&#39;, &#39;bioprocessing&#39;, &#39;biologicals&#39;, &#39;safety&#39;, &#39;Regulatory&#39;, &#39;Intelligence&#39;, &#39;101&#39;, &#39;Recent&#39;, &#39;Trends&#39;, &#39;Noncompliance&#39;, &#39;Briefings&#39;, &#39;Drug&#39;, &#39;Safety&#39;, &#39;Clinical&#39;, &#39;research&#39;, &#39;project&#39;, &#39;mamangement&#39;, &#39;essentials&#39;, &#39;CRA&#39;, &#39;Survival&#39;, &#39;Kit&#39;, &#39;Essential&#39;, &#39;Documentation&#39;, &#39;Extracellular&#39;, &#39;RNA&#39;, &#39;Successful&#39;, &#39;Study&#39;, &#39;Site&#39;, &#39;Start-up&#39;, &#39;Cell&#39;, &#39;Based&#39;, &#39;Therapies&#39;, &#39;Web-Based&#39;, &#39;Training&#39;, &#39;Strategies&#39;, &#39;data&#39;, &#39;mining&#39;, &#39;GLP&#39;, &#39;Bioanalysis&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Finance&#39;, &#39;&amp;&#39;, &#39;Management&#39;, &#39;regulatory&#39;, &#39;Site&#39;, &#39;Relationship/Performance&#39;, &#39;Management&#39;, &#39;Introduction&#39;, &#39;FDA&#39;, &#39;Regulatory&#39;, &#39;Reporter&#39;, &#39;Newsletter&#39;, &#39;multiple&#39;, &#39;sclerosis&#39;, &#39;Data&#39;, &#39;Integration&#39;, &#39;Managing&#39;, &#39;CRAs&#39;, &#39;Improve&#39;, &#39;Performance&#39;, &#39;&amp;&#39;, &#39;Study&#39;, &#39;Outcomes&#39;, &#39;compounds&#39;, &#39;Predictive&#39;, &#39;Toxicity&#39;, &#39;Surviving&#39;, &#39;FDA&#39;, &#39;Site&#39;, &#39;Inspections&#39;, &#39;:&#39;, &#39;Best&#39;, &#39;Practices&#39;, &#39;Site&#39;, &#39;Personnel&#39;, &#39;Phase&#39;, &#39;III&#39;, &#39;(&#39;, &#39;3&#39;, &#39;)&#39;, &#39;/forecasting&#39;, &#39;clinical&#39;, &#39;outcomes&#39;, &#39;Comparing&#39;, &#39;FDA&#39;, &#39;Health&#39;, &#39;Canada&#39;, &#39;Regulations&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Professionals&#39;, &#39;Recombinant&#39;, &#39;Therapeutics&#39;, &#39;Tick&#39;, &#39;Borne&#39;, &#39;Diseases&#39;, &#39;Writing&#39;, &#39;Maintaining&#39;, &#39;EU&#39;, &#39;CTA&#39;, &#39;Orphan&#39;, &#39;Drugs&#39;, &#39;Investigator&#39;, &#39;Initiated&#39;, &#39;Trials&#39;, &#39;Orthopaedic&#39;, &#39;Animal&#39;, &#39;Models&#39;, &#39;Auditing&#39;, &#39;Sponsors&#39;, &#39;CROs&#39;, &#39;Valuing&#39;, &#39;&amp;&#39;, &#39;Pricing&#39;, &#39;Licensing&#39;, &#39;Deals&#39;, &#39;drug&#39;, &#39;delivery&#39;, &#39;Vendor&#39;, &#39;Management&#39;, &#39;Clinical&#39;, &#39;Data&#39;, &#39;Manager&#39;, &#39;Data&#39;, &#39;Quality&#39;, &#39;Patient&#39;, &#39;Engagement&#39;, &#39;FDA&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;Process&#39;, &#39;HIPAA&#39;, &#39;No&#39;, &#39;1&#39;, &#39;Team&#39;, &#39;Training&#39;, &#39;HIPAA&#39;, &#39;&amp;&#39;, &#39;Human&#39;, &#39;Subjects&#39;, &#39;Research&#39;, &#39;Q&#39;, &#39;&amp;&#39;, &#39;A&#39;, &#39;Ubiquitin&#39;, &#39;Europe&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Data&#39;, &#39;Monitoring&#39;, &#39;Investigational&#39;, &#39;Product&#39;, &#39;Accountability&#39;, &#39;Training&#39;, &#39;Research&#39;, &#39;Site&#39;, &#39;Personnel&#39;, &#39;Adverse&#39;, &#39;Event&#39;, &#39;Reporting&#39;, &#39;IRBs&#39;, &#39;Subject&#39;, &#39;Recruitment&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;Antibodies&#39;, &#39;Cancer&#39;, &#39;Cost&#39;, &#39;Management&#39;, &#39;Global&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Portfolio&#39;, &#39;Management&#39;, &#39;Warning&#39;, &#39;Letters&#39;, &#39;Combination&#39;, &#39;Products&#39;, &#39;Observational&#39;, &#39;Studies&#39;, &#39;Molecular&#39;, &#39;Medicine&#39;, &#39;Asia&#39;, &#39;CNS&#39;, &#39;Central&#39;, &#39;nervous&#39;, &#39;system&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;Development&#39;, &#39;Collaboration&#39;, &#39;Cross&#39;, &#39;functional&#39;, &#39;global&#39;, &#39;teams&#39;, &#39;Site&#39;, &#39;Relationship&#39;, &#39;Management&#39;, &#39;peptides&#39;, &#39;Investigator&#39;, &#39;Oversight&#39;, &#39;Writing&#39;, &#39;SOPs&#39;, &#39;pain&#39;, &#39;web&#39;, &#39;2.0&#39;, &#39;Understanding&#39;, &#39;FDAs&#39;, &#39;new&#39;, &#39;Draft&#39;, &#39;Guidance&#39;, &#39;Regarding&#39;, &#39;Supervisory&#39;, &#39;Repons&#39;, &#39;Sponsors/CROs&#39;, &#39;Preparing&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;FDA&#39;, &#39;Inspections&#39;, &#39;eHealth&#39;, &#39;Technologies&#39;, &#39;Introduction&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;FDA&#39;, &#39;Proposed&#39;, &#39;rule&#39;, &#39;2010&#39;, &#39;Teambuilding&#39;, &#39;Cross&#39;, &#39;Functional&#39;, &#39;Global&#39;, &#39;Team&#39;, &#39;Genomic&#39;, &#39;Business&#39;, &#39;Strategies&#39;, &#39;Product&#39;, &#39;Life&#39;, &#39;Cycle&#39;, &#39;RNA&#39;, &#39;Interference&#39;, &#39;Pharmacovigilance&#39;, &#39;Signal&#39;, &#39;Detection&#39;, &#39;Foreign&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Biotech&#39;, &#39;Business&#39;, &#39;Development&#39;, &#39;genomics&#39;, &#39;Portfolio&#39;, &#39;Management&#39;, &#39;Venue&#39;, &#39;II&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Design&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Informed&#39;, &#39;Consent&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Study&#39;, &#39;Wheel&#39;, &#39;Biomarker&#39;, &#39;Data&#39;, &#39;Center&#39;, &#39;Antibody&#39;, &#39;Optimization&#39;, &#39;&amp;&#39;, &#39;Characterization&#39;, &#39;Biologics&#39;, &#39;Chronic&#39;, &#39;Pain&#39;, &#39;cardiovascular&#39;, &#39;Risk&#39;, &#39;based&#39;, &#39;decisions&#39;, &#39;clinical&#39;, &#39;site&#39;, &#39;management&#39;, &#39;Human&#39;, &#39;Participant&#39;, &#39;Protection&#39;, &#39;Training&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Professionals&#39;, &#39;CRC&#39;, &#39;Role/Responsibilities&#39;, &#39;Training&#39;, &#39;Womens&#39;, &#39;Health&#39;, &#39;Current&#39;, &#39;Developments&#39;, &#39;Role&#39;, &#39;IRBs&#39;, &#39;Conduct&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Regulatory&#39;, &#39;Compliance&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;infections&#39;, &#39;Diabetes&#39;, &#39;cancer&#39;, &#39;partnering&#39;, &#39;Preparing&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;510K&#39;, &#39;Submissions&#39;, &#39;Monitoring&#39;, &#39;Informed&#39;, &#39;Consent&#39;, &#39;Business&#39;, &#39;Biobanking&#39;, &#39;Global&#39;, &#39;Site&#39;, &#39;Selection&#39;, &#39;Boston&#39;, &#39;Biomarkers&#39;, &#39;Drug&#39;, &#39;Efficacy&#39;, &#39;Safety&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;European&#39;, &#39;Union&#39;, &#39;Protein&#39;, &#39;Therapeutics&#39;, &#39;Quality&#39;, &#39;Improvement&#39;, &#39;Strategies&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;diagnostics&#39;, &#39;bioprocessing&#39;, &#39;viral&#39;, &#39;hepatitis&#39;, &#39;infections&#39;, &#39;Advanced&#39;, &#39;HIPAA&#39;, &#39;Clinical&#39;, &#39;Sequencing&#39;, &#39;IRB&#39;, &#39;Guidance&#39;, &#39;regenerative&#39;, &#39;healing&#39;, &#39;cell&#39;, &#39;culture&#39;, &#39;Coronavirus&#39;, &#39;Liver&#39;, &#39;Disorders&#39;, &#39;Big&#39;, &#39;pharma&#39;, &#39;Big&#39;, &#39;Data&#39;, &#39;HIPAA&#39;, &#39;Electronic&#39;, &#39;Medical&#39;, &#39;Records&#39;, &#39;blood&#39;, &#39;Pharmaceutical&#39;, &#39;Strategy&#39;, &#39;Series&#39;, &#39;Strategies&#39;, &#39;Accelearted&#39;, &#39;Nonclinical&#39;, &#39;Toxiciology&#39;, &#39;&amp;&#39;, &#39;Safety&#39;, &#39;Assessment&#39;, &#39;Biologics&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;Japan&#39;, &#39;Artificial&#39;, &#39;Intelligence&#39;, &#39;Excel&#39;, &#39;Spreadsheets-Step&#39;, &#39;Step&#39;, &#39;Instructions&#39;, &#39;Compliance&#39;, &#39;Chemistry&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Statistical&#39;, &#39;Sourcebook&#39;, &#39;Upgrade&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Tracking&#39;, &#39;Medical&#39;, &#39;Devices&#39;, &#39;Directive&#39;, &#39;Facilitation&#39;, &#39;Skills&#39;, &#39;Autoimmune&#39;, &#39;anticoagulants&#39;, &#39;bone&#39;, &#39;Clinical&#39;, &#39;Antibodies&#39;, &#39;gene&#39;, &#39;therapy&#39;, &#39;Newborn&#39;, &#39;Diagnostics&#39;, &#39;Real&#39;, &#39;World&#39;, &#39;Monitoring&#39;, &#39;Allergies&#39;, &#39;Performance&#39;, &#39;Improvement&#39;, &#39;Monitoring&#39;, &#39;Model&#39;, &#39;Institutional&#39;, &#39;Review&#39;, &#39;Board&#39;, &#39;Health&#39;, &#39;Outcomes&#39;, &#39;Outsourcing&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Microbiome&#39;, &#39;Key&#39;, &#39;Opinion&#39;, &#39;Leaders&#39;, &#39;Chronic&#39;, &#39;Obstructive&#39;, &#39;Pulmonary&#39;, &#39;Disorder&#39;, &#39;Quality&#39;, &#39;Design&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;&amp;&#39;, &#39;Translational&#39;, &#39;Medicine&#39;, &#39;Series&#39;, &#39;Lupus&#39;, &#39;Multi&#39;, &#39;Drug&#39;, &#39;Resistance&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Coordinator&#39;, &#39;Tool&#39;, &#39;Kit&#39;, &#39;CRC&#39;, &#39;&amp;&#39;, &#39;PI&#39;, &#39;Current&#39;, &#39;Practice&#39;, &#39;Update&#39;, &#39;CRA&#39;, &#39;Facilitator&#39;, &#39;Training&#39;, &#39;21&#39;, &#39;CFR&#39;, &#39;Part&#39;, &#39;11&#39;, &#39;Compliance&#39;, &#39;Electronic&#39;, &#39;Records&#39;, &#39;&amp;&#39;, &#39;Signatures&#39;, &#39;Cancer&#39;, &#39;Diagnostics&#39;, &#39;Electronic&#39;, &#39;Health&#39;, &#39;Record&#39;, &#39;Chiral&#39;, &#39;Intro&#39;, &#39;Combination&#39;, &#39;Products&#39;, &#39;Gastrointestinal&#39;, &#39;Disorders&#39;, &#39;Presentation&#39;, &#39;skills&#39;, &#39;clinical&#39;, &#39;research&#39;, &#39;professionals&#39;, &#39;inflammation&#39;, &#39;Operational&#39;, &#39;Modeling&#39;, &#39;Simulation&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Pharmaceutical&#39;, &#39;&amp;&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Industries&#39;, &#39;Facilitation&#39;, &#39;Skills&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Team&#39;, &#39;Members&#39;, &#39;Diagnostics&#39;, &#39;Partnering&#39;, &#39;Mobile&#39;, &#39;Health&#39;, &#39;Wearables&#39;, &#39;Pharmaceutical&#39;, &#39;Discovery&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Medical&#39;, &#39;device&#39;, &#39;reporting&#39;, &#39;Ubiquitin&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Postmarketing&#39;, &#39;Vigilance&#39;, &#39;Blockchain&#39;, &#39;Alzheimers&#39;, &#39;high&#39;, &#39;performance&#39;, &#39;computing&#39;, &#39;Innovative&#39;, &#39;Preclinical&#39;, &#39;&amp;&#39;, &#39;Clinical&#39;, &#39;Strategies&#39;, &#39;GXP&#39;, &#39;Good&#39;, &#39;Practice&#39;, &#39;Guides&#39;, &#39;Writing&#39;, &#39;Maintaining&#39;, &#39;Canadian&#39;, &#39;CTA&#39;, &#39;3D&#39;, &#39;Printing&#39;, &#39;Key&#39;, &#39;Information&#39;, &#39;Gatherers&#39;, &#39;Respiratory&#39;, &#39;Five&#39;, &#39;Keys&#39;, &#39;COTS&#39;, &#39;Computer&#39;, &#39;System&#39;, &#39;Validation&#39;, &#39;Next-Generation&#39;, &#39;Sequencing&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Open&#39;, &#39;Source&#39;, &#39;Fibrosis/Scarring&#39;, &#39;Biomarker&#39;, &#39;Bridge&#39;, &#39;Genomics&#39;, &#39;101&#39;, &#39;Dummy&#39;, &#39;Keyword&#39;, &#39;DE&#39;, &#39;lists&#39;, &#39;w/more&#39;, &#39;1&#39;, &#39;keyword&#39;, &#39;keywords&#39;, &#39;FDA&#39;, &#39;Form&#39;, &#39;1572&#39;, &#39;Antisense&#39;, &#39;Accountable&#39;, &#39;Care&#39;, &#39;Orgnization&#39;, &#39;ACE&#39;, &#39;inhibitors&#39;, &#39;AI&#39;, &#39;Chips&#39;, &#39;Antibody-Drug&#39;, &#39;Conjugates&#39;, &#39;PEGS&#39;, &#39;Antibody&#39;, &#39;Drug&#39;, &#39;Conjugate&#39;, &#39;Bioprocess&#39;, &#39;Attention&#39;, &#39;Deficit&#39;, &#39;Hyperactivity&#39;, &#39;Disorder&#39;, &#39;Adjuvants&#39;, &#39;ADMET&#39;, &#39;(&#39;, &#39;ADME&#39;, &#39;&amp;&#39;, &#39;Toxicology&#39;, &#39;)&#39;, &#39;adverse&#39;, &#39;drug&#39;, &#39;reactions&#39;, &#39;Aerospace&#39;, &#39;Advanced&#39;, &#39;Energy&#39;, &#39;Technology&#39;, &#39;Congress&#39;, &#39;Affordable&#39;, &#39;Care&#39;, &#39;affinity&#39;, &#39;technologies&#39;, &#39;Affinity&#39;, &#39;Separation&#39;, &#39;Antibody&#39;, &#39;Fragments&#39;, &#39;Agriculture&#39;, &#39;chemistry&#39;, &#39;Aging&#39;, &#39;Antibody&#39;, &#39;Drug&#39;, &#39;Targets&#39;, &#39;Digital&#39;, &#39;Farming&#39;, &#39;angiogenesis&#39;, &#39;AI&#39;, &#39;Business&#39;, &#39;Intelligence&#39;, &#39;Artificial&#39;, &#39;Intelligence&#39;, &#39;Bioprocessing&#39;, &#39;AI&#39;, &#39;Customer&#39;, &#39;Analytics&#39;, &#39;Intelligent&#39;, &#39;Assistants&#39;, &#39;Bots&#39;, &#39;AI&#39;, &#39;Cancer&#39;, &#39;Enterprise&#39;, &#39;AI&#39;, &#39;Case&#39;, &#39;Studies&#39;, &#39;AI&#39;, &#39;Executive&#39;, &#39;Summit&#39;, &#39;Machine&#39;, &#39;Learning&#39;, &#39;Artificial&#39;, &#39;Intelligence&#39;, &#39;Clinical&#39;, &#39;&amp;&#39;, &#39;Post&#39;, &#39;Approval&#39;, &#39;Artificial&#39;, &#39;Intelligence&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;Preclinical&#39;, &#39;Implementing&#39;, &#39;Enterprise&#39;, &#39;AI&#39;, &#39;AI&#39;, &#39;Ethics&#39;, &#39;Future&#39;, &#39;AI&#39;, &#39;Cutting&#39;, &#39;Edge&#39;, &#39;Research&#39;, &#39;AI&#39;, &#39;General&#39;, &#39;AI&#39;, &#39;Business&#39;, &#39;Applications&#39;, &#39;AI&#39;, &#39;Strategic&#39;, &#39;Government&#39;, &#39;Functions&#39;, &#39;Cognitive&#39;, &#39;Computing&#39;, &#39;AI&#39;, &#39;Partnering&#39;, &#39;AI&#39;, &#39;Personalized&#39;, &#39;Medicine&#39;, &#39;Allosteric&#39;, &#39;Modulators&#39;, &#39;Amyotrophic&#39;, &#39;lateral&#39;, &#39;sclerosis&#39;, &#39;Animal&#39;, &#39;Models&#39;, &#39;Cancer&#39;, &#39;Alternative&#39;, &#39;Medicine&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;Execution&#39;, &#39;Asset&#39;, &#39;Management&#39;, &#39;Alliance&#39;, &#39;Management&#39;, &#39;Negotiation&#39;, &#39;Animal&#39;, &#39;Models&#39;, &#39;Pain&#39;, &#39;Animal&#39;, &#39;Models&#39;, &#39;Toxicity&#39;, &#39;angina&#39;, &#39;Anxiety&#39;, &#39;cancer&#39;, &#39;apoptosis&#39;, &#39;Active&#39;, &#39;Pharmaceutical&#39;, &#39;Ingredients&#39;, &#39;Analytical&#39;, &#39;Purification&#39;, &#39;Apoptosis&#39;, &#39;Anti&#39;, &#39;Psychotics&#39;, &#39;Alliances&#39;, &#39;Rx&#39;, &#39;Devices&#39;, &#39;arrhythmias&#39;, &#39;Assays&#39;, &#39;Antibodies&#39;, &#39;Assays&#39;, &#39;Affinity&#39;, &#39;Assays&#39;, &#39;Allosteric&#39;, &#39;Antagonism&#39;, &#39;Immunogenicity&#39;, &#39;Assay&#39;, &#39;Development&#39;, &#39;Assays&#39;, &#39;Primary&#39;, &#39;Cells&#39;, &#39;Quantifying&#39;, &#39;Receptor&#39;, &#39;Activation&#39;, &#39;Agonism&#39;, &#39;asthma&#39;, &#39;Assays&#39;, &#39;atherosclerosis&#39;, &#39;Automotive&#39;, &#39;Automotive&#39;, &#39;Partnering&#39;, &#39;Autophagy&#39;, &#39;Autism&#39;, &#39;Advisory&#39;, &#39;Boards&#39;, &#39;Bacterial&#39;, &#39;Infections&#39;, &#39;Consumer&#39;, &#39;Electronic&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Defense&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Battery&#39;, &#39;Data&#39;, &#39;Science&#39;, &#39;Flexible&#39;, &#39;Battery&#39;, &#39;Power&#39;, &#39;Industrial&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Medical&#39;, &#39;Device&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Stationary&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Automotive&#39;, &#39;Battery&#39;, &#39;Applications&#39;, &#39;Bayesian&#39;, &#39;Statistics&#39;, &#39;Asia&#39;, &#39;US&#39;, &#39;Biotech&#39;, &#39;Alliances&#39;, &#39;Blood&#39;, &#39;Brain&#39;, &#39;Barrier&#39;, &#39;Computational&#39;, &#39;Biology&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;BioIT&#39;, &#39;Best&#39;, &#39;Practices&#39;, &#39;Battery&#39;, &#39;Charging&#39;, &#39;Cheminformatics&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;Biomarker&#39;, &#39;Clinical&#39;, &#39;Applications&#39;, &#39;Preclinical&#39;, &#39;Biologic&#39;, &#39;Development&#39;, &#39;Breast&#39;, &#39;Cancer&#39;, &#39;Backup&#39;, &#39;Compounds&#39;, &#39;biological&#39;, &#39;cancer&#39;, &#39;treatments&#39;, &#39;Biomarker&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Biological&#39;, &#39;Database&#39;, &#39;Discovery&#39;, &#39;Informatics&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;Delivery&#39;, &#39;Biologics&#39;, &#39;Regulatory&#39;, &#39;Business&#39;, &#39;Diagnostics&#39;, &#39;biodiversity&#39;, &#39;screening&#39;, &#39;E&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Battery&#39;, &#39;Energy&#39;, &#39;Storage&#39;, &#39;Biofuels&#39;, &#39;Alliance&#39;, &#39;Biobank&#39;, &#39;Informatics&#39;, &#39;Flow&#39;, &#39;Cell&#39;, &#39;Technologies&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;Data&#39;, &#39;Science&#39;, &#39;Biogenerics&#39;, &#39;Business&#39;, &#39;Genomics&#39;, &#39;biomaterials&#39;, &#39;Bioinformatics&#39;, &#39;Cancer&#39;, &#39;BIO&#39;, &#39;IT&#39;, &#39;World&#39;, &#39;Battery&#39;, &#39;Intellectual&#39;, &#39;Property&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;World&#39;, &#39;Web&#39;, &#39;Resource&#39;, &#39;Alert&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;World&#39;, &#39;Monthly&#39;, &#39;magazine&#39;, &#39;IT&#39;, &#39;&amp;&#39;, &#39;Informatics&#39;, &#39;Series&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;World&#39;, &#39;Weekly&#39;, &#39;Update&#39;, &#39;Bookstore&#39;, &#39;Biomarker&#39;, &#39;Development&#39;, &#39;Advanced&#39;, &#39;Lead&#39;, &#39;Acid&#39;, &#39;Technology&#39;, &#39;Manufacturing&#39;, &#39;&amp;&#39;, &#39;Process&#39;, &#39;Economics&#39;, &#39;Biopharm&#39;, &#39;Executive&#39;, &#39;Summit&#39;, &#39;Biolaw&#39;, &#39;Biomarker&#39;, &#39;&amp;&#39;, &#39;Diagnostics&#39;, &#39;Series&#39;, &#39;High-Througput&#39;, &#39;Screen-Based&#39;, &#39;Biomarker&#39;, &#39;Discovery&#39;, &#39;Battery&#39;, &#39;Manufacturers&#39;, &#39;Battery&#39;, &#39;Manufacturing&#39;, &#39;Battery&#39;, &#39;Management&#39;, &#39;Battery&#39;, &#39;Manufacturing&#39;, &#39;Machinery&#39;, &#39;Battery&#39;, &#39;Market&#39;, &#39;Battery&#39;, &#39;Machine&#39;, &#39;Learning&#39;, &#39;Biomarker&#39;, &#39;Executive&#39;, &#39;Think&#39;, &#39;Tank&#39;, &#39;Battery&#39;, &#39;Materials&#39;, &#39;,&#39;, &#39;Recycling&#39;, &#39;Biomarker&#39;, &#39;Reverse&#39;, &#39;Phase&#39;, &#39;Assays&#39;, &#39;Battery&#39;, &#39;Materials&#39;, &#39;,&#39;, &#39;Solid&#39;, &#39;State&#39;, &#39;bone&#39;, &#39;marrow&#39;, &#39;transplants&#39;, &#39;Biomarker&#39;, &#39;Translational&#39;, &#39;Biomarker&#39;, &#39;Validation&#39;, &#39;Bioinformatics&#39;, &#39;Asia&#39;, &#39;Bioinformatics&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;Bio&#39;, &#39;IT&#39;, &#39;Logistics&#39;, &#39;Sample&#39;, &#39;Biobanking&#39;, &#39;Bioinformatics&#39;, &#39;Genome&#39;, &#39;Era&#39;, &#39;Bioprocess&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Host&#39;, &#39;Cell&#39;, &#39;Protein&#39;, &#39;Assays&#39;, &#39;Bioproduction&#39;, &#39;Continuous&#39;, &#39;Processing&#39;, &#39;biopurification&#39;, &#39;Biological&#39;, &#39;Pharmacokinetics&#39;, &#39;Bioprocessing&#39;, &#39;Quality&#39;, &#39;Bioprocess&#39;, &#39;&amp;&#39;, &#39;Manufacturing&#39;, &#39;Series&#39;, &#39;Bioprocess&#39;, &#39;Validation&#39;, &#39;Bioreactor&#39;, &#39;Design&#39;, &#39;Engineering&#39;, &#39;Battery&#39;, &#39;Regulatory&#39;, &#39;Battery&#39;, &#39;Raw&#39;, &#39;Materials&#39;, &#39;Brain&#39;, &#39;Cancer&#39;, &#39;Battery&#39;, &#39;Repurposing&#39;, &#39;Biological&#39;, &#39;Therapeutics&#39;, &#39;(&#39;, &#39;biotherapeutics&#39;, &#39;)&#39;, &#39;Bispecific&#39;, &#39;Antibodies&#39;, &#39;Immunotherapy&#39;, &#39;Bispecifics&#39;, &#39;Cancer&#39;, &#39;Business&#39;, &#39;Strategies&#39;, &#39;Library&#39;, &#39;Diversity&#39;, &#39;blood&#39;, &#39;safety&#39;, &#39;Europe&#39;, &#39;Battery&#39;, &#39;Shipping&#39;, &#39;Battery&#39;, &#39;Simulation&#39;, &#39;Biosensors&#39;, &#39;bioseparation&#39;, &#39;Biostabilization&#39;, &#39;Biospecimens&#39;, &#39;Biomanufacturing&#39;, &#39;Single&#39;, &#39;Use&#39;, &#39;Technologies&#39;, &#39;Bioassays&#39;, &#39;Battery&#39;, &#39;Commercialization&#39;, &#39;Flow&#39;, &#39;Batteries&#39;, &#39;Battery&#39;, &#39;Materials&#39;, &#39;Sci/Tech&#39;, &#39;Pharma&#39;, &#39;&amp;&#39;, &#39;Biotech&#39;, &#39;Battery&#39;, &#39;Safety&#39;, &#39;Biotech&#39;, &#39;tools&#39;, &#39;Biotech&#39;, &#39;Venture&#39;, &#39;Forum&#39;, &#39;Biomarkers&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Biomarkers&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Cancer&#39;, &#39;Immunotherapy&#39;, &#39;Artifical&#39;, &#39;Intelligence&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;cell&#39;, &#39;adhesion&#39;, &#39;molecules&#39;, &#39;regulatory&#39;, &#39;CANDA&#39;, &#39;Computer&#39;, &#39;Assisted&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Application&#39;, &#39;Chimeric&#39;, &#39;Antigen&#39;, &#39;Receptor&#39;, &#39;Chimeric&#39;, &#39;Antigen&#39;, &#39;Receptor&#39;, &#39;Case&#39;, &#39;Studies&#39;, &#39;catalysis&#39;, &#39;Cell&#39;, &#39;Based&#39;, &#39;Assays&#39;, &#39;Cell&#39;, &#39;Therapy&#39;, &#39;CMC&#39;, &#39;Cancer&#39;, &#39;Biomarker&#39;, &#39;Cell&#39;, &#39;Therapy&#39;, &#39;Production&#39;, &#39;Cord&#39;, &#39;Blood&#39;, &#39;Stem&#39;, &#39;Cells&#39;, &#39;Cell&#39;, &#39;Based&#39;, &#39;Therapies&#39;, &#39;Circulating&#39;, &#39;Tumor&#39;, &#39;Cells&#39;, &#39;Cold&#39;, &#39;Chain&#39;, &#39;Colorectal&#39;, &#39;Cancer&#39;, &#39;cell&#39;, &#39;cycle&#39;, &#39;Collaborations&#39;, &#39;Deals&#39;, &#39;Alliances&#39;, &#39;Chemical&#39;, &#39;Database&#39;, &#39;Co-Development&#39;, &#39;Diagnostics&#39;, &#39;Drugs&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;Europe&#39;, &#39;Case&#39;, &#39;Histories&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Consumer&#39;, &#39;Electronics&#39;, &#39;Cell&#39;, &#39;Biology&#39;, &#39;Clean&#39;, &#39;Tech&#39;, &#39;Solar&#39;, &#39;Wind&#39;, &#39;Comparative&#39;, &#39;Effectiveness&#39;, &#39;Research&#39;, &#39;Ethical&#39;, &#39;Considerations&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Continuing&#39;, &#39;Education&#39;, &#39;Units&#39;, &#39;Circulating&#39;, &#39;Cell-Free&#39;, &#39;DNA&#39;, &#39;Europe&#39;, &#39;Agriculture&#39;, &#39;crop&#39;, &#39;genetics&#39;, &#39;Europe&#39;, &#39;Cancer&#39;, &#39;Genomics&#39;, &#39;Europe&#39;, &#39;congestive&#39;, &#39;heart&#39;, &#39;failure&#39;, &#39;Chemistry&#39;, &#39;Series&#39;, &#39;Chinese&#39;, &#39;Hamster&#39;, &#39;Ovaries&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Conflicts&#39;, &#39;Interest&#39;, &#39;cheminformatics&#39;, &#39;competitive&#39;, &#39;intelligence&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;Asia&#39;, &#39;Integrating&#39;, &#39;Clinical&#39;, &#39;Lab&#39;, &#39;Services&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Clinical&#39;, &#39;Biospecimens&#39;, &#39;Central&#39;, &#39;Lab&#39;, &#39;Solutions&#39;, &#39;Clinical&#39;, &#39;Biospecimens&#39;, &#39;Central&#39;, &#39;Lab&#39;, &#39;Solutions&#39;, &#39;Celiac&#39;, &#39;Disease&#39;, &#39;Cloud&#39;, &#39;Extension&#39;, &#39;Clinical&#39;, &#39;Genomics&#39;, &#39;Europe&#39;, &#39;cellular&#39;, &#39;Conducting&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Asia&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;Resource&#39;, &#39;Management&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;Security&#39;, &#39;Risks&#39;, &#39;Software&#39;, &#39;Development&#39;, &#39;Clinical&#39;, &#39;Genomics&#39;, &#39;Clinical&#39;, &#39;Vaccines&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;West&#39;, &#39;Comparability&#39;, &#39;Chemistry&#39;, &#39;Manufacturing&#39;, &#39;Controls&#39;, &#39;Continuing&#39;, &#39;Medical&#39;, &#39;Education&#39;, &#39;Communications&#39;, &#39;Contract&#39;, &#39;Manufacturing&#39;, &#39;Cancer&#39;, &#39;Microarray&#39;, &#39;Application&#39;, &#39;CNS&#39;, &#39;Biomarkers&#39;, &#39;Miscellaneous&#39;, &#39;CHI&#39;, &#39;conference&#39;, &#39;CNS&#39;, &#39;genetics/genomics&#39;, &#39;CNS&#39;, &#39;Disease&#39;, &#39;Models&#39;, &#39;Counterfeit&#39;, &#39;Drugs&#39;, &#39;Copy&#39;, &#39;Number&#39;, &#39;Variation&#39;, &#39;Cognitive&#39;, &#39;Disorders&#39;, &#39;Battery&#39;, &#39;Components&#39;, &#39;capillary&#39;, &#39;electrophoresis&#39;, &#39;Cancer&#39;, &#39;Prognostic&#39;, &#39;Markers&#39;, &#39;Clinical&#39;, &#39;Pharmacology&#39;, &#39;Clinical&#39;, &#39;Proteomics&#39;, &#39;Clinical&#39;, &#39;Plasma&#39;, &#39;Profiling&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Platform&#39;, &#39;Software&#39;, &#39;Computer&#39;, &#39;Vision&#39;, &#39;cancer&#39;, &#39;prevention&#39;, &#39;CRA&#39;, &#39;8&#39;, &#39;Weeks&#39;, &#39;Fundamental&#39;, &#39;Training&#39;, &#39;Cost&#39;, &#39;Reduction&#39;, &#39;w/o&#39;, &#39;Increasing&#39;, &#39;Regulatory&#39;, &#39;Business&#39;, &#39;Risk&#39;, &#39;Advanced&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Coordinator&#39;, &#39;Critical&#39;, &#39;Care&#39;, &#39;Diagnostics&#39;, &#39;Interviewing&#39;, &#39;Skills&#39;, &#39;CRAs&#39;, &#39;CRCs&#39;, &#39;Customer&#39;, &#39;Relationship&#39;, &#39;Management&#39;, &#39;CRA&#39;, &#39;Monitoring&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Training&#39;, &#39;Week&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Training&#39;, &#39;Week&#39;, &#39;East&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Training&#39;, &#39;Week&#39;, &#39;West&#39;, &#39;Drug-Device&#39;, &#39;Combinations&#39;, &#39;Peptides&#39;, &#39;Cancer&#39;, &#39;Therapeutics&#39;, &#39;Colony&#39;, &#39;Stimulating&#39;, &#39;Factors&#39;, &#39;Cell&#39;, &#39;Signaling&#39;, &#39;Cancer&#39;, &#39;Stem&#39;, &#39;Cells&#39;, &#39;Clinical&#39;, &#39;Supply&#39;, &#39;Chain&#39;, &#39;Clinical&#39;, &#39;Strategic&#39;, &#39;Resource&#39;, &#39;Allocation&#39;, &#39;Country&#39;, &#39;Site&#39;, &#39;Feasibility&#39;, &#39;Selection&#39;, &#39;Mammalian&#39;, &#39;Cell&#39;, &#39;Culture&#39;, &#39;Cloud&#39;, &#39;Security&#39;, &#39;Cybersecurity&#39;, &#39;Clinical&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;eClinical&#39;, &#39;Trials&#39;, &#39;Asia&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Drug&#39;, &#39;Discoverer&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Eastern&#39;, &#39;Europe&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Finance&#39;, &#39;&amp;&#39;, &#39;Management&#39;, &#39;Re&#39;, &#39;Engineering&#39;, &#39;Study&#39;, &#39;Feasibility&#39;, &#39;Assessment&#39;, &#39;Process&#39;, &#39;CRC&#39;, &#39;Training&#39;, &#39;Video&#39;, &#39;&amp;&#39;, &#39;Manual&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Management&#39;, &#39;Systems&#39;, &#39;Cardiotoxicity&#39;, &#39;Query&#39;, &#39;Creation&#39;, &#39;&amp;&#39;, &#39;Processing&#39;, &#39;clinical&#39;, &#39;trials&#39;, &#39;segmentation&#39;, &#39;Neoantigens&#39;, &#39;Cancer&#39;, &#39;Cardiovascular&#39;, &#39;Diagnostics&#39;, &#39;cardiovascular&#39;, &#39;animal&#39;, &#39;models&#39;, &#39;Cardio&#39;, &#39;Metabolic&#39;, &#39;Drug&#39;, &#39;Targets&#39;, &#39;Targeting&#39;, &#39;Cancer&#39;, &#39;Diagnostics&#39;, &#39;cytokines&#39;, &#39;antagonists&#39;, &#39;Cystic&#39;, &#39;Fibrosis&#39;, &#39;Cytogenetics&#39;, &#39;cytokines&#39;, &#39;Targeting&#39;, &#39;Diabetes&#39;, &#39;Novel&#39;, &#39;Therapeutics&#39;, &#39;DBS&#39;, &#39;Optimization&#39;, &#39;Cell&#39;, &#39;drug&#39;, &#39;discovery&#39;, &#39;India&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Map&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Outsourcing&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Technologies&#39;, &#39;drug&#39;, &#39;discovery&#39;, &#39;development&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;&amp;&#39;, &#39;Development&#39;, &#39;Series&#39;, &#39;Dental&#39;, &#39;Depression&#39;, &#39;Detection&#39;, &#39;non&#39;, &#39;biological&#39;, &#39;Treatments&#39;, &#39;Drug&#39;, &#39;Abuse&#39;, &#39;Drug&#39;, &#39;Drug&#39;, &#39;Interactions&#39;, &#39;Digital&#39;, &#39;Therapeutics&#39;, &#39;Digitization&#39;, &#39;Diabetes&#39;, &#39;2&#39;, &#39;Digital&#39;, &#39;Healthcare&#39;, &#39;&amp;&#39;, &#39;Productivity&#39;, &#39;web&#39;, &#39;resource&#39;, &#39;alert&#39;, &#39;drug&#39;, &#39;discovery&#39;, &#39;Duchenne&#39;, &#39;Muscular&#39;, &#39;Dystrophy&#39;, &#39;Drug&#39;, &#39;Metabolism&#39;, &#39;&amp;&#39;, &#39;Pharmacokinetics&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Informatics&#39;, &#39;Europe&#39;, &#39;Data&#39;, &#39;Integrity&#39;, &#39;Diagnostic&#39;, &#39;Informatics&#39;, &#39;DNA&#39;, &#39;Repair&#39;, &#39;Diversity&#39;, &#39;Oriented&#39;, &#39;Synthesis&#39;, &#39;Digital&#39;, &#39;Detection&#39;, &#39;Europe&#39;, &#39;Difficult&#39;, &#39;Express&#39;, &#39;Proteins&#39;, &#39;Executive&#39;, &#39;Perspectives&#39;, &#39;Drug&#39;, &#39;Safety&#39;, &#39;downstream&#39;, &#39;processing&#39;, &#39;Europe&#39;, &#39;Drug&#39;, &#39;Safety&#39;, &#39;Series&#39;, &#39;downstream&#39;, &#39;processing&#39;, &#39;Dosing&#39;, &#39;Selection&#39;, &#39;Data&#39;, &#39;Science/Analytics&#39;, &#39;Direct&#39;, &#39;Consumer&#39;, &#39;Marketing&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Drug&#39;, &#39;Transporters&#39;, &#39;Data&#39;, &#39;Storage&#39;, &#39;Digital&#39;, &#39;Twins&#39;, &#39;Drug&#39;, &#39;Utilization&#39;, &#39;Protein&#39;, &#39;Devices&#39;, &#39;Molecular&#39;, &#39;Companion&#39;, &#39;Diagnostics&#39;, &#39;Asia&#39;, &#39;Clinical&#39;, &#39;Adoption&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Diagnostics&#39;, &#39;Difficult&#39;, &#39;Express&#39;, &#39;Proteins&#39;, &#39;Europe&#39;, &#39;Globalization&#39;, &#39;Dx&#39;, &#39;Diagnostics&#39;, &#39;Immunoassays&#39;, &#39;Diagnostics&#39;, &#39;Automation&#39;, &#39;Detection&#39;, &#39;Informatics&#39;, &#39;engineered&#39;, &#39;animal&#39;, &#39;models&#39;, &#39;Hearing&#39;, &#39;Ebola&#39;, &#39;Diagnostics&#39;, &#39;Evidence&#39;, &#39;Based&#39;, &#39;Medicine&#39;, &#39;Ebola&#39;, &#39;Therapeutics&#39;, &#39;eCapacitors&#39;, &#39;Electrochemistry&#39;, &#39;E&#39;, &#39;Coli&#39;, &#39;Encoded&#39;, &#39;Compound&#39;, &#39;Libraries&#39;, &#39;Ecommerce&#39;, &#39;eCTD&#39;, &#39;Validation&#39;, &#39;Disinfectant&#39;, &#39;Efficacy&#39;, &#39;Effective&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Edge&#39;, &#39;Computing&#39;, &#39;Early&#39;, &#39;Diagnosis&#39;, &#39;Electronic&#39;, &#39;Notebooks&#39;, &#39;endothelium&#39;, &#39;engineering&#39;, &#39;Entertainment&#39;, &#39;Enabling&#39;, &#39;Technology&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Environment&#39;, &#39;Enzymes&#39;, &#39;Economic&#39;, &#39;Outcomes&#39;, &#39;Executives&#39;, &#39;Target&#39;, &#39;Epidemiology&#39;, &#39;epilepsy&#39;, &#39;Epigenetic&#39;, &#39;Readers&#39;, &#39;Epigenetic&#39;, &#39;Targets&#39;, &#39;Examining&#39;, &#39;Impact&#39;, &#39;eCTD&#39;, &#39;Regulatory&#39;, &#39;Submissions&#39;, &#39;Process&#39;, &#39;Emerging&#39;, &#39;Targets&#39;, &#39;Diseases&#39;, &#39;Ethics&#39;, &#39;Emerging&#39;, &#39;Technology&#39;, &#39;Transfer&#39;, &#39;Electric&#39;, &#39;Vehicles&#39;, &#39;Experimental&#39;, &#39;Design&#39;, &#39;Exhibitors&#39;, &#39;Extractables/Leachables&#39;, &#39;Exosomes&#39;, &#39;Exome&#39;, &#39;Sequencing&#39;, &#39;Financial&#39;, &#39;Analysts&#39;, &#39;Hackathon&#39;, &#39;Obesity&#39;, &#39;Batteries&#39;, &#39;France&#39;, &#39;fibrin&#39;, &#39;sealants&#39;, &#39;Fine&#39;, &#39;Chemicals&#39;, &#39;FDA&#39;, &#39;Meetings&#39;, &#39;101&#39;, &#39;Food&#39;, &#39;Safety&#39;, &#39;Financial&#39;, &#39;Disclosure&#39;, &#39;Foods&#39;, &#39;FDA&#39;, &#39;Website&#39;, &#39;Functional&#39;, &#39;Genomics&#39;, &#39;Fragment&#39;, &#39;Based&#39;, &#39;Screening&#39;, &#39;Surface&#39;, &#39;Plasmon&#39;, &#39;Resonance&#39;, &#39;finance&#39;, &#39;Flow&#39;, &#39;Cytometry&#39;, &#39;Influenza&#39;, &#39;Financial&#39;, &#39;Deal&#39;, &#39;Structures&#39;, &#39;Fintech&#39;, &#39;Future&#39;, &#39;Healthcare&#39;, &#39;Fraud&#39;, &#39;Fertility&#39;, &#39;Fibrin&#39;, &#39;sealants&#39;, &#39;Europe&#39;, &#39;blood&#39;, &#39;Fast&#39;, &#39;Track&#39;, &#39;Future&#39;, &#39;Therapeutics&#39;, &#39;fungal&#39;, &#39;infections&#39;, &#39;Follow&#39;, &#39;Up&#39;, &#39;Flow&#39;, &#39;Chemistry&#39;, &#39;Gamification&#39;, &#39;gap&#39;, &#39;junction&#39;, &#39;channels&#39;, &#39;Global&#39;, &#39;Health&#39;, &#39;Good&#39;, &#39;Clinical&#39;, &#39;Practice&#39;, &#39;Pediatric&#39;, &#39;Research&#39;, &#39;GCP&#39;, &#39;Deficiencies&#39;, &#39;Gene&#39;, &#39;Cell&#39;, &#39;Vectors&#39;, &#39;Genomic&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Genomic&#39;, &#39;Data&#39;, &#39;Integration&#39;, &#39;Genetic&#39;, &#39;Screening&#39;, &#39;Wellness&#39;, &#39;General&#39;, &#39;Email&#39;, &#39;Only&#39;, &#39;Gene&#39;, &#39;Editing&#39;, &#39;Part&#39;, &#39;2&#39;, &#39;Gene&#39;, &#39;Editing&#39;, &#39;Gene&#39;, &#39;Expression&#39;, &#39;Monitoring&#39;, &#39;Genomics&#39;, &#39;Series&#39;, &#39;Gene&#39;, &#39;Expression&#39;, &#39;growth&#39;, &#39;factors&#39;, &#39;Gene&#39;, &#39;Identification&#39;, &#39;genetic&#39;, &#39;immunization&#39;, &#39;vaccines&#39;, &#39;gene&#39;, &#39;interference&#39;, &#39;Gene&#39;, &#39;Knockouts&#39;, &#39;Globalization&#39;, &#39;Genome&#39;, &#39;Links&#39;, &#39;newsletter&#39;, &#39;GLP&#39;, &#39;Bioanalysis&#39;, &#39;Leaders&#39;, &#39;Precision&#39;, &#39;Medicine&#39;, &#39;Good&#39;, &#39;Manufacturing&#39;, &#39;Practice&#39;, &#39;Drugs&#39;, &#39;introductory&#39;, &#39;gene&#39;, &#39;mutations&#39;, &#39;genomic&#39;, &#39;medicine&#39;, &#39;Genotyping&#39;, &#39;Government&#39;, &#39;gene&#39;, &#39;probes&#39;, &#39;Genomic&#39;, &#39;partnering&#39;, &#39;Europe&#39;, &#39;Greening&#39;, &#39;Pharma&#39;, &#39;GPCR&#39;, &#39;Targeted&#39;, &#39;Therapies&#39;, &#39;Grid&#39;, &#39;Computing&#39;, &#39;Genomic&#39;, &#39;Service&#39;, &#39;Providers&#39;, &#39;Small&#39;, &#39;GTPases&#39;, &#39;(&#39;, &#39;formerly&#39;, &#39;Gene&#39;, &#39;Town&#39;, &#39;Pass&#39;, &#39;)&#39;, &#39;gene&#39;, &#39;transcription&#39;, &#39;gene&#39;, &#39;therapy&#39;, &#39;technologies&#39;, &#39;Whole&#39;, &#39;Genome&#39;, &#39;Association&#39;, &#39;Studies&#39;, &#39;Humanized&#39;, &#39;Antibodies&#39;, &#39;high&#39;, &#39;throughput&#39;, &#39;analytical&#39;, &#39;chemistry&#39;, &#39;Health&#39;, &#39;&amp;&#39;, &#39;Beauty&#39;, &#39;Aids&#39;, &#39;Hepatitis&#39;, &#39;B&#39;, &#39;Virus&#39;, &#39;High&#39;, &#39;Content&#39;, &#39;Analysis&#39;, &#39;Course&#39;, &#39;HIV&#39;, &#39;cancer&#39;, &#39;Hematological&#39;, &#39;Cancer&#39;, &#39;Pipelines&#39;, &#39;HIV&#39;, &#39;clinical&#39;, &#39;trials&#39;, &#39;hepatitis&#39;, &#39;C&#39;, &#39;virus&#39;, &#39;Heterocycle&#39;, &#39;High&#39;, &#39;Content&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;HDAC&#39;, &#39;Histone&#39;, &#39;Demethylases&#39;, &#39;Healing&#39;, &#39;hematopoesis&#39;, &#39;heat&#39;, &#39;shock&#39;, &#39;proteins&#39;, &#39;Human&#39;, &#39;Factors&#39;, &#39;Engineering&#39;, &#39;Health&#39;, &#39;Information&#39;, &#39;Systems&#39;, &#39;HIV&#39;, &#39;Healthcare&#39;, &#39;Series&#39;, &#39;Health&#39;, &#39;Maintenance&#39;, &#39;Organizations&#39;, &#39;Human&#39;, &#39;Tissue&#39;, &#39;Huntingtons&#39;, &#39;Disease&#39;, &#39;hormones&#39;, &#39;HIPAA&#39;, &#39;#&#39;, &#39;2&#39;, &#39;High&#39;, &#39;Throughput&#39;, &#39;Protein&#39;, &#39;Purification&#39;, &#39;High&#39;, &#39;Performing&#39;, &#39;Operation&#39;, &#39;Human&#39;, &#39;Papilloma&#39;, &#39;Virus&#39;, &#39;transgenics&#39;, &#39;homologous&#39;, &#39;recombinant&#39;, &#39;Human&#39;, &#39;Relations&#39;, &#39;Health&#39;, &#39;Insurance&#39;, &#39;herpes&#39;, &#39;virus&#39;, &#39;HIV&#39;, &#39;Surrogate&#39;, &#39;Markers&#39;, &#39;High&#39;, &#39;Throughput&#39;, &#39;Genomics&#39;, &#39;Hit&#39;, &#39;Lead&#39;, &#39;High&#39;, &#39;Throughput&#39;, &#39;Screening&#39;, &#39;Hepatotoxicity&#39;, &#39;Hybrid&#39;, &#39;Computing&#39;, &#39;hypertension&#39;, &#39;Targeting&#39;, &#39;Antigen&#39;, &#39;Presenting&#39;, &#39;Cells&#39;, &#39;Inflammatory&#39;, &#39;Bowel&#39;, &#39;Disease&#39;, &#39;imaging&#39;, &#39;contrast&#39;, &#39;agents&#39;, &#39;interleukin&#39;, &#39;converting&#39;, &#39;enzymes&#39;, &#39;ICE&#39;, &#39;Improving&#39;, &#39;Drug&#39;, &#39;Safety&#39;, &#39;diagnostics&#39;, &#39;-&#39;, &#39;infections&#39;, &#39;Infections&#39;, &#39;Diagnostics&#39;, &#39;Europe&#39;, &#39;engineering&#39;, &#39;laboratories&#39;, &#39;Integrated&#39;, &#39;Fluidic&#39;, &#39;Circuits&#39;, &#39;DOT&#39;, &#39;Informatics&#39;, &#39;Genomic&#39;, &#39;Medicine&#39;, &#39;Infection&#39;, &#39;Genomics&#39;, &#39;Image&#39;, &#39;Analysis&#39;, &#39;Immunotherapy&#39;, &#39;Biomarkers&#39;, &#39;Immune&#39;, &#39;Profiling&#39;, &#39;Cancer&#39;, &#39;Complement-based&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;immunomodulation&#39;, &#39;Imaging&#39;, &#39;WPC&#39;, &#39;conference&#39;, &#39;Imaging&#39;, &#39;Informatics&#39;, &#39;Immune&#39;, &#39;Impurities&#39;, &#39;Regulatory&#39;, &#39;Immunogenicity&#39;, &#39;Immunosequencing&#39;, &#39;Immuno-Oncology&#39;, &#39;Drug&#39;, &#39;Developement&#39;, &#39;Cancer&#39;, &#39;Immunotherapy&#39;, &#39;Oligonucleotides&#39;, &#39;Cancer&#39;, &#39;Immunotherapy&#39;, &#39;Peptides&#39;, &#39;Cancer&#39;, &#39;Immunotherapy&#39;, &#39;Small&#39;, &#39;Molecules&#39;, &#39;Informatics&#39;, &#39;Partnering&#39;, &#39;Insurance&#39;, &#39;AI&#39;, &#39;IOT&#39;, &#39;Investments&#39;, &#39;Industrial&#39;, &#39;Enzymes&#39;, &#39;Immuno-Oncology&#39;, &#39;Assays&#39;, &#39;Immuno-Oncology&#39;, &#39;Business&#39;, &#39;Strategy&#39;, &#39;Immuno-Oncology&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Immuno-Oncology&#39;, &#39;Models&#39;, &#39;ion&#39;, &#39;channels&#39;, &#39;Protein&#39;, &#39;Engineering&#39;, &#39;Immuno-oncology&#39;, &#39;Immuno-Oncology&#39;, &#39;Sequencing&#39;, &#39;Immuno-Oncology&#39;, &#39;Targets&#39;, &#39;Legal&#39;, &#39;Issues&#39;, &#39;Bioproduction&#39;, &#39;Intellectual&#39;, &#39;Property&#39;, &#39;Pluripotent&#39;, &#39;Stem&#39;, &#39;Cells&#39;, &#39;IRB&#39;, &#39;Compliance&#39;, &#39;Oversight&#39;, &#39;Considerations&#39;, &#39;Adopting&#39;, &#39;Integrated&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Informatics&#39;, &#39;Systems&#39;, &#39;India&#39;, &#39;Re&#39;, &#39;Engineering&#39;, &#39;International&#39;, &#39;Risk&#39;, &#39;Management&#39;, &#39;Drug&#39;, &#39;Discovery&#39;, &#39;Informatics&#39;, &#39;Iron&#39;, &#39;Chelation&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;Software&#39;, &#39;situ&#39;, &#39;hybridization&#39;, &#39;Information&#39;, &#39;Technology&#39;, &#39;IT&#39;, &#39;&amp;&#39;, &#39;Informatics&#39;, &#39;Collaboration&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;Europe&#39;, &#39;Scalable&#39;, &#39;IT&#39;, &#39;&amp;&#39;, &#39;Informatics&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;computer&#39;, &#39;hardware&#39;, &#39;(&#39;, &#39;part&#39;, &#39;2&#39;, &#39;)&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;computer&#39;, &#39;hardware&#39;, &#39;(&#39;, &#39;part&#39;, &#39;3&#39;, &#39;)&#39;, &#39;IT&#39;, &#39;Software&#39;, &#39;Life&#39;, &#39;Sciences&#39;, &#39;IT&#39;, &#39;Infrastructure&#39;, &#39;Virtualization&#39;, &#39;Interviewing&#39;, &#39;Skills&#39;, &#39;Managers&#39;, &#39;Investigator&#39;, &#39;Sites&#39;, &#39;Report&#39;, &#39;1&#39;, &#39;Investigator&#39;, &#39;Sites&#39;, &#39;Report&#39;, &#39;2&#39;, &#39;Imaging&#39;, &#39;Week&#39;, &#39;joints&#39;, &#39;Job&#39;, &#39;recruiters&#39;, &#39;Kinase&#39;, &#39;Chemistry&#39;, &#39;KIN&#39;, &#39;West&#39;, &#39;Coast&#39;, &#39;Kinases&#39;, &#39;DOT&#39;, &#39;Knowledge&#39;, &#39;Management&#39;, &#39;chemokines&#39;, &#39;HIV&#39;, &#39;Kaposis&#39;, &#39;sarcoma&#39;, &#39;Kinetics&#39;, &#39;Structure&#39;, &#39;Relationship&#39;, &#39;laboratories&#39;, &#39;Lead&#39;, &#39;Acid&#39;, &#39;Batteries&#39;, &#39;Label&#39;, &#39;Free&#39;, &#39;Detection&#39;, &#39;Drug&#39;, &#39;Labeling&#39;, &#39;Live&#39;, &#39;Cell&#39;, &#39;Imaging&#39;, &#39;Laser&#39;, &#39;Capture&#39;, &#39;Microdissection&#39;, &#39;Lung&#39;, &#39;Cancer&#39;, &#39;ligase&#39;, &#39;chain&#39;, &#39;reaction&#39;, &#39;leukodepletion&#39;, &#39;Laboratory&#39;, &#39;Developed&#39;, &#39;Tests&#39;, &#39;leukemia&#39;, &#39;Ontologies/Lexicons&#39;, &#39;Legal&#39;, &#39;drug&#39;, &#39;liability&#39;, &#39;screening&#39;, &#39;libraries&#39;, &#39;Life&#39;, &#39;Sciences&#39;, &#39;Protein&#39;, &#39;Ligands&#39;, &#39;lab&#39;, &#39;information&#39;, &#39;management&#39;, &#39;systems&#39;, &#39;LIMS&#39;, &#39;Lipids&#39;, &#39;Large&#39;, &#39;Stationary&#39;, &#39;Batteries&#39;, &#39;Lyophilization&#39;, &#39;Mergers&#39;, &#39;&amp;&#39;, &#39;Acquisitions&#39;, &#39;Monoclonal&#39;, &#39;Antibodies&#39;, &#39;Forum&#39;, &#39;Monoclonal&#39;, &#39;Antibody&#39;, &#39;Process&#39;, &#39;Development&#39;, &#39;Malaria&#39;, &#39;Metabolism&#39;, &#39;Targeted&#39;, &#39;Cancer&#39;, &#39;Therapeutics&#39;, &#39;Microbiome&#39;, &#39;Immuno-Oncology&#39;, &#39;Microbiome&#39;, &#39;Metabolic&#39;, &#39;Syndrome&#39;, &#39;Medicinal&#39;, &#39;Chemistry&#39;, &#39;Part&#39;, &#39;2&#39;, &#39;Mucosal&#39;, &#39;Immunity&#39;, &#39;Microreactors&#39;, &#39;Macrocycles&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Business&#39;, &#39;Multidrug&#39;, &#39;Resistance&#39;, &#39;Cancer&#39;, &#39;Medical&#39;, &#39;Coding&#39;, &#39;multidrug&#39;, &#39;resistant&#39;, &#39;infections&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Non-Invasive&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Microdosing&#39;, &#39;microbial&#39;, &#39;infections&#39;, &#39;Sequencing&#39;, &#39;Based&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Forum&#39;, &#39;Molecular&#39;, &#39;Electronics&#39;, &#39;Metabolic&#39;, &#39;Engineering&#39;, &#39;Melanoma&#39;, &#39;BioMEMS&#39;, &#39;memory&#39;, &#39;enhancement&#39;, &#39;cancer&#39;, &#39;metastasis&#39;, &#39;molecular&#39;, &#39;evolution&#39;, &#39;Mammalian&#39;, &#39;Cell&#39;, &#39;Line&#39;, &#39;Development&#39;, &#39;microfabrication&#39;, &#39;Molecular&#39;, &#39;Genetic&#39;, &#39;Pro&#39;, &#39;Management&#39;, &#39;molecular&#39;, &#39;medicine&#39;, &#39;Novel&#39;, &#39;bioactive&#39;, &#39;high&#39;, &#39;throughput&#39;, &#39;screening&#39;, &#39;europe&#39;, &#39;Myocardial&#39;, &#39;Infarction&#39;, &#39;migraine&#39;, &#39;microtiter&#39;, &#39;plates&#39;, &#39;Molecular&#39;, &#39;Medicine&#39;, &#39;Europe&#39;, &#39;metalloproteinases&#39;, &#39;Molecular&#39;, &#39;Medicine&#39;, &#39;Asia&#39;, &#39;Managed&#39;, &#39;Care&#39;, &#39;Manufacturing&#39;, &#39;Clinical&#39;, &#39;Trial&#39;, &#39;Monitoring&#39;, &#39;Mechanism&#39;, &#39;Action&#39;, &#39;Purifying&#39;, &#39;Antibodies&#39;, &#39;Meeting&#39;, &#39;Planning&#39;, &#39;Services&#39;, &#39;Molecular&#39;, &#39;Pathology&#39;, &#39;Molecular&#39;, &#39;Pathology&#39;, &#39;Basic&#39;, &#39;Molecular&#39;, &#39;Pathology&#39;, &#39;Advanced&#39;, &#39;magnetic&#39;, &#39;resonance&#39;, &#39;imaging&#39;, &#39;Multi&#39;, &#39;Specific&#39;, &#39;Antibodies&#39;, &#39;Mass&#39;, &#39;Spectrometry&#39;, &#39;Protein&#39;, &#39;Biomarker&#39;, &#39;Discovery&#39;, &#39;Muscle&#39;, &#39;Mass&#39;, &#39;Spec&#39;, &#39;Informatics&#39;, &#39;Mass&#39;, &#39;Spec&#39;, &#39;Imaging&#39;, &#39;Modeling&#39;, &#39;Simulation&#39;, &#39;Mass&#39;, &#39;spectrometry&#39;, &#39;Mass&#39;, &#39;Spec&#39;, &#39;Diagnostics&#39;, &#39;Metabolic&#39;, &#39;Disorders&#39;, &#39;Mental&#39;, &#39;Health&#39;, &#39;Materials&#39;, &#39;Testing&#39;, &#39;cellular&#39;, &#39;matrix&#39;, &#39;Multiplexed&#39;, &#39;Assays&#39;, &#39;Moelcular&#39;, &#39;Diagnostics&#39;, &#39;Europe&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Cancer&#39;, &#39;Molecular&#39;, &#39;Diagnostics&#39;, &#39;Infectious&#39;, &#39;Disease&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Antibodies&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Antibodies&#39;, &#39;(&#39;, &#39;PGE&#39;, &#39;)&#39;, &#39;Nucleic&#39;, &#39;Acid&#39;, &#39;Europe&#39;, &#39;National&#39;, &#39;Academy&#39;, &#39;Sciences&#39;, &#39;meeting&#39;, &#39;natural&#39;, &#39;products&#39;, &#39;new&#39;, &#39;antivirals&#39;, &#39;Novel&#39;, &#39;Cancer&#39;, &#39;Informatics&#39;, &#39;Non-Coding&#39;, &#39;RNA&#39;, &#39;Novel&#39;, &#39;Strategies&#39;, &#39;Cancer&#39;, &#39;Novel&#39;, &#39;Cancer&#39;, &#39;Targets&#39;, &#39;Neurodegenerative&#39;, &#39;Nucleotide&#39;, &#39;Delivery&#39;, &#39;Internet&#39;, &#39;New&#39;, &#39;Database&#39;, &#39;comapny&#39;, &#39;names&#39;, &#39;Advances&#39;, &#39;Informatics&#39;, &#39;nerve&#39;, &#39;growth&#39;, &#39;factors&#39;, &#39;NF&#39;, &#39;KB&#39;, &#39;Nanofluidics&#39;, &#39;Informatics&#39;, &#39;Next-Generation&#39;, &#39;Batteries&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Batteries&#39;, &#39;Portable&#39;, &#39;Applications&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Batteries&#39;, &#39;Stationary&#39;, &#39;Power&#39;, &#39;Epigenetic&#39;, &#39;Sequencing&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Imaging&#39;, &#39;Neurogenomics&#39;, &#39;Nuclear&#39;, &#39;Hormone&#39;, &#39;Receptors&#39;, &#39;Novel&#39;, &#39;HIV&#39;, &#39;Strategies&#39;, &#39;Neurotech&#39;, &#39;Industry&#39;, &#39;neuroinjuries&#39;, &#39;NK&#39;, &#39;Cell&#39;, &#39;Based&#39;, &#39;Cancer&#39;, &#39;Immunotherapy&#39;, &#39;Natural&#39;, &#39;Language&#39;, &#39;Processing&#39;, &#39;nuclear&#39;, &#39;matrix&#39;, &#39;Nanomedicine&#39;, &#39;Nitric&#39;, &#39;Oxide&#39;, &#39;Network&#39;, &#39;Pharmacology&#39;, &#39;Energy&#39;, &#39;Neurotoxicity&#39;, &#39;New&#39;, &#39;Drug&#39;, &#39;Approval&#39;, &#39;US&#39;, &#39;nanotech&#39;, &#39;self&#39;, &#39;assembly&#39;, &#39;Internet&#39;, &#39;Supply&#39;, &#39;Chain&#39;, &#39;Internet&#39;, &#39;Supply&#39;, &#39;Chain&#39;, &#39;Europe&#39;, &#39;Neurostimulation&#39;, &#39;Internet&#39;, &#39;Diagnostic&#39;, &#39;Things&#39;, &#39;Internet&#39;, &#39;Energy&#39;, &#39;Internet&#39;, &#39;Energy&#39;, &#39;Europe&#39;, &#39;Internet&#39;, &#39;Things&#39;, &#39;Infrastructure&#39;, &#39;Internet&#39;, &#39;Health&#39;, &#39;Internet&#39;, &#39;Insurance&#39;, &#39;Internet&#39;, &#39;Insurance&#39;, &#39;Europe&#39;, &#39;Internet&#39;, &#39;Things&#39;, &#39;Manufacturing&#39;, &#39;Internet&#39;, &#39;Things&#39;, &#39;Manufacturing&#39;, &#39;Internet&#39;, &#39;Manufacturing&#39;, &#39;Europe&#39;, &#39;Smart&#39;, &#39;Buildings&#39;, &#39;Smart&#39;, &#39;Cities&#39;, &#39;Nephrotoxicity&#39;, &#39;Nuclear&#39;, &#39;Energy&#39;, &#39;nutrition&#39;, &#39;Optimizing&#39;, &#39;Media&#39;, &#39;organ&#39;, &#39;cell&#39;, &#39;transplants&#39;, &#39;Oncology&#39;, &#39;Drug&#39;, &#39;Targets&#39;, &#39;Optical&#39;, &#39;Diagnostics&#39;, &#39;Oncogenomics&#39;, &#39;Office&#39;, &#39;Inspector&#39;, &#39;General&#39;, &#39;Oil&#39;, &#39;Gas&#39;, &#39;oncogenes&#39;, &#39;Oncolytic&#39;, &#39;Viruses&#39;, &#39;Oligo&#39;, &#39;Production&#39;, &#39;opportunistic&#39;, &#39;infections&#39;, &#39;Oligo&#39;, &#39;Regulatory&#39;, &#39;organs&#39;, &#39;transplants&#39;, &#39;oral&#39;, &#39;drug&#39;, &#39;delivery&#39;, &#39;OSTEOARTHRITIS&#39;, &#39;OTC&#39;, &#39;counter&#39;, &#39;Additional&#39;, &#39;Conferences&#39;, &#39;clinical&#39;, &#39;trials&#39;, &#39;outsourcing&#39;, &#39;Oxygen&#39;, &#39;Radicals&#39;, &#39;oncogenes&#39;, &#39;p53&#39;, &#39;Predictive&#39;, &#39;ADME&#39;, &#39;protein&#39;, &#39;aggregation&#39;, &#39;Protein&#39;, &#39;Aggregation&#39;, &#39;(&#39;, &#39;PTK&#39;, &#39;)&#39;, &#39;Packaging&#39;, &#39;parasitic&#39;, &#39;infections&#39;, &#39;Process&#39;, &#39;Analytical&#39;, &#39;Technology&#39;, &#39;Pharmacy&#39;, &#39;Benefit&#39;, &#39;Management&#39;, &#39;Pharmaceutical&#39;, &#39;BioProcess&#39;, &#39;Basic&#39;, &#39;Research&#39;, &#39;&amp;&#39;, &#39;Discovery&#39;, &#39;track&#39;, &#39;PCG&#39;, &#39;Clinical&#39;, &#39;Operations&#39;, &#39;track&#39;, &#39;PCG&#39;, &#39;Preclinical&#39;, &#39;Development&#39;, &#39;track&#39;, &#39;PCG&#39;, &#39;Bridgehead&#39;, &#39;PCI&#39;, &#39;book&#39;, &#39;Preclinical&#39;, &#39;Preclinical&#39;, &#39;Preclinical&#39;, &#39;prostate&#39;, &#39;cancer&#39;, &#39;Preclinical&#39;, &#39;Outcome&#39;, &#39;Predictions&#39;, &#39;preclinical&#39;, &#39;trials&#39;, &#39;Point&#39;, &#39;Care&#39;, &#39;West&#39;, &#39;Protein&#39;, &#39;Crystallography&#39;, &#39;pediatric&#39;, &#39;AIDS/HIV&#39;, &#39;PDA&#39;, &#39;Downloads&#39;, &#39;CHI&#39;, &#39;website&#39;, &#39;Process&#39;, &#39;Development&#39;, &#39;Executives&#39;, &#39;platelet&#39;, &#39;derived&#39;, &#39;growth&#39;, &#39;factors&#39;, &#39;protein&#39;, &#39;drug&#39;, &#39;delivery&#39;, &#39;Preclinical&#39;, &#39;Disease&#39;, &#39;Models&#39;, &#39;photodynamic&#39;, &#39;therapies&#39;, &#39;Phage&#39;, &#39;Display&#39;, &#39;Vaccine&#39;, &#39;Development&#39;, &#39;Proteomic&#39;, &#39;Tools&#39;, &#39;Diagnostics&#39;, &#39;pediatric&#39;, &#39;Pediatric&#39;, &#39;trials&#39;, &#39;CRAS&#39;, &#39;PEGS&#39;, &#39;Virtual&#39;, &#39;Interactive&#39;, &#39;Global&#39;, &#39;Summit&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Monitoring&#39;, &#39;Protein&#39;, &#39;Executive&#39;, &#39;Summit&#39;, &#39;Proof&#39;, &#39;Concept&#39;, &#39;Cancer&#39;, &#39;Protein&#39;, &#39;Function&#39;, &#39;Enterprise&#39;, &#39;Portfolio&#39;, &#39;Management&#39;, &#39;Portfolio&#39;, &#39;Value&#39;, &#39;Protein&#39;, &#39;Aggregates&#39;, &#39;Light&#39;, &#39;Scattering&#39;, &#39;Consumer&#39;, &#39;Genomics/Personal&#39;, &#39;Genomics&#39;, &#39;Protein&#39;, &#39;Engineering&#39;, &#39;Partnering&#39;, &#39;Particulate&#39;, &#39;Screening&#39;, &#39;Phage&#39;, &#39;West&#39;, &#39;Phase&#39;, &#39;II/Reducing&#39;, &#39;Attrition&#39;, &#39;Phase&#39;, &#39;IV&#39;, &#39;Phase&#39;, &#39;IV&#39;, &#39;Pharmacies&#39;, &#39;Phage&#39;, &#39;Display&#39;, &#39;Europe&#39;, &#39;Pharmaceutical&#39;, &#39;Half&#39;, &#39;Life&#39;, &#39;Phase&#39;, &#39;Zero&#39;, &#39;PI3K&#39;, &#39;Phosphoinositide&#39;, &#39;3&#39;, &#39;Kinase&#39;, &#39;Protein&#39;, &#39;Identification&#39;, &#39;Preclinical&#39;, &#39;Imaging&#39;, &#39;protease&#39;, &#39;inhibitors&#39;, &#39;enzymes&#39;, &#39;PLA2&#39;, &#39;blood&#39;, &#39;platelets&#39;, &#39;Membrane&#39;, &#39;Proteins&#39;, &#39;Membrane&#39;, &#39;Protein&#39;, &#39;DOT&#39;, &#39;(&#39;, &#39;part&#39;, &#39;1&#39;, &#39;)&#39;, &#39;Membrane&#39;, &#39;Protein&#39;, &#39;DOT&#39;, &#39;(&#39;, &#39;part&#39;, &#39;2&#39;, &#39;)&#39;, &#39;Protein&#39;, &#39;Manufacturing&#39;, &#39;Clinical&#39;, &#39;Project&#39;, &#39;Management&#39;, &#39;:&#39;, &#39;Intermediate&#39;, &#39;Preventive&#39;, &#39;Medicine&#39;, &#39;Pancreatic&#39;, &#39;Cancer&#39;, &#39;Preclinical&#39;, &#39;Studies&#39;, &#39;IND&#39;, &#39;Protein&#39;, &#39;Computational&#39;, &#39;Tools&#39;, &#39;Prenatal&#39;, &#39;Therapeutics&#39;, &#39;Parenteral&#39;, &#39;Point&#39;, &#39;Care&#39;, &#39;Diagnostics&#39;, &#39;Europe&#39;, &#39;Cannabis&#39;, &#39;Power&#39;, &#39;Utilities&#39;, &#39;protein&#39;, &#39;characterization&#39;, &#39;protein&#39;, &#39;purification&#39;, &#39;Protein&#39;, &#39;Protein&#39;, &#39;Interactions&#39;, &#39;Protein&#39;, &#39;Protein&#39;, &#39;Interactions&#39;, &#39;Part&#39;, &#39;2&#39;, &#39;Process&#39;, &#39;Management&#39;, &#39;Protein&#39;, &#39;Process&#39;, &#39;PepTalk&#39;, &#39;Partnering&#39;, &#39;Personalized&#39;, &#39;Medicine&#39;, &#39;Partnering&#39;, &#39;Proteomics&#39;, &#39;Analytics&#39;, &#39;Predictive&#39;, &#39;Analytics&#39;, &#39;Pricing&#39;, &#39;Parkinsons&#39;, &#39;Predictive&#39;, &#39;Biomedicine&#39;, &#39;Proteins&#39;, &#39;,&#39;, &#39;Peptides&#39;, &#39;&amp;&#39;, &#39;Proteomics&#39;, &#39;Series&#39;, &#39;Protein&#39;, &#39;Quantification&#39;, &#39;Partnering&#39;, &#39;Data&#39;, &#39;Privacy&#39;, &#39;Personalized&#39;, &#39;Medicine&#39;, &#39;Asia&#39;, &#39;Product&#39;, &#39;Service&#39;, &#39;Announcement&#39;, &#39;Production&#39;, &#39;Scale&#39;, &#39;Up&#39;, &#39;Pharma&#39;, &#39;Services&#39;, &#39;News&#39;, &#39;schizophrenia&#39;, &#39;antipsychotics&#39;, &#39;Protein&#39;, &#39;Antibodies&#39;, &#39;Preclinical&#39;, &#39;Toxicology&#39;, &#39;Biologics&#39;, &#39;Protein&#39;, &#39;Technology&#39;, &#39;Engineering&#39;, &#39;Protein&#39;, &#39;Therapeutics&#39;, &#39;Delivery&#39;, &#39;Predictive&#39;, &#39;Toxicity&#39;, &#39;Europe&#39;, &#39;Platform&#39;, &#39;Software&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Studies&#39;, &#39;Phenotype&#39;, &#39;Genotype&#39;, &#39;Pathology&#39;, &#39;Protein&#39;, &#39;drugs&#39;, &#39;&amp;&#39;, &#39;diagnostics&#39;, &#39;Intellectual&#39;, &#39;Property&#39;, &#39;Post&#39;, &#39;Translational&#39;, &#39;Modifications&#39;, &#39;Patient&#39;, &#39;Registries&#39;, &#39;Advancing&#39;, &#39;Therapeutics&#39;, &#39;Current&#39;, &#39;Generation&#39;, &#39;Protein&#39;, &#39;Drug&#39;, &#39;Delivery&#39;, &#39;(&#39;, &#39;part&#39;, &#39;PepTalk&#39;, &#39;)&#39;, &#39;Advancing&#39;, &#39;Therapeutics&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Biological&#39;, &#39;Therapeutic&#39;, &#39;Products&#39;, &#39;Series&#39;, &#39;Pathway/Networks&#39;, &#39;Publications&#39;, &#39;Protein&#39;, &#39;Variations&#39;, &#39;Powertrains&#39;, &#39;Protein&#39;, &#39;Characterization&#39;, &#39;,&#39;, &#39;Purification&#39;, &#39;Screening&#39;, &#39;Protein&#39;, &#39;Characterization&#39;, &#39;,&#39;, &#39;Purification&#39;, &#39;Screening&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Europe&#39;, &#39;Beyond&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Europe&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Host&#39;, &#39;Novel&#39;, &#39;Protein&#39;, &#39;Expression&#39;, &#39;Systems&#39;, &#39;Protein&#39;, &#39;Engineering&#39;, &#39;Vectors&#39;, &#39;Preventive&#39;, &#39;gene&#39;, &#39;quantification&#39;, &#39;Europe&#39;, &#39;QS&#39;, &#39;Regulation&#39;, &#39;Recombinant&#39;, &#39;Antibodies&#39;, &#39;Recombinant&#39;, &#39;Antibodies&#39;, &#39;Recombinant&#39;, &#39;Proteins&#39;, &#39;Forum&#39;, &#39;Radiation&#39;, &#39;Rare&#39;, &#39;Diseases&#39;, &#39;Antibody&#39;, &#39;Drug&#39;, &#39;Products&#39;, &#39;RBE&#39;, &#39;track&#39;, &#39;PGE&#39;, &#39;RBE&#39;, &#39;track&#39;, &#39;PGE&#39;, &#39;Antibody&#39;, &#39;Screening&#39;, &#39;Antibody&#39;, &#39;Translational&#39;, &#39;rapid&#39;, &#39;compound&#39;, &#39;characterization&#39;, &#39;Clinical&#39;, &#39;Enrollment&#39;, &#39;Plan&#39;, &#39;Clinical&#39;, &#39;Recruitment&#39;, &#39;Media&#39;, &#39;Clinical&#39;, &#39;Trials&#39;, &#39;Patient&#39;, &#39;Recruitment&#39;, &#39;Winning&#39;, &#39;Strategies&#39;, &#39;Clinical&#39;, &#39;Recruitment&#39;, &#39;Media&#39;, &#39;Integrating&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Marketing&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;Productivity&#39;, &#39;drug&#39;, &#39;receptors&#39;, &#39;Role&#39;, &#39;Business&#39;, &#39;Process&#39;, &#39;Managment&#39;, &#39;FDA&#39;, &#39;Regulated&#39;, &#39;Industry&#39;, &#39;Worldwide&#39;, &#39;Pharma&#39;, &#39;Regulation&#39;, &#39;Surviving&#39;, &#39;FDA&#39;, &#39;Site&#39;, &#39;Inspections&#39;, &#39;Real&#39;, &#39;Estate&#39;, &#39;Risk&#39;, &#39;Evaluation&#39;, &#39;Mitigation&#39;, &#39;Strategies&#39;, &#39;Renal&#39;, &#39;(&#39;, &#39;kidney&#39;, &#39;)&#39;, &#39;Renewable&#39;, &#39;Energy&#39;, &#39;Storage&#39;, &#39;System&#39;, &#39;RFID&#39;, &#39;Radiofrequency&#39;, &#39;ID&#39;, &#39;Reagents&#39;, &#39;Gap&#39;, &#39;Analysis&#39;, &#39;rheumatoid&#39;, &#39;arthritis&#39;, &#39;gene&#39;, &#39;therapy&#39;, &#39;[&#39;, &#39;RNA&#39;, &#39;blocking&#39;, &#39;]&#39;, &#39;Ribonucleic&#39;, &#39;Acid&#39;, &#39;RNAi&#39;, &#39;Functional&#39;, &#39;Screening&#39;, &#39;RNAi&#39;, &#39;RNAInterference&#39;, &#39;RNAi&#39;, &#39;Discovery&#39;, &#39;Target&#39;, &#39;RNAi&#39;, &#39;Video&#39;, &#39;Request&#39;, &#39;RNA&#39;, &#39;Quality&#39;, &#39;RNA&#39;, &#39;Therapeutics&#39;, &#39;Robotics&#39;, &#39;Regional&#39;, &#39;Organization&#39;, &#39;Robotic&#39;, &#39;Process&#39;, &#39;Automation&#39;, &#39;reperfusion&#39;, &#39;Reproduction&#39;, &#39;Gene&#39;, &#39;Regulation&#39;, &#39;Regulatory&#39;, &#39;Networks&#39;, &#39;Restenosis&#39;, &#39;Retail&#39;, &#39;Real&#39;, &#39;World&#39;, &#39;Data&#39;, &#39;Therapeutics&#39;, &#39;Indications&#39;, &#39;&amp;&#39;, &#39;Drug&#39;, &#39;Targets&#39;, &#39;Series&#39;, &#39;safety&#39;, &#39;Screening&#39;, &#39;3D&#39;, &#39;Models&#39;, &#39;Sickle&#39;, &#39;Cell&#39;, &#39;Anemia&#39;, &#39;Screening&#39;, &#39;Informatics&#39;, &#39;Sequencing&#39;, &#39;Cloud&#39;, &#39;Computing&#39;, &#39;supply&#39;, &#39;chain&#39;, &#39;management&#39;, &#39;SCOPEs&#39;, &#39;Clinical&#39;, &#39;Research&#39;, &#39;Leadership&#39;, &#39;Forum&#39;, &#39;Phenotypic&#39;, &#39;Screening&#39;, &#39;Phenotypic&#39;, &#39;Screening&#39;, &#39;clinical&#39;, &#39;trials&#39;, &#39;strategy&#39;, &#39;IT&#39;, &#39;Security&#39;, &#39;Sequence&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Sequence&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Asia&#39;, &#39;Sidec&#39;, &#39;Executive&#39;, &#39;Forum&#39;, &#39;Sequence&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;Europe&#39;, &#39;Sleeper&#39;, &#39;Disease&#39;, &#39;Indications&#39;, &#39;Sequencing&#39;, &#39;Data&#39;, &#39;Storage&#39;, &#39;&amp;&#39;, &#39;Management&#39;, &#39;Screening&#39;, &#39;Difficult&#39;, &#39;Targets&#39;, &#39;Source&#39;, &#39;Document&#39;, &#39;Verification&#39;, &#39;Sequencing&#39;, &#39;Data&#39;, &#39;Analysis&#39;, &#39;&amp;&#39;, &#39;Storage&#39;, &#39;second&#39;, &#39;messengers&#39;, &#39;sepsis&#39;, &#39;infections&#39;, &#39;Sequencing&#39;, &#39;Forum&#39;, &#39;Serotonin&#39;, &#39;Sexual&#39;, &#39;Small&#39;, &#39;Fuel&#39;, &#39;Cells&#39;, &#39;selective&#39;, &#39;immune&#39;, &#39;suppression&#39;, &#39;skin&#39;, &#39;sleep&#39;, &#39;Pharmaceutical&#39;, &#39;Sales&#39;, &#39;Biologics&#39;, &#39;Small&#39;, &#39;Molecular&#39;, &#39;Comparisons&#39;, &#39;Semiconductors&#39;, &#39;small&#39;, &#39;molecules&#39;, &#39;simple&#39;, &#39;model&#39;, &#39;organisms&#39;, &#39;Small&#39;, &#39;Molecules&#39;, &#39;Synthesis&#39;, &#39;Semantic&#39;, &#39;Web&#39;, &#39;Sensor&#39;, &#39;Applications&#39;, &#39;Synthetic&#39;, &#39;Biology&#39;, &#39;Sensor&#39;, &#39;Data&#39;, &#39;Management&#39;, &#39;Implantable&#39;, &#39;Biomedical&#39;, &#39;Sensors&#39;, &#39;Sensor&#39;, &#39;Materials&#39;, &#39;Sensors&#39;, &#39;Emerging&#39;, &#39;Markets&#39;, &#39;SNPs&#39;, &#39;Sensor&#39;, &#39;Systems&#39;, &#39;Sensor&#39;, &#39;Safety&#39;, &#39;software&#39;, &#39;Solubility&#39;, &#39;Safety&#39;, &#39;Pharmacology&#39;, &#39;Biologics&#39;, &#39;Safety&#39;, &#39;Pharmacology&#39;, &#39;Biologics&#39;, &#39;Genomic&#39;, &#39;Sample&#39;, &#39;Preparation&#39;, &#39;Speciality&#39;, &#39;Pharmaceuticals&#39;, &#39;Alternative&#39;, &#39;Splicing&#39;, &#39;Proteomic&#39;, &#39;Sample&#39;, &#39;Preparation&#39;, &#39;High&#39;, &#39;throughput&#39;, &#39;screening&#39;, &#39;partnering&#39;, &#39;solid&#39;, &#39;phase&#39;, &#39;synthesis&#39;, &#39;Subjective&#39;, &#39;End&#39;, &#39;Points&#39;, &#39;Next&#39;, &#39;Generation&#39;, &#39;Sequencing&#39;, &#39;Applications&#39;, &#39;Sequencing&#39;, &#39;Core&#39;, &#39;Labs&#39;, &#39;Next-Generation&#39;, &#39;Data&#39;, &#39;Generation&#39;, &#39;Plant&#39;, &#39;Sequencing&#39;, &#39;RNA&#39;, &#39;Sequencing&#39;, &#39;Sequencing&#39;, &#39;Solutions&#39;, &#39;Deep&#39;, &#39;Sequencing&#39;, &#39;EU&#39;, &#39;Site&#39;, &#39;Selection&#39;, &#39;,&#39;, &#39;Study&#39;, &#39;Activation&#39;, &#39;,&#39;, &#39;Patient&#39;, &#39;Recruitment&#39;, &#39;Stability&#39;, &#39;stroke&#39;, &#39;Stem&#39;, &#39;Cell&#39;, &#39;Culture&#39;, &#39;Stem&#39;, &#39;Cell&#39;, &#39;Research&#39;, &#39;(&#39;, &#39;part&#39;, &#39;MMTC&#39;, &#39;)&#39;, &#39;Statin&#39;, &#39;Stem&#39;, &#39;Cells&#39;, &#39;Safety&#39;, &#39;Screening&#39;, &#39;Startup&#39;, &#39;Public&#39;, &#39;companies/stock&#39;, &#39;exchanges&#39;, &#39;CHI&#39;, &#39;Surveys&#39;, &#39;Services&#39;, &#39;Systems&#39;, &#39;Biology&#39;, &#39;BYG&#39;, &#39;track&#39;, &#39;synthesis&#39;, &#39;Systems&#39;, &#39;Biology&#39;, &#39;Training&#39;, &#39;&amp;&#39;, &#39;Development&#39;, &#39;Top&#39;, &#39;50&#39;, &#39;Big&#39;, &#39;Pharmas&#39;, &#39;Tissue&#39;, &#39;Microarrays&#39;, &#39;taxol&#39;, &#39;tamoxifen&#39;, &#39;derivatives&#39;, &#39;Tuberculosis&#39;, &#39;Tobacco&#39;, &#39;The&#39;, &#39;Biotech&#39;, &#39;Journal&#39;, &#39;Email&#39;, &#39;List&#39;, &#39;Trust&#39;, &#39;Building&#39;, &#39;Collaborative&#39;, &#39;Innovation&#39;, &#39;Tumor&#39;, &#39;,&#39;, &#39;Circulating&#39;, &#39;Cells&#39;, &#39;Technology&#39;, &#39;Technology&#39;, &#39;Consortium&#39;, &#39;Target&#39;, &#39;Driven&#39;, &#39;Chemistry&#39;, &#39;targeted&#39;, &#39;drug&#39;, &#39;delivery&#39;, &#39;transgenic&#39;, &#39;disease&#39;, &#39;models&#39;, &#39;Thrombotic&#39;, &#39;Disease&#39;, &#39;tissue&#39;, &#39;engineering&#39;, &#39;telomerases&#39;, &#39;Battery&#39;, &#39;Testing&#39;, &#39;Transfection&#39;, &#39;Toxicogenomics&#39;, &#39;Target&#39;, &#39;Prioritization&#39;, &#39;Target&#39;, &#39;Identification&#39;, &#39;tissues&#39;, &#39;Technology&#39;, &#39;Platforms&#39;, &#39;Immunotherapies&#39;, &#39;Telecommunications&#39;, &#39;Telemedicine&#39;, &#39;Tumor&#39;, &#39;Microenvironment&#39;, &#39;Trial&#39;, &#39;Master&#39;, &#39;File&#39;, &#39;Sponsors&#39;, &#39;(&#39;, &#39;pharma&#39;, &#39;)&#39;, &#39;Trial&#39;, &#39;Master&#39;, &#39;File&#39;, &#39;Research&#39;, &#39;Sites&#39;, &#39;Theranostic&#39;, &#39;Market&#39;, &#39;Models&#39;, &#39;tumor&#39;, &#39;necrosis&#39;, &#39;factors&#39;, &#39;Therapeutics&#39;, &#39;Targets&#39;, &#39;Therapeutics&#39;, &#39;&amp;&#39;, &#39;Targets&#39;, &#39;Series&#39;, &#39;immune&#39;, &#39;tolerance&#39;, &#39;Fibrinolytic&#39;, &#39;(&#39;, &#39;clot&#39;, &#39;buster&#39;, &#39;)&#39;, &#39;Transgenic&#39;, &#39;Production&#39;, &#39;Plants&#39;, &#39;Synthetic&#39;, &#39;Biology&#39;, &#39;Transportation&#39;, &#39;Translational&#39;, &#39;Biomarkers&#39;, &#39;Translational&#39;, &#39;Informatics&#39;, &#39;Drug/Disease&#39;, &#39;Targets&#39;, &#39;Drug&#39;, &#39;Targets&#39;, &#39;Series&#39;, &#39;Genome&#39;, &#39;Tri&#39;, &#39;Conference&#39;, &#39;Translation&#39;, &#39;Services&#39;, &#39;transgenics&#39;, &#39;gene&#39;, &#39;knockouts&#39;, &#39;transgenic&#39;, &#39;production&#39;, &#39;Tumor&#39;, &#39;Suppressor&#39;, &#39;Genes&#39;, &#39;tissue&#39;, &#39;safety&#39;, &#39;Technology&#39;, &#39;&amp;&#39;, &#39;Tools&#39;, &#39;Life&#39;, &#39;Sciences&#39;, &#39;Technology&#39;, &#39;&amp;&#39;, &#39;Tools&#39;, &#39;Life&#39;, &#39;Sciences&#39;, &#39;Series&#39;, &#39;Target&#39;, &#39;Validation&#39;, &#39;Text&#39;, &#39;Mining&#39;, &#39;Unmanned&#39;, &#39;Aerial&#39;, &#39;Vehicles&#39;, &#39;Ubiquitin&#39;, &#39;Uninterruptible&#39;, &#39;Power&#39;, &#39;Supplies&#39;, &#39;upcoming&#39;, &#39;conferences&#39;, &#39;upcoming&#39;, &#39;conferences&#39;, &#39;Europe&#39;, &#39;Urinary&#39;, &#39;Incontinence&#39;, &#39;New&#39;, &#39;USP&#39;, &#39;Initiatives&#39;, &#39;Standards&#39;, &#39;Biologics&#39;, &#39;unstable&#39;, &#39;triplets&#39;, &#39;trinucleotide&#39;, &#39;repeats&#39;, &#39;Vaccines&#39;, &#39;(&#39;, &#39;IMT&#39;, &#39;)&#39;, &#39;Vascular&#39;, &#39;Vaccines&#39;, &#39;Business&#39;, &#39;Opportunities&#39;, &#39;Venture&#39;, &#39;Capital&#39;, &#39;Business&#39;, &#39;Opportunities&#39;, &#39;Vaccines&#39;, &#39;Voice&#39;, &#39;Recognition&#39;, &#39;Paperless&#39;, &#39;Validation&#39;, &#39;veterinary&#39;, &#39;viral&#39;, &#39;infections&#39;, &#39;Vaccines&#39;, &#39;Production&#39;, &#39;&amp;&#39;, &#39;Manufacturing&#39;, &#39;Virtual&#39;, &#39;Reality&#39;, &#39;virtual&#39;, &#39;business&#39;, &#39;Virtual&#39;, &#39;Teams&#39;, &#39;Single&#39;, &#39;Use&#39;, &#39;Systems&#39;, &#39;Vaccine&#39;, &#39;Manufacture&#39;, &#39;well&#39;, &#39;characterized&#39;, &#39;biologicals&#39;, &#39;Wellness&#39;, &#39;Wiki&#39;, &#39;wound&#39;, &#39;management&#39;, &#39;Wireless&#39;, &#39;Change&#39;, &#39;Record&#39;, &#39;Change&#39;, &#39;Record&#39;, &#39;Mary&#39;, &#39;Chitty&#39;, &#39;Xenotransplantation&#39;, &#39;Yeast&#39;, &#39;Display&#39;, &#39;Zika&#39;, &#39;Vaccine&#39;, &#39;Development&#39;]
Stemmed Sentence: [&#39;molecular&#39;, &#39;medicin&#39;, &#39;tri&#39;, &#39;confer&#39;, &#39;protein&#39;, &#39;engin&#39;, &#39;peptalk&#39;, &#39;biocomput&#39;, &#39;scope&#39;, &#39;summit&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;oper&#39;, &#39;execut&#39;, &#39;bioproduct&#39;, &#39;discoveri&#39;, &#39;target&#39;, &#39;peg&#39;, &#39;europ&#39;, &#39;drug&#39;, &#39;discoveri&#39;, &#39;chemistri&#39;, &#39;world&#39;, &#39;pharmaceut&#39;, &#39;congress&#39;, &#39;advanc&#39;, &#39;diagnost&#39;, &#39;advanc&#39;, &#39;automot&#39;, &#39;batteri&#39;, &#39;confer&#39;, &#39;(&#39;, &#39;aabc&#39;, &#39;)&#39;, &#39;europ&#39;, &#39;florida&#39;, &#39;batteri&#39;, &#39;confer&#39;, &#39;biomark&#39;, &#39;congress&#39;, &#39;high&#39;, &#39;content&#39;, &#39;analysi&#39;, &#39;advanc&#39;, &#39;automot&#39;, &#39;batteri&#39;, &#39;confer&#39;, &#39;(&#39;, &#39;aabc&#39;, &#39;)&#39;, &#39;immunogen&#39;, &#39;cra&#39;, &#39;&amp;&#39;, &#39;crc&#39;, &#39;beginn&#39;, &#39;biopharmaceut&#39;, &#39;chang&#39;, &#39;control&#39;, &#39;beyond&#39;, &#39;genom&#39;, &#39;immunotherapi&#39;, &#39;allianc&#39;, &#39;manag&#39;, &#39;strategi&#39;, &#39;target&#39;, &#39;imvac&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;molecular&#39;, &#39;medicin&#39;, &#39;marketplac&#39;, &#39;molecular&#39;, &#39;diagnost&#39;, &#39;europ&#39;, &#39;cra&#39;, &#39;beginn&#39;, &#39;AI&#39;, &#39;world&#39;, &#39;data&#39;, &#39;driven&#39;, &#39;discoveri&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;strategi&#39;, &#39;strateg&#39;, &#39;resourc&#39;, &#39;alloc&#39;, &#39;kinas&#39;, &#39;audit&#39;, &#39;clinic&#39;, &#39;research&#39;, &#39;studi&#39;, &#39;acceler&#39;, &#39;develop&#39;, &#39;&amp;&#39;, &#39;advanc&#39;, &#39;person&#39;, &#39;therapi&#39;, &#39;X&#39;, &#39;gen&#39;, &#39;congress&#39;, &#39;biodefens&#39;, &#39;&amp;&#39;, &#39;enabl&#39;, &#39;poc&#39;, &#39;diagnost&#39;, &#39;&amp;&#39;, &#39;microarray&#39;, &#39;data&#39;, &#39;analysi&#39;, &#39;human&#39;, &#39;genom&#39;, &#39;project&#39;, &#39;biobank&#39;, &#39;structur&#39;, &#39;base&#39;, &#39;design&#39;, &#39;batteri&#39;, &#39;portfolio&#39;, &#39;quantit&#39;, &#39;pcr&#39;, &#39;health&#39;, &#39;inform&#39;, &#39;technolog&#39;, &#39;audit&#39;, &#39;techniqu&#39;, &#39;clinic&#39;, &#39;research&#39;, &#39;profession&#39;, &#39;good&#39;, &#39;clinic&#39;, &#39;practic&#39;, &#39;question&#39;, &#39;&amp;&#39;, &#39;answer&#39;, &#39;refer&#39;, &#39;guid&#39;, &#39;cfr/ich&#39;, &#39;gcp&#39;, &#39;immunotherapi&#39;, &#39;europ&#39;, &#39;gene&#39;, &#39;amplif&#39;, &#39;pcr&#39;, &#39;estat&#39;, &#39;:&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;statist&#39;, &#39;sourcebook&#39;, &#39;microrna&#39;, &#39;microarray&#39;, &#39;data&#39;, &#39;analysi&#39;, &#39;intelliig&#39;, &#39;drug&#39;, &#39;discoveri&#39;, &#39;&amp;&#39;, &#39;develop&#39;, &#39;(&#39;, &#39;wpc&#39;, &#39;)&#39;, &#39;monitor&#39;, &#39;clinic&#39;, &#39;drug&#39;, &#39;studi&#39;, &#39;:&#39;, &#39;beginn&#39;, &#39;comprehens&#39;, &#39;monitor&#39;, &#39;medic&#39;, &#39;devic&#39;, &#39;introduct&#39;, &#39;clinic&#39;, &#39;project&#39;, &#39;manag&#39;, &#39;bioprocess&#39;, &#39;summit&#39;, &#39;europ&#39;, &#39;oligonucleotid&#39;, &#39;&amp;&#39;, &#39;peptid&#39;, &#39;summit&#39;, &#39;world&#39;, &#39;pharma&#39;, &#39;week&#39;, &#39;prenat&#39;, &#39;diagnost&#39;, &#39;get&#39;, &#39;optim&#39;, &#39;target&#39;, &#39;librari&#39;, &#39;design&#39;, &#39;&amp;&#39;, &#39;synthesi&#39;, &#39;clinic&#39;, &#39;project&#39;, &#39;manag&#39;, &#39;function&#39;, &#39;genom&#39;, &#39;bacteri&#39;, &#39;infect&#39;, &#39;advanc&#39;, &#39;automot&#39;, &#39;batteri&#39;, &#39;confer&#39;, &#39;(&#39;, &#39;aabc&#39;, &#39;)&#39;, &#39;asia&#39;, &#39;good&#39;, &#39;clinic&#39;, &#39;practic&#39;, &#39;Q&#39;, &#39;&amp;&#39;, &#39;A&#39;, &#39;refer&#39;, &#39;guid&#39;, &#39;screen&#39;, &#39;transmiss&#39;, &#39;spongiform&#39;, &#39;encephalopathi&#39;, &#39;tse&#39;, &#39;biomark&#39;, &#39;discoveri&#39;, &#39;summit&#39;, &#39;clinic&#39;, &#39;genom&#39;, &#39;sequenc&#39;, &#39;asap&#39;, &#39;allianc&#39;, &#39;summit&#39;, &#39;bioterror&#39;, &#39;microarray&#39;, &#39;pharmaceut&#39;, &#39;leadership&#39;, &#39;summit&#39;, &#39;circul&#39;, &#39;cell-fre&#39;, &#39;dna&#39;, &#39;conduct&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;under&#39;, &#39;ich&#39;, &#39;gcp&#39;, &#39;bio&#39;, &#39;IT&#39;, &#39;europ&#39;, &#39;trial&#39;, &#39;master&#39;, &#39;file&#39;, &#39;biomark&#39;, &#39;world&#39;, &#39;preclin&#39;, &#39;congress&#39;, &#39;europ&#39;, &#39;biomem&#39;, &#39;bioinformat&#39;, &#39;genom&#39;, &#39;partner&#39;, &#39;nmr&#39;, &#39;nuclear&#39;, &#39;magnet&#39;, &#39;reson&#39;, &#39;clinic&#39;, &#39;data&#39;, &#39;manag&#39;, &#39;biomark&#39;, &#39;valid&#39;, &#39;proteom&#39;, &#39;statist&#39;, &#39;sensor&#39;, &#39;global&#39;, &#39;summit&#39;, &#39;new&#39;, &#39;drug&#39;, &#39;develop&#39;, &#39;A&#39;, &#39;regulatori&#39;, &#39;overview&#39;, &#39;drug&#39;, &#39;safeti&#39;, &#39;pharmaci&#39;, &#39;diagnost&#39;, &#39;sampl&#39;, &#39;prepar&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;design&#39;, &#39;pharmacovigil&#39;, &#39;metabol&#39;, &#39;profil&#39;, &#39;digit&#39;, &#39;pcr&#39;, &#39;good&#39;, &#39;clinic&#39;, &#39;practic&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;lab&#39;, &#39;chip&#39;, &#39;europ&#39;, &#39;monitor&#39;, &#39;clinic&#39;, &#39;drug&#39;, &#39;studi&#39;, &#39;:&#39;, &#39;intermedi&#39;, &#39;prepar&#39;, &#39;ind&#39;, &#39;submiss&#39;, &#39;antibodi&#39;, &#39;engin&#39;, &#39;asia&#39;, &#39;clinic&#39;, &#39;project&#39;, &#39;manag&#39;, &#39;:&#39;, &#39;intermedi&#39;, &#39;phage&#39;, &#39;display&#39;, &#39;cellut&#39;, &#39;recombin&#39;, &#39;antibodi&#39;, &#39;imag&#39;, &#39;biomark&#39;, &#39;assay&#39;, &#39;develop&#39;, &#39;silico&#39;, &#39;biolog&#39;, &#39;advanc&#39;, &#39;good&#39;, &#39;clinic&#39;, &#39;practic&#39;, &#39;high&#39;, &#39;throughput&#39;, &#39;optim&#39;, &#39;cultur&#39;, &#39;condit&#39;, &#39;bioprocess&#39;, &#39;high&#39;, &#39;throughput&#39;, &#39;technolog&#39;, &#39;gene&#39;, &#39;quantfic&#39;, &#39;[&#39;, &#39;real&#39;, &#39;time&#39;, &#39;pcr&#39;, &#39;]&#39;, &#39;from&#39;, &#39;gene&#39;, &#39;express&#39;, &#39;profil&#39;, &#39;valid&#39;, &#39;biolog&#39;, &#39;clinic&#39;, &#39;project&#39;, &#39;manag&#39;, &#39;:&#39;, &#39;advanc&#39;, &#39;scope&#39;, &#39;summit&#39;, &#39;europ&#39;, &#39;cn&#39;, &#39;partner&#39;, &#39;genom&#39;, &#39;target&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;statist&#39;, &#39;sourcebook&#39;, &#39;multius&#39;, &#39;licens&#39;, &#39;medic&#39;, &#39;devic&#39;, &#39;develop&#39;, &#39;biolog&#39;, &#39;adm&#39;, &#39;protein&#39;, &#39;express&#39;, &#39;blood&#39;, &#39;safeti&#39;, &#39;screen&#39;, &#39;human&#39;, &#39;proteom&#39;, &#39;project&#39;, &#39;project&#39;, &#39;manag&#39;, &#39;high&#39;, &#39;throughput&#39;, &#39;organ&#39;, &#39;synthesi&#39;, &#39;global&#39;, &#39;preclin&#39;, &#39;develop&#39;, &#39;clinic&#39;, &#39;research&#39;, &#39;coordin&#39;, &#39;global&#39;, &#39;drug&#39;, &#39;develop&#39;, &#39;india&#39;, &#39;biomark&#39;, &#39;diagnost&#39;, &#39;molecular&#39;, &#39;divers&#39;, &#39;function&#39;, &#39;genom&#39;, &#39;process&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;summit&#39;, &#39;cloud&#39;, &#39;comput&#39;, &#39;bioinformat&#39;, &#39;europ&#39;, &#39;target&#39;, &#39;valid&#39;, &#39;bispecif&#39;, &#39;antibodi&#39;, &#39;bridg&#39;, &#39;pharma&#39;, &#39;IT&#39;, &#39;green&#39;, &#39;fluoresc&#39;, &#39;protein&#39;, &#39;qualiti&#39;, &#39;system&#39;, &#39;cra&#39;, &#39;monitor&#39;, &#39;drug&#39;, &#39;discoveri&#39;, &#39;&amp;&#39;, &#39;develop&#39;, &#39;AI&#39;, &#39;govern&#39;, &#39;glycotechnolog&#39;, &#39;baculoviru&#39;, &#39;drug&#39;, &#39;repurpos&#39;, &#39;drug&#39;, &#39;discoveri&#39;, &#39;develop&#39;, &#39;japan&#39;, &#39;the&#39;, &#39;cra&#39;, &#39;manag&#39;, &#39;cours&#39;, &#39;state&#39;, &#39;state&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;requir&#39;, &#39;refer&#39;, &#39;guid&#39;, &#39;advers&#39;, &#39;event&#39;, &#39;:&#39;, &#39;manag&#39;, &#39;&amp;&#39;, &#39;report&#39;, &#39;medic&#39;, &#39;devic&#39;, &#39;good&#39;, &#39;laboratori&#39;, &#39;practic&#39;, &#39;process&#39;, &#39;chemistri&#39;, &#39;beyond&#39;, &#39;sequenc&#39;, &#39;process&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;summit&#39;, &#39;glp&#39;, &#39;batteri&#39;, &#39;biomark&#39;, &#39;europ&#39;, &#39;IT&#39;, &#39;infrastructur&#39;, &#39;comput&#39;, &#39;hardwar&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;patient&#39;, &#39;recruit&#39;, &#39;work&#39;, &#39;cro&#39;, &#39;expedit&#39;, &#39;drug&#39;, &#39;biolog&#39;, &#39;develop&#39;, &#39;tissu&#39;, &#39;sealant&#39;, &#39;-&#39;, &#39;one&#39;, &#39;day&#39;, &#39;protein&#39;, &#39;express&#39;, &#39;europ&#39;, &#39;use&#39;, &#39;note&#39;, &#39;file&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;essenti&#39;, &#39;document&#39;, &#39;antibodi&#39;, &#39;engin&#39;, &#39;korea&#39;, &#39;rnai&#39;, &#39;pathway&#39;, &#39;analysi&#39;, &#39;advanc&#39;, &#39;gcp&#39;, &#39;complianc&#39;, &#39;mechan&#39;, &#39;cancer&#39;, &#39;busi&#39;, &#39;diagnost&#39;, &#39;(&#39;, &#39;impact&#39;, &#39;new&#39;, &#39;diagnot&#39;, &#39;)&#39;, &#39;consum&#39;, &#39;genom&#39;, &#39;confer&#39;, &#39;recombin&#39;, &#39;antibodi&#39;, &#39;europ&#39;, &#39;research&#39;, &#39;site&#39;, &#39;clinic&#39;, &#39;studi&#39;, &#39;budget&#39;, &#39;contract&#39;, &#39;proof&#39;, &#39;concept&#39;, &#39;drug&#39;, &#39;develop&#39;, &#39;china&#39;, &#39;futur&#39;, &#39;diagnost&#39;, &#39;medicin&#39;, &#39;chemistri&#39;, &#39;combin&#39;, &#39;therapi&#39;, &#39;cra&#39;, &#39;train&#39;, &#39;seri&#39;, &#39;(&#39;, &#39;1-7&#39;, &#39;)&#39;, &#39;lab&#39;, &#39;chip&#39;, &#39;japan&#39;, &#39;human&#39;, &#39;genom&#39;, &#39;europ&#39;, &#39;tissu&#39;, &#39;base&#39;, &#39;screen&#39;, &#39;lead&#39;, &#39;optim&#39;, &#39;advers&#39;, &#39;event&#39;, &#39;reimburs&#39;, &#39;diagnost&#39;, &#39;label&#39;, &#39;signal&#39;, &#39;detect&#39;, &#39;asap&#39;, &#39;chi&#39;, &#39;bio&#39;, &#39;pharm&#39;, &#39;allianc&#39;, &#39;summit&#39;, &#39;forens&#39;, &#39;diagnost&#39;, &#39;write&#39;, &#39;clinic&#39;, &#39;research&#39;, &#39;molecular&#39;, &#39;profil&#39;, &#39;cellular&#39;, &#39;resolut&#39;, &#39;10&#39;, &#39;rule&#39;, &#39;effect&#39;, &#39;report&#39;, &#39;write&#39;, &#39;pharmacogenom&#39;, &#39;europ&#39;, &#39;explor&#39;, &#39;next&#39;, &#39;gener&#39;, &#39;sequenc&#39;, &#39;confer&#39;, &#39;drug&#39;, &#39;develop&#39;, &#39;&amp;&#39;, &#39;fda&#39;, &#39;regul&#39;, &#39;hca&#39;, &#39;east&#39;, &#39;cancer&#39;, &#39;immunotherapi&#39;, &#39;(&#39;, &#39;formerli&#39;, &#39;cancer&#39;, &#39;vaccin&#39;, &#39;)&#39;, &#39;biolog&#39;, &#39;develop&#39;, &#39;A&#39;, &#39;regulatori&#39;, &#39;overview&#39;, &#39;standard&#39;, &#39;oper&#39;, &#39;proce&#39;, &#39;clinic&#39;, &#39;research&#39;, &#39;molecular&#39;, &#39;pharmacolog&#39;, &#39;rna&#39;, &#39;interfer&#39;, &#39;summit&#39;, &#39;clinic&#39;, &#39;train&#39;, &#39;oligonucleotid&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;protocol&#39;, &#39;toxicolog&#39;, &#39;immunogen&#39;, &#39;test&#39;, &#39;biolog&#39;, &#39;adapt&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;adm&#39;, &#39;stem&#39;, &#39;cell&#39;, &#39;drug&#39;, &#39;discoveri&#39;, &#39;develop&#39;, &#39;drug&#39;, &#39;pipelin&#39;, &#39;success&#39;, &#39;(&#39;, &#39;pipelin&#39;, &#39;success&#39;, &#39;summit&#39;, &#39;)&#39;, &#39;stem&#39;, &#39;cell&#39;, &#39;data&#39;, &#39;visual&#39;, &#39;pharmacokinet&#39;, &#39;transgen&#39;, &#39;anim&#39;, &#39;model&#39;, &#39;busi&#39;, &#39;develop&#39;, &#39;allianc&#39;, &#39;manag&#39;, &#39;interfac&#39;, &#39;monitor&#39;, &#39;clinic&#39;, &#39;drug&#39;, &#39;studi&#39;, &#39;:&#39;, &#39;advanc&#39;, &#39;digit&#39;, &#39;health&#39;, &#39;innov&#39;, &#39;summit&#39;, &#39;data&#39;, &#39;manag&#39;, &#39;electron&#39;, &#39;data&#39;, &#39;captur&#39;, &#39;arena&#39;, &#39;case&#39;, &#39;report&#39;, &#39;form&#39;, &#39;batteri&#39;, &#39;safeti&#39;, &#39;medic&#39;, &#39;devic&#39;, &#39;gcp&#39;, &#39;overview&#39;, &#39;clinic&#39;, &#39;administr&#39;, &#39;support&#39;, &#39;staff&#39;, &#39;allianc&#39;, &#39;manag&#39;, &#39;&amp;&#39;, &#39;project&#39;, &#39;manag&#39;, &#39;pre-implant&#39;, &#39;diagnost&#39;, &#39;eyesight&#39;, &#39;biomark&#39;, &#39;diagnost&#39;, &#39;biomark&#39;, &#39;web&#39;, &#39;symposia&#39;, &#39;drug&#39;, &#39;approv&#39;, &#39;process&#39;, &#39;neglect&#39;, &#39;diseas&#39;, &#39;molecular&#39;, &#39;diagnost&#39;, &#39;medic&#39;, &#39;devic&#39;, &#39;approv&#39;, &#39;process&#39;, &#39;code&#39;, &#39;feder&#39;, &#39;regul&#39;, &#39;medic&#39;, &#39;devic&#39;, &#39;clinic&#39;, &#39;research&#39;, &#39;associ&#39;, &#39;G&#39;, &#39;protein&#39;, &#39;coupl&#39;, &#39;receptor&#39;, &#39;gpcr&#39;, &#39;prenat&#39;, &#39;diagnost&#39;, &#39;europ&#39;, &#39;genom&#39;, &#39;tool&#39;, &#39;&amp;&#39;, &#39;technolog&#39;, &#39;biomark&#39;, &#39;europ&#39;, &#39;symyx&#39;, &#39;busi&#39;, &#39;collabor&#39;, &#39;innov&#39;, &#39;sourc&#39;, &#39;document&#39;, &#39;mitochondria&#39;, &#39;compar&#39;, &#39;genom&#39;, &#39;hybrid&#39;, &#39;lithium&#39;, &#39;batteri&#39;, &#39;power&#39;, &#39;write&#39;, &#39;clinic&#39;, &#39;studi&#39;, &#39;protocol&#39;, &#39;reimburs&#39;, &#39;therapeut&#39;, &#39;genet&#39;, &#39;variat&#39;, &#39;busi&#39;, &#39;investig&#39;, &#39;initi&#39;, &#39;trial&#39;, &#39;burril&#39;, &#39;book&#39;, &#39;bio-it&#39;, &#39;asia&#39;, &#39;compound&#39;, &#39;profil&#39;, &#39;cancer&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;chemic&#39;, &#39;genom&#39;, &#39;safety/tox&#39;, &#39;biomark&#39;, &#39;cancer&#39;, &#39;diagnosi&#39;, &#39;antibodi&#39;, &#39;engin&#39;, &#39;drug&#39;, &#39;develop&#39;, &#39;asia&#39;, &#39;west&#39;, &#39;coast&#39;, &#39;virtual&#39;, &#39;screen&#39;, &#39;point&#39;, &#39;care&#39;, &#39;diagnost&#39;, &#39;protein&#39;, &#39;formul&#39;, &#39;genet&#39;, &#39;diagnost&#39;, &#39;bridg&#39;, &#39;discoveri&#39;, &#39;&amp;&#39;, &#39;IT&#39;, &#39;biofuel&#39;, &#39;translat&#39;, &#39;medicin&#39;, &#39;person&#39;, &#39;medicin&#39;, &#39;clinic&#39;, &#39;research&#39;, &#39;organ&#39;, &#39;allianc&#39;, &#39;manag&#39;, &#39;congress&#39;, &#39;europ&#39;, &#39;new&#39;, &#39;drug&#39;, &#39;approv&#39;, &#39;risk&#39;, &#39;base&#39;, &#39;site&#39;, &#39;monitor&#39;, &#39;root&#39;, &#39;caus&#39;, &#39;analysi&#39;, &#39;monitor&#39;, &#39;phase&#39;, &#39;I&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;drug&#39;, &#39;develop&#39;, &#39;latin&#39;, &#39;america&#39;, &#39;licens&#39;, &#39;vaccin&#39;, &#39;cancer&#39;, &#39;genet&#39;, &#39;genom&#39;, &#39;market&#39;, &#39;reimburs&#39;, &#39;metabol&#39;, &#39;analyt&#39;, &#39;method&#39;, &#39;difficult&#39;, &#39;clinic&#39;, &#39;research&#39;, &#39;site&#39;, &#39;protein&#39;, &#39;chips/array&#39;, &#39;monitor&#39;, &#39;plan&#39;, &#39;develop&#39;, &#39;genom&#39;, &#39;japan&#39;, &#39;immunogen&#39;, &#39;advanc&#39;, &#39;manag&#39;, &#39;reduct&#39;, &#39;clinic&#39;, &#39;audit&#39;, &#39;clinic&#39;, &#39;informat&#39;, &#39;antibody-drug&#39;, &#39;conjug&#39;, &#39;electron&#39;, &#39;medic&#39;, &#39;record&#39;, &#39;&amp;&#39;, &#39;sourc&#39;, &#39;document&#39;, &#39;verif&#39;, &#39;bridg&#39;, &#39;pop&#39;, &#39;health&#39;, &#39;east&#39;, &#39;inform&#39;, &#39;consent&#39;, &#39;pharma&#39;, &#39;futur&#39;, &#39;microarray&#39;, &#39;data&#39;, &#39;analysi&#39;, &#39;europ&#39;, &#39;clinic&#39;, &#39;investig&#39;, &#39;site&#39;, &#39;inspect&#39;, &#39;global&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;protocol&#39;, &#39;deviat&#39;, &#39;immunotherapi&#39;, &#39;west&#39;, &#39;cancer&#39;, &#39;therapi&#39;, &#39;recogn&#39;, &#39;attrit&#39;, &#39;earlier&#39;, &#39;electron&#39;, &#39;data&#39;, &#39;captur&#39;, &#39;clinic&#39;, &#39;imag&#39;, &#39;physic&#39;, &#39;chemistri&#39;, &#39;toll&#39;, &#39;like&#39;, &#39;receptor&#39;, &#39;monoclon&#39;, &#39;antibodi&#39;, &#39;innat&#39;, &#39;immun&#39;, &#39;high&#39;, &#39;content&#39;, &#39;analysi&#39;, &#39;europ&#39;, &#39;negoti&#39;, &#39;skill&#39;, &#39;clinic&#39;, &#39;research&#39;, &#39;profession&#39;, &#39;biotech&#39;, &#39;execut&#39;, &#39;forum&#39;, &#39;cnp&#39;, &#39;partner&#39;, &#39;europ&#39;, &#39;nanotechnolog&#39;, &#39;risk&#39;, &#39;manag&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;medic&#39;, &#39;devic&#39;, &#39;advers&#39;, &#39;event&#39;, &#39;monitor&#39;, &#39;cra&#39;, &#39;vendor&#39;, &#39;manag&#39;, &#39;report&#39;, &#39;write&#39;, &#39;cra&#39;, &#39;symyx&#39;, &#39;europ&#39;, &#39;epigenet&#39;, &#39;regulatori&#39;, &#39;complianc&#39;, &#39;gcp&#39;, &#39;train&#39;, &#39;investig&#39;, &#39;recist&#39;, &#39;1.0&#39;, &#39;1.1&#39;, &#39;pharmacovigil&#39;, &#39;audit&#39;, &#39;microfluid&#39;, &#39;yeast&#39;, &#39;model&#39;, &#39;organ&#39;, &#39;market&#39;, &#39;target&#39;, &#39;&amp;&#39;, &#39;compound&#39;, &#39;critic&#39;, &#39;decis&#39;, &#39;point&#39;, &#39;design&#39;, &#39;&amp;&#39;, &#39;conduct&#39;, &#39;patient&#39;, &#39;registri&#39;, &#39;protein&#39;, &#39;product&#39;, &#39;formul&#39;, &#39;hca&#39;, &#39;europ&#39;, &#39;idiosyncrat&#39;, &#39;toxic&#39;, &#39;protein&#39;, &#39;informat&#39;, &#39;conflict&#39;, &#39;resolut&#39;, &#39;negoti&#39;, &#39;regulatori&#39;, &#39;intellig&#39;, &#39;bioresearch&#39;, &#39;monitor&#39;, &#39;cryobiolog&#39;, &#39;signal&#39;, &#39;transduct&#39;, &#39;emerg&#39;, &#39;compani&#39;, &#39;correct&#39;, &#39;action&#39;, &#39;plan&#39;, &#39;:&#39;, &#39;document&#39;, &#39;site&#39;, &#39;respons&#39;, &#39;gcp&#39;, &#39;defici&#39;, &#39;develop&#39;, &#39;clinic&#39;, &#39;studi&#39;, &#39;budget&#39;, &#39;next&#39;, &#39;gener&#39;, &#39;sequenc&#39;, &#39;data&#39;, &#39;manag&#39;, &#39;fraud&#39;, &#39;clinic&#39;, &#39;research&#39;, &#39;biosimilar&#39;, &#39;dealmak&#39;, &#39;diagnost&#39;, &#39;comprehens&#39;, &#39;crc&#39;, &#39;train&#39;, &#39;cancer&#39;, &#39;cell&#39;, &#39;model&#39;, &#39;digit&#39;, &#39;health&#39;, &#39;patient&#39;, &#39;registri&#39;, &#39;program&#39;, &#39;crop&#39;, &#39;genet&#39;, &#39;glossari&#39;, &#39;&amp;&#39;, &#39;acronym&#39;, &#39;refer&#39;, &#39;biosensor&#39;, &#39;good&#39;, &#39;clinic&#39;, &#39;practic&#39;, &#39;essenti&#39;, &#39;document&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;research&#39;, &#39;site&#39;, &#39;patient&#39;, &#39;center&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;protein&#39;, &#39;profit&#39;, &#39;europ&#39;, &#39;drug&#39;, &#39;metabol&#39;, &#39;intern&#39;, &#39;drug&#39;, &#39;approv&#39;, &#39;regulatori&#39;, &#39;procedur&#39;, &#39;princip&#39;, &#39;investig&#39;, &#39;train&#39;, &#39;orthoped&#39;, &#39;tissu&#39;, &#39;engin&#39;, &#39;investig&#39;, &#39;site&#39;, &#39;cardiovascular&#39;, &#39;genom&#39;, &#39;studi&#39;, &#39;start&#39;, &#39;Up&#39;, &#39;protein&#39;, &#39;fold&#39;, &#39;popul&#39;, &#39;health&#39;, &#39;manag&#39;, &#39;tissu&#39;, &#39;diagnost&#39;, &#39;glp&#39;, &#39;bioanalysi&#39;, &#39;phase&#39;, &#39;I&#39;, &#39;studi&#39;, &#39;manag&#39;, &#39;health&#39;, &#39;autonom&#39;, &#39;drive&#39;, &#39;electron&#39;, &#39;sourc&#39;, &#39;document&#39;, &#39;tool&#39;, &#39;&amp;&#39;, &#39;metric&#39;, &#39;congress&#39;, &#39;global&#39;, &#39;gcp&#39;, &#39;monitor&#39;, &#39;investig&#39;, &#39;non-compli&#39;, &#39;global&#39;, &#39;gcp&#39;, &#39;complianc&#39;, &#39;report&#39;, &#39;protein&#39;, &#39;&amp;&#39;, &#39;peptid&#39;, &#39;array&#39;, &#39;europ&#39;, &#39;internet&#39;, &#39;thing&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;pharmaceut&#39;, &#39;introduct&#39;, &#39;signal&#39;, &#39;detect&#39;, &#39;data&#39;, &#39;mine&#39;, &#39;studi&#39;, &#39;feasibl&#39;, &#39;clinic&#39;, &#39;investig&#39;, &#39;monitor&#39;, &#39;proteom&#39;, &#39;europ&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;develop&#39;, &#39;region&#39;, &#39;pediatr&#39;, &#39;drug&#39;, &#39;develop&#39;, &#39;sponsor&#39;, &#39;monitor&#39;, &#39;inspect&#39;, &#39;maxim&#39;, &#39;valu&#39;, &#39;drug&#39;, &#39;develop&#39;, &#39;protein&#39;, &#39;structur&#39;, &#39;cancer&#39;, &#39;microbi&#39;, &#39;genom&#39;, &#39;translat&#39;, &#39;cancer&#39;, &#39;medicin&#39;, &#39;medic&#39;, &#39;terminalog&#39;, &#39;clinic&#39;, &#39;research&#39;, &#39;profession&#39;, &#39;medic&#39;, &#39;devic&#39;, &#39;write&#39;, &#39;updat&#39;, &#39;investig&#39;, &#39;brochur&#39;, &#39;sunshin&#39;, &#39;act&#39;, &#39;sequenc&#39;, &#39;drug&#39;, &#39;develop&#39;, &#39;standard&#39;, &#39;oper&#39;, &#39;procedur&#39;, &#39;meet&#39;, &#39;intern&#39;, &#39;safeti&#39;, &#39;report&#39;, &#39;requir&#39;, &#39;facili&#39;, &#39;skill&#39;, &#39;clinic&#39;, &#39;research&#39;, &#39;profession&#39;, &#39;bioprocess&#39;, &#39;biolog&#39;, &#39;safeti&#39;, &#39;regulatori&#39;, &#39;intellig&#39;, &#39;101&#39;, &#39;recent&#39;, &#39;trend&#39;, &#39;noncompli&#39;, &#39;brief&#39;, &#39;drug&#39;, &#39;safeti&#39;, &#39;clinic&#39;, &#39;research&#39;, &#39;project&#39;, &#39;mamang&#39;, &#39;essenti&#39;, &#39;cra&#39;, &#39;surviv&#39;, &#39;kit&#39;, &#39;essenti&#39;, &#39;document&#39;, &#39;extracellular&#39;, &#39;rna&#39;, &#39;success&#39;, &#39;studi&#39;, &#39;site&#39;, &#39;start-up&#39;, &#39;cell&#39;, &#39;base&#39;, &#39;therapi&#39;, &#39;web-bas&#39;, &#39;train&#39;, &#39;strategi&#39;, &#39;data&#39;, &#39;mine&#39;, &#39;glp&#39;, &#39;bioanalysi&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;financ&#39;, &#39;&amp;&#39;, &#39;manag&#39;, &#39;regulatori&#39;, &#39;site&#39;, &#39;relationship/perform&#39;, &#39;manag&#39;, &#39;introduct&#39;, &#39;fda&#39;, &#39;regulatori&#39;, &#39;report&#39;, &#39;newslett&#39;, &#39;multipl&#39;, &#39;sclerosi&#39;, &#39;data&#39;, &#39;integr&#39;, &#39;manag&#39;, &#39;cra&#39;, &#39;improv&#39;, &#39;perform&#39;, &#39;&amp;&#39;, &#39;studi&#39;, &#39;outcom&#39;, &#39;compound&#39;, &#39;predict&#39;, &#39;toxic&#39;, &#39;surviv&#39;, &#39;fda&#39;, &#39;site&#39;, &#39;inspect&#39;, &#39;:&#39;, &#39;best&#39;, &#39;practic&#39;, &#39;site&#39;, &#39;personnel&#39;, &#39;phase&#39;, &#39;iii&#39;, &#39;(&#39;, &#39;3&#39;, &#39;)&#39;, &#39;/forecast&#39;, &#39;clinic&#39;, &#39;outcom&#39;, &#39;compar&#39;, &#39;fda&#39;, &#39;health&#39;, &#39;canada&#39;, &#39;regul&#39;, &#39;medic&#39;, &#39;devic&#39;, &#39;profession&#39;, &#39;recombin&#39;, &#39;therapeut&#39;, &#39;tick&#39;, &#39;born&#39;, &#39;diseas&#39;, &#39;write&#39;, &#39;maintain&#39;, &#39;EU&#39;, &#39;cta&#39;, &#39;orphan&#39;, &#39;drug&#39;, &#39;investig&#39;, &#39;initi&#39;, &#39;trial&#39;, &#39;orthopaed&#39;, &#39;anim&#39;, &#39;model&#39;, &#39;audit&#39;, &#39;sponsor&#39;, &#39;cro&#39;, &#39;valu&#39;, &#39;&amp;&#39;, &#39;price&#39;, &#39;licens&#39;, &#39;deal&#39;, &#39;drug&#39;, &#39;deliveri&#39;, &#39;vendor&#39;, &#39;manag&#39;, &#39;clinic&#39;, &#39;data&#39;, &#39;manag&#39;, &#39;data&#39;, &#39;qualiti&#39;, &#39;patient&#39;, &#39;engag&#39;, &#39;fda&#39;, &#39;drug&#39;, &#39;approv&#39;, &#39;process&#39;, &#39;hipaa&#39;, &#39;No&#39;, &#39;1&#39;, &#39;team&#39;, &#39;train&#39;, &#39;hipaa&#39;, &#39;&amp;&#39;, &#39;human&#39;, &#39;subject&#39;, &#39;research&#39;, &#39;Q&#39;, &#39;&amp;&#39;, &#39;A&#39;, &#39;ubiquitin&#39;, &#39;europ&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;data&#39;, &#39;monitor&#39;, &#39;investig&#39;, &#39;product&#39;, &#39;account&#39;, &#39;train&#39;, &#39;research&#39;, &#39;site&#39;, &#39;personnel&#39;, &#39;advers&#39;, &#39;event&#39;, &#39;report&#39;, &#39;irb&#39;, &#39;subject&#39;, &#39;recruit&#39;, &#39;clinic&#39;, &#39;research&#39;, &#39;site&#39;, &#39;antibodi&#39;, &#39;cancer&#39;, &#39;cost&#39;, &#39;manag&#39;, &#39;global&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;portfolio&#39;, &#39;manag&#39;, &#39;warn&#39;, &#39;letter&#39;, &#39;combin&#39;, &#39;product&#39;, &#39;observ&#39;, &#39;studi&#39;, &#39;molecular&#39;, &#39;medicin&#39;, &#39;asia&#39;, &#39;cn&#39;, &#39;central&#39;, &#39;nervou&#39;, &#39;system&#39;, &#39;discoveri&#39;, &#39;&amp;&#39;, &#39;develop&#39;, &#39;collabor&#39;, &#39;cross&#39;, &#39;function&#39;, &#39;global&#39;, &#39;team&#39;, &#39;site&#39;, &#39;relationship&#39;, &#39;manag&#39;, &#39;peptid&#39;, &#39;investig&#39;, &#39;oversight&#39;, &#39;write&#39;, &#39;sop&#39;, &#39;pain&#39;, &#39;web&#39;, &#39;2.0&#39;, &#39;understand&#39;, &#39;fda&#39;, &#39;new&#39;, &#39;draft&#39;, &#39;guidanc&#39;, &#39;regard&#39;, &#39;supervisori&#39;, &#39;repon&#39;, &#39;sponsors/cro&#39;, &#39;prepar&#39;, &#39;clinic&#39;, &#39;research&#39;, &#39;site&#39;, &#39;fda&#39;, &#39;inspect&#39;, &#39;ehealth&#39;, &#39;technolog&#39;, &#39;introduct&#39;, &#39;data&#39;, &#39;manag&#39;, &#39;fda&#39;, &#39;propos&#39;, &#39;rule&#39;, &#39;2010&#39;, &#39;teambuild&#39;, &#39;cross&#39;, &#39;function&#39;, &#39;global&#39;, &#39;team&#39;, &#39;genom&#39;, &#39;busi&#39;, &#39;strategi&#39;, &#39;product&#39;, &#39;life&#39;, &#39;cycl&#39;, &#39;rna&#39;, &#39;interfer&#39;, &#39;pharmacovigil&#39;, &#39;signal&#39;, &#39;detect&#39;, &#39;foreign&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;biotech&#39;, &#39;busi&#39;, &#39;develop&#39;, &#39;genom&#39;, &#39;portfolio&#39;, &#39;manag&#39;, &#39;venu&#39;, &#39;II&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;design&#39;, &#39;medic&#39;, &#39;devic&#39;, &#39;inform&#39;, &#39;consent&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;studi&#39;, &#39;wheel&#39;, &#39;biomark&#39;, &#39;data&#39;, &#39;center&#39;, &#39;antibodi&#39;, &#39;optim&#39;, &#39;&amp;&#39;, &#39;character&#39;, &#39;biolog&#39;, &#39;chronic&#39;, &#39;pain&#39;, &#39;cardiovascular&#39;, &#39;risk&#39;, &#39;base&#39;, &#39;decis&#39;, &#39;clinic&#39;, &#39;site&#39;, &#39;manag&#39;, &#39;human&#39;, &#39;particip&#39;, &#39;protect&#39;, &#39;train&#39;, &#39;clinic&#39;, &#39;research&#39;, &#39;profession&#39;, &#39;crc&#39;, &#39;role/respons&#39;, &#39;train&#39;, &#39;women&#39;, &#39;health&#39;, &#39;current&#39;, &#39;develop&#39;, &#39;role&#39;, &#39;irb&#39;, &#39;conduct&#39;, &#39;clinic&#39;, &#39;research&#39;, &#39;regulatori&#39;, &#39;complianc&#39;, &#39;molecular&#39;, &#39;diagnost&#39;, &#39;infect&#39;, &#39;diabet&#39;, &#39;cancer&#39;, &#39;partner&#39;, &#39;prepar&#39;, &#39;medic&#39;, &#39;devic&#39;, &#39;510k&#39;, &#39;submiss&#39;, &#39;monitor&#39;, &#39;inform&#39;, &#39;consent&#39;, &#39;busi&#39;, &#39;biobank&#39;, &#39;global&#39;, &#39;site&#39;, &#39;select&#39;, &#39;boston&#39;, &#39;biomark&#39;, &#39;drug&#39;, &#39;efficaci&#39;, &#39;safeti&#39;, &#39;new&#39;, &#39;drug&#39;, &#39;approv&#39;, &#39;european&#39;, &#39;union&#39;, &#39;protein&#39;, &#39;therapeut&#39;, &#39;qualiti&#39;, &#39;improv&#39;, &#39;strategi&#39;, &#39;clinic&#39;, &#39;research&#39;, &#39;site&#39;, &#39;diagnost&#39;, &#39;bioprocess&#39;, &#39;viral&#39;, &#39;hepat&#39;, &#39;infect&#39;, &#39;advanc&#39;, &#39;hipaa&#39;, &#39;clinic&#39;, &#39;sequenc&#39;, &#39;irb&#39;, &#39;guidanc&#39;, &#39;regen&#39;, &#39;heal&#39;, &#39;cell&#39;, &#39;cultur&#39;, &#39;coronaviru&#39;, &#39;liver&#39;, &#39;disord&#39;, &#39;big&#39;, &#39;pharma&#39;, &#39;big&#39;, &#39;data&#39;, &#39;hipaa&#39;, &#39;electron&#39;, &#39;medic&#39;, &#39;record&#39;, &#39;blood&#39;, &#39;pharmaceut&#39;, &#39;strategi&#39;, &#39;seri&#39;, &#39;strategi&#39;, &#39;acceleart&#39;, &#39;nonclin&#39;, &#39;toxiciolog&#39;, &#39;&amp;&#39;, &#39;safeti&#39;, &#39;assess&#39;, &#39;biolog&#39;, &#39;new&#39;, &#39;drug&#39;, &#39;approv&#39;, &#39;japan&#39;, &#39;artifici&#39;, &#39;intellig&#39;, &#39;excel&#39;, &#39;spreadsheets-step&#39;, &#39;step&#39;, &#39;instruct&#39;, &#39;complianc&#39;, &#39;chemistri&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;statist&#39;, &#39;sourcebook&#39;, &#39;upgrad&#39;, &#39;medic&#39;, &#39;devic&#39;, &#39;track&#39;, &#39;medic&#39;, &#39;devic&#39;, &#39;direct&#39;, &#39;facilit&#39;, &#39;skill&#39;, &#39;autoimmun&#39;, &#39;anticoagul&#39;, &#39;bone&#39;, &#39;clinic&#39;, &#39;antibodi&#39;, &#39;gene&#39;, &#39;therapi&#39;, &#39;newborn&#39;, &#39;diagnost&#39;, &#39;real&#39;, &#39;world&#39;, &#39;monitor&#39;, &#39;allergi&#39;, &#39;perform&#39;, &#39;improv&#39;, &#39;monitor&#39;, &#39;model&#39;, &#39;institut&#39;, &#39;review&#39;, &#39;board&#39;, &#39;health&#39;, &#39;outcom&#39;, &#39;outsourc&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;microbiom&#39;, &#39;key&#39;, &#39;opinion&#39;, &#39;leader&#39;, &#39;chronic&#39;, &#39;obstruct&#39;, &#39;pulmonari&#39;, &#39;disord&#39;, &#39;qualiti&#39;, &#39;design&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;&amp;&#39;, &#39;translat&#39;, &#39;medicin&#39;, &#39;seri&#39;, &#39;lupu&#39;, &#39;multi&#39;, &#39;drug&#39;, &#39;resist&#39;, &#39;clinic&#39;, &#39;research&#39;, &#39;coordin&#39;, &#39;tool&#39;, &#39;kit&#39;, &#39;crc&#39;, &#39;&amp;&#39;, &#39;PI&#39;, &#39;current&#39;, &#39;practic&#39;, &#39;updat&#39;, &#39;cra&#39;, &#39;facilit&#39;, &#39;train&#39;, &#39;21&#39;, &#39;cfr&#39;, &#39;part&#39;, &#39;11&#39;, &#39;complianc&#39;, &#39;electron&#39;, &#39;record&#39;, &#39;&amp;&#39;, &#39;signatur&#39;, &#39;cancer&#39;, &#39;diagnost&#39;, &#39;electron&#39;, &#39;health&#39;, &#39;record&#39;, &#39;chiral&#39;, &#39;intro&#39;, &#39;combin&#39;, &#39;product&#39;, &#39;gastrointestin&#39;, &#39;disord&#39;, &#39;present&#39;, &#39;skill&#39;, &#39;clinic&#39;, &#39;research&#39;, &#39;profession&#39;, &#39;inflamm&#39;, &#39;oper&#39;, &#39;model&#39;, &#39;simul&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;pharmaceut&#39;, &#39;&amp;&#39;, &#39;medic&#39;, &#39;devic&#39;, &#39;industri&#39;, &#39;facilit&#39;, &#39;skill&#39;, &#39;clinic&#39;, &#39;research&#39;, &#39;team&#39;, &#39;member&#39;, &#39;diagnost&#39;, &#39;partner&#39;, &#39;mobil&#39;, &#39;health&#39;, &#39;wearabl&#39;, &#39;pharmaceut&#39;, &#39;discoveri&#39;, &#39;data&#39;, &#39;manag&#39;, &#39;medic&#39;, &#39;devic&#39;, &#39;report&#39;, &#39;ubiquitin&#39;, &#39;medic&#39;, &#39;devic&#39;, &#39;postmarket&#39;, &#39;vigil&#39;, &#39;blockchain&#39;, &#39;alzheim&#39;, &#39;high&#39;, &#39;perform&#39;, &#39;comput&#39;, &#39;innov&#39;, &#39;preclin&#39;, &#39;&amp;&#39;, &#39;clinic&#39;, &#39;strategi&#39;, &#39;gxp&#39;, &#39;good&#39;, &#39;practic&#39;, &#39;guid&#39;, &#39;write&#39;, &#39;maintain&#39;, &#39;canadian&#39;, &#39;cta&#39;, &#39;3D&#39;, &#39;print&#39;, &#39;key&#39;, &#39;inform&#39;, &#39;gather&#39;, &#39;respiratori&#39;, &#39;five&#39;, &#39;key&#39;, &#39;cot&#39;, &#39;comput&#39;, &#39;system&#39;, &#39;valid&#39;, &#39;next-gener&#39;, &#39;sequenc&#39;, &#39;data&#39;, &#39;manag&#39;, &#39;open&#39;, &#39;sourc&#39;, &#39;fibrosis/scar&#39;, &#39;biomark&#39;, &#39;bridg&#39;, &#39;genom&#39;, &#39;101&#39;, &#39;dummi&#39;, &#39;keyword&#39;, &#39;DE&#39;, &#39;list&#39;, &#39;w/more&#39;, &#39;1&#39;, &#39;keyword&#39;, &#39;keyword&#39;, &#39;fda&#39;, &#39;form&#39;, &#39;1572&#39;, &#39;antisens&#39;, &#39;account&#39;, &#39;care&#39;, &#39;orgniz&#39;, &#39;ace&#39;, &#39;inhibitor&#39;, &#39;AI&#39;, &#39;chip&#39;, &#39;antibody-drug&#39;, &#39;conjug&#39;, &#39;peg&#39;, &#39;antibodi&#39;, &#39;drug&#39;, &#39;conjug&#39;, &#39;bioprocess&#39;, &#39;attent&#39;, &#39;deficit&#39;, &#39;hyperact&#39;, &#39;disord&#39;, &#39;adjuv&#39;, &#39;admet&#39;, &#39;(&#39;, &#39;adm&#39;, &#39;&amp;&#39;, &#39;toxicolog&#39;, &#39;)&#39;, &#39;advers&#39;, &#39;drug&#39;, &#39;reaction&#39;, &#39;aerospac&#39;, &#39;advanc&#39;, &#39;energi&#39;, &#39;technolog&#39;, &#39;congress&#39;, &#39;afford&#39;, &#39;care&#39;, &#39;affin&#39;, &#39;technolog&#39;, &#39;affin&#39;, &#39;separ&#39;, &#39;antibodi&#39;, &#39;fragment&#39;, &#39;agricultur&#39;, &#39;chemistri&#39;, &#39;age&#39;, &#39;antibodi&#39;, &#39;drug&#39;, &#39;target&#39;, &#39;digit&#39;, &#39;farm&#39;, &#39;angiogenesi&#39;, &#39;AI&#39;, &#39;busi&#39;, &#39;intellig&#39;, &#39;artifici&#39;, &#39;intellig&#39;, &#39;bioprocess&#39;, &#39;AI&#39;, &#39;custom&#39;, &#39;analyt&#39;, &#39;intellig&#39;, &#39;assist&#39;, &#39;bot&#39;, &#39;AI&#39;, &#39;cancer&#39;, &#39;enterpris&#39;, &#39;AI&#39;, &#39;case&#39;, &#39;studi&#39;, &#39;AI&#39;, &#39;execut&#39;, &#39;summit&#39;, &#39;machin&#39;, &#39;learn&#39;, &#39;artifici&#39;, &#39;intellig&#39;, &#39;clinic&#39;, &#39;&amp;&#39;, &#39;post&#39;, &#39;approv&#39;, &#39;artifici&#39;, &#39;intellig&#39;, &#39;discoveri&#39;, &#39;&amp;&#39;, &#39;preclin&#39;, &#39;implement&#39;, &#39;enterpris&#39;, &#39;AI&#39;, &#39;AI&#39;, &#39;ethic&#39;, &#39;futur&#39;, &#39;AI&#39;, &#39;cut&#39;, &#39;edg&#39;, &#39;research&#39;, &#39;AI&#39;, &#39;gener&#39;, &#39;AI&#39;, &#39;busi&#39;, &#39;applic&#39;, &#39;AI&#39;, &#39;strateg&#39;, &#39;govern&#39;, &#39;function&#39;, &#39;cognit&#39;, &#39;comput&#39;, &#39;AI&#39;, &#39;partner&#39;, &#39;AI&#39;, &#39;person&#39;, &#39;medicin&#39;, &#39;alloster&#39;, &#39;modul&#39;, &#39;amyotroph&#39;, &#39;later&#39;, &#39;sclerosi&#39;, &#39;anim&#39;, &#39;model&#39;, &#39;cancer&#39;, &#39;altern&#39;, &#39;medicin&#39;, &#39;allianc&#39;, &#39;manag&#39;, &#39;execut&#39;, &#39;asset&#39;, &#39;manag&#39;, &#39;allianc&#39;, &#39;manag&#39;, &#39;negoti&#39;, &#39;anim&#39;, &#39;model&#39;, &#39;pain&#39;, &#39;anim&#39;, &#39;model&#39;, &#39;toxic&#39;, &#39;angina&#39;, &#39;anxieti&#39;, &#39;cancer&#39;, &#39;apoptosi&#39;, &#39;activ&#39;, &#39;pharmaceut&#39;, &#39;ingredi&#39;, &#39;analyt&#39;, &#39;purif&#39;, &#39;apoptosi&#39;, &#39;anti&#39;, &#39;psychot&#39;, &#39;allianc&#39;, &#39;Rx&#39;, &#39;devic&#39;, &#39;arrhythmia&#39;, &#39;assay&#39;, &#39;antibodi&#39;, &#39;assay&#39;, &#39;affin&#39;, &#39;assay&#39;, &#39;alloster&#39;, &#39;antagon&#39;, &#39;immunogen&#39;, &#39;assay&#39;, &#39;develop&#39;, &#39;assay&#39;, &#39;primari&#39;, &#39;cell&#39;, &#39;quantifi&#39;, &#39;receptor&#39;, &#39;activ&#39;, &#39;agon&#39;, &#39;asthma&#39;, &#39;assay&#39;, &#39;atherosclerosi&#39;, &#39;automot&#39;, &#39;automot&#39;, &#39;partner&#39;, &#39;autophagi&#39;, &#39;autism&#39;, &#39;advisori&#39;, &#39;board&#39;, &#39;bacteri&#39;, &#39;infect&#39;, &#39;consum&#39;, &#39;electron&#39;, &#39;batteri&#39;, &#39;applic&#39;, &#39;defens&#39;, &#39;batteri&#39;, &#39;applic&#39;, &#39;batteri&#39;, &#39;data&#39;, &#39;scienc&#39;, &#39;flexibl&#39;, &#39;batteri&#39;, &#39;power&#39;, &#39;industri&#39;, &#39;batteri&#39;, &#39;applic&#39;, &#39;medic&#39;, &#39;devic&#39;, &#39;batteri&#39;, &#39;applic&#39;, &#39;batteri&#39;, &#39;applic&#39;, &#39;stationari&#39;, &#39;batteri&#39;, &#39;applic&#39;, &#39;automot&#39;, &#39;batteri&#39;, &#39;applic&#39;, &#39;bayesian&#39;, &#39;statist&#39;, &#39;asia&#39;, &#39;US&#39;, &#39;biotech&#39;, &#39;allianc&#39;, &#39;blood&#39;, &#39;brain&#39;, &#39;barrier&#39;, &#39;comput&#39;, &#39;biolog&#39;, &#39;bio&#39;, &#39;IT&#39;, &#39;bioit&#39;, &#39;best&#39;, &#39;practic&#39;, &#39;batteri&#39;, &#39;charg&#39;, &#39;cheminformat&#39;, &#39;bio&#39;, &#39;IT&#39;, &#39;biomark&#39;, &#39;clinic&#39;, &#39;applic&#39;, &#39;preclin&#39;, &#39;biolog&#39;, &#39;develop&#39;, &#39;breast&#39;, &#39;cancer&#39;, &#39;backup&#39;, &#39;compound&#39;, &#39;biolog&#39;, &#39;cancer&#39;, &#39;treatment&#39;, &#39;biomark&#39;, &#39;data&#39;, &#39;analysi&#39;, &#39;biolog&#39;, &#39;databas&#39;, &#39;discoveri&#39;, &#39;informat&#39;, &#39;bio&#39;, &#39;IT&#39;, &#39;deliveri&#39;, &#39;biolog&#39;, &#39;regulatori&#39;, &#39;busi&#39;, &#39;diagnost&#39;, &#39;biodivers&#39;, &#39;screen&#39;, &#39;E&#39;, &#39;clinic&#39;, &#39;research&#39;, &#39;batteri&#39;, &#39;energi&#39;, &#39;storag&#39;, &#39;biofuel&#39;, &#39;allianc&#39;, &#39;biobank&#39;, &#39;informat&#39;, &#39;flow&#39;, &#39;cell&#39;, &#39;technolog&#39;, &#39;cloud&#39;, &#39;comput&#39;, &#39;data&#39;, &#39;scienc&#39;, &#39;biogener&#39;, &#39;busi&#39;, &#39;genom&#39;, &#39;biomateri&#39;, &#39;bioinformat&#39;, &#39;cancer&#39;, &#39;bio&#39;, &#39;IT&#39;, &#39;world&#39;, &#39;batteri&#39;, &#39;intellectu&#39;, &#39;properti&#39;, &#39;bio&#39;, &#39;IT&#39;, &#39;world&#39;, &#39;web&#39;, &#39;resourc&#39;, &#39;alert&#39;, &#39;bio&#39;, &#39;IT&#39;, &#39;world&#39;, &#39;monthli&#39;, &#39;magazin&#39;, &#39;IT&#39;, &#39;&amp;&#39;, &#39;informat&#39;, &#39;seri&#39;, &#39;bio&#39;, &#39;IT&#39;, &#39;world&#39;, &#39;weekli&#39;, &#39;updat&#39;, &#39;bookstor&#39;, &#39;biomark&#39;, &#39;develop&#39;, &#39;advanc&#39;, &#39;lead&#39;, &#39;acid&#39;, &#39;technolog&#39;, &#39;manufactur&#39;, &#39;&amp;&#39;, &#39;process&#39;, &#39;econom&#39;, &#39;biopharm&#39;, &#39;execut&#39;, &#39;summit&#39;, &#39;biolaw&#39;, &#39;biomark&#39;, &#39;&amp;&#39;, &#39;diagnost&#39;, &#39;seri&#39;, &#39;high-througput&#39;, &#39;screen-bas&#39;, &#39;biomark&#39;, &#39;discoveri&#39;, &#39;batteri&#39;, &#39;manufactur&#39;, &#39;batteri&#39;, &#39;manufactur&#39;, &#39;batteri&#39;, &#39;manag&#39;, &#39;batteri&#39;, &#39;manufactur&#39;, &#39;machineri&#39;, &#39;batteri&#39;, &#39;market&#39;, &#39;batteri&#39;, &#39;machin&#39;, &#39;learn&#39;, &#39;biomark&#39;, &#39;execut&#39;, &#39;think&#39;, &#39;tank&#39;, &#39;batteri&#39;, &#39;materi&#39;, &#39;,&#39;, &#39;recycl&#39;, &#39;biomark&#39;, &#39;revers&#39;, &#39;phase&#39;, &#39;assay&#39;, &#39;batteri&#39;, &#39;materi&#39;, &#39;,&#39;, &#39;solid&#39;, &#39;state&#39;, &#39;bone&#39;, &#39;marrow&#39;, &#39;transplant&#39;, &#39;biomark&#39;, &#39;translat&#39;, &#39;biomark&#39;, &#39;valid&#39;, &#39;bioinformat&#39;, &#39;asia&#39;, &#39;bioinformat&#39;, &#39;cloud&#39;, &#39;comput&#39;, &#39;IT&#39;, &#39;infrastructur&#39;, &#39;bio&#39;, &#39;IT&#39;, &#39;logist&#39;, &#39;sampl&#39;, &#39;biobank&#39;, &#39;bioinformat&#39;, &#39;genom&#39;, &#39;era&#39;, &#39;bioprocess&#39;, &#39;data&#39;, &#39;analysi&#39;, &#39;host&#39;, &#39;cell&#39;, &#39;protein&#39;, &#39;assay&#39;, &#39;bioproduct&#39;, &#39;continu&#39;, &#39;process&#39;, &#39;biopurif&#39;, &#39;biolog&#39;, &#39;pharmacokinet&#39;, &#39;bioprocess&#39;, &#39;qualiti&#39;, &#39;bioprocess&#39;, &#39;&amp;&#39;, &#39;manufactur&#39;, &#39;seri&#39;, &#39;bioprocess&#39;, &#39;valid&#39;, &#39;bioreactor&#39;, &#39;design&#39;, &#39;engin&#39;, &#39;batteri&#39;, &#39;regulatori&#39;, &#39;batteri&#39;, &#39;raw&#39;, &#39;materi&#39;, &#39;brain&#39;, &#39;cancer&#39;, &#39;batteri&#39;, &#39;repurpos&#39;, &#39;biolog&#39;, &#39;therapeut&#39;, &#39;(&#39;, &#39;biotherapeut&#39;, &#39;)&#39;, &#39;bispecif&#39;, &#39;antibodi&#39;, &#39;immunotherapi&#39;, &#39;bispecif&#39;, &#39;cancer&#39;, &#39;busi&#39;, &#39;strategi&#39;, &#39;librari&#39;, &#39;divers&#39;, &#39;blood&#39;, &#39;safeti&#39;, &#39;europ&#39;, &#39;batteri&#39;, &#39;ship&#39;, &#39;batteri&#39;, &#39;simul&#39;, &#39;biosensor&#39;, &#39;biosepar&#39;, &#39;biostabil&#39;, &#39;biospecimen&#39;, &#39;biomanufactur&#39;, &#39;singl&#39;, &#39;use&#39;, &#39;technolog&#39;, &#39;bioassay&#39;, &#39;batteri&#39;, &#39;commerci&#39;, &#39;flow&#39;, &#39;batteri&#39;, &#39;batteri&#39;, &#39;materi&#39;, &#39;sci/tech&#39;, &#39;pharma&#39;, &#39;&amp;&#39;, &#39;biotech&#39;, &#39;batteri&#39;, &#39;safeti&#39;, &#39;biotech&#39;, &#39;tool&#39;, &#39;biotech&#39;, &#39;ventur&#39;, &#39;forum&#39;, &#39;biomark&#39;, &#39;molecular&#39;, &#39;diagnost&#39;, &#39;biomark&#39;, &#39;molecular&#39;, &#39;diagnost&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;cancer&#39;, &#39;immunotherapi&#39;, &#39;artif&#39;, &#39;intellig&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;cell&#39;, &#39;adhes&#39;, &#39;molecul&#39;, &#39;regulatori&#39;, &#39;canda&#39;, &#39;comput&#39;, &#39;assist&#39;, &#39;new&#39;, &#39;drug&#39;, &#39;applic&#39;, &#39;chimer&#39;, &#39;antigen&#39;, &#39;receptor&#39;, &#39;chimer&#39;, &#39;antigen&#39;, &#39;receptor&#39;, &#39;case&#39;, &#39;studi&#39;, &#39;catalysi&#39;, &#39;cell&#39;, &#39;base&#39;, &#39;assay&#39;, &#39;cell&#39;, &#39;therapi&#39;, &#39;cmc&#39;, &#39;cancer&#39;, &#39;biomark&#39;, &#39;cell&#39;, &#39;therapi&#39;, &#39;product&#39;, &#39;cord&#39;, &#39;blood&#39;, &#39;stem&#39;, &#39;cell&#39;, &#39;cell&#39;, &#39;base&#39;, &#39;therapi&#39;, &#39;circul&#39;, &#39;tumor&#39;, &#39;cell&#39;, &#39;cold&#39;, &#39;chain&#39;, &#39;colorect&#39;, &#39;cancer&#39;, &#39;cell&#39;, &#39;cycl&#39;, &#39;collabor&#39;, &#39;deal&#39;, &#39;allianc&#39;, &#39;chemic&#39;, &#39;databas&#39;, &#39;co-develop&#39;, &#39;diagnost&#39;, &#39;drug&#39;, &#39;cloud&#39;, &#39;comput&#39;, &#39;europ&#39;, &#39;case&#39;, &#39;histori&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;consum&#39;, &#39;electron&#39;, &#39;cell&#39;, &#39;biolog&#39;, &#39;clean&#39;, &#39;tech&#39;, &#39;solar&#39;, &#39;wind&#39;, &#39;compar&#39;, &#39;effect&#39;, &#39;research&#39;, &#39;ethic&#39;, &#39;consider&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;continu&#39;, &#39;educ&#39;, &#39;unit&#39;, &#39;circul&#39;, &#39;cell-fre&#39;, &#39;dna&#39;, &#39;europ&#39;, &#39;agricultur&#39;, &#39;crop&#39;, &#39;genet&#39;, &#39;europ&#39;, &#39;cancer&#39;, &#39;genom&#39;, &#39;europ&#39;, &#39;congest&#39;, &#39;heart&#39;, &#39;failur&#39;, &#39;chemistri&#39;, &#39;seri&#39;, &#39;chines&#39;, &#39;hamster&#39;, &#39;ovari&#39;, &#39;clinic&#39;, &#39;research&#39;, &#39;conflict&#39;, &#39;interest&#39;, &#39;cheminformat&#39;, &#39;competit&#39;, &#39;intellig&#39;, &#39;cloud&#39;, &#39;comput&#39;, &#39;asia&#39;, &#39;integr&#39;, &#39;clinic&#39;, &#39;lab&#39;, &#39;servic&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;clinic&#39;, &#39;biospecimen&#39;, &#39;central&#39;, &#39;lab&#39;, &#39;solut&#39;, &#39;clinic&#39;, &#39;biospecimen&#39;, &#39;central&#39;, &#39;lab&#39;, &#39;solut&#39;, &#39;celiac&#39;, &#39;diseas&#39;, &#39;cloud&#39;, &#39;extens&#39;, &#39;clinic&#39;, &#39;genom&#39;, &#39;europ&#39;, &#39;cellular&#39;, &#39;conduct&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;asia&#39;, &#39;cloud&#39;, &#39;comput&#39;, &#39;project&#39;, &#39;manag&#39;, &#39;cloud&#39;, &#39;comput&#39;, &#39;resourc&#39;, &#39;manag&#39;, &#39;cloud&#39;, &#39;comput&#39;, &#39;secur&#39;, &#39;risk&#39;, &#39;softwar&#39;, &#39;develop&#39;, &#39;clinic&#39;, &#39;genom&#39;, &#39;clinic&#39;, &#39;vaccin&#39;, &#39;cloud&#39;, &#39;comput&#39;, &#39;west&#39;, &#39;compar&#39;, &#39;chemistri&#39;, &#39;manufactur&#39;, &#39;control&#39;, &#39;continu&#39;, &#39;medic&#39;, &#39;educ&#39;, &#39;commun&#39;, &#39;contract&#39;, &#39;manufactur&#39;, &#39;cancer&#39;, &#39;microarray&#39;, &#39;applic&#39;, &#39;cn&#39;, &#39;biomark&#39;, &#39;miscellan&#39;, &#39;chi&#39;, &#39;confer&#39;, &#39;cn&#39;, &#39;genetics/genom&#39;, &#39;cn&#39;, &#39;diseas&#39;, &#39;model&#39;, &#39;counterfeit&#39;, &#39;drug&#39;, &#39;copi&#39;, &#39;number&#39;, &#39;variat&#39;, &#39;cognit&#39;, &#39;disord&#39;, &#39;batteri&#39;, &#39;compon&#39;, &#39;capillari&#39;, &#39;electrophoresi&#39;, &#39;cancer&#39;, &#39;prognost&#39;, &#39;marker&#39;, &#39;clinic&#39;, &#39;pharmacolog&#39;, &#39;clinic&#39;, &#39;proteom&#39;, &#39;clinic&#39;, &#39;plasma&#39;, &#39;profil&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;platform&#39;, &#39;softwar&#39;, &#39;comput&#39;, &#39;vision&#39;, &#39;cancer&#39;, &#39;prevent&#39;, &#39;cra&#39;, &#39;8&#39;, &#39;week&#39;, &#39;fundament&#39;, &#39;train&#39;, &#39;cost&#39;, &#39;reduct&#39;, &#39;w/o&#39;, &#39;increas&#39;, &#39;regulatori&#39;, &#39;busi&#39;, &#39;risk&#39;, &#39;advanc&#39;, &#39;clinic&#39;, &#39;research&#39;, &#39;coordin&#39;, &#39;critic&#39;, &#39;care&#39;, &#39;diagnost&#39;, &#39;interview&#39;, &#39;skill&#39;, &#39;cra&#39;, &#39;crc&#39;, &#39;custom&#39;, &#39;relationship&#39;, &#39;manag&#39;, &#39;cra&#39;, &#39;monitor&#39;, &#39;clinic&#39;, &#39;research&#39;, &#39;train&#39;, &#39;week&#39;, &#39;clinic&#39;, &#39;research&#39;, &#39;train&#39;, &#39;week&#39;, &#39;east&#39;, &#39;clinic&#39;, &#39;research&#39;, &#39;train&#39;, &#39;week&#39;, &#39;west&#39;, &#39;drug-devic&#39;, &#39;combin&#39;, &#39;peptid&#39;, &#39;cancer&#39;, &#39;therapeut&#39;, &#39;coloni&#39;, &#39;stimul&#39;, &#39;factor&#39;, &#39;cell&#39;, &#39;signal&#39;, &#39;cancer&#39;, &#39;stem&#39;, &#39;cell&#39;, &#39;clinic&#39;, &#39;suppli&#39;, &#39;chain&#39;, &#39;clinic&#39;, &#39;strateg&#39;, &#39;resourc&#39;, &#39;alloc&#39;, &#39;countri&#39;, &#39;site&#39;, &#39;feasibl&#39;, &#39;select&#39;, &#39;mammalian&#39;, &#39;cell&#39;, &#39;cultur&#39;, &#39;cloud&#39;, &#39;secur&#39;, &#39;cybersecur&#39;, &#39;clinic&#39;, &#39;data&#39;, &#39;manag&#39;, &#39;eclin&#39;, &#39;trial&#39;, &#39;asia&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;drug&#39;, &#39;discover&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;eastern&#39;, &#39;europ&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;financ&#39;, &#39;&amp;&#39;, &#39;manag&#39;, &#39;Re&#39;, &#39;engin&#39;, &#39;studi&#39;, &#39;feasibl&#39;, &#39;assess&#39;, &#39;process&#39;, &#39;crc&#39;, &#39;train&#39;, &#39;video&#39;, &#39;&amp;&#39;, &#39;manual&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;manag&#39;, &#39;system&#39;, &#39;cardiotox&#39;, &#39;queri&#39;, &#39;creation&#39;, &#39;&amp;&#39;, &#39;process&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;segment&#39;, &#39;neoantigen&#39;, &#39;cancer&#39;, &#39;cardiovascular&#39;, &#39;diagnost&#39;, &#39;cardiovascular&#39;, &#39;anim&#39;, &#39;model&#39;, &#39;cardio&#39;, &#39;metabol&#39;, &#39;drug&#39;, &#39;target&#39;, &#39;target&#39;, &#39;cancer&#39;, &#39;diagnost&#39;, &#39;cytokin&#39;, &#39;antagonist&#39;, &#39;cystic&#39;, &#39;fibrosi&#39;, &#39;cytogenet&#39;, &#39;cytokin&#39;, &#39;target&#39;, &#39;diabet&#39;, &#39;novel&#39;, &#39;therapeut&#39;, &#39;db&#39;, &#39;optim&#39;, &#39;cell&#39;, &#39;drug&#39;, &#39;discoveri&#39;, &#39;india&#39;, &#39;drug&#39;, &#39;discoveri&#39;, &#39;map&#39;, &#39;drug&#39;, &#39;discoveri&#39;, &#39;outsourc&#39;, &#39;drug&#39;, &#39;discoveri&#39;, &#39;technolog&#39;, &#39;drug&#39;, &#39;discoveri&#39;, &#39;develop&#39;, &#39;drug&#39;, &#39;discoveri&#39;, &#39;&amp;&#39;, &#39;develop&#39;, &#39;seri&#39;, &#39;dental&#39;, &#39;depress&#39;, &#39;detect&#39;, &#39;non&#39;, &#39;biolog&#39;, &#39;treatment&#39;, &#39;drug&#39;, &#39;abus&#39;, &#39;drug&#39;, &#39;drug&#39;, &#39;interact&#39;, &#39;digit&#39;, &#39;therapeut&#39;, &#39;digit&#39;, &#39;diabet&#39;, &#39;2&#39;, &#39;digit&#39;, &#39;healthcar&#39;, &#39;&amp;&#39;, &#39;product&#39;, &#39;web&#39;, &#39;resourc&#39;, &#39;alert&#39;, &#39;drug&#39;, &#39;discoveri&#39;, &#39;duchenn&#39;, &#39;muscular&#39;, &#39;dystrophi&#39;, &#39;drug&#39;, &#39;metabol&#39;, &#39;&amp;&#39;, &#39;pharmacokinet&#39;, &#39;drug&#39;, &#39;discoveri&#39;, &#39;informat&#39;, &#39;europ&#39;, &#39;data&#39;, &#39;integr&#39;, &#39;diagnost&#39;, &#39;informat&#39;, &#39;dna&#39;, &#39;repair&#39;, &#39;divers&#39;, &#39;orient&#39;, &#39;synthesi&#39;, &#39;digit&#39;, &#39;detect&#39;, &#39;europ&#39;, &#39;difficult&#39;, &#39;express&#39;, &#39;protein&#39;, &#39;execut&#39;, &#39;perspect&#39;, &#39;drug&#39;, &#39;safeti&#39;, &#39;downstream&#39;, &#39;process&#39;, &#39;europ&#39;, &#39;drug&#39;, &#39;safeti&#39;, &#39;seri&#39;, &#39;downstream&#39;, &#39;process&#39;, &#39;dose&#39;, &#39;select&#39;, &#39;data&#39;, &#39;science/analyt&#39;, &#39;direct&#39;, &#39;consum&#39;, &#39;market&#39;, &#39;data&#39;, &#39;manag&#39;, &#39;drug&#39;, &#39;transport&#39;, &#39;data&#39;, &#39;storag&#39;, &#39;digit&#39;, &#39;twin&#39;, &#39;drug&#39;, &#39;util&#39;, &#39;protein&#39;, &#39;devic&#39;, &#39;molecular&#39;, &#39;companion&#39;, &#39;diagnost&#39;, &#39;asia&#39;, &#39;clinic&#39;, &#39;adopt&#39;, &#39;next&#39;, &#39;gener&#39;, &#39;diagnost&#39;, &#39;difficult&#39;, &#39;express&#39;, &#39;protein&#39;, &#39;europ&#39;, &#39;global&#39;, &#39;Dx&#39;, &#39;diagnost&#39;, &#39;immunoassay&#39;, &#39;diagnost&#39;, &#39;autom&#39;, &#39;detect&#39;, &#39;informat&#39;, &#39;engin&#39;, &#39;anim&#39;, &#39;model&#39;, &#39;hear&#39;, &#39;ebola&#39;, &#39;diagnost&#39;, &#39;evid&#39;, &#39;base&#39;, &#39;medicin&#39;, &#39;ebola&#39;, &#39;therapeut&#39;, &#39;ecapacitor&#39;, &#39;electrochemistri&#39;, &#39;E&#39;, &#39;coli&#39;, &#39;encod&#39;, &#39;compound&#39;, &#39;librari&#39;, &#39;ecommerc&#39;, &#39;ectd&#39;, &#39;valid&#39;, &#39;disinfect&#39;, &#39;efficaci&#39;, &#39;effect&#39;, &#39;drug&#39;, &#39;discoveri&#39;, &#39;edg&#39;, &#39;comput&#39;, &#39;earli&#39;, &#39;diagnosi&#39;, &#39;electron&#39;, &#39;notebook&#39;, &#39;endothelium&#39;, &#39;engin&#39;, &#39;entertain&#39;, &#39;enabl&#39;, &#39;technolog&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;environ&#39;, &#39;enzym&#39;, &#39;econom&#39;, &#39;outcom&#39;, &#39;execut&#39;, &#39;target&#39;, &#39;epidemiolog&#39;, &#39;epilepsi&#39;, &#39;epigenet&#39;, &#39;reader&#39;, &#39;epigenet&#39;, &#39;target&#39;, &#39;examin&#39;, &#39;impact&#39;, &#39;ectd&#39;, &#39;regulatori&#39;, &#39;submiss&#39;, &#39;process&#39;, &#39;emerg&#39;, &#39;target&#39;, &#39;diseas&#39;, &#39;ethic&#39;, &#39;emerg&#39;, &#39;technolog&#39;, &#39;transfer&#39;, &#39;electr&#39;, &#39;vehicl&#39;, &#39;experiment&#39;, &#39;design&#39;, &#39;exhibitor&#39;, &#39;extractables/leach&#39;, &#39;exosom&#39;, &#39;exom&#39;, &#39;sequenc&#39;, &#39;financi&#39;, &#39;analyst&#39;, &#39;hackathon&#39;, &#39;obes&#39;, &#39;batteri&#39;, &#39;franc&#39;, &#39;fibrin&#39;, &#39;sealant&#39;, &#39;fine&#39;, &#39;chemic&#39;, &#39;fda&#39;, &#39;meet&#39;, &#39;101&#39;, &#39;food&#39;, &#39;safeti&#39;, &#39;financi&#39;, &#39;disclosur&#39;, &#39;food&#39;, &#39;fda&#39;, &#39;websit&#39;, &#39;function&#39;, &#39;genom&#39;, &#39;fragment&#39;, &#39;base&#39;, &#39;screen&#39;, &#39;surfac&#39;, &#39;plasmon&#39;, &#39;reson&#39;, &#39;financ&#39;, &#39;flow&#39;, &#39;cytometri&#39;, &#39;influenza&#39;, &#39;financi&#39;, &#39;deal&#39;, &#39;structur&#39;, &#39;fintech&#39;, &#39;futur&#39;, &#39;healthcar&#39;, &#39;fraud&#39;, &#39;fertil&#39;, &#39;fibrin&#39;, &#39;sealant&#39;, &#39;europ&#39;, &#39;blood&#39;, &#39;fast&#39;, &#39;track&#39;, &#39;futur&#39;, &#39;therapeut&#39;, &#39;fungal&#39;, &#39;infect&#39;, &#39;follow&#39;, &#39;Up&#39;, &#39;flow&#39;, &#39;chemistri&#39;, &#39;gamif&#39;, &#39;gap&#39;, &#39;junction&#39;, &#39;channel&#39;, &#39;global&#39;, &#39;health&#39;, &#39;good&#39;, &#39;clinic&#39;, &#39;practic&#39;, &#39;pediatr&#39;, &#39;research&#39;, &#39;gcp&#39;, &#39;defici&#39;, &#39;gene&#39;, &#39;cell&#39;, &#39;vector&#39;, &#39;genom&#39;, &#39;drug&#39;, &#39;discoveri&#39;, &#39;genom&#39;, &#39;data&#39;, &#39;integr&#39;, &#39;genet&#39;, &#39;screen&#39;, &#39;well&#39;, &#39;gener&#39;, &#39;email&#39;, &#39;onli&#39;, &#39;gene&#39;, &#39;edit&#39;, &#39;part&#39;, &#39;2&#39;, &#39;gene&#39;, &#39;edit&#39;, &#39;gene&#39;, &#39;express&#39;, &#39;monitor&#39;, &#39;genom&#39;, &#39;seri&#39;, &#39;gene&#39;, &#39;express&#39;, &#39;growth&#39;, &#39;factor&#39;, &#39;gene&#39;, &#39;identif&#39;, &#39;genet&#39;, &#39;immun&#39;, &#39;vaccin&#39;, &#39;gene&#39;, &#39;interfer&#39;, &#39;gene&#39;, &#39;knockout&#39;, &#39;global&#39;, &#39;genom&#39;, &#39;link&#39;, &#39;newslett&#39;, &#39;glp&#39;, &#39;bioanalysi&#39;, &#39;leader&#39;, &#39;precis&#39;, &#39;medicin&#39;, &#39;good&#39;, &#39;manufactur&#39;, &#39;practic&#39;, &#39;drug&#39;, &#39;introductori&#39;, &#39;gene&#39;, &#39;mutat&#39;, &#39;genom&#39;, &#39;medicin&#39;, &#39;genotyp&#39;, &#39;govern&#39;, &#39;gene&#39;, &#39;probe&#39;, &#39;genom&#39;, &#39;partner&#39;, &#39;europ&#39;, &#39;green&#39;, &#39;pharma&#39;, &#39;gpcr&#39;, &#39;target&#39;, &#39;therapi&#39;, &#39;grid&#39;, &#39;comput&#39;, &#39;genom&#39;, &#39;servic&#39;, &#39;provid&#39;, &#39;small&#39;, &#39;gtpase&#39;, &#39;(&#39;, &#39;formerli&#39;, &#39;gene&#39;, &#39;town&#39;, &#39;pass&#39;, &#39;)&#39;, &#39;gene&#39;, &#39;transcript&#39;, &#39;gene&#39;, &#39;therapi&#39;, &#39;technolog&#39;, &#39;whole&#39;, &#39;genom&#39;, &#39;associ&#39;, &#39;studi&#39;, &#39;human&#39;, &#39;antibodi&#39;, &#39;high&#39;, &#39;throughput&#39;, &#39;analyt&#39;, &#39;chemistri&#39;, &#39;health&#39;, &#39;&amp;&#39;, &#39;beauti&#39;, &#39;aid&#39;, &#39;hepat&#39;, &#39;B&#39;, &#39;viru&#39;, &#39;high&#39;, &#39;content&#39;, &#39;analysi&#39;, &#39;cours&#39;, &#39;hiv&#39;, &#39;cancer&#39;, &#39;hematolog&#39;, &#39;cancer&#39;, &#39;pipelin&#39;, &#39;hiv&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;hepat&#39;, &#39;C&#39;, &#39;viru&#39;, &#39;heterocycl&#39;, &#39;high&#39;, &#39;content&#39;, &#39;data&#39;, &#39;analysi&#39;, &#39;hdac&#39;, &#39;histon&#39;, &#39;demethylas&#39;, &#39;heal&#39;, &#39;hematopoesi&#39;, &#39;heat&#39;, &#39;shock&#39;, &#39;protein&#39;, &#39;human&#39;, &#39;factor&#39;, &#39;engin&#39;, &#39;health&#39;, &#39;inform&#39;, &#39;system&#39;, &#39;hiv&#39;, &#39;healthcar&#39;, &#39;seri&#39;, &#39;health&#39;, &#39;mainten&#39;, &#39;organ&#39;, &#39;human&#39;, &#39;tissu&#39;, &#39;huntington&#39;, &#39;diseas&#39;, &#39;hormon&#39;, &#39;hipaa&#39;, &#39;#&#39;, &#39;2&#39;, &#39;high&#39;, &#39;throughput&#39;, &#39;protein&#39;, &#39;purif&#39;, &#39;high&#39;, &#39;perform&#39;, &#39;oper&#39;, &#39;human&#39;, &#39;papilloma&#39;, &#39;viru&#39;, &#39;transgen&#39;, &#39;homolog&#39;, &#39;recombin&#39;, &#39;human&#39;, &#39;relat&#39;, &#39;health&#39;, &#39;insur&#39;, &#39;herp&#39;, &#39;viru&#39;, &#39;hiv&#39;, &#39;surrog&#39;, &#39;marker&#39;, &#39;high&#39;, &#39;throughput&#39;, &#39;genom&#39;, &#39;hit&#39;, &#39;lead&#39;, &#39;high&#39;, &#39;throughput&#39;, &#39;screen&#39;, &#39;hepatotox&#39;, &#39;hybrid&#39;, &#39;comput&#39;, &#39;hypertens&#39;, &#39;target&#39;, &#39;antigen&#39;, &#39;present&#39;, &#39;cell&#39;, &#39;inflammatori&#39;, &#39;bowel&#39;, &#39;diseas&#39;, &#39;imag&#39;, &#39;contrast&#39;, &#39;agent&#39;, &#39;interleukin&#39;, &#39;convert&#39;, &#39;enzym&#39;, &#39;ice&#39;, &#39;improv&#39;, &#39;drug&#39;, &#39;safeti&#39;, &#39;diagnost&#39;, &#39;-&#39;, &#39;infect&#39;, &#39;infect&#39;, &#39;diagnost&#39;, &#39;europ&#39;, &#39;engin&#39;, &#39;laboratori&#39;, &#39;integr&#39;, &#39;fluidic&#39;, &#39;circuit&#39;, &#39;dot&#39;, &#39;informat&#39;, &#39;genom&#39;, &#39;medicin&#39;, &#39;infect&#39;, &#39;genom&#39;, &#39;imag&#39;, &#39;analysi&#39;, &#39;immunotherapi&#39;, &#39;biomark&#39;, &#39;immun&#39;, &#39;profil&#39;, &#39;cancer&#39;, &#39;complement-bas&#39;, &#39;drug&#39;, &#39;discoveri&#39;, &#39;immunomodul&#39;, &#39;imag&#39;, &#39;wpc&#39;, &#39;confer&#39;, &#39;imag&#39;, &#39;informat&#39;, &#39;immun&#39;, &#39;impur&#39;, &#39;regulatori&#39;, &#39;immunogen&#39;, &#39;immunosequenc&#39;, &#39;immuno-oncolog&#39;, &#39;drug&#39;, &#39;develop&#39;, &#39;cancer&#39;, &#39;immunotherapi&#39;, &#39;oligonucleotid&#39;, &#39;cancer&#39;, &#39;immunotherapi&#39;, &#39;peptid&#39;, &#39;cancer&#39;, &#39;immunotherapi&#39;, &#39;small&#39;, &#39;molecul&#39;, &#39;informat&#39;, &#39;partner&#39;, &#39;insur&#39;, &#39;AI&#39;, &#39;iot&#39;, &#39;invest&#39;, &#39;industri&#39;, &#39;enzym&#39;, &#39;immuno-oncolog&#39;, &#39;assay&#39;, &#39;immuno-oncolog&#39;, &#39;busi&#39;, &#39;strategi&#39;, &#39;immuno-oncolog&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;immuno-oncolog&#39;, &#39;model&#39;, &#39;ion&#39;, &#39;channel&#39;, &#39;protein&#39;, &#39;engin&#39;, &#39;immuno-oncolog&#39;, &#39;immuno-oncolog&#39;, &#39;sequenc&#39;, &#39;immuno-oncolog&#39;, &#39;target&#39;, &#39;legal&#39;, &#39;issu&#39;, &#39;bioproduct&#39;, &#39;intellectu&#39;, &#39;properti&#39;, &#39;pluripot&#39;, &#39;stem&#39;, &#39;cell&#39;, &#39;irb&#39;, &#39;complianc&#39;, &#39;oversight&#39;, &#39;consider&#39;, &#39;adopt&#39;, &#39;integr&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;informat&#39;, &#39;system&#39;, &#39;india&#39;, &#39;Re&#39;, &#39;engin&#39;, &#39;intern&#39;, &#39;risk&#39;, &#39;manag&#39;, &#39;drug&#39;, &#39;discoveri&#39;, &#39;informat&#39;, &#39;iron&#39;, &#39;chelat&#39;, &#39;IT&#39;, &#39;infrastructur&#39;, &#39;softwar&#39;, &#39;situ&#39;, &#39;hybrid&#39;, &#39;inform&#39;, &#39;technolog&#39;, &#39;IT&#39;, &#39;&amp;&#39;, &#39;informat&#39;, &#39;collabor&#39;, &#39;IT&#39;, &#39;infrastructur&#39;, &#39;europ&#39;, &#39;scalabl&#39;, &#39;IT&#39;, &#39;&amp;&#39;, &#39;informat&#39;, &#39;IT&#39;, &#39;infrastructur&#39;, &#39;comput&#39;, &#39;hardwar&#39;, &#39;(&#39;, &#39;part&#39;, &#39;2&#39;, &#39;)&#39;, &#39;IT&#39;, &#39;infrastructur&#39;, &#39;comput&#39;, &#39;hardwar&#39;, &#39;(&#39;, &#39;part&#39;, &#39;3&#39;, &#39;)&#39;, &#39;IT&#39;, &#39;softwar&#39;, &#39;life&#39;, &#39;scienc&#39;, &#39;IT&#39;, &#39;infrastructur&#39;, &#39;virtual&#39;, &#39;interview&#39;, &#39;skill&#39;, &#39;manag&#39;, &#39;investig&#39;, &#39;site&#39;, &#39;report&#39;, &#39;1&#39;, &#39;investig&#39;, &#39;site&#39;, &#39;report&#39;, &#39;2&#39;, &#39;imag&#39;, &#39;week&#39;, &#39;joint&#39;, &#39;job&#39;, &#39;recruit&#39;, &#39;kinas&#39;, &#39;chemistri&#39;, &#39;kin&#39;, &#39;west&#39;, &#39;coast&#39;, &#39;kinas&#39;, &#39;dot&#39;, &#39;knowledg&#39;, &#39;manag&#39;, &#39;chemokin&#39;, &#39;hiv&#39;, &#39;kaposi&#39;, &#39;sarcoma&#39;, &#39;kinet&#39;, &#39;structur&#39;, &#39;relationship&#39;, &#39;laboratori&#39;, &#39;lead&#39;, &#39;acid&#39;, &#39;batteri&#39;, &#39;label&#39;, &#39;free&#39;, &#39;detect&#39;, &#39;drug&#39;, &#39;label&#39;, &#39;live&#39;, &#39;cell&#39;, &#39;imag&#39;, &#39;laser&#39;, &#39;captur&#39;, &#39;microdissect&#39;, &#39;lung&#39;, &#39;cancer&#39;, &#39;ligas&#39;, &#39;chain&#39;, &#39;reaction&#39;, &#39;leukodeplet&#39;, &#39;laboratori&#39;, &#39;develop&#39;, &#39;test&#39;, &#39;leukemia&#39;, &#39;ontologies/lexicon&#39;, &#39;legal&#39;, &#39;drug&#39;, &#39;liabil&#39;, &#39;screen&#39;, &#39;librari&#39;, &#39;life&#39;, &#39;scienc&#39;, &#39;protein&#39;, &#39;ligand&#39;, &#39;lab&#39;, &#39;inform&#39;, &#39;manag&#39;, &#39;system&#39;, &#39;lim&#39;, &#39;lipid&#39;, &#39;larg&#39;, &#39;stationari&#39;, &#39;batteri&#39;, &#39;lyophil&#39;, &#39;merger&#39;, &#39;&amp;&#39;, &#39;acquisit&#39;, &#39;monoclon&#39;, &#39;antibodi&#39;, &#39;forum&#39;, &#39;monoclon&#39;, &#39;antibodi&#39;, &#39;process&#39;, &#39;develop&#39;, &#39;malaria&#39;, &#39;metabol&#39;, &#39;target&#39;, &#39;cancer&#39;, &#39;therapeut&#39;, &#39;microbiom&#39;, &#39;immuno-oncolog&#39;, &#39;microbiom&#39;, &#39;metabol&#39;, &#39;syndrom&#39;, &#39;medicin&#39;, &#39;chemistri&#39;, &#39;part&#39;, &#39;2&#39;, &#39;mucos&#39;, &#39;immun&#39;, &#39;microreactor&#39;, &#39;macrocycl&#39;, &#39;molecular&#39;, &#39;diagnost&#39;, &#39;busi&#39;, &#39;multidrug&#39;, &#39;resist&#39;, &#39;cancer&#39;, &#39;medic&#39;, &#39;code&#39;, &#39;multidrug&#39;, &#39;resist&#39;, &#39;infect&#39;, &#39;next&#39;, &#39;gener&#39;, &#39;non-invas&#39;, &#39;molecular&#39;, &#39;diagnost&#39;, &#39;microdos&#39;, &#39;microbi&#39;, &#39;infect&#39;, &#39;sequenc&#39;, &#39;base&#39;, &#39;molecular&#39;, &#39;diagnost&#39;, &#39;molecular&#39;, &#39;diagnost&#39;, &#39;forum&#39;, &#39;molecular&#39;, &#39;electron&#39;, &#39;metabol&#39;, &#39;engin&#39;, &#39;melanoma&#39;, &#39;biomem&#39;, &#39;memori&#39;, &#39;enhanc&#39;, &#39;cancer&#39;, &#39;metastasi&#39;, &#39;molecular&#39;, &#39;evolut&#39;, &#39;mammalian&#39;, &#39;cell&#39;, &#39;line&#39;, &#39;develop&#39;, &#39;microfabr&#39;, &#39;molecular&#39;, &#39;genet&#39;, &#39;pro&#39;, &#39;manag&#39;, &#39;molecular&#39;, &#39;medicin&#39;, &#39;novel&#39;, &#39;bioactiv&#39;, &#39;high&#39;, &#39;throughput&#39;, &#39;screen&#39;, &#39;europ&#39;, &#39;myocardi&#39;, &#39;infarct&#39;, &#39;migrain&#39;, &#39;microtit&#39;, &#39;plate&#39;, &#39;molecular&#39;, &#39;medicin&#39;, &#39;europ&#39;, &#39;metalloproteinas&#39;, &#39;molecular&#39;, &#39;medicin&#39;, &#39;asia&#39;, &#39;manag&#39;, &#39;care&#39;, &#39;manufactur&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;monitor&#39;, &#39;mechan&#39;, &#39;action&#39;, &#39;purifi&#39;, &#39;antibodi&#39;, &#39;meet&#39;, &#39;plan&#39;, &#39;servic&#39;, &#39;molecular&#39;, &#39;patholog&#39;, &#39;molecular&#39;, &#39;patholog&#39;, &#39;basic&#39;, &#39;molecular&#39;, &#39;patholog&#39;, &#39;advanc&#39;, &#39;magnet&#39;, &#39;reson&#39;, &#39;imag&#39;, &#39;multi&#39;, &#39;specif&#39;, &#39;antibodi&#39;, &#39;mass&#39;, &#39;spectrometri&#39;, &#39;protein&#39;, &#39;biomark&#39;, &#39;discoveri&#39;, &#39;muscl&#39;, &#39;mass&#39;, &#39;spec&#39;, &#39;informat&#39;, &#39;mass&#39;, &#39;spec&#39;, &#39;imag&#39;, &#39;model&#39;, &#39;simul&#39;, &#39;mass&#39;, &#39;spectrometri&#39;, &#39;mass&#39;, &#39;spec&#39;, &#39;diagnost&#39;, &#39;metabol&#39;, &#39;disord&#39;, &#39;mental&#39;, &#39;health&#39;, &#39;materi&#39;, &#39;test&#39;, &#39;cellular&#39;, &#39;matrix&#39;, &#39;multiplex&#39;, &#39;assay&#39;, &#39;moelcular&#39;, &#39;diagnost&#39;, &#39;europ&#39;, &#39;molecular&#39;, &#39;diagnost&#39;, &#39;cancer&#39;, &#39;molecular&#39;, &#39;diagnost&#39;, &#39;infecti&#39;, &#39;diseas&#39;, &#39;next&#39;, &#39;gener&#39;, &#39;antibodi&#39;, &#39;next&#39;, &#39;gener&#39;, &#39;antibodi&#39;, &#39;(&#39;, &#39;pge&#39;, &#39;)&#39;, &#39;nucleic&#39;, &#39;acid&#39;, &#39;europ&#39;, &#39;nation&#39;, &#39;academi&#39;, &#39;scienc&#39;, &#39;meet&#39;, &#39;natur&#39;, &#39;product&#39;, &#39;new&#39;, &#39;antivir&#39;, &#39;novel&#39;, &#39;cancer&#39;, &#39;informat&#39;, &#39;non-cod&#39;, &#39;rna&#39;, &#39;novel&#39;, &#39;strategi&#39;, &#39;cancer&#39;, &#39;novel&#39;, &#39;cancer&#39;, &#39;target&#39;, &#39;neurodegen&#39;, &#39;nucleotid&#39;, &#39;deliveri&#39;, &#39;internet&#39;, &#39;new&#39;, &#39;databas&#39;, &#39;comapni&#39;, &#39;name&#39;, &#39;advanc&#39;, &#39;informat&#39;, &#39;nerv&#39;, &#39;growth&#39;, &#39;factor&#39;, &#39;NF&#39;, &#39;KB&#39;, &#39;nanofluid&#39;, &#39;informat&#39;, &#39;next-gener&#39;, &#39;batteri&#39;, &#39;next&#39;, &#39;gener&#39;, &#39;batteri&#39;, &#39;portabl&#39;, &#39;applic&#39;, &#39;next&#39;, &#39;gener&#39;, &#39;batteri&#39;, &#39;stationari&#39;, &#39;power&#39;, &#39;epigenet&#39;, &#39;sequenc&#39;, &#39;next&#39;, &#39;gener&#39;, &#39;imag&#39;, &#39;neurogenom&#39;, &#39;nuclear&#39;, &#39;hormon&#39;, &#39;receptor&#39;, &#39;novel&#39;, &#39;hiv&#39;, &#39;strategi&#39;, &#39;neurotech&#39;, &#39;industri&#39;, &#39;neuroinjuri&#39;, &#39;NK&#39;, &#39;cell&#39;, &#39;base&#39;, &#39;cancer&#39;, &#39;immunotherapi&#39;, &#39;natur&#39;, &#39;languag&#39;, &#39;process&#39;, &#39;nuclear&#39;, &#39;matrix&#39;, &#39;nanomedicin&#39;, &#39;nitric&#39;, &#39;oxid&#39;, &#39;network&#39;, &#39;pharmacolog&#39;, &#39;energi&#39;, &#39;neurotox&#39;, &#39;new&#39;, &#39;drug&#39;, &#39;approv&#39;, &#39;US&#39;, &#39;nanotech&#39;, &#39;self&#39;, &#39;assembl&#39;, &#39;internet&#39;, &#39;suppli&#39;, &#39;chain&#39;, &#39;internet&#39;, &#39;suppli&#39;, &#39;chain&#39;, &#39;europ&#39;, &#39;neurostimul&#39;, &#39;internet&#39;, &#39;diagnost&#39;, &#39;thing&#39;, &#39;internet&#39;, &#39;energi&#39;, &#39;internet&#39;, &#39;energi&#39;, &#39;europ&#39;, &#39;internet&#39;, &#39;thing&#39;, &#39;infrastructur&#39;, &#39;internet&#39;, &#39;health&#39;, &#39;internet&#39;, &#39;insur&#39;, &#39;internet&#39;, &#39;insur&#39;, &#39;europ&#39;, &#39;internet&#39;, &#39;thing&#39;, &#39;manufactur&#39;, &#39;internet&#39;, &#39;thing&#39;, &#39;manufactur&#39;, &#39;internet&#39;, &#39;manufactur&#39;, &#39;europ&#39;, &#39;smart&#39;, &#39;build&#39;, &#39;smart&#39;, &#39;citi&#39;, &#39;nephrotox&#39;, &#39;nuclear&#39;, &#39;energi&#39;, &#39;nutrit&#39;, &#39;optim&#39;, &#39;media&#39;, &#39;organ&#39;, &#39;cell&#39;, &#39;transplant&#39;, &#39;oncolog&#39;, &#39;drug&#39;, &#39;target&#39;, &#39;optic&#39;, &#39;diagnost&#39;, &#39;oncogenom&#39;, &#39;offic&#39;, &#39;inspector&#39;, &#39;gener&#39;, &#39;oil&#39;, &#39;ga&#39;, &#39;oncogen&#39;, &#39;oncolyt&#39;, &#39;virus&#39;, &#39;oligo&#39;, &#39;product&#39;, &#39;opportunist&#39;, &#39;infect&#39;, &#39;oligo&#39;, &#39;regulatori&#39;, &#39;organ&#39;, &#39;transplant&#39;, &#39;oral&#39;, &#39;drug&#39;, &#39;deliveri&#39;, &#39;osteoarthr&#39;, &#39;otc&#39;, &#39;counter&#39;, &#39;addit&#39;, &#39;confer&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;outsourc&#39;, &#39;oxygen&#39;, &#39;radic&#39;, &#39;oncogen&#39;, &#39;p53&#39;, &#39;predict&#39;, &#39;adm&#39;, &#39;protein&#39;, &#39;aggreg&#39;, &#39;protein&#39;, &#39;aggreg&#39;, &#39;(&#39;, &#39;ptk&#39;, &#39;)&#39;, &#39;packag&#39;, &#39;parasit&#39;, &#39;infect&#39;, &#39;process&#39;, &#39;analyt&#39;, &#39;technolog&#39;, &#39;pharmaci&#39;, &#39;benefit&#39;, &#39;manag&#39;, &#39;pharmaceut&#39;, &#39;bioprocess&#39;, &#39;basic&#39;, &#39;research&#39;, &#39;&amp;&#39;, &#39;discoveri&#39;, &#39;track&#39;, &#39;pcg&#39;, &#39;clinic&#39;, &#39;oper&#39;, &#39;track&#39;, &#39;pcg&#39;, &#39;preclin&#39;, &#39;develop&#39;, &#39;track&#39;, &#39;pcg&#39;, &#39;bridgehead&#39;, &#39;pci&#39;, &#39;book&#39;, &#39;preclin&#39;, &#39;preclin&#39;, &#39;preclin&#39;, &#39;prostat&#39;, &#39;cancer&#39;, &#39;preclin&#39;, &#39;outcom&#39;, &#39;predict&#39;, &#39;preclin&#39;, &#39;trial&#39;, &#39;point&#39;, &#39;care&#39;, &#39;west&#39;, &#39;protein&#39;, &#39;crystallographi&#39;, &#39;pediatr&#39;, &#39;aids/hiv&#39;, &#39;pda&#39;, &#39;download&#39;, &#39;chi&#39;, &#39;websit&#39;, &#39;process&#39;, &#39;develop&#39;, &#39;execut&#39;, &#39;platelet&#39;, &#39;deriv&#39;, &#39;growth&#39;, &#39;factor&#39;, &#39;protein&#39;, &#39;drug&#39;, &#39;deliveri&#39;, &#39;preclin&#39;, &#39;diseas&#39;, &#39;model&#39;, &#39;photodynam&#39;, &#39;therapi&#39;, &#39;phage&#39;, &#39;display&#39;, &#39;vaccin&#39;, &#39;develop&#39;, &#39;proteom&#39;, &#39;tool&#39;, &#39;diagnost&#39;, &#39;pediatr&#39;, &#39;pediatr&#39;, &#39;trial&#39;, &#39;cra&#39;, &#39;peg&#39;, &#39;virtual&#39;, &#39;interact&#39;, &#39;global&#39;, &#39;summit&#39;, &#39;protein&#39;, &#39;express&#39;, &#39;monitor&#39;, &#39;protein&#39;, &#39;execut&#39;, &#39;summit&#39;, &#39;proof&#39;, &#39;concept&#39;, &#39;cancer&#39;, &#39;protein&#39;, &#39;function&#39;, &#39;enterpris&#39;, &#39;portfolio&#39;, &#39;manag&#39;, &#39;portfolio&#39;, &#39;valu&#39;, &#39;protein&#39;, &#39;aggreg&#39;, &#39;light&#39;, &#39;scatter&#39;, &#39;consum&#39;, &#39;genomics/person&#39;, &#39;genom&#39;, &#39;protein&#39;, &#39;engin&#39;, &#39;partner&#39;, &#39;particul&#39;, &#39;screen&#39;, &#39;phage&#39;, &#39;west&#39;, &#39;phase&#39;, &#39;ii/reduc&#39;, &#39;attrit&#39;, &#39;phase&#39;, &#39;IV&#39;, &#39;phase&#39;, &#39;IV&#39;, &#39;pharmaci&#39;, &#39;phage&#39;, &#39;display&#39;, &#39;europ&#39;, &#39;pharmaceut&#39;, &#39;half&#39;, &#39;life&#39;, &#39;phase&#39;, &#39;zero&#39;, &#39;pi3k&#39;, &#39;phosphoinositid&#39;, &#39;3&#39;, &#39;kinas&#39;, &#39;protein&#39;, &#39;identif&#39;, &#39;preclin&#39;, &#39;imag&#39;, &#39;proteas&#39;, &#39;inhibitor&#39;, &#39;enzym&#39;, &#39;pla2&#39;, &#39;blood&#39;, &#39;platelet&#39;, &#39;membran&#39;, &#39;protein&#39;, &#39;membran&#39;, &#39;protein&#39;, &#39;dot&#39;, &#39;(&#39;, &#39;part&#39;, &#39;1&#39;, &#39;)&#39;, &#39;membran&#39;, &#39;protein&#39;, &#39;dot&#39;, &#39;(&#39;, &#39;part&#39;, &#39;2&#39;, &#39;)&#39;, &#39;protein&#39;, &#39;manufactur&#39;, &#39;clinic&#39;, &#39;project&#39;, &#39;manag&#39;, &#39;:&#39;, &#39;intermedi&#39;, &#39;prevent&#39;, &#39;medicin&#39;, &#39;pancreat&#39;, &#39;cancer&#39;, &#39;preclin&#39;, &#39;studi&#39;, &#39;ind&#39;, &#39;protein&#39;, &#39;comput&#39;, &#39;tool&#39;, &#39;prenat&#39;, &#39;therapeut&#39;, &#39;parenter&#39;, &#39;point&#39;, &#39;care&#39;, &#39;diagnost&#39;, &#39;europ&#39;, &#39;cannabi&#39;, &#39;power&#39;, &#39;util&#39;, &#39;protein&#39;, &#39;character&#39;, &#39;protein&#39;, &#39;purif&#39;, &#39;protein&#39;, &#39;protein&#39;, &#39;interact&#39;, &#39;protein&#39;, &#39;protein&#39;, &#39;interact&#39;, &#39;part&#39;, &#39;2&#39;, &#39;process&#39;, &#39;manag&#39;, &#39;protein&#39;, &#39;process&#39;, &#39;peptalk&#39;, &#39;partner&#39;, &#39;person&#39;, &#39;medicin&#39;, &#39;partner&#39;, &#39;proteom&#39;, &#39;analyt&#39;, &#39;predict&#39;, &#39;analyt&#39;, &#39;price&#39;, &#39;parkinson&#39;, &#39;predict&#39;, &#39;biomedicin&#39;, &#39;protein&#39;, &#39;,&#39;, &#39;peptid&#39;, &#39;&amp;&#39;, &#39;proteom&#39;, &#39;seri&#39;, &#39;protein&#39;, &#39;quantif&#39;, &#39;partner&#39;, &#39;data&#39;, &#39;privaci&#39;, &#39;person&#39;, &#39;medicin&#39;, &#39;asia&#39;, &#39;product&#39;, &#39;servic&#39;, &#39;announc&#39;, &#39;product&#39;, &#39;scale&#39;, &#39;Up&#39;, &#39;pharma&#39;, &#39;servic&#39;, &#39;new&#39;, &#39;schizophrenia&#39;, &#39;antipsychot&#39;, &#39;protein&#39;, &#39;antibodi&#39;, &#39;preclin&#39;, &#39;toxicolog&#39;, &#39;biolog&#39;, &#39;protein&#39;, &#39;technolog&#39;, &#39;engin&#39;, &#39;protein&#39;, &#39;therapeut&#39;, &#39;deliveri&#39;, &#39;predict&#39;, &#39;toxic&#39;, &#39;europ&#39;, &#39;platform&#39;, &#39;softwar&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;studi&#39;, &#39;phenotyp&#39;, &#39;genotyp&#39;, &#39;patholog&#39;, &#39;protein&#39;, &#39;drug&#39;, &#39;&amp;&#39;, &#39;diagnost&#39;, &#39;intellectu&#39;, &#39;properti&#39;, &#39;post&#39;, &#39;translat&#39;, &#39;modif&#39;, &#39;patient&#39;, &#39;registri&#39;, &#39;advanc&#39;, &#39;therapeut&#39;, &#39;current&#39;, &#39;gener&#39;, &#39;protein&#39;, &#39;drug&#39;, &#39;deliveri&#39;, &#39;(&#39;, &#39;part&#39;, &#39;peptalk&#39;, &#39;)&#39;, &#39;advanc&#39;, &#39;therapeut&#39;, &#39;next&#39;, &#39;gener&#39;, &#39;biolog&#39;, &#39;therapeut&#39;, &#39;product&#39;, &#39;seri&#39;, &#39;pathway/network&#39;, &#39;public&#39;, &#39;protein&#39;, &#39;variat&#39;, &#39;powertrain&#39;, &#39;protein&#39;, &#39;character&#39;, &#39;,&#39;, &#39;purif&#39;, &#39;screen&#39;, &#39;protein&#39;, &#39;character&#39;, &#39;,&#39;, &#39;purif&#39;, &#39;screen&#39;, &#39;protein&#39;, &#39;express&#39;, &#39;europ&#39;, &#39;beyond&#39;, &#39;protein&#39;, &#39;express&#39;, &#39;europ&#39;, &#39;protein&#39;, &#39;express&#39;, &#39;host&#39;, &#39;novel&#39;, &#39;protein&#39;, &#39;express&#39;, &#39;system&#39;, &#39;protein&#39;, &#39;engin&#39;, &#39;vector&#39;, &#39;prevent&#39;, &#39;gene&#39;, &#39;quantif&#39;, &#39;europ&#39;, &#39;QS&#39;, &#39;regul&#39;, &#39;recombin&#39;, &#39;antibodi&#39;, &#39;recombin&#39;, &#39;antibodi&#39;, &#39;recombin&#39;, &#39;protein&#39;, &#39;forum&#39;, &#39;radiat&#39;, &#39;rare&#39;, &#39;diseas&#39;, &#39;antibodi&#39;, &#39;drug&#39;, &#39;product&#39;, &#39;rbe&#39;, &#39;track&#39;, &#39;pge&#39;, &#39;rbe&#39;, &#39;track&#39;, &#39;pge&#39;, &#39;antibodi&#39;, &#39;screen&#39;, &#39;antibodi&#39;, &#39;translat&#39;, &#39;rapid&#39;, &#39;compound&#39;, &#39;character&#39;, &#39;clinic&#39;, &#39;enrol&#39;, &#39;plan&#39;, &#39;clinic&#39;, &#39;recruit&#39;, &#39;media&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;patient&#39;, &#39;recruit&#39;, &#39;win&#39;, &#39;strategi&#39;, &#39;clinic&#39;, &#39;recruit&#39;, &#39;media&#39;, &#39;integr&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;market&#39;, &#39;R&#39;, &#39;&amp;&#39;, &#39;D&#39;, &#39;product&#39;, &#39;drug&#39;, &#39;receptor&#39;, &#39;role&#39;, &#39;busi&#39;, &#39;process&#39;, &#39;manag&#39;, &#39;fda&#39;, &#39;regul&#39;, &#39;industri&#39;, &#39;worldwid&#39;, &#39;pharma&#39;, &#39;regul&#39;, &#39;surviv&#39;, &#39;fda&#39;, &#39;site&#39;, &#39;inspect&#39;, &#39;real&#39;, &#39;estat&#39;, &#39;risk&#39;, &#39;evalu&#39;, &#39;mitig&#39;, &#39;strategi&#39;, &#39;renal&#39;, &#39;(&#39;, &#39;kidney&#39;, &#39;)&#39;, &#39;renew&#39;, &#39;energi&#39;, &#39;storag&#39;, &#39;system&#39;, &#39;rfid&#39;, &#39;radiofrequ&#39;, &#39;ID&#39;, &#39;reagent&#39;, &#39;gap&#39;, &#39;analysi&#39;, &#39;rheumatoid&#39;, &#39;arthriti&#39;, &#39;gene&#39;, &#39;therapi&#39;, &#39;[&#39;, &#39;rna&#39;, &#39;block&#39;, &#39;]&#39;, &#39;ribonucl&#39;, &#39;acid&#39;, &#39;rnai&#39;, &#39;function&#39;, &#39;screen&#39;, &#39;rnai&#39;, &#39;rnainterfer&#39;, &#39;rnai&#39;, &#39;discoveri&#39;, &#39;target&#39;, &#39;rnai&#39;, &#39;video&#39;, &#39;request&#39;, &#39;rna&#39;, &#39;qualiti&#39;, &#39;rna&#39;, &#39;therapeut&#39;, &#39;robot&#39;, &#39;region&#39;, &#39;organ&#39;, &#39;robot&#39;, &#39;process&#39;, &#39;autom&#39;, &#39;reperfus&#39;, &#39;reproduct&#39;, &#39;gene&#39;, &#39;regul&#39;, &#39;regulatori&#39;, &#39;network&#39;, &#39;restenosi&#39;, &#39;retail&#39;, &#39;real&#39;, &#39;world&#39;, &#39;data&#39;, &#39;therapeut&#39;, &#39;indic&#39;, &#39;&amp;&#39;, &#39;drug&#39;, &#39;target&#39;, &#39;seri&#39;, &#39;safeti&#39;, &#39;screen&#39;, &#39;3D&#39;, &#39;model&#39;, &#39;sickl&#39;, &#39;cell&#39;, &#39;anemia&#39;, &#39;screen&#39;, &#39;informat&#39;, &#39;sequenc&#39;, &#39;cloud&#39;, &#39;comput&#39;, &#39;suppli&#39;, &#39;chain&#39;, &#39;manag&#39;, &#39;scope&#39;, &#39;clinic&#39;, &#39;research&#39;, &#39;leadership&#39;, &#39;forum&#39;, &#39;phenotyp&#39;, &#39;screen&#39;, &#39;phenotyp&#39;, &#39;screen&#39;, &#39;clinic&#39;, &#39;trial&#39;, &#39;strategi&#39;, &#39;IT&#39;, &#39;secur&#39;, &#39;sequenc&#39;, &#39;data&#39;, &#39;analysi&#39;, &#39;sequenc&#39;, &#39;data&#39;, &#39;analysi&#39;, &#39;asia&#39;, &#39;sidec&#39;, &#39;execut&#39;, &#39;forum&#39;, &#39;sequenc&#39;, &#39;data&#39;, &#39;analysi&#39;, &#39;europ&#39;, &#39;sleeper&#39;, &#39;diseas&#39;, &#39;indic&#39;, &#39;sequenc&#39;, &#39;data&#39;, &#39;storag&#39;, &#39;&amp;&#39;, &#39;manag&#39;, &#39;screen&#39;, &#39;difficult&#39;, &#39;target&#39;, &#39;sourc&#39;, &#39;document&#39;, &#39;verif&#39;, &#39;sequenc&#39;, &#39;data&#39;, &#39;analysi&#39;, &#39;&amp;&#39;, &#39;storag&#39;, &#39;second&#39;, &#39;messeng&#39;, &#39;sepsi&#39;, &#39;infect&#39;, &#39;sequenc&#39;, &#39;forum&#39;, &#39;serotonin&#39;, &#39;sexual&#39;, &#39;small&#39;, &#39;fuel&#39;, &#39;cell&#39;, &#39;select&#39;, &#39;immun&#39;, &#39;suppress&#39;, &#39;skin&#39;, &#39;sleep&#39;, &#39;pharmaceut&#39;, &#39;sale&#39;, &#39;biolog&#39;, &#39;small&#39;, &#39;molecular&#39;, &#39;comparison&#39;, &#39;semiconductor&#39;, &#39;small&#39;, &#39;molecul&#39;, &#39;simpl&#39;, &#39;model&#39;, &#39;organ&#39;, &#39;small&#39;, &#39;molecul&#39;, &#39;synthesi&#39;, &#39;semant&#39;, &#39;web&#39;, &#39;sensor&#39;, &#39;applic&#39;, &#39;synthet&#39;, &#39;biolog&#39;, &#39;sensor&#39;, &#39;data&#39;, &#39;manag&#39;, &#39;implant&#39;, &#39;biomed&#39;, &#39;sensor&#39;, &#39;sensor&#39;, &#39;materi&#39;, &#39;sensor&#39;, &#39;emerg&#39;, &#39;market&#39;, &#39;snp&#39;, &#39;sensor&#39;, &#39;system&#39;, &#39;sensor&#39;, &#39;safeti&#39;, &#39;softwar&#39;, &#39;solubl&#39;, &#39;safeti&#39;, &#39;pharmacolog&#39;, &#39;biolog&#39;, &#39;safeti&#39;, &#39;pharmacolog&#39;, &#39;biolog&#39;, &#39;genom&#39;, &#39;sampl&#39;, &#39;prepar&#39;, &#39;special&#39;, &#39;pharmaceut&#39;, &#39;altern&#39;, &#39;splice&#39;, &#39;proteom&#39;, &#39;sampl&#39;, &#39;prepar&#39;, &#39;high&#39;, &#39;throughput&#39;, &#39;screen&#39;, &#39;partner&#39;, &#39;solid&#39;, &#39;phase&#39;, &#39;synthesi&#39;, &#39;subject&#39;, &#39;end&#39;, &#39;point&#39;, &#39;next&#39;, &#39;gener&#39;, &#39;sequenc&#39;, &#39;applic&#39;, &#39;sequenc&#39;, &#39;core&#39;, &#39;lab&#39;, &#39;next-gener&#39;, &#39;data&#39;, &#39;gener&#39;, &#39;plant&#39;, &#39;sequenc&#39;, &#39;rna&#39;, &#39;sequenc&#39;, &#39;sequenc&#39;, &#39;solut&#39;, &#39;deep&#39;, &#39;sequenc&#39;, &#39;EU&#39;, &#39;site&#39;, &#39;select&#39;, &#39;,&#39;, &#39;studi&#39;, &#39;activ&#39;, &#39;,&#39;, &#39;patient&#39;, &#39;recruit&#39;, &#39;stabil&#39;, &#39;stroke&#39;, &#39;stem&#39;, &#39;cell&#39;, &#39;cultur&#39;, &#39;stem&#39;, &#39;cell&#39;, &#39;research&#39;, &#39;(&#39;, &#39;part&#39;, &#39;mmtc&#39;, &#39;)&#39;, &#39;statin&#39;, &#39;stem&#39;, &#39;cell&#39;, &#39;safeti&#39;, &#39;screen&#39;, &#39;startup&#39;, &#39;public&#39;, &#39;companies/stock&#39;, &#39;exchang&#39;, &#39;chi&#39;, &#39;survey&#39;, &#39;servic&#39;, &#39;system&#39;, &#39;biolog&#39;, &#39;byg&#39;, &#39;track&#39;, &#39;synthesi&#39;, &#39;system&#39;, &#39;biolog&#39;, &#39;train&#39;, &#39;&amp;&#39;, &#39;develop&#39;, &#39;top&#39;, &#39;50&#39;, &#39;big&#39;, &#39;pharma&#39;, &#39;tissu&#39;, &#39;microarray&#39;, &#39;taxol&#39;, &#39;tamoxifen&#39;, &#39;deriv&#39;, &#39;tuberculosi&#39;, &#39;tobacco&#39;, &#39;the&#39;, &#39;biotech&#39;, &#39;journal&#39;, &#39;email&#39;, &#39;list&#39;, &#39;trust&#39;, &#39;build&#39;, &#39;collabor&#39;, &#39;innov&#39;, &#39;tumor&#39;, &#39;,&#39;, &#39;circul&#39;, &#39;cell&#39;, &#39;technolog&#39;, &#39;technolog&#39;, &#39;consortium&#39;, &#39;target&#39;, &#39;driven&#39;, &#39;chemistri&#39;, &#39;target&#39;, &#39;drug&#39;, &#39;deliveri&#39;, &#39;transgen&#39;, &#39;diseas&#39;, &#39;model&#39;, &#39;thrombot&#39;, &#39;diseas&#39;, &#39;tissu&#39;, &#39;engin&#39;, &#39;telomeras&#39;, &#39;batteri&#39;, &#39;test&#39;, &#39;transfect&#39;, &#39;toxicogenom&#39;, &#39;target&#39;, &#39;priorit&#39;, &#39;target&#39;, &#39;identif&#39;, &#39;tissu&#39;, &#39;technolog&#39;, &#39;platform&#39;, &#39;immunotherapi&#39;, &#39;telecommun&#39;, &#39;telemedicin&#39;, &#39;tumor&#39;, &#39;microenviron&#39;, &#39;trial&#39;, &#39;master&#39;, &#39;file&#39;, &#39;sponsor&#39;, &#39;(&#39;, &#39;pharma&#39;, &#39;)&#39;, &#39;trial&#39;, &#39;master&#39;, &#39;file&#39;, &#39;research&#39;, &#39;site&#39;, &#39;theranost&#39;, &#39;market&#39;, &#39;model&#39;, &#39;tumor&#39;, &#39;necrosi&#39;, &#39;factor&#39;, &#39;therapeut&#39;, &#39;target&#39;, &#39;therapeut&#39;, &#39;&amp;&#39;, &#39;target&#39;, &#39;seri&#39;, &#39;immun&#39;, &#39;toler&#39;, &#39;fibrinolyt&#39;, &#39;(&#39;, &#39;clot&#39;, &#39;buster&#39;, &#39;)&#39;, &#39;transgen&#39;, &#39;product&#39;, &#39;plant&#39;, &#39;synthet&#39;, &#39;biolog&#39;, &#39;transport&#39;, &#39;translat&#39;, &#39;biomark&#39;, &#39;translat&#39;, &#39;informat&#39;, &#39;drug/diseas&#39;, &#39;target&#39;, &#39;drug&#39;, &#39;target&#39;, &#39;seri&#39;, &#39;genom&#39;, &#39;tri&#39;, &#39;confer&#39;, &#39;translat&#39;, &#39;servic&#39;, &#39;transgen&#39;, &#39;gene&#39;, &#39;knockout&#39;, &#39;transgen&#39;, &#39;product&#39;, &#39;tumor&#39;, &#39;suppressor&#39;, &#39;gene&#39;, &#39;tissu&#39;, &#39;safeti&#39;, &#39;technolog&#39;, &#39;&amp;&#39;, &#39;tool&#39;, &#39;life&#39;, &#39;scienc&#39;, &#39;technolog&#39;, &#39;&amp;&#39;, &#39;tool&#39;, &#39;life&#39;, &#39;scienc&#39;, &#39;seri&#39;, &#39;target&#39;, &#39;valid&#39;, &#39;text&#39;, &#39;mine&#39;, &#39;unman&#39;, &#39;aerial&#39;, &#39;vehicl&#39;, &#39;ubiquitin&#39;, &#39;uninterrupt&#39;, &#39;power&#39;, &#39;suppli&#39;, &#39;upcom&#39;, &#39;confer&#39;, &#39;upcom&#39;, &#39;confer&#39;, &#39;europ&#39;, &#39;urinari&#39;, &#39;incontin&#39;, &#39;new&#39;, &#39;usp&#39;, &#39;initi&#39;, &#39;standard&#39;, &#39;biolog&#39;, &#39;unstabl&#39;, &#39;triplet&#39;, &#39;trinucleotid&#39;, &#39;repeat&#39;, &#39;vaccin&#39;, &#39;(&#39;, &#39;imt&#39;, &#39;)&#39;, &#39;vascular&#39;, &#39;vaccin&#39;, &#39;busi&#39;, &#39;opportun&#39;, &#39;ventur&#39;, &#39;capit&#39;, &#39;busi&#39;, &#39;opportun&#39;, &#39;vaccin&#39;, &#39;voic&#39;, &#39;recognit&#39;, &#39;paperless&#39;, &#39;valid&#39;, &#39;veterinari&#39;, &#39;viral&#39;, &#39;infect&#39;, &#39;vaccin&#39;, &#39;product&#39;, &#39;&amp;&#39;, &#39;manufactur&#39;, &#39;virtual&#39;, &#39;realiti&#39;, &#39;virtual&#39;, &#39;busi&#39;, &#39;virtual&#39;, &#39;team&#39;, &#39;singl&#39;, &#39;use&#39;, &#39;system&#39;, &#39;vaccin&#39;, &#39;manufactur&#39;, &#39;well&#39;, &#39;character&#39;, &#39;biolog&#39;, &#39;well&#39;, &#39;wiki&#39;, &#39;wound&#39;, &#39;manag&#39;, &#39;wireless&#39;, &#39;chang&#39;, &#39;record&#39;, &#39;chang&#39;, &#39;record&#39;, &#39;mari&#39;, &#39;chitti&#39;, &#39;xenotransplant&#39;, &#39;yeast&#39;, &#39;display&#39;, &#39;zika&#39;, &#39;vaccin&#39;, &#39;develop&#39;]
</pre>
</div>
</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[35]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="kn">import</span> <span class="nn">nltk</span>
<span class="n">nltk</span><span class="o">.</span><span class="n">download</span><span class="p">(</span><span class="s1">&#39;wordnet&#39;</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stderr output_text">
<pre>[nltk_data] Downloading package wordnet to
[nltk_data]     C:\Users\vmohite\AppData\Roaming\nltk_data...
[nltk_data]   Unzipping corpora\wordnet.zip.
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt output_prompt">Out[35]:</div>




<div class="output_text output_subarea output_execute_result">
<pre>True</pre>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[39]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="kn">from</span> <span class="nn">nltk.stem.wordnet</span> <span class="k">import</span> <span class="n">WordNetLemmatizer</span>
<span class="n">lem</span> <span class="o">=</span> <span class="n">WordNetLemmatizer</span><span class="p">()</span>

<span class="kn">from</span> <span class="nn">nltk.stem.porter</span> <span class="k">import</span> <span class="n">PorterStemmer</span>
<span class="n">stem</span> <span class="o">=</span> <span class="n">PorterStemmer</span><span class="p">()</span>

<span class="n">word</span> <span class="o">=</span> <span class="s2">&quot;Molecule&quot;</span>
<span class="nb">print</span><span class="p">(</span><span class="s2">&quot;Lemmatized Word:&quot;</span><span class="p">,</span><span class="n">lem</span><span class="o">.</span><span class="n">lemmatize</span><span class="p">(</span><span class="n">word</span><span class="p">,</span><span class="s2">&quot;v&quot;</span><span class="p">))</span>
<span class="nb">print</span><span class="p">(</span><span class="s2">&quot;Stemmed Word:&quot;</span><span class="p">,</span><span class="n">stem</span><span class="o">.</span><span class="n">stem</span><span class="p">(</span><span class="n">word</span><span class="p">))</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>Lemmatized Word: Molecule
Stemmed Word: molecul
</pre>
</div>
</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[42]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="kn">from</span> <span class="nn">nltk.probability</span> <span class="k">import</span> <span class="n">FreqDist</span>
<span class="n">fdist</span> <span class="o">=</span> <span class="n">FreqDist</span><span class="p">(</span><span class="n">stemmed_words</span><span class="p">)</span>
<span class="nb">print</span><span class="p">(</span><span class="n">fdist</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>&lt;FreqDist with 1262 samples and 4515 outcomes&gt;
</pre>
</div>
</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[50]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">fdist</span><span class="o">.</span><span class="n">most_common</span><span class="p">(</span><span class="mi">2000</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt output_prompt">Out[50]:</div>




<div class="output_text output_subarea output_execute_result">
<pre>[(&#39;clinic&#39;, 123),
 (&#39;drug&#39;, 77),
 (&#39;&amp;&#39;, 75),
 (&#39;protein&#39;, 61),
 (&#39;manag&#39;, 59),
 (&#39;europ&#39;, 58),
 (&#39;trial&#39;, 52),
 (&#39;diagnost&#39;, 52),
 (&#39;cancer&#39;, 50),
 (&#39;batteri&#39;, 45),
 (&#39;data&#39;, 41),
 (&#39;develop&#39;, 41),
 (&#39;genom&#39;, 39),
 (&#39;research&#39;, 38),
 (&#39;cell&#39;, 34),
 (&#39;target&#39;, 31),
 (&#39;biomark&#39;, 30),
 (&#39;discoveri&#39;, 29),
 (&#39;biolog&#39;, 29),
 (&#39;molecular&#39;, 28),
 (&#39;antibodi&#39;, 28),
 (&#39;(&#39;, 24),
 (&#39;)&#39;, 24),
 (&#39;sequenc&#39;, 24),
 (&#39;site&#39;, 24),
 (&#39;IT&#39;, 23),
 (&#39;comput&#39;, 23),
 (&#39;gene&#39;, 22),
 (&#39;medic&#39;, 22),
 (&#39;screen&#39;, 22),
 (&#39;medicin&#39;, 21),
 (&#39;studi&#39;, 21),
 (&#39;technolog&#39;, 21),
 (&#39;monitor&#39;, 21),
 (&#39;process&#39;, 21),
 (&#39;informat&#39;, 21),
 (&#39;safeti&#39;, 20),
 (&#39;devic&#39;, 19),
 (&#39;busi&#39;, 19),
 (&#39;model&#39;, 19),
 (&#39;therapeut&#39;, 19),
 (&#39;engin&#39;, 18),
 (&#39;summit&#39;, 18),
 (&#39;advanc&#39;, 18),
 (&#39;health&#39;, 18),
 (&#39;analysi&#39;, 17),
 (&#39;AI&#39;, 17),
 (&#39;regulatori&#39;, 17),
 (&#39;train&#39;, 17),
 (&#39;seri&#39;, 17),
 (&#39;product&#39;, 17),
 (&#39;gener&#39;, 16),
 (&#39;high&#39;, 15),
 (&#39;strategi&#39;, 15),
 (&#39;preclin&#39;, 15),
 (&#39;manufactur&#39;, 15),
 (&#39;cra&#39;, 14),
 (&#39;infect&#39;, 14),
 (&#39;asia&#39;, 14),
 (&#39;partner&#39;, 14),
 (&#39;global&#39;, 14),
 (&#39;internet&#39;, 14),
 (&#39;applic&#39;, 14),
 (&#39;confer&#39;, 13),
 (&#39;chemistri&#39;, 13),
 (&#39;system&#39;, 13),
 (&#39;fda&#39;, 13),
 (&#39;diseas&#39;, 13),
 (&#39;investig&#39;, 13),
 (&#39;immunotherapi&#39;, 12),
 (&#39;allianc&#39;, 12),
 (&#39;R&#39;, 12),
 (&#39;D&#39;, 12),
 (&#39;therapi&#39;, 12),
 (&#39;practic&#39;, 12),
 (&#39;new&#39;, 12),
 (&#39;imag&#39;, 12),
 (&#39;assay&#39;, 12),
 (&#39;express&#39;, 12),
 (&#39;cloud&#39;, 12),
 (&#39;execut&#39;, 11),
 (&#39;pharmaceut&#39;, 11),
 (&#39;project&#39;, 11),
 (&#39;base&#39;, 11),
 (&#39;bioprocess&#39;, 11),
 (&#39;report&#39;, 11),
 (&#39;next&#39;, 11),
 (&#39;vaccin&#39;, 11),
 (&#39;electron&#39;, 11),
 (&#39;world&#39;, 10),
 (&#39;human&#39;, 10),
 (&#39;:&#39;, 10),
 (&#39;pharma&#39;, 10),
 (&#39;bio&#39;, 10),
 (&#39;intellig&#39;, 10),
 (&#39;part&#39;, 10),
 (&#39;good&#39;, 9),
 (&#39;gcp&#39;, 9),
 (&#39;valid&#39;, 9),
 (&#39;metabol&#39;, 9),
 (&#39;digit&#39;, 9),
 (&#39;throughput&#39;, 9),
 (&#39;tissu&#39;, 9),
 (&#39;approv&#39;, 9),
 (&#39;translat&#39;, 9),
 (&#39;phase&#39;, 9),
 (&#39;immuno-oncolog&#39;, 9),
 (&#39;design&#39;, 8),
 (&#39;inform&#39;, 8),
 (&#39;function&#39;, 8),
 (&#39;proteom&#39;, 8),
 (&#39;sensor&#39;, 8),
 (&#39;organ&#39;, 8),
 (&#39;infrastructur&#39;, 8),
 (&#39;patient&#39;, 8),
 (&#39;document&#39;, 8),
 (&#39;write&#39;, 8),
 (&#39;rna&#39;, 8),
 (&#39;stem&#39;, 8),
 (&#39;tool&#39;, 8),
 (&#39;genet&#39;, 8),
 (&#39;forum&#39;, 8),
 (&#39;deliveri&#39;, 8),
 (&#39;track&#39;, 8),
 (&#39;,&#39;, 8),
 (&#39;2&#39;, 8),
 (&#39;congress&#39;, 7),
 (&#39;profession&#39;, 7),
 (&#39;lab&#39;, 7),
 (&#39;recombin&#39;, 7),
 (&#39;blood&#39;, 7),
 (&#39;recruit&#39;, 7),
 (&#39;complianc&#39;, 7),
 (&#39;detect&#39;, 7),
 (&#39;regul&#39;, 7),
 (&#39;anim&#39;, 7),
 (&#39;receptor&#39;, 7),
 (&#39;west&#39;, 7),
 (&#39;care&#39;, 7),
 (&#39;risk&#39;, 7),
 (&#39;market&#39;, 7),
 (&#39;analyt&#39;, 7),
 (&#39;immun&#39;, 7),
 (&#39;skill&#39;, 7),
 (&#39;biotech&#39;, 7),
 (&#39;integr&#39;, 7),
 (&#39;energi&#39;, 7),
 (&#39;scienc&#39;, 7),
 (&#39;servic&#39;, 7),
 (&#39;novel&#39;, 7),
 (&#39;oper&#39;, 6),
 (&#39;automot&#39;, 6),
 (&#39;crc&#39;, 6),
 (&#39;microarray&#39;, 6),
 (&#39;peptid&#39;, 6),
 (&#39;week&#39;, 6),
 (&#39;optim&#39;, 6),
 (&#39;synthesi&#39;, 6),
 (&#39;bioinformat&#39;, 6),
 (&#39;prepar&#39;, 6),
 (&#39;profil&#39;, 6),
 (&#39;qualiti&#39;, 6),
 (&#39;transgen&#39;, 6),
 (&#39;compound&#39;, 6),
 (&#39;virtual&#39;, 6),
 (&#39;record&#39;, 6),
 (&#39;predict&#39;, 6),
 (&#39;life&#39;, 6),
 (&#39;character&#39;, 6),
 (&#39;disord&#39;, 6),
 (&#39;materi&#39;, 6),
 (&#39;chain&#39;, 6),
 (&#39;softwar&#39;, 6),
 (&#39;factor&#39;, 6),
 (&#39;small&#39;, 6),
 (&#39;hiv&#39;, 6),
 (&#39;immunogen&#39;, 5),
 (&#39;resourc&#39;, 5),
 (&#39;audit&#39;, 5),
 (&#39;person&#39;, 5),
 (&#39;portfolio&#39;, 5),
 (&#39;statist&#39;, 5),
 (&#39;cn&#39;, 5),
 (&#39;advers&#39;, 5),
 (&#39;rnai&#39;, 5),
 (&#39;consum&#39;, 5),
 (&#39;futur&#39;, 5),
 (&#39;signal&#39;, 5),
 (&#39;pharmacolog&#39;, 5),
 (&#39;web&#39;, 5),
 (&#39;collabor&#39;, 5),
 (&#39;sourc&#39;, 5),
 (&#39;power&#39;, 5),
 (&#39;point&#39;, 5),
 (&#39;inspect&#39;, 5),
 (&#39;thing&#39;, 5),
 (&#39;pediatr&#39;, 5),
 (&#39;outcom&#39;, 5),
 (&#39;hipaa&#39;, 5),
 (&#39;team&#39;, 5),
 (&#39;select&#39;, 5),
 (&#39;industri&#39;, 5),
 (&#39;purif&#39;, 5),
 (&#39;storag&#39;, 5),
 (&#39;tumor&#39;, 5),
 (&#39;suppli&#39;, 5),
 (&#39;mass&#39;, 5),
 (&#39;content&#39;, 4),
 (&#39;kinas&#39;, 4),
 (&#39;biobank&#39;, 4),
 (&#39;structur&#39;, 4),
 (&#39;pcr&#39;, 4),
 (&#39;refer&#39;, 4),
 (&#39;guid&#39;, 4),
 (&#39;introduct&#39;, 4),
 (&#39;librari&#39;, 4),
 (&#39;A&#39;, 4),
 (&#39;circul&#39;, 4),
 (&#39;conduct&#39;, 4),
 (&#39;file&#39;, 4),
 (&#39;nuclear&#39;, 4),
 (&#39;sampl&#39;, 4),
 (&#39;phage&#39;, 4),
 (&#39;display&#39;, 4),
 (&#39;cultur&#39;, 4),
 (&#39;real&#39;, 4),
 (&#39;adm&#39;, 4),
 (&#39;bridg&#39;, 4),
 (&#39;japan&#39;, 4),
 (&#39;event&#39;, 4),
 (&#39;laboratori&#39;, 4),
 (&#39;glp&#39;, 4),
 (&#39;essenti&#39;, 4),
 (&#39;combin&#39;, 4),
 (&#39;lead&#39;, 4),
 (&#39;chi&#39;, 4),
 (&#39;test&#39;, 4),
 (&#39;innov&#39;, 4),
 (&#39;case&#39;, 4),
 (&#39;compar&#39;, 4),
 (&#39;difficult&#39;, 4),
 (&#39;plan&#39;, 4),
 (&#39;epigenet&#39;, 4),
 (&#39;toxic&#39;, 4),
 (&#39;emerg&#39;, 4),
 (&#39;cardiovascular&#39;, 4),
 (&#39;meet&#39;, 4),
 (&#39;improv&#39;, 4),
 (&#39;perform&#39;, 4),
 (&#39;1&#39;, 4),
 (&#39;irb&#39;, 4),
 (&#39;artifici&#39;, 4),
 (&#39;flow&#39;, 4),
 (&#39;acid&#39;, 4),
 (&#39;molecul&#39;, 4),
 (&#39;interact&#39;, 4),
 (&#39;enzym&#39;, 4),
 (&#39;viru&#39;, 4),
 (&#39;insur&#39;, 4),
 (&#39;dot&#39;, 4),
 (&#39;patholog&#39;, 4),
 (&#39;peptalk&#39;, 3),
 (&#39;scope&#39;, 3),
 (&#39;bioproduct&#39;, 3),
 (&#39;peg&#39;, 3),
 (&#39;aabc&#39;, 3),
 (&#39;beginn&#39;, 3),
 (&#39;chang&#39;, 3),
 (&#39;beyond&#39;, 3),
 (&#39;strateg&#39;, 3),
 (&#39;sourcebook&#39;, 3),
 (&#39;oligonucleotid&#39;, 3),
 (&#39;prenat&#39;, 3),
 (&#39;dna&#39;, 3),
 (&#39;master&#39;, 3),
 (&#39;reson&#39;, 3),
 (&#39;overview&#39;, 3),
 (&#39;pharmaci&#39;, 3),
 (&#39;pharmacovigil&#39;, 3),
 (&#39;chip&#39;, 3),
 (&#39;intermedi&#39;, 3),
 (&#39;submiss&#39;, 3),
 (&#39;licens&#39;, 3),
 (&#39;coordin&#39;, 3),
 (&#39;india&#39;, 3),
 (&#39;divers&#39;, 3),
 (&#39;bispecif&#39;, 3),
 (&#39;govern&#39;, 3),
 (&#39;state&#39;, 3),
 (&#39;hardwar&#39;, 3),
 (&#39;sealant&#39;, 3),
 (&#39;use&#39;, 3),
 (&#39;reimburs&#39;, 3),
 (&#39;label&#39;, 3),
 (&#39;cellular&#39;, 3),
 (&#39;effect&#39;, 3),
 (&#39;east&#39;, 3),
 (&#39;standard&#39;, 3),
 (&#39;interfer&#39;, 3),
 (&#39;protocol&#39;, 3),
 (&#39;toxicolog&#39;, 3),
 (&#39;pipelin&#39;, 3),
 (&#39;success&#39;, 3),
 (&#39;pharmacokinet&#39;, 3),
 (&#39;captur&#39;, 3),
 (&#39;hybrid&#39;, 3),
 (&#39;variat&#39;, 3),
 (&#39;initi&#39;, 3),
 (&#39;chemic&#39;, 3),
 (&#39;conjug&#39;, 3),
 (&#39;consent&#39;, 3),
 (&#39;monoclon&#39;, 3),
 (&#39;negoti&#39;, 3),
 (&#39;registri&#39;, 3),
 (&#39;intern&#39;, 3),
 (&#39;Up&#39;, 3),
 (&#39;bioanalysi&#39;, 3),
 (&#39;mine&#39;, 3),
 (&#39;feasibl&#39;, 3),
 (&#39;sponsor&#39;, 3),
 (&#39;valu&#39;, 3),
 (&#39;updat&#39;, 3),
 (&#39;101&#39;, 3),
 (&#39;surviv&#39;, 3),
 (&#39;financ&#39;, 3),
 (&#39;3&#39;, 3),
 (&#39;deal&#39;, 3),
 (&#39;subject&#39;, 3),
 (&#39;ubiquitin&#39;, 3),
 (&#39;central&#39;, 3),
 (&#39;relationship&#39;, 3),
 (&#39;pain&#39;, 3),
 (&#39;current&#39;, 3),
 (&#39;diabet&#39;, 3),
 (&#39;hepat&#39;, 3),
 (&#39;big&#39;, 3),
 (&#39;facilit&#39;, 3),
 (&#39;outsourc&#39;, 3),
 (&#39;microbiom&#39;, 3),
 (&#39;key&#39;, 3),
 (&#39;resist&#39;, 3),
 (&#39;simul&#39;, 3),
 (&#39;next-gener&#39;, 3),
 (&#39;keyword&#39;, 3),
 (&#39;affin&#39;, 3),
 (&#39;enterpris&#39;, 3),
 (&#39;ethic&#39;, 3),
 (&#39;activ&#39;, 3),
 (&#39;stationari&#39;, 3),
 (&#39;databas&#39;, 3),
 (&#39;intellectu&#39;, 3),
 (&#39;properti&#39;, 3),
 (&#39;transplant&#39;, 3),
 (&#39;continu&#39;, 3),
 (&#39;biospecimen&#39;, 3),
 (&#39;antigen&#39;, 3),
 (&#39;solut&#39;, 3),
 (&#39;secur&#39;, 3),
 (&#39;platform&#39;, 3),
 (&#39;prevent&#39;, 3),
 (&#39;healthcar&#39;, 3),
 (&#39;financi&#39;, 3),
 (&#39;well&#39;, 3),
 (&#39;growth&#39;, 3),
 (&#39;identif&#39;, 3),
 (&#39;spec&#39;, 3),
 (&#39;pge&#39;, 3),
 (&#39;media&#39;, 3),
 (&#39;aggreg&#39;, 3),
 (&#39;pcg&#39;, 3),
 (&#39;membran&#39;, 3),
 (&#39;phenotyp&#39;, 3),
 (&#39;tri&#39;, 2),
 (&#39;control&#39;, 2),
 (&#39;driven&#39;, 2),
 (&#39;alloc&#39;, 2),
 (&#39;enabl&#39;, 2),
 (&#39;estat&#39;, 2),
 (&#39;wpc&#39;, 2),
 (&#39;comprehens&#39;, 2),
 (&#39;bacteri&#39;, 2),
 (&#39;Q&#39;, 2),
 (&#39;asap&#39;, 2),
 (&#39;leadership&#39;, 2),
 (&#39;cell-fre&#39;, 2),
 (&#39;biomem&#39;, 2),
 (&#39;magnet&#39;, 2),
 (&#39;ind&#39;, 2),
 (&#39;[&#39;, 2),
 (&#39;]&#39;, 2),
 (&#39;green&#39;, 2),
 (&#39;repurpos&#39;, 2),
 (&#39;the&#39;, 2),
 (&#39;cours&#39;, 2),
 (&#39;requir&#39;, 2),
 (&#39;cro&#39;, 2),
 (&#39;-&#39;, 2),
 (&#39;mechan&#39;, 2),
 (&#39;impact&#39;, 2),
 (&#39;budget&#39;, 2),
 (&#39;contract&#39;, 2),
 (&#39;proof&#39;, 2),
 (&#39;concept&#39;, 2),
 (&#39;resolut&#39;, 2),
 (&#39;rule&#39;, 2),
 (&#39;hca&#39;, 2),
 (&#39;formerli&#39;, 2),
 (&#39;form&#39;, 2),
 (&#39;code&#39;, 2),
 (&#39;associ&#39;, 2),
 (&#39;gpcr&#39;, 2),
 (&#39;symyx&#39;, 2),
 (&#39;book&#39;, 2),
 (&#39;diagnosi&#39;, 2),
 (&#39;coast&#39;, 2),
 (&#39;formul&#39;, 2),
 (&#39;biofuel&#39;, 2),
 (&#39;I&#39;, 2),
 (&#39;reduct&#39;, 2),
 (&#39;antibody-drug&#39;, 2),
 (&#39;verif&#39;, 2),
 (&#39;attrit&#39;, 2),
 (&#39;vendor&#39;, 2),
 (&#39;yeast&#39;, 2),
 (&#39;critic&#39;, 2),
 (&#39;decis&#39;, 2),
 (&#39;conflict&#39;, 2),
 (&#39;action&#39;, 2),
 (&#39;defici&#39;, 2),
 (&#39;fraud&#39;, 2),
 (&#39;crop&#39;, 2),
 (&#39;biosensor&#39;, 2),
 (&#39;center&#39;, 2),
 (&#39;procedur&#39;, 2),
 (&#39;region&#39;, 2),
 (&#39;microbi&#39;, 2),
 (&#39;kit&#39;, 2),
 (&#39;newslett&#39;, 2),
 (&#39;sclerosi&#39;, 2),
 (&#39;best&#39;, 2),
 (&#39;personnel&#39;, 2),
 (&#39;maintain&#39;, 2),
 (&#39;EU&#39;, 2),
 (&#39;cta&#39;, 2),
 (&#39;price&#39;, 2),
 (&#39;account&#39;, 2),
 (&#39;cost&#39;, 2),
 (&#39;cross&#39;, 2),
 (&#39;oversight&#39;, 2),
 (&#39;guidanc&#39;, 2),
 (&#39;cycl&#39;, 2),
 (&#39;chronic&#39;, 2),
 (&#39;role&#39;, 2),
 (&#39;efficaci&#39;, 2),
 (&#39;viral&#39;, 2),
 (&#39;heal&#39;, 2),
 (&#39;assess&#39;, 2),
 (&#39;direct&#39;, 2),
 (&#39;bone&#39;, 2),
 (&#39;board&#39;, 2),
 (&#39;leader&#39;, 2),
 (&#39;multi&#39;, 2),
 (&#39;present&#39;, 2),
 (&#39;3D&#39;, 2),
 (&#39;list&#39;, 2),
 (&#39;inhibitor&#39;, 2),
 (&#39;reaction&#39;, 2),
 (&#39;fragment&#39;, 2),
 (&#39;agricultur&#39;, 2),
 (&#39;custom&#39;, 2),
 (&#39;assist&#39;, 2),
 (&#39;machin&#39;, 2),
 (&#39;learn&#39;, 2),
 (&#39;post&#39;, 2),
 (&#39;edg&#39;, 2),
 (&#39;cognit&#39;, 2),
 (&#39;alloster&#39;, 2),
 (&#39;altern&#39;, 2),
 (&#39;apoptosi&#39;, 2),
 (&#39;US&#39;, 2),
 (&#39;brain&#39;, 2),
 (&#39;cheminformat&#39;, 2),
 (&#39;treatment&#39;, 2),
 (&#39;E&#39;, 2),
 (&#39;alert&#39;, 2),
 (&#39;econom&#39;, 2),
 (&#39;solid&#39;, 2),
 (&#39;host&#39;, 2),
 (&#39;singl&#39;, 2),
 (&#39;ventur&#39;, 2),
 (&#39;chimer&#39;, 2),
 (&#39;consider&#39;, 2),
 (&#39;educ&#39;, 2),
 (&#39;marker&#39;, 2),
 (&#39;interview&#39;, 2),
 (&#39;mammalian&#39;, 2),
 (&#39;Re&#39;, 2),
 (&#39;video&#39;, 2),
 (&#39;cytokin&#39;, 2),
 (&#39;downstream&#39;, 2),
 (&#39;transport&#39;, 2),
 (&#39;util&#39;, 2),
 (&#39;adopt&#39;, 2),
 (&#39;autom&#39;, 2),
 (&#39;ebola&#39;, 2),
 (&#39;ectd&#39;, 2),
 (&#39;vehicl&#39;, 2),
 (&#39;fibrin&#39;, 2),
 (&#39;food&#39;, 2),
 (&#39;websit&#39;, 2),
 (&#39;gap&#39;, 2),
 (&#39;channel&#39;, 2),
 (&#39;vector&#39;, 2),
 (&#39;email&#39;, 2),
 (&#39;edit&#39;, 2),
 (&#39;knockout&#39;, 2),
 (&#39;genotyp&#39;, 2),
 (&#39;hormon&#39;, 2),
 (&#39;legal&#39;, 2),
 (&#39;multidrug&#39;, 2),
 (&#39;basic&#39;, 2),
 (&#39;spectrometri&#39;, 2),
 (&#39;matrix&#39;, 2),
 (&#39;natur&#39;, 2),
 (&#39;network&#39;, 2),
 (&#39;smart&#39;, 2),
 (&#39;build&#39;, 2),
 (&#39;oncogen&#39;, 2),
 (&#39;oligo&#39;, 2),
 (&#39;platelet&#39;, 2),
 (&#39;deriv&#39;, 2),
 (&#39;IV&#39;, 2),
 (&#39;quantif&#39;, 2),
 (&#39;public&#39;, 2),
 (&#39;rbe&#39;, 2),
 (&#39;robot&#39;, 2),
 (&#39;indic&#39;, 2),
 (&#39;synthet&#39;, 2),
 (&#39;plant&#39;, 2),
 (&#39;upcom&#39;, 2),
 (&#39;opportun&#39;, 2),
 (&#39;biocomput&#39;, 1),
 (&#39;florida&#39;, 1),
 (&#39;biopharmaceut&#39;, 1),
 (&#39;imvac&#39;, 1),
 (&#39;marketplac&#39;, 1),
 (&#39;acceler&#39;, 1),
 (&#39;X&#39;, 1),
 (&#39;gen&#39;, 1),
 (&#39;biodefens&#39;, 1),
 (&#39;poc&#39;, 1),
 (&#39;quantit&#39;, 1),
 (&#39;techniqu&#39;, 1),
 (&#39;question&#39;, 1),
 (&#39;answer&#39;, 1),
 (&#39;cfr/ich&#39;, 1),
 (&#39;amplif&#39;, 1),
 (&#39;microrna&#39;, 1),
 (&#39;intelliig&#39;, 1),
 (&#39;get&#39;, 1),
 (&#39;transmiss&#39;, 1),
 (&#39;spongiform&#39;, 1),
 (&#39;encephalopathi&#39;, 1),
 (&#39;tse&#39;, 1),
 (&#39;bioterror&#39;, 1),
 (&#39;under&#39;, 1),
 (&#39;ich&#39;, 1),
 (&#39;nmr&#39;, 1),
 (&#39;cellut&#39;, 1),
 (&#39;silico&#39;, 1),
 (&#39;condit&#39;, 1),
 (&#39;quantfic&#39;, 1),
 (&#39;time&#39;, 1),
 (&#39;from&#39;, 1),
 (&#39;multius&#39;, 1),
 (&#39;fluoresc&#39;, 1),
 (&#39;glycotechnolog&#39;, 1),
 (&#39;baculoviru&#39;, 1),
 (&#39;work&#39;, 1),
 (&#39;expedit&#39;, 1),
 (&#39;one&#39;, 1),
 (&#39;day&#39;, 1),
 (&#39;note&#39;, 1),
 (&#39;korea&#39;, 1),
 (&#39;pathway&#39;, 1),
 (&#39;diagnot&#39;, 1),
 (&#39;china&#39;, 1),
 (&#39;1-7&#39;, 1),
 (&#39;pharm&#39;, 1),
 (&#39;forens&#39;, 1),
 (&#39;10&#39;, 1),
 (&#39;pharmacogenom&#39;, 1),
 (&#39;explor&#39;, 1),
 (&#39;proce&#39;, 1),
 (&#39;adapt&#39;, 1),
 (&#39;visual&#39;, 1),
 (&#39;interfac&#39;, 1),
 (&#39;arena&#39;, 1),
 (&#39;administr&#39;, 1),
 (&#39;support&#39;, 1),
 (&#39;staff&#39;, 1),
 (&#39;pre-implant&#39;, 1),
 (&#39;eyesight&#39;, 1),
 (&#39;symposia&#39;, 1),
 (&#39;neglect&#39;, 1),
 (&#39;feder&#39;, 1),
 (&#39;G&#39;, 1),
 (&#39;coupl&#39;, 1),
 (&#39;mitochondria&#39;, 1),
 (&#39;lithium&#39;, 1),
 (&#39;burril&#39;, 1),
 (&#39;bio-it&#39;, 1),
 (&#39;safety/tox&#39;, 1),
 (&#39;root&#39;, 1),
 (&#39;caus&#39;, 1),
 (&#39;latin&#39;, 1),
 (&#39;america&#39;, 1),
 (&#39;method&#39;, 1),
 (&#39;chips/array&#39;, 1),
 (&#39;pop&#39;, 1),
 (&#39;deviat&#39;, 1),
 (&#39;recogn&#39;, 1),
 (&#39;earlier&#39;, 1),
 (&#39;physic&#39;, 1),
 (&#39;toll&#39;, 1),
 (&#39;like&#39;, 1),
 (&#39;innat&#39;, 1),
 (&#39;cnp&#39;, 1),
 (&#39;nanotechnolog&#39;, 1),
 (&#39;recist&#39;, 1),
 (&#39;1.0&#39;, 1),
 (&#39;1.1&#39;, 1),
 (&#39;microfluid&#39;, 1),
 (&#39;idiosyncrat&#39;, 1),
 (&#39;bioresearch&#39;, 1),
 (&#39;cryobiolog&#39;, 1),
 (&#39;transduct&#39;, 1),
 (&#39;compani&#39;, 1),
 (&#39;correct&#39;, 1),
 (&#39;respons&#39;, 1),
 (&#39;biosimilar&#39;, 1),
 (&#39;dealmak&#39;, 1),
 (&#39;program&#39;, 1),
 (&#39;glossari&#39;, 1),
 (&#39;acronym&#39;, 1),
 (&#39;profit&#39;, 1),
 (&#39;princip&#39;, 1),
 (&#39;orthoped&#39;, 1),
 (&#39;start&#39;, 1),
 (&#39;fold&#39;, 1),
 (&#39;popul&#39;, 1),
 (&#39;autonom&#39;, 1),
 (&#39;drive&#39;, 1),
 (&#39;metric&#39;, 1),
 (&#39;non-compli&#39;, 1),
 (&#39;array&#39;, 1),
 (&#39;maxim&#39;, 1),
 (&#39;terminalog&#39;, 1),
 (&#39;brochur&#39;, 1),
 (&#39;sunshin&#39;, 1),
 (&#39;act&#39;, 1),
 (&#39;facili&#39;, 1),
 (&#39;recent&#39;, 1),
 (&#39;trend&#39;, 1),
 (&#39;noncompli&#39;, 1),
 (&#39;brief&#39;, 1),
 (&#39;mamang&#39;, 1),
 (&#39;extracellular&#39;, 1),
 (&#39;start-up&#39;, 1),
 (&#39;web-bas&#39;, 1),
 (&#39;relationship/perform&#39;, 1),
 (&#39;multipl&#39;, 1),
 (&#39;iii&#39;, 1),
 (&#39;/forecast&#39;, 1),
 (&#39;canada&#39;, 1),
 (&#39;tick&#39;, 1),
 (&#39;born&#39;, 1),
 (&#39;orphan&#39;, 1),
 (&#39;orthopaed&#39;, 1),
 (&#39;engag&#39;, 1),
 (&#39;No&#39;, 1),
 (&#39;warn&#39;, 1),
 (&#39;letter&#39;, 1),
 (&#39;observ&#39;, 1),
 (&#39;nervou&#39;, 1),
 (&#39;sop&#39;, 1),
 (&#39;2.0&#39;, 1),
 (&#39;understand&#39;, 1),
 (&#39;draft&#39;, 1),
 (&#39;regard&#39;, 1),
 (&#39;supervisori&#39;, 1),
 (&#39;repon&#39;, 1),
 (&#39;sponsors/cro&#39;, 1),
 (&#39;ehealth&#39;, 1),
 (&#39;propos&#39;, 1),
 (&#39;2010&#39;, 1),
 (&#39;teambuild&#39;, 1),
 (&#39;foreign&#39;, 1),
 (&#39;venu&#39;, 1),
 (&#39;II&#39;, 1),
 (&#39;wheel&#39;, 1),
 (&#39;particip&#39;, 1),
 (&#39;protect&#39;, 1),
 (&#39;role/respons&#39;, 1),
 (&#39;women&#39;, 1),
 (&#39;510k&#39;, 1),
 (&#39;boston&#39;, 1),
 (&#39;european&#39;, 1),
 (&#39;union&#39;, 1),
 (&#39;regen&#39;, 1),
 (&#39;coronaviru&#39;, 1),
 (&#39;liver&#39;, 1),
 (&#39;acceleart&#39;, 1),
 (&#39;nonclin&#39;, 1),
 (&#39;toxiciolog&#39;, 1),
 (&#39;excel&#39;, 1),
 (&#39;spreadsheets-step&#39;, 1),
 (&#39;step&#39;, 1),
 (&#39;instruct&#39;, 1),
 (&#39;upgrad&#39;, 1),
 (&#39;autoimmun&#39;, 1),
 (&#39;anticoagul&#39;, 1),
 (&#39;newborn&#39;, 1),
 (&#39;allergi&#39;, 1),
 (&#39;institut&#39;, 1),
 (&#39;review&#39;, 1),
 (&#39;opinion&#39;, 1),
 (&#39;obstruct&#39;, 1),
 (&#39;pulmonari&#39;, 1),
 (&#39;lupu&#39;, 1),
 (&#39;PI&#39;, 1),
 (&#39;21&#39;, 1),
 (&#39;cfr&#39;, 1),
 (&#39;11&#39;, 1),
 (&#39;signatur&#39;, 1),
 (&#39;chiral&#39;, 1),
 (&#39;intro&#39;, 1),
 (&#39;gastrointestin&#39;, 1),
 (&#39;inflamm&#39;, 1),
 (&#39;member&#39;, 1),
 (&#39;mobil&#39;, 1),
 (&#39;wearabl&#39;, 1),
 (&#39;postmarket&#39;, 1),
 (&#39;vigil&#39;, 1),
 (&#39;blockchain&#39;, 1),
 (&#39;alzheim&#39;, 1),
 (&#39;gxp&#39;, 1),
 (&#39;canadian&#39;, 1),
 (&#39;print&#39;, 1),
 (&#39;gather&#39;, 1),
 (&#39;respiratori&#39;, 1),
 (&#39;five&#39;, 1),
 (&#39;cot&#39;, 1),
 (&#39;open&#39;, 1),
 (&#39;fibrosis/scar&#39;, 1),
 (&#39;dummi&#39;, 1),
 (&#39;DE&#39;, 1),
 (&#39;w/more&#39;, 1),
 (&#39;1572&#39;, 1),
 (&#39;antisens&#39;, 1),
 (&#39;orgniz&#39;, 1),
 (&#39;ace&#39;, 1),
 (&#39;attent&#39;, 1),
 (&#39;deficit&#39;, 1),
 (&#39;hyperact&#39;, 1),
 (&#39;adjuv&#39;, 1),
 (&#39;admet&#39;, 1),
 (&#39;aerospac&#39;, 1),
 (&#39;afford&#39;, 1),
 (&#39;separ&#39;, 1),
 (&#39;age&#39;, 1),
 (&#39;farm&#39;, 1),
 (&#39;angiogenesi&#39;, 1),
 (&#39;bot&#39;, 1),
 (&#39;implement&#39;, 1),
 (&#39;cut&#39;, 1),
 (&#39;modul&#39;, 1),
 (&#39;amyotroph&#39;, 1),
 (&#39;later&#39;, 1),
 (&#39;asset&#39;, 1),
 (&#39;angina&#39;, 1),
 (&#39;anxieti&#39;, 1),
 (&#39;ingredi&#39;, 1),
 (&#39;anti&#39;, 1),
 (&#39;psychot&#39;, 1),
 (&#39;Rx&#39;, 1),
 (&#39;arrhythmia&#39;, 1),
 (&#39;antagon&#39;, 1),
 (&#39;primari&#39;, 1),
 (&#39;quantifi&#39;, 1),
 (&#39;agon&#39;, 1),
 (&#39;asthma&#39;, 1),
 (&#39;atherosclerosi&#39;, 1),
 (&#39;autophagi&#39;, 1),
 (&#39;autism&#39;, 1),
 (&#39;advisori&#39;, 1),
 (&#39;defens&#39;, 1),
 (&#39;flexibl&#39;, 1),
 (&#39;bayesian&#39;, 1),
 (&#39;barrier&#39;, 1),
 (&#39;bioit&#39;, 1),
 (&#39;charg&#39;, 1),
 (&#39;breast&#39;, 1),
 (&#39;backup&#39;, 1),
 (&#39;biodivers&#39;, 1),
 (&#39;biogener&#39;, 1),
 (&#39;biomateri&#39;, 1),
 (&#39;monthli&#39;, 1),
 (&#39;magazin&#39;, 1),
 (&#39;weekli&#39;, 1),
 (&#39;bookstor&#39;, 1),
 (&#39;biopharm&#39;, 1),
 (&#39;biolaw&#39;, 1),
 (&#39;high-througput&#39;, 1),
 (&#39;screen-bas&#39;, 1),
 (&#39;machineri&#39;, 1),
 (&#39;think&#39;, 1),
 (&#39;tank&#39;, 1),
 (&#39;recycl&#39;, 1),
 (&#39;revers&#39;, 1),
 (&#39;marrow&#39;, 1),
 (&#39;logist&#39;, 1),
 (&#39;era&#39;, 1),
 (&#39;biopurif&#39;, 1),
 (&#39;bioreactor&#39;, 1),
 (&#39;raw&#39;, 1),
 (&#39;biotherapeut&#39;, 1),
 (&#39;ship&#39;, 1),
 (&#39;biosepar&#39;, 1),
 (&#39;biostabil&#39;, 1),
 (&#39;biomanufactur&#39;, 1),
 (&#39;bioassay&#39;, 1),
 (&#39;commerci&#39;, 1),
 (&#39;sci/tech&#39;, 1),
 (&#39;artif&#39;, 1),
 (&#39;adhes&#39;, 1),
 (&#39;canda&#39;, 1),
 (&#39;catalysi&#39;, 1),
 (&#39;cmc&#39;, 1),
 (&#39;cord&#39;, 1),
 (&#39;cold&#39;, 1),
 (&#39;colorect&#39;, 1),
 (&#39;co-develop&#39;, 1),
 (&#39;histori&#39;, 1),
 (&#39;clean&#39;, 1),
 (&#39;tech&#39;, 1),
 (&#39;solar&#39;, 1),
 (&#39;wind&#39;, 1),
 (&#39;unit&#39;, 1),
 (&#39;congest&#39;, 1),
 (&#39;heart&#39;, 1),
 (&#39;failur&#39;, 1),
 (&#39;chines&#39;, 1),
 (&#39;hamster&#39;, 1),
 (&#39;ovari&#39;, 1),
 (&#39;interest&#39;, 1),
 (&#39;competit&#39;, 1),
 (&#39;celiac&#39;, 1),
 (&#39;extens&#39;, 1),
 (&#39;commun&#39;, 1),
 (&#39;miscellan&#39;, 1),
 (&#39;genetics/genom&#39;, 1),
 (&#39;counterfeit&#39;, 1),
 (&#39;copi&#39;, 1),
 (&#39;number&#39;, 1),
 (&#39;compon&#39;, 1),
 (&#39;capillari&#39;, 1),
 (&#39;electrophoresi&#39;, 1),
 (&#39;prognost&#39;, 1),
 (&#39;plasma&#39;, 1),
 (&#39;vision&#39;, 1),
 (&#39;8&#39;, 1),
 (&#39;fundament&#39;, 1),
 (&#39;w/o&#39;, 1),
 (&#39;increas&#39;, 1),
 (&#39;drug-devic&#39;, 1),
 (&#39;coloni&#39;, 1),
 (&#39;stimul&#39;, 1),
 (&#39;countri&#39;, 1),
 (&#39;cybersecur&#39;, 1),
 (&#39;eclin&#39;, 1),
 (&#39;discover&#39;, 1),
 (&#39;eastern&#39;, 1),
 (&#39;manual&#39;, 1),
 (&#39;cardiotox&#39;, 1),
 (&#39;queri&#39;, 1),
 (&#39;creation&#39;, 1),
 (&#39;segment&#39;, 1),
 (&#39;neoantigen&#39;, 1),
 (&#39;cardio&#39;, 1),
 (&#39;antagonist&#39;, 1),
 (&#39;cystic&#39;, 1),
 (&#39;fibrosi&#39;, 1),
 (&#39;cytogenet&#39;, 1),
 (&#39;db&#39;, 1),
 (&#39;map&#39;, 1),
 (&#39;dental&#39;, 1),
 (&#39;depress&#39;, 1),
 (&#39;non&#39;, 1),
 (&#39;abus&#39;, 1),
 (&#39;duchenn&#39;, 1),
 (&#39;muscular&#39;, 1),
 (&#39;dystrophi&#39;, 1),
 (&#39;repair&#39;, 1),
 (&#39;orient&#39;, 1),
 (&#39;perspect&#39;, 1),
 (&#39;dose&#39;, 1),
 (&#39;science/analyt&#39;, 1),
 (&#39;twin&#39;, 1),
 (&#39;companion&#39;, 1),
 (&#39;Dx&#39;, 1),
 (&#39;immunoassay&#39;, 1),
 (&#39;hear&#39;, 1),
 (&#39;evid&#39;, 1),
 (&#39;ecapacitor&#39;, 1),
 (&#39;electrochemistri&#39;, 1),
 (&#39;coli&#39;, 1),
 (&#39;encod&#39;, 1),
 (&#39;ecommerc&#39;, 1),
 (&#39;disinfect&#39;, 1),
 (&#39;earli&#39;, 1),
 (&#39;notebook&#39;, 1),
 (&#39;endothelium&#39;, 1),
 (&#39;entertain&#39;, 1),
 (&#39;environ&#39;, 1),
 (&#39;epidemiolog&#39;, 1),
 (&#39;epilepsi&#39;, 1),
 (&#39;reader&#39;, 1),
 (&#39;examin&#39;, 1),
 (&#39;transfer&#39;, 1),
 (&#39;electr&#39;, 1),
 (&#39;experiment&#39;, 1),
 (&#39;exhibitor&#39;, 1),
 (&#39;extractables/leach&#39;, 1),
 (&#39;exosom&#39;, 1),
 (&#39;exom&#39;, 1),
 (&#39;analyst&#39;, 1),
 (&#39;hackathon&#39;, 1),
 (&#39;obes&#39;, 1),
 (&#39;franc&#39;, 1),
 (&#39;fine&#39;, 1),
 (&#39;disclosur&#39;, 1),
 (&#39;surfac&#39;, 1),
 (&#39;plasmon&#39;, 1),
 (&#39;cytometri&#39;, 1),
 (&#39;influenza&#39;, 1),
 (&#39;fintech&#39;, 1),
 (&#39;fertil&#39;, 1),
 (&#39;fast&#39;, 1),
 (&#39;fungal&#39;, 1),
 (&#39;follow&#39;, 1),
 (&#39;gamif&#39;, 1),
 (&#39;junction&#39;, 1),
 (&#39;onli&#39;, 1),
 (&#39;link&#39;, 1),
 (&#39;precis&#39;, 1),
 (&#39;introductori&#39;, 1),
 (&#39;mutat&#39;, 1),
 (&#39;probe&#39;, 1),
 (&#39;grid&#39;, 1),
 (&#39;provid&#39;, 1),
 (&#39;gtpase&#39;, 1),
 (&#39;town&#39;, 1),
 (&#39;pass&#39;, 1),
 (&#39;transcript&#39;, 1),
 (&#39;whole&#39;, 1),
 (&#39;beauti&#39;, 1),
 (&#39;aid&#39;, 1),
 (&#39;B&#39;, 1),
 (&#39;hematolog&#39;, 1),
 (&#39;C&#39;, 1),
 (&#39;heterocycl&#39;, 1),
 (&#39;hdac&#39;, 1),
 (&#39;histon&#39;, 1),
 (&#39;demethylas&#39;, 1),
 (&#39;hematopoesi&#39;, 1),
 (&#39;heat&#39;, 1),
 (&#39;shock&#39;, 1),
 (&#39;mainten&#39;, 1),
 (&#39;huntington&#39;, 1),
 (&#39;#&#39;, 1),
 (&#39;papilloma&#39;, 1),
 (&#39;homolog&#39;, 1),
 (&#39;relat&#39;, 1),
 (&#39;herp&#39;, 1),
 (&#39;surrog&#39;, 1),
 (&#39;hit&#39;, 1),
 (&#39;hepatotox&#39;, 1),
 (&#39;hypertens&#39;, 1),
 (&#39;inflammatori&#39;, 1),
 (&#39;bowel&#39;, 1),
 (&#39;contrast&#39;, 1),
 (&#39;agent&#39;, 1),
 (&#39;interleukin&#39;, 1),
 (&#39;convert&#39;, 1),
 (&#39;ice&#39;, 1),
 (&#39;fluidic&#39;, 1),
 (&#39;circuit&#39;, 1),
 (&#39;complement-bas&#39;, 1),
 (&#39;immunomodul&#39;, 1),
 ...]</pre>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[58]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="kn">import</span> <span class="nn">pandas</span> <span class="k">as</span> <span class="nn">pd</span>
<span class="kn">from</span> <span class="nn">nltk.probability</span> <span class="k">import</span> <span class="n">FreqDist</span>
<span class="n">fdist</span> <span class="o">=</span> <span class="n">FreqDist</span><span class="p">(</span><span class="n">stemmed_words</span><span class="p">)</span>  
<span class="n">df_fdist</span> <span class="o">=</span> <span class="n">pd</span><span class="o">.</span><span class="n">DataFrame</span><span class="o">.</span><span class="n">from_dict</span><span class="p">(</span><span class="n">fdist</span><span class="p">,</span> <span class="n">orient</span><span class="o">=</span><span class="s1">&#39;index&#39;</span><span class="p">)</span>
<span class="n">df_fdist</span><span class="o">.</span><span class="n">columns</span> <span class="o">=</span> <span class="p">[</span><span class="s1">&#39;Frequency&#39;</span><span class="p">]</span>
<span class="n">df_fdist</span><span class="o">.</span><span class="n">index</span><span class="o">.</span><span class="n">name</span> <span class="o">=</span> <span class="s1">&#39;Term&#39;</span>
<span class="nb">print</span><span class="p">(</span><span class="n">df_fdist</span><span class="p">)</span>
<span class="n">df_fdist</span><span class="o">.</span><span class="n">to_csv</span><span class="p">(</span><span class="sa">r</span><span class="s2">&quot;C:\Users\vmohite\Desktop\Upload\Tokens.csv&quot;</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>                Frequency
Term                     
molecular              28
medicin                21
tri                     2
confer                 13
protein                61
engin                  18
peptalk                 3
biocomput               1
scope                   3
summit                 18
clinic                123
trial                  52
oper                    6
execut                 11
bioproduct              3
discoveri              29
target                 31
peg                     3
europ                  58
drug                   77
chemistri              13
world                  10
pharmaceut             11
congress                7
advanc                 18
diagnost               52
automot                 6
batteri                45
(                      24
aabc                    3
...                   ...
drug/diseas             1
suppressor              1
text                    1
unman                   1
aerial                  1
uninterrupt             1
upcom                   2
urinari                 1
incontin                1
usp                     1
unstabl                 1
triplet                 1
trinucleotid            1
repeat                  1
imt                     1
vascular                1
opportun                2
capit                   1
voic                    1
recognit                1
paperless               1
veterinari              1
realiti                 1
wiki                    1
wound                   1
wireless                1
mari                    1
chitti                  1
xenotransplant          1
zika                    1

[1262 rows x 1 columns]
</pre>
</div>
</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[48]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="kn">import</span> <span class="nn">matplotlib.pyplot</span> <span class="k">as</span> <span class="nn">plt</span>
<span class="n">fdist</span><span class="o">.</span><span class="n">plot</span><span class="p">(</span><span class="mi">25</span><span class="p">,</span><span class="n">cumulative</span><span class="o">=</span><span class="kc">False</span><span class="p">)</span>
<span class="n">plt</span><span class="o">.</span><span class="n">show</span><span class="p">()</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>




<div class="output_png output_subarea ">
<img src="data:image/png;base64,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
"
>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[&nbsp;]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span> 
</pre></div>

    </div>
</div>
</div>

</div>
    </div>
  </div>
</body>

 


</html>
